,compound_id,standard_inchi_key,compound_name,synonym,target_id,target_pref_name,gene_names,wildtype_or_mutant,mutation_info,pubmed_id,standard_type,standard_relation,standard_value,standard_units,ep_action_mode,assay_format,assaytype,assay_subtype,inhibitor_type,detection_tech,assay_cell_line,compound_concentration_value,compound_concentration_value_unit,substrate_type,substrate_relation,substrate_value,substrate_units,assay_description,title,journal,doc_type,annotation_comments
3893402,CHEMBL1449346,RJIDGRHOHFDKKB-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
2744924,CHEMBL1456303,MNIPKPBXCNYLLX-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2089192,CHEMBL1096032,JTTGRNWIRRFPKZ-UHFFFAOYSA-N,,,P11387,DNA TOPOISOMERASE I,TOP1,,,20392646.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Inhibition of human recombinant TOP1-mediated relaxation of supercoiled Escherichia coli pBR322 DNA at 20 uM after 30 mins by transillumination,"Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of hydroxylated 2,4-diphenyl-6-aryl pyridines.",Bioorg. Med. Chem.,PUBLICATION,
4126374,CHEMBL1721911,SJACXJCFCJVRHS-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3323555,CHEMBL1337862,OZBLYGXPDUZZSH-UHFFFAOYSA-N,,,P27467,PROTEIN WNT-3A,,,,,IC50,,8160.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose response validation of uHTS Gli-SUFU antagonist hits in a Wnt3a luminescent reporter assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3856586,CHEMBL1590408,RFIPNSBNUGWGCD-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3050116,CHEMBL1990248,NVFYHANSBCMKIF-SSDVNMTOSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
5257352,CHEMBL1416371,XVULUMKVYHUBOB-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5723459,CHEMBL1347553,ZUHUPNVZKHINMK-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
5041258,CHEMBL1302913,WYMJVURMLBGQIY-UHFFFAOYSA-M,,,O14924,REGULATOR OF G-PROTEIN SIGNALING 12,RGS12,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore). (Class of assay: confirmatory) [Related pubchem assays: 880 (qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore)), 879 (qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Green Fluorophore))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1044843,CHEMBL1591465,FIRGBYDRLDOESU-GZTJUZNOSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5536319,CHEMBL1306338,ZAARVYFQWAENCI-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
851317,CHEMBL3192135,DNVDAFYAUXUSPD-HZHRSRAPSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,5173.5,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3820728,CHEMBL1599605,RBNZTCQQYDIQKV-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4274844,CHEMBL202661,SZRNKXYBFFECAE-UHFFFAOYSA-N,,,Q9N1N9,BUTYRYLCHOLINESTERASE,,,,16420031.0,IC50,=,15.0,NM,,,,,,,,,,,,,,Inhibition of BuChE from horse serum,"Novel tacrine-melatonin hybrids as dual-acting drugs for Alzheimer disease, with improved acetylcholinesterase inhibitory and antioxidant properties.",J. Med. Chem.,PUBLICATION,
3281036,CHEMBL447756,OUKULVHRQDUFNL-UHFFFAOYSA-N,,,P0A0J7,QUINOLONE RESISTANCE PROTEIN NORA,,,,21141825.0,INHIBITION,=,67.9,%,,,,,,,,,,,,,,Inhibition of NorA in Staphylococcus aureus 1199B assessed as reduction in ethidium bromide efflux at 50 uM by fluorimetry after 5 mins,Discovery of novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus.,J. Med. Chem.,PUBLICATION,
1814540,CHEMBL614,IPEHBUMCGVEMRF-UHFFFAOYSA-N,PYRAZINAMIDE,,P12530,ARACHIDONATE 15-LIPOXYGENASE,,,,,IC50,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DrugMatrix in vitro pharmacology data,,DATASET,
3390920,CHEMBL253851,PGUFJRICHTWPRF-NMSHJFGGSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,18255290.0,KI,=,618.0,NM,,,,,,,,,,,,,,Displacement of [3H]Rosiglitazone from human PPARgamma,"4,4-Dimethyl-1,2,3,4-tetrahydroquinoline-based PPARalpha/gamma agonists. Part I: synthesis and pharmacological evaluation.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3508511,CHEMBL1452132,PTJZCAZOEZCNSV-DHZHZOJOSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,3013.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
963982,CHEMBL598214,DZVNNLCYWPVJPN-UHFFFAOYSA-N,,,Q01726,MELANOCORTIN RECEPTOR 1,MC1R,,,20172734.0,EC50,=,1.58,NM,,cell_based,,,,,CHO,,,,,,,Agonist activity at human MC1R expressed in CHO cells after 4 hrs by luciferase reporter gene assay,"A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity.",Bioorg. Med. Chem.,PUBLICATION,
3982648,CHEMBL259398,RSZXSEGUKBAUIU-UHFFFAOYSA-N,,,P43490,NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE,NAMPT,,,24433859.0,IC50,=,13000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of full length C-terminal His6-tagged human NAMPT expressed in Escherichia coli Rosetta (DE3) cells using PRPP/NAM as substrate/cofactor preincubated for 15 mins followed by substrate/cofactor addition measured after 30 mins,Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).,Bioorg. Med. Chem. Lett.,PUBLICATION,
222967,CHEMBL31815,AWQLTDUXGVCRBV-UHFFFAOYSA-N,,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,,,10346932.0,IC50,=,2.2,NM,,cell_based,,,,,MDA-MB-453,,,,,,,Inhibition of heregulin-stimulated autophosphorylation of ERBB2 receptor kinase in MDA-MB-453 cells.,Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor.,J. Med. Chem.,PUBLICATION,
2578194,CHEMBL2145022,LUZAXXCMDSTBSM-LBNVMWSVSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1778.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1057164,CHEMBL430266,FKAWLXNLHHIHLA-YCBIHMBMSA-N,CALYCULIN A,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4281484,CHEMBL56543,TUCIOBMMDDOEMM-RIYZIHGNSA-N,AG-490,,P36507,DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 2,MAP2K2,wild_type,,22037377.0,ACTIVITY,=,104.6931656,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ERK(K52R) ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
1626495,CHEMBL2391482,HUQDZMOHVVJHEF-UHFFFAOYSA-N,,,P81908,CHOLINESTERASE,,,,23685572.0,IC50,=,4510.0,NM,,,,,,,,,,,,,,Inhibition of equine serum BChE using S-butyrylthiocholine iodide as substrate preincubated for 6 mins prior to substrate addition measured at 60 to 180 seconds by Ellman's method,"Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.",Eur. J. Med. Chem.,PUBLICATION,
1652607,CHEMBL1485134,HXLJNAMOSGLKND-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5562538,CHEMBL1373559,ZCPKWILBNRTFOF-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5532309,CHEMBL1201038,YZODJQFXMFEJRM-UHFFFAOYSA-N,ACRISORCIN,,P29466,CASPASE-1,CASP1,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
654426,CHEMBL1400664,CSTQSWOQMKSAFI-RMKNXTFCSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2554052,CHEMBL1378626,LSNOHYQIJSBYPH-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5089590,CHEMBL185710,XDQUYQKTDSDQRL-UHFFFAOYSA-N,SB-738561,,P24941,CYCLIN-DEPENDENT KINASE 2,CDK2,,,,INHIBITION,=,4.47,%,,,,,,,,,,,,,,GSK_PKIS: CDK2/cyclinA mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2231619,CHEMBL729,KJHKTHWMRKYKJE-SUGCFTRWSA-N,LOPINAVIR,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,17149864.0,KI,=,6.1,NM,,,,,,,,,,,,,,Inhibition of HIV1 protease L10I/G48V/I54V/L63P/V82A mutant,Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.,J. Med. Chem.,PUBLICATION,
1301574,CHEMBL2181541,GLBHDBKJJWTLPC-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,22916707.0,INHIBITION,,,,,cell_based,,,,,CHO,,,,,,,Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation using [3H]-cAMP at 1 uM after 5 mins by liquid scintillation counter relative to CP55940,7-Alkyl-3-benzylcoumarins: a versatile scaffold for the development of potent and selective cannabinoid receptor agonists and antagonists.,J. Med. Chem.,PUBLICATION,
4157400,CHEMBL1909410,SMQZLZAGBDDASN-ZHEQYFEDSA-N,GSK-259178A,,P07949,TYROSINE-PROTEIN KINASE RECEPTOR RET,RET,,,,INHIBITION,=,4.91,%,,,,,,,,,,,,,,GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
36816,CHEMBL540851,ACHKKGDWZVCSNH-UHFFFAOYSA-N,,,P10145,INTERLEUKIN-8,CXCL8,,,,POTENCY,,66824.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4467507,CHEMBL1490486,UOFYJYKABKOIPY-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,14575.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5794347,CHEMBL3729035,,,,Q16875,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 3",PFKFB3,,,,IC50,=,0.0,NM,,,,,,,,,,,,,,Inhibition of iPFK2 (unknown origin) assessed as reduction in enzyme-mediated fructose-6-phosphate phosphorylation by measuring NADH absorbance pre-incubated for 10 mins before ATP/substrate addition followed by incubation for 1 hr by UV-Visible spectrometry based iPFK-2/PPI-PFK coupled enzyme assay,Inhibitors of inducible form of 6-phosphofructose-2-kinase,,PATENT,
2964542,CHEMBL1412622,NLPSGIYLSFRILD-UHFFFAOYSA-N,,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3544407,CHEMBL85106,PXJKYEMXHIFINY-UHFFFAOYSA-N,3-CHLORORUTAECARPINE,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,12852960.0,IC50,=,29.0,NM,,,,,,,,,,,,,,Inhibition of Cytochrome P450 1A2 enzyme in bacterial membrane expressing human P450s,"Effect of structural modification on the inhibitory selectivity of rutaecarpine derivatives on human CYP1A1, CYP1A2, and CYP1B1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5665006,CHEMBL2036421,ZNXQLJCFXDOQIJ-UHFFFAOYSA-N,,,P28845,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,HSD11B1,,,,IC50,=,363.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Homogenous Time-Resolved Fluorescence (HTRF) Assay. The in vitro inhibitory activities of the novel compounds to human 11ß-HSD1 were evaluated in accordance with homogenous time-resolved fluorescence (HTRF). The human 11ß-HSD1 overexpressing cells were subcultured at the number of 2.5×104 cells in 96-well plate and stabilized for 24 hr. The cells in each well were incubated with 100 µl of medium containing 160 nM cortisone (Sigma) and diluted compound for 3 hr at 37° C. in an incubator. Then, samples of the medium (10 µl) were transferred to 384-well plate and the amounts of cortisol produced were measured using a cortisol kit (Cisbio international) in accordance with manufacturer's instruction. The control group was incubated with 160 nM cortisone and 0.1% DMSO.",Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt,,PATENT,
3648322,CHEMBL334275,QJGPDQXLXVZMSB-UHFFFAOYSA-N,,,P21556,PLATELET ACTIVATING FACTOR RECEPTOR,,,,7658438.0,IC50,=,0.5,NM,,,,,,,,,,,,,,Antagonistic activity was tested against Platelet-Activating Factor-induced aggregation of rabbit washed platelets.,"Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.",J. Med. Chem.,PUBLICATION,
3145745,CHEMBL1699632,OFSXQGMYQNKMEE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5691180,CHEMBL256835,ZQUSFAUAYSEREK-UHFFFAOYSA-N,,,Q9Y6M4,CASEIN KINASE I ISOFORM GAMMA-3,CSNK1G3,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3,PUBCHEM BIOASSAY DATA SET,,DATASET,
462540,CHEMBL424557,BXHCOGBRUYEEON-UHFFFAOYSA-N,,,"P22909, P19328, P22086",ADRENERGIC RECEPTOR ALPHA-2,,,,11262089.0,KI,=,1584.89,NM,,,,,,,,,,,,,,In vitro binding affinity against alpha-2 adrenergic receptor of rat in presence of [3H]-RX 821002 radioligand,Potential antidepressants displayed combined alpha(2)-adrenoceptor antagonist and monoamine uptake inhibitor properties.,J. Med. Chem.,PUBLICATION,
4756160,CHEMBL1410470,VTKLJXCBXOTXLU-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
681553,CHEMBL522709,CVLJBLIMHPEZJC-GFCCVEGCSA-N,GSK-317315A,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,INHIBITION,=,-1.45,%,,,,,,,,,,,,,,GSK_PKIS: EGFR (T790M mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1778568,CHEMBL1087760,ILLDAVHWKOCNHO-UHFFFAOYSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,20138760.0,INHIBITION,=,85.0,%,,,,,,,,,,,,,,Inhibition of human EGFR assessed as remaining enzyme activity at 10 uM,"Novel 6-N-arylcarboxamidopyrazolo[4,3-d]pyrimidin-7-one derivatives as potential anti-cancer agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4853552,CHEMBL1464316,WEAABOAXWGOJPX-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3134738,CHEMBL1477373,OEOBDIBAGJRHBM-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3625012,CHEMBL1404303,QGNHYAGRDGPFIP-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
1014126,CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2533810,CHEMBL1500566,LQDRDRPBNJRSBA-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1995.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4389863,CHEMBL3310818,UFYLDDGHOARTCT-UHFFFAOYSA-N,,,Q96EB6,NAD-DEPENDENT DEACETYLASE SIRTUIN 1,SIRT1,,,24880902.0,IC50,=,66600.0,NM,,,,,,,,,,,,,,Inhibition of hexa-His-tagged recombinant human SIRT1 expressed in Escherichia coli BL21(DE3) using AMC-labeled Arg-His-Lys-Lys(ac) as substrate assessed as inhibition of deacetylation of peptide after 45 mins by fluorescence assay,"Structure-activity relationship and interaction studies of new SIRT1 inhibitors with the scaffold of 3-(furan-2-yl)-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1210180,CHEMBL1401130,GBHJFOBQBDRBGL-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1641807,CHEMBL1398682,HWIWBBBQTXZASV-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,1000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
5475014,CHEMBL1627619,YTFBWWVIESDPNF-YWBWYGPRSA-N,,,P08842,STERYL-SULFATASE,STS,,,11087571.0,INHIBITION,=,86.0,%,,cell_based,,,,,,,,,,,,Inhibition of steroid sulfatase activity in JEG-3 cells at 20 uM as [3H]-E1-estrone formed from [3H]estrone sulfate,Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.,J. Med. Chem.,PUBLICATION,
3904285,CHEMBL3212735,RKMAFNOHYOPCMP-GIJQJNRQSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,3662.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
654157,CHEMBL3685440,CSSVZSHLVNYVMT-UHFFFAOYSA-N,,,Q9Y233,PHOSPHODIESTERASE 10A,PDE10A,,,,IC50,=,495.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Scintillation Proximity Assay. PDE10 activity of the compounds of the present invention was determined using a Scintillation Proximity Assay (SPA)-based method similar to the one previously described (Fawcett, L. et al., Proc Natl Acad Sci USA (2000) 97(7):3702-3707). The human PDE10A full length assay was performed in 96-well micro titer plates. The reaction mixture of 50 µl contained 20 mM HEPES pH=7.5/10 mM MgCl2/0.05 mg/ml BSA (Sigma cat. # A-7906), 50 nM cGMP (Sigma, cat. # G6129) and 50 nM [3H]-cGMP (GE Healthcare, cat. # TRK392 S.A. 13.2 Ci/mmol), 3.75 ng/well PDE10A enzyme (Enzo Life Science, Lausen, Switzerland cat #SE-534) with or without a specific test compound.",Nitrogen containing heteroaryl compounds,,PATENT,
5187107,CHEMBL1304204,XNYYNFJPXKHMHX-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,158.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1389999,CHEMBL1587804,GVDMPWQNNRNDOG-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2416436,CHEMBL2004871,LDNDTZTXPRCUJS-UHFFFAOYSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
2431284,CHEMBL206974,LFIFGNCFEBAIHA-JCOUAQLOSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,16686530.0,EMAX,=,56.0,%,,cell_based,,,,,,,,,,,,Activity against [35S]GTP-gamma-S binding to human delta opioid receptor expressed in HN9.10 cells,Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.,J. Med. Chem.,PUBLICATION,
196483,CHEMBL137692,ATSLCAISNROVSQ-UHFFFAOYSA-N,,,P08842,STERYL-SULFATASE,STS,,,12213072.0,IC50,=,403.0,NM,,,,,,,,,,,,,,Inhibitory activity against purified human steroid sulfatase (STS),2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.,J. Med. Chem.,PUBLICATION,
4659147,CHEMBL267894,VIROVYVQCGLCII-UHFFFAOYSA-N,AMOBARBITAL,,P32241,VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1,VIPR1,,,,IC50,,,,,,,,,,HT-29,,,,,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),DrugMatrix in vitro pharmacology data,,DATASET,
3550419,CHEMBL3658527,PYCQVDFSUIAJGB-NQYYFHDYSA-N,,,P53634,DIPEPTIDYL PEPTIDASE I,CTSC,,,,IC50,=,112.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. The following buffers were used: MES buffer: 25 mM MES, 50 mM NaCl, 5 mM DTT, adjusted to pH 6.0, containing 0.1% BSA; TAGZyme Buffer: 20 mM NaH2PO4, 150 mM NaCl adjusted to pH 6.0 with HCl. Assay Conditions: The recombinant human DPPI was diluted in TAGZyme buffer to 1 U/ml (38.1 ug/ml, respectively), and then activated by mixing in a 1:2 ratio with a Cysteamine aqueous solution (2 mM) and incubating for 5 min at room temperature.Five uL test compound (final concentration 0.1 nM to 100 uM) in aqua bidest (containing 4% DMSO, final DMSO concentration 1%) were mixed with 10 uL of DPPI in MES buffer (final concentration 0.0125 ng/uL) and incubated for 10 min. Then, 5 uL of substrate in MES buffer (final concentration 50 uM) were added. The microtiter plates were then incubated at room temperature for 30 min. Then, the reaction was stopped by adding 10 uL of Gly-Phe-DMK in MES-buffer (final concentration 1 uM).",Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C,,PATENT,
2445622,CHEMBL156455,LGXVIGDEPROXKC-UHFFFAOYSA-N,"1,1-DICHLOROETHENE",,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DrugMatrix in vitro pharmacology data,,DATASET,
5214278,CHEMBL420724,XRANYZPOLRGKGE-UJMJMXFNSA-N,,,Q13002,GLUTAMATE RECEPTOR IONOTROPIC KAINATE 2,GRIK2,,,8809152.0,RESPONSE,=,16.0,%,,cell_based,,,,,HEK293,,,,,,,Electrophysiological activity at 30 uM domoate from HEK293 cells transfected with ionotropic glutamate receptor kainate 2,Synthesis of a series of aryl kainic acid analogs and evaluation in cells stably expressing the kainate receptor humGluR6.,J. Med. Chem.,PUBLICATION,
3011040,CHEMBL3415141,NQSHXMGADFCSKT-UHFFFAOYSA-N,,,Q9WKE8,REVERSE TRANSCRIPTASE,,,,25707013.0,IC50,=,5900.0,NM,,,,,,,,,,,,,,Inhibition of HIV1 reverse transcriptase assessed as reduction in biotin-labeled dUTP incorporation into DNA using poly(A) x oligo(dT)15 as template/primer after 1 hr by ELISA,"Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 4: design, synthesis and biological evaluation of novel imidazo[1,2-a]pyrazines.",Eur. J. Med. Chem.,PUBLICATION,
5449930,CHEMBL1391172,YQFRLLJRMCOYKE-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2629422,CHEMBL2297588,MAUDBTSCSBAQQG-AUWJEWJLSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,50000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1510337,CHEMBL255863,HHZIURLSWUIHRB-UHFFFAOYSA-N,NILOTINIB,,Q9NWZ3,INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4,IRAK4,wild_type,,22037377.0,ACTIVITY,=,80.17957036,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,MBP,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2540481,CHEMBL1547079,LRAIWDUUEWMNSD-JXMROGBWSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2234765,CHEMBL1571627,KJQLEEQCBCIIHS-UHFFFAOYSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5042509,CHEMBL1549235,WYPXMWJYJFZHON-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
665958,CHEMBL1460134,CTVPWOGGAJWDEK-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4783032,CHEMBL406931,VWNMWKSURFWKAL-HXOBKFHXSA-N,RPR-260243,,Q12809,HERG,KCNH2,,,17693551.0,FOLD CHANGE,=,3.0,,,cell_based,,,,,Oocytes,,,,,,,Activation of human ERG1 isoform 1 expressed in Xenopus laevis oocytes assessed as increase in peak tail current at 30 uM by two electrode voltage clamp technique,Structural basis of action for a human ether-a-go-go-related gene 1 potassium channel activator.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
2287961,CHEMBL1065,KPJZHOPZRAFDTN-ZRGWGRIASA-N,METHYSERGIDE,,P18089,ALPHA-2B ADRENERGIC RECEPTOR,ADRA2B,,,,IC50,=,4763.0,NM,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DrugMatrix in vitro pharmacology data,,DATASET,
2933368,CHEMBL394620,NIHONILVXALYIH-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,17188869.0,IC50,=,520.0,NM,,,,,,,,,,,,,,Inhibition of KDR,Thienopyridine urea inhibitors of KDR kinase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5166824,CHEMBL325329,XLTKWRONBZSSRI-FCCZITBLSA-N,,,P00797,RENIN,REN,,,1956045.0,IC50,=,8.0,NM,,,,,,,,,,,,,,In vitro for inhibitory activity against human renin,Substrate analogue renin inhibitors containing replacements of histidine in P2 or isosteres of the amide bond between P3 and P2 sites.,J. Med. Chem.,PUBLICATION,
5857663,CHEMBL3828598,,,,P00915,CARBONIC ANHYDRASE I,CA1,,,27396930.0,Ki,=,41.4,NM,,,,,,,,,,,,,,Inhibition of human CA1 preincubated for 15 mins by stopped flow CO2 hydration assay,Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties.,Bioorg. Med. Chem.,PUBLICATION,
4613665,CHEMBL1390399,VDVUQDXJGUWTNV-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3725845,CHEMBL557547,QRJZCXSRTBCYIW-CQSZACIVSA-N,,,P61169,DOPAMINE D2 RECEPTOR,,,,19454369.0,EC50,=,43.0,NM,,cell_based,,,,,CHO-K1,,,,,,,Agonist activity at rat dopamine D2short receptor expressed in CHO-K1 cells assessed as stimulation of [35S]GTPgammaS binding by liquid scintillation counting,"N-Substituted-2-alkyl- and 2-arylnorapomorphines: novel, highly active D2 agonists.",Bioorg. Med. Chem.,PUBLICATION,
9600,CHEMBL1453381,AAVPPMSHZNOENG-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3470288,CHEMBL159050,PPDWKJHROGNHDT-UHFFFAOYSA-N,,,P04818,THYMIDYLATE SYNTHASE,TYMS,,,1542093.0,KII,=,180.0,NM,,,,,,,,,,,,,,Inhibitory activity against thymidylate synthase from human,Crystal-structure-based design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthase.,J. Med. Chem.,PUBLICATION,
776533,CHEMBL584514,DFRBIKWTAAEZHP-UHFFFAOYSA-M,GNF-PF-4242,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
940045,CHEMBL1821986,DXINWPCQBUXMER-STJBOKOVSA-N,TSANGIBEILIN B,,P29477,"NITRIC OXIDE SYNTHASE, INDUCIBLE",,,,21846089.0,IC50,=,42300.0,NM,,cell_based,,,,,RAW264.7,,,,,,,Inhibition of iNOS in mouse RAW264.7 cells assessed as anti-inflammatory activity by measuring maximum inhibition of LPS-induced nitric oxide production after 24 hrs,Anti-inflammatory endiandric acid analogues from the roots of Beilschmiedia tsangii.,J. Nat. Prod.,PUBLICATION,
2445518,CHEMBL1425919,LGXOILVHSIPSNL-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
826546,CHEMBL3618125,DLDDUEIHEHVJRK-UHFFFAOYSA-N,,,"P11274, P00519",BCR/ABL FUSION PROTEIN,"ABL1, BCR",,,26298495.0,IC50,=,9240.0,NM,,,,,,,,,,,,,,Inhibition of Bcr-Abl (unknown origin) after 1 hr by luminescence assay,Expanding the structural diversity of Bcr-Abl inhibitors: Hybrid molecules based on GNF-2 and Imatinib.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4035293,CHEMBL3325767,RZBFPDQKWUWUCK-SFUBKHQQSA-N,,,O75762,TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY A MEMBER 1,TRPA1,,,,IC50,,,,,cell_based,,,,,,,,,,,,Antagonist activity against human TRPA1 expressed in T-REx HEK cells assessed as inhibition of AITC-induced increase in intracellular Ca2+ accumulation pre-incubated for 3 mins prior to AITC stimulation by Fluo-4 AM dye based fluorescence assay,,J. Nat. Prod.,PUBLICATION,
1932743,CHEMBL539474,JCFJQIHDZHHMQT-UHFFFAOYSA-N,,,P22607,FIBROBLAST GROWTH FACTOR RECEPTOR 3,FGFR3,,,,KI,>,1995.26,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR3,PUBCHEM BIOASSAY DATA SET,,DATASET,
4705747,CHEMBL1438959,VNSZCCNYBOWQMW-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5496835,CHEMBL1488270,YVWZALFIIUFBHL-BQYQJAHWSA-N,,,Q9UBT6,DNA POLYMERASE KAPPA,POLK,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],PUBCHEM BIOASSAY DATA SET,,DATASET,
3435949,CHEMBL1706338,PLNMDGZBZDYYEK-UHFFFAOYSA-N,,,P11411,GLUCOSE-6-PHOSPHATE 1-DEHYDROGENASE,,,,,IC50,,25000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: G6DPH counterscreen for TbHK1 inhibitors - Analogues series. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1430, AID1632, AID2230, AID2600, AID449725, AID492951]",PUBCHEM BIOASSAY DATA SET,,DATASET,
899970,CHEMBL2048791,DSVDKYADAKKORA-UHFFFAOYSA-N,,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,,,22439974.0,INHIBITION,,,,,,,,,,,,,,,,,Pseudo-irreversible inhibition of N-terminus peptide-tagged human recombinant HER2 expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins at 10 times IC50 concentration measured after 10 mins by scintillation counting,"Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket binders.",J. Med. Chem.,PUBLICATION,
2301752,CHEMBL538965,KQSABULTKYLFEV-UHFFFAOYSA-N,"1,5-NAPHTHALENEDIAMINE",,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3862752,CHEMBL567,RGCVKNLCSQQDEP-UHFFFAOYSA-N,PERPHENAZINE,,,5-HT2,,,,7908055.0,KI,=,2.51,NM,,,,,,,,,,,,,,,,,,
2114988,CHEMBL525768,JWNAVYMNAQDLHX-UHFFFAOYSA-N,,,Q06124,PROTEIN-TYROSINE PHOSPHATASE 2C,PTPN11,,,18680359.0,IC50,=,1800.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant SHP2,Inhibitors of Src homology-2 domain containing protein tyrosine phosphatase-2 (Shp2) based on oxindole scaffolds.,J. Med. Chem.,PUBLICATION,
3488193,CHEMBL1375187,PRHDQUXPNWNOMC-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5119779,CHEMBL260111,XGVIWQRWYMJWCJ-UHFFFAOYSA-N,,,Q05769,CYCLOOXYGENASE-2,,,,17434872.0,INHIBITION,<,20.0,%,,,,,,,,,,,,,,Inhibition of mouse COX2 at 4 uM 20 mins pre-incubated before addition of [1-14C]arachidonic acid,Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.,J. Biol. Chem.,PUBLICATION,
3446842,CHEMBL220890,PMSUAYIHWVITQX-QPSGOUHRSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,16979339.0,IC50,=,44.0,NM,,,,,,,,,,,,,,Inhibition of VEGFR2,Synthesis and biological study of 4-aminopyrimidine-5-carboxaldehyde oximes as antiproliferative VEGFR-2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1993922,CHEMBL1512925,JJEUHHOBVBKNGG-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3429640,CHEMBL1545348,PKVJKEAMWZANQA-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3591716,CHEMBL261249,QCXQFRHFMCBJBN-UHFFFAOYSA-N,,,Q9BXA7,TESTIS-SPECIFIC SERINE/THREONINE-PROTEIN KINASE 1,TSSK1B,,,,INHIBITION,=,25.5,%,,,,,,,,,,,,,,Inhibition of human full length TSSK1 expressed in baculovirus assessed as substrate phosphorylation using fluorescence-labelled peptides as substrate at 8 uM after 90 mins by microfluidic peptide phosphorylation assay,,MedChemComm,PUBLICATION,
1641177,CHEMBL570408,HWHFKYJAAJPFQF-UHFFFAOYSA-N,"1,4-DIMETHOXYANTHRAQUINONE",,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1623207,CHEMBL1309243,HUGQCGWAJKBREY-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
1406488,CHEMBL1603287,GXAMFVAJNBIQOG-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3934820,CHEMBL1909355,RNVAYYNPHCMLEQ-UHFFFAOYSA-N,GW461104A,,P17948,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1,FLT1,,,,INHIBITION,=,-0.42,%,,,,,,,,,,,,,,GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5251000,CHEMBL1497316,XVAZSZOISVGIDR-UHFFFAOYSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
5613637,CHEMBL1336167,ZIEBLUOERWGLBU-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3086467,CHEMBL1474479,NZHGWWWHIYHZNX-NTMALXAHSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3901452,CHEMBL158851,RKCDZVUATWNDHM-UHFFFAOYSA-K,,,Q02769,SQUALENE SYNTHETASE,,,,8576905.0,IC50,=,35.0,NM,,,,,,,,,,,,,,Inhibitory activity against rat liver microsomal squalene synthase was determined using [3H]FPP as radioligand,alpha-Phosphonosulfonic acids: potent and selective inhibitors of squalene synthase.,J. Med. Chem.,PUBLICATION,
5156595,CHEMBL1392949,XKTORIOZFKWNRZ-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
566634,CHEMBL2203552,CIUATZJWGJGLPW-UHFFFAOYSA-N,,,P78368,CASEIN KINASE I GAMMA 2,CSNK1G2,,,,IC50,=,348.0,NM,,cell_based,,,,,HEK293,,,,,,,Inhibition of human CK1-gamma2 in HEK293 cells assessed as inhibition of doxcycline-induced LRP6 phosphorylation after 2 hrs by electrochemiluminescence analysis,,ACS Med. Chem. Lett.,PUBLICATION,
5369373,CHEMBL1493517,YHSBIVWEAJHTIP-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5727383,CHEMBL1538564,ZUVLFPKGXLUIKG-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4568848,CHEMBL1470522,UYWSDFSQRVWSEI-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,5802.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2187346,CHEMBL2132401,KEIAPPCJXMSHIV-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2069729,CHEMBL493304,JRRYFXZBVRBKOV-UHFFFAOYSA-N,,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,18785725.0,KI,>,1000000.0,NM,,,,,,,,,,,,,,Binding affinity to ERbeta assessed as inhibition of fluorescein-labeled nuclear receptor domain of steroid receptor coactivator 3 by TR-FRET assay,Blocking estrogen signaling after the hormone: pyrimidine-core inhibitors of estrogen receptor-coactivator binding.,J. Med. Chem.,PUBLICATION,
5595991,CHEMBL505867,ZGDXELBYJCXCFK-QQQRNOSGSA-N,,,Q8BZP8,NEUROPEPTIDE S RECEPTOR,,,,19473027.0,EMAX,,,,,cell_based,,,,,HEK293,,,,,,,Agonist activity at mouse NPSR expressed in HEK293 cells up to 10 uM by calcium mobilization assay,Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.,J. Med. Chem.,PUBLICATION,
332225,CHEMBL2135261,BINZOFPGFLKHRW-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
868177,CHEMBL1603331,DPKKMKZTXPSIHJ-XYOKQWHBSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,7307.8,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5447739,CHEMBL1312353,YPZQOGXDABJTKM-VOTSOKGWSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,18887.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4021125,CHEMBL1354200,RXMRINCMBNJOTM-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2635368,,MBKWQJQPXPFLOL-GKDYZWDQSA-N,VIP ALA13,,P41587,VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 2,VIPR2,,,12388623.0,KI,=,81.3,NM,,,,,,,,,,,,,,,,,,
3474074,CHEMBL1366013,PPQFXGIDZZFHHE-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4680634,CHEMBL83527,VLEUZFDZJKSGMX-ONEGZZNKSA-N,PTEROSTILBENE,,Q6RI86,TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY A MEMBER 1,,,,26750258.0,IC50,=,7500.0,NM,,,,,,,,,,,,,,Antagonist activity at rat TRPA1 expressed in HEK293 cells assessed as inhibition of allyl isothiocyanate-induced increase of intracellular calcium level,TRPA1 channels as targets for resveratrol and related stilbenoids.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3813799,CHEMBL217276,RATQXYIMHHYOQT-UHFFFAOYSA-N,,,P32239,CHOLECYSTOKININ B RECEPTOR,CCKBR,,,17034143.0,KI,<,10000.0,NM,,,,,,,,,,,,,,Displacement of [125I]CCK-8S from human CCK2R,"Identification and optimization of anthranilic sulfonamides as novel, selective cholecystokinin-2 receptor antagonists.",J. Med. Chem.,PUBLICATION,
5150709,CHEMBL1386400,XKEAICWUUUFORE-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
128930,CHEMBL488031,AMOQRGVXFGDBST-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,18243711.0,IC50,>,10000.0,NM,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]WIN-55212-2 from human CB2 receptor expressed in CHOK1 cells,"Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.",Bioorg. Med. Chem.,PUBLICATION,
1737701,CHEMBL1545708,IGQADNUQTYXBEI-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2570073,CHEMBL1565094,LUCBLAAMDMJATQ-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5575571,CHEMBL578402,ZEACHMAUZGHOTQ-WLRWDXFRSA-N,LILIFLOL A,,P79208,CYCLOOXYGENASE-2,,,,19880317.0,IC50,=,98700.0,NM,,,,,,,,,,,,,,Inhibition of ovine COX-2 assessed as inhibition of transformation of AA to PGH2 by EIA,"COX, LOX and platelet aggregation inhibitory properties of Lauraceae neolignans.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5218305,CHEMBL222102,XRKYMMUGXMWDAO-UHFFFAOYSA-N,KU-55933,,P50750,CYCLIN-DEPENDENT KINASE 9,CDK9,wild_type,,22037377.0,ACTIVITY,=,100.289647,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3695862,CHEMBL1544308,QOIOXCVSPRIGMT-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2034234,CHEMBL1540,JNTOCHDNEULJHD-UHFFFAOYSA-N,PENCICLOVIR,,P04293,HUMAN HERPESVIRUS 1 DNA POLYMERASE,,,,2848125.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Inhibition of DNA polymerase,Synthesis and antiherpetic activity of (+/-)-9-[[(Z)-2-(hydroxymethyl)cyclopropyl]methyl]guanine and related compounds.,J. Med. Chem.,PUBLICATION,
4222808,CHEMBL2205620,STRRJWGQVOFPKF-UHFFFAOYSA-N,,,P20272,CANNABINOID CB1 RECEPTOR,,,,23147076.0,KI,>,30000.0,NM,,,,,,,,,,,,,,"Displacement of [3H]-CP55,940 from rat CB1 receptor after 60 mins by microscintillation counting analysis","Structure-activity relationships of 2-arylamido-5,7-dihydro-4H-thieno[2,3-c]pyran-3-carboxamide derivatives as cannabinoid receptor agonists and their analgesic action.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4598092,CHEMBL309490,VCCRNZQBSJXYJD-UHFFFAOYSA-N,GALANGIN,,P32897,MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE SUBUNIT TIM23,,,,,IC50,=,8560.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of tim23-1 yeast via a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463212, AID463216, AID504657, AID504672]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1958716,CHEMBL1348844,JFGMWIFQCLGOCV-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
21570,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,,Matrix metalloproteinase-14 (MMP14),,,,22689580.0,KI,=,968.0,NM,,,,,,,,,,,,,,,,,,
1353042,CHEMBL1725541,GQUIBJMBIMFMDA-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3454427,CHEMBL1733192,PNKYYSDVRPSGKB-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,8199.5,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3605655,CHEMBL1513314,QEOYYMPCEDQQCW-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3028090,CHEMBL1480241,NSQKAUNDMZCXQV-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2196858,CHEMBL1417448,KFIWUXVSYNYXIU-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
642749,CHEMBL1443968,CRIDWQRCAMWXSF-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5272494,CHEMBL1539793,XXNSCVDJXOAZKG-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1620174,CHEMBL1404611,HTVQQOPIPCYOMJ-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
106,CHEMBL3545284,,CERDULATINIB,,P09619,PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA,PDGFRB,,,29191878.0,KDAPP,=,202.88,NM,inhibition,cell_free,binding,binding_reversible,,label_free_technology,"K-562, COLO 205, MV-4-11, SK-N-BE(2)",3-30,NM-UM,,,,,LC-MS/MS BASED KINOBEADS COMPETITIVE PULL-DOWN ASSAY,THE TARGET LANDSCAPE OF CLINICAL KINASE DRUGS,SCIENCE,,
1371227,CHEMBL1519461,GTBHMWTZZZJXBK-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,794.3,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
808531,CHEMBL487894,DJGAAPFSPWAYTJ-UHFFFAOYSA-M,DIPYRONE SODIUM,,P08913,ALPHA-2A ADRENERGIC RECEPTOR,ADRA2A,,,,IC50,,,,,,,,,,Sf9,,,,,,,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DrugMatrix in vitro pharmacology data,,DATASET,
5570853,CHEMBL120077,ZDNURMVOKAERHZ-UHFFFAOYSA-N,JNJ-10198409,,Q07912,TYROSINE KINASE NON-RECEPTOR PROTEIN 2,TNK2,wild_type,,22037377.0,ACTIVITY,=,15.06885704,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ABLTIDE ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2623891,CHEMBL3194014,MAEKQEYJXJFYLI-QGOAFFKASA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4743550,CHEMBL1400945,VSBHRRMYCDQLJF-ZDNYCOCVSA-N,PREGNENOLONE CARBONITRILE ,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
5783929,CHEMBL3740121,,,,"Q9BVA1, Q9BUF5, Q9BQE3, Q6PEY2, Q13885, P68363, Q13509, P68371, Q71U36, P07437, Q3ZCM7, P04350, Q9H4B7, P68366, Q13748",TUBULIN,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",,,,IC50,=,8920.0,NM,,,,,,,,,,,,,,Inhibition of tubulin polymerization (unknown origin) by fluorescence analysis,"Synthesis, biological evaluation and mechanism study of a class of benzylideneindanone derivatives as novel anticancer agents",MedChemComm,PUBLICATION,
2474069,CHEMBL1870566,LKFNNZJNUPGQIF-HNNXBMFYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,946.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2451633,CHEMBL347099,LHPPNUAJOLSUPA-UHFFFAOYSA-N,,,Q4U254,HUMAN RHINOVIRUS A PROTEASE,,,,8978838.0,KI,=,6.0,NM,,,,,,,,,,,,,,Inhibition of human rhinovirus 3C protease,"Design, synthesis, and evaluation of nonpeptidic inhibitors of human rhinovirus 3C protease.",J. Med. Chem.,PUBLICATION,
1652470,CHEMBL193010,HXKYTCGOCJUQSE-UHFFFAOYSA-N,,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,15943471.0,IC50,=,1452.0,NM,,,,,,,,,,,,,,Inhibition of [3H]17-beta-estradiol binding to human estrogen receptor alpha expressed in Escherichia coli,ERbeta ligands. 3. Exploiting two binding orientations of the 2-phenylnaphthalene scaffold to achieve ERbeta selectivity.,J. Med. Chem.,PUBLICATION,
5156407,CHEMBL1339329,XKSZUJVLXLFQJO-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
698145,CHEMBL1401841,CXHKQNZBSNIFHR-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1391157,CHEMBL1447548,GVGSZMQJNKGSJY-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4195886,CHEMBL3195749,SQTXZQUPJDPRBX-HKOYGPOVSA-N,,,O14727,APOPTOTIC PROTEASE-ACTIVATING FACTOR 1,APAF1,,,,IC50,>,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response validation of Inhibitors of Apaf-1 using a Fluorescent Interference Counterscreen assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID489030, AID492945]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3526393,CHEMBL1454718,PVJUCSOYEJNSRU-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,2238.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2159001,CHEMBL2000429,KBFBKKNSHPUFET-UHFFFAOYSA-N,,,Q16513,PROTEIN KINASE N2,PKN2,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PKN2,PUBCHEM BIOASSAY DATA SET,,DATASET,
773584,CHEMBL1421937,DFJNAHZXFFHPDU-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5053990,CHEMBL3196314,WZQDNFBUWQZOFB-WOJGMQOQSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3489261,CHEMBL1328593,PRINKDVMZBLMDE-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4198423,CHEMBL104042,SQZBAUUHDXMUTO-FNHZYXHNSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,20055417.0,KI,=,2.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [125I]OXY from human delta opioid receptor expressed in CHO cells,"Synthesis and opioid activity of enantiomeric N-substituted 2,3,4,4a,5,6,7,7a-octahydro-1H-benzofuro[3,2-e]isoquinolines.",J. Med. Chem.,PUBLICATION,
5018551,CHEMBL119443,WVVSZNPYNCNODU-XTQGRXLLSA-N,ERGONOVINE,,P03956,MATRIX METALLOPROTEINASE-1,MMP1,,,,IC50,,,,,tissue,,,,,,,,,,,,"DRUGMATRIX: Peptidase, Matrix Metalloprotease-1 (MMP-1) enzyme inhibition (substrate: Mca-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2)",DrugMatrix in vitro pharmacology data,,DATASET,
328705,CHEMBL1443319,BIGUCKFIBBSIFQ-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1309326,CHEMBL428877,GLWRGNCTKNNGMV-UHFFFAOYSA-N,SB-242719,,O94806,PROTEIN KINASE C NU,PRKD3,,,,INHIBITION,=,9.71,%,,,,,,,,,,,,,,GSK_PKIS: PRKD3 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5491357,CHEMBL1504305,YVGRIPYLOKTUSJ-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1448134,CHEMBL1408259,HBQQSGHIYIJHBG-ZACQAIPSSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5514855,,YXSWCPGXIDXFKC-UHFFFAOYSA-N,,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,12.98,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2334501,CHEMBL3265285,KTWUJSNNFLXRRL-UHFFFAOYSA-N,,,O75460,SERINE/THREONINE-PROTEIN KINASE/ENDORIBONUCLEASE IRE1,ERN1,,,24749861.0,IC50,=,118.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant puritin-His-tagged IRE-1 RNase expressed in SF21 cells using XBP-1 RNA stem loop as substrate incubated for 30 mins prior to substrate addition measured after 2 hrs by FRET-suppression assay,Synthesis of Novel Tricyclic Chromenone-Based Inhibitors of IRE-1 RNase Activity.,J. Med. Chem.,PUBLICATION,
2662871,CHEMBL2218941,MENDIXKFTXYTHJ-DMDINBDXSA-N,,,Q96SB4,SERINE/THREONINE-PROTEIN KINASE SRPK1,SRPK1,wild_type,,23398362.0,ACTIVITY,=,106.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of SRPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3563106,CHEMBL36076,PZQCNOKCBJYQHG-MYYSRTQBSA-N,,,P06401,PROGESTERONE RECEPTOR,PGR,,,10212133.0,EC50,=,48.0,NM,,cell_based,,,,,CV-1,,,,,,,Compound was tested for agonistic activity by cotransfection assay against human Progesterone receptor in CV-1 cells,"5-Aryl-1,2,3,4-tetrahydrochromeno[3,4-f]quinolin-3-ones as a novel class of nonsteroidal progesterone receptor agonists: effect of A-ring modification.",J. Med. Chem.,PUBLICATION,
1541486,CHEMBL1608321,HKZHFCQAUFSCMS-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2964682,CHEMBL1407383,NLQGZVKXLTWART-DPLHUUCSSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
55077,CHEMBL1541973,AEEMKLGKYAOKOA-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1733233,CHEMBL512275,IGDBRYFDPWPBAI-OAQYLSRUSA-N,,,P45452,MATRIX METALLOPROTEINASE 13,MMP13,,,19422229.0,IC50,=,81.2,NM,,,,,,,,,,,,,,Inhibition of MMP13 in presence of 1% bovine serum albumin,"Discovery of potent, selective, and orally active carboxylic acid based inhibitors of matrix metalloproteinase-13.",J. Med. Chem.,PUBLICATION,
4210288,CHEMBL1728938,SSGANXXXQPFWGE-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2568825,CHEMBL271595,LTYGAJVXAFJKSY-XFFZJAGNSA-N,GW297361X,,O15530,3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1,PDPK1,,,,INHIBITION,=,20.79,%,,,,,,,,,,,,,,GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
651660,CHEMBL1479501,CSJVCIGQMYYABP-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1780232,CHEMBL1583067,ILOVXTYBYWSMBS-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1542114,CHEMBL1363350,HLAWLTIZZHWOLT-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,100.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
3673340,CHEMBL2218938,QMBDONCHHMIWFJ-UHFFFAOYSA-N,,,Q05513,PROTEIN KINASE C ZETA,PRKCZ,wild_type,,23398362.0,ACTIVITY,=,107.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of PRKCZ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1836165,CHEMBL1412637,IRQSFUSXNVUVHL-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
816951,CHEMBL1556915,DKEHVXLGLYZRNF-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
17101,CHEMBL1716552,ABSZVKNCZYCVTE-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3702197,CHEMBL1719996,QOZLDPHQOHRGDG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1074291,CHEMBL118466,FMCXTTHVULYFDI-UHFFFAOYSA-N,,,P45984,C-JUN N-TERMINAL KINASE 2,MAPK9,,,12540232.0,INHIBITION,=,4.0,%,,,,,,,,,,,,,,Inhibition of recombinant human flag-tagged JNK2-beta-2 at 5000 nM,Hybrid-designed inhibitors of p38 MAP kinase utilizing N-arylpyridazinones.,J. Med. Chem.,PUBLICATION,
1925239,CHEMBL404941,JBJYTZXCZDNOJW-RAXLEYEMSA-N,,,P06239,TYROSINE-PROTEIN KINASE LCK,LCK,wild_type,,23398362.0,ACTIVITY,=,82.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,90,uM,"Millipore: Percentage of residual kinase activity of LCK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4891222,CHEMBL3426142,WIBUVWKPGPLBOZ-GDBMZVCRSA-N,,,O43614,OREXIN RECEPTOR 2,HCRTR2,,,25981685.0,IC50,=,10.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity against human OX2R expressed in CHOK1 cells assessed as inhibition of orexin A-induced intercellular Ca2+ mobilization by FLIPR assay,Identification of MK-8133: An orexin-2 selective receptor antagonist with favorable development properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3665846,CHEMBL303753,QLDOJGXGPYBGDM-RFJCEXLZSA-N,,,"P05026, P50993, P54709, P54710, Q13733, P13637, P14415, P05023",SODIUM/POTASSIUM-TRANSPORTING ATPASE,"ATP1A1, ATP1A2, ATP1A3, ATP1A4, ATP1B1, ATP1B2, ATP1B3, FXYD2",,,11754591.0,IC50,=,1600.0,NM,,,,,,,,,,,,,,50% displacement of the specific [3H]ouabain binding from the dog kidney Na+/K+ ATPase,"Synthesis and inotropic activity of 1-(O-aminoalkyloximes) of perhydroindene derivatives as simplified digitalis-like compounds acting on the Na(+),K(+)-ATPase.",J. Med. Chem.,PUBLICATION,
4222118,CHEMBL178,STQGQHZAVUOBTE-VGBVRHCVSA-N,DAUNORUBICIN,,P35372,MU OPIOID RECEPTOR,OPRM1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DrugMatrix in vitro pharmacology data,,DATASET,
4774396,CHEMBL1441834,VVNCPCPSSPVRCK-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
81858,CHEMBL236615,AHBIRSCEARQARK-RVDMUPIBSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2511500,CHEMBL1497926,LNYORWBKWKWCQM-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3910014,CHEMBL418367,RKYCRMZFYDRREV-SFYZADRCSA-N,,,"Q14432, Q13370",PHOSPHODIESTERASE 3,"PDE3A, PDE3B",,,9990447.0,IC50,=,150000.0,NM,,,,,,,,,,,,,,Optimum inhibitory concentration required to inhibit cGMP specific phosphodiesterase 3 (PDE3),Synthesis and evaluation of potent and selective c-GMP phosphodiesterase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4871144,CHEMBL1558,WFXFYZULCQKPIP-UHFFFAOYSA-N,PRAZOSIN HYDROCHLORIDE,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5768133,CHEMBL2135695,ZZKANAOTXJNJBA-XBXARRHUSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,1778.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5263915,CHEMBL510182,XWOCEZSKLHXLBX-XAHDOWKMSA-N,,,P00918,CARBONIC ANHYDRASE II,CA2,,,19362844.0,KI,=,34.0,NM,,,,,,,,,,,,,,Inhibition of human carbonic anhydrase 2 by Lineweaver-Burke plot,"Effects of new 5-amino-1,3,4-thiadiazole-2-sulfonamide derivatives on human carbonic anhydrase isozymes.",Bioorg. Med. Chem.,PUBLICATION,
4814693,CHEMBL1710562,VZXXKDXPNLDDQT-QUCCMNQESA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3493201,CHEMBL1453903,PRTIBHBKPFBRPF-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4310149,CHEMBL149667,TXCZFZKWSPPSHR-UHFFFAOYSA-N,"(+)-PYRIDO[3,4-B]HOMOTROPANE",,"P43681, P17787",NEURONAL ACETYLCHOLINE RECEPTOR; ALPHA4/BETA2,"CHRNA4, CHRNB2",,,16722642.0,ACTIVITY,=,10.0,%,,cell_based,,,,,,,,,,,,Activity at human alpha-4-beta-2 nACHR assessed as inhibition of ACh-induced current in SH-EP1 cells at 40 uM,"Synthesis and pharmacological characterization of nicotinic acetylcholine receptor properties of (+)- and (-)-pyrido-[3,4-b]homotropanes.",J. Med. Chem.,PUBLICATION,
3969639,CHEMBL61126,RRPMQMRUEOLDST-UHFFFAOYSA-N,,,P22303,ACETYLCHOLINESTERASE,ACHE,,,11755352.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,In vitro inhibitory activity against human recombinant AChE,Oxyaniliniums as acetylcholinesterase inhibitors for the reversal of neuromuscular block.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5144171,CHEMBL1600494,XJKINLCAYZXYIQ-VAWYXSNFSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,11582.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5267842,CHEMBL2326364,XXBXRJDBCMCGGD-UHFFFAOYSA-N,,,P45452,MATRIX METALLOPROTEINASE 13,MMP13,,,23458498.0,IC50,=,386.0,NM,,,,,,,,,,,,,,Inhibition of MMP-13 (unknown origin) using Mca-Lys-Pro-Leu-Gly-Leu-Dap(Dnp)-Ala-Arg-NH2 as substrate after 4 hrs by fluorometric assay,Synthesis and preliminary evaluation in tumor bearing mice of new (18)f-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.,J. Med. Chem.,PUBLICATION,
5621951,CHEMBL1363868,ZJCNBWBCHYCDPG-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
394664,CHEMBL1453437,BPLAMKJMGIAXNJ-UHFFFAOYSA-N,,,"Q01196, Q13951",RUNT-RELATED TRANSCRIPTION FACTOR 1/CORE-BINDING FACTOR SUBUNIT BETA,"CBFB, RUNX1",,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1220348,CHEMBL572878,GCIKSSRWRFVXBI-UHFFFAOYSA-N,TOZASERTIB,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,wild_type,,21336281.0,KI,=,398.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
5360914,CHEMBL424,YGSDEFSMJLZEOE-UHFFFAOYSA-N,SALICYLIC ACID,,Q9Y271,CYSTEINYL LEUKOTRIENE RECEPTOR 1,CYSLTR1,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),DrugMatrix in vitro pharmacology data,,DATASET,
2592137,CHEMBL1733260,LWOXBRYGPQGVFO-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4890529,CHEMBL440981,WHZCBTLRGGDXDM-UHFFFAOYSA-L,,,"P09483, P12390",NEURONAL ACETYLCHOLINE RECEPTOR; ALPHA4/BETA2,,,,18029180.0,INHIBITION,=,13.0,%,,,,,,,,,,,,,,Displacement of [3H]NIC from alpha-4-beta-2 nAChR expressed in rat brain membrane at 100 uM,Bis-azaaromatic quaternary ammonium salts as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release: An investigation of binding conformation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
238409,CHEMBL1418139,AYJIUOZKKTUKKD-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2099699,CHEMBL429023,JUVIOZPCNVVQFO-HBGVWJBISA-N,ROTENONE,,P03887,NADH-UBIQUINONE OXIDOREDUCTASE CHAIN 1,,,,16218678.0,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of Bos taurus (beef) heart NAD1,Novel inhibitors of the mitochondrial respiratory chain: oximes and pyrrolines isolated from Penicillium brevicompactum and synthetic analogues.,J Agric Food Chem,PUBLICATION,
1221934,CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,,,,KI,,,,,cell_based,,,,,Insect cells,,,,,,,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DrugMatrix in vitro pharmacology data,,DATASET,
2985423,CHEMBL1589491,NNXAQKIRVMTURV-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1668410,CHEMBL1308557,HZCHKJSROOTQJN-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5234689,CHEMBL1574272,XTDUGLTWLDNJBT-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1145732,CHEMBL3208389,FTSQGEWZFGNMEQ-CXUHLZMHSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3855823,CHEMBL2218925,RFHPWPWVGFSLOP-NTEUORMPSA-N,,,P42680,TYROSINE-PROTEIN KINASE TEC,TEC,wild_type,,23398362.0,ACTIVITY,=,105.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,120.0,uM,"Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3922840,CHEMBL3084966,RMJFXTVVOBTABN-RWWKDMOOSA-N,,,P08253,MATRIX METALLOPROTEINASE-2,MMP2,,,11266157.0,IC50,=,251.0,NM,,,,,,,,,,,,,,Inhibition of gelatinase A (Matrix metalloprotease-2),Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5618960,CHEMBL89746,ZIUGFBPZKPIFII-RZTYMHDWSA-N,,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,,IC50,=,600.0,NM,,,,,,,,,,,,,,Tested for the binding potency against NMDA site of the glutamate receptor complex using rat brain cortical membranes in a competitive binding assay with [3H]CPP as radioligand,,Bioorg. Med. Chem. Lett.,PUBLICATION,
1056662,CHEMBL57013,FJZWVTQJLJAQAE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
340602,CHEMBL1836398,BJKIMQXSNZGBHQ-UHFFFAOYSA-N,,,P53667,LIM DOMAIN KINASE 1,LIMK1,,,21852129.0,IC50,=,9500.0,NM,,,,,,,,,,,,,,Inhibition of LIMK1 using cofilin-2 as substrate after 60 mins by TR-FRET assay,"Identification of 5,6-substituted 4-aminothieno[2,3-d]pyrimidines as LIMK1 inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1399679,CHEMBL354676,GWEHVDNNLFDJLR-UHFFFAOYSA-N,DIPHENYLUREA,,Q9HAZ1,DUAL SPECIFICITY PROTEIN KINASE CLK4,CLK4,wild_type,,21336281.0,KI,<,7943.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
2854096,CHEMBL336968,MZOHOVZOVHUMCJ-UHFFFAOYSA-N,,,P25099,ADENOSINE A1 RECEPTOR,,,,8558508.0,KI,=,50000.0,NM,,,,,,,,,,,,,,Tested for the displacement [3H]PIA from Adenosine A1 receptor in rat brain membrane,Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists.,J. Med. Chem.,PUBLICATION,
3476830,CHEMBL1698826,PPXYEDVUVZHDLC-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3817584,CHEMBL1701339,RBEVSQNMNBEQBU-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,7307.8,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4842474,CHEMBL1356141,WCZCYYDBAVRKAK-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
3804785,CHEMBL1407672,QZZHZDLTRHSVBX-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
2338303,CHEMBL1258396,KUJFUTJUYANNOM-UHFFFAOYSA-N,,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,20728355.0,IC50,,,,,,,,,,,,,,,,,Antagonist activity at adenosine A3 receptor by cAMP assay,Identification and optimization of substituted 5-aminopyrazoles as potent and selective adenosine A1 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1396017,CHEMBL1439818,GVTGOADPJYUJLL-UHFFFAOYSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,15811.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2688736,CHEMBL1090487,MHIILDKFLFPQES-FCHUYYIVSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,20329799.0,EMAX,=,87.0,%,,cell_based,,,,,CHO,,,,,,,Agonist activity at human recombinant MC4 receptor expressed in CHO cells by cAMP responsive beta lactamase reporter gene assay relative to melanocortin 2,Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans.,J. Med. Chem.,PUBLICATION,
4361599,CHEMBL1995832,UCOWZARZLHNDKP-UHFFFAOYSA-N,,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,,,,KI,>,2511.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT3,PUBCHEM BIOASSAY DATA SET,,DATASET,
4107553,CHEMBL1472677,SGYKTXYLIQOTCW-OMBKBZADSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2743959,CHEMBL338249,MNGJIGCQEBFWQQ-HMMYKYKNSA-N,,,"P25095, P35351, P29089",ANGIOTENSIN II RECEPTOR,,,,1433195.0,IC50,=,6800.0,NM,,,,,,,,,,,,,,Inhibition of [125I]angiotensin II specific binding to rat mesenteric arteries,Imidazole-5-acrylic acids: potent nonpeptide angiotensin II receptor antagonists designed using a novel peptide pharmacophore model.,J. Med. Chem.,PUBLICATION,
4390423,CHEMBL3133815,UGAAWODPRRSBJP-UHFFFAOYSA-N,,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,,,,IC50,=,8830.0,NM,,cell_based,,,,,,,,,,,,"Inhibition of human recombinant GST-fused HER2 expressed in baculovirus Sf9 insect cells using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting",,MedChemComm,PUBLICATION,
1581112,CHEMBL1444,HPJKCIUCZWXJDR-UHFFFAOYSA-N,LETROZOLE,,P08172,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,CHRM2,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M2 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
5321020,CHEMBL280998,YCIMNLLNPGFGHC-UHFFFAOYSA-N,CATECHOL,,P08575,LEUKOCYTE COMMON ANTIGEN,PTPRC,,,,KI,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",DrugMatrix in vitro pharmacology data,,DATASET,
418150,CHEMBL1337145,BSFWGAXBDAOEPJ-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5864474,CHEMBL3754583,,,,O15054,LYSINE-SPECIFIC DEMETHYLASE 6B,KDM6B,,,26776360.0,Inhibition,=,32.9,%,,,,,,,,,,,,,,Inhibition of JMJD3 (unknown origin) using biotinylated H3K27me3 peptide as substrate at 10 uM after 1 hr by AlphaLISA assay,Design and discovery of new pyrimidine coupled nitrogen aromatic rings as chelating groups of JMJD3 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1986079,CHEMBL1579833,JIHQIRFYNAQVNT-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,354.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5004997,CHEMBL188762,WUPUZEMRHDROEO-UHFFFAOYSA-N,PD-174265,,Q15375,EPHRIN TYPE-A RECEPTOR 7,EPHA7,wild_type,,22037377.0,ACTIVITY,=,102.345,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,PEY,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
1027027,CHEMBL520037,FGUYNCHKIOFPMS-UHFFFAOYSA-N,GW837331X,,Q16832,DISCOIDIN DOMAIN-CONTAINING RECEPTOR 2,DDR2,,,,INHIBITION,=,0.73,%,,,,,,,,,,,,,,GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2717780,CHEMBL1520726,MKURUVKEYHSKKR-UHFFFAOYSA-N,,,P15917,ANTHRAX LETHAL FACTOR,,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
655407,CHEMBL1418168,CSXDJDQEQGACBI-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4399930,CHEMBL222419,UHCHLTQBLNUYRT-GFCCVEGCSA-N,GSK-237701A,,Q16832,DISCOIDIN DOMAIN-CONTAINING RECEPTOR 2,DDR2,,,,INHIBITION,=,12.0,%,,,,,,,,,,,,,,GSK_PKIS: DDR2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1369054,CHEMBL1344010,GSTYOSKTMANUGO-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
2405460,CHEMBL1545267,LCGIPPCNDCDHCJ-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,1000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3681395,CHEMBL122097,QMTPHPHFBVWTJM-UHFFFAOYSA-N,METHYLSULFANYLMETHYL-PHOSPHONOTHIOIC ACID,,P03772,SERINE/THREONINE-PROTEIN PHOSPHATASE,,,,12904075.0,KI,=,1200000.0,NM,,,,,,,,,,,,,,Inhibitory activity against Serine/Threonine Protein Phosphatase (Lambda protein phosphatase),A comparison of phosphonothioic acids with phosphonic acids as phosphatase inhibitors.,J. Med. Chem.,PUBLICATION,
4855602,CHEMBL485259,WEEGYLXZBRQIMU-UHFFFAOYSA-N,EUCALYPTOL,,P21452,NEUROKININ 2 RECEPTOR,TACR2,,,,KI,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),DrugMatrix in vitro pharmacology data,,DATASET,
2777165,CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,P28482,MAP KINASE ERK2,MAPK1,,,,IC50,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DrugMatrix in vitro pharmacology data,,DATASET,
3929804,CHEMBL1390223,RNFIGXQSDZBODZ-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1622897,CHEMBL1309159,HUFIDXAJKMIYID-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3518611,CHEMBL3582291,PUNMOMPUTCNIOA-UHFFFAOYSA-N,,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,26005523.0,IC50,=,16.2,NM,,,,,,,,,,,,,,"Inhibition of C-Met (unknown origin) using polu (Glu,Tyr)4:1 substrate after 30 mins incubation by multi-well spectrophotometry",,ACS Med. Chem. Lett.,PUBLICATION,
2082243,CHEMBL347296,JSXUDXGPZPGJOP-OFNKIYASSA-N,,,"P08514, P05106",INTEGRIN ALPHA-IIB/BETA-3,"ITGA2B, ITGB3",,,10602710.0,IC50,=,0.37,NM,,,,,,,,,,,,,,In vitro inhibition of biotinylated fibrinogen binding to immobilized fibrinogen receptor.,"Potent, orally active GPIIb/IIIa antagonists containing a nipecotic acid subunit. Structure-activity studies leading to the discovery of RWJ-53308.",J. Med. Chem.,PUBLICATION,
1602162,CHEMBL1555646,HRUKRGREPIONPY-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
735458,CHEMBL1986265,DBFCGNXJRISFMI-UHFFFAOYSA-N,,,Q06187,TYROSINE-PROTEIN KINASE BTK,BTK,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: BTK,PUBCHEM BIOASSAY DATA SET,,DATASET,
3321277,CHEMBL273611,OYUMKIMOEUHNPB-UHFFFAOYSA-N,SB-250715,,Q08881,TYROSINE-PROTEIN KINASE ITK/TSK,ITK,,,,INHIBITION,=,3.21,%,,,,,,,,,,,,,,GSK_PKIS: ITK mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3871943,CHEMBL3196392,RGYUPWNJJSKIQV-PXLXIMEGSA-N,,,Q13315,SERINE-PROTEIN KINASE ATM,ATM,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4797961,CHEMBL1320183,VYAKWNMJPBYNBM-UHFFFAOYSA-N,,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5227338,CHEMBL2047662,XSIKFDATKJWESS-GCPWLZLNSA-N,KMI-1793,,P56817,BETA-SECRETASE 1,BACE1,,,,IC50,=,169.0,NM,,,,,,,,,,,,,,"Inhibition of human recombinant BACE1 using 7-methoxycoumarin-4-yl)acetyl-Ser-Glu-Val-Asn-Leu*Asp-Ala- Glu-Phe-Arg-Lys(2,4-dinitrophenyl)-Arg-Arg-NH2 as substrate by FRET assay",,ACS Med. Chem. Lett.,PUBLICATION,
394383,CHEMBL1605464,BPKAIDOAJPDWJW-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
891625,CHEMBL1469115,DRWUDXYRAPUUFX-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5077344,CHEMBL1986590,XCGXAWJRNVHWAI-UHFFFAOYSA-N,,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,,KI,>,5011.87,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3,PUBCHEM BIOASSAY DATA SET,,DATASET,
5331427,CHEMBL1576553,YDLFYKWVVWCKKW-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4074232,CHEMBL1372830,SDIDKIVXKCMKPK-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
833250,CHEMBL1388064,DLWHASPDCNHWPN-UHFFFAOYSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,15811.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3251936,CHEMBL2408382,ORHMVTHJIPEHLL-NMFUWQPSSA-N,,,P22513,"GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE, GLYCOSOMAL",,,,23850203.0,KI,=,17100.0,NM,,,,,,,,,,,,,,Competitive inhibition of Trypanosoma cruzi glycosomal GAPDH NAD+ binding site by ITC method,"Molecular design, synthesis and biological evaluation of 1,4-dihydro-4-oxoquinoline ribonucleosides as TcGAPDH inhibitors with trypanocidal activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1769663,CHEMBL343721,IKJVWZDFWJUWCD-ROUUACIJSA-N,,,P14780,MATRIX METALLOPROTEINASE 9,MMP9,,,14643312.0,KI,>,2128.0,NM,,,,,,,,,,,,,,Inhibition of matrix metalloprotease-9 (MMP-9),"Rational design, synthesis and structure-activity relationships of a cyclic succinate series of TNF-alpha converting enzyme inhibitors. Part 1: lead identification.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1791570,CHEMBL1485850,IMWIBCFLGGZQCV-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2239539,CHEMBL1475807,KKDYBKWXWGJSHC-UHFFFAOYSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
4255336,CHEMBL1512347,SXKPIFDJSNJIKF-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4017418,CHEMBL1361779,RWZQVHOGEURBGY-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1212992,CHEMBL3127016,GBPNLMRKZPVHEU-UHFFFAOYSA-N,,,P37136,ACETYLCHOLINESTERASE,,,,24589487.0,IC50,=,36290.0,NM,,,,,,,,,,,,,,Inhibition of rat cortex homogenate AchE using acetylthiocholine iodide as substrate after 15 mins by Ellman's method,"Design, synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer's disease.",Eur. J. Med. Chem.,PUBLICATION,
2530204,CHEMBL1288936,LPTRRECWRHWOEU-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4340396,CHEMBL328710,UAKWLVYMKBWHMX-PTNGSMBKSA-N,SU-4312,,O14920,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE BETA SUBUNIT,IKBKB,wild_type,,22037377.0,ACTIVITY,=,105.4483297,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,IKKTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
727463,CHEMBL486969,DAHOTEDIQMMTIX-UKOKCHKQSA-N,,,P21980,PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE,TGM2,,,23835447.0,IC50,=,20000.0,NM,,,,,,,,,,,,,,"Inhibition of recombinant human tissue transglutaminase-mediated biotin X-cadaverine incorporation into N,N'-dimethylcasein after 1 hr",Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
1812391,CHEMBL1080987,IOZQUAOEHCYANX-NKEDHYFDSA-N,,,Q62226,SONIC HEDGEHOG PROTEIN,,,,19819139.0,EC50,=,30000.0,NM,,cell_based,,,,,Shh Light II,,,,,,,Inhibition of SHH in mouse Shh Light2 cells after 30 hrs by GLI-responsive bright glo luciferase reporter gene assay,Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2005849,CHEMBL574323,JKQXAKZVTHNFEB-UHFFFAOYSA-N,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,19501513.0,KI,=,193.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]NECA from human adenosine A2A receptor expressed in CHO cells,Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.,Bioorg. Med. Chem.,PUBLICATION,
5778555,CHEMBL3735212,,,,Q9UBN7,HISTONE DEACETYLASE 6,HDAC6,,,26585275.0,IC50,=,17.5,NM,,,,,,,,,,,,,,Inhibition of recombinant HDAC6 (unknown origin) expressed in Escherichia coli BL21(DE3) after 60 mins using trichostatin A by label-free mass spectrometry-based SAMDI assay,A structure-activity relationship of non-peptide macrocyclic histone deacetylase inhibitors and their anti-proliferative and anti-inflammatory activities.,Bioorg. Med. Chem.,PUBLICATION,
4412065,CHEMBL2177470,UICGCQDWRACUBV-MHECFPHRSA-N,,,P07339,CATHEPSIN D,CTSD,,,22984865.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of cathepsin D up to 100 uM,"Spirocyclic Sulfamides as ß-Secretase 1 (BACE-1) Inhibitors for the Treatment of Alzheimer's Disease: Utilization of Structure Based Drug Design, WaterMap, and CNS Penetration Studies To Identify Centrally Efficacious Inhibitors.",J. Med. Chem.,PUBLICATION,
2490305,CHEMBL1313790,LLRVIIZNKCRMGG-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2600380,CHEMBL1447634,LXLSYBQANVZKSJ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18348.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3368030,CHEMBL473229,PEGXADGTBNRSGV-CYBMUJFWSA-N,,,P43405,TYROSINE-PROTEIN KINASE SYK,SYK,,,18938080.0,KI,=,210.0,NM,,,,,,,,,,,,,,Inhibition of SYK,Discovery and SAR of novel 4-thiazolyl-2-phenylaminopyrimidines as potent inhibitors of spleen tyrosine kinase (SYK).,Bioorg. Med. Chem. Lett.,PUBLICATION,
3516888,CHEMBL519986,PUJUKPUUKDRJKY-LTCKWSDVSA-N,,,Q8G2R2,HISTIDINOL DEHYDROGENASE,,,,17698620.0,IC50,=,6.0,NM,,,,,,,,,,,,,,Inhibition of Brucella suis histidinol dehydrogenase,Targeting of the Brucella suis virulence factor histidinol dehydrogenase by histidinol analogues results in inhibition of intramacrophagic multiplication of the pathogen.,Antimicrob. Agents Chemother.,PUBLICATION,
2724004,CHEMBL1605248,MLEJCMBLQQWZQP-UHFFFAOYSA-N,,,P34949,MANNOSE-6-PHOSPHATE ISOMERASE,MPI,,,,IC50,>,50000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate. (Class of assay: confirmatory) [Related pubchem assays: 1209 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
383512,CHEMBL3605284,BODXKWPKEKMDKV-UHFFFAOYSA-N,,,P41594,METABOTROPIC GLUTAMATE RECEPTOR 5,GRM5,,,26183084.0,%MAX,=,75.0,%,,cell_based,,,,,,,,,,,,Positive allosteric modulation of human mGlu5 receptor expressed in HEK293 cells by calcium mobilization assay relative to glutamate,Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2563425,CHEMBL3681376,LTMGOEAKUDIGQE-RZDIXWSQSA-N,,,P34998,CORTICOTROPIN RELEASING FACTOR RECEPTOR 1,CRHR1,,,,IC50,=,318.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Homogeneous Time-Resolved Fluorescence Assay. Chinese hamster ovary (CHO) cells expressing either the human or rat recombinant CRF-1 or human CRF-2alpha (Chen et al, Proc Natl Acad Sci USA 90, 8967-8971, 1993; Liaw et al, Endocrinology 137, 72-77, 1996) are propagated in Dulbecco's modified Eagle medium supplemented with 10% foetal calf serum, non-essential amino acids, 100 U/ml penicillin, 100 mg/l streptomycin and 1 g/l geneticin. CHO cells expressing the rat CRF-2beta receptor (Wu et al, Endocrinology 148, 1675-1687, 2007) are propagated in HAM's-F12 Glutamax supplemented with 10% foetal calf serum, 100 IU/ml penicillin, 100 mg/l streptomycin, 600 ug/ml hygromycin, 10 ug/ml blasticidin and induced with 1 ug/ml of tetracyclin for 24 hours prior to experimentation. For cyclic AMP determinations the Homogeneous Time-Resolved Fluoresce (HTRF) CAMP dynamic 2 kit (Cisbio International, France) was used as per manufacturers' instructions.",Cyclohexyl amide derivatives as CRF receptor antagonists,,PATENT,
4854618,CHEMBL1413811,WECRZNWEEHIFPR-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1375591,CHEMBL1477934,GTOGGNBOCNFIMN-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5505457,CHEMBL1078628,YWSWCOZFNGPLJG-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,19682899.0,IC50,<,10000.0,NM,,,,,,,,,,,,,,Inhibition of CYP3A4,"Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
927765,CHEMBL3196704,DWCQXZSEATZNGJ-JXAWBTAJSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
180341,CHEMBL2392751,ASDPKGVXTPRBSD-UHFFFAOYSA-N,,,P34913,EPOXIDE HYDRATASE,EPHX2,,,23498915.0,IC50,=,775.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human soluble epoxide hydrolase using CMNPC as substrate preincubated for 5 mins before substrate addition measured after 10 mins by fluorescence assay,"Design, synthesis and anti-tuberculosis activity of 1-adamantyl-3-heteroaryl ureas with improved in vitro pharmacokinetic properties.",Bioorg. Med. Chem.,PUBLICATION,
932846,CHEMBL1860272,DWPUERZIWCQCEW-UHFFFAOYSA-N,DNDI884132,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,,PAPP,=,34.8,10-6 CM/S,,cell_based,,,,,MDCK,,,,,,,DNDI: Apparent permeability from basolateral to apical side of the MDCK cell transfected with human MDR1 after 60 mins at a concentration of 3uM,Screening and optimization of specific chemical series against human African Trypanosomiasis (HAT),,DATASET,
844525,CHEMBL1399454,DNATVEAMVQJOSK-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
953059,CHEMBL1682553,DYSRECIVMDGUQU-UHFFFAOYSA-N,,,P45984,C-JUN N-TERMINAL KINASE 2,MAPK9,,,,KI,>,3981.07,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK9,PUBCHEM BIOASSAY DATA SET,,DATASET,
3425922,CHEMBL1451147,PKJYYOGRHWGJBE-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,IC50,=,3680.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of APOBEC3A DNA Deaminase Inhibitors via a A3G counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493011, AID493024]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2069967,CHEMBL1543270,JRSSDHSXGXHEQC-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5283375,CHEMBL1988657,XYPSMTZLBJAMNC-KGENOOAVSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4917770,CHEMBL271867,WKRVNRRBAKSSCD-UHFFFAOYSA-N,,,P45452,MATRIX METALLOPROTEINASE 13,MMP13,,,17980583.0,IC50,=,13.4,NM,,,,,,,,,,,,,,Inhibition of MMP13,Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs).,Bioorg. Med. Chem. Lett.,PUBLICATION,
169657,CHEMBL1880765,AQYMILPUFGLKPF-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2407879,CHEMBL595840,LCNDUGHNYMJGIW-UHFFFAOYSA-N,,,Q9GZR1,SENTRIN-SPECIFIC PROTEASE 6,SENP6,,,,IC50,=,1510.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS for inhibitors of Sentrin-specific protease 6 (SENP6) using a Luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2575, AID2582, AID2599]",PUBCHEM BIOASSAY DATA SET,,DATASET,
379608,CHEMBL1460113,BNSHWEKHNGIVJJ-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5063527,CHEMBL1486864,XASNKYCGWLTPPC-UHFFFAOYSA-N,,,P38532,HEAT SHOCK FACTOR PROTEIN 1,,,,,EC50,=,71687.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). (Class of assay: confirmatory) [Related pubchem assays: 2118 (Project Summary), 2098 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3797020,CHEMBL1909381,QZFLQLMWGKMMGY-UHFFFAOYSA-N,GW575808A,,P07948,TYROSINE-PROTEIN KINASE LYN,LYN,,,,INHIBITION,=,61.18,%,,,,,,,,,,,,,,GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1768836,CHEMBL1380801,IKHISGUWORJMOR-UHFFFAOYSA-N,,,P9WMR3,REPLICATIVE DNA HELICASE,,,,,AC50,=,1790.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence Cell-Free Homogeneous Secondary Screen to Identify Inhibitors of DnaB-Intein Splicing Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2223, AID489010, AID492950]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3883861,CHEMBL506153,RIIYKHQJSKRYKG-UHFFFAOYSA-N,GW876790X,,P78368,CASEIN KINASE I GAMMA 2,CSNK1G2,,,,INHIBITION,=,3.81,%,,,,,,,,,,,,,,GSK_PKIS: CK1-g2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2718669,CHEMBL1479202,MKWIABDPSURUEB-UHFFFAOYSA-N,,,O75604,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2,USP2,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
932329,CHEMBL1304888,DWNXKVBAOKIMQH-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
5386270,CHEMBL1403606,YJQTZMCQCQZVAR-UHFFFAOYSA-N,,,P10696,ALKALINE PHOSPHATASE PLACENTAL-LIKE,ALPPL2,,,,EC50,=,9080.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Luminescent assay for HTS discovery of chemical activators of placental alkaline phosphatase. (Class of assay: confirmatory) [Related pubchem assays: 518 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2790349,CHEMBL185875,MSRMAGLOYWBNOO-UHFFFAOYSA-N,,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,15293986.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity for human recombinant dopamine receptor D3,Dopamine/serotonin receptor ligands. 9. Oxygen-containing midsized heterocyclic ring systems and nonrigidized analogues. A step toward dopamine D5 receptor selectivity.,J. Med. Chem.,PUBLICATION,
4468230,CHEMBL77456,UOHFCPXBKJPCAD-UHFFFAOYSA-N,TYRPHOSTIN 1,,P54132,BLOOM SYNDROME PROTEIN,BLM,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
551862,CHEMBL327273,CGYRKCVESRIDHW-UHFFFAOYSA-N,,,"P33533, P34975, Q9R0C9, P33535",OPIOID RECEPTOR,,,,8411007.0,IC50,>,1000.0,NM,,tissue,,,,,,,,,,,,Inhibition of [3H]naxolone binding to opiate receptors in rat brain,"Chemistry, binding affinities, and behavioral properties of a new class of ""antineophobic"" mitochondrial DBI receptor complex (mDRC) ligands.",J. Med. Chem.,PUBLICATION,
3902372,CHEMBL1608825,RKFTZIAMCCNALR-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
455245,CHEMBL3414686,BWIXYHYMTKUOAF-UHFFFAOYSA-N,,,O60346,PH DOMAIN LEUCINE-RICH REPEAT-CONTAINING PROTEIN PHOSPHATASE 1,PHLPP1,,,25689347.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of PHLPP1-mediated reduction in phosphorylation of MDM2 in human PC3 cells after 24 hrs by Western blot analysis,Exploitation of the ability of ¿-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors.,J. Med. Chem.,PUBLICATION,
544138,CHEMBL132945,CGAYPCFRXYLKOE-SXINAPMGSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,1560443.0,IC50,=,84.0,NM,,,,,,,,,,,,,,Inhibitory activity of the Compound was tested against HIV protease enzyme.,Intriguing structure-activity relations underlie the potent inhibition of HIV protease by norstatine-based peptides.,J. Med. Chem.,PUBLICATION,
1025565,CHEMBL1479133,FGQAKTRLJLGYHD-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,9200.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3757938,CHEMBL1463072,QVAPLHWCWZKASO-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1448866,CHEMBL3334951,HBSSVIWDNWXSOY-UHFFFAOYSA-N,,,O94768,SERINE/THREONINE-PROTEIN KINASE 17B,STK17B,,,25178155.0,KD,,,,,,,,,,,,,,,,,Binding affinity to DRAK2 (unknown origin) ATP site,Discovery of dual death-associated protein related apoptosis inducing protein kinase 1 and 2 inhibitors by a scaffold hopping approach.,J. Med. Chem.,PUBLICATION,
4917493,CHEMBL1312313,WKQYCYIBTQRMTP-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4851721,CHEMBL1313343,WDWAIMPPHCHMRR-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,26679.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5418265,CHEMBL2037218,YNADGIAXXBCSQT-MWLSYYOVSA-N,,,Q16620,NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 2,NTRK2,,,,IC50,=,27.0,NM,,,,,,,,,,,,,,Inhibition of TRKB by HTRF assay,,ACS Med. Chem. Lett.,PUBLICATION,
5807202,CHEMBL1578706,,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1364025,CHEMBL4,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,OFLOXACIN,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,,KI,,,,,,,,,,Chem-1,,,,,,,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),DrugMatrix in vitro pharmacology data,,DATASET,
3449866,CHEMBL1621,PMXMIIMHBWHSKN-UHFFFAOYSA-N,PALIPERIDONE,,P28335,SEROTONIN 2C (5-HT2C) RECEPTOR,HTR2C,,,11132243.0,KI,=,48.0,NM,,,,,,,,,,,,,,,,,,
3038093,CHEMBL598996,NTUOVTZYWIFOND-UHFFFAOYSA-N,,,P00742,COAGULATION FACTOR X,F10,,,20121197.0,KI,=,1482.0,NM,,,,,,,,,,,,,,Inhibition of factor 10a by amidolytic assay,Structure based drug design: development of potent and selective factor IXa (FIXa) inhibitors.,J. Med. Chem.,PUBLICATION,
5337667,CHEMBL1420189,YEEBRLYWONMNBK-UHFFFAOYSA-N,,,Q9UBT6,DNA POLYMERASE KAPPA,POLK,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],PUBCHEM BIOASSAY DATA SET,,DATASET,
5560851,CHEMBL359283,ZCMSIAOBLBPCMZ-MDWZMJQESA-N,,,"P10980, P08911, P08485, P08482, P08483",MUSCARINIC ACETYLCHOLINE RECEPTOR,,,,,IC50,=,11000.0,NM,,,,,,,,,,,,,,In vitro binding affinity against Muscarinic receptor in rat cerebral cortex using [3H]- oxotremorine-M (OXO-M) using as a radioligand,,Bioorg. Med. Chem. Lett.,PUBLICATION,
5275705,CHEMBL1651129,XXUHSYCMSYGREM-UHFFFAOYSA-N,,,P22303,ACETYLCHOLINESTERASE,ACHE,,,21074294.0,IC50,=,3.63,NM,,,,,,,,,,,,,,Inhibition of human acetylcholinesterase,Receptor-dependent (RD) 3D-QSAR approach of a series of benzylpiperidine inhibitors of human acetylcholinesterase (HuAChE).,Eur. J. Med. Chem.,PUBLICATION,
3578597,CHEMBL1500690,QBJQEQYZERVILO-LCYFTJDESA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3300267,CHEMBL1472278,OWNGGUQUSRKSHE-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
401872,CHEMBL1446880,BQHMKUHKKQPGKA-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3833489,CHEMBL3687473,RCZYLHFODBPYHX-DUGAHGDYSA-N,,,Q86V86,SERINE/THREONINE-PROTEIN KINASE PIM3,PIM3,,,,IC50,=,94.75,NM,,,,,,,,,,,,,,"BindingDB_Patents: AlphaScreen Assay. Pim 1, Pim 2  and  Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2,  and  Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",Ring-substituted N-pyridinyl amides as kinase inhibitors,,PATENT,
1689321,CHEMBL53926,IBDYTAASXOAYPU-UHFFFAOYSA-N,,,Q15722,LEUKOTRIENE B4 RECEPTOR 1,LTB4R,,,1316967.0,INHIBITION,=,23.0,%,,,,,,,,,,,,,,"Inhibition of [3H]LTB4 binding to leukotriene B4 receptor from human peripheral neutrophils (PMN), at a concentration of 1 uM",Leukotriene B4 receptor antagonists: the LY255283 series of hydroxyacetophenones.,J. Med. Chem.,PUBLICATION,
4096143,CHEMBL406255,SFTBITFMIRXEJU-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4969777,CHEMBL1544904,WQRNWHAQOXBYKH-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,316227.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
874874,CHEMBL19019,DQCKKXVULJGBQN-XFWGSAIBSA-N,NALTREXONE,,P35372,MU OPIOID RECEPTOR,OPRM1,,,19282177.0,IMAX,=,93.0,%,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human mu opioid receptor expressed in CHO cells assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding,Syntheses of novel high affinity ligands for opioid receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4980138,CHEMBL2420556,WRXMCDABCCZKSX-NSISKUIASA-N,,,Q9UBS0,RIBOSOMAL PROTEIN S6 KINASE 2,RPS6KB2,,,23916259.0,INHIBITION,<,35.0,%,,,,,,,,,,,,,,Inhibition of p70S6Kbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,"Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5173353,CHEMBL3654387,XMIOVXNHWDNUGJ-UHFFFAOYSA-N,,,P27815,PHOSPHODIESTERASE 4A,PDE4A,,,,IC50,=,106.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. Human recombinant PDE4 (Genbank accession no NM006203) was incubated for 1 hour, with the test compound at concentrations up to 10 µM, with cAMP (1x10-5M) , and with a low amount (0.021 MBq) of radioactively labelled cAMP. At the end of the incubation, the cleavage of the substrate was evaluated by the binding of the AMP product to SPA beads, which generate chemoluminescence when bound to the radioactive tracer. The AMP product inhibited the binding of the radioactive tracer to the beads, and the luminescent signal was competed.",Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitors,,PATENT,
3572618,CHEMBL1430240,QARIOAFKWVRWIH-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5366195,CHEMBL1491332,YHIGKRWMMAMOII-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1458730,CHEMBL365286,HCRQPXYLXXLKPT-UHFFFAOYSA-N,GW549034X,UNC10112830A,P57059,SERINE/THREONINE-PROTEIN KINASE SIK1,SIK1,,,,INHIBITION,=,7.65,%,,,,,,,,,,,,,,GSK_PKIS: SNF1LK (SIK) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5111925,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,GEFITINIB,,P11362,FIBROBLAST GROWTH FACTOR RECEPTOR 1,FGFR1,,,,KI,>,3981.07,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FGFR1,PUBCHEM BIOASSAY DATA SET,,DATASET,
889297,CHEMBL1452621,DRORPJHUSREEOR-UHFFFAOYSA-N,,,P34949,MANNOSE-6-PHOSPHATE ISOMERASE,MPI,,,,IC50,>,50000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS identification of compounds inhibiting phosphomannose isomerase (PMI) via a fluorescence intensity assay using a high concentration of mannose 6-phosphate. (Class of assay: confirmatory) [Related pubchem assays: 1209 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2543253,CHEMBL1550429,LRGZDVZRQLEOKY-YBFXNURJSA-N,,,Q9Y2R2,HEMATOPOIETIC CELL PROTEIN-TYROSINE PHOSPHATASE 70Z-PEP,PTPN22,,,,IC50,=,2600.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR LYP1 Fluorescent Assay using OMFP substrate for In Vitro dose response studies - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1779, AID1784, AID2140, AID2686]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4393814,CHEMBL1547049,UGJWYHQQHCLYME-UHFFFAOYSA-N,,,"Q00975, Q02410",VOLTAGE-GATED N-TYPE CALCIUM CHANNEL ALPHA-1B SUBUNIT/AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING FAMILY A MEMBER 1,"APBA1, CACNA1B",,,,IC50,>,50000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: uHTS Homogeneous Terbium Time-Resolved Fluorescence Resonance Energy Transfer (HTRF) Assay. Confirmatory Screen for inhibitors of association between Mint1-PDZ domains and N-type Ca2+ channel carboxyl-terminal peptide (NC peptide). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2093, AID2489, AID2496, AID434980]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2417460,CHEMBL1350970,LDQPURBNRXHPMQ-UHFFFAOYSA-N,,,Q06710,PAIRED BOX PROTEIN PAX-8,PAX8,,,,AC50,=,41470.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4753661,CHEMBL1377539,VTCWYLBKAXUUEM-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3577689,CHEMBL1581772,QBGNBCNFOZTKHI-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5788659,CHEMBL1527836,,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
2876196,CHEMBL163,NCDNCNXCDXHOMX-XGKFQTDJSA-N,RITONAVIR,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,16248836.0,KINACT,=,0.135,MIN-1,,,,,,,,,,,,,,Mechanism based inhibition of human cytochrome P450 3A4 using recombinant CYP3A4,Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.,Curr. Drug Metab.,PUBLICATION,
5089658,CHEMBL185710,XDQUYQKTDSDQRL-UHFFFAOYSA-N,SB-738561,,P07949,TYROSINE-PROTEIN KINASE RECEPTOR RET,RET,,,,INHIBITION,=,1.52,%,,,,,,,,,,,,,,GSK_PKIS: RET (Y791F mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4328644,CHEMBL580100,TZGCXBDYBGHQNZ-UHFFFAOYSA-N,TCMDC-138054,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,0.12,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1498202,CHEMBL1464803,HGTVASIJTSGWKX-UHFFFAOYSA-N,,,P54132,BLOOM SYNDROME PROTEIN,BLM,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
866078,CHEMBL410456,DPDZHVCKYBCJHW-UHFFFAOYSA-N,,,P05129,PROTEIN KINASE C GAMMA,PRKCG,wild_type,,22037377.0,ACTIVITY,=,93.17196059,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,HISTONE H1 + ,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
4694540,CHEMBL206544,VMRIQAPFNJVYQI-UHFFFAOYSA-N,GW682841X,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,,INHIBITION,=,3.3,%,,,,,,,,,,,,,,GSK_PKIS: MET mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3796930,CHEMBL1909381,QZFLQLMWGKMMGY-UHFFFAOYSA-N,GW575808A,,P29376,LEUKOCYTE TYROSINE KINASE RECEPTOR,LTK,,,,INHIBITION,=,15.94,%,,,,,,,,,,,,,,GSK_PKIS: LTK mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4580185,CHEMBL3623448,VACYSOBRJYAGAW-NOLDGVLCSA-N,,,P62993,GROWTH FACTOR RECEPTOR-BOUND PROTEIN 2,GRB2,,,26359549.0,KD,=,200000.0,NM,,,,,,,,,,,,,,Binding affinity to GST-tagged Grb2-SH2 domain (58 to 160 amino acid residues) (unknown origin) expressed in Escherichia coli BL21 (DE3) using 20 mM Tris/1 mM NaPO4 buffer by SPR analysis,Cyclic Peptides Incorporating Phosphotyrosine Mimetics as Potent and Specific Inhibitors of the Grb7 Breast Cancer Target.,J. Med. Chem.,PUBLICATION,
5475523,CHEMBL3431488,YTHCTEVKCAABIK-GOSISDBHSA-N,,,P50416,"CARNITINE O-PALMITOYLTRANSFERASE 1, LIVER ISOFORM",CPT1A,,,,IC50,=,177.1,NM,,,,,,,,,,,,,,"SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 1, liver isoform",Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752).,,DATASET,
966147,CHEMBL423106,FACAUYLYCYUNSS-NNQWSVJYSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,2002465.0,IC50,=,12.0,NM,,,,,,,,,,,,,,Inhibition of HIV-1 protease,"L-687,908, a potent hydroxyethylene-containing HIV protease inhibitor.",J. Med. Chem.,PUBLICATION,
191195,CHEMBL1466730,ATFGMWVJEANVNV-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,501.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1427810,CHEMBL68673,GZLYKTPRCWBDRJ-UHFFFAOYSA-N,,,P16184,DIHYDROFOLATE REDUCTASE,,,,7783147.0,IC50,=,279000.0,NM,,,,,,,,,,,,,,Inhibition of Pneumocystis carinii (pc) Dihydrofolate reductase,"Novel 2,4-diamino-5-substituted-pyrrolo[2,3-d]pyrimidines as classical and nonclassical antifolate inhibitors of dihydrofolate reductases.",J. Med. Chem.,PUBLICATION,
496527,CHEMBL1798007,CBAVAZZYVBNYMS-YZYNAAERSA-N,,,Q9UBN7,HISTONE DEACETYLASE 6,HDAC6,,,21476600.0,IC50,=,94.0,NM,,,,,,,,,,,,,,Inhibition of HDAC6 in human HeLa cell nuclear extract after 30 mins by fluorescence microplate reader,Development of tetrahydroisoquinoline-based hydroxamic Acid derivatives: potent histone deacetylase inhibitors with marked in vitro and in vivo antitumor activities.,J. Med. Chem.,PUBLICATION,
3458620,CHEMBL1555276,PNXHSSOWTQDWLE-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1546436,CHEMBL317047,HLKHIJZYKGDCJM-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
1308956,CHEMBL428877,GLWRGNCTKNNGMV-UHFFFAOYSA-N,SB-242719,,Q9BUB5,MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE MNK1,MKNK1,,,,INHIBITION,=,2.17,%,,,,,,,,,,,,,,GSK_PKIS: MKNK1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4713166,CHEMBL1309100,VOQFSAABMCFTSE-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4257876,CHEMBL2139261,SXSHDFFJJUKAHR-OMCISZLKSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,23109.3,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1336633,CHEMBL3319485,GOYGSVJFUAFYBM-UHFFFAOYSA-N,,,P42338,PI3-KINASE P110-BETA SUBUNIT,PIK3CB,,,24992874.0,IC50,=,4.0,NM,,cell_based,,,,,,,,,,,,Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay,"Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kß/d inhibitors for the treatment of PTEN-deficient tumours.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2848560,CHEMBL1575242,MYWXEAVGQMULNC-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,5.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3177817,CHEMBL121306,OJEWBVIQOKRDGN-OBGWFSINSA-N,,,P21731,THROMBOXANE A2 RECEPTOR,TBXA2R,,,7932586.0,IC50,=,19700.0,NM,,,,,,,,,,,,,,In vitro thromboxane-A2 receptor binding affinity to displace by 50% [3H]-SQ 29548 binding from washed human platelets,Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.,J. Med. Chem.,PUBLICATION,
2332733,CHEMBL941,KTUFNOKKBVMGRW-UHFFFAOYSA-N,IMATINIB,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,wild_type,,21336281.0,KI,<,2511.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
3535343,CHEMBL1386999,PWJSLQXLZBRLLC-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1992466,CHEMBL157681,JJASUKKHMYLBLQ-FLIBITNWSA-N,,,"P08173, P11229, P08912, P20309, P08172",MUSCARINIC ACETYLCHOLINE RECEPTOR,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",,,8496940.0,ED50,=,3.38,MG.KG-1,,organism_based,,,,,,,,,,,,In vivo antimuscarinic activity evaluated for its liability to cause mydriasis in guinea pig,Synthesis and antimuscarinic activity of some 1-cycloalkyl-1-hydroxy-1-phenyl-3-(4-substituted piperazinyl)-2-propanones and related compounds.,J. Med. Chem.,PUBLICATION,
2477596,CHEMBL2356471,LKOQAWXJCPYWSX-CWJKEVGVSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,562.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5367323,CHEMBL1317546,YHKSBKQXCWHTQL-UHFFFAOYSA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,wild_type,,23398362.0,ACTIVITY,=,148.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of IGF1R at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1852152,CHEMBL2058631,ITKQNORKNISIMB-UHFFFAOYSA-N,,,"P18825, P08913, P18089",ADRENERGIC RECEPTOR ALPHA-2,"ADRA2A, ADRA2B, ADRA2C",,,25521963.0,KI,>,1949.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]RX821002 from human alpha2 adrenoceptor expressed in CHO cell membranes after 60 mins,Synthesis and biological evaluation of 2-aryliminopyrrolidines as selective ligands for I1 imidazoline receptors: discovery of new sympatho-inhibitory hypotensive agents with potential beneficial effects in metabolic syndrome.,J. Med. Chem.,PUBLICATION,
255038,CHEMBL1567171,BAGOULQZYKWFAB-PKNBQFBNSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2995279,CHEMBL757,NPAGDVCDWIYMMC-IZPLOLCNSA-N,NANDROLONE,,P27361,MAP KINASE ERK1,MAPK3,,,,KI,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK1 enzyme inhibition (substrate: Myelin Basic Protein)",DrugMatrix in vitro pharmacology data,,DATASET,
1001323,CHEMBL1398567,FDWLJUMPTGOJRS-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5690028,CHEMBL1474637,ZQRLQLAIUNELOZ-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3184257,CHEMBL1539677,OJZJBJXHNJXFCJ-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5505322,CHEMBL1413611,YWSINDKDXWZJJY-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5599748,CHEMBL1940990,ZGPDFKYQHBHSHB-LBPRGKRZSA-N,,,O14920,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE BETA SUBUNIT,IKBKB,,,22202172.0,INHIBITION,<,35.0,%,,cell_based,,,,,HL-60,,,,,,,Inhibition of human IKK-beta in HL-60 cells lysate assessed as reduction of labelling of acyl-phosphate ATP probe at 100 nM,6-Position optimization of tricyclic 4-quinolone-based inhibitors of glycogen synthase kinase-3ß: discovery of nitrile derivatives with picomolar potency.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4241847,CHEMBL204203,SVTVRSOEVPGOAD-UHFFFAOYSA-N,,,O49150,5-LIPOXYGENASE,,,,16509583.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibitory activity against potato 5LOX,"Synthesis and structure-activity relationship studies of 1,3-diarylprop-2-yn-1-ones: dual inhibitors of cyclooxygenases and lipoxygenases.",J. Med. Chem.,PUBLICATION,
4724534,CHEMBL1320454,VPUNIILZZWBPBX-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,946.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5445945,CHEMBL3286535,YPUAFOARVDJZIY-UHFFFAOYSA-N,,,P63096,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(I), ALPHA-1 SUBUNIT",GNAI1,,,24818958.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Binding affinity to Galphai1 (unknown origin) coupled with alpha-2 adrenoceptor transfected in HEK293 GloSensor cells assessed as restoration of Fsk/UK14304-induced reduction of cAMP at 0.1 to 10 uM preincubated for 20 mins followed by Fsk/UK14304 induction measured every 2 secs by FLIPR assay,Development of inhibitors of heterotrimeric Gai subunits.,Bioorg. Med. Chem.,PUBLICATION,
5635713,CHEMBL1893682,ZKTPJKZATUUCSI-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,1778.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5333301,CHEMBL318825,YDPXWWTXCJURFR-QLTSDVKISA-N,,,Q95214,ACYL-COA:CHOLESTEROL ACYLTRANSFERASE,,,,8411011.0,IC50,=,210.0,NM,,,,,,,,,,,,,,In vitro inhibition of Acyl coenzyme A:cholesterol acyltransferase in intestinal microsomes isolated from cholesterol-fed rabbits,Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agents.,J. Med. Chem.,PUBLICATION,
3561493,CHEMBL1400568,PZJPBWRMOCJEBR-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3143337,CHEMBL1454701,OFLVUPBFIQKJIE-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3232963,CHEMBL1794068,OPJOIUDMJCRLNO-QGZVFWFLSA-N,GSK-326090A,,Q13188,SERINE/THREONINE-PROTEIN KINASE MST2,STK3,,,,INHIBITION,=,56.72,%,,,,,,,,,,,,,,GSK_PKIS: MST2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1596476,CHEMBL2180579,HRDUBWKMVYMKHI-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,23098137.0,INHIBITION,=,8.0,%,,,,,,,,,,,,,,"Inhibition of KDR at 10 uM incubated for 60 mins using poly(Glu,Tyr)4:1 substrate and 10 uM ATP by ELISA","Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties.",J. Med. Chem.,PUBLICATION,
4433660,CHEMBL476259,UKKOZAHWQFYYRW-UHFFFAOYSA-N,GSK-1326255A,,Q9HBH9,MAP KINASE SIGNAL-INTEGRATING KINASE 2,MKNK2,,,,INHIBITION,=,3.26,%,,,,,,,,,,,,,,GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4108753,CHEMBL148369,SHCLHGQKJMOYER-UHFFFAOYSA-M,,,P04058,ACETYLCHOLINESTERASE,,,,8978837.0,IC50,=,1160000.0,NM,,,,,,,,,,,,,,Inhibitory activity against Acetylcholinesterase,Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors.,J. Med. Chem.,PUBLICATION,
496818,CHEMBL75860,CBBXSFLTMNJOGU-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,,ED50,>,30.0,MG.KG-1,,organism_based,,,,,,,,,,,,In vivo potency was determined in anti-mescaline scratch assay(peroral administration),,Bioorg. Med. Chem. Lett.,PUBLICATION,
4200520,CHEMBL1431953,SRFXJTJKQWBUMX-UHFFFAOYSA-N,,,Q9Y5X4,PHOTORECEPTOR-SPECIFIC NUCLEAR RECEPTOR,NR2E3,,,,IC50,=,18815.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: TR-FRET-based biochemical high throughput dose response assay to identify NR2E3 inverse agonists. (Class of assay: confirmatory) [Related pubchem assays: 2379 (Confirmation (NR2E3 agonists in quadruplicate)), 2759 (Dose response counterscreen (PPARg and NCOR2 interaction agonists in triplicate)), 2758 (Dose response (NR2E3 agonists in quadruplicate)), 2325 (Summary (NR2E3 agonists)), 2300 (Primary screen (NR2E3 agonists in singlicate))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1219671,CHEMBL572878,GCIKSSRWRFVXBI-UHFFFAOYSA-N,TOZASERTIB,,Q8IWQ3,BR SERINE/THREONINE-PROTEIN KINASE 2,BRSK2,wild_type,,19035792.0,ACTIVITY,=,8.7,%,inhibition,physiochemical,binding,binding_reversible,competitive_inhibitor,qPCR,,10000,NM,,,,,Binding affinity to human BRSK2 at 10 uM relative to control,Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.,J. Med. Chem.,PUBLICATION,
4292494,CHEMBL1582442,TVEMCWDCOUVOPM-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3326901,CHEMBL1454826,OZNCQCKNEBLWAM-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4411937,CHEMBL2391917,UIBSLLYDPMQGGE-UHFFFAOYSA-N,,,P42574,CASPASE-3,CASP3,,,23632366.0,IC50,=,4167.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human caspase-3 using Ac-LDEVD-AMC as substrate assessed as accumulation of 7-AMC incubated for 10 mins followed by substrate addition measured for 10 mins by fluorimetric analysis,"Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
2361071,CHEMBL1465869,KXAHTHUGPBSXNS-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,3264.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3987158,CHEMBL99,RTKIYFITIVXBLE-QEQCGCAPSA-N,TRICHOSTATIN,,"Q5RJZ2, Q4QQW4, Q99P96, Q99P97, Q6P6W3, Q99P99, B1WBY8",HISTONE DEACETYLASE,,,,15456267.0,IC50,=,26.3,NM,,,,,,,,,,,,,,Inhibitory concentration against rat liver histone deacetylase (HDAC) with substrate 5a,Subtype selective substrates for histone deacetylases.,J. Med. Chem.,PUBLICATION,
4986471,CHEMBL1491841,WSOISFMHBFFWRQ-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,1584.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3441885,CHEMBL1525314,PMDXJRHNRGXQOK-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1781940,CHEMBL2007163,ILTZFGLQVVJAHO-VCHYOVAHSA-N,,,P10520,STREPTOKINASE A,,,,,EC50,>,150000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Absorbance Microorganism-Based Dose Response HTS to Identify Inhibitors of Streptokinase Expression. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1902 (Retest at Dose), 1900 (Counter Screen), 1662 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
476415,CHEMBL1256914,BYWAIYMZODCNFQ-ASTDGNLGSA-M,,,P0A6C1,ENDONUCLEASE 4,,,,,POTENCY,=,11.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen for APE1 Inhibitors: qHTS Validation Assay for Inhibitors of Endonuclease IV. (Class of assay: confirmatory) [Related pubchem assays: 1705, 1707 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3173809,CHEMBL1446583,OIRRLBNRSNJFIQ-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
2053866,CHEMBL47156,JQANFDBJZOIYMB-QJCLFNHPSA-N,,,P97266,MU OPIOID RECEPTOR,,,,1851843.0,IC50,=,350.0,NM,,tissue,,,,,,,,,,,,Inhibition of opioid receptor mu in guinea pig ileum (GPI),Synthesis and structure-activity relationships of deltorphin analogues.,J. Med. Chem.,PUBLICATION,
4806380,CHEMBL1398884,VYYKPJBFJUHMNG-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
932220,CHEMBL2171208,DWNPMJOWAWGIMM-HTKHVQBFSA-N,10ALPHA-DIHYDROXYAROMADENDRANE,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,22934600.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of c-MET assessed as inhibition of HGF-induced phosphorylation at 5 uM by Western blotting analysis,Potent HGF/c-Met axis inhibitors from Eucalyptus globulus: the coupling of phloroglucinol and sesquiterpenoid is essential for the activity.,J. Med. Chem.,PUBLICATION,
3606801,CHEMBL13868,QESOEGOVASIYOF-UHFFFAOYSA-N,SB-245392,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,,INHIBITION,=,1.04,%,,,,,,,,,,,,,,GSK_PKIS: JAK3 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2966933,CHEMBL222955,NLWVUJBQWNYFGM-UHFFFAOYSA-N,,,Q8TDS4,HYDROXYCARBOXYLIC ACID RECEPTOR 2,HCAR2,,,17358052.0,EC50,=,41000.0,NM,,cell_based,,,,,CHO,,,,,,,Activity at GPR109a in CHO cells assessed as inhibition of forskolin-induced cAMP generation,"Analogues of acifran: agonists of the high and low affinity niacin receptors, GPR109a and GPR109b.",J. Med. Chem.,PUBLICATION,
1567121,CHEMBL3207809,HNVGWSFMBJIGDZ-CPNJWEJPSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2301152,CHEMBL43612,KQPYUDDGWXQXHS-UHFFFAOYSA-N,JUGLONE,,P46063,ATP-DEPENDENT DNA HELICASE Q1,RECQL,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 594 (Rhodamine region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2549 (qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5229228,CHEMBL284969,XSMYYYQVWPZWIZ-IDTAVKCVSA-N,,,P28647,ADENOSINE A3 RECEPTOR,,,,16366590.0,KI,=,237.0,NM,,cell_based,,,,,CHO,,,,,,,Binding affinity to rat adenosine A3 receptor in CHO cells,Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection.,J. Med. Chem.,PUBLICATION,
4051642,CHEMBL1741737,SATGOWLCENJTDP-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
398143,CHEMBL1605789,BPVFSHVFYDLETP-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3490540,CHEMBL1945307,PRMGBNOSLSTPFM-UHFFFAOYSA-N,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,22112208.0,IC50,=,600.0,NM,,cell_based,,,,,MDCK,,,,,,,Inhibition of human MDR1 expressed in MDCK cells assessed as calcein AM accumulation after 30 mins by fluorescence assay,Potent galloyl-based selective modulators targeting multidrug resistance associated protein 1 and P-glycoprotein.,J. Med. Chem.,PUBLICATION,
3945226,CHEMBL385486,ROWADKGPCYXCSV-UHFFFAOYSA-N,,,P16581,SELECTIN E,SELE,,,17004713.0,INHIBITION,=,44.0,%,,,,,,,,,,,,,,Inhibition of MM6 cell adhesion to recombinant E-selectin at 100 uM relative to control by flow chamber assay,A novel class of potent nonglycosidic and nonpeptidic pan-selectin inhibitors.,J. Med. Chem.,PUBLICATION,
291001,CHEMBL1398488,BEJUIUSGRZJQQS-ZDUSSCGKSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1391359,CHEMBL1532212,GVHRWZDQEOFUJU-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4595626,CHEMBL1994029,VBURFKNIYQPTAJ-VYKQZUBZSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3300188,CHEMBL299147,OWMWWMZMOLIDRD-UHFFFAOYSA-N,,,Q9WTR4,NOREPINEPHRINE TRANSPORTER,,,,2754707.0,IC50,=,270.0,NM,,,,,,,,,,,,,,Inhibition of norepinephrine reuptake in rat whole brains minus cerebellar,"9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.",J. Med. Chem.,PUBLICATION,
2607329,CHEMBL605756,LYHDMCHAMJFTNL-UHFFFAOYSA-N,,,P28845,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,HSD11B1,,,20064717.0,IC50,=,18.3,NM,,cell_based,,,,,,,,,,,,Inhibition of 11beta-HSD1 in human adipocytes assessed as conversion of [3H]cortisone to [3H]cortisol after 2 hrs by SPA,Spirocyclic ureas: orally bioavailable 11beta-HSD1 inhibitors identified by computer-aided drug design.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2769553,CHEMBL1630737,MQFZSQWLAAKTRJ-UHFFFAOYSA-N,,,P05164,MYELOPEROXIDASE,MPO,,,21090682.0,IC50,=,17.0,NM,,,,,,,,,,,,,,Inhibition of recombinant MPO mediated LDL oxidation using MPO/Cl-/H2O2 system,"Structure-based design, synthesis, and pharmacological evaluation of 3-(Aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors.",J. Med. Chem.,PUBLICATION,
5458786,CHEMBL3676324,YRFNUGHTYVDUEW-UHFFFAOYSA-N,,,P11362,FIBROBLAST GROWTH FACTOR RECEPTOR 1,FGFR1,,,,IC50,=,10.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Inhibition Assay. The FGFR1-inhibiting activity was measured based on the activity to inhibit phosphorylation of the biotinylated peptide EGPWLEEEEEAYGWMDF by the human FGFR1 enzyme (Carna Biosciences, cat. 08-133). Phosphorylated biotinylated peptides were detected by the time-resolved fluorescent measurement using a europium cryptate-linked anti-phophotyrosine antibody and a streptavidin to which XL665, a derivative of allophycocyanine, is linked. The 50% inhibitory concentration (IC50) was calculated based on the inhibitory rate against the control group without test substances.",Aminopyrazole derivative,,PATENT,
852754,CHEMBL1557340,DNYFQKUVLWRPEU-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
246827,CHEMBL1508733,AZIBZDBUNORFDM-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4139932,CHEMBL1221505,SKRPIZKCJOMGQH-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,20659802.0,KI,=,650.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells by liquid scintillation counting,Hit-to-lead optimization of a series of carboxamides of ethyl 2-amino-4-phenylthiazole-5-carboxylates as novel adenosine A2A receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2677108,CHEMBL1565788,MFXBSJCZJNBVBS-UHFFFAOYSA-M,,,O75496,GEMININ,GMNN,,,,POTENCY,,29.1,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2767049,CHEMBL3321790,MPWWGTFDWDZHRM-UHFFFAOYSA-N,,,P41595,SEROTONIN 2B (5-HT2B) RECEPTOR,HTR2B,,,25070422.0,KI,=,1057.0,NM,,,,,,,,,,,,,,Displacement of [3H]LSD from human 5-HT2B receptor by liquid scintillation counting,Further evaluation of the tropane analogs of haloperidol.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1869178,CHEMBL1351826,IVJJXOJDKQMWEP-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
499159,CHEMBL58300,CBHVQNBRMQPDQO-UHFFFAOYSA-N,,,"P0AES4, P0AES6",DNA GYRASE,,,,8393112.0,IC50,=,3.8,UG.ML-1,,,,,,,,,,,,,,Inhibition of the gyrase mediated cleavage of supercoiled DNA,Quinolone antibacterials: synthesis and biological activity of carbon isosteres of the 1-piperazinyl and 3-amino-1-pyrrolidinyl side chains.,J. Med. Chem.,PUBLICATION,
2075325,CHEMBL1592,JSDRRTOADPPCHY-HSQYWUDLSA-N,QUINAPRIL,,P08173,MUSCARINIC ACETYLCHOLINE RECEPTOR M4,CHRM4,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
5101184,CHEMBL1513876,XEYPTLMTBIQIKN-UHFFFAOYSA-N,,,P15917,ANTHRAX LETHAL FACTOR,,,,,POTENCY,=,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2579408,CHEMBL29582,LVACOVVOTCZAIW-JVVMDBNWSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,12467633.0,IC50,=,150.0,NM,,,,,,,,,,,,,,Binding affinity towards human melanocortin receptor hMC4R by using radioligand NDP-MSH,Structure-activity relationship of linear peptide Bu-His-DPhe-Arg-Trp-Gly-NH(2) at the human melanocortin-1 and -4 receptors: histidine substitution.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2950570,CHEMBL1589737,NKBSAVIPKRSEKM-KORDQABASA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2829185,CHEMBL1230790,MWYBBCLGEHZSCP-UHFFFAOYSA-N,,,Q13188,SERINE/THREONINE-PROTEIN KINASE MST2,STK3,,,18849971.0,INHIBITION,=,68.0,%,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,1,uM,ATP,=,10.0,uM,Inhibition of STK3 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP,Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases.,Nat. Chem. Biol.,PUBLICATION,Z'LYTE - Traditional FRET
1344964,CHEMBL394458,GPVSZOMDYRDHHS-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,1835.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1627739,CHEMBL3189331,HUTIQFNMDMVQLK-CXUHLZMHSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
304537,CHEMBL269985,BFVNHKDXWONWHN-UHFFFAOYSA-N,GW701032X,,Q9Y243,SERINE/THREONINE-PROTEIN KINASE AKT3,AKT3,,,,INHIBITION,=,0.06,%,,,,,,,,,,,,,,GSK_PKIS: AKT3 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4132316,CHEMBL2031659,SJSKVKZHRFSEFG-SANMLTNESA-N,,,P20292,5-LIPOXYGENASE ACTIVATING PROTEIN,ALOX5AP,,,22578458.0,IC50,=,534.0,NM,,,,,,,,,,,,,,Inhibition of 5-lipoxygenase-activating protein in human polymorphonuclear cells assessed as inhibition of calcium ionophore-induced LTB4 production in presence of human whole blood,Evaluation of endo- and exo-aryl-substitutions and central scaffold modifications on diphenyl substituted alkanes as 5-lipoxygenase activating protein inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3667069,CHEMBL1461004,QLIOCPLACUJFCE-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
985826,CHEMBL3194720,FCCJENFMZNHMMA-LFYBBSHMSA-N,,,Q94696,LUCIFERASE,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Counterscreen for Luciferase (Kinase-Glo TM) Inhibition. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1031277,CHEMBL495506,FHGXQWVKVRXZHN-UHFFFAOYSA-N,,,Q03181,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA,PPARD,,,18722772.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human PPARdelta by Gal4 chimera cell-based reporter assay,Discovery of a novel class of PPARdelta partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2995186,CHEMBL2133591,NPAFYIBJLDOSDY-UBFVSLLYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2131751,CHEMBL1427554,JYFIHIWXQSVJIL-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4569652,CHEMBL396567,UYZGGVMCTYTMRJ-WCBMZHEXSA-N,,,"P43681, P17787",NEURONAL ACETYLCHOLINE RECEPTOR; ALPHA4/BETA2,"CHRNA4, CHRNB2",,,17929796.0,EC50,=,1600.0,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at recombinant human alpha-4-beta-2 nAChR expressed in HEK293 cells assessed as induction of calcium influx by FLIPR assay,"Synthesis and structure-activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel alpha4beta2 nicotinic acetylcholine receptor selective agonists.",J. Med. Chem.,PUBLICATION,
5845423,CHEMBL3735080,,,,P11214,TISSUE-TYPE PLASMINOGEN ACTIVATOR,,,,26536069.0,Ki,>,1000000.0,NM,,,,,,,,,,,,,,Inhibition of mouse tPA after 15 mins using Z-D-Arg-Gly-Arg-p-nitroanilide as substrate,Design of Specific Serine Protease Inhibitors Based on a Versatile Peptide Scaffold: Conversion of a Urokinase Inhibitor to a Plasma Kallikrein Inhibitor.,J. Med. Chem.,PUBLICATION,
1459414,CHEMBL247067,HCTDQRULARFYTB-UHFFFAOYSA-N,,,P48730,CASEIN KINASE I DELTA,CSNK1D,,,17350261.0,INHIBITION,=,111.0,%,,,,,,,,,,,,,,Inhibition of CK1delta at 1 uM relative to control,"Novel bis(indolyl)maleimide pyridinophanes that are potent, selective inhibitors of glycogen synthase kinase-3.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5755160,CHEMBL1341300,ZXWAHHRBFVCEAR-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1885903,CHEMBL197717,IXGRKPFGSCOIIW-KEKNWZKVSA-N,,,P10980,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,,,,16220976.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity for rat heart muscarinic acetylcholine receptor M2 using [3H]quinuclidinyl benzilate,"Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.",J. Med. Chem.,PUBLICATION,
4751050,CHEMBL1682341,VSVKFEMFAYXZKR-UHFFFAOYSA-N,,,Q96GD4,SERINE/THREONINE-PROTEIN KINASE AURORA-B,AURKB,,,,KI,=,398.11,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK12,PUBCHEM BIOASSAY DATA SET,,DATASET,
5635980,CHEMBL1345080,ZKUHFPXPISFEHA-UHFFFAOYSA-N,,,P10520,STREPTOKINASE A,,,,,EC50,=,5057.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
325358,CHEMBL36450,BHWCZLOXTLWZAQ-UHFFFAOYSA-N,SC-68376,,"O96020, P24941, P24864",CYCLIN-DEPENDENT KINASE 2/CYCLIN E,"CCNE1, CCNE2, CDK2",,,23398362.0,ACTIVITY,=,95.0,%,,,,,,,,,,,,,,"Millipore: Percentage of residual kinase activity of CDK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,
5164421,CHEMBL1713443,XLMOXUBIZAOHKV-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3076032,CHEMBL153771,NYDUUDHYORKLIC-UHFFFAOYSA-N,,,P12268,INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2,IMPDH2,,,12565969.0,IC50,=,83.0,NM,,,,,,,,,,,,,,Inhibitory activity against inosine monophosphate dehydrogenase IMPDH II,"Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4099201,CHEMBL852,SGDBTWWWUNNDEQ-LBPRGKRZSA-N,MELPHALAN,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of androgen receptor signaling. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5770227,CHEMBL2140720,ZZQHFWRILVFBSH-CLFOAKAGSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2892529,CHEMBL1382038,NDZFCCMKWOPQPB-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,112.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3232829,CHEMBL1794068,OPJOIUDMJCRLNO-QGZVFWFLSA-N,GSK-326090A,,Q9UHD2,SERINE/THREONINE-PROTEIN KINASE TBK1,TBK1,,,,INHIBITION,=,11.0,%,,,,,,,,,,,,,,GSK_PKIS: TBK1 % inhibition at 1 uM [UNC Frye lab],Compounds: GSK PKIS; Assays: UNC Frye lab,,DATASET,
3908372,CHEMBL517712,RKUNBYITZUJHSG-SPUOUPEWSA-N,ATROPINE,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,1447741.0,KB,=,0.4,NM,,,,,,,,,,,,,,Antimuscarinic activity test against muscarinic acetylcholine receptor M1 from rabbit vas deferens,"Synthesis and antimuscarinic properties of some N-substituted 5-(aminomethyl)-3,3-diphenyl-2(3H)-furanones.",J. Med. Chem.,PUBLICATION,
3972234,CHEMBL2180342,RRXTULKMGZYRRL-ZVGWPXEBSA-N,,,P07711,CATHEPSIN L,CTSL,,,23167554.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of recombinant cathepsin L using ZFR-pNA as substrate preincubated for 45 mins,Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice.,J. Med. Chem.,PUBLICATION,
4312497,CHEMBL1404934,TXJWHLXWWHOMOT-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3441497,CHEMBL1909383,PMDIOXBUJXUENT-KVQMOARXSA-N,GW784307A,,P51451,TYROSINE-PROTEIN KINASE BLK,BLK,,,,INHIBITION,=,73.04,%,,,,,,,,,,,,,,GSK_PKIS: BLK mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5441957,CHEMBL123292,YPHMISFOHDHNIV-FSZOTQKASA-N,CYCLOHEXIMIDE,,P41595,SEROTONIN 2B (5-HT2B) RECEPTOR,HTR2B,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide),DrugMatrix in vitro pharmacology data,,DATASET,
4734711,CHEMBL363085,VQZAQWGYQWKWRQ-UHFFFAOYSA-N,,,P09619,PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA,PDGFRB,,,15341941.0,IC50,=,12100.0,NM,,cell_based,,,,,MG-63,,,,,,,In vitro inhibition of Platelet derived growth factor receptor beta autophosphorylation in MG-63 cells without plasma,"Identification of 4-piperazin-1-yl-quinazoline template based aryl and benzyl thioureas as potent, selective, and orally bioavailable inhibitors of platelet-derived growth factor (PDGF) receptor.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1964638,CHEMBL549562,JFVULYYKNAEJNA-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,19469546.0,INHIBITION,=,2.0,%,,cell_based,,,,,HEK293,,,,,,,Inhibition of human ERG expressed in HEK293 cells assessed as blockade of KCl-stimulated depolarization relative to terfenadine,Improvement of pharmacological properties of irreversible thyroid receptor coactivator binding inhibitors.,J. Med. Chem.,PUBLICATION,
2445203,CHEMBL1353020,LGWJEWXKHZCKPV-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
144361,CHEMBL1536299,AOIHZLCKLGKTMY-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2849227,CHEMBL2205815,MYZBXDLMEOAPIJ-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,22959245.0,KI,,,,,,,,,,,,,,,,,Binding affinity to Histamine H1 receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
3383002,CHEMBL1335502,PFXVPQCNGGTFIM-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1221882,CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P11509,CYTOCHROME P450 2A6,CYP2A6,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
5432318,CHEMBL387187,YOHYSYJDKVYCJI-UHFFFAOYSA-N,,,P23443,RIBOSOMAL PROTEIN S6 KINASE 1,RPS6KB1,wild_type,,23398362.0,ACTIVITY,=,110.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15,uM,"Millipore: Percentage of residual kinase activity of RPS6KB1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2135487,CHEMBL1984038,JYRQCAFYZKCCBK-UHFFFAOYSA-N,,,P78368,CASEIN KINASE I GAMMA 2,CSNK1G2,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G2,PUBCHEM BIOASSAY DATA SET,,DATASET,
821677,CHEMBL1922858,DKRHOIWFCLJSFS-UHFFFAOYSA-N,,,Q9KM66,CAI-1 AUTOINDUCER SENSOR KINASE/PHOSPHATASE CQSS,,,,22001326.0,RATIO EC50,=,84.0,,,,,,,,,,,,,,,"Ratio of compound EC50 to (S)-CAI-1 EC50 for CqsS receptor in cqsA-deficient, luxQ-deficient Vibrio cholerae MM920 harboring cosmid pBB1 carrying Vibrio harveyi luxCDABE gene assessed as induction of quorum sensing regulated bioluminescence after 4 hrs by scintillation counting",Small molecule probes of the receptor binding site in the Vibrio cholerae CAI-1 quorum sensing circuit.,Bioorg. Med. Chem.,PUBLICATION,
2565089,CHEMBL1727685,LTPVBTXVQWEYSE-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,1584.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2403244,CHEMBL524266,LCBAQTCTQXHTJG-ZETCQYMHSA-N,,,Q9H2G2,SERINE/THREONINE-PROTEIN KINASE 2,SLK,,,19115845.0,IC50,>,4000.0,NM,,,,,,,,,,,,,,Inhibition of STLK2,First Cdc7 kinase inhibitors: pyrrolopyridinones as potent and orally active antitumor agents. 2. Lead discovery.,J. Med. Chem.,PUBLICATION,
1833684,CHEMBL1713672,IRJASAYZMABEKG-UHFFFAOYSA-M,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
535910,CHEMBL526901,CFDCGXXHXUZSNP-UHFFFAOYSA-N,,,O95819,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4,MAP4K4,wild_type,,19035792.0,ACTIVITY,,,,inhibition,physiochemical,binding,binding_reversible,competitive_inhibitor,qPCR,,10000,NM,,,,,Binding affinity to human MAP3K4 at 10 uM relative to control,Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.,J. Med. Chem.,PUBLICATION,"IN THIS ASSAY, 0% MEANS PHAGE/KINASE-FUSION WAS POTENTLY DISPLACED BY THE DRUG, WHICH MEANS THE DRUG IS VERY EFFECTIVE. CONVERSELY, 100% MEANS ALL PHAGE REMAINED BOUND, WHICH SIGNIFIES THE DRUG HAD NO EFFECT = NO BINDING TO THE KINASE"
620384,CHEMBL602933,COTQFOUJZXUUCG-OAQYLSRUSA-N,,,P13516,ACYL-COA DESATURASE 1,,,,23245208.0,IC50,=,25.0,NM,,,,,,,,,,,,,,"Inhibition of SCD1 in ICR mouse liver microsome using [9,10 3H]- stearoyl-Coenzyme A substrate assessed as decreased production of tritiated water after 20 hrs by scintillation counting analysis",Discovery of piperazin-1-ylpyridazine-based potent and selective stearoyl-CoA desaturase-1 inhibitors for the treatment of obesity and metabolic syndrome.,J. Med. Chem.,PUBLICATION,
2525540,CHEMBL1903763,LPHDYKCTQHQVKE-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,84921.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5506342,CHEMBL496111,YWUITLRVOVKLQQ-UHFFFAOYSA-N,,,Q9Y345,GLYCINE TRANSPORTER 2,SLC6A5,,,18752953.0,EC50,>,30000.0,NM,,cell_based,,,,,CHO,,,,,,,Inhibition of [3H]glycine uptake at human glycine transporter 2 expressed in CHO cells by scintillation counter,Discovery of benzoylpiperazines as a novel class of potent and selective GlyT1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3660286,CHEMBL70789,QKNPCCKKMYTRGV-UHFFFAOYSA-N,,,P30556,TYPE-1 ANGIOTENSIN II RECEPTOR,AGTR1,,,,IC50,=,0.1,NM,,,,,,,,,,,,,,"Binding affinity for Angiotensin II receptor, type 1",,Bioorg. Med. Chem. Lett.,PUBLICATION,
729840,CHEMBL1305514,DAOJEQLQWZKXBS-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
973350,CHEMBL1359031,FATYVKUBSAPMRH-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2580417,CHEMBL3197009,LVDHDRPSCLIFHH-RDRPBHBLSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3602298,CHEMBL1400959,QEFUHWGZELGJMJ-UXBLZVDNSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,23934.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1721852,CHEMBL1522538,IESCCWOVPKJHAO-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3358241,CHEMBL1715433,PDDFMXXRWAEABA-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
69258,CHEMBL1423439,AFRKXFPBSFJILQ-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,95283.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4763753,CHEMBL1796450,VUFNGWHOQUAHRK-UHFFFAOYSA-N,,,P21397,MONOAMINE OXIDASE A,MAOA,,,21680183.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Competitive inhibition of human MAO-A expressed in BTI insect cells using p-tyramine as substrate after 60 mins,"Pyrazoline based MAO inhibitors: synthesis, biological evaluation and SAR studies.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4003898,CHEMBL1301318,RVKFHQUOVGYSQJ-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3686962,CHEMBL1583871,QNMJDNDHYLGRSK-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3549623,CHEMBL1983345,PYAHCANWMVTMGR-LSHDLFTRSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3416438,CHEMBL1535304,PJJGCSOCNPBPPD-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,2238.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3065557,CHEMBL1501444,NXANSMQWMSOKQV-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4990714,CHEMBL233002,WTBQHGKQMCKGNX-UHFFFAOYSA-N,SB-814597,,P42681,TYROSINE-PROTEIN KINASE TXK,TXK,,,,INHIBITION,=,3.72,%,,,,,,,,,,,,,,GSK_PKIS: TXK mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4374965,CHEMBL1611502,UEHFXGLDRJNENN-ACCUITESSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
348472,CHEMBL1523477,BKKXZNNKFNWFBH-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5012784,CHEMBL1436366,WVHHPOGBJOENMP-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2637556,CHEMBL2004872,MBRVCJRFWYHVHE-UHFFFAOYSA-N,,,Q9NWZ3,INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4,IRAK4,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: IRAK4,PUBCHEM BIOASSAY DATA SET,,DATASET,
1723941,CHEMBL1364633,IEZSNPNKNGWEET-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
829367,CHEMBL1548884,DLLNLXISNQAKJZ-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
406498,CHEMBL1408386,BQTUXRVYFMJTKF-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1636651,CHEMBL460065,HVUCUDQSNADOAT-HNNXBMFYSA-N,,,Q86TI2,DIPEPTIDYL PEPTIDASE IX,DPP9,,,18556199.0,IC50,=,14500.0,NM,,,,,,,,,,,,,,Inhibition of DPP9,Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1718071,CHEMBL1487793,IEHSGTWWHGBQIT-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
267646,CHEMBL1393549,BBQUYTRIRNUYGJ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4132877,CHEMBL1880087,SJUIZIMXCATEHK-ZCVJKFOLSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
192339,CHEMBL3191509,ATGWZTWNHUIYMD-CXUHLZMHSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,14581.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2838883,CHEMBL1465091,MYEKQJSGTSNJHK-VAWYXSNFSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
4599052,CHEMBL1972220,VCFDMLBPASGZTP-UHFFFAOYSA-N,,,P51812,RIBOSOMAL PROTEIN S6 KINASE ALPHA 3,RPS6KA3,,,,KI,=,794.33,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA3,PUBCHEM BIOASSAY DATA SET,,DATASET,
3472783,CHEMBL1320913,PPMFMAOFTZHACB-FAMHBGTDSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3385920,CHEMBL1345250,PGGKJODOYIILOE-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
846931,CHEMBL1583838,DNIHCFWMWZCKCQ-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,1122.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2576596,CHEMBL2163958,LUTFEJUSDOPSHW-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,22738271.0,IC50,=,110.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant CB2 receptor expressed in CHO cell membranes assessed as inhibition of forskolin-induced cAMP accumulation,"7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as selective CB(2) cannabinoid receptor ligands: structural investigations around a novel class of full agonists.",J. Med. Chem.,PUBLICATION,
4695321,CHEMBL3431478,VMTUKCFGNXNXEC-UHFFFAOYSA-N,,,P32198,CARNITINE PALMITOYLTRANSFERASE 1A,,,,,IC50,=,53.7,NM,,,,,,,,,,,,,,"SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 1, liver isoform",Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752).,,DATASET,
3567425,CHEMBL1552573,QACDXXBJOJANSX-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1919324,CHEMBL1363806,JAWGLPSGCCLFJW-WJDWOHSUSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1532614,CHEMBL1384901,HKIJOXXCFDEUTL-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1660367,CHEMBL1561666,HYGIWTYYBBTQAL-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
338037,CHEMBL489430,BJEHRWOPXIHXCX-UVTDQMKNSA-N,,,P24941,CYCLIN-DEPENDENT KINASE 2,CDK2,,,19317452.0,IC50,=,6900.0,NM,,,,,,,,,,,,,,Inhibition of CDK2/Cyclin E assessed as inhibition of retinoblastoma susceptibility gene product phosphorylation,"Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.",J. Med. Chem.,PUBLICATION,
2231852,CHEMBL386543,KJIBIEKHVWDGDU-UHFFFAOYSA-N,,,P34995,PROSTANOID EP1 RECEPTOR,PTGER1,,,16843659.0,KI,=,1122.02,NM,,cell_based,,,,,CHO-K1,,,,,,,Antagonist activity at EP1 receptor expressed in CHO-K1 cells assessed as inhibition of PGE2-stimulated calcium ion mobilization by FLIPR assay,Identification of novel pyrazole acid antagonists for the EP1 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3737490,CHEMBL269612,QSSXSMKCIZLOKB-UHFFFAOYSA-N,,,P19327,SEROTONIN 1A (5-HT1A) RECEPTOR,,,,8289207.0,KI,=,1.78,NM,,,,,,,,,,,,,,In vitro ability to inhibit binding of radioligand [3H]8-OH-DPAT to 5-hydroxytryptamine 1A receptor in rat cerebral cortex,"Mixed 5-HT1A/D-2 activity of a new model of arylpiperazines: 1-aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines. 1. Synthesis and structure-activity relationships.",J. Med. Chem.,PUBLICATION,
2035025,CHEMBL3132878,JNWFZQZGJWEPFC-UHFFFAOYSA-N,,,O60760,HEMATOPOIETIC PROSTAGLANDIN D SYNTHASE,HPGDS,,,,IC50,=,4000.0,NM,,,,,,,,,,,,,,Inhibition of hematopoietic prostaglandin D2 synthase in IgE and IL-5 primed human LAD2 cells assessed as reduction in PGD2 production by mass spectrometry,,MedChemComm,PUBLICATION,
5031887,CHEMBL1495774,WXLHGVADSVDFPI-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,125892.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5386461,CHEMBL1290748,YJRFEVRDDAASMO-IDTAVKCVSA-N,N6-BUTYLADENOSINE,,P02769,SERUM ALBUMIN,,,,2999397.0,K,=,2.89,M-1,,,,,,,,,,,,,,"Serum albumin binding, dissociation constant",Dog coronary artery adenosine receptor: structure of the N6-alkyl subregion.,J. Med. Chem.,PUBLICATION,
3215429,CHEMBL397570,ONINFKOEYCCERZ-UHFFFAOYSA-N,SB-347804,,P29597,TYROSINE-PROTEIN KINASE TYK2,TYK2,,,,INHIBITION,=,-3.45,%,,,,,,,,,,,,,,GSK_PKIS: TYK2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
32514,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,O95372,ACYL-PROTEIN THIOESTERASE 2,LYPLA2,,,23239555.0,IC50,=,1980.0,NM,,,,,,,,,,,,,,,,,,
4282614,CHEMBL1357927,TUETUSIPABMOIZ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,9196.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2821398,CHEMBL427319,MVZLOHBQRNMNNQ-UHFFFAOYSA-N,,,P12530,ARACHIDONATE 15-LIPOXYGENASE,,,,15713402.0,IC50,=,179.0,NM,,,,,,,,,,,,,,Inhibitory concentration against rabbit reticulocyte 15-lipoxygenase with substrate arachidonic acid,Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5340164,CHEMBL517123,YEIAMNOHYKXSFB-TZIWHRDSSA-N,GSK-182497A,,Q12866,PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER,MERTK,,,,INHIBITION,=,0.43,%,,,,,,,,,,,,,,GSK_PKIS: MER mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4655982,CHEMBL3190920,VIICNTOGPGVCNL-VZUCSPMQSA-N,,,Q57TT1,PUTATIVE UNCHARACTERIZED PROTEIN,,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3048392,CHEMBL355001,NVBFHJWHLNUMCV-UHFFFAOYSA-N,SULFAMIDE,,P00918,CARBONIC ANHYDRASE II,CA2,,,20472429.0,KI,=,1130000.0,NM,,,,,,,,,,,,,,Inhibition of full length human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay,Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mammalian isoforms I-XV.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1416751,CHEMBL1434274,GYEUWPACRADVFE-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,631.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2879163,CHEMBL1366012,NCJZANHDHLKJNX-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5111515,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,GEFITINIB,,P51955,SERINE/THREONINE-PROTEIN KINASE NEK2,NEK2,,,15711537.0,KD,,,,,,,,,,,,,,,,,Average Binding Constant for NEK2; NA=Not Active at 10 uM,A small molecule-kinase interaction map for clinical kinase inhibitors.,Nat. Biotechnol.,PUBLICATION,
5445268,CHEMBL3415182,YPRKVQKJNRKXFN-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,25719566.0,IC50,=,1070.0,NM,,,,,,,,,,,,,,Displacement of H3K14Ac from BAZ2B (unknown origin) preincubated for 30 mins with non-biotinylated peptide followed by addition of biotinylated peptide measured after 30 mins by AlphaScreen assay,"Structure enabled design of BAZ2-ICR, a chemical probe targeting the bromodomains of BAZ2A and BAZ2B.",J. Med. Chem.,PUBLICATION,
1420297,CHEMBL1465720,GYQNXYQGNUDXME-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2236928,CHEMBL1171678,KJXHYBWPKVGFJG-JGLNRKDHSA-N,,,Q1R2J4,TYPE 1 FIMBIRAL ADHESIN FIMH,,,,21105658.0,IC50,=,33000.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at Escherichia coli UT189 FimH in guinea pig red blood cells assessed as disaggregation of bacteria after 600 secs by aggregometry assay,FimH antagonists for the oral treatment of urinary tract infections: from design and synthesis to in Vitro and in Vivo evaluation.,J. Med. Chem.,PUBLICATION,
1204488,CHEMBL1511112,GAPCJAXXLNJDHC-HJWRWDBZSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4488584,CHEMBL1240885,UQPMANVRZYYQMD-UHFFFAOYSA-N,CGP-57380,,Q9HBH9,MAP KINASE SIGNAL-INTEGRATING KINASE 2,MKNK2,,,23398362.0,ACTIVITY,=,60.0,%,,,,,,,,,,,,,,"Millipore: Percentage of residual kinase activity of MKNK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,
1795287,CHEMBL328412,INEQQSYFBJJTKI-FQAXKGDYSA-N,,,P55212,CASPASE-6,CASP6,,,12270185.0,IC50,=,10.0,NM,,,,,,,,,,,,,,Inhibitory concentration of compound required against Caspase-6 compared to acylated dipeptides,Acyl dipeptides as reversible caspase inhibitors. Part 1: initial lead optimization.,Bioorg. Med. Chem. Lett.,PUBLICATION,
476459,CHEMBL1713230,BYWCNTWCEYAMHC-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5237050,CHEMBL3192930,XTLRDYSHESABLK-VZUCSPMQSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5079376,CHEMBL1725080,XCMQCRDSEIMJRM-UHFFFAOYSA-N,,,Q96RJ0,TRACE AMINE-ASSOCIATED RECEPTOR 1,TAAR1,,,,IC50,=,2409.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. Counterscreen for agonists of the human trace amine associated receptor 1 (hTAAR1): Fluorescence-based cell-based high throughput dose response assay to identify hTAAR1 agonist that also desensitize TAAR1 receptor response. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2121749,CHEMBL350130,JXDJARWIPBCTJS-UHFFFAOYSA-N,,,P04818,THYMIDYLATE SYNTHASE,TYMS,,,8459400.0,KI,=,66.0,NM,,,,,,,,,,,,,,Inhibition of human Thymidylate synthase,Design of thymidylate synthase inhibitors using protein crystal structures: the synthesis and biological evaluation of a novel class of 5-substituted quinazolinones.,J. Med. Chem.,PUBLICATION,
3660528,CHEMBL101401,QKNZZHHRLYHBSF-QMMMGPOBSA-N,,,Q9UHL4,DIPEPTIDYL PEPTIDASE II,DPP7,,,15139769.0,IC50,=,1.8,NM,,,,,,,,,,,,,,Inhibition of human Dipeptidylpeptidase II (DPP II),"Gamma-amino-substituted analogues of 1-[(S)-2,4-diaminobutanoyl]piperidine as highly potent and selective dipeptidyl peptidase II inhibitors.",J. Med. Chem.,PUBLICATION,
4106063,CHEMBL1582448,SGUDOLPTULDWPK-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5430031,CHEMBL313417,YOELZIQOLWZLQC-UHFFFAOYSA-N,SK&F-86002,,Q06187,TYROSINE-PROTEIN KINASE BTK,BTK,wild_type,,23398362.0,ACTIVITY,=,100.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200,uM,"Millipore: Percentage of residual kinase activity of BTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1857929,CHEMBL13,IUBSYMUCCVWXPE-UHFFFAOYSA-N,METOPROLOL,,P23219,CYCLOOXYGENASE-1,PTGS1,,,,IC50,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DrugMatrix in vitro pharmacology data,,DATASET,
210112,CHEMBL563451,AVFYUSOOXDDQAW-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,19553115.0,KI,=,73.0,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]dofetolide from human ERG channel expressed in HEK293 cells at 37 degC by liquid scintillation assay,Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2869208,CHEMBL1573637,NBIHRGRKTZYHIT-UZINWLIJSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4502415,CHEMBL1091501,URVWBJYKWNSVGT-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,39.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Secondary assay for Activators of Human Pyruvate Kinase M1 isoform. (Class of assay: confirmatory) [Related pubchem assays: 954 (Counter assay for activators of Human Pyruvate Kinase M2 isoform)],PUBCHEM BIOASSAY DATA SET,,DATASET,
3740862,CHEMBL379787,QTCFYQHZJIIHBS-UHFFFAOYSA-N,,,Q16832,DISCOIDIN DOMAIN-CONTAINING RECEPTOR 2,DDR2,wild_type,,23398362.0,ACTIVITY,=,110.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of DDR2 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4285927,CHEMBL1579673,TUPASQKQKKXVLR-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,1299.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4922768,CHEMBL145381,WLHLKVDHKQZIAY-UHFFFAOYSA-N,,,Q8K4Z4,BETA-2 ADRENERGIC RECEPTOR,,,,1346651.0,POTENCY RATIO,=,0.0093,,,,,,,,,,,,,,,Potency ratio was measured as EC50 (trimetoquinol )/EC50 (drug) after treatment with the compound,Synthesis of halogenated trimetoquinol derivatives and evaluation of their beta-agonist and thromboxane A2 (TXA2) antagonist activities.,J. Med. Chem.,PUBLICATION,
1598614,CHEMBL1446659,HRKGWPYFZAQHNA-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3541664,CHEMBL2030636,PXBKRGXXBYALIH-UHFFFAOYSA-N,,,P08172,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,CHRM2,,,22607684.0,KI,,,,,,,,,,,,,,,,,Inhibition of M2 muscarinic receptor,7-Azabicyclo[2.2.1]heptane as a scaffold for the development of selective sigma-2 (s(2)) receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5785346,CHEMBL3714921,,,,Q96RI0,PROTEINASE ACTIVATED RECEPTOR 4,F2RL3,,,,EC50,=,0.79,NM,,,,,,,,,,,,,,Antagonist activity against human PAR4 expressed in HEK293 cells assessed as reduction in H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2-induced intracellular calcium mobilization incubated for 30 mins by FLIPR assay,Imidazothiadiazole and imidazopyrazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation,,PATENT,
2557699,CHEMBL273564,LSVIBAPJYUUVJJ-UHFFFAOYSA-N,GW795493X,,P11309,SERINE/THREONINE-PROTEIN KINASE PIM1,PIM1,,,,INHIBITION,=,1.56,%,,,,,,,,,,,,,,GSK_PKIS: PIM1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2601030,CHEMBL1393,LXMSZDCAJNLERA-ZHYRCANASA-N,SPIRONOLACTONE,,O70528,SEROTONIN 4 (5-HT4) RECEPTOR,,,,,IC50,,,,,,,,,,,,,,,,,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DrugMatrix in vitro pharmacology data,,DATASET,
1324961,CHEMBL2138844,GNQHAOUPPHWQGH-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1474629,CHEMBL1448876,HEGADLSVWOYXFY-UHFFFAOYSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,7062.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3157496,CHEMBL331661,OGYVFRIFTOYZBU-KTKRTIGZSA-N,,,Q9HBW0,LYSOPHOSPHATIDIC ACID RECEPTOR EDG-4,LPAR2,,,15177455.0,EC50,>,5000.0,NM,,,,,,,,,,,,,,Agonistic activity against lysophosphatidic acid receptor 2 using [35S]GTP-gamma-S as radioligand tested in vitro,Synthesis and biological evaluation of phosphonic and thiophosphoric acid derivatives of lysophosphatidic acid.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5107642,CHEMBL2103747,XFSBVAOIAHNAPC-FKHWODAVSA-N,ACONITINE,,Q16539,MAP KINASE P38 ALPHA,MAPK14,,,,KI,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DrugMatrix in vitro pharmacology data,,DATASET,
4652257,CHEMBL96083,VHVPHEQZIBIJKB-ZROIWOOFSA-N,,,"P20420, P43143, P12392, P09483, P12389, Q05941, P04757, P12391, P12390, Q9JLB5, P43144",NEURONAL ACETYLCHOLINE RECEPTOR,,,,10522693.0,INHIBITION,=,19.0,%,,,,,,,,,,,,,,Ability to displace [3H]cytisine binding to nicotinic receptor in synaptic membrane fractions from rat cerebral cortices at a concentration of 10 uM.,Binding affinities of 3-(3-phenylisoxazol-5-yl)methylidene-1-azabicycles to acetylcholine receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4789571,CHEMBL2036809,VXENEMCDVCFWGW-JKIUYZKVSA-N,,,Q12866,PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER,MERTK,,,,KI,=,2.0,NM,,,,,,,,,,,,,,Inhibition of Mer using EFPIYDFLPAKKK-CONH2 as substrate by Michaelis-Menten equation,,ACS Med. Chem. Lett.,PUBLICATION,
3919899,CHEMBL1363376,RMBBGYYJTMLZBI-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,2310.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
752613,CHEMBL1508210,DDCFLVDGBLZPSP-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1193216,CHEMBL3581743,FZDIMXLFHUBMEZ-KTLUODIZSA-N,,,P33535,MU OPIOID RECEPTOR,,,,25898137.0,EC50,=,0.22,NM,,cell_based,,,,,,,,,,,,Agonist activity at rat mu opioid receptor expressed in rat C6 cell membranes assessed as stimulation of [35S]GTPgammaS binding,"C7ß-methyl analogues of the orvinols: the discovery of kappa opioid antagonists with nociceptin/orphanin FQ peptide (NOP) receptor partial agonism and low, or zero, efficacy at mu opioid receptors.",J. Med. Chem.,PUBLICATION,
1297300,CHEMBL1973868,GKODJBVKKLQMEY-UHFFFAOYSA-N,,,Q05397,FOCAL ADHESION KINASE 1,PTK2,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PTK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
3230608,CHEMBL1512947,OPBUBZOZLDZCMH-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3019941,CHEMBL237821,NRSLKKPSVPOIBM-UHFFFAOYSA-N,,,P10828,THYROID HORMONE RECEPTOR BETA-1,THRB,,,17918822.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,,Displacement of labeled SRC2-2 from human TRbeta expressed in BL21 (DE3) cells FP assay,Inhibitors of the interaction of a thyroid hormone receptor and coactivators: preliminary structure-activity relationships.,J. Med. Chem.,PUBLICATION,
126674,CHEMBL1392252,AMHQJGAWSNOOKL-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3999961,CHEMBL378618,RUYQFOIEMVGGQT-UHFFFAOYSA-N,N-(3-AMINOPHENYL)BENZENESULFONAMIDE,,P50406,SEROTONIN 6 (5-HT6) RECEPTOR,HTR6,,,16913710.0,KI,=,2840.0,NM,,cell_based,,,,,HEK293,,,,,,,Binding affinity to human 5HT6 receptor in HEK293 cells by radioligand binding assay,Binding of sulfonyl-containing arylalkylamines at human 5-HT6 serotonin receptors.,J. Med. Chem.,PUBLICATION,
5024850,CHEMBL1474115,WWOVGSGRUXDSGA-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6513.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4103510,CHEMBL1494495,SGPDNXJSGDOXFV-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4465187,CHEMBL228511,UOAMTSKGCBMZTC-UHFFFAOYSA-N,DICOFOL,,P19838,NUCLEAR FACTOR NF-KAPPA-B P105 SUBUNIT,NFKB1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4089923,CHEMBL165790,SFBODOKJTYAUCM-UHFFFAOYSA-N,IPRIFLAVONE,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,KI,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
1766038,CHEMBL1367313,IJZJAZUPUBWDBK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4570466,CHEMBL1878267,UZCGKGPEKUCDTF-UHFFFAOYSA-N,FLUAZINAM,,P05412,PROTO-ONCOGENE C-JUN,JUN,,,,POTENCY,,19493.8,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the AP-1 signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
411491,CHEMBL1381551,BRJHWFYMRHVVEW-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2124350,CHEMBL539844,JXLIEEVHVHBAMI-YBFBCAGJSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,15715480.0,SPECIFIC BINDING,=,97.0,%,,,,,,,,,,,,,,Inhibition of [3H]CCPA binding to human Adenosine A1 receptor at 10e-7 M,"Synthesis and biological evaluation of a new series of 2,3,5-substituted [1,2,4]-thiadiazoles as modulators of adenosine A1 receptors and their molecular mechanism of action.",J. Med. Chem.,PUBLICATION,
4707930,CHEMBL375025,VNZCTJLIVONUDE-HOJIFOFPSA-N,,,P33533,DELTA OPIOID RECEPTOR,,,,17539621.0,KI,=,0.43,NM,,,,,,,,,,,,,,Displacement of [3H]DPDPE from delta opioid receptor in rat brain membrane,Synthesis of stable and potent delta/mu opioid peptides: analogues of H-Tyr-c[D-Cys-Gly-Phe-D-Cys]-OH by ring-closing metathesis.,J. Med. Chem.,PUBLICATION,
2990090,CHEMBL1469715,NOJUNBFTWAOWAI-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
736760,CHEMBL1507841,DBIHAOPELCQPAM-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3433885,CHEMBL263642,PLHMFMNGOAPGBB-QGZVFWFLSA-N,,,Q13370,PHOSPHODIESTERASE 3B,PDE3B,,,18299198.0,KI,=,56.0,NM,,,,,,,,,,,,,,Inhibition of PDE3B,"CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
924364,CHEMBL1392667,DVRKSCMBYKLPBJ-JYRVWZFOSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,3264.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5830124,CHEMBL136478,,SODIUM NITROPRUSSIDE,,P28564,SEROTONIN 1B (5-HT1B) RECEPTOR,,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DrugMatrix in vitro pharmacology data,,DATASET,
2692585,CHEMBL1332004,MHVFDDCTRFWAMO-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3328196,CHEMBL1569300,OZSDAMINISVBDB-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1210187,CHEMBL3359955,GBHJIQHETMVFEI-UHFFFAOYSA-N,,,P11511,CYTOCHROME P450 19A1,CYP19A1,,,25462231.0,IC50,=,584.0,NM,,,,,,,,,,,,,,Inhibition of human placental microsomal CYP19 using [1beta-3H]androstenedione substrate pre-incubated for 5 mins by scintillation counting method,Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11ß-hydroxylase.,Eur. J. Med. Chem.,PUBLICATION,
5822723,CHEMBL3775265,,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,26922225.0,EC50,=,670.0,NM,,,,,,,,,,,,,,Inverse agonist activity at human CB2 receptor transfected in CHO cells assessed as increase in forksolin stimulated cAMP production by scintillation counting analysis,"Synthesis and structure activity relationship investigation of triazolo[1,5-a]pyrimidines as CB2 cannabinoid receptor inverse agonists.",Eur. J. Med. Chem.,PUBLICATION,
3109500,CHEMBL2023527,OBZKXYPZHKMZMG-WNRPIQNBSA-N,,,Q13547,HISTONE DEACETYLASE 1,HDAC1,,,22260166.0,IC50,=,4600.0,NM,,,,,,,,,,,,,,Inhibition of HDAC1 in human HeLa cell nuclear extract using Fluor de Lys as substrate after 15 mins by fluorometric analysis,Dual targeting of histone deacetylase and topoisomerase II with novel bifunctional inhibitors.,J. Med. Chem.,PUBLICATION,
2881060,CHEMBL1311041,NCPRFMSDMBYOFZ-UHFFFAOYSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1539999,CHEMBL1628027,HKVOYFRRZULPDD-PDQRKMNRSA-N,,,P14061,ESTRADIOL 17-BETA-DEHYDROGENASE 1,HSD17B1,,,16480268.0,INHIBITION,=,33.0,%,,cell_based,,,,,T47D,,,,,,,Inhibition of 17-beta HSD1 in T47D cells at 10 uM,"Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.",J. Med. Chem.,PUBLICATION,
4293214,CHEMBL1310632,TVFWQQFKFQPBNK-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3889617,CHEMBL231209,RIUZPIBUSOHUKF-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,wild_type,,21336281.0,KI,<,7943.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
4984239,CHEMBL27642,WSHCJNSZXLKWSM-UHFFFAOYSA-N,,,Q05932,FOLYLPOLY-GAMMA-GLUTAMATE SYNTHETASE,FPGS,,,3385729.0,KI,=,185000.0,NM,,,,,,,,,,,,,,Inhibition of Folyl-polyglutamate synthase from mouse liver,"Methotrexate analogues. 32. Chain extension, alpha-carboxyl deletion, and gamma-carboxyl replacement by sulfonate and phosphonate: effect on enzyme binding and cell-growth inhibition.",J. Med. Chem.,PUBLICATION,
5515071,CHEMBL159117,YXTWBVKPNWJNBW-UHFFFAOYSA-N,,,"P13945, P08588, P07550",ADRENERGIC RECEPTOR BETA,"ADRB1, ADRB2, ADRB3",,,6124636.0,ACTIVITY,=,6.0,,,,,,,,,,,,,,,Beta-adrenoceptor blocking activity expressed as the ability to antagonize effect of intravenously administered (-)-isoproterenol on heart rate in anesthetized dog,"Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.",J. Med. Chem.,PUBLICATION,
4455943,CHEMBL1477569,UNANWAJNTACVAV-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2338129,CHEMBL315712,KUIYHMJCKWAKMA-UHFFFAOYSA-N,,,P08842,STERYL-SULFATASE,STS,,,11277533.0,POTENCY,=,0.0893,,,,,,,,,,,,,,,Relative potency compared to EMATE against Estrone sulfatase,Novel inhibitors of the enzyme estrone sulfatase (ES).,Bioorg. Med. Chem. Lett.,PUBLICATION,
5467544,CHEMBL142853,YSHVGBBWHQFDTL-UHFFFAOYSA-N,,,Q72547,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE,,,,7490732.0,IC50,=,340.0,NM,,,,,,,,,,,,,,Inhibitory concentration against mutant reverse transcriptase of P236L was determined which is in turn resistant to BHAP,Novel non-nucleoside inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. 4. 2-Substituted dipyridodiazepinones as potent inhibitors of both wild-type and cysteine-181 HIV-1 reverse transcriptase enzymes.,J. Med. Chem.,PUBLICATION,
985204,CHEMBL1465039,FCALUMRONOOSMX-GHRIWEEISA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
433779,CHEMBL301223,BTXTXCJNBCOTSR-UHFFFAOYSA-N,,,"Q13547, Q92769",HISTONE DEACETYLASE (HDAC1 AND HDAC2),"HDAC1, HDAC2",,,12749893.0,IC50,=,3.5,NM,,,,,,,,,,,,,,Inhibitory activity was tested against histone deacetylase (HDAC).,Indole amide hydroxamic acids as potent inhibitors of histone deacetylases.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3221893,CHEMBL3196115,ONZCRCBDAUVROD-FSJBWODESA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,9196.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1117568,CHEMBL1439063,FQQIMKOHFSKRNY-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2306469,CHEMBL1399957,KRGCBBAQRVOYPZ-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5099609,CHEMBL1487506,XEUFRASSRWPSAQ-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,39.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4671202,CHEMBL1331319,VKFMALOYCIXIFM-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2240685,CHEMBL274866,KKIMDKMETPPURN-UHFFFAOYSA-N,,,P28335,SEROTONIN 2C (5-HT2C) RECEPTOR,HTR2C,,,3543362.0,KI,,,,,,,,,,,,,,,,,Evaluated for the binding affinity to porcine choroid plexus at 5-hydroxytryptamine 2C receptor binding site by using [3H]-MES as a radioligand.,Central serotonin receptors as targets for drug research.,J. Med. Chem.,PUBLICATION,
3379084,CHEMBL3220730,PFMLNVKPOPJNRO-UHFFFAOYSA-N,,,"P19490, P19493, P19491, P19492","GLUTAMATE RECEPTOR IONOTROPIC, AMPA",,,,,MAX ACTIVATION,<,200.0,%,,cell_based,,,,,,,,,,,,Positive allosteric modulation of AMPA receptor in embryonic rat brain cells assessed as potentiation of membrane depolarization after 3 mins by fluorescence assay relative to AMPA,,MedChemComm,PUBLICATION,
4741518,CHEMBL1353133,VRVMAUYZMWAGEO-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2593682,CHEMBL1395219,LWTWOXFSTFQFHW-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3353535,CHEMBL1300312,PCOMOZFNQLODPV-UHFFFAOYSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,17740.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3970115,CHEMBL404233,RRRGNIDYMUNGFN-UHFFFAOYSA-N,,,P53582,METHIONINE AMINOPEPTIDASE 1,METAP1,,,18343108.0,KI,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of human methionine aminopeptidase 1,Synthesis of barbiturate-based methionine aminopeptidase-1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2541631,CHEMBL1364199,LRCWDEHVVIDYET-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
324703,CHEMBL36450,BHWCZLOXTLWZAQ-UHFFFAOYSA-N,SC-68376,,Q9Y463,DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1B,DYRK1B,wild_type,,22037377.0,ACTIVITY,=,98.91732101,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,CASEIN ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2278584,CHEMBL212410,KOKWQVJPVOHNKZ-UHFFFAOYSA-N,,,P37088,AMILORIDE-SENSITIVE SODIUM CHANNEL ALPHA-SUBUNIT,SCNN1A,,,16821771.0,IC50,=,21.0,NM,,,,,,,,,,,,,,Inhibition of dog bronchi prototypical epithelial sodium channel by electrophysiological assay,"Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis.",J. Med. Chem.,PUBLICATION,
2854323,CHEMBL78150,MZOPWQKISXCCTP-UHFFFAOYSA-N,TYRPHOSTIN A9,,O75496,GEMININ,GMNN,,,,POTENCY,,10322.5,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3110558,CHEMBL1993780,OCCKQEHFGGLPHK-KEBDBYFISA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1888.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1132632,CHEMBL1451618,FSKWTFJYVNPIJB-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4388314,CHEMBL42651,UFSJAWLGOHKVBH-UHFFFAOYSA-N,,,"P35354, P23219",CYCLOOXYGENASE,"PTGS1, PTGS2",,,9171873.0,RATIO,=,327.0,,,,,,,,,,,,,,,IC50 ratio measured as the IC50 of COX-1 to that of COX-2,"1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents.",J. Med. Chem.,PUBLICATION,
205722,CHEMBL1357253,AUUWVLLYFXPKRU-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,26121.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2660, AID2666, AID2667, AID2668, AID2681, AID504465]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1065419,CHEMBL1946958,FLAUJYDYJZIENE-UHFFFAOYSA-N,,,P14550,ALDEHYDE REDUCTASE,AKR1A1,,,22104435.0,IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of human recombinant AKR1A1 expressed in Escherichia coli BL21 cells using D-glucuronate as substrate by spectrophotometry,"Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-ß-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.",Bioorg. Med. Chem.,PUBLICATION,
5371081,CHEMBL1580409,YHXAHURDOPRQCT-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1556320,CHEMBL1343966,HMNVREUITHREJF-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2222100,CHEMBL1531572,KIFFIUXDPAUYJT-UHFFFAOYSA-N,,,Q9H0H5,RAC GTPASE-ACTIVATING PROTEIN 1,RACGAP1,,,,IC50,,127380.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5271987,CHEMBL3672063,XXMDMGCWKMTCOF-UHFFFAOYSA-N,,,P31751,SERINE/THREONINE-PROTEIN KINASE AKT2,AKT2,,,,IC50,=,7.0,NM,,cell_based,,,,,,,,,,,,"BindingDB_Patents: TR-FRET Assay. Akt2 inhibitory activity of compounds of the present invention was quantified employing the Akt2 TR-FRET assay as described in the following paragraphs.His-tagged human recombinant kinase full-length Akt2 expressed in insect cells and activated by PDK1 was purchased form Invitrogen (part number PV 3975). As substrate for the kinase reaction the biotinylated peptide biotin-Ahx- KKLNRTLSFAEPG (C-terminus in amide form) was used which can be purchased e.g. from the company Biosynthan GmbH (Berlinn-Buch, Germany). For the assay 50 nl of a 10Ofold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384well microtiter plate (Greiner Bio- One, Frickenhausen, Germany), 2 ul of a solution of Akt2 in assay buffer [50 mM TRIS/HCI pH 7.5, 5 mM MgCI2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22C to allow pre-binding of the test compounds to the enzyme before the start of the kinase reaction.",Fused pyrimidines,,PATENT,
4283999,CHEMBL563343,TUJKFLFRSWBCFZ-QHCPKHFHSA-N,,,P39900,MATRIX METALLOPROTEINASE 12,MMP12,,,19725580.0,IC50,=,34.1,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP12,Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.,J. Med. Chem.,PUBLICATION,
4738816,CHEMBL3394491,VRMYKABCYNPNTM-UHFFFAOYSA-N,,,P27338,MONOAMINE OXIDASE B,MAOB,,,25541201.0,IC50,=,59400.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant MAO-B using p-tyramine as substrate assessed as production of H2O2 incubated for 15 mins prior to substrate addition measured after 20 mins by microplate fluorescence reader analysis,Design and synthesis of novel 2-pyrazoline-1-ethanone derivatives as selective MAO inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
4317934,CHEMBL1597538,TYAQBFYQXNIDBA-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,517.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5436965,CHEMBL1423868,YOTOYGHHWCITRO-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2136497,CHEMBL461291,JYUUCEVKOOBPLE-IUCAKERBSA-N,,,P27487,DIPEPTIDYL PEPTIDASE IV,DPP4,,,18556199.0,IC50,=,15000.0,NM,,,,,,,,,,,,,,Inhibition of DPP4,Inhibitors of dipeptidyl peptidase 8 and dipeptidyl peptidase 9. Part 1: identification of dipeptide derived leads.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5543378,CHEMBL1223508,ZAXCUTVDCNWYKH-UHFFFAOYSA-N,,,P41180,CALCIUM SENSING RECEPTOR,CASR,,,20685119.0,IC50,=,16.0,NM,,,,,,,,,,,,,,Antagonist activity at human CaSR expressed in hamster fibroblasts assessed as inhibition of calcium mobilization,Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists).,Bioorg. Med. Chem. Lett.,PUBLICATION,
4054085,CHEMBL257167,SAYGKHKXGCPTLX-UHFFFAOYSA-N,,,P35916,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3,FLT4,wild_type,,23398362.0,ACTIVITY,=,0.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
298872,CHEMBL1243041,BFFSMCNJSOPUAY-UNTBIKODSA-N,,,P02768,SERUM ALBUMIN,ALB,,,20646793.0,KB,=,2.68,10'3L/MOL,,,,,,,,,,,,,,Binding affinity to human serum albumin at pH 8.5,Study on the binding of chiral drug duloxetine hydrochloride to human serum albumin.,Eur. J. Med. Chem.,PUBLICATION,
1558070,CHEMBL1455799,HMTNMXGXXVUTTB-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2863125,CHEMBL578523,NARDPMGENFYXQE-UHFFFAOYSA-N,GNF-PF-5298,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1624099,CHEMBL1387416,HUJQOHMOYGRIRS-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5478149,CHEMBL37976,YTPVKTLAFFSGBR-UHFFFAOYSA-N,,,"P06756, P05106",INTEGRIN ALPHA-V/BETA-3,"ITGAV, ITGB3",,,15006384.0,IC50,=,0.27,NM,,,,,,,,,,,,,,Binding affinity towards alpha V/beta3 receptor by solid-phase receptor binding assays (SPRA),Synthesis of cinnamic acids and related isosteres as potent and selective alpha v beta 3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3173273,CHEMBL477,OIRDTQYFTABQOQ-KQYNXXCUSA-N,ADENOSINE,,Q9JIM1,EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1,,,,20421393.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Transport through ENT1 in mouse hepatocytes by oil filtration assay in presence 100 uM of transporter inhibitor NBMRP,Striking species difference in the contribution of concentrative nucleoside transporter 2 to nucleoside uptake between mouse and rat hepatocytes.,Antimicrob. Agents Chemother.,PUBLICATION,
1646064,CHEMBL3211742,HWURGDFPJRCUEH-DHRITJCHSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2024054,CHEMBL357232,JMPGEOYGXFCUQS-XJDOXCRVSA-N,,,P23687,PROLYL ENDOPEPTIDASE,,,,12238937.0,IC50,=,68.0,NM,,,,,,,,,,,,,,In vitro inhibitory activity against prolyl oligopeptidase (POP) from pig brain; value ranges from (44-110),Dicarboxylic acid bis(L-prolyl-pyrrolidine) amides as prolyl oligopeptidase inhibitors.,J. Med. Chem.,PUBLICATION,
2905593,CHEMBL1870811,NFKXCZDDLIBKKW-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3227094,CHEMBL1414493,OOQCTFLZJJMJEW-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,=,707.95,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5403155,CHEMBL1361905,YLKFQKPLNMHTFX-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,12589.25,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3342044,CHEMBL3220851,PBEFYWVVHKTYKA-UHFFFAOYSA-N,,,O60885,BROMODOMAIN-CONTAINING PROTEIN 4,BRD4,,,,IC50,=,63095.73,NM,,,,,,,,,,,,,,Inhibition of BRD4 bromodomain-1 (unknown origin) by AlphaScreen assay,,MedChemComm,PUBLICATION,
545376,CHEMBL1463106,CGFOAEFSQMBASA-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1595836,CHEMBL1549872,HRBRGMSDONMATP-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2759329,CHEMBL2237290,MPAHDNFCERDKSX-UHFFFAOYSA-N,,,P06276,BUTYRYLCHOLINESTERASE,BCHE,,,,IC50,,,,,,,,,,,,,,,,,Inhibition of BChE (unknown origin) using butyrylthiocholine chloride as substrate preincubated for 15 min,,Med Chem Res,PUBLICATION,
1557093,CHEMBL1382968,HMQMBRGCCRWBLB-WUKNDPDISA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
3291322,CHEMBL1076379,OVMNIKGRTOYPDR-JATJWMBJSA-N,,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,19860431.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Displacement of [3H]nisoxetine from human NET expressed in COS7 cells,chi-Conopeptide pharmacophore development: toward a novel class of norepinephrine transporter inhibitor (Xen2174) for pain.,J. Med. Chem.,PUBLICATION,
5673286,CHEMBL1325157,ZOWLTPUWIYPXAX-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2262150,CHEMBL1408640,KMKJOCBSUBEJLY-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,5.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2450769,CHEMBL521851,LHNIIDJUOCFXAP-UHFFFAOYSA-N,PICTILISIB,,P53779,C-JUN N-TERMINAL KINASE 3,MAPK10,wild_type,,22037378.0,KD,=,560.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for JNK3 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
1979608,CHEMBL1345907,JHMLWQWKVSDFLZ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4464320,CHEMBL36821,UNYAELQTCSOYQB-LPHOPBHVSA-N,,,Q05655,PROTEIN KINASE C DELTA,PRKCD,,,9554881.0,KI,=,1700.0,NM,,,,,,,,,,,,,,Displacement of [3H]PDBu from recombinant Protein kinase C delta,"Clarification of the binding mode of teleocidin and benzolactams to the Cys2 domain of protein kinase Cdelta by synthesis of hydrophobically modified, teleocidin-mimicking benzolactams and computational docking simulation.",J. Med. Chem.,PUBLICATION,
3357971,CHEMBL1431053,PDCKZTLYBBKGBR-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2483788,CHEMBL157258,LLELAEGDEATZFN-UHFFFAOYSA-N,SB-390523,,P07948,TYROSINE-PROTEIN KINASE LYN,LYN,,,,INHIBITION,=,4.88,%,,,,,,,,,,,,,,GSK_PKIS: LYN B (splice variant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3177464,CHEMBL131139,OJDXKBJOHNWAJF-QHGLUPRGSA-N,,,P08246,LEUKOCYTE ELASTASE,ELANE,,,7966161.0,K_ON,=,90.0,M-1.S-1,,,,,,,,,,,,,,Tested for the rate constant against Human Leukocyte Elastase (HLE) inactivation,"Cephem sulfones as inactivators of human leukocyte elastase. 5. 7 alpha-Methoxy- and 7 alpha-chloro-1,1-dioxocephem 4-ketones.",J. Med. Chem.,PUBLICATION,
1254143,CHEMBL1864008,GFYOUSRPBVSONT-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5498443,CHEMBL1504493,YVZLQONMQJQDEV-PLRJNAJWSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,16360.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3538799,CHEMBL1510023,PWTYGDOFAUBOTG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5763703,CHEMBL1352586,ZYVXYXANIFTTCA-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1068497,CHEMBL1967185,FLKOSYUFXVTPTM-UVHMKAGCSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4984655,CHEMBL3192903,WSIQUHMTOGAROP-LAKPCLNZSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,168.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1915467,CHEMBL474432,JAMDNXUAYUHJLJ-UHFFFAOYSA-N,,,Q96SB4,SERINE/THREONINE-PROTEIN KINASE SRPK1,SRPK1,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SRPK1,PUBCHEM BIOASSAY DATA SET,,DATASET,
479500,CHEMBL107268,BZEQVHKJCVLJMC-GFCCVEGCSA-N,,,P09810,TRYPTOPHAN 5-MONOOXYGENASE 1,,,,8426360.0,VMAX,=,17.7,UM MIN-1 (MG OF PROTEIN)-1,,tissue,,,,,,,,,,,,Compound was evaluated as a substrate for P815 tryptophan hydroxylase in rat brain,Enantiospecific syntheses of alpha-(fluoromethyl)tryptophan analogues: interactions with tryptophan hydroxylase and aromatic L-amino acid decarboxylase.,J. Med. Chem.,PUBLICATION,
4357335,CHEMBL1343238,UCDCNUGIXHXJMX-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
454976,CHEMBL1256876,BWHPNJVKFAPVOG-QYFJGNGUSA-N,A-77636 HCL,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
730821,CHEMBL442201,DARQQJKHXPXSRO-UHFFFAOYSA-N,,,P00750,TISSUE-TYPE PLASMINOGEN ACTIVATOR,PLAT,,,14711304.0,KI,=,1120.0,NM,,,,,,,,,,,,,,Binding affinity towards human Tissue type plasminogen activator.,"Identification of novel binding interactions in the development of potent, selective 2-naphthamidine inhibitors of urokinase. Synthesis, structural analysis, and SAR of N-phenyl amide 6-substitution.",J. Med. Chem.,PUBLICATION,
5071334,CHEMBL1566826,XBPHOHHTAHAEAX-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,12.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
199533,CHEMBL1389666,AUCCSLDJMHOAAZ-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1792057,CHEMBL1873829,IMXYDTMMTLPMDN-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
465833,CHEMBL383274,BXPBVHNXTDZAAM-BPAPFQSLSA-N,,,P00489,"GLYCOGEN PHOSPHORYLASE, MUSCLE FORM",,,,16546381.0,IC50,=,461000.0,NM,,,,,,,,,,,,,,Inhibition of rabbit muscle GPa,Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1800942,CHEMBL129341,INSUFLQAMNJRIS-UHFFFAOYSA-N,,,P09917,ARACHIDONATE 5-LIPOXYGENASE,ALOX5,,,7562928.0,IC50,=,20.0,NM,,,,,,,,,,,,,,Inhibition of LT biosynthesis in vitro using A-23187-stimulated human whole blood.,Chiral dioxolane inhibitors of leukotriene biosynthesis: structure-activity relationships and syntheses using asymmetric dihydroxylation.,J. Med. Chem.,PUBLICATION,
5408241,CHEMBL1914740,YMALNMKYJXDZRH-HDICACEKSA-N,,,P42336,PI3-KINASE P110-ALPHA SUBUNIT,PIK3CA,,,21612232.0,IC50,=,247.0,NM,,cell_based,,,,,,,,,,,,Inhibition of PI3Kalpha-mediated Akt phosphorylation at Ser 473 in human U87MG cells,Phospshoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: discovery and structure-activity relationships of a series of quinoline and quinoxaline derivatives.,J. Med. Chem.,PUBLICATION,
1668059,CHEMBL1374906,HZBDUBMSTOBGML-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,33587.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4035731,CHEMBL2393502,RZCLLWVFGVZYFK-UHFFFAOYSA-N,,,O42275,ACETYLCHOLINESTERASE,,,,23644208.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 10 mins prior to substrate addition by Ellman's method,Synthesis and evaluation of 4-substituted coumarins as novel acetylcholinesterase inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
466250,CHEMBL1603897,BXQIVOMSRNFTNH-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
128309,CHEMBL1299713,AMMMMNLBSKHZDE-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5204229,CHEMBL67356,XPYONBNHCBGSPY-UHFFFAOYSA-N,,,P23944,ALPHA-1D ADRENERGIC RECEPTOR,,,,16513345.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of phenylephrine-stimulated Wistar rat aorta contraction at 100 uM,Vasorelaxant activity of phthalazinones and related compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1498792,CHEMBL76070,HGVIVDKXCLULHE-MEKGRNQZSA-N,,,"Q9BZJ3, Q15661, Q9NRR2",TRYPTASE,"TPSAB1, TPSD1, TPSG1",,,11055356.0,KI,=,46000.0,NM,,,,,,,,,,,,,,Evaluated for its inhibitory potency against tryptase,Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3993418,CHEMBL1544793,RUDVYHQSPGKLTL-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,316.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2063731,CHEMBL1438593,JRAVLTMEUUWOEH-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4165685,CHEMBL1545059,SNNXIODDPLUZAZ-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1362263,CHEMBL1608681,GRZPNAWSSAGQAR-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1014087,CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P20813,CYTOCHROME P450 2B6,CYP2B6,,,22815312.0,EMAX,=,21.5,,,cell_based,,,,,,,,,,,,Induction of CYP2B6 activity in human donor hepatocytes assessed as hydroxybupropion formation after 48 hrs by LC/MS method relative to untreated control,,Drug Metab. Dispos.,PUBLICATION,
3434498,CHEMBL1528726,PLISQVZGUCUXSY-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4160874,CHEMBL1575038,SNBWLODWSIALSV-AWEZNQCLSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2289553,CHEMBL294113,KPPADAGTNGHGBR-UHFFFAOYSA-N,IMIDAZOLE-1-CARBOXYLIC ACID PHENYLAMIDE,,P53582,METHIONINE AMINOPEPTIDASE 1,METAP1,,,25148591.0,INHIBITION,<,15.0,%,,,,,,,,,,,,,,Inhibition of human MetAP at 25 uM after 20 mins by HPLC analysis,Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments.,J. Med. Chem.,PUBLICATION,
4033601,CHEMBL123405,RYWZPRVUQHMJFF-BZSNNMDCSA-N,,,"P03372, Q92731",ESTROGEN RECEPTOR,"ESR1, ESR2",,,9357533.0,KA,=,1520000000.0,M-1,,,,,,,,,,,,,,Estrogen receptor (ER) binding affinity,Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study.,J. Med. Chem.,PUBLICATION,
816125,CHEMBL3323019,DKBPQSXNYNGHQK-UHFFFAOYSA-N,,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,25126833.0,KI,=,25.0,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]IABN from human D3R expressed in HEK293 cell membranes by gamma counting method,"Design, synthesis, and structure-activity relationship studies of a series of [4-(4-carboxamidobutyl)]-1-arylpiperazines: insights into structural features contributing to dopamine D3 versus D2 receptor subtype selectivity.",J. Med. Chem.,PUBLICATION,
2445817,CHEMBL1491855,LGXXWDUNEDGSKK-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5739185,CHEMBL1499343,ZWDKNVXAOVIBMY-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,79.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5840435,CHEMBL3792996,,,,P15538,CYTOCHROME P450 11B1,CYP11B1,,,26938274.0,IC50,=,222.5,NM,,,,,,,,,,,,,,"Inhibition of human CYP11B1 expressed in V79 MZh cells using [1,2-3H]-11-deoxycorticosterone as substrate for 6 hrs by HPTLC analysis",Exploiting the Chromone Scaffold for the Development of Inhibitors of Corticosteroid Biosynthesis.,J. Med. Chem.,PUBLICATION,
5199671,CHEMBL13485,XPLJEFSRINKZLC-ATVHPVEESA-N,SU-11652,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,wild_type,,23398362.0,ACTIVITY,=,107.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of EGFR at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
5332950,CHEMBL1403281,YDOTUXAWKBPQJW-NSLWYYNWSA-N,ERGOCRYPTINE,,P05181,CYTOCHROME P450 2E1,CYP2E1,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
2806923,CHEMBL1200845,MUQNGPZZQDCDFT-JNQJZLCISA-N,HALCINONIDE,,P25025,INTERLEUKIN-8 RECEPTOR B,CXCR2,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Chemokine CXCR2 (IL-8B) radioligand binding (ligand: [125I] IL-8),DrugMatrix in vitro pharmacology data,,DATASET,
4326518,CHEMBL44,TZBJGXHYKVUXJN-UHFFFAOYSA-N,GENISTEIN,,P28564,SEROTONIN 1B (5-HT1B) RECEPTOR,,,,,IC50,,,,,,,,,,,,,,,,,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DrugMatrix in vitro pharmacology data,,DATASET,
380983,CHEMBL1383372,BNWZMXWDFBBYTM-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5390107,CHEMBL1380376,YKCNIVFLKXYNJW-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,1995.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3861975,CHEMBL33096,RGAJIKNGJBAVQP-UHFFFAOYSA-N,,,P16257,PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR,,,,8182701.0,IC50,=,9.0,NM,,,,,,,,,,,,,,Displacement of [3H]-PK 11195 from peripheral (mitochondrial) benzodiazepine receptor,"Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activity relationships, and molecular modeling studies.",J. Med. Chem.,PUBLICATION,
2594447,CHEMBL590186,LWWDHCWUGFVCRN-PTNGSMBKSA-N,SJ000147784,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4430385,CHEMBL1405344,UKBAWZGPIHFUES-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1200065,CHEMBL1533592,GACCXSFXHHUJEO-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2731170,CHEMBL1969597,MLTWEYZZORFWHY-VGOFMYFVSA-N,,,Q57TT1,PUTATIVE UNCHARACTERIZED PROTEIN,,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1466248,CHEMBL197821,HDLNHNIGZWGTPR-UHFFFAOYSA-N,,,"P28472, P18507, P31644",GABA-A RECEPTOR; ALPHA-5/BETA-3/GAMMA-2,"GABRA5, GABRB3, GABRG2",,,16162003.0,EFFICACY,=,14.0,,,cell_based,,,,,,,,,,,,Efficacy at GABAA alpha-5-beta-3-gamma-2 receptor expressed in mouse fibroblast L(tk-) cells measured at 300 nM derived from at least three plates/day screened over a minimum of 2 days,A new pyridazine series of GABAA alpha5 ligands.,J. Med. Chem.,PUBLICATION,
2158110,CHEMBL517449,KBDSLGBFQAGHBE-MSGMIQHVSA-N,LIMONIN,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,16248836.0,KI,=,23200.0,NM,,,,,,,,,,,,,,Mechanism based inhibition of human cytochrome P450 3A4 measured by (14C)formaldehyde production from (N-methyl-14C)-erythromycin,Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.,Curr. Drug Metab.,PUBLICATION,
5743086,CHEMBL3144947,ZWQAEERTGYKMAZ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5338087,CHEMBL603,YEEZWCHGZNKEEK-UHFFFAOYSA-N,ZAFIRLUKAST,,P20309,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
1025735,CHEMBL1458595,FGQLRTRSYCXMCD-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23099.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
174727,CHEMBL1716073,ARLHWYFAPHJCJT-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
191987,CHEMBL3262553,ATGGZTWGPMWHPU-UHFFFAOYSA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,24657054.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human mu opioid receptor transfected in CHO cell membranes assessed as stimulation of [35S]GTPgammaS binding after 60 mins by scintillation counting analysis,Designing bifunctional NOP receptor-mu opioid receptor ligands from NOP-receptor selective scaffolds. Part II.,Bioorg. Med. Chem.,PUBLICATION,
2164212,CHEMBL404860,KBVLEFMPBGNUPK-UHFFFAOYSA-N,,,P56817,BETA-SECRETASE 1,BACE1,,,18162398.0,IC50,=,3000.0,NM,,,,,,,,,,,,,,Inhibition of BACE1 by FRET assay,Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4280589,CHEMBL1558461,TUBJXKBDAVRNIU-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3813769,CHEMBL1604652,RATPJWLDDWKQIN-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3235615,CHEMBL83980,OPQGFIAVPSXOBO-UHFFFAOYSA-N,BOHEMINE,,Q9P0L2,SERINE/THREONINE-PROTEIN KINASE MARK1,MARK1,wild_type,,23398362.0,ACTIVITY,=,81.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of MARK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2453272,CHEMBL3675551,LHURUBKIFBZDNZ-OALUTQOASA-N,,,P08253,MATRIX METALLOPROTEINASE-2,MMP2,,,,KI,>,1000.0,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibition tests and the evaluation of the inhibition constants (Ki) on the various MMPs were carried out as described by Devel et al. (Devel et al. 2006 J. Biol. Chem. (7)).,Pseudodipeptides as MMP inhibitors,,PATENT,
3021757,CHEMBL33431,NRWOARXNGLTTHY-PMACEKPBSA-N,,,"P08514, P05106",INTEGRIN ALPHA-IIB/BETA-3,"ITGA2B, ITGB3",,,,IC50,=,640.0,NM,,,,,,,,,,,,,,Inhibition of human platelet adhesion to fibrinogen,,Bioorg. Med. Chem. Lett.,PUBLICATION,
2735263,CHEMBL428069,MMGXDAVKLOGDHY-UHFFFAOYSA-N,,,P29474,"NITRIC-OXIDE SYNTHASE, ENDOTHELIAL",NOS3,,,18024030.0,IC50,=,220.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human eNOS expressed in insect SF9 cells after 1 hr,Discovery of a series of aminopiperidines as novel iNOS inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5504782,CHEMBL1089197,YWQKKXCQKRAICT-UHFFFAOYSA-N,,,Q16539,MAP KINASE P38 ALPHA,MAPK14,,,20227876.0,IC50,=,70.0,NM,,,,,,,,,,,,,,Inhibition of p38alpha assessed as gamma-[33P]ATP incorporation by scintillation counting,"Identification of SD-0006, a potent diaryl pyrazole inhibitor of p38 MAP kinase.",Bioorg. Med. Chem. Lett.,PUBLICATION,
832300,CHEMBL135902,DLSREUWBAOWMKZ-UHFFFAOYSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,IC50,=,10.0,NM,,,,,,,,,,,,,,Inhibition of Epidermal growth factor receptor autophosphorylation.,,Bioorg. Med. Chem. Lett.,PUBLICATION,
2148181,CHEMBL1397978,JZZCCLRWJNJEEV-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3955647,CHEMBL1337414,RQABYHLIAJVIRI-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5518489,CHEMBL2218939,YYDPEIRKANIXMV-XUTLUUPISA-N,,,P07948,TYROSINE-PROTEIN KINASE LYN,LYN,wild_type,,23398362.0,ACTIVITY,=,93.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,70,uM,"Millipore: Percentage of residual kinase activity of LYN at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
282962,CHEMBL1732672,BDJQUMFXFGIMBB-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3441712,CHEMBL1909383,PMDIOXBUJXUENT-KVQMOARXSA-N,GW784307A,,O60285,NUAK FAMILY SNF1-LIKE KINASE 1,NUAK1,,,,INHIBITION,=,43.94,%,,,,,,,,,,,,,,GSK_PKIS: ARK5 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4239156,CHEMBL1888104,SVMSPCODNMIVPY-UHFFFAOYSA-N,,,P19367,HEXOKINASE TYPE I,HK1,,,,IC50,=,40300.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR analysis of small molecule inhibitors of hexokinase domain containing I (HKDC1) in the hexokinase 1 selectivity assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493160, AID493190]",PUBCHEM BIOASSAY DATA SET,,DATASET,
930170,CHEMBL259389,DWHVZCLBMTZRQM-UHFFFAOYSA-N,QUINOXALINE1,,P09619,PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA,PDGFRB,wild_type,,23398362.0,ACTIVITY,=,102.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of PDGFRB at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4640423,CHEMBL1494169,VGOGVFHWIJPDAN-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2548857,CHEMBL1438341,LRYYTVIRDAICBP-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2539807,CHEMBL1495153,LQYHNBQEVDGJMB-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease: Purified N370S Glucocerebrosidase Cleavage of Glucosylceramide. (Class of assay: confirmatory) [Related pubchem assays: 2101 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5231161,CHEMBL1901193,XSSRMCSHLCYGFH-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
328227,CHEMBL385479,BIFFYWVZRGCPLC-UHFFFAOYSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,16806916.0,IC50,=,21.0,NM,,cell_based,,,,,,,,,,,,Antiproliferative activity against EGF-stimulated KB cells,Inhibitors of epidermal growth factor receptor tyrosine kinase: optimisation of potency and in vivo pharmacokinetics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4669347,CHEMBL1461331,VKAACGJVQMXIEB-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5343441,CHEMBL1389044,YERDVWZHKSLSFG-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
758085,CHEMBL1423310,DDQNCXZIMSLVGW-UHFFFAOYSA-N,,,Q13315,SERINE-PROTEIN KINASE ATM,ATM,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
413836,CHEMBL527573,BRQWGQONCQGFRK-UHFFFAOYSA-N,TCMDC-136575,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,5.73,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1408015,CHEMBL1222078,GXENINBGBQDWTM-GXBQSFKZSA-N,,,P47871,GLUCAGON RECEPTOR,GCGR,,,19597507.0,ACTIVITY,=,70.0,%,,cell_based,,,,,HEK293,,,,,,,Agonist activity at GCGR expressed in HEK293 cells assessed as stimulation of cAMP production by luciferase reporter gene assay relative to glucagon,A new glucagon and GLP-1 co-agonist eliminates obesity in rodents.,Nat. Chem. Biol.,PUBLICATION,
1262786,CHEMBL1537810,GGWFPGAJYPEHPU-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
150559,CHEMBL1426599,AOYGMEPSXVHVNP-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1084893,CHEMBL1390265,FNGZXNPODUHAQJ-UHFFFAOYSA-N,,,Q13315,SERINE-PROTEIN KINASE ATM,ATM,,,,POTENCY,,6535.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia: Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485356],PUBCHEM BIOASSAY DATA SET,,DATASET,
3695990,CHEMBL1520214,QOIZVPXCIKQNNN-UHFFFAOYSA-N,,,Q8VNN2,BETA-GALACTOSIDASE,,,,,EC50,>,31500.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: HTS Dose response counterscreen for assays utilizing the enzyme, b-galactosidase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1778, AID1785, AID1786, AID2284, AID2285, AID2348, AID2352, AID2357, AID2359, AID2370, AID2420, AID2478, AID2491, AID2492, AID2493, AID2495, AID2497, AID2498, AID2500, AID434981, AID449737, AID463105, AID485352, AID488822, AID488842, AID488935]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3008090,CHEMBL3699277,NQJNAZRAZSXLJA-JKSUJKDBSA-N,,,P68400,CASEIN KINASE II ALPHA,CSNK2A1,,,,IC50,=,0.45,NM,,,,,,,,,,,,,,"BindingDB_Patents: Kinase Assay. The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in the art. For example, in vitro protein kinase assays may be conducted with a relevant purified protein kinase and an appropriate synthetic substrate to determine the inhibitory activity of the compounds. Assays for inhibition of CK2 by the instant compounds were performed in 384-well plates with reaction mixtures containing 10 uM of peptide substrate (RRRADDSDDDDD-NH2), [gamma-33P]ATP (10 uCi) at 25 uM (CK2A1) or 5 uM (CK2A2), 20 mM Hepes (pH 7.4), 100 mM NaCl, 10 mM MgCl2, 0.25 mM dithiothreitol, Brij-35 at 0.015%, and recombinant CK2A1 (10 nM, Invitrogen) or CK2A2 (5 nM, Upstate Biotechnology). Reaction mixtures were incubated at 30 C. for 1 hour, and reaction products were captured by binding to phosphocellulose (P81) filter plates.",Imidazotriazinecarbonitriles useful as kinase inhibitors,,PATENT,
5527404,CHEMBL1598977,YZABJKQJXWLEOK-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5538256,CHEMBL1716062,ZAGJEDHNPYKKIZ-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3301729,CHEMBL1515858,OWRGXZDIORYMBE-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9. (Class of assay: confirmatory) [Related pubchem assays: 885, 884, 410 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5232179,CHEMBL636,XSVMFMHYUFZWBK-NSHDSACASA-N,RIVASTIGMINE,,P06276,BUTYRYLCHOLINESTERASE,BCHE,,,19520578.0,INHIBITION,=,76.0,%,,,,,,,,,,,,,,Inhibition of BChE in human serum assessed as hydrolysis of butyrylthiocholine at 0.1 ug/mL by Ellman's method,Synthesis of novel purine nucleosides towards a selective inhibition of human butyrylcholinesterase.,Bioorg. Med. Chem.,PUBLICATION,
3963151,CHEMBL370485,RQXGJGJDXGEQTI-UHFFFAOYSA-N,,,P06493,CYCLIN-DEPENDENT KINASE 1,CDK1,,,15808450.0,IC50,=,34.0,NM,,,,,,,,,,,,,,Inhibitory concentration against Cyclin dependent kinase 1,Substituted aminobenzimidazole pyrimidines as cyclin-dependent kinase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4478707,CHEMBL473074,UPNQAUFZWGKHGZ-IAURBROLSA-N,CYCLOASPEPTIDE A,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,6510.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
490966,CHEMBL2003602,CAIOAFRWOLEVOM-PXLXIMEGSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3219334,CHEMBL1501151,ONUHLYCFPJAGTC-UHFFFAOYSA-N,,,Q57TT1,PUTATIVE UNCHARACTERIZED PROTEIN,,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5116084,CHEMBL3091618,XGKYULQERWQZOR-UHFFFAOYSA-N,,,P56373,P2X PURINOCEPTOR 3,P2RX3,,,24246730.0,IC50,=,824.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at recombinant human P2X3 receptor expressed in Xenopus oocytes assessed as inhibition of ATP-induced ion current preincubated for 20 mins followed by ATP addition by two-electrode voltage clamp assay,Design and synthesis of potent and selective P2X3 receptor antagonists derived from PPADS as potential pain modulators.,Eur. J. Med. Chem.,PUBLICATION,
5439149,CHEMBL3194052,YOZPQVTVHKUPCG-BWJHVJOTSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
5814908,CHEMBL1909071,,,,P43140,ALPHA-1A ADRENERGIC RECEPTOR,,,,,IC50,,,,,,,,,,,,,,,,,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),DrugMatrix in vitro pharmacology data,,DATASET,
1136312,CHEMBL1402872,FSSWUKWMFICFRR-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
273265,CHEMBL554,BCFGMOOMADDAQU-UHFFFAOYSA-N,LAPATINIB,,P29317,EPHRIN TYPE-A RECEPTOR 2,EPHA2,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for EPHA2 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4981019,CHEMBL1879895,WRYILOABMMPSHS-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
180349,CHEMBL1447881,ASDPYEVJFNDYAM-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,1458.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5201793,CHEMBL1579003,XPPWBHFKFCPHJJ-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
699879,CHEMBL1327678,CXMPDJAWLASBEI-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
584694,CHEMBL1573398,CKTUBRPTJQKUHE-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3013395,CHEMBL480725,NQXNVQDFPSSMKO-LJQANCHMSA-N,,,P35557,HEXOKINASE TYPE IV,GCK,,,18588279.0,ACTIVITY,=,50.0,NM,,,,,,,,,,,,,,Activation of GST fused human liver glucokinase assessed as concentration required to double glucokinase activity by G6PDH coupled assay,"SAR, pharmacokinetics, safety, and efficacy of glucokinase activating 2-(4-sulfonylphenyl)-N-thiazol-2-ylacetamides: discovery of PSN-GK1.",J. Med. Chem.,PUBLICATION,
1492027,CHEMBL1467791,HGAJSFFOKDMJNF-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1862103,CHEMBL111882,IUNCSMWCZTUPAK-UHFFFAOYSA-N,,,"P35563, Q9JJ16",SEROTONIN 3 (5-HT3) RECEPTOR,,,,9341912.0,KI,=,10.0,NM,,,,,,,,,,,,,,In vitro affinity for 5-hydroxytryptamine 3 (5-HT3) receptor by displacement of [3H]BRL-43694 from rat entorhinal cortex,Phenylimidazolidin-2-one derivatives as selective 5-HT3 receptor antagonists and refinement of the pharmacophore model for 5-HT3 receptor binding.,J. Med. Chem.,PUBLICATION,
8789,CHEMBL1309999,AATJKJCNJBQHHV-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5369826,CHEMBL1301792,YHTOHELNPXFSHO-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5422092,CHEMBL2140301,YNJSZXXTSHNNHR-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,707.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5734282,CHEMBL3199456,ZVPBSQJAXFCKGQ-PEZBUJJGSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
313195,CHEMBL252857,BGRGYPWSRFVWGD-UHFFFAOYSA-N,,,Q9Y243,SERINE/THREONINE-PROTEIN KINASE AKT3,AKT3,,,18249537.0,IC50,=,2474.0,NM,,,,,,,,,,,,,,Inhibition of Akt3,Development of pyridopyrimidines as potent Akt1/2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2513152,CHEMBL3115899,LODHLSDCVURQKQ-IZLXSDGUSA-N,,,P04070,VITAMIN K-DEPENDENT PROTEIN C,PROC,,,24418773.0,KI,=,300.0,NM,,,,,,,,,,,,,,Competitive inhibition of human APC using S-2366 as substrate,"Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophilia.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2166967,CHEMBL1545277,KCEVVDXFYDUBSL-KRWDZBQOSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1500902,CHEMBL1995448,HHBRVCNUTJEMPJ-UHFFFAOYSA-N,,,P68400,CASEIN KINASE II ALPHA,CSNK2A1,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK2A1,PUBCHEM BIOASSAY DATA SET,,DATASET,
1560975,CHEMBL1388036,HNCBLYGQFOIUEM-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,23778.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
33624,CHEMBL112991,ACAUQEGNMPUJPW-MDWZMJQESA-N,,,O70526,BRADYKININ B2 RECEPTOR,,,,10091678.0,KI,=,2.8,NM,,tissue,,,,,,,,,,,,Inhibition of specific binding of [3H]BK to bradykinin B2 receptors of guinea pig ileum (GPI),Novel series of O-substituted 8-quinolines and 4-benzothiazoles as potent antagonists of the bradykinin B2 receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
997026,CHEMBL2425158,FDJZQQFTZNUNEI-UHFFFAOYSA-N,,,Q05397,FOCAL ADHESION KINASE 1,PTK2,,,23973211.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of FAK (unknown origin) using biotinylated-His-TEVhsFAK(31-686)(K454R) as substrate after 2 hrs by scintillation counting analysis,Fragment-based discovery of focal adhesion kinase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1592205,CHEMBL74911,HQQREVQTBOMVGU-UHFFFAOYSA-N,,,P06870,KALLIKREIN 1,KLK1,,,9873535.0,KI,=,21.0,NM,,,,,,,,,,,,,,Compound was evaluated for its inhibitory activity against Kallikrein,Highly efficient and versatile synthesis of libraries of constrained beta-strand mimetics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5272041,CHEMBL2312337,XXMNFZCEHJUMAD-UHFFFAOYSA-N,,,P07943,ALDOSE REDUCTASE,,,,23312612.0,IC50,=,5630.0,NM,,,,,,,,,,,,,,"Inhibition of Fischer-344 rat kidney ALR1 using D,L-glyceraldehyde as substrate by spectrophotometry",Synthesis of derivatives of the keto-pyrrolyl-difluorophenol scaffold: some structural aspects for aldose reductase inhibitory activity and selectivity.,Bioorg. Med. Chem.,PUBLICATION,
2552040,CHEMBL1514905,LSHVYAFMTMFKBA-YMBRHYMPSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1274893,CHEMBL205755,GICHEGMKPKHVKZ-ZDUSSCGKSA-N,,,P33905,TRANSCRIPTIONAL ACTIVATOR PROTEIN TRAR,,,,21798749.0,INHIBITION,=,-4.0,%,,,,,,,,,,,,,,Antagonist activity at Agrobacterium tumefaciens WCF (pCF372) TraR assessed as inhibition of OOHL-induced quorum sensing activation at 10 uM relative to untreated control,"Design, synthesis, and biological evaluation of abiotic, non-lactone modulators of LuxR-type quorum sensing.",Bioorg. Med. Chem.,PUBLICATION,
1764066,CHEMBL1399134,IJSRZRBTLZHKOY-UHFFFAOYSA-N,,,P18054,ARACHIDONATE 12-LIPOXYGENASE,ALOX12,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1082393,CHEMBL447048,FNAIOOGHXYZWCB-UHFFFAOYSA-N,,,P10845,BOTULINUM NEUROTOXIN TYPE A,,,,24984937.0,RATIO,=,0.94,/M/S,,,,,,,,,,,,,,Inhibition of recombinant Clostridium botulinum neurotoxin serotype A light chain assessed as Kinact to KI ratio at 50 uM after 1.5 hrs by SNAPtide FRET based assay,Benzoquinones as inhibitors of botulinum neurotoxin serotype A.,Bioorg. Med. Chem.,PUBLICATION,
5675030,CHEMBL2164330,ZPCWKQFBWBASPL-UHFFFAOYSA-N,,,P34969,SEROTONIN 7 (5-HT7) RECEPTOR,HTR7,,,22738316.0,KI,=,1.4,NM,,,,,,,,,,,,,,Displacement of [3H]-5-CT from human cloned 5HT7 receptor,Investigations on the 1-(2-biphenyl)piperazine motif: identification of new potent and selective ligands for the serotonin(7) (5-HT(7)) receptor with agonist or antagonist action in vitro or ex vivo.,J. Med. Chem.,PUBLICATION,
924678,CHEMBL200416,DVSLSPWSCJLOGG-UHFFFAOYSA-N,,,P08172,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,CHRM2,,,16275087.0,KI,=,25.0,NM,,,,,,,,,,,,,,Binding affinity to human muscarinic M2 receptor,Potent anti-muscarinic activity in a novel series of quinuclidine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4015425,CHEMBL914,RWTNPBWLLIMQHL-UHFFFAOYSA-N,FEXOFENADINE,,Q12809,HERG,KCNH2,,,19110341.0,IC50,=,21379.62,NM,,cell_based,,,,,MCF7,,,,,,,Inhibition of human ERG in MCF7 cells,GRIND-based 3D-QSAR and CoMFA to investigate topics dominated by hydrophobic interactions: the case of hERG K+ channel blockers.,Eur. J. Med. Chem.,PUBLICATION,
5551857,CHEMBL1421,ZBNZXTGUTAYRHI-UHFFFAOYSA-N,DASATINIB,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,mutated,EGFR(L858R),19039322.0,ACTIVITY,=,7.0,%,inhibition,biochemical,functional,binding_saturation,competitive_inhibitor,radiometry,,1000,NM,?-33P- ATP ,=,500.0, CPM/PMOL ,AT 1 UM OF DRUG CONCENTRATION,Global target profile of the kinase inhibitor bosutinib in primary chronic myeloid leukemia cells.,Leukemia,PUBLICATION,
239545,CHEMBL1888009,AYMYIKSUYDGIEW-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3529049,CHEMBL1412159,PVQKVWHUKMQJIS-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,5173.5,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
54368,CHEMBL1400815,AECDMGQTJIORMB-ULJHMMPZSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4071364,CHEMBL1425261,SCZCOHIZVQWVAV-IWRZYZMASA-N,,,O00167,EYES ABSENT HOMOLOG 2,EYA2,,,,POTENCY,,316227.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939],PUBCHEM BIOASSAY DATA SET,,DATASET,
4215009,CHEMBL3212397,SSUDPOUOKXFIFQ-HYARGMPZSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
352211,CHEMBL1404779,BKWJYJIWUUDCMS-UHFFFAOYSA-N,,,O15648,6-PHOSPHO-1-FRUCTOKINASE,,,,,POTENCY,,21331.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",PUBCHEM BIOASSAY DATA SET,,DATASET,
280824,CHEMBL1430130,BDBZEQKQCFNEDT-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1232913,CHEMBL573578,GDQXJQSQYMMKRA-UHFFFAOYSA-N,,,Q96GD4,SERINE/THREONINE-PROTEIN KINASE AURORA-B,AURKB,,,17850214.0,ACTIVITY,=,106.0,%,activation,biochemical,functional,enzyme_activity,competitive_inhibitor,radiometry,,1,uM,ATP,=,20.0,uM,Percentage Aurora B activity remaining in the presence of 1uM inhibitor,The selectivity of protein kinase inhibitors: a further update.,Biochem. J.,PUBLICATION,
1210547,CHEMBL1642591,GBJFVLFWUDEZIA-URORMMCBSA-N,,,P28845,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,HSD11B1,,,21093258.0,IC50,=,3.9,NM,,,,,,,,,,,,,,Inhibition of human full length 11beta-HSD1 assessed as inhibition of conversion of [3H]cortisone to [3H]cortisol by scintillation proximity assay,"Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11ß-HSD1 inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5697420,CHEMBL1255901,ZRJBHWIHUMBLCN-HZRLMBICSA-N,HUPERZINE A,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
814628,CHEMBL182227,DJXDQVVNDSVVRH-VLGSPTGOSA-N,,,O76074,PHOSPHODIESTERASE 5A,PDE5A,,,15324874.0,IC50,=,5180.0,NM,,cell_based,,,,,MCF7,,,,,,,Inhibition of human Phosphodiesterase 5 purified from MCF-7 cells,"Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4634426,CHEMBL475987,VFXYGRWDLAQGRF-JQFXXIQLSA-N,,,P32300,DELTA OPIOID RECEPTOR,,,,19211245.0,KI,>,1000.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]diprenorphine from mouse delta opioid receptor expressed in CHO cells,Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin A.,Bioorg. Med. Chem. Lett.,PUBLICATION,
343558,CHEMBL1401345,BJTOOOKODUSQTN-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,,13039.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators: Hit Validation Using Renilla Luciferase Read-Out for Rab9. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
820052,CHEMBL1526924,DKNMWSHHJHRNMX-UHFFFAOYSA-N,,,O15648,6-PHOSPHO-1-FRUCTOKINASE,,,,,POTENCY,,23934.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768],PUBCHEM BIOASSAY DATA SET,,DATASET,
2742824,CHEMBL1326452,MNCOVVCUWIJYPF-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3233079,CHEMBL1794068,OPJOIUDMJCRLNO-QGZVFWFLSA-N,GSK-326090A,,P31749,SERINE/THREONINE-PROTEIN KINASE AKT,AKT1,,,,INHIBITION,=,-0.94,%,,,,,,,,,,,,,,GSK_PKIS: AKT1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4821332,CHEMBL1410515,WAORDGOWMGVLES-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,7307.8,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1377416,CHEMBL1531750,GTTHEKSDBORJDR-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
277694,CHEMBL1311767,BCSSRIADXUKQFO-AATRIKPKSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2806222,CHEMBL1230165,MUOKSQABCJCOPU-UHFFFAOYSA-N,SILMITASERTIB,,P19784,CASEIN KINASE II ALPHA (PRIME),CSNK2A2,,,26850376.0,IC50,=,11.0,NM,,,,,,,,,,,,,,Inhibition of GST-tagged human CK2alpha' (1 to 350 residues) using CK2tide as substrate incubated for 1 hr by off-chip mobility shift assay,Structure-activity relationship study of 4-(thiazol-5-yl)benzoic acid derivatives as potent protein kinase CK2 inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
4274418,CHEMBL1950009,SZQLJRUPQGEKLC-UHFFFAOYSA-N,,,P23219,CYCLOOXYGENASE-1,PTGS1,,,22373734.0,IC50,=,33500.0,NM,,,,,,,,,,,,,,Inhibition of COX-1-mediated TXB2 production in human whole blood after 15 mins post A23187 stimulation by RIA,"Novel acid-type cyclooxygenase-2 inhibitors: Design, synthesis, and structure-activity relationship for anti-inflammatory drug.",Eur. J. Med. Chem.,PUBLICATION,
4095678,CHEMBL1320711,SFRVFQUOIAHVPE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2672667,CHEMBL1310861,MFKLIPXMBOATPW-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3481663,CHEMBL1460478,PQNQVDRTTPICCK-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5406054,CHEMBL1083483,YLSNDJMDGONFPZ-UHFFFAOYSA-N,,,O14920,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE BETA SUBUNIT,IKBKB,,,20471256.0,IC50,=,280.0,NM,,,,,,,,,,,,,,Inhibition of FLAG-tagged IKK-beta after 30 mins,Synthesis and biological evaluation of tricyclic anilinopyrimidines as IKKbeta inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3805158,CHEMBL3191067,RAAFVVPEQKFDGH-RCCKNPSSSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
2886967,CHEMBL1424272,NDFGVILRKJFZNW-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
568450,CHEMBL1382788,CIZGMCNDVSHGLG-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
817833,CHEMBL267930,DKGZKTPJOSAWFA-UHFFFAOYSA-N,SPIPERONE,,P34969,SEROTONIN 7 (5-HT7) RECEPTOR,HTR7,,,7518496.0,KI,=,100.0,NM,,,,,,,,,,,,,,,,,,
4757403,CHEMBL1478778,VTNVCLYVBVVCHW-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4131507,CHEMBL291338,SJQBHPJLLIJASD-UHFFFAOYSA-N,"3,3',4',5-TETRACHLOROSALICYLANILIDE",,P25021,HISTAMINE H2 RECEPTOR,HRH2,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DrugMatrix in vitro pharmacology data,,DATASET,
4948389,CHEMBL1521213,WOGULGPHXFTJTL-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,5804.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2759123,CHEMBL33884,MOZPSIXKYJUTKI-UHFFFAOYSA-N,GR-113808,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3640080,CHEMBL346957,QIEPWCSVQYUPIY-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2901311,CHEMBL1290612,NEXVKNHJGXACAF-UXHICEINSA-N,,,Q12809,HERG,KCNH2,,,20971003.0,IC50,=,4000.0,NM,,,,,,,,,,,,,,Displacement of [3H]-dofetilide from human hERG,N-substituted pyrrolidines and tetrahydrofurans as novel AMPAR positive modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
802128,CHEMBL1597576,DINFBIHQBARJSG-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5461169,CHEMBL286742,YRNLXUHCTRMFCI-UHFFFAOYSA-N,,,P21836,ACETYLCHOLINESTERASE,,,,2016712.0,NO. OF SURVIVORS,=,1.0,,,,,,,,,,,,,,,antidotal activity measured in mice exposed to soman; activity expressed as the no. of survivors at 24 hr out of population of 10 mice exposed intramuscularly at the dose 1/4 of 2LD50 of the compound,"Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 5. Structure-activity relationships for side-chain nitro-, sulfone-, amino-, and aminosulfonyl-substituted analogues for therapy against anticholinesterase intoxication.",J. Med. Chem.,PUBLICATION,
581449,CHEMBL1582477,CKJMBJBYXLDVMX-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,1901.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1670078,CHEMBL1482663,HZHKVMFXFWRDBO-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4958053,CHEMBL1362600,WPKAZGAVLVHNCS-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,562.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5129404,CHEMBL1544895,XHRMJUKRQNSAAI-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4565944,CHEMBL1443300,UYMYHIMTFNHCAN-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5259437,CHEMBL1602721,XWBFKTDOMCTTDQ-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1176576,CHEMBL1446882,FXJGSNNVFDHFEX-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,20.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4125932,CHEMBL1321524,SIZCAHKKHRKDBC-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5059060,CHEMBL1320596,XADAXACPZSUSLG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16353.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3978216,CHEMBL2234402,RSPCTNSOBBGJSK-UHFFFAOYSA-N,,,P62937,CYCLOPHILIN A,PPIA,,,,IC50,,,,,,,,,,,,,,,,,Inhibition of Homo sapiens (human) cyclophilin A PPIase activity expressed in Escherichia coli BL21(DE3) using Suc-AAPF-pNA as substrate measured after 6 secs for 20 secs by spectrophotometric analysis,,Med Chem Res,PUBLICATION,
4362890,CHEMBL372795,UCSJYZPVAKXKNQ-HZYVHMACSA-N,STREPTOMYCIN,,P25103,NEUROKININ 1 RECEPTOR,TACR1,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Tachykinin NK1 radioligand binding (ligand: [3H] Substance P),DrugMatrix in vitro pharmacology data,,DATASET,
521526,CHEMBL1490414,CDPKQGUFQABMHH-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,=,7079.46,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3807786,CHEMBL572881,RAHBGWKEPAQNFF-UHFFFAOYSA-N,MOTESANIB,,O14757,SERINE/THREONINE-PROTEIN KINASE CHK1,CHEK1,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for CHEK1 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
1595672,CHEMBL485407,HRBJVYYIBYQKRV-TYZXPVIJSA-N,,,P31645,SEROTONIN TRANSPORTER,SLC6A4,,,18834188.0,IC50,=,291.0,NM,,cell_based,,,,,,,,,,,,Inhibition of 5-HT transporter-mediated [3H]5HT uptake in human Jar cells,Advances toward new antidepressants with dual serotonin transporter and 5-HT1A receptor affinity within a class of 3-aminochroman derivatives. Part 2.,J. Med. Chem.,PUBLICATION,
3333182,CHEMBL1549628,PAFDHYZZBXGAHT-ACCUITESSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2729024,CHEMBL275798,MLNSFBMGRWGGII-UHFFFAOYSA-N,SB-239272,,P07947,TYROSINE-PROTEIN KINASE YES,YES1,,,,INHIBITION,=,-0.9,%,,,,,,,,,,,,,,GSK_PKIS: YES mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3983511,CHEMBL1577208,RTCVJYQAXQBCEU-UHFFFAOYSA-N,,,Q9XUB2,ZINC FINGER PROTEIN MEX-5,,,,,EC50,>,300000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescent Polarization Homogeneous Dose Response HTS to Identify Inhibitors of Mex-5 Binding to TCR-2. (Class of assay: confirmatory) [Related pubchem assays: 1833 (Project Summary), 1832 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4507048,CHEMBL1402277,USKHCLAXJXCWMO-OAHLLOKOSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2281674,CHEMBL1362648,KOTVTQGXUGEEQL-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4263499,CHEMBL359185,SYJITPNVVAEGJT-IADYIPOJSA-N,,,"Q08499, P27815, Q07343, Q08493",PHOSPHODIESTERASE 4,"PDE4A, PDE4B, PDE4C, PDE4D",,,8120866.0,IC50,=,44000.0,NM,,,,,,,,,,,,,,Concentration required to inhibit 50% activity of phosphodiesterase IV isoenzyme (at 100 uM).,"Inhibition of cyclic nucleotide phosphodiesterase by derivatives of 1,3-bis(cyclopropylmethyl)xanthine.",J. Med. Chem.,PUBLICATION,
615967,CHEMBL137384,COFRKLYXCWVCKM-JZGIUJARSA-N,,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,9435896.0,IC50,=,1180.0,NM,,,,,,,,,,,,,,In vitro affinity against human Muscarinic acetylcholine receptor M1 using quinuclidynyl benzylate (QNB),"Design of [R-(Z)]-(+)-alpha-(methoxyimino)-1-azabicyclo[2.2.2]octane-3-acetonitri le (SB 202026), a functionally selective azabicyclic muscarinic M1 agonist incorporating the N-methoxy imidoyl nitrile group as a novel ester bioisostere.",J. Med. Chem.,PUBLICATION,
223270,,AWRMNKFDOAUSCG-OOSWLFMASA-N,BIM 23056,,P30936,SOMATOSTATIN RECEPTOR 3,,,,9166718.0,KI,=,380.0,NM,,,,,,,,,,,,,,,,,,
2087724,CHEMBL224654,JTOQURWMEPBQCH-CASJYSRLSA-N,,,P10275,ANDROGEN RECEPTOR,AR,,,17064916.0,FI5,>,10000.0,NM,,cell_based,,,,,HeLa,,,,,,,Agonist activity at androgen receptor expressed in HeLa cells assessed as effect on dihydrotestosterone-induced transcriptional activity by reporter gene assay,Discovery of 7alpha-substituted dihydrotestosterones as androgen receptor pure antagonists and their structure-activity relationships.,Bioorg. Med. Chem.,PUBLICATION,
1840712,CHEMBL1306021,ISDWZLXZFPPMNI-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1711620,CHEMBL1386967,IDOQJONLXBRNRW-BQYQJAHWSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,501.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1592795,CHEMBL1455660,HQSKFVIMLMHPJD-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,13371.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5418170,CHEMBL1456469,YMZUPSZNNZBHHA-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5856736,CHEMBL1494657,,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1806882,CHEMBL3211667,IOHZDORJRGUQQZ-FOKLQQMPSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3050960,CHEMBL235157,NVINUNQBDNEMSY-UHFFFAOYSA-N,,,Q00535,CYCLIN-DEPENDENT KINASE 5,CDK5,,,,KI,>,3162.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK5,PUBCHEM BIOASSAY DATA SET,,DATASET,
2925400,CHEMBL45247,NHLJHJZGXAAQEQ-UHFFFAOYSA-N,,,P35354,CYCLOOXYGENASE-2,PTGS2,,,15026050.0,IC50,=,150.0,NM,,cell_based,,,,,,,,,,,,In vitro inhibitory activity against human recombinant prostaglandin G/H synthase 2 expressed in sf-9 cells infected with baculovirus,"Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5101025,,XEYBRNLFEZDVAW-BRNHSORCSA-N,5-TRANS-PGE2,,P43119,PROSTANOID IP RECEPTOR,PTGIR,,,6266565.0,KI,=,735.0,NM,,,,,,,,,,,,,,,,,,
2395452,CHEMBL200687,LBEUNKXGRPZDQP-UHFFFAOYSA-N,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,16335918.0,INHIBITION,=,8.8,%,,,,,,,,,,,,,,Percentage inhibition of [3H]CGS 21680 binding to adenosine A2A receptor in bovine striatal membranes at 20 uM,"1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.",J. Med. Chem.,PUBLICATION,
789137,CHEMBL1314147,DHDHZKHTNUDMEA-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,2229.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation Concentration-Response Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction, SAR for Probe. (Class of assay: confirmatory) [Related pubchem assays: 1493, 1492, 2566, 2570, 1461, 1489, 2567, 1491, 1464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1311761,CHEMBL83255,GMCCBRBEVQXKMD-UHFFFAOYSA-N,,,P50391,NEUROPEPTIDE Y RECEPTOR TYPE 4,NPY4R,,,15109631.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,In vitro binding affinity against rat neuropeptide Y4 receptor,"Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2753056,CHEMBL3104704,MOGZMXKHFUIRHE-RYQLWAFASA-N,,,P28593,TRYPANOTHIONE REDUCTASE,,,,24321832.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Inhibition of Trypanosoma cruzi trypanothione reductase expressed in Escherichia coli BL21(DE3) assessed as reduction of oxidized trypanothione at 100 uM preincubated for 30 mins measured for 30 mins by spectrophotometric analysis relative to DMSO-treated control,Synthesis and evaluation of the antiparasitic activity of bis-(arylmethylidene) cycloalkanones.,Eur. J. Med. Chem.,PUBLICATION,
1585799,CHEMBL1313044,HPXUDIALYYMYIT-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3079352,CHEMBL1392412,NYNVEVKWIJIVIH-CHHCPSLASA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,37933.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4780118,CHEMBL1604350,VWDOEFIYQBBRAM-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,,16944.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in Parental Cell Line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1054424,CHEMBL1382322,FJSHFENULQVICW-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,14575.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
503126,CHEMBL1582472,CBSZVPKUGQCGOE-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,95283.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5481555,CHEMBL1515391,YUAJTWWWVLDORZ-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4153767,CHEMBL1470076,SMFBKQJAWVCWTP-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1221821,CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),DrugMatrix in vitro pharmacology data,,DATASET,
4067019,CHEMBL1410734,SCKYLISPOXJRGR-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3800768,CHEMBL1589065,QZRSKXAARXIOIE-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2236163,CHEMBL84350,KJUXYSPBVYVNHD-UHFFFAOYSA-N,,,"Q08499, P27815, Q07343, Q08493",PHOSPHODIESTERASE 4,"PDE4A, PDE4B, PDE4C, PDE4D",,,12852946.0,IC50,=,2.0,NM,,,,,,,,,,,,,,Inhibitory concentration against phosphodiesterase 4.,Comparative molecular field analysis (CoMFA) of phthalazine derivatives as phosphodiesterase IV inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2429306,CHEMBL1357567,LFAQSMZJJAVQFG-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4251065,CHEMBL1733280,SWXLNLBTHNSVSB-UHFFFAOYSA-N,,,Q9Y239,NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN-CONTAINING PROTEIN 1,NOD1,,,,IC50,=,5760.0,NM,,cell_based,,,,,,,,,,,,Inhibition of NOD-1 mediated NFkappaB activation in HEK293T cells assessed as inhibition of gamma-tri-DAP-induced luciferase activity after 14 hrs by reporter gene assay,,ACS Med. Chem. Lett.,PUBLICATION,
413612,CHEMBL1341918,BRQFEESCSQEAAU-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
375619,CHEMBL444749,BNFYASKYUGOCBF-IFDNYZKCSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,18682322.0,KI,=,83.0,NM,,,,,,,,,,,,,,Binding affinity to human MC4 receptor,Structure-activity relationship studies on a series of piperazinebenzylalcohols and their ketone and amine analogs as melanocortin-4 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4373263,CHEMBL1258164,UEAVWGGGKFMVLR-IZZQQSIFSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,20727752.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Antagonist activity at human delta opioid receptor assessed as inhibition of SNC80-stimulated [35S]GTPgammaS binding,Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1904229,CHEMBL932,IZEKFCXSFNUWAM-UHFFFAOYSA-N,DIPYRIDAMOLE,,P35372,MU OPIOID RECEPTOR,OPRM1,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DrugMatrix in vitro pharmacology data,,DATASET,
470090,CHEMBL314639,BYBYHCOEAFHGJL-UHFFFAOYSA-N,SDZ-201106,,Q14524,SODIUM CHANNEL PROTEIN TYPE V ALPHA SUBUNIT,SCN5A,,,7629798.0,CHANGE,=,239.0,%,,cell_based,,,,,Oocytes,,,,,,,Inactivation process of guinea pig cardiac Na channels expressed in xenopus oocytes was determined by measuring increase in current integral in presence of compound versus control at 10 uM,Synthesis and structure-activity relationships of 6-heterocyclic-substituted purines as inactivation modifiers of cardiac sodium channels.,J. Med. Chem.,PUBLICATION,
1459806,CHEMBL1584002,HCUFUIAOECNGFY-UHFFFAOYSA-N,,,P10520,STREPTOKINASE A,,,,,EC50,=,2637.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4113123,CHEMBL547988,SHNIMDNPRGWJOD-UHFFFAOYSA-N,TCMDC-138716,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,2.82,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4448634,CHEMBL503089,UMEKRJBKRPLHKL-NJNXFGOHSA-N,,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,18676143.0,IC50,=,3.46,NM,,,,,,,,,,,,,,Inhibition of human recombinant B-Raf by fluorescence anisotropy,Potent and selective pyrazole-based inhibitors of B-Raf kinase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
628882,CHEMBL1321,CPTBDICYNRMXFX-UHFFFAOYSA-N,PROCARBAZINE,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DrugMatrix in vitro pharmacology data,,DATASET,
196001,CHEMBL254916,ATRCUYKKJRLYQA-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
150926,CHEMBL220431,AOZIYHRDHCZRJS-KRWDZBQOSA-N,,,Q07869,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA,PPARA,,,17274610.0,EC50,>,10000.0,NM,,,,,,,,,,,,,,Agonist activity at human PPAR alpha by FRET assay,"Indanylacetic acid derivatives carrying 4-thiazolyl-phenoxy tail groups, a new class of potent PPAR alpha/gamma/delta pan agonists: synthesis, structure-activity relationship, and in vivo efficacy.",J. Med. Chem.,PUBLICATION,
3705719,CHEMBL1306024,QPKWNEWUSVXGHE-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
87498,CHEMBL1724086,AHSMUGYEUDLUEJ-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3101461,CHEMBL125073,OBDCSTNDGGOQNF-CUVJYRNJSA-N,,,P18405,STEROID 5-ALPHA-REDUCTASE 1,SRD5A1,,,11020287.0,IC50,=,9100.0,NM,,cell_based,,,,,CHO,,,,,,,Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cells,Benzo[c]quinolizin-3-ones: a novel class of potent and selective nonsteroidal inhibitors of human steroid 5alpha-reductase 1.,J. Med. Chem.,PUBLICATION,
1080309,CHEMBL473427,FMSVVUDMNOXYTG-UHFFFAOYSA-N,,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,,,19111461.0,IC50,=,113.0,NM,,,,,,,,,,,,,,Inhibition of ErbB2,Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2773965,CHEMBL1542262,MQSVICKTFXDDDG-UHFFFAOYSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,=,5011.87,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4401174,CHEMBL803,UHDGCWIWMRVCDJ-CCXZUQQUSA-N,CYTARABINE,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D2L radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
795837,CHEMBL442661,DHXIUUKDDYVBSZ-GFULKKFKSA-N,,,Q9UBN7,HISTONE DEACETYLASE 6,HDAC6,,,18701301.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Inhibition of HDAC6 in human U937 cells assessed as induction of alpha-tubulin acetylation after 24 hrs by Western blot analysis,"Design, synthesis and biological evaluation of novel compounds with conjugated structure as anti-tumor agents.",Bioorg. Med. Chem.,PUBLICATION,
3224802,CHEMBL1400764,OOHWDQXDMKMDMN-UHFFFAOYSA-N,,,O15648,6-PHOSPHO-1-FRUCTOKINASE,,,,,POTENCY,,21331.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2406150,CHEMBL1710322,LCIADWBDPMYEMJ-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,25929.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
261536,CHEMBL1422657,BAZQPZSKCSOREV-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
3093576,CHEMBL96223,OAEGXHVKQGQHEN-UHFFFAOYSA-N,,,P04049,SERINE/THREONINE-PROTEIN KINASE RAF,RAF1,,,11591521.0,INHIBITION,=,31.0,%,,,,,,,,,,,,,,Inhibitory activity against raf kinase at 25 uM concentration.,Discovery of heterocyclic ureas as a new class of raf kinase inhibitors: identification of a second generation lead by a combinatorial chemistry approach.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4680692,CHEMBL1719447,VLEVWKRTWXWDGW-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,4109.5,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4754811,CHEMBL466942,VTGTUKGXWKZUEG-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,18640036.0,IC50,=,310.0,NM,,cell_based,,,,,,,,,,,,Inhibition of KDR autophosphorylation by cell based assay,Synthesis and evaluation of heteroaryl-ketone derivatives as a novel class of VEGFR-2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2264250,CHEMBL373074,KMRIBBKLCIMDTB-UVTDQMKNSA-N,,,P11511,CYTOCHROME P450 19A1,CYP19A1,,,15743198.0,IC50,=,2800.0,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against human placental CYP19 incubated with 500 nM of substrate androstenedione in presence of the compound,Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase.,J. Med. Chem.,PUBLICATION,
3410601,CHEMBL1479409,PIQUZPIBLRARAO-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4715723,CHEMBL1426956,VOXLBUWOUKPRSZ-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1330838,CHEMBL179311,GOGIUMBXFRNDRK-UHFFFAOYSA-N,GW580509X,,P04049,SERINE/THREONINE-PROTEIN KINASE RAF,RAF1,,,,INHIBITION,=,5.24,%,,,,,,,,,,,,,,GSK_PKIS: CRAF mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1220168,CHEMBL572878,GCIKSSRWRFVXBI-UHFFFAOYSA-N,TOZASERTIB,,P51817,SERINE/THREONINE-PROTEIN KINASE PRKX,PRKX,wild_type,,22037377.0,ACTIVITY,=,136.85628169999998,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,KEMPTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
4589486,CHEMBL1200787,VBCPVIWPDJVHAN-UHFFFAOYSA-N,PHENOXYBENZAMINE HYDROCHLORIDE,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4058042,CHEMBL1627869,SBJMSRGJIXBEKA-VXNCWWDNSA-N,,,P08842,STERYL-SULFATASE,STS,,,8295207.0,INHIBITION,=,74.0,%,,cell_based,,,,,MCF7,,,,,,,Tested for inhibition of estrone sulfatase in MCF-7 breast cancer cells using 2 nM substrate concentration at 1 uM,Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential.,J. Med. Chem.,PUBLICATION,
793774,CHEMBL1583743,DHQXBXRCCQYOCX-ZROIWOOFSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
581674,CHEMBL1480661,CKJYLWGFRFMBRG-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
2333980,CHEMBL1327248,KTVGANCJGKCBJU-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,37933.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2877063,CHEMBL1364365,NCFDOXWUWRWZFU-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
890384,CHEMBL1650436,DRSHNENJAZVBLE-CQSZACIVSA-N,,,P27487,DIPEPTIDYL PEPTIDASE IV,DPP4,,,21186796.0,IC50,=,57.0,NM,,,,,,,,,,,,,,Inhibition of human DPP4,Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV.,J. Med. Chem.,PUBLICATION,
271696,CHEMBL1540053,BCDRZNPOBRAABB-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
5398503,CHEMBL1722392,YKYOAIUBJPNMBR-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,14581.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
457944,CHEMBL6753,BWSMJWLWXNCHHP-UHFFFAOYSA-N,,,P00915,CARBONIC ANHYDRASE I,CA1,,,11229775.0,KI,=,9300.0,NM,,,,,,,,,,,,,,"Inhibition of cloned isozyme, human carbonic anhydrase I",Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4247236,CHEMBL139578,SWKWOPAFNKTWHV-UHFFFAOYSA-N,,,P61168,DOPAMINE D2 RECEPTOR,,,,1360026.0,IC50,=,2964.0,NM,,,,,,,,,,,,,,In vitro binding affinity towards dopamine receptor D2,Novel piperidine sigma receptor ligands as potential antipsychotic drugs.,J. Med. Chem.,PUBLICATION,
1892345,CHEMBL1588324,IXZCTRUQJCROAK-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
642224,CHEMBL1700496,CRGYPOYNKYNYNT-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
476937,CHEMBL347810,BYXSOYBFGIAIKM-UHFFFAOYSA-N,,,P33535,MU OPIOID RECEPTOR,,,,2563773.0,KI,>,100.0,NM,,,,,,,,,,,,,,The ability to displace [3H]naloxone from the Opioid receptor mu 1 isolated from rat brain membrane; >= no displacement,"New 4-(heteroanilido)piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties.",J. Med. Chem.,PUBLICATION,
1525670,CHEMBL1410041,HJOUPSHCKZTNEX-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3073652,CHEMBL1576144,NXVVFMGMENNIJR-DHDCSXOGSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4576631,CHEMBL557063,UZTWTKGFIWIYEJ-HJNYFJLDSA-N,,,P00797,RENIN,REN,,,19615901.0,IC50,=,2.0,NM,,,,,,,,,,,,,,Inhibition of purified recombinant human renin,The P1N-isopropyl motif bearing hydroxyethylene dipeptide isostere analogues of aliskiren are in vitro potent inhibitors of the human aspartyl protease renin.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3530116,CHEMBL527584,PVTJLEVGBWKJFS-UHFFFAOYSA-N,TCMDC-124518,,O75496,GEMININ,GMNN,,,,POTENCY,,4109.5,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1732451,CHEMBL508864,IGAMPBMZUPINSL-DIPNUNPCSA-N,,,P10415,APOPTOSIS REGULATOR BCL-2,BCL2,,,18841882.0,KI,<,1.0,NM,,,,,,,,,,,,,,Displacement of fluorescein labeled Bax peptide from Bcl2 by fluorescence polarization assay,Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins.,J. Med. Chem.,PUBLICATION,
4193242,CHEMBL1447100,SQOIHAZRLHDUOY-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,89125.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4831114,CHEMBL1591346,WBUKMDBZYSJICV-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2857593,CHEMBL3207849,MZZMERQMHJZGEX-UVHMKAGCSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
2954725,CHEMBL1061,NKOHRVBBQISBSB-UHFFFAOYSA-N,GLITAZONE,,P08503,"MEDIUM-CHAIN SPECIFIC ACYL-COA DEHYDROGENASE, MITOCHONDRIAL",,,,22970990.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to mitochondrial medium-chain specific acyl-CoA dehydrogenase in Sprague-Dawley rat heart homogenate after 15 mins by chromatographic analysis,Chemical proteomics-based analysis of off-target binding profiles for rosiglitazone and pioglitazone: clues for assessing potential for cardiotoxicity.,J. Med. Chem.,PUBLICATION,
3719218,CHEMBL296586,QQUXFYAWXPMDOE-UHFFFAOYSA-N,KENPAULLONE,,Q13555,CAM KINASE II GAMMA,CAMK2G,wild_type,,22037377.0,ACTIVITY,=,116.1340626,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ZIPTIDE + CA-,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3050709,CHEMBL287165,NVHYHKRZUDLBBQ-WXVAWEFUSA-N,,,"P26010, P13612",INTEGRIN ALPHA-4/BETA-7,"ITGA4, ITGB7",,,12031329.0,RATIO,=,39.0,,,,,,,,,,,,,,,Selectivity for alpha4-beta7 to that of alpha4-beta1,Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2541031,CHEMBL506247,LRBQNJMCXXYXIU-PPKXGCFTSA-N,TANNIC ACID,,P51679,C-C CHEMOKINE RECEPTOR TYPE 4,CCR4,,,,IC50,,,,,,,,,,Chem-1,,,,,,,DRUGMATRIX: Chemokine CCR4 radioligand binding (ligand: [125I] TARC),DrugMatrix in vitro pharmacology data,,DATASET,
4041641,CHEMBL1494756,RZPFHRZHWJQMTE-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,12.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
393662,CHEMBL297362,BPICBUSOMSTKRF-UHFFFAOYSA-N,XYLAZINE,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1412.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4669194,CHEMBL1428270,VJZKDCNBNSJZHF-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
1657167,CHEMBL1994048,HXZATFHWUJOHEE-FMQZQXMHSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,30131.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
589984,CHEMBL1650951,CLGRAWDGLMENOD-UHFFFAOYSA-N,,,P17252,PROTEIN KINASE C ALPHA,PRKCA,,,21155605.0,IC50,=,13.0,NM,,,,,,,,,,,,,,Inhibition of PKCalpha,Identification of a potent Janus kinase 3 inhibitor with high selectivity within the Janus kinase family.,J. Med. Chem.,PUBLICATION,
2946710,CHEMBL194814,NJQQVASVGXHRDC-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1400304,CHEMBL1203728,GWGHLWITMJFPQQ-UHFFFAOYSA-N,,,"P18825, P08913, P35368, P35348, P25100, P18089",ADRENERGIC RECEPTOR ALPHA,"ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C",,,6124636.0,ACTIVITY,=,59.0,,,,,,,,,,,,,,,Inhibition of phenylephrine induced increase in blood pressure in the dog.,"Arylethanolamines derived from salicylamide with alpha- and beta-adrenoceptor blocking activities. Preparation of labetalol, its enantiomers, and related salicylamides.",J. Med. Chem.,PUBLICATION,
5031660,CHEMBL1485620,WXKDRZQZVWPFSI-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5528472,CHEMBL1230020,YZDJQTHVDDOVHR-UHFFFAOYSA-N,PLX-4720,,Q13470,NON-RECEPTOR TYROSINE-PROTEIN KINASE TNK1,TNK1,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for TNK1 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
3132112,CHEMBL254529,OEGCGEQYCKTJHY-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,18255291.0,EC50,=,215.0,NM,,cell_based,,,,,CHO,,,,,,,Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP level,Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
824826,CHEMBL571,DKYWVDODHFEZIM-UHFFFAOYSA-N,KETOPROFEN,,P08912,MUSCARINIC ACETYLCHOLINE RECEPTOR M5,CHRM5,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
2839611,CHEMBL1950283,MYHAEFWAINZSOU-XGNXJENSSA-N,,,O89017,LEGUMAIN,,,,22243962.0,IC50,=,4.4,NM,,,,,,,,,,,,,,Inhibition of mouse recombinant legumain using Cbz-Ala-Ala-Asn-AMC as substrate measured every 30 secs for 2.5 hrs by fluorimetry,"Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5769965,CHEMBL405791,ZZPIZTRTJLPEKP-FKSJIRLYSA-N,,,Q01726,MELANOCORTIN RECEPTOR 1,MC1R,,,14998337.0,IC50,,,,,,,,,,,,,,,,,Inhibition of 1 nM alpha melanocortin stimulating hormone from frog skin; No activity up to 10-5 M.,"De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.",J. Med. Chem.,PUBLICATION,
1970873,CHEMBL252556,JGPMMRGNQUBGND-UHFFFAOYSA-N,IDEBENONE,,P31645,SEROTONIN TRANSPORTER,SLC6A4,,,,IC50,,,,,,,,,,HEK293,,,,,,,"DRUGMATRIX: Transporter, Serotonin (5-Hydroxytryptamine) (SERT) radioligand binding (ligand: [3H] Paroxetine)",DrugMatrix in vitro pharmacology data,,DATASET,
3930412,CHEMBL331924,RNHPXWHVVUIJJX-KAYWLYCHSA-N,,,O70536,ACYL COENZYME A:CHOLESTEROL ACYLTRANSFERASE 1,,,,8809157.0,INHIBITION,=,59.0,%,,,,,,,,,,,,,,In vitro for inhibitory activity against Acyl coenzyme A:cholesterol acyltransferase 1 from rat liver microsomes at 50 uM,2-Azetidinone cholesterol absorption inhibitors: structure-activity relationships on the heterocyclic nucleus.,J. Med. Chem.,PUBLICATION,
4946556,CHEMBL109788,WOBGAHDETZNABX-UHFFFAOYSA-N,,,Q7ZJM1,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE,,,,9703465.0,IC50,=,236000.0,NM,,,,,,,,,,,,,,Inhibitory concentration was evaluated as 50% inhibition of HIV-1 integrase enzyme at strand transfer stage of DNA integration in experiment I,Salicylhydrazine-containing inhibitors of HIV-1 integrase: implication for a selective chelation in the integrase active site.,J. Med. Chem.,PUBLICATION,
1260257,CHEMBL101683,GGPZCOONYBPZEW-UHFFFAOYSA-N,,,P04629,NERVE GROWTH FACTOR RECEPTOR TRK-A,NTRK1,wild_type,,23398362.0,ACTIVITY,=,80.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,120.0,uM,"Millipore: Percentage of residual kinase activity of NTRK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
521261,CHEMBL535517,CDOQHVAIXLNOPU-UHFFFAOYSA-N,TCMDC-141443,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,8.35,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2699824,CHEMBL445793,MIQNXDQFAOFYCN-UHFFFAOYSA-N,,,P00489,"GLYCOGEN PHOSPHORYLASE, MUSCLE FORM",,,,18485716.0,INHIBITION,=,15.0,%,,,,,,,,,,,,,,Inhibition of rabbit glycogen phosphorylase assessed as release of phosphate from glucose 1 phosphate at 3 mM,Evaluation of novel hyphodermin derivatives as glycogen phosphorylase a inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
1364866,CHEMBL1571017,GSGCYZMWGQJNNC-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,1778.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4814725,CHEMBL1530274,VZYADZNYZDPHDV-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
92162,CHEMBL1412286,AIGOSUULOHPKMF-ARJAWSKDSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1694811,CHEMBL1474147,IBSAYVKUTDUAPV-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,100.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1632593,CHEMBL2135554,HVIJILMNABLWQY-QJPTWQEYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1736336,CHEMBL1714344,IGLMYOAGGPTZQO-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2348008,CHEMBL1352909,KVPDHBLADVOVQH-YFHOEESVSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2003702,CHEMBL1547152,JKKKEJNQASIJPP-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3143081,CHEMBL1446973,OFKYNOGEHLLOPY-PGMHBOJBSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
3390995,CHEMBL486478,PGUVAKMIEAFDEA-UHFFFAOYSA-N,PSB-09120,,P29275,ADENOSINE A2B RECEPTOR,ADORA2B,,,19569717.0,KI,=,0.157,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]PSB-603 from human recombinant adenosine A2B receptor expressed in CHO cells,1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity.,J. Med. Chem.,PUBLICATION,
4503618,CHEMBL1464641,URYYSTAMVXOYDZ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2242800,CHEMBL1378845,KKMMBSVYIIGEQM-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5303978,CHEMBL1722340,YANQCNMDAUDMBG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,31528.7,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation in Cell-Based Luciferin Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
737947,CHEMBL23393,DBMJMQXJHONAFJ-UHFFFAOYSA-M,SODIUM LAURYL SULFATE,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,75864.4,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2287693,CHEMBL1397576,KPJZHOPZRAFDTN-YZVOILCLSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,=,12589.25,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3158257,CHEMBL188048,OHBDLKLACOYJNL-UHFFFAOYSA-N,SB-736290,,Q00526,CYCLIN-DEPENDENT KINASE 3,CDK3,,,,INHIBITION,=,2.12,%,,,,,,,,,,,,,,GSK_PKIS: CDK3/cyclinE mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
959357,CHEMBL1499626,DZKPHHMCRPGNLD-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1193989,CHEMBL208698,FZGDBDUTUSHERH-WQLSENKSSA-N,,,P48736,PI3-KINASE P110-GAMMA SUBUNIT,PIK3CG,,,25050878.0,IC50,=,20000.0,NM,,,,,,,,,,,,,,Inhibition of PI3Kgamma (unknown origin) assessed as decrease in fluorescence intensity using phosphorylated substrate,Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3K¿) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.,Eur. J. Med. Chem.,PUBLICATION,
1167698,CHEMBL1483832,FWHLVHFWWWVAPQ-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
603931,CHEMBL1392842,CMTQNBFLWOSGAE-UHFFFAOYSA-N,,,Q27686,PYRUVATE KINASE,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3820639,CHEMBL3353354,RBNRSVPXZPBXCD-LUCHDKOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,24867403.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of CYP2D6 (unknown origin) using AMMC substrate after 45 mins by fluorescence assay,"The discovery of Polo-like kinase 4 inhibitors: design and optimization of spiro[cyclopropane-1,3'[3H]indol]-2'(1'H).ones as orally bioavailable antitumor agents.",J. Med. Chem.,PUBLICATION,
1039970,CHEMBL1535796,FIEWMDQEAPHSBE-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2161521,CHEMBL1344551,KBMPZZVPNBAXNU-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1380981,CHEMBL3194085,GUEFLPCYJCZKAU-NTEUORMPSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3111463,CHEMBL1335837,OCFOSEIPUGJGQS-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5540894,CHEMBL3259830,ZAOJHZGIRKVCBH-UHFFFAOYSA-N,,,Q00987,P53-BINDING PROTEIN MDM-2,MDM2,,,24751445.0,KI,=,400.0,NM,,,,,,,,,,,,,,Displacement of fluorescent P4 peptide from MDM2 (unknown origin) by fluorescence polarization assay,Hot spot-based design of small-molecule inhibitors for protein-protein interactions.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2831038,CHEMBL2001226,MXDVJHBTVUQFFD-BRJLIKDPSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4118898,CHEMBL1512573,SIDVJOKCLJCJOP-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3574798,CHEMBL1773180,QAXOVMMDPXUGKF-UHFFFAOYSA-N,,,Q9Y2R2,HEMATOPOIETIC CELL PROTEIN-TYROSINE PHOSPHATASE 70Z-PEP,PTPN22,,,21116447.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibition of human Lyp expressed in Escherichia coli after 5 mins by microplate spectrophotometer analysis,"Identification and characterization of novel inhibitors of mPTPB, an essential virulent phosphatase from Mycobacterium tuberculosis.",ACS Med. Chem. Lett.,PUBLICATION,
3813628,CHEMBL3190340,RATDWVDVSQDWCF-LFIBNONCSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
37742,CHEMBL1574623,ACKMIUUIECOWJX-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1300447,CHEMBL1373339,GKWXPVYKHAXXOX-SFQUDFHCSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
397954,CHEMBL3197478,BPUGMVDOYKLDRW-BIZUNTBRSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3525086,CHEMBL2135751,PVHPHJLFVJEJLC-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2368647,CHEMBL1303527,KXZWPMIYLHXBPE-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1955876,CHEMBL1456642,JEWOUWCNKJLSOO-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3155694,CHEMBL1581199,OGUHZBZEVODPDF-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5190287,CHEMBL1464144,XOJBAQLBKXHBEW-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3136458,CHEMBL1417438,OETPUFFGQRURCG-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6513.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3197676,CHEMBL147741,OLNJUISKUQQNIM-UHFFFAOYSA-N,3-FORMYLINDOLE,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,26331552.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human 15-LOX1 assessed as conversion of linoleic acid to 13(S)-HpODE at 50 uM after 10 mins by UV analysis,Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties.,J. Med. Chem.,PUBLICATION,
5317707,CHEMBL401321,YBZHQFAVAQZLFB-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,18835161.0,KI,=,9.2,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]DPCPX form human adenosine A1 receptor expressed in HEK293 cells,"2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A(2A) antagonists with improved solubility and metabolic stability.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4249619,CHEMBL1411399,SWTLKIRMTPXUTI-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,517.4,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4579411,CHEMBL1401399,VABKGTKCKZQGGK-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2136581,CHEMBL1398376,JYUZMLYVLMBHFA-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1055462,CHEMBL397829,FJVYPXVLXQXDHM-UHFFFAOYSA-N,,,"P53609, P49354",GERANYLGERANYL TRANSFERASE TYPE I,"FNTA, PGGT1B",,,25935643.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of GGTase 1 in human RPMI8226 cells assessed as unmodified Rap1a accumulation at 5 mM incubated for 48 hrs by immunoblot method,N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2590910,CHEMBL1541593,LWKVKOWDANKBGD-NHDPSOOVSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5605221,CHEMBL527592,ZHGKZVGSRIYFLD-UHFFFAOYSA-N,TCMDC-131290,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,7.41,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4632932,CHEMBL326762,VFSOHDUOFSENHF-UHFFFAOYSA-N,,,"P28473, P28471, P23574, P15431, P63079, O09028, P30191, Q91ZM7, P18508, P62813, P20236, P19969, P23576, P63138, Q9ES14, P18506",GABA-A RECEPTOR; ANION CHANNEL,,,,,GABA SHIFT,=,1.1,,,,,,,,,,,,,,,Ratio of IC50 (no GABA) to IC50 (GABA) was measured as GABA Shift (GS),,Bioorg. Med. Chem. Lett.,PUBLICATION,
4729741,CHEMBL3184542,VQJLZFISLUXPQW-JBYIUTFZSA-N,,,Q9NZ08,ENDOPLASMIC RETICULUM AMINOPEPTIDASE 1,ERAP1,,,,AC50,,2920.0,NM,,biochemical,,,,,,,,,,,,PubChem BioAssay. MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_Dose_CherryPick_Activity_Set2.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1321737,CHEMBL3354745,GNESVQSQMKQSMV-VXLDWYAESA-N,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,25438763.0,RATIO,=,22.6,,,cell_based,,,,,,,,,,,,Inhibition of human MDR1 expressed in mouse L5178Y cells assessed as Rhodamine-123 accumulation measured as fluorescence activity at 80 uM after 20 mins by flow cytometry relative to control,"Improving the MDR reversal activity of 6,17-epoxylathyrane diterpenes.",Bioorg. Med. Chem.,PUBLICATION,
3350961,CHEMBL221047,PCGISRHGYLRXSR-UHFFFAOYSA-N,NSC-45174,,Q99873,PROTEIN-ARGININE N-METHYLTRANSFERASE 1,PRMT1,,,20666457.0,IC50,=,375600.0,NM,,,,,,,,,,,,,,Inhibition of His6x-tagged PRMT1-mediated protein arginine methylation expressed in Escherichia coli BL21 (DE3) using GAR R4 peptide and [14C]-AdoMet by scintillation counting,Discovery and mechanistic study of a class of protein arginine methylation inhibitors.,J. Med. Chem.,PUBLICATION,
1058957,CHEMBL521442,FKFLVZYWXOJIMQ-UHFFFAOYSA-N,,,P19793,RETINOID X RECEPTOR ALPHA,RXRA,,,19095448.0,IC50,=,5200.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at RXRalpha expressed in african green monkey COS1 cells assessed as inhibition of LGD-1069-induced agonist activity,Replacing alkyl sulfonamide with aromatic sulfonamide in sulfonamide-type RXR agonists favors switch towards antagonist activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3291816,CHEMBL1307526,OVOMQAOITSHXAG-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,67455.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4251975,CHEMBL1736185,SWZYNBMBDHWTGU-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4020222,CHEMBL90667,RXJLPWXRPNCGLY-PAMZHZACSA-N,MCL-110,,P97266,MU OPIOID RECEPTOR,,,,11591513.0,KI,=,0.11,NM,,,,,,,,,,,,,,Binding affinity towards Opioid receptor mu 1 in guinea pig brain membranes using [3H]DAMGO as radioligand,Mixed kappa agonists and mu agonists/antagonists as potential pharmacotherapeutics for cocaine abuse: synthesis and opioid receptor binding affinity of N-substituted derivatives of morphinan.,Bioorg. Med. Chem. Lett.,PUBLICATION,
207439,CHEMBL85861,AUZCXFQYQQUAFH-UHFFFAOYSA-N,,,"P47869, P28472, P18507",GABA-A RECEPTOR; ALPHA-2/BETA-3/GAMMA-2,"GABRA2, GABRB3, GABRG2",,,9651158.0,KI,=,18.7,NM,,,,,,,,,,,,,,Binding affinity measured using LtK- cell membranes expressing GABA alpha-2-beta-3-gamma-2 receptor,Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-beta-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors.,J. Med. Chem.,PUBLICATION,
1953416,CHEMBL209301,JEOIMYUIHSWTEE-BZKUTMRRSA-N,,,A5A4K8,MOTILIN RECEPTOR,,,,16650762.0,IC50,=,10.0,NM,,,,,,,,,,,,,,Inhibition of [125]I-motilin binding to rabbit motilin receptor,"Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3664281,CHEMBL3309549,QKYKUTTWIHRLFI-HNNXBMFYSA-N,,,P06239,TYROSINE-PROTEIN KINASE LCK,LCK,,,24878193.0,INHIBITION,=,5.8,%,,,,,,,,,,,,,,Inhibition of LCK (unknown origin) at 10 uM,"Design, synthesis and biological evaluation of benzyl 2-(1H-imidazole-1-yl) pyrimidine analogues as selective and potent Raf inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1436928,CHEMBL1488097,HANFBAPEIJHZSD-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4257194,CHEMBL1306565,SXQCTESRRZBPHJ-UHFFFAOYSA-M,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
284701,CHEMBL1312251,BDPAGHWJLYCUKV-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4532059,CHEMBL1702651,UVBQDZBIEPGUMZ-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,21331.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2737637,CHEMBL1300980,MMNICKFKXZDTEL-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
3834166,CHEMBL1348273,RDCLDNUTFWCRNO-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
689223,CHEMBL1585327,CWFJUPQLRJEEGA-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3104368,CHEMBL3134106,OBMARJCENXFSJY-UHFFFAOYSA-N,,,Q3SYC2,2-ACYLGLYCEROL O-ACYLTRANSFERASE 2,MOGAT2,,,,IC50,=,911.0,NM,,,,,,,,,,,,,,Inhibition of human MGAT2 by Rapidfire LCMS assay,,MedChemComm,PUBLICATION,
729523,CHEMBL1964275,DANPUZSWWCDWEM-UHFFFAOYSA-N,,,O95819,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4,MAP4K4,wild_type,,19035792.0,ACTIVITY,,,,inhibition,physiochemical,binding,binding_reversible,competitive_inhibitor,qPCR,,10000,NM,,,,,Binding affinity to human MAP3K4 at 10 uM relative to control,Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.,J. Med. Chem.,PUBLICATION,"IN THIS ASSAY, 0% MEANS PHAGE/KINASE-FUSION WAS POTENTLY DISPLACED BY THE DRUG, WHICH MEANS THE DRUG IS VERY EFFECTIVE. CONVERSELY, 100% MEANS ALL PHAGE REMAINED BOUND, WHICH SIGNIFIES THE DRUG HAD NO EFFECT = NO BINDING TO THE KINASE"
3526068,CHEMBL306865,PVIMTNAWPMEBAK-LSHDLFTRSA-N,GW784752X,,O15111,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE ALPHA SUBUNIT,CHUK,,,,INHIBITION,=,1.55,%,,,,,,,,,,,,,,GSK_PKIS: IKKA mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4517462,CHEMBL1479791,UTMULNNHXORQRG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,25918.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
748966,CHEMBL2326755,DCRPPFHJAFKVCR-UHFFFAOYSA-N,,,Q15858,SODIUM CHANNEL PROTEIN TYPE IX ALPHA SUBUNIT,SCN9A,,,23177785.0,IC50,=,1100.02,NM,,,,,,,,,,,,,,Inhibition of NaV1.7 ion channel (unknown origin),QSAR investigation of NaV1.7 active compounds using the SVM/Signature approach and the Bioclipse Modeling platform.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1362108,CHEMBL3360530,GRYYOMJWZHIYKM-UHFFFAOYSA-N,,,P28161,GLUTATHIONE S-TRANSFERASE MU 2,GSTM2,,,25462236.0,IC50,=,8.0,NM,,,,,,,,,,,,,,Inhibition of GSTM2-2 (unknown origin) using GSH substrate by spectrophotometric method,Synthesis and structure-activity relationship of new cytotoxic agents targeting human glutathione-S-transferases.,Eur. J. Med. Chem.,PUBLICATION,
4286582,CHEMBL3667153,TURFAFSCSMANPJ-KBXCAEBGSA-N,,,O00763,ACETYL-COA CARBOXYLASE 2,ACACB,,,,IC50,=,113.0,NM,,cell_based,,,,,,,,,,,,"BindingDB_Patents: Spectrophotometric 384 Well Assay. Malonyl CoA formation by acetyl CoA carboxylases is stoichometrically linked to the consumption of ATP. ACC2 activity is measured in a NADH-linked kinetic method measuring ADP generated during the ACC reaction using a coupled lactate dehydrogenase/pyruvate kinase reaction.For biological testing, a human ACC2 construct which lacks the 128 amino acids at the N-terminus for increased solubility (nt 385-6966 in Genbank entry AJ575592) is cloned. The protein is then expressed in insect cells using a baculoviral expression system. Protein purification is performed by anion exchange.All compounds are dissolved in dimethyl sulfoxide (DMSO) to a concentration of 10 mM.Assay reactions are then carried out in 384-well plates, with hACC2 in an appropriate dilution and at final assay concentrations (f.c.) of 100 mM Tris (pH 7.5), 10 mM trisodium citrate, 25 mM KHCO3, 10 mM MgCl2, 0.5 mg/ml BSA, 3.75 mM reduced L-glutathione, 15 U/ml lactate dehydrogenase, 0.5 mM phosphoenolpyruvate.","Pyrimidine-substituted pyrrolidine derivatives, pharmaceutical compositions and uses thereof",,PATENT,
3731398,CHEMBL413965,QRZAKQDHEVVFRX-UHFFFAOYSA-N,FELBINAC,,P41597,C-C CHEMOKINE RECEPTOR TYPE 2,CCR2,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),DrugMatrix in vitro pharmacology data,,DATASET,
1382837,CHEMBL1991800,GUHUQPHEGAYGKK-UHFFFAOYSA-N,,,P17948,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1,FLT1,,,,KI,>,398.11,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1,PUBCHEM BIOASSAY DATA SET,,DATASET,
68635,CHEMBL1339113,AFOUUUKRDLZLOC-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
201010,CHEMBL469884,AUGGMUVNPWIEHR-DEOSSOPVSA-N,,,P13945,BETA-3 ADRENERGIC RECEPTOR,ADRB3,,,18553954.0,EC50,=,2.6,NM,,cell_based,,,,,CHO,,,,,,,Agonist activity at human recombinant beta3 adrenergic receptor expressed in CHO cells assessed as cAMP accumulation by enzyme immuno assay,Discovery of a novel series of biphenyl benzoic acid derivatives as highly potent and selective human beta3 adrenergic receptor agonists with good oral bioavailability. Part II.,J. Med. Chem.,PUBLICATION,
619944,CHEMBL1496049,COSCHVOSSWLRBI-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3114289,CHEMBL2336238,OCPRKHMINMQDBA-UHFFFAOYSA-N,,,Q8TDU6,G-PROTEIN COUPLED BILE ACID RECEPTOR 1,GPBAR1,,,,EC50,=,212.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant TGR5 receptor expressed in CHO cells assessed as cAMP accumulation after 30 mins by spectrophotometry,,MedChemComm,PUBLICATION,
1411780,CHEMBL408,GXPHKUHSUJUWKP-UHFFFAOYSA-N,TROGLITAZONE,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,32196.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Biochemical firefly luciferase enzyme assay for NPC. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5606913,CHEMBL1339954,ZHJOVGGRJFTZQE-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5580,CHEMBL7735,AALNCHNFTKRFEL-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
20867,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,,HIV-1 Protease,,,,8894098.0,IC50,=,19000.0,NM,,,,,,,,,,,,,,,,,,
5683730,CHEMBL17370,ZPXPEKQMLOAPLT-UHFFFAOYSA-N,,,P29317,EPHRIN TYPE-A RECEPTOR 2,EPHA2,wild_type,,21336281.0,KI,<,3162.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
1261058,CHEMBL1587367,GGQUJVFIKJYUSM-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,18356.4,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4536642,CHEMBL1426641,UVPFMOQJDMJGBY-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,125892.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5373410,CHEMBL2218936,YIECEZWWJSWRJN-MYYYXRDXSA-N,,,"Q15078, Q00535",CYCLIN-DEPENDENT KINASE 5/CDK5 ACTIVATOR 1,"CDK5, CDK5R1",,,23398362.0,ACTIVITY,=,78.0,%,,,,,,,,,,,,,,"Millipore: Percentage of residual kinase activity of CDK5 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,
4977322,CHEMBL1408255,WRPKEXYRFXCKKW-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3859578,CHEMBL1382429,RFTKKJMESXPXLC-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3946362,CHEMBL1741987,ROZRNHKQOQPQJU-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5788891,CHEMBL3814945,,,,Q92793,CREB-BINDING PROTEIN,CREBBP,,,27190605.0,IC50,>,200000.0,NM,,,,,,,,,,,,,,Displacement of biotinylated ligand from recombinant His-tagged CBP (unknown origin) incubated for 10 mins by TR-FRET assay,Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637).,ACS Med. Chem. Lett.,PUBLICATION,
4016396,CHEMBL1909065,RWVUEZAROXKXRT-VQLSFVLHSA-N,LYSERGOL,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
3870679,CHEMBL1595495,RGWGQAIGACORTH-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1464677,CHEMBL1412067,HDGAYMVNWSXKLI-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4108471,CHEMBL194099,SHBKBFYVWDZZMP-UHFFFAOYSA-N,,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,16134944.0,EC50,=,4.5,NM,,,,,,,,,,,,,,Effective concentration against dopamine D3 receptor,Pharmacophore-guided drug discovery investigations leading to bioactive 5-aminotetrahydropyrazolopyridines. Implications for the binding mode of heterocyclic dopamine D3 receptor agonists.,J. Med. Chem.,PUBLICATION,
1603245,CHEMBL1529802,HRYJPHOTGFERGT-UHFFFAOYSA-N,THONZYLAMINE HYDROCHLORIDE,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4856564,CHEMBL1608744,WEHGHHGTLLLURL-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
5502989,CHEMBL1555610,YWMAXDMCZCOQKC-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2524638,CHEMBL23588,LPEPZBJOKDYZAD-UHFFFAOYSA-N,FLUFENAMIC ACID,,O60218,ALDO-KETO REDUCTASE FAMILY 1 MEMBER B10,AKR1B10,,,25375908.0,IC50,=,760.0,NM,,,,,,,,,,,,,,Inhibition of wild-type N-terminal 6-His tagged AKR1B10 (unknown origin) expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction by spectrophotometry,Targeting aldose reductase for the treatment of diabetes complications and inflammatory diseases: new insights and future directions.,J. Med. Chem.,PUBLICATION,
1702220,CHEMBL1200585,ICMWWNHDUZJFDW-DHODBPELSA-N,OXYMETHOLONE,,P25021,HISTAMINE H2 RECEPTOR,HRH2,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DrugMatrix in vitro pharmacology data,,DATASET,
4619823,CHEMBL609010,VEPHUPSGUQCBDH-BOVPIJFQSA-N,,,P45983,C-JUN N-TERMINAL KINASE 1,MAPK8,,,19674907.0,ACTIVITY,=,100.0,%,,cell_based,,,,,,,,,,,,Binding affinity to human JNK1 at 50 nM by cell-based competition binding assay relative to control in presence of DTT,Staurosporine tethered peptide ligands that target cAMP-dependent protein kinase (PKA): optimization and selectivity profiling.,Bioorg. Med. Chem.,PUBLICATION,
3703502,CHEMBL1415216,QPDQBBHIWIIBOP-WJDWOHSUSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,17740.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3486729,CHEMBL1584543,PRCIPJYATKXWLA-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,31.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1645562,CHEMBL477979,HWUIKJWOZNTZQM-UHFFFAOYSA-N,GW785974X,,Q9NQU5,SERINE/THREONINE-PROTEIN KINASE PAK6,PAK6,,,,INHIBITION,=,-11.8,%,,,,,,,,,,,,,,GSK_PKIS: PAK6 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2501059,CHEMBL1880739,LMXYVLFTZRPNRV-UHFFFAOYSA-N,GW305074X,,Q00526,CYCLIN-DEPENDENT KINASE 3,CDK3,,,,INHIBITION,=,-2.28,%,,,,,,,,,,,,,,GSK_PKIS: CDK3/cyclinE mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3942139,CHEMBL7939,RONQPWQYDRPRGG-UHFFFAOYSA-N,CGP-53353,,Q02156,PROTEIN KINASE C EPSILON,PRKCE,wild_type,,23398362.0,ACTIVITY,=,73.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,45.0,uM,"Millipore: Percentage of residual kinase activity of PRKCE at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 20 mM HEPES pH 7.4, 0.03% Triton X-100, 0.1 mg/mL phosphatidylserine, 10 ug/mL diacylglycerol",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4515836,CHEMBL3108781,UTHVSBDCNLCZHF-UHFFFAOYSA-N,,,Q9H8M2,BROMODOMAIN-CONTAINING PROTEIN 9,BRD9,wild_type,,24313754.0,IC50,=,1584.89,NM,,biochemical,binding,binding_saturation,,AlphaScreen,,,,Peptide,,,,Displacement of H2K9(Ac)K13(Ac)K15(Ac) peptide from BRD9 bromodomain (unknown origin) by AlphaScreen assay,"[1,2,4]Triazolo[4,3-a]phthalazines: Inhibitors of Diverse Bromodomains.",J. Med. Chem.,PUBLICATION,AlphaScreen peptide displacement assay
5565395,CHEMBL1969049,ZCXXFPLQFFRMPN-UHFFFAOYSA-N,,,P43405,TYROSINE-PROTEIN KINASE SYK,SYK,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SYK,PUBCHEM BIOASSAY DATA SET,,DATASET,
1359512,CHEMBL1386856,GRQYOUXMVUPVTN-UHFFFAOYSA-N,,,Q14191,WERNER SYNDROME ATP-DEPENDENT HELICASE,WRN,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1083087,CHEMBL1256750,FNDGLVOYAQNQPE-UHFFFAOYSA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,,EC50,>,92535.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. Counterscreen for agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors: Luminescence-based cell-based high throughput dose response assay to identify agonists of OPRM1 homodimerization. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1293270,CHEMBL3651625,GKCIDSIFAMSUJW-LBPRGKRZSA-N,,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,,IC50,=,0.55,NM,,,,,,,,,,,,,,BindingDB_Patents: Raf/Mek Amplified Luminescence Proximity Homogeneous Assay. Raf/Mek amplified luminescence proximity homogeneous assay.,Compounds and compositions as protein kinase inhibitors,,PATENT,
5193157,CHEMBL3586592,XOSFOGCCJRNZJO-UHFFFAOYSA-N,,,O42275,ACETYLCHOLINESTERASE,,,,26107513.0,IC50,=,750.0,NM,,,,,,,,,,,,,,Inhibition of electric eel AChE by spectrophotometric Ellman's method,Structure-Based Design and Optimization of Multitarget-Directed 2H-Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases.,J. Med. Chem.,PUBLICATION,
1820036,CHEMBL271475,IPVFGAYTKQKGBM-BYPJNBLXSA-N,FIALURIDINE,,O70127,BILE SALT EXPORT PUMP,,,,21965623.0,IC50,>,1000000.0,NM,,,,,,,,,,,,,,Inhibition of Sprague-Dawley rat Bsep expressed in plasma membrane vesicles of Sf21 cells assessed as inhibition of ATP-dependent [3H]taurocholate uptake,In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.,Drug Metab. Dispos.,PUBLICATION,
1268811,CHEMBL1375921,GHKMYUZJPSACAM-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3215124,CHEMBL1254183,ONILRJBDHIKGPC-VQQFHTKMSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,20805033.0,ACTIVITY,,,,,,,,,,,,,,,,,Increase of NRF2-mediated HO-1 expression in hormone-refractory human DU145 cells at 5 uM after 24 hrs by Western blotting,Identification of organoselenium compounds that possess chemopreventive properties in human prostate cancer LNCaP cells.,Bioorg. Med. Chem.,PUBLICATION,
4811389,CHEMBL1579850,VZMVVTYNZSDARD-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1468436,CHEMBL227305,HDRGFAQXTKVBGE-UHFFFAOYSA-N,,,P10275,ANDROGEN RECEPTOR,AR,,,17439112.0,KI,=,4.2,NM,,cell_based,,,,,MDA-MB-453,,,,,,,Displacement of [3H]DHT from human AR expressed in MDA-MB-453 cells,"Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.",J. Med. Chem.,PUBLICATION,
17354,CHEMBL605,ABTXGJFUQRCPNH-UHFFFAOYSA-N,PROCAINAMIDE HYDROCHLORIDE,,Q9NPD5,SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B3,SLCO1B3,,,23571415.0,INHIBITION,=,104.36,%,inhibition,cell_based,functional,uptake,competitive_inhibitor,fluorescence_polarization,CHO,10,uM,Fluorescein,=,10.0,uM,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Structure-based identification of OATP1B1/3 inhibitors.,Mol. Pharmacol.,PUBLICATION,
5071787,CHEMBL3143386,XBQMARLCINVHEM-JSRHHAARSA-N,,,P32239,CHOLECYSTOKININ B RECEPTOR,CCKBR,,,2918498.0,IC50,=,1500.0,NM,,,,,,,,,,,,,,In vitro inhibition of binding of [125I]-(Nle)-HG-13 labeled Cholecystokinin type B receptor on isolated gastric mucosal cells of rabbit,"Synthesis of gastrin antagonists, analogues of the C-terminal tetrapeptide of gastrin, by introduction of a beta-homo residue.",J. Med. Chem.,PUBLICATION,
1592401,CHEMBL3213002,HQRCFDHXONQXFL-LFIBNONCSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
641959,CHEMBL1533992,CRGDNKVHBULMIE-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1491749,CHEMBL1346181,HFZLYANSSCHHHZ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3602021,CHEMBL1418739,QEERXEDLDIQNOJ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4483746,CHEMBL581373,UQCHNAMEPDHQAG-UHFFFAOYSA-N,TCMDC-141735,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,-3.12,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
5006181,CHEMBL1899684,WUROHZXYZZNTPZ-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3968285,CHEMBL1450907,RRKHFIOMQASCQM-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2764169,CHEMBL1340565,MPQDYLJVMYGFRE-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,25929.0,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2479714,CHEMBL1997747,LKUZUQUARWLJBC-GHKDQAKYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4664625,CHEMBL44657,VJJPUSNTGOMMGY-MRVIYFEKSA-N,ETOPOSIDE,,P04035,HMG-COA REDUCTASE,HMGCR,,,,IC50,,,,,,,,,,,,,,,,,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),DrugMatrix in vitro pharmacology data,,DATASET,
4133262,CHEMBL1454049,SJVJSPWKPCUULI-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2119542,CHEMBL29278,JWYMJWDIWFHMKV-UHFFFAOYSA-N,,,P61169,DOPAMINE D2 RECEPTOR,,,,2898533.0,INHIBITION,=,43.0,%,,,,,,,,,,,,,,In vitro inhibition of [3H]spiperone binding to dopamine receptor D2 from rat brain limbic tissue at 1 uM,Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
2815495,CHEMBL1987034,MVJMMLFMPWITEJ-UHFFFAOYSA-N,,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,,,,KI,=,3.98,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT3,PUBCHEM BIOASSAY DATA SET,,DATASET,
16606,CHEMBL1568451,ABROOOZQBGVEKG-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5427510,CHEMBL1526513,YNYMEHJYXFFCLR-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,16944.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1908777,CHEMBL1344975,IZRUDTFTHPRXRP-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5716407,CHEMBL1375715,ZTPDPILJGVVPQH-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4644627,CHEMBL1351830,VHAVIKGAQMJXAD-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3411667,CHEMBL1895659,PIUGQEPCDYVCPF-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,4.6,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4408303,CHEMBL3706842,UHVIRIZFQYNLSJ-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,16302797.0,IC50,=,1.7,NM,,,,,,,,,,,,,,Inhibition of poly(Glu4-Tyr)peptide phosphorylation by recombinant VEGFR2 at 1 mm ATP,"2-(Quinazolin-4-ylamino)-[1,4]benzoquinones as covalent-binding, irreversible inhibitors of the kinase domain of vascular endothelial growth factor receptor-2.",J. Med. Chem.,PUBLICATION,
5405684,CHEMBL1530127,YLRBQPFFCAMCQC-UHFFFAOYSA-N,,,P9WMN3,BIFUNCTIONAL PROTEIN GLMU,,,,,IC50,=,59050.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU). Secondary screen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1025702,CHEMBL1509259,FGQKDQZUFNBIPZ-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5032836,CHEMBL567170,WXOUBYSCCFVWLI-AZHDDYPTSA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,19928862.0,KI,=,67.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]U69593 from human kappa opioid receptor expressed in CHO cells,"Synthesis and opioid receptor binding affinities of 2-substituted and 3-aminomorphinans: ligands for mu, kappa, and delta opioid receptors.",J. Med. Chem.,PUBLICATION,
4202555,CHEMBL1231533,SRLVNYDXMUGOFI-YWEYNIOJSA-N,,,Q8NG66,SERINE/THREONINE-PROTEIN KINASE NEK11,NEK11,wild_type,,22037377.0,ACTIVITY,=,110.8156002,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,MBP,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3552303,CHEMBL1472044,PYHVEKUSRUJANV-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2862327,CHEMBL1345790,NANYFGLPVQNYSC-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2486889,CHEMBL380071,LLJRXVHJOJRCSM-UHFFFAOYSA-N,,,P23443,RIBOSOMAL PROTEIN S6 KINASE 1,RPS6KB1,wild_type,,22037377.0,ACTIVITY,=,97.81404555,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,S6K/RSK2 PEPTIDE 2,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3297556,CHEMBL2287384,OWFFCDUVEQIDNU-UHFFFAOYSA-N,,,Q75NA5,GABA RECEPTOR SUBUNIT,,,,,INHIBITION,=,76.0,%,,,,,,,,,,,,,,Displacement of [35S]TBPS from GABA-gated chloride channel in Musca domestica (house fly) head membrane at 10 uM after 50 min by liquid scintillation counting,,J Pesticide Sci,PUBLICATION,
27380,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,26851736.0,KI,=,3640.0,NM,,,,,,,,,,,,,,,,,,
5847555,CHEMBL3827331,,,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,27485602.0,Inhibition,=,75.0,%,,,,,,,,,,,,,,Displacement of [3H]PSB11 from recombinant human adenosine receptor A3 expressed in CHO cell membranes at 1 uM,Similarities and differences in affinity and binding modes of tricyclic pyrimido- and pyrazinoxanthines at human and rat adenosine receptors.,Bioorg. Med. Chem.,PUBLICATION,
2357952,CHEMBL1483607,KWRJOCXPEVTQAL-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
4629604,CHEMBL195110,VFJOTTZGMDRNPT-MUUNZHRXSA-N,,,Q01726,MELANOCORTIN RECEPTOR 1,MC1R,,,15863313.0,KI,=,6900.0,NM,,cell_based,,,,,HEK293,,,,,,,Binding affinity at melanocortin-1 receptor stably transfected in HEK 293 cells using [125I]NDP-MSH as radiolabeled,A potent and selective nonpeptide antagonist of the melanocortin-4 receptor induces food intake in satiated mice.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3904527,CHEMBL533358,RKMZFBAXCSAZLL-UHFFFAOYSA-N,TCMDC-133583,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,2.41,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4865447,CHEMBL1338335,WFJZFAOVXFVMSL-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4679511,CHEMBL1361509,VLCGLMKWSBSFEC-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3716021,CHEMBL3189857,QQNWJPFMAYYSPQ-VIZOYTHASA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4757359,CHEMBL1517425,VTNQPKFIQCLBDU-UHFFFAOYSA-N,ACETOCHLOR,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of estrogen receptor alpha signaling. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2056718,CHEMBL13972,JQHSODWZKVGCLV-UHFFFAOYSA-N,SB-242721,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,,INHIBITION,=,3.62,%,,,,,,,,,,,,,,GSK_PKIS: ABL1 (T315I mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5734721,CHEMBL1313424,ZVPHCDJOLSFWGW-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,2592.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3673268,CHEMBL2218938,QMBDONCHHMIWFJ-UHFFFAOYSA-N,,,Q16620,NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 2,NTRK2,wild_type,,23398362.0,ACTIVITY,=,98.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,90.0,uM,"Millipore: Percentage of residual kinase activity of NTRK2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
5302526,CHEMBL3191841,YALMAOZXWDQBIS-DHDCSXOGSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5784910,CHEMBL3771092,,,,Q99500,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-3,S1PR3,,,26751273.0,EC50,=,19952.62,NM,,,,,,,,,,,,,,Agonist activity at human S1P3 receptor expressed in RBL cells by [35S]GTP-gammaS accumulation assay,Discovery of Tetrahydropyrazolopyridine as Sphingosine 1-Phosphate Receptor 3 (S1P3)-Sparing S1P1 Agonists Active at Low Oral Doses.,J. Med. Chem.,PUBLICATION,
173254,CHEMBL261720,ARIOBGGRZJITQX-UHFFFAOYSA-N,,,Q06418,TYROSINE-PROTEIN KINASE RECEPTOR TYRO3,TYRO3,wild_type,,23398362.0,ACTIVITY,=,-1.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,45.0,uM,"Millipore: Percentage of residual kinase activity of TYRO3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4875401,CHEMBL1812920,WGLLEESJSUVMDV-UHFFFAOYSA-N,,,P08253,MATRIX METALLOPROTEINASE-2,MMP2,,,21764590.0,IC50,=,16.0,NM,,,,,,,,,,,,,,"Inhibition of AMPA-activated human recombinant MMP2 using fluorogenic substrate (7-methoxycoumarin-4-yl)-acetyl-pro-Leu-Gly-Leu-(3-(2,4-dinitrophenyl)-L-2,3-diaminopropionyl)-Ala-Arg-NH2 by fluorogenic assay",N-substituted homopiperazine barbiturates as gelatinase inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
2214802,CHEMBL1868837,KHJDZRMPBDLKBM-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,920.0,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1310698,CHEMBL1909342,GLZXTMBTCQJTRD-UHFFFAOYSA-N,SB-657836AAA,,Q86Z02,HOMEODOMAIN-INTERACTING PROTEIN KINASE 1,HIPK1,,,,INHIBITION,=,6.67,%,,,,,,,,,,,,,,GSK_PKIS: HIPK1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1721942,CHEMBL1326765,IESNKQUDFZLCQJ-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2748135,CHEMBL1411788,MNRAXEGMXLANIQ-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4155238,CHEMBL1732910,SMJUNVUWZNCIRM-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16353.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5621291,CHEMBL666,ZJAOAACCNHFJAH-UHFFFAOYSA-N,FOSCARNET,,P25105,PLATELET ACTIVATING FACTOR RECEPTOR,PTAFR,,,,KI,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Platelet Activating Factor (PAF) radioligand binding (ligand: [3H] PAF),DrugMatrix in vitro pharmacology data,,DATASET,
3211564,CHEMBL31965,OMZCMEYTWSXEPZ-UHFFFAOYSA-N,CANERTINIB,,Q00537,SERINE/THREONINE-PROTEIN KINASE PCTAIRE-2,CDK17,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for full-length PCTK2,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2313439,CHEMBL1564686,KRVXHTQCDABARS-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2464634,CHEMBL1602429,LJDMEBGCPQFSCG-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1038703,CHEMBL2181202,FIAKHZXVLBNZLW-NFGXINMFSA-N,,,P97266,MU OPIOID RECEPTOR,,,,23102273.0,IC50,=,1.41,NM,,tissue,,,,,,,,,,,,Agonist activity at mu opioid receptor in guinea pig ileum,"Variation of the Net Charge, Lipophilicity, and Side Chain Flexibility in Dmt(1)-DALDA: Effect on Opioid Activity and Biodistribution.",J. Med. Chem.,PUBLICATION,
3446135,CHEMBL2036635,PMRJMYCLQDPGBL-JOCHJYFZSA-N,,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,22450133.0,KI,=,1.9,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]NAMH from human histamine H3 receptor expressed in CHO cells,Substituted phenoxypropyl-(R)-2-methylpyrrolidine aminomethyl ketones as histamine-3 receptor inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3401737,CHEMBL833,PHWBOXQYWZNQIN-UHFFFAOYSA-N,TICLOPIDINE,,P25929,NEUROPEPTIDE Y RECEPTOR TYPE 1,NPY1R,,,,KI,,,,,,,,,,SK-N-MC,,,,,,,DRUGMATRIX: Neuropeptide Y Y1 radioligand binding (ligand: [125I] Peptide YY),DrugMatrix in vitro pharmacology data,,DATASET,
3645513,CHEMBL1977713,QIXBPDJPNDOGRJ-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PLK1,PUBCHEM BIOASSAY DATA SET,,DATASET,
723623,CHEMBL2323567,CZWUYUYQOZHEAK-MRXNPFEDSA-N,,,"P12390, P12389",NEURONAL ACETYLCHOLINE RECEPTOR; ALPHA2/BETA2,,,,23540678.0,KI,=,22000.0,NM,,,,,,,,,,,,,,Displacement of [3H]-Epibatidine from rat alpha2beta2 nACHR expressed in HEK293 cell membranes by liquid scintillation counting analysis,"Chemistry and Pharmacological Studies of 3-Alkoxy-2,5-Disubstituted-Pyridinyl Compounds as Novel Selective a4ß2 Nicotinic Acetylcholine Receptor Ligands That Reduce Alcohol Intake in Rats.",J. Med. Chem.,PUBLICATION,
4464289,CHEMBL2420916,UNXZAUBGJWJTCA-UHFFFAOYSA-N,,,Q15418,RIBOSOMAL PROTEIN S6 KINASE ALPHA 1,RPS6KA1,,,23920481.0,INHIBITION,=,42.0,%,,,,,,,,,,,,,,Inhibition of RSK1 (unknown origin) at 30 uM by microfluidic mobility shift assay relative to control,Synthesis and evaluation of heteroaryl substituted diazaspirocycles as scaffolds to probe the ATP-binding site of protein kinases.,Bioorg. Med. Chem.,PUBLICATION,
905210,CHEMBL3189657,DTKZRUGSXJZQAU-FRKPEAEDSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3646285,CHEMBL2069804,QIZIZVBSJUAZHS-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,22185670.0,IC50,>,20000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant CYP1A2 coexpressed in Escherichia coli using phenacetin as probe,Oxadiazoles in medicinal chemistry.,J. Med. Chem.,PUBLICATION,
3851956,CHEMBL408192,REYDHEVFSZYDKB-BDYUSTAISA-N,,,P23977,DOPAMINE TRANSPORTER,,,,15456254.0,IC50,=,22.5,NM,,,,,,,,,,,,,,Inhibition of [3H]WIN-35428 binding to dopamine transporter of rat striatum,"Further structurally constrained analogues of cis-(6-benzhydrylpiperidin-3-yl)benzylamine with elucidation of bioactive conformation: discovery of 1,4-diazabicyclo[3.3.1]nonane derivatives and evaluation of their biological properties for the monoamine transporters.",J. Med. Chem.,PUBLICATION,
3276696,CHEMBL353815,OTYAZVZPQIOMFF-OWCZDTJQSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,8464047.0,IC50,=,12.0,NM,,,,,,,,,,,,,,Tested against S2-binding site of HIV-1 protease,Cyclic sulfolanes as novel and high affinity P2 ligands for HIV-1 protease inhibitors.,J. Med. Chem.,PUBLICATION,
2112897,CHEMBL1335480,JWHAIYMPIRVVED-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
574213,CHEMBL814,CJOFXWAVKWHTFT-XSFVSMFZSA-N,FLUVOXAMINE,,P23977,DOPAMINE TRANSPORTER,,,,2905001.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,
4966101,CHEMBL2105807,WQGJEAMPBSZCIF-HKSLRPGUSA-N,MADURAMICIN,,P41597,C-C CHEMOKINE RECEPTOR TYPE 2,CCR2,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),DrugMatrix in vitro pharmacology data,,DATASET,
3853976,CHEMBL1590781,RFDIHGWWXXBTAM-QNAMKHHVSA-N,,,Q4R6F8,T-COMPLEX PROTEIN 1 SUBUNIT BETA,,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991],PUBCHEM BIOASSAY DATA SET,,DATASET,
4572403,CHEMBL80,UZHSEJADLWPNLE-GRGSLBFTSA-N,NALOXONE,,Q60492,SIGMA-1 RECEPTOR,,,,21481987.0,KI,,,,,,,,,,,,,,,,,Displacement of [3H]-(+)-pentazocine from sigma 1 receptor in guinea pig brain membranes,"Synthesis of 7,9-diazabicyclo[4.2.2]decanes as conformationally restricted ¿ receptor agonists: Fine tuning of the dihedral angle of the ethylenediamine pharmacophore.",Eur. J. Med. Chem.,PUBLICATION,
3511061,CHEMBL1339389,PTRDPDAHPUDGQR-CPNJWEJPSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4782291,CHEMBL1322311,VWLAXRKXUAJELW-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5321966,CHEMBL1350283,YCLHOOVCNFENHP-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1900387,CHEMBL1713680,IYSZDQUYRABFPT-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
5145611,CHEMBL1720568,XJNXQMQRAIZMCS-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5275927,CHEMBL1893328,XXUPRIHOKUSPRT-FYZNHFMZSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3748661,CHEMBL1327543,QTVMSBWTXWBAJS-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3974524,CHEMBL7634,RSDOPYMFZBJHRL-UHFFFAOYSA-N,OXOTREMORINE,,P10980,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,,,,8246221.0,KI,=,60.0,NM,,,,,,,,,,,,,,Binding affinity at [3H]QNB radiolabeled muscarinic M2 receptor in rat cortex.,The synthesis and biochemical pharmacology of enantiomerically pure methylated oxotremorine derivatives.,J. Med. Chem.,PUBLICATION,
957410,CHEMBL408678,DZFBYHUKZSRPHU-UHFFFAOYSA-N,,,Q9UEE5,SERINE/THREONINE-PROTEIN KINASE 17A,STK17A,,,18077363.0,THERMAL MELTING CHANGE,=,0.2,DEGREES C,,,,,,,,,,,,,,Delta TM value showing the stabilisation of DRAK1 produced by compound binding,A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
4852748,CHEMBL2333274,WDYVOVWWKMVZQY-FMIVXFBMSA-N,,,P03956,MATRIX METALLOPROTEINASE-1,MMP1,,,23353736.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP1 catalytic domain using Dnp-Pro-beta-cyclohexyl-Ala-Gly-Cys(Me)-His-Lys-(Nma)-NH2 as substrate preincubated with enzyme for 30 mins prior to substrate addition measured after 20 mins by fluorometric assay,Synthesis of derivatives of methyl rosmarinate and their inhibitory activities against matrix metalloproteinase-1 (MMP-1).,Eur. J. Med. Chem.,PUBLICATION,
5569303,CHEMBL1923201,ZDJZJCGVCBBGDA-UHFFFAOYSA-N,,,P45983,C-JUN N-TERMINAL KINASE 1,MAPK8,,,22004719.0,IC50,=,44.0,NM,,,,,,,,,,,,,,Inhibition of JNK1 using biotinylated-ATF2 as substrate by HTRF assay,Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2640225,CHEMBL400777,MBZKDBQDALOSRP-UHFFFAOYSA-N,ROBUSTIC ACID,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,1995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2129938,CHEMBL1540286,JYBSFIPTUDGTPV-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2670920,CHEMBL1710033,MFESPQYOEIZYDF-UHFFFAOYSA-N,,,Q9HC29,NUCLEOTIDE-BINDING OLIGOMERIZATION DOMAIN-CONTAINING PROTEIN 2,NOD2,,,,IC50,=,1620.0,NM,,cell_based,,,,,,,,,,,,Inhibition of NOD-2 mediated NFkappaB activation in HEK293T cells assessed as inhibition of MDP-induced luciferase activity after 14 hrs by reporter gene assay,,ACS Med. Chem. Lett.,PUBLICATION,
4685710,CHEMBL396107,VLTNUYNTYZRWQD-UHFFFAOYSA-N,GW795486X,,P54646,"AMP-ACTIVATED PROTEIN KINASE, ALPHA-2 SUBUNIT",PRKAA2,,,,INHIBITION,=,4.79,%,,,,,,,,,,,,,,GSK_PKIS: AMPKA2 (A2B1G1) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4905121,CHEMBL3211375,WJFNMDDZICPGQN-LZYBPNLTSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
673621,CHEMBL1577293,CUOPAVNWQCBPKJ-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,14044.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for inhibitors of Vif-A3F interactions: Cherry picks. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1822130,CHEMBL1371861,IQCNYVDNVXAQIA-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1378610,CHEMBL1487197,GTWZNHLARDJZPJ-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1060554,CHEMBL1511408,FKKMRNUHQCHJCX-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,3981.07,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
732863,CHEMBL355857,DAXUVEJLUCSOEI-UHFFFAOYSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,8145236.0,IC50,=,400.0,NM,,,,,,,,,,,,,,Inhibitory potency against protein tyrosine kinase activity associated with EGFR was evaluated using ER 22 cell membrane,"Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactions.",J. Med. Chem.,PUBLICATION,
5525317,CHEMBL1466820,YYTNTCHZIPXYQM-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,67455.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1437162,CHEMBL11515,HANVENUBICTJAH-UHFFFAOYSA-N,,,P31390,HISTAMINE H1 RECEPTOR,,,,10737740.0,RELATIVE POTENCY,=,684.0,,,,,,,,,,,,,,,"Relative potency was recorded in relaxed rat aortic rings with intact endothelium, submaximally precontracted with 15.8 nM U-46,619; value ranges from 473 to 989","Histaprodifens: synthesis, pharmacological in vitro evaluation, and molecular modeling of a new class of highly active and selective histamine H(1)-receptor agonists.",J. Med. Chem.,PUBLICATION,
4795309,CHEMBL1706085,VXTNZIGEFBFARF-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
4991624,CHEMBL1009,WTDRDQBEARUVNC-LURJTMIESA-N,LEVODOPA,,Q16665,HYPOXIA-INDUCIBLE FACTOR 1 ALPHA,HIF1A,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1320041,CHEMBL1610385,GMZBMDOUZLUAMY-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4673023,CHEMBL12089,VKJGBAJNNALVAV-UHFFFAOYSA-M,BERBERINE CHLORIDE,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,IC50,=,4504.2,NM,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
5695769,CHEMBL2130761,ZRGUEBOECAIQTL-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5713283,CHEMBL1539831,ZTERYJRVCJZSHN-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,60119.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1478792,CHEMBL2425145,HEQHRPBZBOEOFA-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,23973211.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of CYP3A4 (unknown origin),Fragment-based discovery of focal adhesion kinase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
53098,CHEMBL1380315,ADYJSDPXHLCCER-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2649093,CHEMBL1461723,MCVMASKKAZFGBG-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1633780,CHEMBL559194,HVLSJACRSUDQQE-ZSLVVFSXSA-N,,,P00760,TRYPSIN I,,,,7966150.0,KI,=,17000.0,NM,,,,,,,,,,,,,,In vitro binding affinity by measuring the inhibition of bovine trypsin,Design and synthesis of potent and highly selective thrombin inhibitors.,J. Med. Chem.,PUBLICATION,
5225293,CHEMBL1972158,XSDJOIOVIMPMHD-UHFFFAOYSA-N,,,P49760,DUAL SPECIFICITY PROTEIN KINASE CLK2,CLK2,,,,KI,=,100.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CLK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
5114288,,XGGAZYFKWBUJKK-UHFFFAOYSA-N,,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,6.72,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
473608,CHEMBL79140,BYOBCYXURWDEDS-IUCAKERBSA-N,L-THREO-BENZYLOXY ASPARTATE,,P43003,EXCITATORY AMINO ACID TRANSPORTER 1,SLC1A3,,,11078189.0,IC50,=,23000.0,NM,,cell_based,,,,,COS-1,,,,,,,Concentration required for blocking [14C]glutamate uptake in COS-1 cells expressing human Excitatory amino acid transporter 1,Syntheses of optically pure beta-hydroxyaspartate derivatives as glutamate transporter blockers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5660802,CHEMBL608154,ZNOLRTPMNMPLHY-UHFFFAOYSA-N,ML-120B,,Q9UHD2,SERINE/THREONINE-PROTEIN KINASE TBK1,TBK1,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for TBK1 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
397100,CHEMBL1532255,BPRKJWIISIYGHR-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
76878,CHEMBL3212246,AGLSTAVNMVELAE-LERQAXIQSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3050947,CHEMBL235157,NVINUNQBDNEMSY-UHFFFAOYSA-N,,,Q06187,TYROSINE-PROTEIN KINASE BTK,BTK,wild_type,,21336281.0,KI,<,6309.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
3542218,CHEMBL102936,PXDJFHKHAHQLSC-UHFFFAOYSA-N,SB-742865,,Q9UHD2,SERINE/THREONINE-PROTEIN KINASE TBK1,TBK1,,,,INHIBITION,=,0.86,%,,,,,,,,,,,,,,GSK_PKIS: TBK1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5272595,CHEMBL1407437,XXOBFJSJJGUUPJ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3122114,CHEMBL441702,ODLNBFNBEPOFNC-UHFFFAOYSA-N,GSK-270822A,,P16234,PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA,PDGFRA,,,,INHIBITION,=,5.83,%,,,,,,,,,,,,,,GSK_PKIS: PDGFRA (D842V mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2337050,CHEMBL2398369,KUFCFGLBJSLQCH-UHFFFAOYSA-N,,,P19793,RETINOID X RECEPTOR ALPHA,RXRA,,,23685180.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Transactivation of full-length RXRalpha (unknown origin) expressed in African green monkey COS1 cells at 1000 nM by luciferase reporter gene assay,"Design, synthesis and evaluation of retinoids with novel bulky hydrophobic partial structures.",Bioorg. Med. Chem.,PUBLICATION,
5101008,CHEMBL548,XEYBRNLFEZDVAW-ARSRFYASSA-N,DINOPROSTONE,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,21.1,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5168872,CHEMBL2070634,XLZOIIVTFPXQAK-UHFFFAOYSA-N,,,O00408,PHOSPHODIESTERASE 2A,PDE2A,,,22902656.0,IC50,=,15.8,NM,,,,,,,,,,,,,,Inhibition of PDE2,Novel triazines as potent and selective phosphodiesterase 10A inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2171266,CHEMBL1329754,KCQZKVWIZXQNGT-GEIYVISESA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
31354,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P01282,VIP PEPTIDES,VIP,,,11907155.0,KI,=,15.9,NM,,,,,,,,,,,,,,,,,,
5527893,CHEMBL3137970,YZBSLZRJCVEJEA-BPMCRWTASA-N,,,"P62813, P63138, P18508",GABA-A RECEPTOR; ALPHA-1/BETA-2/GAMMA-2,,,,14640542.0,RATIO,=,1.12,,,cell_based,,,,,Oocytes,,,,,,,In vitro current effect against rat GABA receptor alpha-1-beta-2-gamma-2 subunits expressed in Xenopus laevis oocytes at 0.1 uM (ratio +/- compound),"Neurosteroid analogues. 9. Conformationally constrained pregnanes: structure-activity studies of 13,24-cyclo-18,21-dinorcholane analogues of the GABA modulatory and anesthetic steroids (3alpha,5alpha)- and (3alpha,5beta)-3-hydroxypregnan-20-one.",J. Med. Chem.,PUBLICATION,
923119,CHEMBL1594211,DVMQHIJJUZRTNW-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2366545,CHEMBL187390,KXSRHFDSVLRCCT-HHHXNRCGSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,15950470.0,STIMULATION,=,2.7,%,,cell_based,,,,,HEK293,,,,,,,Stimulation of cAMP levels in the HEK293 cell line at 10 uM,Structure-activity relationship of a series of cyclohexylpiperidines bearing an amide side chain as antagonists of the human melanocortin-4 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
932224,CHEMBL2143052,DWNRJQSNTHKJOE-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,,158489.3,NM,,,,,,,,,,,,,,PubChem BioAssay. Gel-Based Assay for Inhibitos of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase): Chemistry Optimization Follow up. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1240785,CHEMBL1706128,GEMVXGZBNSVVGD-UHFFFAOYSA-N,,,Q9GZU7,CARBOXY-TERMINAL DOMAIN RNA POLYMERASE II POLYPEPTIDE A SMALL PHOSPHATASE 1,CTDSP1,,,,IC50,=,4083.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493091, AID493120]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2615794,CHEMBL1531365,LZHNMKDOHFOONY-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1617260,CHEMBL1398593,HTOOUEHQGQZUHN-VGOFMYFVSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2045947,CHEMBL1361088,JPAWQFULSSSDRM-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,18887.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3975859,CHEMBL3314013,RSINIPXJQJTQLA-GBESFXJTSA-N,,,P51449,NUCLEAR RECEPTOR ROR-GAMMA,RORC,,,24502334.0,EC50,=,53.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human RoRc-LBD expressed in CHO cells assessed as transcriptional activity by GAL4 reporter assay,Modulators of the nuclear receptor retinoic acid receptor-related orphan receptor-¿ (ROR¿ or RORc).,J. Med. Chem.,PUBLICATION,
4535067,CHEMBL648,UVKZSORBKUEBAZ-UHFFFAOYSA-N,CYCLIZINE,,Q9Y271,CYSTEINYL LEUKOTRIENE RECEPTOR 1,CYSLTR1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),DrugMatrix in vitro pharmacology data,,DATASET,
3743664,CHEMBL513573,QTIVANCGWUMBSQ-BEIZIEJFSA-N,,,P13053,VITAMIN D RECEPTOR,,,,18539034.0,ACTIVITY,=,12.0,%,,,,,,,,,,,,,,"Displacement of [3H]1-alpha,25-(OH)2D3 from rat recombinant VDR expressed in Escherichia coli BL21 (DE3)","2-Substituted-16-ene-22-thia-1alpha,25-dihydroxy-26,27-dimethyl-19-norvitamin D3 analogs: Synthesis, biological evaluation, and crystal structure.",Bioorg. Med. Chem.,PUBLICATION,
1235130,CHEMBL588028,GDVYWOZPTMXQGS-UHFFFAOYSA-N,TCMDC-125204,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,0.98,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1537831,CHEMBL388978,HKSZLNNOFSGOKW-FYTWVXJKSA-N,STAUROSPORINE,,P49674,CASEIN KINASE I EPSILON,CSNK1E,wild_type,,22037378.0,KD,=,73.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for CSNK1E kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4852734,CHEMBL1535092,WDYUNUCVUSFZSB-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4706777,CHEMBL260417,VNVKSDCWJDOWNE-UHFFFAOYSA-N,SB-725317,,P06239,TYROSINE-PROTEIN KINASE LCK,LCK,,,,INHIBITION,=,6.75,%,,,,,,,,,,,,,,GSK_PKIS: LCK mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1910986,CHEMBL1456467,IZZADQISBIXZEX-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4958891,CHEMBL421645,WPNDUQHFNYURGH-WCQYABFASA-N,,,P08246,LEUKOCYTE ELASTASE,ELANE,,,1433188.0,K OBS / 1,=,16000.0,M-1 S-1,,,,,,,,,,,,,,In vitro inhibitory activity against human leukocyte elastase,"Inhibition of human leukocyte elastase. 4. Selection of a substituted cephalosporin (L-658,758) as a topical aerosol.",J. Med. Chem.,PUBLICATION,
3234064,CHEMBL209770,OPLYAGXSXQZTGM-UHFFFAOYSA-N,,,P45983,C-JUN N-TERMINAL KINASE 1,MAPK8,,,16759099.0,IC50,=,300.0,NM,,,,,,,,,,,,,,Inhibition of JNK1-mediated ATF2 phosphorylation,Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity.,J. Med. Chem.,PUBLICATION,
3121078,CHEMBL1601919,ODKCSOPYXDQUAG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,25918.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3533391,CHEMBL73962,PWDGTQXZLNDOKS-UHFFFAOYSA-N,BENZOLAMIDE,,P00918,CARBONIC ANHYDRASE II,CA2,,,26832216.0,Ki,=,9.0,NM,,,,,,,,,,,,,,Inhibition of human carbonic anhydrase 2 preincubated for 15 mins by CO2 hydrase stopped flow assay,Sulfonamide inhibition studies of the -carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5822462,CHEMBL3730505,,,,P34998,CORTICOTROPIN RELEASING FACTOR RECEPTOR 1,CRHR1,,,,IC50,=,205.0,NM,,,,,,,,,,,,,,Antagonist activity against rat/human CRFR1 expressed in CHO cells assessed as inhibition of rat/human CRF-induced cAMP accumulation pre-incubated for 15 mins before CRF stimulation for 30 mins by FRET based HTRF assay,Cyclohexyl amide derivatives as CRF receptor antagonists,,PATENT,
1860260,CHEMBL288060,IUHOHDJSCNYKAW-UHFFFAOYSA-N,,,P11597,CHOLESTERYL ESTER TRANSFER PROTEIN,CETP,,,11425523.0,IC50,=,480.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human CETP mediated transfer of [3H]cholesteryl ester from HDL to LDL,Novel heteroaryl replacements of aromatic 3-tetrafluoroethoxy substituents in trifluoro-3-(tertiaryamino)-2-propanols as potent inhibitors of cholesteryl ester transfer protein.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2204401,CHEMBL3209252,KGBNPUJGRLUWIP-CLFYSBASSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3376477,CHEMBL1315601,PFEALFXACDYEAP-XVNBXDOJSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,21192.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
289084,CHEMBL1507819,BEDWAXDWZAFXKE-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
424758,CHEMBL302773,BSZYWCVHKOGYIH-UHFFFAOYSA-N,,,"P06493, P14635",CYCLIN-DEPENDENT KINASE 1/CYCLIN B1,"CCNB1, CDK1",,,12482427.0,INHIBITION,=,21.0,%,,cell_based,,,,,Oocytes,,,,,,,Inhibition of Cyclin dependent kinase 1-cyclin B1 from starfish oocytes at 10 uM,"4-Alkoxy-2,6-diaminopyrimidine derivatives: inhibitors of cyclin dependent kinases 1 and 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4810769,CHEMBL1875979,VZKYAJFJVJGSRY-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,4.6,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2491717,CHEMBL1517107,LLWGECDSVWTFQA-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3927994,CHEMBL2136103,RMZGJSLXUIRDMP-QMTMVMCOSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4822752,CHEMBL1387923,WAUBPIYCKFHHSE-UHFFFAOYSA-N,,,Q9Y6Q9,NUCLEAR RECEPTOR COACTIVATOR 3,NCOA3,,,,IC50,=,3623.0,NM,,cell_based,,,,,,,,,,,,PUBCHEM_BIOASSAY: Counterscreen for inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1): Luminescence-based cell-based high throughput dose response assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3990820,CHEMBL1522964,RTWLUSHRFBYNSN-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
858300,CHEMBL1467051,DOKKEBCAENOAAK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5718851,CHEMBL561415,ZTVIQFFINYCDOR-UHFFFAOYSA-N,,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,19552431.0,IC50,=,70.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at B2 receptor in human HF15 cells assessed as inhibition of bradykinin-induced calcium mobilization,Novel small molecule bradykinin B2 receptor antagonists.,J. Med. Chem.,PUBLICATION,
2300850,CHEMBL447,KQPKPCNLIDLUMF-UHFFFAOYSA-N,SECOBARBITAL,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DrugMatrix in vitro pharmacology data,,DATASET,
5629368,CHEMBL1388432,ZJZLRPAGGRICSC-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
253944,CHEMBL137795,BADKZHZZWRDDGZ-UHFFFAOYSA-N,,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,11708925.0,RBA,=,0.63,%,,,,,,,,,,,,,,Relative binding affinity (RBA) at Human estrogen receptor alpha (radiometric binding assay with [3H]estradiol using full-length human ER alpha),Estrogen receptor-beta potency-selective ligands: structure-activity relationship studies of diarylpropionitriles and their acetylene and polar analogues.,J. Med. Chem.,PUBLICATION,
791515,CHEMBL17205,DHKKONBXGAAFTB-OTYYAQKOSA-N,CYCLOVALONE,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
584636,CHEMBL3683280,CKTRIHBHQJSVJA-RRPNLBNLSA-N,,,P20292,5-LIPOXYGENASE ACTIVATING PROTEIN,ALOX5AP,,,,KI,=,43.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. The assay below is used to test the modulatory activity of compounds against FLAP. Human and mouse FLAP-encoding DNA was amplified by polymerase chain reaction and cloned into pFastBac1 (Invitrogen) with a NH2-terminal 6-His tag for expression in Spodoptera frugiperda (Sf-9) cells. FLAP-containing membranes were prepared as was a FITC-labeled FLAP modulator (3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoic acid). The FLAP binding assay is performed in HTRF format (homogeneous time resolved fluorescence). FLAP-containing membranes (1 ug/well final for human) are incubated in the presence of the HTRF ligand, [5-[({[2-(2-{3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropanoyl}hydrazino)-2-oxoethyl]sulfanyl}acetyl)amino]-2-(6-hydroxy-3-oxo-3H-xanthen-9-yl)benzoic acid] (25 nM final), a terbium labeled anti-His tag antibody (0.5 ng/well final, from Cisbio) and compounds.","1,2,5-substituted benzimidazoles as FLAP modulators",,PATENT,
5821774,CHEMBL1909079,,STANNOUS FLUORIDE,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Histamine H1, Central radioligand binding (ligand: [3H] Pyrilamine)",DrugMatrix in vitro pharmacology data,,DATASET,
2141463,CHEMBL3685657,JZJCYCNGEXYTSB-UHFFFAOYSA-N,,,Q13418,SERINE/THREONINE-PROTEIN KINASE ILK-1,ILK,,,,IC50,=,200.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Ezyme Assay. 5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted of the following volumes: 5 uL diluted compound, 10 uL target enzyme preparation, 1 uL substrate, 5 uL assay ATP. From each assay mixture, 10 uL of assay mixture was spotted onto Millipore Multiscreen-PH opaque plates and washed twice for 10 minutes in 1% phosphoric acid. The plates were dried at 40 C. for 30 minutes, then substrate-phosphate complexes were quantitated by scintillation counting. These Millipore plates are in a 96-well format with immobilized P81 phosphocellulose membranes in the wells. Both the phosphorylated and non-phosphorylated form of the substrate bind to the membrane while ATP (unincorporated phosphate) is removed by subsequent wash steps.",Pyrazolylbenzothiazole derivatives and their use as therapeutic agents,,PATENT,
1872291,CHEMBL1576429,IVTWYJRMCCRDBE-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3310044,CHEMBL368508,OXPMICXMRBWJPE-UHFFFAOYSA-N,,,P35354,CYCLOOXYGENASE-2,PTGS2,,,9083488.0,INHIBITION,=,38.0,%,,,,,,,,,,,,,,Inhibition of human Prostaglandin G/H synthase 2 at 0.1 ug/mL expressed as mean percent inhibition of control PGE-2 production,Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.,J. Med. Chem.,PUBLICATION,
5171845,CHEMBL1516718,XMEUTNQKZRCMIG-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,28.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4390586,CHEMBL3196920,UGAXFBRRNXWQOZ-ZVHZXABRSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2194215,CHEMBL6325,KFCWTQZXACGAEC-UHFFFAOYSA-N,,,P07607,THYMIDYLATE SYNTHASE,,,,8576912.0,IC50,=,110.0,NM,,cell_based,,,,,L1210,,,,,,,In vitro inhibitory activity against thymidylate synthase partially purified from L1210 mouse leukemia cells,Quinazoline antifolates thymidylate synthase inhibitors: lipophilic analogues with modification to the C2-methyl substituent.,J. Med. Chem.,PUBLICATION,
4570628,CHEMBL1546166,UZCVJDZDRUYTBU-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2975640,CHEMBL1474056,NMTXFMNCOFPEEI-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3856072,CHEMBL88606,RFHPWPWVGFSLOP-ZROIWOOFSA-N,,,Q6XUX3,DUAL SERINE/THREONINE AND TYROSINE PROTEIN KINASE,DSTYK,wild_type,,22037377.0,ACTIVITY,=,93.05427999,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,MBP,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
5002820,CHEMBL3191055,WUKMQXRMGZTKNP-MHWRWJLKSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1864823,CHEMBL1562245,IUWRXHBJYXHDJC-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,562.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2081779,CHEMBL1395774,JSWXPDDMZPOKTG-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,100.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
3675414,CHEMBL7463,QMGUOJYZJKLOLH-UHFFFAOYSA-N,GF-109203,,Q9UL54,SERINE/THREONINE-PROTEIN KINASE TAO2,TAOK2,wild_type,,22037377.0,ACTIVITY,=,75.71579971,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,MBP,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
1710988,CHEMBL2321970,IDNCAECPRUAUFO-SQFISAMPSA-N,,,B2LUN4,GLYCOGEN SYNTHASE KINASE 3 BETA,,,,,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of porcine brain GSK3beta using YRRAAVPPSPSLSRHSSPHQSpEDEEE as substrate,,ACS Med. Chem. Lett.,PUBLICATION,
4533976,CHEMBL423182,UVIAMIQSBXZGNV-YVNNRUMDSA-N,,,P00797,RENIN,REN,,,8474101.0,IC50,=,2.8,NM,,,,,,,,,,,,,,Inhibition of human plasma renin at pH 7.4,Studies directed toward the design of orally active renin inhibitors. 1. Some factors influencing the absorption of small peptides.,J. Med. Chem.,PUBLICATION,
550553,CHEMBL1379370,CGUDEHADYKCENA-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2347627,CHEMBL3209425,KVNXFKMMVOABSE-PJQLUOCWSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
781781,CHEMBL1572592,DGHCZBUMYGDBTO-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4504525,CHEMBL377463,USCJBUZPUNRXEU-UHFFFAOYSA-N,,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,16678414.0,IC50,=,150.0,NM,,,,,,,,,,,,,,Inhibition of c-ABL,3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1011104,CHEMBL1320387,FEYULAKGDCUMBJ-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
350281,CHEMBL157138,BKRGVLQUQGGVSM-KBXCAEBGSA-N,LISURIDE,,P23219,CYCLOOXYGENASE-1,PTGS1,,,,KI,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid),DrugMatrix in vitro pharmacology data,,DATASET,
2640656,CHEMBL479533,MCAHMSDENAOJFZ-GDYSMBPZSA-N,HERBIMYCIN,,Q9BYT3,SERINE/THREONINE-PROTEIN KINASE 33,STK33,wild_type,,23398362.0,ACTIVITY,=,98.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,155.0,uM,"Millipore: Percentage of residual kinase activity of STK33 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2155103,CHEMBL3262142,KATRCJGDNRGUPX-UHFFFAOYSA-N,,,Q05941,NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN ALPHA-7 SUBUNIT,,,,24814197.0,IC50,=,132.0,NM,,cell_based,,,,,,,,,,,,Inhibition of biotinylated alpha-bungarotoxin binding to alpha7 nAChR in rat PC12 cells by FACS analysis,Discovery of Novel 2-((Pyridin-3-yloxy)methyl)piperazines as a7 Nicotinic Acetylcholine Receptor Modulators for the Treatment of Inflammatory Disorders.,J. Med. Chem.,PUBLICATION,
4951290,CHEMBL2064346,WOQUVNKDDWFSGT-UHFFFAOYSA-N,,,P42338,PI3-KINASE P110-BETA SUBUNIT,PIK3CB,wild_type,,22524426.0,IC50,=,10.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,TR_FRET,,,,,,,,"Inhibition of N-terminus poly-His tagged human PI3Kbeta expressed in baculovirus infected insect S21 cells coexpressing p85alpha using PI(4,5)P2 as substrate preincubated with compound for 15 mins measured after 10 mins by HTRF assay",Discovery and Optimization of New Benzimidazole- and Benzoxazole-Pyrimidone Selective PI3Kß Inhibitors for the Treatment of Phosphatase and TENsin homologue (PTEN)-Deficient Cancers.,J. Med. Chem.,PUBLICATION,
1650958,CHEMBL1483,HXHWSAZORRCQMX-UHFFFAOYSA-N,ALBENDAZOLE,,P25024,INTERLEUKIN-8 RECEPTOR A,CXCR1,,,,IC50,,,,,,,,,,,,,,,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),DrugMatrix in vitro pharmacology data,,DATASET,
3570592,CHEMBL100057,QAKKTLZWZARYJA-VWLOTQADSA-N,,,P13945,BETA-3 ADRENERGIC RECEPTOR,ADRB3,,,12270183.0,EC50,=,29.0,NM,,cell_based,,,,,CHO,,,,,,,In vitro agonist activity measured by increase in cAMP levels in chinese hamster ovary cells (CHO) cells expressing human Beta-3 adrenergic receptor,Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 1: aryloxypropanolaminomethylpiperidines.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4380429,CHEMBL1318988,UETQYGACINQVKI-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2987721,CHEMBL3199331,NODKTAFDLVLLRV-XLNRJJMWSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
162200,CHEMBL412142,AQGNHMOJWBZFQQ-UHFFFAOYSA-N,CHIR-99021,CHIR99021,P27448,SERINE/THREONINE-PROTEIN KINASE C-TAK1,MARK3,,,17850214.0,ACTIVITY,=,91.0,%,activation,biochemical,functional,enzyme_activity,competitive_inhibitor,radiometry,,1,uM,ATP,=,5.0,uM,Percentage MARK3 activity remaining in the presence of 1uM inhibitor,The selectivity of protein kinase inhibitors: a further update.,Biochem. J.,PUBLICATION,
2662329,CHEMBL3601544,MELLLIWJFNLRKQ-UHFFFAOYSA-N,,,O43570,CARBONIC ANHYDRASE XII,CA12,,,26233796.0,KI,=,8.6,NM,,,,,,,,,,,,,,Inhibition of human recombinant carbonic anhydrase-12 pre-incubated for 15 mins by stopped-flow CO2 hydration assay,"Synthesis and carbonic anhydrase I, II, IX and XII inhibitory activity of sulfamates incorporating piperazinyl-ureido moieties.",Bioorg. Med. Chem.,PUBLICATION,
9769,CHEMBL1404165,AAWIMEARVIVJPT-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1877888,CHEMBL207247,IWKYADYEFPLAEG-UHFFFAOYSA-N,GW807930X,,P30530,TYROSINE-PROTEIN KINASE RECEPTOR UFO,AXL,,,,INHIBITION,=,0.14,%,,,,,,,,,,,,,,GSK_PKIS: AXL mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
159542,CHEMBL560401,APYXVASDIFELRE-XCQFTPQJSA-N,,,Q16739,CERAMIDE GLUCOSYLTRANSFERASE,UGCG,,,24457089.0,RATIO,=,0.9,,,cell_based,,,,,,,,,,,,Inhibition of GCS in human OVCAR8 cells assessed as decrease in ratio of glucosylceramide to ceramide level at IC50 after 4 hrs by TLC assay,"3-Ketone-4,6-diene ceramide analogs exclusively induce apoptosis in chemo-resistant cancer cells.",Bioorg. Med. Chem.,PUBLICATION,
1272349,CHEMBL1352778,GHUYLCXBDJBFFV-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5545006,CHEMBL1093467,ZBCHPELLPQXWIX-UHFFFAOYSA-N,,,Q9NYK1,TOLL-LIKE RECEPTOR 7,TLR7,,,20232824.0,EC50,=,187.9,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at human TLR7 expressed in HEK293 cells coexpressing pNiFty2-SEAP reporter by reporter gene assay,Synthesis and biological evaluation of 8-oxoadenine derivatives as toll-like receptor 7 agonists introducing the antedrug concept.,J. Med. Chem.,PUBLICATION,
870674,CHEMBL370252,DPSPPJIUMHPXMA-UHFFFAOYSA-N,FLUMEQUINE,,Q9NPD5,SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B3,SLCO1B3,,,23571415.0,INHIBITION,=,107.05,%,inhibition,cell_based,functional,uptake,competitive_inhibitor,fluorescence_polarization,CHO,10,uM,Fluorescein,=,10.0,uM,Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Structure-based identification of OATP1B1/3 inhibitors.,Mol. Pharmacol.,PUBLICATION,
4861142,CHEMBL483847,WEVYNIUIFUYDGI-UHFFFAOYSA-N,GNF-2,,Q06187,TYROSINE-PROTEIN KINASE BTK,BTK,wild_type,,23398362.0,ACTIVITY,=,96.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of BTK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2203049,CHEMBL1339750,KFWSQDZOTORXQH-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2588579,CHEMBL74741,LWCIHDKWTYEHAX-UHFFFAOYSA-N,,,"P69905, P68871",HEMOGLOBIN HBA,"HBA1, HBA2, HBB",,,2795607.0,RATIO,=,2.34,,,,,,,,,,,,,,,Ratio of effect of compound on affinity of hemoglobin for oxygen to that of control,Synthesis and investigation of effects of 2-[4- [[(arylamino)carbonyl]amino]phenoxy]-2-methylpropionic acids on the affinity of hemoglobin for oxygen: structure-activity relationships.,J. Med. Chem.,PUBLICATION,
3848681,CHEMBL1892201,REOJLIXKJWXUGB-UHFFFAOYSA-N,MOFEBUTAZONE,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1685884,CHEMBL2420820,IAXCYABTSAPPTJ-UHFFFAOYSA-N,,,P23458,TYROSINE-PROTEIN KINASE JAK1,JAK1,,,23867602.0,KI,>,3500.0,NM,,,,,,,,,,,,,,Inhibition of JAK1 (unknown origin),Lead identification of novel and selective TYK2 inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
5027927,CHEMBL3213479,WWYRIHRQIOINLV-VSLWDWNJSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1937556,CHEMBL1733275,JCTVREZSGBDFSG-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4697160,CHEMBL1982202,VMWVYUDRQDYCBN-UFFVCSGVSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
3550124,CHEMBL1706535,PYBWEBMUEPIZSF-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
975037,CHEMBL1487964,FAYBXLDJSJPFDR-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
901980,CHEMBL1572491,DTBCAHAQPHLERZ-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3951776,CHEMBL377847,RPPGVDYXUYGNDX-UHFFFAOYSA-N,,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,16632357.0,IC50,=,2530.0,NM,,,,,,,,,,,,,,Binding affinity to ERalpha by scintillation proximity assay,The discovery of tetrahydrofluorenones as a new class of estrogen receptor beta-subtype selective ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3261177,CHEMBL1731911,OSKBCMPUKHBTTP-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2240607,CHEMBL1723138,KKIFNGUMEDQAHY-UHFFFAOYSA-N,,,Q9UBT6,DNA POLYMERASE KAPPA,POLK,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],PUBCHEM BIOASSAY DATA SET,,DATASET,
1258671,CHEMBL1773486,GGNRKWVBPHCWIF-UHFFFAOYSA-N,,,P22303,ACETYLCHOLINESTERASE,ACHE,,,21397996.0,IC50,=,144.0,NM,,,,,,,,,,,,,,Inhibition of human AChE using acetylthiocholine iodide as substrate by Ellman's assay,Benzophenone-based derivatives: a novel series of potent and selective dual inhibitors of acetylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.,Eur. J. Med. Chem.,PUBLICATION,
4008707,CHEMBL1583342,RVYQBZFINYKNLS-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
5777479,CHEMBL3785665,,,,Q9UM73,ALK TYROSINE KINASE RECEPTOR,ALK,,,26979157.0,IC50,=,18.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human ALK L1196M mutant using tyrosine kinase substrate-biotin after 30 mins by HTRF assay,Design and synthesis of novel 3-sulfonylpyrazol-4-amino pyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2271037,CHEMBL105952,KNMJAZUTBMPTPA-UHFFFAOYSA-N,,,P25021,HISTAMINE H2 RECEPTOR,HRH2,,,12372505.0,KI,=,7585.78,NM,,,,,,,,,,,,,,Binding affinity at human cortical Histamine 2 receptor,Aminoalkoxybiphenylnitriles as histamine-3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4142724,CHEMBL27577,SKZKKFZAGNVIMN-UHFFFAOYSA-N,SALICYLAMIDE,,P21728,DOPAMINE D1 RECEPTOR,DRD1,,,,KI,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D1 radioligand binding (ligand: [3H] SCH-23390),DrugMatrix in vitro pharmacology data,,DATASET,
996248,CHEMBL1404388,FDGKMVFUFQGDDC-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2722304,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,SORAFENIB,,Q13705,ACTIVIN RECEPTOR TYPE-2B,ACVR2B,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for ACVR2B kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2312759,CHEMBL1394394,KRULXQRCZJZJIK-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of TGF-b: Hit Validation in HepG2 Cells using COP promoter.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3027357,CHEMBL556979,NSNXYLYKGIWDIN-IXCAENJASA-N,,,Q9UHL4,DIPEPTIDYL PEPTIDASE II,DPP7,,,18201067.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of QPP,Discovery of potent and selective dipeptidyl peptidase IV inhibitors derived from beta-aminoamides bearing subsituted triazolopiperazines.,J. Med. Chem.,PUBLICATION,
1164363,CHEMBL1464689,FVWUAEMADGZQHX-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,7304.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1886337,CHEMBL198463,IXHFUNSVBJAYHP-UHFFFAOYSA-N,,,P28222,SEROTONIN 1B (5-HT1B) RECEPTOR,HTR1B,,,16219465.0,IC50,=,85.0,NM,,cell_based,,,,,HEK293,,,,,,,Inhibitory activity against human recombinant 5HT1B receptor co-expressed with G-protein chimera Gqo5 in HEK293 cells by FLIPR,Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4237925,CHEMBL270724,SVJQCVOKYJWUBC-OWOJBTEDSA-N,"3-(2,3,4,5-TETRABROMOPHENYL)ACRYLIC ACID",,Q05513,PROTEIN KINASE C ZETA,PRKCZ,wild_type,,23398362.0,ACTIVITY,=,88.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of PRKCZ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
5213457,CHEMBL1524206,XQYXDHAVRKKOHV-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,446.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
117475,CHEMBL3318954,ALDJQYJOXDCKFF-BHDDXSALSA-N,,,P00797,RENIN,REN,,,,IC50,=,0.6,NM,,,,,,,,,,,,,,BindingDB_Patents: FRET Assay. Inhibition activity of renin using FRET assay.,Organic compounds,,PATENT,
3158085,CHEMBL188048,OHBDLKLACOYJNL-UHFFFAOYSA-N,SB-736290,,Q9UK32,RIBOSOMAL PROTEIN S6 KINASE ALPHA 6,RPS6KA6,,,,INHIBITION,=,2.49,%,,,,,,,,,,,,,,GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3623622,CHEMBL34894,QGJKHQRFJGLJLV-VFFRCKCKSA-N,CI-992,,P0DJD9,PEPSIN A,PGA5,,,1635057.0,IC50,=,202000.0,NM,,,,,,,,,,,,,,Inhibitory activity against pepsin.,Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.,J. Med. Chem.,PUBLICATION,
609013,CHEMBL10115,CNKACCQCBCIPTI-INIZCTEOSA-N,,,P31652,SEROTONIN TRANSPORTER,,,,9089327.0,IC50,=,19.4,NM,,,,,,,,,,,,,,Inhibition of uptake of [3H]5-HT in synaptosomes from rat cortex,"Structure-activity studies for a novel series of N-(arylethyl)-N-(1,2,3,4-tetrahydronaphthalen-1-ylmethyl)-N-methylamine s possessing dual 5-HT uptake inhibiting and alpha2-antagonistic activities.",J. Med. Chem.,PUBLICATION,
1944404,CHEMBL280301,JDLUQLOIECPIFX-XRIYMHTPSA-N,,,A3EZI9,HEPATITIS C VIRUS NS3 PROTEASE/HELICASE,,,,12643933.0,IC50,=,180.0,NM,,,,,,,,,,,,,,Inhibitory concentration against HCV NS3 protease.,"Design and synthesis of potent, non-peptide inhibitors of HCV NS3 protease.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5156748,CHEMBL1789963,XKTUKRBLWOHYIL-UHFFFAOYSA-N,GW406108X,,Q8TDX7,SERINE/THREONINE-PROTEIN KINASE NEK7,NEK7,,,,INHIBITION,=,3.97,%,,,,,,,,,,,,,,GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
794831,CHEMBL1436867,DHUBEWYHEWPAPH-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5125258,CHEMBL1904795,XHFHCXFXISBJEL-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,501.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3337470,CHEMBL1332228,PASAUQLHGPTUFC-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1642628,CHEMBL582147,HWLJNBFHEXALCB-UHFFFAOYSA-N,TCMDC-131654,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,10.64,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
3528452,CHEMBL1978671,PVOLBLVRNQMSJN-UXHLAJHPSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5218873,CHEMBL1889359,XRLRERMCDCXHEV-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
978352,CHEMBL1571454,FBJIKLLEMOTHEW-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,26854.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5686663,CHEMBL1565251,ZQEUIAUWNOKRCE-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2939623,CHEMBL3657340,NIVYQPWPSLHFAJ-UHFFFAOYSA-N,,,Q05397,FOCAL ADHESION KINASE 1,PTK2,,,,IC50,=,11.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. This test uses active PTK2 enzyme (Invitrogen Code PV3832) and poly-Glu-Tyr (4:1, Sigma P-0275) as the kinase substrate. The kinase activity is detected by means of the phosphorylation of the substrate in a DELFIA assay. The phosphorylated substrate is detected with the europium-labelled phosphotyrosine antibody PY20 (Perkin Elmer, No.: AD0038).In order to determine concentration-activity curves with PTK2-inhibitors the compounds are serially diluted in 10% DMSO/H2O and 10 uL of each dilution are dispensed per well in a 96-well microtitre plate (clear U-shaped base plate, Greiner No. 650101) (the inhibitors are tested in duplicates) and mixed with 10 uL/well of PTK2 kinase (0.01 ug/well). PTK2 kinase is diluted accordingly beforehand with kinase dilution buffer (20 mM TRIS/HCl pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 0.286 mM sodium orthovanadate, 10% glycerol with the addition of freshly prepared BSA (fraction V 1 mg/mL) and DTT (1 mM)).",Substituted pyrimidines for the treatment of diseases such as cancer,,PATENT,
5204295,CHEMBL343922,XPYXUCFHJJCHDH-UHFFFAOYSA-N,,,P61169,DOPAMINE D2 RECEPTOR,,,,7473566.0,ED50,=,5.5,UMOL.KG-1,,,,,,,,,,,,,,Antagonism of pergolide-induced circling behavior in rats with unilateral 6-OHDA generated lesions,Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.,J. Med. Chem.,PUBLICATION,
445884,CHEMBL237347,BVHZLDLRNBQWRF-UHFFFAOYSA-N,GW559768X,,Q16644,MAP KINASE-ACTIVATED PROTEIN KINASE 3,MAPKAPK3,,,,INHIBITION,=,24.19,%,,,,,,,,,,,,,,GSK_PKIS: MAPKAPK3 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4597647,CHEMBL1569564,VCBJLGXHPJFFNI-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4830749,CHEMBL1532928,WBTCERKLDKQMFI-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,2909.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3377268,CHEMBL1518035,PFGNAHWXWSMBLS-UHFFFAOYSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,=,25118.86,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4164635,CHEMBL362097,SNKZGUVEFOMERT-SIKLNZKXSA-N,,,P49286,MELATONIN RECEPTOR 1B,MTNR1B,,,15380218.0,KI,=,90.0,NM,,cell_based,,,,,NIH3T3,,,,,,,Inhibition of 2-[125I]iodomelatonin binding to membrane preparations of NIH3T3 cells stably expressing human Melatonin receptor type 1B,N-[2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl]acetamide: an orally bioavailable melatonin receptor agonist.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5781305,,,UNC10225168A,,Q9HCP0,CASEIN KINASE 1 GAMMA 1,None,,,28767711.0,INHIBITION,=,91.7,%,inhibition,biochemical,binding,,,qPCR,,1,UM,,,,,KINOMESCAN BEADS,PROGRESS TOWARDS A PUBLIC CHEMOGENOMIC SET FOR PROTEIN KINASES AND A CALL FOR CONTRIBUTIONS,PLOS ONE,,CSNK1G1
2867651,CHEMBL1470888,NBDOSEUNJLCDLN-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1423013,CHEMBL2333974,GYVVZOPLCVADLE-UHFFFAOYSA-N,,,P00915,CARBONIC ANHYDRASE I,CA1,,,22705188.0,KI,=,6764.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay,Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
3824481,CHEMBL3416922,RBZHSWMHSXFMSD-ZLTIQJTMSA-N,,,Q15858,SODIUM CHANNEL PROTEIN TYPE IX ALPHA SUBUNIT,SCN9A,,,25658507.0,IC50,=,9.0,NM,,,,,,,,,,,,,,Inhibition of human NaV1.7 at -140 mV holding potential by whole-cell patch clamp assay,"Engineering potent and selective analogues of GpTx-1, a tarantula venom peptide antagonist of the Na(V)1.7 sodium channel.",J. Med. Chem.,PUBLICATION,
1548330,CHEMBL288096,HLRBSTGXOFUEHW-OAHLLOKOSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
117205,CHEMBL192794,ALCQZHWTJMXWQI-UHFFFAOYSA-N,,,"P35563, Q9JJ16",SEROTONIN 3 (5-HT3) RECEPTOR,,,,15887964.0,KI,=,0.84,NM,,,,,,,,,,,,,,Displacement of [3H]granisetron from 5-hydroxytryptamine 3 receptor of rat cortical membrane,Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands. development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties.,J. Med. Chem.,PUBLICATION,
3339969,CHEMBL1411731,PAZSYTCTHYSIAO-WVFSJLEKSA-N,TALAMPICILLIN HYDROCHLORIDE,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1169741,CHEMBL1933738,FWOTUKBPQCIXBN-UHFFFAOYSA-N,,,P12931,TYROSINE-PROTEIN KINASE SRC,SRC,,,22119472.0,IC50,=,50700.0,NM,,,,,,,,,,,,,,Inhibition of His6-tagged c-Src kinase domain using AEEEIYGEFEAKKKK as substrate pre-incubated for 10 mins before substrate addition measured after 30 mins by Transcreener ADP2 FI Assay,One-pot regioselective synthesis of tetrahydroindazolones and evaluation of their antiproliferative and Src kinase inhibitory activities.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5636246,CHEMBL2158602,ZKVMGHUNBFIVQU-BTQIASGJSA-N,,,P98170,INHIBITOR OF APOPTOSIS PROTEIN 3,XIAP,,,22148838.0,IC50,=,161.0,NM,,,,,,,,,,,,,,Binding affinity to BIR3 domain of XIAP by fluorescence polarization assay,Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.,J. Med. Chem.,PUBLICATION,
1980566,CHEMBL1388319,JHPZFNSQFYWHNU-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5371791,CHEMBL3196347,YHYDTWDUSXRFQC-LDADJPATSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4022281,CHEMBL1488056,RXQMXOKIXOVTJH-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,18356.4,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1556897,CHEMBL2418337,HMPQQYCOBUJYSG-ZDUSSCGKSA-N,,,P42336,PI3-KINASE P110-ALPHA SUBUNIT,PIK3CA,,,23932790.0,KI,=,370.0,NM,,,,,,,,,,,,,,"Displacement of TAMRA-PIP3 from PI3Kalpha GRP-1 pleckstrin homology domain (unknown origin) assessed as formation of 3,4,5-inositoltriphosphate after 30 mins by fluorescence polarization assay","A hit to lead discovery of novel N-methylated imidazolo-, pyrrolo-, and pyrazolo-pyrimidines as potent and selective mTOR inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2453186,CHEMBL1557778,LHUIZUDXTZMSSR-UHFFFAOYSA-N,,,P29466,CASPASE-1,CASP1,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
760702,CHEMBL2001408,DDWTUHATLIIVDQ-FRKPEAEDSA-N,,,P63165,SMALL UBIQUITIN-RELATED MODIFIER 1,SUMO1,,,,IC50,,66600.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose response confirmation of uHTS inhibitor hits of SUMO1-mediated protein-protein interactions using a fluorescence polarization assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
818732,CHEMBL1350959,DKJBQTQOPDHCFZ-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4531929,CHEMBL1329059,UVBDXUUXCFGDNY-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4633488,CHEMBL1721407,VFUMNYRTPAPJFI-RCUDDFTLSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2511140,CHEMBL3093076,LNXSSTKGTQNUBH-CQSZACIVSA-N,,,"P50750, O60563",CDK9/CYCLIN T1,"CCNT1, CDK9",,,24120542.0,IC50,=,120.0,NM,,,,,,,,,,,,,,Inhibition of CDK9/cyclin T1 (unknown origin) using 4eBP1 ULight peptide as substrate by HTRF assay,The optimization of aminooxadiazoles as orally active inhibitors of Cdc7.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2711864,CHEMBL1835011,MKAVSGZPSXLJKL-QMMMGPOBSA-N,(-)-TRYPETHELONE,,O42275,ACETYLCHOLINESTERASE,,,,21923104.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibition of electric eel AChE,HLE-Inhibitory Alkaloids with a Polyketide Skeleton from the Marine-Derived Fungus Coniothyrium cereale.,J. Nat. Prod.,PUBLICATION,
5683013,CHEMBL1325023,ZPVXOYCFXQVDEF-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2547359,CHEMBL3659046,LRTHXEJLGFGXPG-HQFBBTJKSA-N,,,O00421,C-C CHEMOKINE RECEPTOR-LIKE 2,CCRL2,,,,IC50,=,430.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Receptor Binding Assay. Human monocytic cell line THP-1 cells were obtained from American Type Culture Collection (Manassas, Va., USA). The THP-1 cells were grown in RPMI-1640 (RPMI: Roswell Park Memorial Institute Medium-cell culture growth media) supplemented with 10% fetal bovine serum in a humidified 5% CO2 atmosphere at 37° C. The cell density was maintained between 0.5×106 cells/mL.",Cyclohexyl-azetidinyl antagonists of CCR2,,PATENT,
5163061,CHEMBL1785003,XLIWJFSCQYQXAI-UHFFFAOYSA-N,SB-264866,,P23458,TYROSINE-PROTEIN KINASE JAK1,JAK1,,,,INHIBITION,=,-4.59,%,,,,,,,,,,,,,,GSK_PKIS: JAK1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1710830,CHEMBL1441493,IDMQEXSBJYWIFV-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1394824,CHEMBL1516046,GVQYVWYDPUKWOO-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5149628,CHEMBL1520081,XKAORSCBVZYBHD-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2849630,CHEMBL1346965,MZARBBXWEPWNRA-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3056442,CHEMBL1415245,NVXGRADJIFIBIO-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1155158,CHEMBL1774309,FUUIYLWURGZBJB-UHFFFAOYSA-N,,,O14684,PROSTAGLANDIN E SYNTHASE,PTGES,,,21466167.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human microsomal PGES1 in cell-free system assessed as inhibition of conversion of PGH2 to PGE2 by HPLC assay,Pharmacophore Modeling and Virtual Screening for Novel Acidic Inhibitors of Microsomal Prostaglandin E(2) Synthase-1 (mPGES-1).,J. Med. Chem.,PUBLICATION,
3082846,CHEMBL1562439,NYXLCSQALOVWCX-UHFFFAOYSA-N,,,P49327,FATTY ACID SYNTHASE,FASN,,,,IC50,,2040.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose response confirmation of uHTS inhibitor hits of the thioesterase domain of fatty acid synthase via a fluorescence intensity assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4959728,CHEMBL379372,WPPDVRZORMAVOK-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,16735117.0,IC50,=,19.0,NM,,,,,,,,,,,,,,Inhibition of KDR,Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3750791,CHEMBL3421984,QUDRGKCUYXLVFJ-UHFFFAOYSA-N,,,P29371,NEUROKININ 3 RECEPTOR,TACR3,,,25738882.0,IC50,>,31622.78,NM,,cell_based,,,,,,,,,,,,Antagonist activity at recombinant human NK3R expressed in CHO cells assessed as inhibition of NKB-induced Ca2+ signaling by aequorin Ca2+ bioluminescence assay,Discovery and optimization of novel antagonists to the human neurokinin-3 receptor for the treatment of sex-hormone disorders (part I).,J. Med. Chem.,PUBLICATION,
4949516,CHEMBL1389165,WOKONWIJENVFOJ-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3977034,CHEMBL1610697,RSMIAYBJEBVZMI-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3015424,CHEMBL1452938,NREUYNCSBGDFLU-WQLSENKSSA-N,,,P03070,LARGE T ANTIGEN,,,,,IC50,,36920.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1909, AID2102, AID2501, AID2615, AID2775, AID449729, AID485276, AID485288]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1542815,CHEMBL1221601,HLCDNLNLQNYZTK-UHFFFAOYSA-N,,,Q13043,SERINE/THREONINE-PROTEIN KINASE MST1,STK4,wild_type,,23398362.0,ACTIVITY,=,92.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,90.0,uM,"Millipore: Percentage of residual kinase activity of STK4 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1181481,CHEMBL166801,FXUISTFGWWDLAJ-UHFFFAOYSA-N,,,P00736,COMPLEMENT C1R,C1R,,,10206542.0,IC50,=,6000.0,NM,,,,,,,,,,,,,,Evaluated in vitro for inhibitory activity against purified human C1r protease incubated in buffer for 60 minutes,"Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5277997,CHEMBL1466881,XXZTYYUKZVNQCA-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1109088,CHEMBL261641,FPYJSJDOHRDAMT-KQWNVCNZSA-N,SU-11274,,Q8N568,SERINE/THREONINE-PROTEIN KINASE DCLK2,DCLK2,wild_type,,22037377.0,ACTIVITY,=,90.37259532,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,AUTOCAMTIDE 2 + CA-CAM,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
957269,CHEMBL1589179,DZESWQADJGZDFL-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,35375.8,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation in Cell-Based Luciferin Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3511286,CHEMBL10646,PTRUGAYWWQMKAT-UHFFFAOYSA-N,,,P08253,MATRIX METALLOPROTEINASE-2,MMP2,,,11297453.0,IC50,=,100.0,NM,,,,,,,,,,,,,,Inhibitory activity against matrix metalloprotease-2 (MMP-2) in quenched fluorescence assay at pH 7.4,Development of new carboxylic acid-based MMP inhibitors derived from functionalized propargylglycines.,J. Med. Chem.,PUBLICATION,
2390158,CHEMBL1602781,LAOFJWJLSOEHMB-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3797312,CHEMBL358326,QZGCHMZBGHVZFB-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
4821310,CHEMBL2070453,WAORBOVWEZBARO-UHFFFAOYSA-N,,,P55055,LXR-BETA,NR1H2,,,22901900.0,IC50,=,600.0,NM,,,,,,,,,,,,,,"Displacement of [3H]N-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)-N-methylbenzenesulfonamide from GST-tagged LXRbeta ligand binding domain after 1 hr by scintillation proximity assay",Discovery and optimization of a series of liver X receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
465019,CHEMBL1706892,BXNBGCOJYSPASM-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3543157,CHEMBL562495,PXEWPYFQFZXVIQ-IEBWSBKVSA-N,,,Q9QYN8,HISTAMINE H3 RECEPTOR,,,,19588934.0,KI,>,1000.0,NM,,,,,,,,,,,,,,Displacement of [3H]N-alpha methyl histamine from rat cortical membrane histamine H3 receptor,"Design of a new histamine H3 receptor antagonist chemotype: (3aR,6aR)-5-alkyl-1-aryl-octahydropyrrolo[3,4-b]pyrroles, synthesis, and structure-activity relationships.",J. Med. Chem.,PUBLICATION,
2508199,CHEMBL1890869,LNOONYYMKWMXCL-UHFFFAOYSA-N,,,P78536,ADAM17,ADAM17,,,,IC50,,69456.0,NM,,,,,,,,,,,,,,PubChem BioAssay. QFRET-based biochemical high throughput dose response assay to identify exosite inhibitors of ADAM17.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3062314,CHEMBL1504089,NWPANAJPHRXMQR-UHFFFAOYSA-N,,,"P19838, Q04206, Q00653",NUCLEAR FACTOR NF-KAPPA-B COMPLEX,"NFKB1, NFKB2, RELA",,,,EC50,=,2183.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Name: High Throughput Screen to Identify Compounds that increase expression of NF-kB in Human Neuronal Cells - Dose Response. (Class of assay: confirmatory) [Related pubchem assays: 1239 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1739171,CHEMBL434002,IGVPZJXNGDQLRO-MUEFQPRUSA-N,,,P34995,PROSTANOID EP1 RECEPTOR,PTGER1,,,12643927.0,KI,>,13000.0,NM,,cell_based,,,,,HEK293,,,,,,,Binding affinity towards EP1 receptor expressed in HEK293 ebna cells recombinantly expressing the corresponding human prostanoid cDNAs,Discovery of a potent and selective agonist of the prostaglandin EP4 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1368117,CHEMBL3192459,GSRCZINUQSKFQB-JFLMPSFJSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1349534,CHEMBL1574110,GQJYDGFCSQTZBT-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1305847,CHEMBL1988537,GLMWKEAUVZDGKE-UHFFFAOYSA-N,,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK3,PUBCHEM BIOASSAY DATA SET,,DATASET,
1230671,CHEMBL1435875,GDLCHXBEXYXYFA-SFQUDFHCSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,3689.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2660, AID2666, AID2667, AID2668, AID2681, AID504465]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4923371,CHEMBL426915,WLJQCKZUHRFXBV-UHFFFAOYSA-N,,,P06276,BUTYRYLCHOLINESTERASE,BCHE,,,17681794.0,IC50,=,15670.0,NM,,,,,,,,,,,,,,Inhibition of human BChE by Ellman's method,"Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.",Bioorg. Med. Chem.,PUBLICATION,
2126752,CHEMBL1508567,JXRDMQOGXULYQE-XBXARRHUSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3325281,CHEMBL60214,OZHIZRHVFRTGRO-UHFFFAOYSA-N,,,Q72547,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE,,,,7520080.0,INITIAL ACTIVITY,=,90.0,%,,,,,,,,,,,,,,Inhibition of DNA polymerase activity of HIV-1 reverse transcriptase (at 50 uM),Synthesis of naphthalenesulfonic acid small molecules as selective inhibitors of the DNA polymerase and ribonuclease H activities of HIV-1 reverse transcriptase.,J. Med. Chem.,PUBLICATION,
3842210,CHEMBL1606961,RDWNNSDJKHVPQK-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3473510,CHEMBL67736,PPOKXJQYYQBZNT-UHFFFAOYSA-N,,,O76074,PHOSPHODIESTERASE 5A,PDE5A,,,8027992.0,IC50,=,2300.0,NM,,,,,,,,,,,,,,Inhibitory activity against cGMP-phosphodiesterase from porcine aorta,Cyclic GMP phosphodiesterase inhibitors. 2. Requirement of 6-substitution of quinazoline derivatives for potent and selective inhibitory activity.,J. Med. Chem.,PUBLICATION,
2174822,CHEMBL266267,KDCGCMAFBGTQKE-UHFFFAOYSA-N,,,P25099,ADENOSINE A1 RECEPTOR,,,,3361572.0,RATIO,=,2.6,,,,,,,,,,,,,,,Ratio of Ki at A2 to Ki at A1 receptors,Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists.,J. Med. Chem.,PUBLICATION,
4598226,CHEMBL1506460,VCCVQBWEEFJPBZ-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
209299,CHEMBL1383035,AVDKNUNMNZNUPV-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3060408,CHEMBL105,NWIBSHFKIJFRCO-WUDYKRTCSA-N,MITOMYCIN,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DrugMatrix in vitro pharmacology data,,DATASET,
2822915,CHEMBL150023,MWEXIACDYMVJBD-ZBJSNUHESA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3100568,CHEMBL1419296,OBAFGHPNKQGMRQ-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
323157,CHEMBL1571631,BHSOHTBZIYCWHG-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4366683,CHEMBL1449047,UDEBKOBVOYCHSY-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
622584,CHEMBL1304009,CPAMZMMYEPRNLO-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1351742,CHEMBL1336519,GQPJFGVMPNCNLR-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3862727,CHEMBL1558387,RGCRVJRRKZPHIU-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
792389,CHEMBL773,DHMQDGOQFOQNFH-UHFFFAOYSA-N,GLYCINE,,P13945,BETA-3 ADRENERGIC RECEPTOR,ADRB3,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DrugMatrix in vitro pharmacology data,,DATASET,
2993538,CHEMBL1317144,NOVCVIHKUSKQHJ-GMASTSJYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4119192,CHEMBL3196543,SIEVSHLBDITTKF-FRKPEAEDSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1989721,CHEMBL1547836,JITBOTGCIMNEBT-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1058885,CHEMBL406491,FKFGMQQTWSHGDT-RRBMOYSISA-N,,,"P30938, P30680, P30937, P30936, P28646",SOMATOSTATIN RECEPTOR,,,,10354394.0,IC50,=,393.0,NM,,,,,,,,,,,,,,Antagonism of in vitro SRIF inhibition of GH release in rat in vitro pituitary cell assay,Highly potent cyclic disulfide antagonists of somatostatin.,J. Med. Chem.,PUBLICATION,
1115192,CHEMBL7724,FQNCLVJEQCJWSU-UHFFFAOYSA-N,AG1295,,Q13976,CGMP-DEPENDENT PROTEIN KINASE 1 BETA,PRKG1,wild_type,,23398362.0,ACTIVITY,=,110.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,90.0,uM,"Millipore: Percentage of residual kinase activity of PRKG1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 uM cGMP",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3746729,CHEMBL223460,QTQUAHGXBLFSCH-UHFFFAOYSA-N,,,Q13627,DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REGULATED KINASE 1A,DYRK1A,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: DYRK1A,PUBCHEM BIOASSAY DATA SET,,DATASET,
3459546,CHEMBL1525461,PNZKINYMIXXSQV-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2024292,CHEMBL89241,JMPZTWDLOGTBPM-OUQSKUGOSA-N,,,P10826,RETINOIC ACID RECEPTOR BETA,RARB,,,8709094.0,EFFICACY,=,45.0,%,,cell_based,,,,,CV-1,,,,,,,Percent transcriptional activation relative to ATRA in CV-1 cells expressing Retinoic acid receptor RAR beta,Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.,J. Med. Chem.,PUBLICATION,
3480149,CHEMBL1533224,PQIFAYVROCLPJO-KHPPLWFESA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5130516,CHEMBL550035,XHUGCOUNHPKMDJ-UHFFFAOYSA-N,,,P55055,LXR-BETA,NR1H2,,,19394832.0,EC50,=,3630.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human LXRbeta ligand binding domain (219-462) expressed in human HuH7 cells co-transfected with Gal4-DBD by luciferase transactivation assay,Discovery and SAR of cinnolines/quinolines as liver X receptor (LXR) agonists with binding selectivity for LXRbeta.,Bioorg. Med. Chem.,PUBLICATION,
2271637,CHEMBL1385816,KNOKQUMOCIQGNV-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3614534,CHEMBL1439665,QFJRQXHZRGAWQM-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4807266,CHEMBL3084449,VZBIHFDPWCGOCN-QLPKVWCKSA-N,,,P08173,MUSCARINIC ACETYLCHOLINE RECEPTOR M4,CHRM4,,,22507963.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Antagonist activity at human muscarinic M4 receptor by calcium mobilization assay,Continued optimization of the MLPCN probe ML071 into highly potent agonists of the hM1 muscarinic acetylcholine receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5579468,CHEMBL1387790,ZELFHSXQFBBQEA-VKAVYKQESA-N,,,G5EF15,CYTOPLASMIC ZINC-FINGER PROTEIN,,,,,EC50,=,27116.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescent Polarization Homogeneous Dose Response HTS to Identify Inhibitors of POS-1 Binding to mex-3-RNA. (Class of assay: confirmatory) [Related pubchem assays: 1833 (Project Summary), 1832 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
429918,CHEMBL1563453,BTLPOZXBXXBJBO-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4690881,CHEMBL269354,VMHUDGCLHHBWCK-GIUUGQLDSA-N,,,P08709,COAGULATION FACTOR VII,F7,,,12270169.0,IC50,=,1.0,NM,,,,,,,,,,,,,,Inhibition of amino terminally biotinylated E-76 peptide binding to immobilized fVIIa,Albumin affinity tags increase peptide half-life in vivo.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4505370,CHEMBL1601205,USFOMBZENAQSQM-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4064316,CHEMBL130575,SCDBDOBRVVKAKB-UHFFFAOYSA-N,,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,9406596.0,IC50,=,10.2,NM,,,,,,,,,,,,,,"Affinity for the glycine binding site on rat N-methyl-D-aspartate glutamate receptor 1, determined by displacement of the glycine site antagonist [3H]L-689,560 from rat cortical membranes",Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.,J. Med. Chem.,PUBLICATION,
2276744,CHEMBL1408627,KOEREEZJOBNEBN-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4071206,CHEMBL520920,SCYQIQINYUMLPD-UHFFFAOYSA-N,"2,7-BIS(CYCLOPROPANECARBONAMIDO)ANTHRAQUINONE",,O14746,TELOMERASE REVERSE TRANSCRIPTASE,TERT,,,18571928.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of human TERT expressed in BJ1 cells at 10 uM after 24 hrs by SEAP assay realtive to control,"Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives.",Bioorg. Med. Chem.,PUBLICATION,
1881644,CHEMBL1517,IWVCMVBTMGNXQD-PXOLEDIWSA-N,OXYTETRACYCLINE,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,,KI,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
4007477,CHEMBL1448278,RVUWJJVLTHJFPZ-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1017221,CHEMBL115676,FFPHAWVFZQFOJA-PSHWQTJJSA-N,,,P07711,CATHEPSIN L,CTSL,,,10669559.0,IC50,=,1.9,NM,,,,,,,,,,,,,,Inhibitory activity against cathepsin L,Protease inhibitors: current status and future prospects.,J. Med. Chem.,PUBLICATION,
2472981,CHEMBL177,LKCWBDHBTVXHDL-RMDFUYIESA-N,AMIKACIN,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
4648187,,VHKSSHRSJGZQOV-UHFFFAOYSA-N,KDOAM-29,,P41229,LYSINE-SPECIFIC DEMETHYLASE 5C,KDM5C,,,28262558.0,IC50,=,800.0,NM,,,,,,,,,,,,,,,,,,
2380773,CHEMBL3416555,KZLLABWWTTXZLK-UHFFFAOYSA-N,,,P30838,ALDEHYDE DEHYDROGENASE DIMERIC NADP-PREFERRING,ALDH3A1,,,25634381.0,ACTIVITY,<,10.0,%,,,,,,,,,,,,,,Activation of recombinant human ALDH3A1 using benzaldehyde as substrate at 20 uM preincubated for 2 mins with NAD+ followed by substrate addition by UV-Vis spectrophotometric analysis,Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.,J. Med. Chem.,PUBLICATION,
667118,CHEMBL1343831,CTYJCTRYAPVVBZ-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2533664,CHEMBL2137654,LQDARGUHUSPFNL-UHFFFAOYSA-N,TETRACONAZOLE,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,68171.3,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1693156,CHEMBL1909413,IBPFBGKKYDZPON-UHFFFAOYSA-N,SB-610251B,,P07948,TYROSINE-PROTEIN KINASE LYN,LYN,,,,INHIBITION,=,31.27,%,,,,,,,,,,,,,,GSK_PKIS: LYN A (splice variant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4502638,CHEMBL221886,URWAJWIAIPFPJE-YFMIWBNJSA-N,SISOMICIN,,P08575,LEUKOCYTE COMMON ANTIGEN,PTPRC,,,,IC50,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",DrugMatrix in vitro pharmacology data,,DATASET,
3569509,CHEMBL1256191,QAIGGSDECIJPNW-UHFFFAOYSA-N,SKF-89626,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3996616,CHEMBL1324710,RUOBGDINBKJHFC-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
2320989,CHEMBL2347589,KSSDYLDWAFPPIT-XMMPIXPASA-N,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,23294831.0,FICI,=,0.413,,,,,,,,,,,,,,,Inhibition of P-gp activity in human paclitaxel-resistant A549 cells potentiation of 10 uM paclitaxel-induced cytotoxicity at 0.2 uM by SRB assay,"Design, synthesis, and evaluation of a water-soluble antofine analogue with high antiproliferative and antitumor activity.",Bioorg. Med. Chem.,PUBLICATION,
1966363,CHEMBL2007479,JGBCLJZMLUMHOO-UHFFFAOYSA-N,,,O95819,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4,MAP4K4,,,,KI,>,5011.87,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K4,PUBCHEM BIOASSAY DATA SET,,DATASET,
4231324,CHEMBL285801,SUQYTYOVPXAUGB-RDPSFJRHSA-N,,,Q9R1K8,RAS GUANYL RELEASING PROTEIN 1,,,,11831896.0,KI,=,0.85,NM,,,,,,,,,,,,,,Binding affinity against RAS guanyl releasing protein using [3H]- PDBu as the labeled ligand,Structural basis of RasGRP binding to high-affinity PKC ligands.,J. Med. Chem.,PUBLICATION,
5472687,CHEMBL3694703,YSYCIRQVBMAPCV-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,,IC50,=,820.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Kinase Inhibition Assay. VEGFR2 (from Upstate), prepared at 2x final concentration, was incubated with test compounds, biotinylated Flt3 substrate (biotin-VASSDNEYFYVDF) (Cell Signalling Technology Inc.) and ATP in the appropriate assay buffer (Table 1). The reaction was allowed to proceed for 1 hour at room temperature on a plate shaker at 700 rpm before being stopped with 35 mM EDTA, pH 8 (VEGFR2). 5x detection mix (50 mM HEPES, pH 7.5, 0.1% BSA, 11.34 nM Eu-anti-pY (PY20), 187.5 nM SA-XL665) was then added to each well and the plate sealed and incubated at room temperature for one hour on a plate shaker at 700 rpm. The plate was then read on a Packard Fusion plate reader or a BMG Pherastar both in TRF mode. Kinase Assay buffers were: 50 mM HEPES pH 7.5, 6 mM MnCl2, 1 mM DTT, 0.01% TritonX-100, 0.1 mM Sodium orthovanadate.",Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases,,PATENT,
87004,CHEMBL2403078,AHQWIBJDMASYON-UHFFFAOYSA-N,,,Q13153,SERINE/THREONINE-PROTEIN KINASE PAK 1,PAK1,,,23756368.0,IC50,=,61.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant PAK1 using MBP as substrate by scintillation counting analysis in presence of [gamma-32P]ATP,Synthesis and structure-activity relationship of 2-arylamino-4-aryl-pyrimidines as potent PAK1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3908082,CHEMBL1802727,RKUMZEVCWKZXFV-LCLDVOFVSA-N,,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,wild_type,,22037377.0,ACTIVITY,=,71.92413428,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ABLTIDE ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
1858862,CHEMBL1672245,IUDNWUABFDZWBF-UHFFFAOYSA-N,,,P31423,METABOTROPIC GLUTAMATE RECEPTOR 4,,,,21247167.0,ACTIVITY,=,118.8,%,,cell_based,,,,,CHO,,,,,,,Positive allosteric modulation of rat mGluR4 expressed in CHO cells coexpressing Gqi5 assessed as calcium mobilization relative to PHCCC,"Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats.",J. Med. Chem.,PUBLICATION,
4571602,CHEMBL230592,UZFISAOOMRYRDS-UHFFFAOYSA-N,GSK-635416A,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,,,,INHIBITION,=,-1.38,%,,,,,,,,,,,,,,GSK_PKIS: FLT3 (D835Y mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2806113,CHEMBL3431874,MUOIQSQXHCNIFW-HXUWFJFHSA-N,,,P18886,CARNITINE PALMITOYLTRANSFERASE 2,,,,,IC50,>,100000.0,NM,,,,,,,,,,,,,,SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 2,Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752).,,DATASET,
1461726,CHEMBL299155,HCZHHEIFKROPDY-UHFFFAOYSA-N,TRANSTORINE,,Q9HC97,G-PROTEIN COUPLED RECEPTOR 35,GPR35,,,22572579.0,EFFICACY,>,60.0,%,,cell_based,,,,,U2OS,,,,,,,Agonist activity at GPR35 in human U2OS cells expressing beta-lactamase and Gal4-VP16 transcription factor assessed as beta arrestin translocation after 5 hrs by Tango assay relative to zaprinast,"Thieno[3,2-b]thiophene-2-carboxylic acid derivatives as GPR35 agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4574576,CHEMBL3288123,UZMXCMBPCJXJOD-UHFFFAOYSA-N,,,Q9H244,PURINERGIC RECEPTOR P2Y12,P2RY12,,,24835983.0,IC50,=,41.0,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]AZ11931285 from human P2Y12 receptor expressed in CHOK1 cell membrane after 30 seconds,Optimization of ketone-based P2Y12 receptor antagonists as antithrombotic agents: Pharmacodynamics and receptor kinetics considerations.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2620195,CHEMBL1536585,LZTXMVHCZHWAOQ-UHFFFAOYSA-N,,,P38532,HEAT SHOCK FACTOR PROTEIN 1,,,,,EC50,>,260000.0,NM,,cell_based,,,,,,,,,,,,PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Retest to Identify Potentiators of Heat Shock Factor 1 (HSF1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493224],PUBCHEM BIOASSAY DATA SET,,DATASET,
2578864,CHEMBL27266,LUZOFMGZMUZSSK-LRDDRELGSA-N,INDOLACTUM,,P28867,PROTEIN KINASE C DELTA,,,,11356104.0,KI,=,1100.0,NM,,,,,,,,,,,,,,Displacement of [3H]PDBu from protein kinase C delta C1b domain mutant (Q27V),Structural basis of binding of high-affinity ligands to protein kinase C: prediction of the binding modes through a new molecular dynamics method and evaluation by site-directed mutagenesis.,J. Med. Chem.,PUBLICATION,
2084990,CHEMBL505431,JTGBYRRUQUQVJF-UFADHCMUSA-N,,,P31645,SEROTONIN TRANSPORTER,SLC6A4,,,19256502.0,KI,=,156.0,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [125I]RTI-55 from human recombinant SERT expressed in HEK293 cells by scintillation counting,Dual inhibitors of phosphodiesterase-4 and serotonin reuptake.,J. Med. Chem.,PUBLICATION,
4869605,CHEMBL111620,WFTBLYUVDBPJAV-UHFFFAOYSA-N,,,P05771,PROTEIN KINASE C BETA,PRKCB,,,15149684.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of protein kinase C-betaII at 10 uM,"3-(7-Azaindolyl)-4-arylmaleimides as potent, selective inhibitors of glycogen synthase kinase-3.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2623358,CHEMBL1984363,MADCXGNPDBWPLM-UHFFFAOYSA-N,,,P06493,CYCLIN-DEPENDENT KINASE 1,CDK1,,,,KI,=,3981.07,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC2,PUBCHEM BIOASSAY DATA SET,,DATASET,
4091434,CHEMBL1173260,SFFLHOMUFWFHRI-UHFFFAOYSA-N,,,P05093,CYTOCHROME P450 17A1,CYP17A1,,,20684610.0,IC50,=,186.0,NM,,,,,,,,,,,,,,Inhibition of human CYP17 expressed in Escherichia coli,Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer.,J. Med. Chem.,PUBLICATION,
555391,CHEMBL431333,CHKABOTZDQWHMF-UHFFFAOYSA-N,,,P35354,CYCLOOXYGENASE-2,PTGS2,,,15026050.0,INHIBITION,=,64.0,%,,cell_based,,,,,,,,,,,,In vitro inhibitory activity against human recombinant prostaglandin G/H synthase 2 (COX-2) at 10 uM expressed in sf-9 cells infected with baculovirus,"Methanesulfonamide group at position-4 of the C-5-phenyl ring of 1,5-diarylpyrazole affords a potent class of cyclooxygenase-2 (COX-2) inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5401165,CHEMBL283097,YLGGQMUYDSKQIG-UHFFFAOYSA-N,,,P00915,CARBONIC ANHYDRASE I,CA1,,,14971907.0,KI,=,17650.0,NM,,,,,,,,,,,,,,Inhibition of cloned human cytosolic isozyme Carbonic anhydrase I,Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.,J. Med. Chem.,PUBLICATION,
2717879,CHEMBL541401,MKUURCYBUTWIJT-UHFFFAOYSA-N,,,Q16659,MITOGEN-ACTIVATED PROTEIN KINASE 6,MAPK6,,,18077363.0,THERMAL MELTING CHANGE,=,0.7,DEGREES C,,,,,,,,,,,,,,Delta TM value showing the stabilisation of ERK3 produced by compound binding,A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
555297,CHEMBL1584327,CHJNWOMSFMONSK-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2599805,CHEMBL8488,LXJSJIXZOAMHTG-UHFFFAOYSA-N,8-(P-SULFOPHENYL)THIOPHYLLINE,,P25099,ADENOSINE A1 RECEPTOR,,,,8410976.0,KI,=,1000.0,NM,,,,,,,,,,,,,,Binding affinity for adenosine A1 receptor from rat brain membranes using [3H]PIA as radioligand,Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors.,J. Med. Chem.,PUBLICATION,
2189904,CHEMBL1543632,KEQFTVQCIQJIQW-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2854102,CHEMBL1425462,MZOINBOXULCRCF-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4197492,CHEMBL2218934,SQWZFLMPDUSYGV-UXBLZVDNSA-N,,,P21802,FIBROBLAST GROWTH FACTOR RECEPTOR 2,FGFR2,wild_type,,23398362.0,ACTIVITY,=,98.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,90.0,uM,"Millipore: Percentage of residual kinase activity of FGFR2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3631780,CHEMBL1360269,QHIPQNVMPVSFGX-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5627450,CHEMBL1367112,ZJTGPKNBBXBLRC-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,398.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4789056,CHEMBL348443,VXCUALOQISCVQB-UHFFFAOYSA-N,,,P00743,COAGULATION FACTOR X,,,,9876114.0,KI,=,42000.0,NM,,,,,,,,,,,,,,Inhibitory activity against bovine coagulation factor X expressed as dissociation constant,"Structural and functional analyses of benzamidine-based inhibitors in complex with trypsin: implications for the inhibition of factor Xa, tPA, and urokinase.",J. Med. Chem.,PUBLICATION,
2088227,CHEMBL3212550,JTQNHNYLFZVFPQ-GIJQJNRQSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1374906,CHEMBL210032,GTMGQYXCPKUZAD-UHFFFAOYSA-N,,,Q9HBH9,MAP KINASE SIGNAL-INTEGRATING KINASE 2,MKNK2,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MKNK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
2032984,CHEMBL1723826,JNPOMGJVVCGLSY-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2711712,CHEMBL3261903,MKAKYVNCTBFMFV-UHFFFAOYSA-N,,,P16257,PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR,,,,24580635.0,KI,=,719.0,NM,,,,,,,,,,,,,,Displacement of [3H]PK11195 from TSPO in rat kidney mitochondrial membranes,Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors.,J. Med. Chem.,PUBLICATION,
3698877,CHEMBL1864648,QOPPELYBPTZXGT-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5570450,CHEMBL514730,ZDNTVQRVHFQZNJ-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,19053752.0,KS,=,1280.0,NM,,,,,,,,,,,,,,Binding affinity to CYP2C9 assessed as spectral dissociation constant,Cytochrome P450 2C9 type II binding studies on quinoline-4-carboxamide analogues.,J. Med. Chem.,PUBLICATION,
980615,CHEMBL34259,FBOZXECLQNJBKD-ZDUSSCGKSA-N,METHOTREXATE,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,27535.7,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1999220,CHEMBL1543535,JJWGGVNWXYAHRI-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
152853,CHEMBL1471043,APFFWYUUHAUDLW-DHZHZOJOSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4676098,CHEMBL3648489,VKQZQIDNZZTHCQ-UHFFFAOYSA-N,,,P01042,KININOGEN-1,KNG1,,,,IC50,=,0.2,NM,,,,,,,,,,,,,,BindingDB_Patents: Calcium Mobilization Assay. Calcium mobilization assay using Bradykinin-1 receptor.,Aryl-benzocycloalkyl amide derivatives,,PATENT,
3012212,CHEMBL80713,NQVIIUBWMBHLOZ-UHFFFAOYSA-N,,,Q15139,PROTEIN KINASE C MU,PRKD1,wild_type,,22037377.0,ACTIVITY,=,92.59647178,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,GLYCOGEN ,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3727282,CHEMBL303687,QRNLICFNSFQHBO-FOKLQQMPSA-N,GW829877X,,P29320,EPHRIN TYPE-A RECEPTOR 3,EPHA3,,,,INHIBITION,=,3.46,%,,,,,,,,,,,,,,GSK_PKIS: EPHA3 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2980022,CHEMBL28607,NNGCXJPRHBHODU-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,10098669.0,KI,>,1500.0,NM,,cell_based,,,,,CHO,,,,,,,Ability to displace [3H]spiperone from cloned human dopamine D2 receptor stably expressed in CHO cells,Synthesis and sar of 2- and 3-substituted 7-azaindoles as potential dopamine D4 ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3891364,CHEMBL1389324,RJASYARWPWIJED-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2915993,CHEMBL38380,NGOGFTYYXHNFQH-UHFFFAOYSA-N,FASUDIL,,Q9NR20,DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 4,DYRK4,wild_type,,22037377.0,ACTIVITY,=,97.92161283,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,CASEIN ,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
4739740,CHEMBL3648167,VRQOXMOCYHOPGD-UHFFFAOYSA-N,,,P01275,GLUCAGON,GCG,,,,KI,=,25.7,NM,,,,,,,,,,,,,,BindingDB_Patents: Glucagon SPA Assay. The Glucagon SPA assay is used to determine the ability of test compounds to block the binding of glucagon-cex to the glucagon receptors.,Glucagon receptor modulators,,PATENT,
4043154,CHEMBL280888,RZTHAJGTOALPFX-UHFFFAOYSA-N,,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,12646033.0,KI,=,224.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]- MRE 308F20 binding from human Adenosine A3 receptor expressed in CHO cells,"Design, synthesis, and biological evaluation of C9- and C2-substituted pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as new A2A and A3 adenosine receptors antagonists.",J. Med. Chem.,PUBLICATION,
4130349,CHEMBL1469052,SJMOFJCSARDYDW-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5651562,CHEMBL1597736,ZMNQQLUVQRJHRI-UHFFFAOYSA-N,,,P9WHJ3,PROTEIN RECA,,,,,EC50,>,380000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2097, AID2223, AID489010, AID492950]",PUBCHEM BIOASSAY DATA SET,,DATASET,
917796,CHEMBL1318116,DUYHGAPJNBUILH-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,16944.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5243360,CHEMBL902,XUFQPHANEAPEMJ-UHFFFAOYSA-N,FAMOTIDINE,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,,KI,,,,,,,,,,HEK293,,,,,,,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DrugMatrix in vitro pharmacology data,,DATASET,
4981316,CHEMBL1487310,WRZJOBREMUDSSV-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
464753,CHEMBL1402286,BXMFBVSLAAZQII-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1584.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1421767,CHEMBL1462300,GYSQGUHYYBYHEM-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4937683,CHEMBL1425508,WNCXCNZQDZMWGW-UHFFFAOYSA-N,,,Q9NXA8,"NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5, MITOCHONDRIAL",SIRT5,,,,AC50,,22110.0,NM,,biochemical,,,,,,,,,,,,PubChem BioAssay. MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_Dose_CherryPick_Activity_Set5.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5492051,CHEMBL1708022,YVJMAMMDKUHGQD-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,4983.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for inhibitors of Vif-A3F interactions: Cherry picks counterscreen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2581344,CHEMBL1564192,LVFDFRKDGAKIEZ-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1489057,CHEMBL1393617,HFPSVKHYDRNUPJ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1870856,CHEMBL382337,IVPKKLVYDLVEIX-UHFFFAOYSA-N,,,P41594,METABOTROPIC GLUTAMATE RECEPTOR 5,GRM5,,,16380255.0,IC50,=,3100.0,NM,,,,,,,,,,,,,,Inhibition of glutamate-induced calcium influx in human mGluR5d by FLIPR,Phenyl ureas of creatinine as mGluR5 antagonists. A structure-activity relationship study of fenobam analogues.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2907955,CHEMBL1305655,NFRZLVDOMKNAJV-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5752526,CHEMBL3325868,ZXQFFNQELPCOLJ-CYVYTNFQSA-N,,,P00921,CARBONIC ANHYDRASE II,,,,25147151.0,KI,=,1490.0,NM,,,,,,,,,,,,,,Inhibition of bovine erythrocyte carbonic anhydrase 2 using 4-nitrophenyl acetate substrate by photometric assay,Sulfamates of methyl triterpenoates are effective and competitive inhibitors of carbonic anhydrase II.,Eur. J. Med. Chem.,PUBLICATION,
4039174,CHEMBL1502871,RZIKUIXNAKQGGU-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,1412.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
504474,CHEMBL1303880,CBWAMGMAFZDXKO-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,21331.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4902758,CHEMBL3668732,WJBLVIOZBZQDOO-ZMYBRWDISA-N,,,P00746,COMPLEMENT FACTOR D,CFD,,,,IC50,=,417.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Assay. Recombinant human factor D (expressed in E. coli and purified using standard methods) at 10 nM concentration is incubated with test compound at various concentrations for 1 hour at room temperature in 0.1 M Hepes buffer, pH 7.5, containing 1 mM MgCl2, 1 M NaCl and 0.05% CHAPS. A synthetic substrate Z-Lys-thiobenzyl and 2,4-dinitrobenzenesulfonyl-fluoresceine are added to final concentrations of 200 µM and 25 µM, respectively. The increase in fluorescence is recorded at excitation of 485 nm and emission at 535 nm in a microplate spectrofluorimeter. IC50 values are calculated from percentage of inhibition of complement factor D-activity as a function of test compound concentration.",Complement pathway modulators and uses thereof,,PATENT,
4746823,CHEMBL2324860,VSLLFAMBTCCKME-UHFFFAOYSA-N,,,P14920,D-AMINO-ACID OXIDASE,DAO,,,23391306.0,IC50,>,1000000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant N-terminal His-tagged DAO expressed in Escherichia coli BL21(DE3) using D-serine as substrate by colorimetric assay,Identification of novel D-amino acid oxidase inhibitors by in silico screening and their functional characterization in vitro.,J. Med. Chem.,PUBLICATION,
1469885,CHEMBL1301322,HDVUAGRUGJCLIM-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
4646566,CHEMBL1575953,VHFZTJUAHHMLNF-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1388598,CHEMBL1744235,GUYUBZLIIYAUTQ-BTJKTKAUSA-N,,,P04818,THYMIDYLATE SYNTHASE,TYMS,,,1542093.0,KIS,=,20.0,NM,,,,,,,,,,,,,,Inhibitory activity against thymidylate synthase from human,Crystal-structure-based design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthase.,J. Med. Chem.,PUBLICATION,
4941540,CHEMBL1915438,WNOHFJIMKSDPHP-UHFFFAOYSA-N,,,Q9NWZ3,INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4,IRAK4,wild_type,,21982499.0,INHIBITION,=,88.0,%,inhibition,biochemical,,,competitive_inhibitor,radiometry,,0.5,UM,,,,,Inhibition of human recombinant IRAK4 at 0.5 uM by radiometric filter-binding assay,"7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3966499,CHEMBL3197870,RRFFYTHKGKKIJK-GIDUJCDVSA-N,,,Q27686,PYRUVATE KINASE,,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3262317,CHEMBL1725618,OSMQSYGTMQDQRQ-UHFFFAOYSA-N,,,Q9HC97,G-PROTEIN COUPLED RECEPTOR 35,GPR35,,,,EC50,>,32000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR analysis of Agonists of the GPR35 Receptor using an Image-Based Assay - Set 4. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2013, AID2026]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5788820,CHEMBL3809876,,,,Q92793,CREB-BINDING PROTEIN,CREBBP,,,26982797.0,Delta Tm,=,3.3,DEGREES C,,,,,,,,,,,,,,Binding affinity to CBP bromodomain (unknown origin) assessed as shift in melting temperature at 100 uM by thermal shift assay,"The ""Gatekeeper"" Residue Influences the Mode of Binding of Acetyl Indoles to Bromodomains.",J. Med. Chem.,PUBLICATION,
86801,CHEMBL122709,AHPYFQGQOJASKP-UHFFFAOYSA-N,,,P56560,MONOAMINE OXIDASE B,,,,8809158.0,RATIO,=,790.0,,,,,,,,,,,,,,,Ratio of Kcat and KM against monoamine oxidase B (MAO-B) from beef liver was calculated,"Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.",J. Med. Chem.,PUBLICATION,
881594,CHEMBL1171822,DQVOWUXKZUVAOF-UHFFFAOYSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,20627597.0,IC50,=,19320.0,NM,,cell_based,,,,,Sf9,,,,,,,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents.,Bioorg. Med. Chem.,PUBLICATION,
4167128,CHEMBL1373751,SNRFOGLNNUGYKT-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4606041,CHEMBL1202046,VCVLQEYNUAPQOU-UHFFFAOYSA-N,,,P20309,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,,,2153827.0,ACTIVITY,=,8.0,%,,cell_based,,,,,SK-N-SH,,,,,,,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,PUBLICATION,
2763599,CHEMBL1573910,MPNPNWNKSXTRFL-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3640245,CHEMBL1544136,QIFHZCHUACPGJA-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3700196,CHEMBL1651838,QOTZMNSNGYSYQL-UHFFFAOYSA-N,"3,4-DICHLOROBENZYLPHOSPHONIC ACID",,P45568,1-DEOXYXYLULOSE-5-PHOSPHATE REDUCTOISOMERASE,,,,21379374.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of Escherichia coli DXR,Structures of 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase/Lipophilic Phosphonate Complexes.,ACS Med. Chem. Lett.,PUBLICATION,
2099202,CHEMBL1311971,JUUWNIIXPHIWON-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1360607,CHEMBL354259,GRUCVBWUZVLLAP-ZHACJKMWSA-N,,,"P10980, P08911, P08485, P08482, P08483",MUSCARINIC ACETYLCHOLINE RECEPTOR,,,,,IC50,=,88.0,NM,,,,,,,,,,,,,,Compound was evaluated for inhibition of [3H]cis-methyldioxolane binding to label agonist sites (RCMD) in rat neocortex,,Bioorg. Med. Chem. Lett.,PUBLICATION,
2158023,CHEMBL1445885,KBDOKTJKCAHONB-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5555535,CHEMBL1324028,ZBYPBXPZJKZFIP-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,354.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1031977,CHEMBL480615,FHITVFDYWLZSRT-UHFFFAOYSA-N,,,P09874,POLY [ADP-RIBOSE] POLYMERASE-1,PARP1,,,19125579.0,IC50,=,274.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant PARP1,"Design, synthesis, and cytoprotective effect of 2-aminothiazole analogues as potent poly(ADP-ribose) polymerase-1 inhibitors.",J. Med. Chem.,PUBLICATION,
2352885,CHEMBL3686302,KWAXDDHRMSTKBE-PFELRWOZSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,,KI,=,2.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. HEK293 cells stably expressing human CB2 receptors were grown until a confluent monolayer was formed. Briefly, the cells were harvested and homogenized in TE buffer (50 mM Tris-HCl, 1 mM MgCl2, and 1 mM EDTA) using a polytron for 2X10 second bursts in the presence of protease inhibitors, followed by centrifugation at 45,000 ug for 20 minutes. The final membrane pellet was re-homogenized in storage buffer (50 mM Tris-HCl, 1 mM MgCl2, and 1 mM EDTA and 10% sucrose) and frozen at -78 C. until used. Saturation binding reactions were initiated by the addition of membrane preparation (protein concentration of 5 ug/well for human CB2) into wells of a deep well plate containing [3H]CP 55,940 (120 Ci/mmol, a nonselective CB agonist commercially available from Tocris) in assay buffer (50 mM Tris, 2.5 mM EDTA, 5 mM MgCl2, and 0.5 mg/mL fatty acid free BSA, pH 7.4). After 90 min incubation at 30 C., binding reaction was terminated by the addition of 300 uL/well of cold assay buffer.",Compounds as cannabinoid receptor ligands,,PATENT,
4171085,CHEMBL1546034,SOCZTSTYAHRSNO-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4207252,CHEMBL1430778,SRVIFDUIJBULOP-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,177827.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation of Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) [Related pubchem assays: 1768, 2076, 1766 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3932714,CHEMBL2372256,RNOUTIRQWZWSHX-RMCMQRDFSA-N,,,P06756,VITRONECTIN RECEPTOR ALPHA,ITGAV,,,19113865.0,IC50,=,85.45,NM,,cell_based,,,,,,,,,,,,Displacement of [125I][Tyr4]BBN form integrin alphaVbeta3 receptor in human PC3 cells,Dual integrin and gastrin-releasing peptide receptor targeted tumor imaging using 18F-labeled PEGylated RGD-bombesin heterodimer 18F-FB-PEG3-Glu-RGD-BBN.,J. Med. Chem.,PUBLICATION,
4113849,CHEMBL1908396,SHPFDGWALWEPGS-UHFFFAOYSA-N,KI-20227,,Q8TD19,SERINE/THREONINE-PROTEIN KINASE NEK9,NEK9,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for NEK9 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
1067260,CHEMBL3660593,FLGSYQDCLVWROB-UHFFFAOYSA-N,,,Q9QYJ6,"CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE 10A",,,,,IC50,=,3.42,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Inhibition Assay. An IMAP TR-FRET assay was used to analyze the enzyme activity (Molecular Devices Corp., Sunnyvale Calif.). 5 µL of serial diluted PDE10A (BPS Bioscience, San Diego, Calif.) or tissue homogenate was incubated with equal volumes of diluted fluorescein labeled cAMP or cGMP for 60 min in 384-well polystyrene assay plates (Corning, Corning, N.Y.) at room temperature. After incubation, the reaction was stopped by adding 60 µL of diluted binding reagents and was incubated for 3 hours to overnight at room temperature. The plates were read on an Envision (Perkin Elmer, Waltham, Mass.) for time resolved fluorescence resonance energy transfer.",Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors,,PATENT,
4041624,CHEMBL148110,RZPCRDAETGUIHA-HXUWFJFHSA-N,,,P28222,SEROTONIN 1B (5-HT1B) RECEPTOR,HTR1B,,,10585208.0,IC50,=,85.0,NM,,cell_based,,,,,CHO,,,,,,,Binding affinity at cloned human 5-hydroxytryptamine 1B receptor stably expressed in CHO cells by [3H]5-HT displacement.,3-[3-(Piperidin-1-yl)propyl]indoles as highly selective h5-HT(1D) receptor agonists.,J. Med. Chem.,PUBLICATION,
5301720,CHEMBL288316,YAIOVNRRAGKGDY-UHFFFAOYSA-N,,,O42275,ACETYLCHOLINESTERASE,,,,2913310.0,KOX,=,1.6,M-1 MIN-1,,,,,,,,,,,,,,Bimolecular reactivation rate constant,Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 2. Preparation and in vitro and in vivo evaluation of 1-(alkoxymethyl)-2-[(hydroxyimino)methyl]-3-methylimida zolium halides for reactivation of organophosphorus-inhibited acetylcholinesterases.,J. Med. Chem.,PUBLICATION,
4401770,CHEMBL1581594,UHEQYUBAQCODRU-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1329415,CHEMBL160148,GODQIDMDYBTWQN-UHFFFAOYSA-N,,,P12527,ARACHIDONATE 5-LIPOXYGENASE,,,,,IC50,=,2240.0,NM,,cell_based,,,,,RBL-2H3,,,,,,,In vitro inhibition of 5-lipoxygenase in RBL-2H3 (Rat basophilic leukemia) cells.,,Bioorg. Med. Chem. Lett.,PUBLICATION,
2698558,CHEMBL310340,MIMMUUIYLKITIG-UHFFFAOYSA-N,,,P45452,MATRIX METALLOPROTEINASE 13,MMP13,,,12773042.0,IC50,=,1.4,NM,,,,,,,,,,,,,,In vitro inhibitory activity against matrix metalloprotease-13.,"Synthesis and structure-activity relationship of N-substituted 4-arylsulfonylpiperidine-4-hydroxamic acids as novel, orally active matrix metalloproteinase inhibitors for the treatment of osteoarthritis.",J. Med. Chem.,PUBLICATION,
1049897,CHEMBL2325410,FJGPSDKLLKURQL-QFIPXVFZSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,23394180.0,INH,>,25000.0,NM,,,,,,,,,,,,,,Inhibition of CYP2D6 (unknown origin) by LC-MS/MS analysis,Optimized S-trityl-L-cysteine-based inhibitors of kinesin spindle protein with potent in vivo antitumor activity in lung cancer xenograft models.,J. Med. Chem.,PUBLICATION,
5672383,CHEMBL1457013,ZOUZBYNFKZTCNL-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3535190,CHEMBL121224,PWJHAOSBIAVUPS-SANMLTNESA-N,,,P00734,THROMBIN,F2,,,10091685.0,K ASS,=,9.07,L M-1,,,,,,,,,,,,,,Binding affinity for human Prothrombin as apparent association constant (Kass),"Diamino benzo[b]thiophene derivatives as a novel class of active site directed thrombin inhibitors: 3. Enhancing activity by imposing conformational restriction in the C-4"" side chain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5391476,CHEMBL1502633,YKGCZCCWEDPNIP-UHFFFAOYSA-N,,,P54132,BLOOM SYNDROME PROTEIN,BLM,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
589487,CHEMBL1581364,CLEUGETVQSSVBO-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3268578,CHEMBL22167,OTDWDRRWRHNHTJ-UHFFFAOYSA-N,,,P34976,ANGIOTENSIN II TYPE 1A (AT-1A) RECEPTOR,,,,,PKB,=,7.5,,,,,,,,,,,,,,,In vitro inhibition of ATII induced contractions of the isolated rabbit aorta.,,Bioorg. Med. Chem. Lett.,PUBLICATION,
3090714,CHEMBL1972576,NZVDDFRUBIEKLV-UHFFFAOYSA-N,,,Q06187,TYROSINE-PROTEIN KINASE BTK,BTK,,,,KI,>,1258.93,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: BTK,PUBCHEM BIOASSAY DATA SET,,DATASET,
557915,CHEMBL1596620,CHQSGTNPKSMRNB-QPLCGJKRSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,15101.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4653356,CHEMBL289712,VHYNCEYTMNADJU-HVNZXBJASA-N,,,"P26010, P13612",INTEGRIN ALPHA-4/BETA-7,"ITGA4, ITGB7",,,12031329.0,IC50,=,99.5,NM,,,,,,,,,,,,,,Inhibition of alpha4-beta7 antigen with MAdCAM immunoglobulin,Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1486992,CHEMBL1789941,HFNKQEVNSGCOJV-OAHLLOKOSA-N,RUXOLITINIB,,Q9Y2H9,MICROTUBULE-ASSOCIATED SERINE/THREONINE-PROTEIN KINASE 1,MAST1,wild_type,,22037378.0,KD,=,520.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for MAST1 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
5455822,CHEMBL381473,YQXDRLYPDKTPAP-UHFFFAOYSA-N,,,P29275,ADENOSINE A2B RECEPTOR,ADORA2B,wild_type,,16392813.0,INHIBITION,=,5.0,%,inhibition,cell_based,binding,binding_reversible,competitive_inhibitor,radiometry,HeLa,0.1-1,uM,,,,,Displacement of [3H]DPCPX from recombinant human adenosine A2B receptor expressed in HeLa cells at 0.01 uM,"Design, synthesis, and structure-activity relationships of 1-,3-,8-, and 9-substituted-9-deazaxanthines at the human A2B adenosine receptor.",J. Med. Chem.,PUBLICATION,
357291,CHEMBL2283174,BLIMAHXYOZZLTM-RCCKNPSSSA-N,,,P35354,CYCLOOXYGENASE-2,PTGS2,,,,-LOG(RATIOIC50),=,-0.21100000000000002,,,,,,,,,,,,,,,Ratio of compound IC50 to celecoxib IC50 for Inhibition of COX2 (unknown origin),,Med Chem Res,PUBLICATION,
5480315,CHEMBL1304584,YTWOPTMZSPJZRV-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5231426,CHEMBL229337,XSTJYPVMOMXVNU-UHFFFAOYSA-N,,,O14842,FREE FATTY ACID RECEPTOR 1,FFAR1,,,17500511.0,ED50,=,1200.0,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at human GPR40 expressed in HEK293 cells assessed as effect on calcium flux,Synthesis and biological evaluation of 3-aryl-3-(4-phenoxy)-propionic acid as a novel series of G protein-coupled receptor 40 agonists.,J. Med. Chem.,PUBLICATION,
213489,CHEMBL191384,AVLYNJZZQYEFEA-XDJHFCHBSA-N,AS-601245,,O43781,DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REGULATED KINASE 3,DYRK3,wild_type,,22037377.0,ACTIVITY,=,103.23560309999999,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,CASEIN ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3240416,CHEMBL1556564,OQCUFYBTOAIEJT-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
2456320,CHEMBL2133796,LIEKUNYYPLIGRD-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2537386,CHEMBL1589778,LQOSQQKRWLQIQB-NTUHNPAUSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,10621.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4863084,CHEMBL1536010,WFBKPRSCLOHXMD-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2699837,CHEMBL1324,MIQPIUSUKVNLNT-UHFFFAOYSA-N,TOLCAPONE,,Q9BV57,"1,2-DIHYDROXY-3-KETO-5-METHYLTHIOPENTENE DIOXYGENASE",ADI1,,,27074629.0,FC,=,7.59,,,,,,,,,,,,,,,Binding affinity to ADL1 in human HepG2 assessed as intensity fold change of cumulated normalized intensity of protein between capture and competition assay at 100 uM after 1 hr in presence of active Tcp-CC-13 by differential competition capture compound mass spectrometry,Identification of Potential Off-target Toxicity Liabilities of Catechol-O-methyltransferase Inhibitors by Differential Competition Capture Compound Mass Spectrometry.,J. Med. Chem.,PUBLICATION,
4237555,CHEMBL270724,SVJQCVOKYJWUBC-OWOJBTEDSA-N,"3-(2,3,4,5-TETRABROMOPHENYL)ACRYLIC ACID",,Q9UEE5,SERINE/THREONINE-PROTEIN KINASE 17A,STK17A,wild_type,,23398362.0,ACTIVITY,=,39.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of STK17A at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3361121,CHEMBL1333848,PDMLLNQYMCCSSC-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4973900,CHEMBL853,WREGKURFCTUGRC-POYBYMJQSA-N,ZALCITABINE,,Q72547,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE,,,,7520081.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of HIV-1 reverse transcriptase; + = active,HIV-1 reverse transcriptase inhibitor design using artificial neural networks.,J. Med. Chem.,PUBLICATION,
314967,CHEMBL381976,BGUQWVMLZHLCFY-UHFFFAOYSA-N,,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,16300947.0,EFFICACY,=,115.0,%,,,,,,,,,,,,,,Effect on binding to ER in Ad5-wt-ER-infected HAECT1 cells by NF-kappaB luciferase reporter at 10 uM relative to estradiol,Substituted 4-hydroxyphenyl sulfonamides as pathway-selective estrogen receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1307744,CHEMBL152997,GLTVVRJGWNLKEM-UHFFFAOYSA-N,,,P19327,SEROTONIN 1A (5-HT1A) RECEPTOR,,,,14640559.0,KI,=,70.2,NM,,tissue,,,,,,,,,,,,Displacement of [3H]8-OH-DPAT from 5-hydroxytryptamine 1A receptor of rat hippocampus mambranes,Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.,J. Med. Chem.,PUBLICATION,
659442,CHEMBL2391481,CTGCJJGSKOQITO-UHFFFAOYSA-N,,,P05067,BETA AMYLOID A4 PROTEIN,APP,,,23685572.0,INHIBITION,=,29.5,%,,,,,,,,,,,,,,Inhibition of self-induced amyloid beta (1 to 42) (unknown origin) aggregation at 20 uM after 46 to 48 hrs by thioflavin T-based fluorometric assay,"Design, synthesis and evaluation of novel tacrine-coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer's disease.",Eur. J. Med. Chem.,PUBLICATION,
1543703,CHEMBL1433682,HLDFMGJMWVMRNX-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5742786,CHEMBL1964407,ZWPCTBYNLWBREY-CSKARUKUSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
330606,CHEMBL428690,BIIVYFLTOXDAOV-YVEFUNNKSA-N,ALVOCIDIB,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for ABL1(E255K) kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
813376,CHEMBL167810,DJTWCUVOEIDFJZ-UHFFFAOYSA-N,,,"P21397, P27338",MONOAMINE OXIDASE,"MAOA, MAOB",,,3127589.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Monoamine oxidase activity measured at 0 min of incubation at 1 uM concentration,Inhibition of copper-dependent amine oxidases by some hydrazides of pyrrol-1-ylbenzoic and pyrrol-1-ylphenylacetic acids.,J. Med. Chem.,PUBLICATION,
2478154,CHEMBL1536540,LKQJINYEHSDHIK-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4367229,CHEMBL1528373,UDFMLCREIMSEIU-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5677766,CHEMBL1330087,ZPHKIJHPMZCGOP-MQGQQMBBSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2515815,CHEMBL236664,LOJORHPOXAEPAJ-UHFFFAOYSA-N,,,Q03181,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA,PPARD,,,18029178.0,EC50,=,38.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human PPARdelta expressed in CV1 cells by receptor transactivation assay,Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
796543,CHEMBL3211423,DHYOXIWFGKAZBE-WOJGMQOQSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2129670,CHEMBL2335047,JYAROLONGLXUOT-QFIPXVFZSA-N,,,Q92633,LYSOPHOSPHATIDIC ACID RECEPTOR EDG-2,LPAR1,,,23395664.0,EC50,=,10.23,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at human LPA1 receptor transfected in HEK293 cells after 1 hr by TGFalpha shedding assay,Phosphorothioate analogs of sn-2 radyl lysophosphatidic acid (LPA): metabolically stabilized LPA receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1947246,CHEMBL3683250,JDTSMWBMEDXGCW-UHFFFAOYSA-N,,,Q15858,SODIUM CHANNEL PROTEIN TYPE IX ALPHA SUBUNIT,SCN9A,,,,IC50,=,220.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: PatchExpress (PX) Assay. 293 cells stably transfected with human Navl .7 were recorded in whole cell voltage clamp mode with the PatchXpress automated electrophysiology system (Molecular Devices, LLC, Sunnyvale, CA). Compound effects were measured on a partially inactivated state of the sodium channel. Cells were clamped to a holding potential yielding 20 to 50% inactivation. To elicit sodium current, channels were activated by pulsing to -10 mV for 20 msec. This voltage protocol was repeated at a rate of 0.1 Hz throughout the experiment. A single concentration of test compound was applied to cells for a duration of 3 minutes. Peak sodium current was measured at the end of the compound addition period to determine percent inhibition.",Sulfamide sodium channel inhibitors,,PATENT,
4012178,CHEMBL1355029,RWKFYFGGCAYHSC-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3704203,CHEMBL1520058,QPFZPXOEZDJIPK-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3021851,CHEMBL545114,NRXDJHNJORUIQM-UHFFFAOYSA-N,,,P47747,HISTAMINE H2 RECEPTOR,,,,7904648.0,INHIBITION,=,82.0,%,,,,,,,,,,,,,,H2 receptor antagonistic activity against histamine stimulated chronotropic response in isolated guinea pig right atrium at 1x10E-6 g/mL.,Studies on antiulcer drugs. 7. 2-Guanidino-4-pyridylthiazoles as histamine H2-receptor antagonists with potent gastroprotective effects against nonsteroidal antiinflammatory drug-induced injury.,J. Med. Chem.,PUBLICATION,
2389576,CHEMBL1410843,LAMHBMMHCLQIKD-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4365440,CHEMBL3421733,UCZWHTSRFTVJRI-QHCPKHFHSA-N,,,O60825,"6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2",PFKFB2,,,25849762.0,IC50,=,141.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human PFKFB2 using fructose 6 phosphate as substrate assessed as ADP generation after 1 hr by ADP Glo assay,Structure-Based Design of Potent and Selective Inhibitors of the Metabolic Kinase PFKFB3.,J. Med. Chem.,PUBLICATION,
2431240,CHEMBL400309,LFIBJUGNWDZWLQ-UHFFFAOYSA-N,,,Q07869,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA,PPARA,,,17601734.0,EC50,=,890.0,NM,,,,,,,,,,,,,,Agonist activity at PPARalpha by FRET assay,Indanylacetic acids as PPAR-delta activator insulin sensitizers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
376850,CHEMBL102339,BNJREURCIDOWSG-VWLOTQADSA-N,,,"P05556, P13612",INTEGRIN ALPHA-4/BETA-1,"ITGA4, ITGB1",,,11714601.0,IC50,=,550.0,NM,,cell_based,,,,,Jurkat,,,,,,,Inhibition of VCAM-1 binding to integrin alpha4-beta1 of Jurkat cells,Discovery and evaluation of piperidinyl carboxylic acid derivatives as potent alpha(4)beta(1) integrin antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
889067,CHEMBL1641746,DRNPXCOTCYRPEY-XUXIUFHCSA-N,,,Q6P7A9,ACIDIC ALPHA-GLUCOSIDASE,,,,21185187.0,IC50,=,840.0,NM,,,,,,,,,,,,,,Inhibition of Wistar rat small intestine maltase after 30 mins,"The synthesis and biological evaluation of 1-C-alkyl-l-arabinoiminofuranoses, a novel class of a-glucosidase inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5031546,CHEMBL3237275,WXJRFUCTFAICAK-UHFFFAOYSA-N,,,"Q62645, P35439",IONOTROPIC GLUTAMATE RECEPTOR NMDA 1/2D,,,,24512267.0,ACTIVITY,=,88.0,%,,cell_based,,,,,,,,,,,,Potentiation of rat recombinant GluN1/GluN2D expressed in Xenopus laevis oocytes assessed as increase in glutamate/glycine-induced current response at 30 uM by two-electrode voltage clamp technique relative to control,"Design, synthesis, and structure-activity relationship of a novel series of GluN2C-selective potentiators.",J. Med. Chem.,PUBLICATION,
5066789,CHEMBL579893,XBDBDGFELDTGFF-UHFFFAOYSA-N,TCMDC-140066,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,73.45,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4954596,CHEMBL1581349,WPAQUMQXNJZFBM-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3793816,CHEMBL215152,QYZOGCMHVIGURT-UHFFFAOYSA-N,AZD-1152-HQPA,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for BRAF(V600E) kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
5513683,CHEMBL400312,YXOZWAFCDLJIBZ-UHFFFAOYSA-N,,,Q8NER1,VANILLOID RECEPTOR,TRPV1,,,17892935.0,IC50,=,13.0,NM,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at human recombinant TRPV1 expressed in HEK293 cells assessed as inhibition of capsaicin-induced calcium by FLIPR method,Heteroaryl beta-tetralin ureas as novel antagonists of human TRPV1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2918528,CHEMBL66879,NGSWKAQJJWESNS-ZZXKWVIFSA-N,COUMARIC ACID,,O42713,TYROSINASE,,,,17287127.0,INHIBITION,=,8.87,%,,,,,,,,,,,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.041 mM,Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.,Bioorg. Med. Chem.,PUBLICATION,
5243008,CHEMBL1596811,XUEPYELDAHBGCR-UHFFFAOYSA-N,,,P10828,THYROID HORMONE RECEPTOR BETA-1,THRB,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1129671,CHEMBL1361588,FSCBVUHJGJZAGV-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4382171,CHEMBL1997597,UEZPPFDNXOFISI-UHFFFAOYSA-N,,,P49137,MAP KINASE-ACTIVATED PROTEIN KINASE 2,MAPKAPK2,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPKAPK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
5337284,CHEMBL1527850,YECYAUDYCWFTQA-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5802408,CHEMBL3741164,,,,Q12809,HERG,KCNH2,,,26519929.0,Activity,=,65.0,%,,,,,,,,,,,,,,Allosteric modulation of [3H]-dofetilide binding at Kv11.1 channel (unknown origin) expressed in HEK293 cells at 10 uM after 6 mins by scintillation spectrometer analysis relative to control,Synthesis and biological evaluation of negative allosteric modulators of the Kv11.1(hERG) channel.,Eur. J. Med. Chem.,PUBLICATION,
3898292,CHEMBL1554,RJURFGZVJUQBHK-IIXSONLDSA-N,DACTINOMYCIN,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,25.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of androgen receptor signaling. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2242474,CHEMBL1794066,KKMDOYLDYOJWIA-UHFFFAOYSA-N,GSK-619487A,,P49760,DUAL SPECIFICITY PROTEIN KINASE CLK2,CLK2,,,,INHIBITION,=,2.21,%,,,,,,,,,,,,,,GSK_PKIS: CLK2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2489807,CHEMBL1869439,LLQCRTZROWMVOL-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5454449,CHEMBL1553380,YQSPWOSSTNJGEL-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,11995.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1511852,CHEMBL1895607,HIBLXINPOYYHFI-AATRIKPKSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
679265,CHEMBL257945,CVFPHGFCTDPKCP-UHFFFAOYSA-N,,,O00519,ANANDAMIDE AMIDOHYDROLASE,FAAH,,,18289847.0,IC50,=,77.0,NM,,,,,,,,,,,,,,Inhibition of human FAAH,Novel ketooxazole based inhibitors of fatty acid amide hydrolase (FAAH).,Bioorg. Med. Chem. Lett.,PUBLICATION,
4749312,CHEMBL1481748,VSPNBUXZOABUHJ-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
4887123,CHEMBL2163592,WHQXEGKAFBEKSG-UHFFFAOYSA-N,,,Q09472,HISTONE ACETYLTRANSFERASE P300,EP300,,,22746274.0,IC50,<,5000.0,NM,,cell_based,,,,,CH1,,,,,,,Inhibition of P300 CH1 domain-mediated HIF1 transcriptional activity in human LN229-V6R cells assessed as reduction in luciferase activity incubated for 1 hr under normoxia followed by 24 hrs under hypoxia by reporter gene assay,"Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.",J. Med. Chem.,PUBLICATION,
5762743,CHEMBL1513732,ZYTAWAQRVZVUPO-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,7980.5,NM,,cell_based,,,,,,,,,,,,PUBCHEM_BIOASSAY: FLuc inhibitory activity for the follow-up compounds in a cell-based assay to assess the activity of miR-21. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4783753,CHEMBL649,VWPOSFSPZNDTMJ-UCWKZMIHSA-N,NADOLOL,,P12530,ARACHIDONATE 15-LIPOXYGENASE,,,,,KI,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DrugMatrix in vitro pharmacology data,,DATASET,
912627,CHEMBL190320,DUHXHINAOXQPMB-UHFFFAOYSA-N,,,Q25270,BETA TUBULIN,,,,16005627.0,IC50,=,1300.0,NM,,,,,,,,,,,,,,Concentration required to inhibit tubulin polymerization at 10 uM,Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5254760,CHEMBL3264809,XVMGFGDLZKOSLZ-XZWHSSHBSA-N,,,P39898,PLASMEPSIN 1,,,,,IC50,=,7600.0,NM,,,,,,,,,,,,,,Inhibition of Plasmodium falciparum plasmepsin-1 using DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS as substrate preincubated for 30 mins by FRET assay,,ACS Med. Chem. Lett.,PUBLICATION,
2443999,CHEMBL1406111,LGTUPTATXMSKPT-KCWXNJEJSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4180876,CHEMBL1585388,SPGRBNPMEJKKSO-BJMVGYQFSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5792206,CHEMBL3735433,,,,Q6V1X1,DIPEPTIDYL PEPTIDASE VIII,DPP8,,,26546218.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of C-terminal His-tagged DPP8 (unknown origin) expressed in COS7 cells using H-Ala-Pro-pNA substrate preincubated for 15 mins,Structure-activity-relationship of amide and sulfonamide analogs of omarigliptin.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2373694,CHEMBL1341924,KYPNRQRUJSJAIR-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,517.4,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2787470,CHEMBL1533366,MSIIQGRNGMMSTR-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1622942,CHEMBL1443913,HUFKNJSBWFUDIY-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2587529,CHEMBL1394389,LVZBQXXNZKBSIW-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
966862,CHEMBL1289930,FAEKNHGJJLXASS-HNNXBMFYSA-N,,,Q9UBN7,HISTONE DEACETYLASE 6,HDAC6,,,20947351.0,INHIBITION,=,3.0,%,,,,,,,,,,,,,,Inhibition of recombinant human HDAC6 at 1 uM using Boc-Lys(Ac)-AMC as substrate by fluorometric analysis,Inhibitors selective for HDAC6 in enzymes and cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1696088,CHEMBL1329554,IBVDUESHTFZMLI-UHFFFAOYSA-N,,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1211152,CHEMBL300837,GBKRMFYJUBHTAK-UHFFFAOYSA-N,,,"P09483, P12390",NEURONAL ACETYLCHOLINE RECEPTOR; ALPHA4/BETA2,,,,15050621.0,KI,=,8.5,NM,,,,,,,,,,,,,,Inhibition of [3H]nicotine binding to Nicotinic acetylcholine receptor alpha4-beta2 from rat membranes,Epibatidine structure-activity relationships.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1541292,CHEMBL443745,HKYMJMGAGKAVQD-UHFFFAOYSA-N,,,P08246,LEUKOCYTE ELASTASE,ELANE,,,2299617.0,LOG KOFF,=,-4.13,,,,,,,,,,,,,,,Component deacylation rate constant for interaction with human leukocyte elastase,"Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastase.",J. Med. Chem.,PUBLICATION,
2143754,CHEMBL1350309,JZOWBXPOIZLFTM-UHFFFAOYSA-N,,,Q8IEK1,M1-FAMILY AMINOPEPTIDASE,,,,,IC50,=,51080.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Plasmodium falciparum M1- Family Alanyl Aminopeptidase (M1AAP). Inhibition of the rate of hydrolysis of fluorogenic peptide substrate (H-Leu-NHMec). Secondary screen (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1671772,CHEMBL495902,HZKJOEBOIMSMJP-UHFFFAOYSA-N,GW820759X,,P10721,STEM CELL GROWTH FACTOR RECEPTOR,KIT,,,,INHIBITION,=,-5.04,%,,,,,,,,,,,,,,GSK_PKIS: KIT mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
402050,CHEMBL2312290,BQICBFKSXAVIBF-UHFFFAOYSA-N,,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,23312472.0,IC50,=,910.0,NM,,,,,,,,,,,,,,Inhibition of ABL (unknown origin),"Highly selective 2,4-diaminopyrimidine-5-carboxamide inhibitors of Sky kinase.",Bioorg. Med. Chem. Lett.,PUBLICATION,
750981,CHEMBL40755,DCWVLTZRAKSVEY-UHFFFAOYSA-N,,,"Q8TCU5, Q14957, Q12879, O15399, Q13224, Q05586, O60391",GLUTAMATE [NMDA] RECEPTOR,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",,,12699379.0,IC50,=,19952623149.69,NM,,,,,,,,,,,,,,Compound was tested for inhibition of [3H]DCKA binding to N-methyl-D-aspartate glutamate receptor,CoMFA and homology-based models of the glycine binding site of N-methyl-d-aspartate receptor.,J. Med. Chem.,PUBLICATION,
2367140,CHEMBL1448090,KXUJMMQOOIHITJ-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5807556,CHEMBL3828621,,,,P61073,C-X-C CHEMOKINE RECEPTOR TYPE 4,CXCR4,,,27179215.0,Ratio,=,1000.0,,,,,,,,,,,,,,,"Potency index, ratio of AMD3100 EC to compound EC for displacement of biotinylated TN14003 from CXCR4 CXCL12 binding domain in human MDA-MB-231 cells",Symmetrical bis-tertiary amines as novel CXCR4 inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
4658924,CHEMBL1864153,VIQVIKWNYCRJHG-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5745996,CHEMBL170664,ZWYLMMDJESRZSO-DZUOILHNSA-N,,,P30553,CHOLECYSTOKININ B RECEPTOR,,,,,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of specific [3H]propionyl-CCK-8 binding to rat cerebral cortex membrane Cholecystokinin type B receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
3959169,CHEMBL1713668,RQKZPANBRYNUEY-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2842746,CHEMBL1569086,MYNKLGZVBMXIGU-UHFFFAOYSA-N,,,P54132,BLOOM SYNDROME PROTEIN,BLM,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3520242,CHEMBL3669336,PURKIMHKDQGDHR-BDPMCISCSA-N,,,P28845,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,HSD11B1,,,,IC50,=,551.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Inhibition Assay. In vitro inhibition of 11beta-HSD1 by test compounds is determined with HTRF (Homogeneous Time-Resolved Fluoresence) technology (cisbio international, France) detecting cortisol generated from cortisterone by human liver microsomes.",Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline,,PATENT,
2190926,CHEMBL1420582,KETUQBGPMYUQCB-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2596154,CHEMBL179085,LXBIFEVIBLOUGU-BXKVDMCESA-N,,,P04066,ALPHA-L-FUCOSIDASE I,FUCA1,,,15771446.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Percent inhibition of human alpha-fucosidase at 1000 uM,Biological properties of D- and L-1-deoxyazasugars.,J. Med. Chem.,PUBLICATION,
4977382,CHEMBL1493766,WRPQOSPYXMAFJL-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2866821,CHEMBL1321520,NBALGEYRZJMNRV-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,11582.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5281013,CHEMBL1354119,XYIVIMJCMQWMEE-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3242940,CHEMBL1559715,OQIXLVRBMMQBAP-UHFFFAOYSA-N,,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,,IC50,=,2919.45,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this dose response confirmation assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
4295946,CHEMBL224207,TVOBMQIZLQHIGU-UHFFFAOYSA-N,,,P10275,ANDROGEN RECEPTOR,AR,,,17439112.0,EC50,=,3.9,NM,,cell_based,,,,,,,,,,,,Agonist activity at human androgen receptor expressed in CV1 cells by transcriptional activation assay,"Novel series of potent, nonsteroidal, selective androgen receptor modulators based on 7H-[1,4]oxazino[3,2-g]quinolin-7-ones.",J. Med. Chem.,PUBLICATION,
4753560,CHEMBL2337846,VTCPKUWVGRDXTB-BFFKYOPISA-N,,,P28074,PROTEASOME MACROPAIN SUBUNIT MB1,PSMB5,,,23540790.0,IC50,=,19.1,NM,,,,,,,,,,,,,,Inhibition of chymotrypsin-like activity of human constitutive 20s proteasome beta-5 subunit using Suc-LLVY-AMC as substrate assessed as remaining activity incubated for 15 mins prior to substrate addition measured after 45 mins by fluorescence assay,Dimerized linear mimics of a natural cyclopeptide (TMC-95A) are potent noncovalent inhibitors of the eukaryotic 20S proteasome.,J. Med. Chem.,PUBLICATION,
3541010,CHEMBL2396663,PWZPBZQTTHOCIS-HHHXNRCGSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,25734236.0,EMAX,=,93.0,%,,cell_based,,,,,,,,,,,,Agonist activity at ARMS2-PK2-tagged human dopamine D2S receptor expressed in HEK293 cells co-expressing (EA)-tagged beta arrestin fusion protein assessed as recruitment of beta-arrestin-2 after 5 hrs by chemiluminescence assay relative to quinpirole,Molecular determinants of biased agonism at the dopamine d2 receptor.,J. Med. Chem.,PUBLICATION,
4812416,CHEMBL1894853,VZQJPCMZPHADBY-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
262341,CHEMBL3426797,BBCHHZHONQIODT-UHFFFAOYSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,25901762.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human delta opioid receptor-1 expressed in CHO cells after 90 mins by beta-arrestin recruitment assay,"Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the d-opioid receptor.",J. Med. Chem.,PUBLICATION,
2820006,CHEMBL1558287,MVWGWZINKBTODU-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5650568,CHEMBL538662,ZMKIAFJBCJTUFC-CUNXSJBXSA-N,,,"P26010, P13612",INTEGRIN ALPHA-4/BETA-7,"ITGA4, ITGB7",,,12031329.0,IC50,=,11.0,NM,,,,,,,,,,,,,,Inhibition of alpha4-beta7 integrin binding to MAdCAM immunoglobulin,Substituted tetrahydrofuroyl-1-phenylalanine derivatives as potent and specific VLA-4 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2665955,CHEMBL98719,MEVVOZVAMXABEA-UHFFFAOYSA-N,,,P14324,FARNESYL DIPHOSPHATE SYNTHASE,FDPS,,,18327899.0,KI,=,196.2,NM,,,,,,,,,,,,,,Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10 mins,Structure-activity relationships among the nitrogen containing bisphosphonates in clinical use and other analogues: time-dependent inhibition of human farnesyl pyrophosphate synthase.,J. Med. Chem.,PUBLICATION,
5004200,CHEMBL1329321,WUOGQGGQBXISOE-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,13459.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
559787,CHEMBL1421116,CHWPJTMCMGLFAG-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
850513,CHEMBL1200709,DNTGGZPQPQTDQF-XBXARRHUSA-N,CROTAMITON,,P08912,MUSCARINIC ACETYLCHOLINE RECEPTOR M5,CHRM5,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
2958980,CHEMBL460878,NLAGXJFULIZSCV-FQEVSTJZSA-N,,,P06737,LIVER GLYCOGEN PHOSPHORYLASE,PYGL,,,18554908.0,IC50,>,7500.0,NM,,cell_based,,,,,HepG2,,,,,,,Inhibition of human glycogen phosphorylase alpha in HepG2 cells assessed as inhibition of forskolin-induced glycogenolysis after 60 mins,Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1380638,CHEMBL570628,GUDGUBGIHMEFND-IPBHJUQPSA-N,,,P11388,DNA TOPOISOMERASE II ALPHA,TOP2A,,,19819135.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human DNA topoisomerase 2alpha-mediated relaxation of supercoiled pRYG DNA at 10 uM after 30 mins by SDS-PAGE,"Design, synthesis and bioevaluation of novel maleamic amino acid ester conjugates of 3,5-bisarylmethylene-4-piperidones as cytostatic agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4628812,CHEMBL219850,VFGZXEXGWRTGHY-MRXNPFEDSA-N,,,P53985,MONOCARBOXYLATE TRANSPORTER 1,SLC16A1,,,17228867.0,ACTIVITY,=,8.5,NM,,,,,,,,,,,,,,Potency at MCT1 after 3 hrs by SPA assay,Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion properties.,J. Med. Chem.,PUBLICATION,
4820991,CHEMBL2304126,WANZYUNNKZWPKD-GUTWEWJGSA-N,,,P14600,NEUROKININ 1 RECEPTOR,,,,2433443.0,IC50,=,12000.0,NM,,,,,,,,,,,,,,Histamine releasing activity of Substance P from isolated rat peritoneal mast cells,"Antagonists of substance P. Further modifications of substance P antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residues.",J. Med. Chem.,PUBLICATION,
5384049,CHEMBL433148,YJJZLIOHRPPHJA-YFQWSKTNSA-N,,,P56481,CHOLECYSTOKININ B RECEPTOR,,,,1635058.0,IC50,=,23.0,NM,,,,,,,,,,,,,,Evaluated for inhibition of cholecystokinin type B receptor by displacing [125I]-Bolton hunter CCK-8 radioligand in the mouse cerebral cortex,"Rationally designed ""dipeptoid"" analogues of CCK. Acid mimics of the potent and selective non-peptide CCK-B receptor antagonist CI-988.",J. Med. Chem.,PUBLICATION,
1678334,CHEMBL3199140,IAEAEBWWPMMKPU-KVKBGZNUSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4420469,CHEMBL417570,UJBVSJAOMNPPER-UHFFFAOYSA-N,,,P79400,SEROTONIN 1D (5-HT1D) RECEPTOR,,,,8642566.0,IC50,=,128824.96,NM,,,,,,,,,,,,,,Binding affinity for 5-hydroxytryptamine 1D receptor,Novel selective and partial agonists of 5-HT3 receptors. Part 1. Synthesis and biological evaluation of piperazinopyrrolothienopyrazines.,J. Med. Chem.,PUBLICATION,
4843484,CHEMBL1387688,WDAVIQBJLVXQGA-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,2059.6,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1303245,CHEMBL1905911,GLFNGHOUCVCEIZ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1497959,CHEMBL1539740,HGSUQLIMCIMDFH-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4891856,CHEMBL1417651,WIEARTGNBIZIBU-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
760560,CHEMBL1426673,DDWNXOMTWKGOOY-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1751508,CHEMBL3326937,IIGAHOVZPBLFRR-UHFFFAOYSA-N,,,Q9NYK1,TOLL-LIKE RECEPTOR 7,TLR7,,,25102141.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human TLR7 stably expressed in HEK293 cells co-expressing secreted alkaline phosphatase assessed as NF-kappaB induction by liquid handler-assisted reporter gene assay,Human Toll-like receptor 8-selective agonistic activities in 1-alkyl-1H-benzimidazol-2-amines.,J. Med. Chem.,PUBLICATION,
801521,CHEMBL1570492,DILXENIQRJYKLY-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,29934.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4459252,CHEMBL1605,UNJFKXSSGBWRBZ-BJCIPQKHSA-N,CEFTIBUTEN,,P46059,OLIGOPEPTIDE TRANSPORTER SMALL INTESTINE ISOFORM,SLC15A1,,,15567297.0,KI,=,340000.0,NM,,cell_based,,,,,Caco-2,,,,,,,TP_TRANSPORTER: inhibition of Gly-Sar uptake (pH6.0) in Caco-2 cells,Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.,Eur. J. Pharm. Biopharm.,PUBLICATION,
3553534,CHEMBL334885,PYLTWZXLMIVOSX-VWLOTQADSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,14643311.0,KI,>,300.0,NM,,,,,,,,,,,,,,Inhibitory activity against HIV-1 protease,Lysine sulfonamides as novel HIV-protease inhibitors: optimization of the Nepsilon-acyl-phenyl spacer.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3922839,CHEMBL3084966,RMJFXTVVOBTABN-RWWKDMOOSA-N,,,P08254,MATRIX METALLOPROTEINASE 3,MMP3,,,11266157.0,IC50,=,6150.0,NM,,,,,,,,,,,,,,Inhibition of Stromelysin (Matrix metalloprotease-3),Chemoenzymatic synthesis of functionalized cyclohexylglycines and alpha-methylcyclohexylglycines via Kazmaier-Claisen rearrangement.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4149367,CHEMBL3264818,SLTRBEQNZSGFTF-OAQYLSRUSA-N,,,O14842,FREE FATTY ACID RECEPTOR 1,FFAR1,,,,EMAX,=,72.0,%,,cell_based,,,,,,,,,,,,Agonist activity at GPR40 (unknown origin) expressed in CHO cells assessed as luminescence for 20 seconds interval by aequorin assay in presence of 0.01% human serum albumin relative to AM-1638,,ACS Med. Chem. Lett.,PUBLICATION,
3709924,CHEMBL1321202,QPWPXMRHOLVFLD-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5495524,CHEMBL368421,YVTDFKWJICCMTQ-SXNYVGIYSA-N,,,P41144,KAPPA OPIOID RECEPTOR,,,,11294396.0,KI,=,9.84,NM,,,,,,,,,,,,,,Binding affinity to Opioid receptor kappa 1 by using [3H]U-69593 as a radioligand from guinea pig,Selective delta-opioid receptor ligands: potential PET ligands based on naltrindole.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2761047,CHEMBL1546209,MPFLIDQWRONEAU-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
868830,CHEMBL1706335,DPMMBTHTYCBMDP-UHFFFAOYSA-N,,,P01375,TNF-ALPHA,TNF,,,,IC50,=,752.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR analysis of inhibitors of TNFa specific NF-kB induction revised. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1566, AID1575, AID1578, AID1579, AID1852, AID2469, AID2483, AID2485, AID2800, AID2801]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1709794,CHEMBL524554,IDINOJQYORVIHD-UHFFFAOYSA-N,TCMDC-138833,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,-0.82,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2864277,CHEMBL357916,NAUHGGACLDPEFJ-UHFFFAOYSA-N,,,"P19490, P19493, P19491, P19492","GLUTAMATE RECEPTOR IONOTROPIC, AMPA",,,,9871605.0,IC50,~,10000.0,NM,,,,,,,,,,,,,,In vitro binding assay for the displacement of [3H]AMPA from AMPA receptor,"5-Aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
904249,CHEMBL1535220,DTIBXSPFOVBNLI-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3401327,CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,P11509,CYTOCHROME P450 2A6,CYP2A6,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
5790210,CHEMBL3828433,,,,Q8NET8,TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 3,TRPV3,,,27077528.0,Kb,=,910.0,NM,,,,,,,,,,,,,,Antagonist activity at human TRPV3 expressed in recombinant HEK293 cells assessed as inhibition of 2-APB induced calcium flux by FLIPR analysis,Synthesis and Pharmacology of (Pyridin-2-yl)methanol Derivatives as Novel and Selective Transient Receptor Potential Vanilloid 3 Antagonists.,J. Med. Chem.,PUBLICATION,
1227246,CHEMBL1730547,GDABTFLMRDGWOL-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
201373,CHEMBL439904,AUHJXHCVECGTKR-DQNUUZSMSA-N,,,P50391,NEUROPEPTIDE Y RECEPTOR TYPE 4,NPY4R,,,,EC50,=,141.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human NPYY4 receptor expressed in HEK293 cells assessed as decrease in isoproterenol-induced cAMP level measured every 30 secs for 360 secs by FLIPR assay,,ACS Med. Chem. Lett.,PUBLICATION,
675550,CHEMBL176078,CUTRRQNUXLUQCJ-UHFFFAOYSA-N,,,P06213,INSULIN RECEPTOR,INSR,,,15771417.0,IC50,=,4000.0,NM,,,,,,,,,,,,,,Inhibition of beta IRK tyrosine kinase,"2-Hydroxy-4,6-diamino-[1,3,5]triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors.",J. Med. Chem.,PUBLICATION,
5373611,CHEMBL2218936,YIECEZWWJSWRJN-MYYYXRDXSA-N,,,P17948,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1,FLT1,wild_type,,23398362.0,ACTIVITY,=,13.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
164183,CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
5856581,CHEMBL3810103,,,,P02769,SERUM ALBUMIN,,,,27089212.0,Activity,=,72.31,%,,,,,,,,,,,,,,Binding affinity to bovine serum albumin assessed as hyperchromicity in absorption spectra up to 20 uM after 5 mins by UV-visible spectroscopic analysis relative to control,Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin.,Eur. J. Med. Chem.,PUBLICATION,
2613127,CHEMBL3647816,LYYZKRXKCSOYTL-BEYVXOHHSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,IC50,=,265.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: HTRF Assay. The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAK1 #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 mL of diluted compounds in DMSO were dispensed into the wells of a dry 384-well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser. Subsequent reagent additions employed an Agilent Bravo. Next, 18 uL of 1.11x enzyme and 1.11x substrate in 1x assay buffer (Invitrogen kinase buffer #PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at ambient temperature to allow compound binding to equilibrate. After equilibration, 2 uL of 10xATP in 1x assay buffer was added to initiate the kinase reaction.",Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors,,PATENT,
3952899,CHEMBL524057,RPRZAINAFJBVOV-UHFFFAOYSA-N,GW683768X,,P07948,TYROSINE-PROTEIN KINASE LYN,LYN,,,,INHIBITION,=,2.13,%,,,,,,,,,,,,,,GSK_PKIS: LYN A (splice variant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5385822,CHEMBL1485378,YJPVGMGQFGRONY-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2747650,CHEMBL1497251,MNPQZMBRVKSCDW-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
2515437,CHEMBL1881477,LOHYONMRKZZAAH-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4267016,CHEMBL1446517,SYTDSNGTXVTWCR-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5329575,CHEMBL1376013,YDEVHVNTRINAPT-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2623291,CHEMBL1984363,MADCXGNPDBWPLM-UHFFFAOYSA-N,,,Q13557,CAM KINASE II DELTA,CAMK2D,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CAMK2D,PUBCHEM BIOASSAY DATA SET,,DATASET,
2220000,CHEMBL1494116,KHXYRLIHCRAYSU-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2909189,CHEMBL1606819,NFVRGDRCCNEGBS-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3946307,CHEMBL1538297,ROZNJMOOTMTNFH-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
27470,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P29275,ADENOSINE A2B RECEPTOR,ADORA2B,,,15734651.0,EC50,=,1000.0,NM,,,,,,,,,,,,,,,,,,
4962044,CHEMBL3195775,WPXGPXDDUVBRQM-DWFDGKQZSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2089882,CHEMBL1587172,JTVJAMKZNXJIHP-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3316367,CHEMBL303579,OYHLRJGDELITAF-INIZCTEOSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,21192.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5782398,CHEMBL3806162,,,,Q9H3N8,HISTAMINE H4 RECEPTOR,HRH4,,,27007611.0,Intrinsic activity,=,0.32,,,,,,,,,,,,,,,Intrinsic activity at human histamine H4 receptor expressed in sf9 cell membrane co-expressing mammalian Galphai2 and Gbeta1gamma2 at 10 uM incubated for 90 mins by [35S]GTPgammaS binding assay relative to histamine,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
4510057,CHEMBL1557015,USSUECRVHBFCJW-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5231664,CHEMBL1720858,XSTZFRSITJRPEI-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5603912,CHEMBL1558410,ZHCMQUXVGLVNPJ-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,5173.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1975791,CHEMBL1987136,JHBLCZRYGJRHFA-XLWYYFMFSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2230415,CHEMBL1899978,KJDWBRQRAFJEIZ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1924508,CHEMBL489156,JBJYTZXCZDNOJW-JLHYYAGUSA-N,,,Q96SB4,SERINE/THREONINE-PROTEIN KINASE SRPK1,SRPK1,wild_type,,22037377.0,ACTIVITY,=,102.0012176,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,RS PEPTIDE,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
5572746,CHEMBL1363069,ZDSKHJDFGSYCHR-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5177158,CHEMBL1321154,XMVJITFPVVRMHC-UHFFFAOYSA-N,ROXARSONE,,Q9Y6L6,SOLUTE CARRIER ORGANIC ANION TRANSPORTER FAMILY MEMBER 1B1,SLCO1B1,,,23571415.0,INHIBITION,=,82.84,%,inhibition,cell_based,functional,uptake,competitive_inhibitor,fluorescence_polarization,CHO,10,uM,Fluorescein,=,10.0,uM,Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM,Structure-based identification of OATP1B1/3 inhibitors.,Mol. Pharmacol.,PUBLICATION,
4316325,CHEMBL3423403,TXVUROLPUDSHNS-IRUKTGRDSA-N,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,25969169.0,KD,=,37000.0,NM,,,,,,,,,,,,,,Displacement of [3H]-ZM241385 from adenosine A2 receptor (unknown origin) expressed in sheep striatum membranes after 1.5 hrs by scintillation counting analysis,A solid-phase combinatorial approach for indoloquinolizidine-peptides with high affinity at D(1) and D(2) dopamine receptors.,Eur. J. Med. Chem.,PUBLICATION,
5776517,CHEMBL3781224,,,,Q9Y2T6,G-PROTEIN COUPLED RECEPTOR 55,GPR55,,,26789378.0,EC50,=,29.3,NM,,,,,,,,,,,,,,Antagonist activity at recombinant human GPR55 expressed in HEK293 cells assessed as inhibition of LPI mediated receptor activation by measuring LPI EC50 after 5 mins by xCELLigence assay (Rvb = 1.6 to 4.1 nM),Identification of Novel GPR55 Modulators Using Cell-Impedance-Based Label-Free Technology.,J. Med. Chem.,PUBLICATION,
4524531,CHEMBL1330256,UUIBLEFZMRHXHR-OUKQBFOZSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2372277,CHEMBL123462,KYKFWXJBEABAMM-UHFFFAOYSA-N,,,P29275,ADENOSINE A2B RECEPTOR,ADORA2B,,,12166943.0,KI,=,6660.0,NM,,cell_based,,,,,,,,,,,,Inhibition of [3H]DPCPX binding to human Adenosine A2B receptor expressed in HEK cells; Range 3580-12400,"1,2,4-Triazolo[5,1-i]purine derivatives as highly potent and selective human adenosine A(3) receptor ligands.",J. Med. Chem.,PUBLICATION,
850374,CHEMBL1200709,DNTGGZPQPQTDQF-XBXARRHUSA-N,CROTAMITON,,P50052,ANGIOTENSIN II TYPE 2 (AT-2) RECEPTOR,AGTR2,,,,IC50,,,,,cell_based,,,,,CHO-K1,,,,,,,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),DrugMatrix in vitro pharmacology data,,DATASET,
928768,CHEMBL225963,DWFZBUWUXWZWKD-UHFFFAOYSA-N,PYRIDABEN,,C4YTQ8,ATP-DEPENDENT MOLECULAR CHAPERONE HSP82,,,,,EC50,>,160000.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Luminescence Cell-Based Secondary Assay to Identify Inhibitors of Hsp90. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1979, AID2007, AID434938]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2106329,CHEMBL3262916,JVOMBGDXAFKVNQ-UHFFFAOYSA-N,,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,24684213.0,IC50,=,6300.0,NM,,,,,,,,,,,,,,Inhibition of recombinant N-terminal His6-tagged human reticulocyte 12/15-lipoxygenase using arachidonic acid as substrate by UV-vis spectrometric analysis,Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.,J. Med. Chem.,PUBLICATION,
932435,CHEMBL1340446,DWOFIMUFCYMGPZ-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,6745.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
486010,CHEMBL1430113,BZTGYMVSCXQSQG-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2858990,CHEMBL1304181,NAEFYYSGQKULFI-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,1122.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
791347,CHEMBL1524986,DHJZPZSPKUWRMG-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5771290,CHEMBL1492297,ZZSCBMLJMLQWBJ-AATRIKPKSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1258933,CHEMBL1569403,GGOGASVIGCGHDI-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1014108,CHEMBL108,FFGPTBGBLSHEPO-UHFFFAOYSA-N,CARBAMAZEPINE,,P15823,ALPHA-1B ADRENERGIC RECEPTOR,,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DrugMatrix in vitro pharmacology data,,DATASET,
3020431,CHEMBL275724,NRSWDNMMJZYTGV-UHFFFAOYSA-N,SB-242718,,P06493,CYCLIN-DEPENDENT KINASE 1,CDK1,,,,INHIBITION,=,1.41,%,,,,,,,,,,,,,,GSK_PKIS: CDK1/cyclinB mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2389834,CHEMBL571271,LAMXJZBUJRLGFR-UHFFFAOYSA-N,,,Q14432,PHOSPHODIESTERASE 3A,PDE3A,,,19836860.0,INHIBITION,=,4.0,%,,,,,,,,,,,,,,Inhibition of human recombinant PDE3A at 50 uM by fluorescence polarization assay using cAMP as substrate,Discovery of colon tumor cell growth inhibitory agents through a combinatorial approach.,Eur. J. Med. Chem.,PUBLICATION,
5202098,CHEMBL1450244,XPQWMGWXYPBSTH-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5162995,CHEMBL1785003,XLIWJFSCQYQXAI-UHFFFAOYSA-N,SB-264866,,P49137,MAP KINASE-ACTIVATED PROTEIN KINASE 2,MAPKAPK2,,,,INHIBITION,=,-2.03,%,,,,,,,,,,,,,,GSK_PKIS: MAPKAPK2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2605742,CHEMBL457299,LYCAIKOWRPUZTN-UHFFFAOYSA-N,ETHYLENE GLYCOL,,P19838,NUCLEAR FACTOR NF-KAPPA-B P105 SUBUNIT,NFKB1,,,,POTENCY,,21300.8,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the NFkB signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3031507,CHEMBL295464,NTBVARLSFWGEMB-FLBADVGZSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,15027855.0,KI,=,1.6,NM,,,,,,,,,,,,,,Tested for inhibition of synthetic HIV-1 protease by using fluorometric assay,Countering cooperative effects in protease inhibitors using constrained beta-strand-mimicking templates in focused combinatorial libraries.,J. Med. Chem.,PUBLICATION,
4886282,CHEMBL1093846,WHPJOAUPIZDJNX-KPOIJUDDSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,20329799.0,EMAX,=,86.0,%,,cell_based,,,,,CHO,,,,,,,Agonist activity at human recombinant MC4 receptor expressed in CHO cells by cAMP responsive beta lactamase reporter gene assay relative to melanocortin 2,Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans.,J. Med. Chem.,PUBLICATION,
1074054,CHEMBL1569898,FMCDJFGRDIVKSU-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3368643,CHEMBL2022741,PEIFUGDCVSOBAT-UHFFFAOYSA-N,,,P36544,NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN ALPHA-7 SUBUNIT,CHRNA7,,,22503453.0,EC50,=,79.43,NM,,cell_based,,,,,,,,,,,,Agonist activity at human alpha7 nAChR expressed in GH4C1 cells by FLIPR assay,"The discovery of 2-fluoro-N-(3-fluoro-4-(5-((4-morpholinobutyl)amino)-1,3,4-oxadiazol-2-yl)phenyl)benzamide, a full agonist of the alpha-7 nicotinic acetylcholine receptor showing efficacy in the novel object recognition model of cognition enhancement.",Bioorg. Med. Chem. Lett.,PUBLICATION,
105097,CHEMBL1358743,AJTULIWKBMDPCJ-RJRNDHSQSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,398.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1450314,CHEMBL92461,HBWLNACPIFKNIP-UHFFFAOYSA-N,,,Q9P286,SERINE/THREONINE-PROTEIN KINASE PAK7,PAK7,wild_type,,22037377.0,ACTIVITY,=,78.1063255,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ZIPTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3417935,CHEMBL1415791,PJNNYTISODUAQG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5389064,CHEMBL1082685,YJYSIKYGGKRZBW-UHFFFAOYSA-N,,,P34998,CORTICOTROPIN RELEASING FACTOR RECEPTOR 1,CRHR1,,,20471832.0,ACTIVITY,,,,,cell_based,,,,,IMR-32,,,,,,,Antagonist activity at human CRF1 receptor expressed in human IMR-32 cells assessed as inhibition of CRF-stimulated cAMP production,"Discovery of 6-chloro-2-trifluoromethyl-7-aryl-7H-imidazo[1,2-a]imidazol-3-ylmethylamines, a novel class of corticotropin-releasing factor receptor type 1 (CRF1R) antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1065534,CHEMBL1417924,FLBICQWIIXGWJA-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1452424,CHEMBL1357143,HCASGLNFZLDXNN-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2154872,CHEMBL1300695,KASXQVKGTIOCGV-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3375629,CHEMBL1387378,PFBPXMWXDNQIIC-GOPRIXMCSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4926388,CHEMBL1359196,WLQXIXYLOXQXRX-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
591489,CHEMBL1407203,CLLDGZJVIZEVBU-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3285465,CHEMBL1894298,OUUSOYLQIIIYKP-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3971759,CHEMBL3652400,RRWIERVKMPBTBE-CVYDXHPNSA-N,,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,,IC50,=,12.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzymatic Assay. A peptide mobility shift assay was used to quantify the phosphorylation of the JAKtide (JAK2 and JAK3) or the IRS-1 peptide (JAK1 and Tyk2). Reactions were carried out in a 384-well plate (Matrical MP-101) in a 10 L total volume. Reaction mixtures contained 20 mM HEPES, pH 7.4, 10 mM magnesium chloride, 0.01% bovine serum albumin (BSA), 0.0005% Tween-20, ATP (4 M for JAK2 and JAK3, 40 M for JAK1 and 7 M for Tyk2)), 2% DMSO and 1 M peptide substrate (JAKtide for JAK2 and JAK3 and IRS-1 peptide for JAK1 and Tyk2). Compounds were diluted serially in 100% dimethyl sulfoxide and tested in an 11 point dose response in duplicate or quadruplicate (200 nl of compound/DMSO was added per 10 L reaction). The reactions were initiated by the addition of enzyme to the final concentration of 2 nM JAK2, 1 nM JAK3, 12 nM Tyk2 or 20 nM JAK1. The assay was run for 240 minutes for JAK1, 150 minutes for JAK2, 90 minutes for JAK3 and 70 minutes for Tyk2.","Pyrrolo[2,3-D]pyrimidine compounds",,PATENT,
5161106,CHEMBL1412584,XLFIDJOXRYHGGG-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2540272,CHEMBL1307794,LQZRMTPVIGRXRI-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1872676,CHEMBL1315904,IVUXZWYNNMABAD-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2032580,CHEMBL48358,JNOHYAULZURALP-UHFFFAOYSA-N,,,P04150,GLUCOCORTICOID RECEPTOR,NR3C1,wild_type,,8627601.0,KI,=,2781.0,NM,inhibition,cell_free,binding,binding_saturation,competitive_inhibitor,radiometry,,,,,,,,Binding affinity was determined for human glucocorticoid receptor(hGR).,Synthesis and biological activity of novel nonsteroidal progesterone receptor antagonists based on cyclocymopol monomethyl ether.,J. Med. Chem.,PUBLICATION,
542184,CHEMBL179702,CFUHKRLMDNFZED-NHCUHLMSSA-N,,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,15634000.0,KI,=,0.41,NM,,,,,,,,,,,,,,In vitro binding affinity was determined as displacement of [3H]N-R-methylhistamine from C6 cell membranes expressing human histamine H3 receptor,4-(2-[2-(2(R)-methylpyrrolidin-1-yl)ethyl]benzofuran-5-yl)benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention.,J. Med. Chem.,PUBLICATION,
576086,CHEMBL1509075,CJSRHKKCGJFMKE-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3114129,CHEMBL1375315,OCPDYWQXVYDNJK-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1339835,CHEMBL3198825,GPIWOEZJRYCGCX-LFYBBSHMSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4419477,CHEMBL1301342,UIYSWMPVFYORSM-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,13459.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3560185,CHEMBL1319601,PZGFEDYHJMLVGX-UHFFFAOYSA-N,,,P54132,BLOOM SYNDROME PROTEIN,BLM,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4736701,CHEMBL1401316,VRFGGUCITZBUFC-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5700064,CHEMBL3105201,ZRQYABBZGJNCMK-UHFFFAOYSA-N,,,P47900,PURINERGIC RECEPTOR P2Y1,P2RY1,,,24164581.0,IC50,=,18500.0,NM,,,,,,,,,,,,,,Antagonist activity at P2Y1 receptor in platelet-enriched human plasma assessed as 10 uM ADP-induced platelet aggregation preincubated for 1 min followed by ADP induction measured at 5 mins by aggregometric analysis,"Conformationally constrained ortho-anilino diaryl ureas: discovery of 1-(2-(1'-neopentylspiro[indoline-3,4'-piperidine]-1-yl)phenyl)-3-(4-(trifluoromethoxy)phenyl)urea, a potent, selective, and bioavailable P2Y1 antagonist.",J. Med. Chem.,PUBLICATION,
5334286,CHEMBL1567804,YDTKIHGCMPEERA-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1668415,CHEMBL1308557,HZCHKJSROOTQJN-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
822963,CHEMBL3215837,DKVJSNADPNDKRH-UHFFFAOYSA-N,,,P14842,SEROTONIN 2A (5-HT2A) RECEPTOR,,,,21601317.0,INHIBITION,=,45.0,%,,,,,,,,,,,,,,Displacement of [3H]ketanserin from 5HT2A receptor in rat cortex membrane at 10'-6 M by radioligand binding assay,"Synthesis and structural investigation of some pyrimido[5,4-c]quinolin-4(3H)-one derivatives with a long-chain arylpiperazine moiety as potent 5-HT(1A/2A) and 5-HT(7) receptor ligands.",Eur. J. Med. Chem.,PUBLICATION,
812990,CHEMBL490600,DJSWNINDPRRCLC-SFHVURJKSA-N,,,Q8TDS4,HYDROXYCARBOXYLIC ACID RECEPTOR 2,HCAR2,,,18752940.0,IC50,=,3300.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]nicotinic acid from human GPR109A receptor expressed in CHO cells,Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5390329,CHEMBL1470218,YKDDUTNHDBYTLW-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3662435,CHEMBL1334904,QKTMGIZLWUDFQZ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2409335,CHEMBL1079461,LCSARSYDEHXRBQ-UHFFFAOYSA-N,,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,19891474.0,PKB,=,7.2,,,cell_based,,,,,CHO,,,,,,,Binding affinity to human histamine H3 receptor expressed in CHO cells by FLIPR assay,"1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists.",J. Med. Chem.,PUBLICATION,
5638866,CHEMBL1589279,ZLAZENKFQYTDGL-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1384871,CHEMBL1520801,GUNDYOSMXWMGCV-UHFFFAOYSA-N,,,Q2TB90,PUTATIVE HEXOKINASE HKDC1,HKDC1,,,,IC50,>,80000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of inhibitors of hexokinase domain containing I (HKDC1) in the hexokinase 1 selectivity assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493160, AID493190]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1782486,CHEMBL218562,ILVFNAZMSMNXJG-RMKNXTFCSA-N,,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,wild_type,,22037377.0,ACTIVITY,=,107.737706,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,PEY + MN,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
5487607,CHEMBL1539621,YUUHGOOEBBHKMI-BQYQJAHWSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3993550,CHEMBL3649107,RUEIQQRBMMEJMQ-UHFFFAOYSA-N,,,O43613,OREXIN RECEPTOR 1,HCRTR1,,,,Ki,=,137.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Biological Assay. The in vitro affinity of the compounds for the human orexin-1 and orexin-2 receptors was determined by competitive radioligand binding using [3H]SB SB674042 (1-(5-(2-fluoro-phenyl)-2-methyl-thiazol-4-yl)-1-((S)-2-(5-phenyl-(1,3,4)oxadiazol-2-ylmethyl)-pyrrolidin-1-yl)-methanone) (Langmead et al., British Journal of Pharmacology 2004, 141:340-346) and [3H]EMPA (N-ethyl-2[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl acetamide) (Malherbe et al., British Journal of Pharmacology, 2009, 156(8), 1326-1341), respectively.  The in vitro functional antagonism of the compounds on the human orexin-1 and orexin-2 receptors was determined using fluorometric imaging plate reader (FLIPR) based calcium assays.","Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators",,PATENT,
4492508,CHEMBL1909385,URAIHJKKRZAQEB-UHFFFAOYSA-N,GW458787A,,Q9UBF8,PI4-KINASE BETA SUBUNIT,PI4KB,,,,INHIBITION,=,0.91,%,,,,,,,,,,,,,,GSK_PKIS: PI4K-beta mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5522768,CHEMBL434729,YYNPIMSTDPEJPS-UHFFFAOYSA-N,GW829906X,,Q7KZI7,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2,MARK2,,,,INHIBITION,=,1.89,%,,,,,,,,,,,,,,GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1022977,CHEMBL99067,FGHYDVABQZJIHA-UHFFFAOYSA-N,,,P23946,CHYMASE,CMA1,,,12467610.0,INHIBITORY ACTIVITY,=,27000.0,NM,,,,,,,,,,,,,,Inhibitory activity against serine protease chymase was determined,Identification of a stable chymase inhibitor using a pharmacophore-Based database search.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4395715,CHEMBL1314837,UGOLHUCQYDXTIW-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4868155,CHEMBL1721616,WFQQFZSIGAKECL-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5677625,CHEMBL1602292,ZPHBCOITRGMVGO-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4209629,CHEMBL251642,SSEBTPPFLLCUMN-CYBMUJFWSA-N,(R)-BUFURALOL,,P18090,BETA-1 ADRENERGIC RECEPTOR,,,,2866246.0,ED30,>,1000.0,UG KG-1,,,,,,,,,,,,,,Beta-1 adrenergic receptor agonist activity as increased heart rate by 30 beats/min in rats,Beta-adrenoceptor activity of the stereoisomers of the bufuralol alcohol and ketone metabolites.,J. Med. Chem.,PUBLICATION,
5410672,CHEMBL1589033,YMGGPJLYJPAEMX-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4190604,CHEMBL1982725,SQGVUSFOXWJNHK-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2965473,CHEMBL319440,NLTAOJSBWKLHME-UHFFFAOYSA-N,,,"P0AES4, P0AES6",DNA GYRASE,,,,8759628.0,ED50,>,5.0,MG.KG-1,,organism_based,,,,,,,,,,,,In vivo efficacy against Escherichia coli JUHL after oral administration,Synthesis and structure-activity relationships of 2-pyridones: a novel series of potent DNA gyrase inhibitors as antibacterial agents.,J. Med. Chem.,PUBLICATION,
1933137,CHEMBL397476,JCGVHNRXCIXGCT-UHFFFAOYSA-N,,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,17084080.0,KI,=,3.98,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [125I]iodosulpiride from human recombinant dopamine D3 receptor expressed in CHO cells,Studies towards the identification of a new generation of atypical antipsychotic agents.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2307448,CHEMBL1725279,KRIUNPBAQZGFQA-UHFFFAOYSA-N,SP-600125,,Q8TDX7,SERINE/THREONINE-PROTEIN KINASE NEK7,NEK7,,,17850214.0,ACTIVITY,=,112.0,%,activation,biochemical,functional,enzyme_activity,competitive_inhibitor,radiometry,,1,uM,ATP,=,20,uM,Percentage NEK7 activity remaining in the presence of 1uM inhibitor,The selectivity of protein kinase inhibitors: a further update.,Biochem. J.,PUBLICATION,
46928,CHEMBL1800248,ADGPHPSNLKLQDU-UHFFFAOYSA-N,,,Q9UKV0,HISTONE DEACETYLASE 9,HDAC9,,,21696956.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of recombinant HDAC9 assessed as inhibition of fluorogenic aminocoumarin release from substrate by trypsin-coupled biochemical assay,A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3219295,CHEMBL3192618,ONUDNVGCRRDQCZ-FOWTUZBSSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,13459.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2872080,CHEMBL1741990,NBQJKNSAKITVLO-VXPUYCOJSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5671467,CHEMBL1435525,ZOTGTJNCCPPJCY-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1872406,CHEMBL2140408,IVUGFMLRJOCGAS-UHFFFAOYSA-N,AMG-900,,Q08345,EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1,DDR1,,,29191878.0,KDAPP,=,110.34,NM,inhibition,cell_free,binding,binding_reversible,,label_free_technology,"K-562, COLO 205, MV-4-11, SK-N-BE(2)",3-30,NM-UM,,,,,LC-MS/MS BASED KINOBEADS COMPETITIVE PULL-DOWN ASSAY,THE TARGET LANDSCAPE OF CLINICAL KINASE DRUGS,SCIENCE,,
3339542,CHEMBL538,PAYRUJLWNCNPSJ-UHFFFAOYSA-N,ANILINE,,,Cytochrome P450 130,,,,19605350.0,KD,=,55200.0,NM,,,,,,,,,,,,,,,,,,
4582496,CHEMBL241975,VAKQBHALQXEEAG-UHFFFAOYSA-N,,,P11474,ESTROGEN-RELATED RECEPTOR ALPHA,ESRRA,,,21958216.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human ERRalpha ligand binding domain expressed in human 293FT cells coexpressing Gal4 DNA binding domain assessed as increased transcriptional activity at 10 uM after 24 hrs by dual luciferase reporter gene assay relative to control,"Identification of pyrido[1,2-a]pyrimidine-4-ones as new molecules improving the transcriptional functions of estrogen-related receptor a.",J. Med. Chem.,PUBLICATION,
2161395,CHEMBL3145383,KBMCQMGJQGUZHR-FMQUCBEESA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
4707633,CHEMBL812,VNYBTNPBYXSMOO-UHFFFAOYSA-M,PYRIDOSTIGMINE BROMIDE,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,3.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4246931,CHEMBL1720149,SWKFMLKEZUTIOY-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4259933,CHEMBL566534,SXYIRMFQILZOAM-HVNFFKDJSA-N,ARTEMETHER,,P21452,NEUROKININ 2 RECEPTOR,TACR2,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),DrugMatrix in vitro pharmacology data,,DATASET,
20707,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,,Glucose-1-phosphate thymidylyltransferase (RmlA),,,,23138692.0,IC50,=,10000.0,NM,,,,,,,,,,,,,,,,,,
3120368,CHEMBL1322748,ODHWVRVAHORMNP-QINSGFPZSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3924872,CHEMBL1320710,RMPUCWLQCSXYGC-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2811769,CHEMBL103667,MVCOAUNKQVWQHZ-UHFFFAOYSA-N,DORAMAPIMOD,,Q03181,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA,PPARD,,,,POTENCY,,11882.3,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2309944,CHEMBL629,KRMDCWKBEZIMAB-UHFFFAOYSA-N,AMITRIPTYLINE,,P30988,CALCITONIN RECEPTOR,CALCR,,,,IC50,,,,,,,,,,T47D,,,,,,,DRUGMATRIX: Calcitonin radioligand binding (ligand: [125I] Calcitonin (salmon)),DrugMatrix in vitro pharmacology data,,DATASET,
5789020,CHEMBL1351,,CARBOPLATIN,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,,KI,,,,,cell_based,,,,,Sf9,,,,,,,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),DrugMatrix in vitro pharmacology data,,DATASET,
3282102,CHEMBL1720243,OUOITKOJXGTRBR-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1933815,CHEMBL507249,JCJAEEODSKNKTC-MQMHXKEQSA-N,,,P24941,CYCLIN-DEPENDENT KINASE 2,CDK2,,,19327989.0,IC50,=,590.0,NM,,,,,,,,,,,,,,Inhibition of CDK2/cyclinA,Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1226433,CHEMBL1587500,GCYNSTIQWLSYFZ-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4205642,CHEMBL249282,SRROIPFGGDHJCJ-UHFFFAOYSA-N,,,P51817,SERINE/THREONINE-PROTEIN KINASE PRKX,PRKX,wild_type,,21336281.0,KI,<,1584.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
500301,CHEMBL1705040,CBJFCSYRIYLHSP-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,7307.8,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3353107,CHEMBL2376603,PCNBFKWGHGQLDN-UHFFFAOYSA-N,,,P10845,BOTULINUM NEUROTOXIN TYPE A,,,,23545109.0,KI,>,300000.0,NM,,,,,,,,,,,,,,Inhibition of Clostridium botulinum BoNT/A light chain (1 to 429 amino acid) using Abz-Thr-dArg-Ile-Asp-Glu-Ala-Asn-Gln-Arg-Ala-Thr-Lys-Nle-Lys(Dnp)-NH2 as substrate after 10 mins by FRET assay,Virtual medicinal chemistry: In silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2120996,CHEMBL3195383,JXAZPVQRTHQWHL-IPPBACCNSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1275735,CHEMBL1900012,GIEPRMIPFUOGHP-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5274159,CHEMBL234926,XXROGKLTLUQVRX-UHFFFAOYSA-N,ALLYL ALCOHOL,,P08913,ALPHA-2A ADRENERGIC RECEPTOR,ADRA2A,,,,KI,,,,,,,,,,Sf9,,,,,,,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DrugMatrix in vitro pharmacology data,,DATASET,
787555,CHEMBL120854,DGYJKQOJYXKULA-UHFFFAOYSA-N,,,Q9H3N8,HISTAMINE H4 RECEPTOR,HRH4,,,16366610.0,KD,=,125.89,NM,,cell_based,,,,,SK-N-MC,,,,,,,Antagonistic activity at human histamine H4 receptor in SK-N-MC cells by inhibition of forskolin-stimulated cAMP-mediated reporter gene activity,"Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.",J. Med. Chem.,PUBLICATION,
2878072,CHEMBL271191,NCHYTWNAUIQXAH-ZYPCNODZSA-N,,,P42336,PI3-KINASE P110-ALPHA SUBUNIT,PIK3CA,,,18269228.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of PI3K expressed in Escherichia coli by microtiter plate-based fluorescence polarization assay,Synthesis and structure-activity relationships of ring-opened 17-hydroxywortmannins: potent phosphoinositide 3-kinase inhibitors with improved properties and anticancer efficacy.,J. Med. Chem.,PUBLICATION,
868112,CHEMBL81880,DPKHZNPWBDQZCN-UHFFFAOYSA-N,ACRIDINE ORANGE,,O14746,TELOMERASE REVERSE TRANSCRIPTASE,TERT,,,11591511.0,IC50,=,12200.0,NM,,,,,,,,,,,,,,Inhibitory activity against telomerase (Compound released from underivatized resin,Small molecule/nucleic acid affinity chromatography: application for the identification of telomerase inhibitors which target its key RNA/DNA heteroduplex.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2471185,CHEMBL1359942,LJYDATBQQUCGRQ-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4584264,CHEMBL1299645,VAORILFRBQMIFM-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4725590,CHEMBL405759,VPVLEBIVXZSOMQ-UHFFFAOYSA-N,TWS-119,,O00506,SERINE/THREONINE-PROTEIN KINASE 25,STK25,wild_type,,22037377.0,ACTIVITY,=,91.57809843,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,MBP,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3778364,CHEMBL1548763,QXIIWARBAQNJOV-XNTDXEJSSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
447428,CHEMBL1651678,BVLKXGHXDPHLOX-UHFFFAOYSA-N,,,P05480,TYROSINE-PROTEIN KINASE SRC,,,,21243039.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of EGF-srimulated SRC phosphorylation in mouse NIH/3T3 cells overexpressing human EGFR at 40 uM after 15 to 60 mins by immunoblotting,Identification of Purine-Scaffold Small-Molecule Inhibitors of Stat3 Activation by QSAR Studies.,ACS Med. Chem. Lett.,PUBLICATION,
3171446,CHEMBL1592750,OINCTLBMEDNSTN-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1278724,CHEMBL1202043,GILYLJWBFGKOQY-UHFFFAOYSA-N,,,P20309,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,,,2153827.0,ACTIVITY,<,1.0,%,,cell_based,,,,,SK-N-SH,,,,,,,Percent increase in [3H]myo-inositol at muscarinic acetylcholine receptor M3 from SK-N-SH human neuroblastoma cells,Functionalized congener approach for the design of novel muscarinic agents. Synthesis and pharmacological evaluation of N-methyl-N-[4-(1-pyrrolidinyl)-2-butynyl] amides.,J. Med. Chem.,PUBLICATION,
1330997,CHEMBL364634,GOGNQFCSONPHIS-ZETCQYMHSA-N,,,"P04757, P12392",NEURONAL ACETYLCHOLINE RECEPTOR; ALPHA3/BETA4,,,,16033252.0,RMAX,=,50.0,%,,,,,,,,,,,,,,Maximal response against rat neural Nicotinic acetylcholine receptor alpha3-beta4,"Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.",J. Med. Chem.,PUBLICATION,
1893187,CHEMBL541521,IYBQHJMYDGVZRY-UHFFFAOYSA-N,LIDOCAINE HYDROCHLORIDE,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,316.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4542127,CHEMBL1556203,UWEJLYYDHCFLJM-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1241529,CHEMBL3193303,GEPJGKKELCVHTF-YBFXNURJSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3894197,CHEMBL103,RJKFOVLPORLFTN-LEKSSAKUSA-N,PROGESTERONE,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,22931300.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human CYP2C19 assessed as ratio of IC50 in absence of NADPH to IC50 for presence of NADPH using 3-butyryl-7-methoxycoumarin as substrate after 30 mins,Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.,Chem. Res. Toxicol.,PUBLICATION,
3352452,CHEMBL499684,PCKXOBFTBPFENG-UHFFFAOYSA-N,,,P21396,MONOAMINE OXIDASE A,,,,18980841.0,IC50,=,466200.0,NM,,,,,,,,,,,,,,Inhibition of MAOA in rat liver homogenates preincubated for 60 mins,Pyrazoline-based mycobactin analogues as MAO-inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4167337,CHEMBL188381,SNRUTMWCDZHKKM-UHFFFAOYSA-N,GW806742X,,Q96L34,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4,MARK4,,,,INHIBITION,=,1.56,%,,,,,,,,,,,,,,GSK_PKIS: MARK4 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
790492,CHEMBL1509773,DHHDNSOYQIAXCV-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3078272,CHEMBL1531165,NYLHMPRJAHCONY-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1804397,CHEMBL1545951,IOADGBPTDRSNRW-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,177.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5202063,CHEMBL84201,XPQUKIWYNRMSGS-UHFFFAOYSA-N,,,P16116,ALDOSE REDUCTASE,,,,1908522.0,INHIBITION,=,85.0,%,,,,,,,,,,,,,,In vitro % decrease of aldose reductase measured in isolated partially purified bovine lens preparations at 10e-7 M concentration,"Syntheses of tolrestat analogues containing additional substituents in the ring and their evaluation as aldose reductase inhibitors. Identification of potent, orally active 2-fluoro derivatives.",J. Med. Chem.,PUBLICATION,
4828564,CHEMBL1367484,WBMMFDGNOQLZNF-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,199.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5045774,CHEMBL1396756,WYWWVJHQDVCHKF-PFHUQVSOSA-J,,,P18054,ARACHIDONATE 12-LIPOXYGENASE,ALOX12,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
686401,CHEMBL576982,CVWXJKQAOSCOAB-UHFFFAOYSA-N,QUIZARTINIB,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,22037378.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for ABL1(Y253F)-phosphorylated kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2696650,CHEMBL1346308,MIHHBQQSXMMRIY-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
223992,CHEMBL1632391,AWTRAMMHFMCVHF-HKUYNNGSSA-N,,,P24723,PROTEIN KINASE C ETA,PRKCH,,,20971641.0,INHIBITION,>,50.0,%,,,,,,,,,,,,,,Inhibition of PKCeta at 1 uM,Discovery of dihydrothieno- and dihydrofuropyrimidines as potent pan Akt inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4014407,CHEMBL1375098,RWRLGYYQFKUVIX-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
627235,CHEMBL418204,CPNXSABCIFWCDQ-UHFFFAOYSA-N,,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,1533422.0,IC50,=,2800.0,NM,,,,,,,,,,,,,,Ability to displace [3H]CPP from NMDA receptor in rat brain membrane,Generation of N-methyl-D-aspartate agonist and competitive antagonist pharmacophore models. Design and synthesis of phosphonoalkyl-substituted tetrahydroisoquinolines as novel antagonists.,J. Med. Chem.,PUBLICATION,
3649982,CHEMBL1520919,QJKNMDBYTWNCSZ-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4781853,CHEMBL1454021,VWJVNWXLNQTPKA-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4740576,CHEMBL411932,VRSUHJFYRRJBQO-ROFXEPAZSA-N,,,P25774,CATHEPSIN S,CTSS,,,12781193.0,KI,>,150000.0,NM,,,,,,,,,,,,,,Inhibitory activity was measured against Cathepsin S,"3,4-disubstituted azetidinones as selective inhibitors of the cysteine protease cathepsin K. Exploring P2 elements for selectivity.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4484281,CHEMBL1215127,UQDSHTUMDVKJES-OAQYLSRUSA-N,,,P08235,MINERALOCORTICOID RECEPTOR,NR3C2,,,20672822.0,IC50,=,16.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at Gal4-tagged mineralocorticoid receptor expressed in human Huh7 cells by luciferase reporter gene assay,"Discovery of (3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid (PF-3882845), an orally efficacious mineralocorticoid receptor (MR) antagonist for hypertension and nephropathy.",J. Med. Chem.,PUBLICATION,
5802329,CHEMBL306043,,GOLD SODIUM THIOMALATE,,Q12809,HERG,KCNH2,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DrugMatrix in vitro pharmacology data,,DATASET,
3943807,CHEMBL3235973,RORQRTUPQNMYOQ-HXUWFJFHSA-N,,,Q8R455,TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY M MEMBER 8,,,,24597733.0,IC50,=,534.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at rat TRPM8 expressed in CHO cells assessed as inhibition of icilin-induced Ca2+ influx incubated 2.5 mins prior to icilin challenge by luminometry,Optimization of potency and pharmacokinetic properties of tetrahydroisoquinoline transient receptor potential melastatin 8 (TRPM8) antagonists.,J. Med. Chem.,PUBLICATION,
3333289,CHEMBL139345,PAFOMDPWWHFCGE-LLVKDONJSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,8893836.0,KI,=,582.0,NM,,,,,,,,,,,,,,Inhibition of [3H]raclopride binding to Dopamine receptor D2,Novel (R)-2-amino-5-fluorotetralins: dopaminergic antagonists and inverse agonists.,J. Med. Chem.,PUBLICATION,
2605925,CHEMBL1360128,LYCLQJCJLLWDFY-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1738856,CHEMBL2313215,IGUVJKICKDRMPR-UHFFFAOYSA-N,,,P35354,CYCLOOXYGENASE-2,PTGS2,,,23237838.0,INHIBITION,=,23.0,%,,,,,,,,,,,,,,Inhibition of COX-2 (unknown origin) at 5 uM,Synthesis and biological activity of aminophthalazines and aminopyridazines as novel inhibitors of PGE2 production in cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
635750,CHEMBL1327629,CQNGNEZNNBMPPY-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1401289,CHEMBL1966524,GWJHMRBQEUHFOC-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PLK1,PUBCHEM BIOASSAY DATA SET,,DATASET,
5332362,CHEMBL446756,YDOIHIWSLMXTHV-BDAKNGLRSA-N,CROCUSATIN K,,O42713,TYROSINASE,,,,15043425.0,INHIBITION,=,66.7,%,,,,,,,,,,,,,,Inhibition of mushroom tyrosinase at 333.3 uM/mL by spectrophotometry,Antityrosinase principles and constituents of the petals of Crocus sativus.,J. Nat. Prod.,PUBLICATION,
2003448,CHEMBL1289957,JKJZGYCRJXNWCU-UHFFFAOYSA-N,,,P28845,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,HSD11B1,,,20971000.0,IC50,=,36.6,NM,,,,,,,,,,,,,,Inhibition of human 11beta-HSD1 by scintillation proximity assay,The synthesis and SAR of novel diarylsulfone 11ß-HSD1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2634313,CHEMBL1497331,MBHHTOJLMGYQCY-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4039891,CHEMBL122,RZJQGNCSTQAWON-UHFFFAOYSA-N,ROFECOXIB,,P09917,ARACHIDONATE 5-LIPOXYGENASE,ALOX5,,,18272371.0,INHIBITION,=,11.0,%,,,,,,,,,,,,,,Inhibition of LOX5 from human PBML cells at 10 uM by enzyme immuno assay,"Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
1842963,CHEMBL207977,ISKXPUZPVCCNMQ-UHFFFAOYSA-N,,,P47712,CYTOSOLIC PHOSPHOLIPASE A2,PLA2G4A,,,16610804.0,IC50,=,6.4,NM,,,,,,,,,,,,,,Inhibition of cPLA2-alpha activity assessed by TPA-induced arachidonic acid release in human platelet,Design and synthesis of 1-indol-1-yl-propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha.,J. Med. Chem.,PUBLICATION,
3354377,CHEMBL2029885,PCRLBWQGZGUXJH-UHFFFAOYSA-N,,,P20393,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP D MEMBER 1,NR1D1,,,22560469.0,FC,=,0.5,,,,,,,,,,,,,,,Agonist activity at Rev-erbalpha assessed as repression of transcription at 10 uM by luciferase-reporter gene assay relative to control,Synthesis and SAR of tetrahydroisoquinolines as Rev-erba agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5736703,CHEMBL1988838,ZVWRFVCNQOECJS-UHFFFAOYSA-N,,,Q14680,MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE,MELK,,,,KI,=,1258.93,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MELK,PUBCHEM BIOASSAY DATA SET,,DATASET,
3427037,CHEMBL1509449,PKNUEDARTUTGLI-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1598286,CHEMBL1306284,HRJPJKYVYIRMPZ-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4623202,CHEMBL1480974,VETPWJIYZLGEPA-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
346417,CHEMBL1386776,BKDKGEYABKVUPM-UHFFFAOYSA-N,,,Q8NER1,VANILLOID RECEPTOR,TRPV1,,,,POTENCY,,8162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Compounds that Act as Agonists of the Vanilloid Receptor 1: Hit Validation. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4413546,CHEMBL1082947,UIGFLXPQJQGFDX-TZPCGENMSA-N,,,P17948,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 1,FLT1,,,20462213.0,IC50,,,,,,,,,,,,,,,,,Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay,Biochemical and structural analysis of the binding determinants of a vascular endothelial growth factor receptor peptidic antagonist.,J. Med. Chem.,PUBLICATION,
894282,CHEMBL1401483,DSHBALNIPCXQFC-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1258.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5237685,CHEMBL3193629,XTOAWMVAZOOIGP-BZZOAKBMSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3675772,CHEMBL7463,QMGUOJYZJKLOLH-UHFFFAOYSA-N,GF-109203,,Q02763,TYROSINE-PROTEIN KINASE TIE-2,TEK,wild_type,,23398362.0,ACTIVITY,=,120.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of TEK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 0.5 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4510644,CHEMBL285629,USUMXADKOISKIL-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5733305,CHEMBL1487369,ZVMAMXBAYDOUHS-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4906565,CHEMBL58071,WJKSCUWBYPTSMN-GKFVBPDJSA-N,,,P97612,ANANDAMIDE AMIDOHYDROLASE,,,,12781177.0,KI,=,2100.0,NM,,,,,,,,,,,,,,Binding affinity towards Fatty-acid amide hydrolase (FAAH) in rat forebrain membranes,Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1236755,CHEMBL1094682,GEAQYDCYSOSTEE-MQPGJTPFSA-N,,,P11388,DNA TOPOISOMERASE II ALPHA,TOP2A,,,20371180.0,IC50,>,250000.0,NM,,,,,,,,,,,,,,Inhibition of human DNA topoisomerase 2-mediated relaxation of supercoiled DNA by gel electrophoresis,Cytotoxicity and inhibition of DNA topoisomerase I of polyhydroxylated triterpenoids and triterpenoid glycosides.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3216326,CHEMBL3695908,ONKNVTVXRZIDCU-GDLZYMKVSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,,IC50,=,5.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Lanthascreen Competitive Binding Assay. The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 µM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 µL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",N-biphenylmethylindole modulators of PPARG,,PATENT,
2062362,CHEMBL1541546,JQXWYJCUDRTLMO-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5714155,CHEMBL1767039,ZTGXBIBUKIFSTB-ITYLOYPMSA-N,,,Q13547,HISTONE DEACETYLASE 1,HDAC1,,,21417297.0,IC50,=,19300.0,NM,,,,,,,,,,,,,,Inhibition of human HDAC1 using ArgHisLysLys(Ac) fluorogenic peptide as a substrate by fluorimetric assay,"Oxime amides as a novel zinc binding group in histone deacetylase inhibitors: synthesis, biological activity, and computational evaluation.",J. Med. Chem.,PUBLICATION,
1549514,CHEMBL1433195,HLUVIKAIEKRHKU-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3633225,CHEMBL278041,QHKYPYXTTXKZST-UHFFFAOYSA-N,SB-202190,,P53779,C-JUN N-TERMINAL KINASE 3,MAPK10,,,18183025.0,KD,=,42.0,NM,,,,,,,,,,,,,,Binding constant for JNK3 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
3288348,CHEMBL432562,OVDFWHHAHLPTKG-OFUZFLEOSA-N,,,O14746,TELOMERASE REVERSE TRANSCRIPTASE,TERT,,,11551754.0,IC50,=,300.0,NM,,,,,,,,,,,,,,Inhibitory activity against telomerase extracted from HCT 116 cell lines,"Solid-Phase synthesis of a library constructed of aromatic phosphate, long alkyl chains and tryptophane components, and identification of potent dipeptide telomerase inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
246718,CHEMBL1399271,AZHNVOMDNWDNKE-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1069864,CHEMBL19,FLOSMHQXBMRNHR-QPJJXVBHSA-N,METHAZOLAMIDE,,Q16790,CARBONIC ANHYDRASE IX,CA9,,,18042384.0,KI,=,27.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant CA9 by CO2 hydration stopped flow assay,Carbonic anhydrase inhibitors: copper(II) complexes of polyamino-polycarboxylamido aromatic/heterocyclic sulfonamides are very potent inhibitors of the tumor-associated isoforms IX and XII.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3298542,CHEMBL2164579,OWHAXINQHAYRCT-UHFFFAOYSA-N,,,O75469,PREGNANE X RECEPTOR,NR1I2,,,,ACTIVITY,=,42.0,%,,,,,,,,,,,,,,Activation of PXR at 10 uM,,ACS Med. Chem. Lett.,PUBLICATION,
2088670,CHEMBL226232,JTRXEPCDEVNYPE-UHFFFAOYSA-N,,,O95819,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4,MAP4K4,,,,KI,=,100.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAP4K4,PUBCHEM BIOASSAY DATA SET,,DATASET,
5253453,CHEMBL1446559,XVHABBHIPRXOBH-XNTDXEJSSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
401033,CHEMBL3110075,BQERIMYONAXXOG-HNNXBMFYSA-N,,,Q13085,ACETYL-COA CARBOXYLASE 1,ACACA,,,24294923.0,IC50,=,811.0,NM,,,,,,,,,,,,,,Inhibition of human ACC1 assessed as acetylCoA to malonylCoA conversion after 10 mins by LC-MS/MS analysis,Piperazine oxadiazole inhibitors of acetyl-CoA carboxylase.,J. Med. Chem.,PUBLICATION,
1187881,CHEMBL1733892,FYNUGRXGFNTUNW-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,8199.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3800296,CHEMBL1361517,QZPZDORKJFULJP-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
531937,CHEMBL1112,CEUORZQYGODEFX-UHFFFAOYSA-N,ARIPIPRAZOLE,,Q60492,SIGMA-1 RECEPTOR,,,,21536445.0,KI,,,,,,,,,,,,,,,,,Displacement of [3H](+)-pentazocine from guinea pig brain sigma-1 receptor after 90 mins by liquid scintillation counter,Synthesis and characterization of selective dopamine D(2) receptor ligands using aripiprazole as the lead compound.,Bioorg. Med. Chem.,PUBLICATION,
1393788,CHEMBL1368657,GVOMNKSWFHIHOR-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
870785,CHEMBL1545367,DPTAVTYCNALVCD-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,29934.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1746280,CHEMBL1366046,IHRUNOMGHVUAOU-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1164708,CHEMBL1774129,FVXPBEUYCCZFJT-UHFFFAOYSA-N,,,P11387,DNA TOPOISOMERASE I,TOP1,,,21425770.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human topoisomerase I mediated DNA relaxation at 1 to 100 uM,Solid phase synthesis and biological activity of tuftsin conjugates.,J. Med. Chem.,PUBLICATION,
1629969,CHEMBL1449854,HVAIKTLHBMCOBP-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1792737,CHEMBL382590,IMYVCWQAHSYYOO-UHFFFAOYSA-N,ANILINOQUINAZOLINE1,,P11362,FIBROBLAST GROWTH FACTOR RECEPTOR 1,FGFR1,wild_type,,23398362.0,ACTIVITY,=,121.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of FGFR1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
105616,CHEMBL1878470,AJVWNWKMKOEJSP-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4924592,CHEMBL1992732,WLLUQXGGNFUQGM-UHFFFAOYSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
5858562,CHEMBL3754564,,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,Kd,=,350.0,NM,,,,,,,,,,,,,,Binding affinity to wild type human EGFR expressed in Escherichia coli BL21 incubated for 1 hr,"C5-substituted pyrido[2,3-d]pyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFRT790Mmutant",MedChemComm,PUBLICATION,
3824130,CHEMBL1480811,RBYBAYRGEKJMIW-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1122.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3663184,CHEMBL1462717,QKVPTJMGYXIZKW-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
4442057,CHEMBL423514,ULKRWCRZHRHCHT-UHFFFAOYSA-N,,,"Q6B856, Q862F3, Q862L2",TUBULIN,,,,10514278.0,INHIBITION,=,22.0,%,,,,,,,,,,,,,,Concentration inhibiting [3H]-colchicine binding to tubulin,"Antitumor agents. 196. Substituted 2-thienyl-1,8-naphthyridin-4-ones: their synthesis, cytotoxicity, and inhibition of tubulin polymerization.",J. Med. Chem.,PUBLICATION,
4642723,CHEMBL1494100,VGURZRGFTKLITA-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,=,2818.38,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1171731,CHEMBL1545112,FWVMGWSZOGISOQ-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5857015,CHEMBL3758373,,,,P00918,CARBONIC ANHYDRASE II,CA2,,,26810710.0,Ki,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped flow CO2 hydration assay,A novel library of saccharin and acesulfame derivatives as potent and selective inhibitors of carbonic anhydrase IX and XII isoforms.,Bioorg. Med. Chem.,PUBLICATION,
265893,CHEMBL1460981,BBMJABPZWRIPHD-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1336549,CHEMBL435022,GOYAQHRLQPUEKB-UHFFFAOYSA-N,,,"P29274, P29275",ADENOSINE A2 RECEPTOR,"ADORA2A, ADORA2B, SPECC1L-ADORA2A",,,13678407.0,RATIO,=,1.5,,,,,,,,,,,,,,,Relative inhibitory activity against adenosine A2A and A2B receptors,"Pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as adenosine receptor antagonists. Influence of the N5 substituent on the affinity at the human A 3 and A 2B adenosine receptor subtypes: a molecular modeling investigation.",J. Med. Chem.,PUBLICATION,
5315530,CHEMBL85728,YBRVSVVVWCFQMG-UHFFFAOYSA-N,"4,4'-METHYLENEDIANILINE",,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
2443564,CHEMBL107989,LGSONVJOYHVSKC-UHFFFAOYSA-N,,,Q95323,CARBONIC ANHYDRASE IV,,,,11784136.0,KI,=,125.0,NM,,,,,,,,,,,,,,Inhibitory effect on bovine Carbonic anhydrase IV,Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties.,J. Med. Chem.,PUBLICATION,
4925568,CHEMBL1384896,WLOBNIMHPCNIKT-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4704780,CHEMBL403773,VNPBUFXHTACLEO-UHFFFAOYSA-N,,,P08173,MUSCARINIC ACETYLCHOLINE RECEPTOR M4,CHRM4,,,18395442.0,KI,=,74.13,NM,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]N-methylscopolamine from human muscarinic M4 receptor expressed in CHO-K1 cells,Diphenidol-related diamines as novel muscarinic M4 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2010545,CHEMBL188247,JLEUOCWABWBHQW-UHFFFAOYSA-N,GW832467X,,P24723,PROTEIN KINASE C ETA,PRKCH,,,,INHIBITION,=,0.94,%,,,,,,,,,,,,,,GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3763204,CHEMBL2370377,QVRWEJXXUPOVPH-IJSOUHPMSA-N,,,Q00788,VASOPRESSIN V2 RECEPTOR,,,,2231609.0,RATIO,=,2.1,,,,,,,,,,,,,,,Selectivity ratio of antidiuretic Vasopressin V2 receptor ED /antivasopressor Vasopressin V2 receptor ED,Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin.,J. Med. Chem.,PUBLICATION,
3077820,CHEMBL70586,NYKCGQQJNVPOLU-ONTIZHBOSA-N,SPIRADOLINE,,P29476,"NITRIC-OXIDE SYNTHASE, BRAIN",,,,,KI,,,,,tissue,,,,,,,,,,,,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",DrugMatrix in vitro pharmacology data,,DATASET,
2243881,CHEMBL3677609,KKOSIMNAQGXCCL-UHFFFAOYSA-N,,,Q9Y5X9,ENDOTHELIAL LIPASE,LIPG,,,,IC50,=,17.9,NM,,,,,,,,,,,,,,"BindingDB_Patents: Biological Assay. Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artificial vesicle containing DMPG (Avanti Polar Lipids) as the excipient. Vesicles were prepared by combining 571 uL of 29 mM DMPG in a 1:1 mixture of MeOH and CHCl3 with 2000 uL of 1 mM A10070 in a 1:1 mixture of MeOH and CHCl3. The mixture was dried under nitrogen in multiple vials then resuspended in 20 mL total volume of 50 mM HEPES pH 8.0 buffer containing 50 mM NaCl and 0.2 mM EDTA. The sample was allowed to sit at room temperature for 15 min and then was sonicated 3x4 mins on ice with a Branson Sonicator using duty cycle 1. This preparation provides vesicles with a mole fraction of 0.11 for the FRET substrate.The enzymatic assay was measured using 384-well white Optiplates. Each well contained 20 uL of assay buffer (50 mM HEPES pH 8.0, 50 mM NaCl and 1 mM CaCl2) and 0.25 uL of a DMSO solution containing a compound.","Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase",,PATENT,
665955,CHEMBL3660056,CTVPSIXLKPKNTQ-UHFFFAOYSA-N,,,O70444,SERINE/THREONINE-PROTEIN KINASE PIM-3,,,,,IC50,=,98.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: PIM-3 Enzyme Assay. The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 30 uM [gamma-33P] ATP (20 uCi/mL), 3.75 uM PIM2tide and 0.5 nM recombinant rat PIM-3 in place of PIM-1.",Triazolopyridine compounds as PIM kinase inhibitors,,PATENT,
2774444,CHEMBL529,MQTOSJVFKKJCRP-BICOPXKESA-N,AZITHROMYCIN,,P00918,CARBONIC ANHYDRASE II,CA2,,,,KI,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DrugMatrix in vitro pharmacology data,,DATASET,
2666150,CHEMBL209650,MEWRVCQMJAABQU-UHFFFAOYSA-N,,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,16730987.0,EC50,=,1170.0,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at human ERalpha transfected in HEK293 cells assessed as transactivation of alkaline phosphatase reporter gene,Estrogen receptor beta-subtype selective tetrahydrofluorenones: use of a fused pyrazole as a phenol bioisostere.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2260350,CHEMBL1409488,KMGBXNMPKWXWPC-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3403030,CHEMBL1364857,PHZLPPXHFATYTA-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
327937,CHEMBL3084803,BIDUPMYXGFNAEJ-APGVDKLISA-N,ASTROMICIN,,O70528,SEROTONIN 4 (5-HT4) RECEPTOR,,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT4 radioligand binding (ligand: [3H] GR-113808),DrugMatrix in vitro pharmacology data,,DATASET,
5752552,CHEMBL95700,ZXQHMEUGMCXKLO-KPKJPENVSA-N,,,,"Retinoic Acid Receptor, beta",,,,10964567.0,KD,=,3.5,NM,,,,,,,,,,,,,,,,,,
5639842,CHEMBL323950,ZLEDGBHPLZJCAM-WWBVHEESSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,8765511.0,IC95,>,200.0,NM,,,,,,,,,,,,,,Inhibitory activity against HIV-1 protease enzyme,"Nonpeptidal P2 ligands for HIV protease inhibitors: structure-based design, synthesis, and biological evaluation.",J. Med. Chem.,PUBLICATION,
1326534,CHEMBL1435535,GNVBLJMGFATSBK-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
4093707,CHEMBL1818224,SFMJMKMVPCKUNE-QUCCMNQESA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,21744827.0,KI,>,3000.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]diprenorphine from human mu opioid receptor expressed in CHO cells after 1 hr by liquid scintillation counting,"Design and discovery of a selective small molecule ¿ opioid antagonist (2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine, PF-4455242).",J. Med. Chem.,PUBLICATION,
3867582,CHEMBL490355,RGNXWPVNPFAADO-NSIKDUERSA-N,SULFURETIN,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1572676,CHEMBL312066,HOKKHKUKGHKMAT-UHFFFAOYSA-N,,,"P29089, P25095",ANGIOTENSIN II RECEPTOR (AT-1) TYPE-1,,,,8360878.0,KI,=,0.4,NM,,,,,,,,,,,,,,"Binding affinity of compound in presence of bovine serum albumin (BSA) at 0% against rat adrenal Angiotensin II receptor, type 1","Quinoxaline N-oxide containing potent angiotensin II receptor antagonists: synthesis, biological properties, and structure-activity relationships.",J. Med. Chem.,PUBLICATION,
1083607,CHEMBL1938954,FNEPZGYORBGUCH-UHFFFAOYSA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,,,22104147.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of IGF1R at 10 uM by colorimetric analysis,Design and combinatorial synthesis of a novel kinase-focused library using click chemistry-based fragment assembly.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3729508,CHEMBL1557092,QRUCQDJDFMNIMB-UHFFFAOYSA-N,,,P21462,FORMYL PEPTIDE RECEPTOR 1,FPR1,,,,KI_MICROM,=,1800.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Formylpeptide Receptor (FPR) Ligand Structure Activity Relationship (SAR) Analysis: Dose Response Assay. (Class of assay: confirmatory) [Related pubchem assays: 519, 520, 440, 699, 441 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2559543,CHEMBL1323376,LSZQUPRZSNNOKU-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
3106960,CHEMBL445332,OBSYBRPAKCASQB-AGQYDFLVSA-N,SALVINORIN A,,,&#954; opioid receptor (KOR K227A),,,,24121503.0,EC50,=,0.51,NM,,,,,,,,,,,,,,,,,,
4329897,CHEMBL1357710,TZJZAUXBKLPQJS-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3307493,CHEMBL1338231,OXGZRRABURDAKT-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
261434,CHEMBL109745,BAZGFSKJAVQJJI-CHHCPSLASA-N,DARBUFELONE MESYLATE,,P12527,ARACHIDONATE 5-LIPOXYGENASE,,,,8295221.0,IC50,=,770.0,NM,,cell_based,,,,,RBL-1,,,,,,,Inhibition of 5-lipoxygenase in intact rat basophilic leukemia cells stimulated with the calcium ionophore A-23187,"Synthesis and biological evaluation of 5-[[3,5-bis(1,1-dimethylethyl)- 4-hydroxyphenyl]methylene]oxazoles, -thiazoles, and -imidazoles: novel dual 5-lipoxygenase and cyclooxygenase inhibitors with antiinflammatory activity.",J. Med. Chem.,PUBLICATION,
2827952,CHEMBL1556524,MWUSGFOPNMJXFH-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1674416,CHEMBL1898443,HZSTXKBUJYHSGP-DVSDUFGPSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1378075,CHEMBL1465530,GTVPGDGHQCDZLA-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3062293,CHEMBL1403980,NWOYVUWTTVJPLW-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4227292,CHEMBL1586330,SUFMGXRFGOESBK-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5201618,CHEMBL1424328,XPPNRGQFMOVHDO-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,12995.3,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3905107,CHEMBL176553,RKNRDRPDYXCRPG-UHFFFAOYSA-N,GW631581B,,P07949,TYROSINE-PROTEIN KINASE RECEPTOR RET,RET,,,,INHIBITION,=,8.97,%,,,,,,,,,,,,,,GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5176452,CHEMBL1533621,XMTFENPYHJQFJS-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,84367.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5863904,CHEMBL3814929,,,,O15530,3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1,PDPK1,,,27217002.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins,Discovery of novel 7-azaindoles as PDK1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2211825,CHEMBL1378242,KGYCDYAHEUVOHX-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,177.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3680183,CHEMBL1429303,QMQXKMRAOKKVLD-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2583006,CHEMBL3353932,LVLKGQVXAXXSJJ-PBHNCVLYSA-N,,,P30518,VASOPRESSIN V2 RECEPTOR,AVPR2,,,24874785.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Antagonist activity at human vasopressin V2 expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay,"New, potent, and selective peptidic oxytocin receptor agonists.",J. Med. Chem.,PUBLICATION,
1228609,CHEMBL3393549,GDERZZCOGRXYBU-UHFFFAOYSA-N,,,Q9H3N8,HISTAMINE H4 RECEPTOR,HRH4,,,25595684.0,KI,=,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]histamine from human recombinant histamine H4 receptor,"Diaminopyrimidines, diaminopyridines and diaminopyridazines as histamine H4 receptor modulators.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2715759,CHEMBL1423507,MKOABWNEWKDAIC-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4260648,CHEMBL1552829,SYABMPVTGWRJNM-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2074476,CHEMBL1531156,JSCIXFOQZQNPTM-UHFFFAOYSA-N,,,P18054,ARACHIDONATE 12-LIPOXYGENASE,ALOX12,,,,POTENCY,=,35.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1963013,CHEMBL235512,JFRHIMKWWJQUOG-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,17927167.0,KI,=,256.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,"5-amino-2-phenyl[1,2,3]triazolo[1,2-a][1,2,4]benzotriazin-1-one: a versatile scaffold to obtain potent and selective A3 adenosine receptor antagonists.",J. Med. Chem.,PUBLICATION,
3887745,CHEMBL376588,RIRXINSSSSGINV-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,16279775.0,KI,=,19.95,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells,"Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.",J. Med. Chem.,PUBLICATION,
1602286,CHEMBL2018916,HRUYBRGMRSNLNW-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,22239545.0,IC50,=,6730.0,NM,,,,,,,,,,,,,,Inhibition of CYP2C9 in human liver microsomes using diclofenac as substrate preincubated for 5 mins by LC-MS/MS analysis,Ligand-based design of a potent and selective inhibitor of cytochrome P450 2C19.,J. Med. Chem.,PUBLICATION,
1726421,CHEMBL302067,IFHWJTOFROTZBD-UHFFFAOYSA-N,,,P15086,CARBOXYPEPTIDASE B,CPB1,,,15080996.0,IC50,=,70.0,NM,,,,,,,,,,,,,,Inhibition of human carboxypeptidase B (CPB),Imidazole acetic acid TAFIa inhibitors: SAR studies centered around the basic P(1)(') group.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1029537,CHEMBL2142079,FHAXYOMUNOUCPO-HRFSGMKKSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3208036,CHEMBL450266,OMPIYXLSPSTIIT-UHFFFAOYSA-N,,,P31749,SERINE/THREONINE-PROTEIN KINASE AKT,AKT1,,,18550373.0,IC50,=,71.0,NM,,,,,,,,,,,,,,Inhibition of Akt1 by cellular assay,The design and synthesis of potent and cell-active allosteric dual Akt 1 and 2 inhibitors devoid of hERG activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2738482,CHEMBL2347186,MMPPCMJOPZGPPA-MAUKXSAKSA-N,,,Q12809,HERG,KCNH2,,,23590342.0,INHIBITION,=,65.0,%,,,,,,,,,,,,,,Inhibition of human ERG channel at 10 uM,ß-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
5859725,CHEMBL3740492,,,,O96017,SERINE/THREONINE-PROTEIN KINASE CHK2,CHEK2,,,,Inhibition,=,55.0,%,,,,,,,,,,,,,,Inhibition of CHK2 (unknown origin) at 30 uM by microfluidic assay relative to control,"Novel pyrrole derivatives as selective CHK1 inhibitors: design, regioselective synthesis and molecular modeling",MedChemComm,PUBLICATION,
2276301,CHEMBL220465,KODFUVBIVXFWPF-UHFFFAOYSA-N,GSK-248233A,,P07332,TYROSINE-PROTEIN KINASE FES,FES,,,,INHIBITION,=,1.31,%,,,,,,,,,,,,,,GSK_PKIS: FES mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3787190,CHEMBL2048325,QYIXCDOBOSTCEI-NWKZBHTNSA-N,COPROSTANOL,,P9WPP1,PUTATIVE CYTOCHROME P450 125,,,,22647881.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to Mycobacterium tuberculosis CYP125A1 assessed as type 1 binding mode at 0.05 to 0.2 uM by UV-visible spectrophotometry,"Substrate analog studies of the ¿-regiospecificity of Mycobacterium tuberculosis cholesterol metabolizing cytochrome P450 enzymes CYP124A1, CYP125A1 and CYP142A1.",Bioorg. Med. Chem.,PUBLICATION,
5546374,CHEMBL1475252,ZBFDAUIVDSSISP-UHFFFAOYSA-N,TENATOPRAZOLE,,Q8R0V5,"INDOLEAMINE 2,3-DIOXYGENASE 2",,,,23122865.0,IC50,=,1800.0,NM,,cell_based,,,,,,,,,,,,Inhibition of mouse Ido2 transfected in HEK293T cells using L-tryptophan as substrate assessed as kynurenine formation after 45 mins by spectrophotometric analysis,"Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5406793,CHEMBL1541040,YLVNNRKUFKXGGJ-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4044687,CHEMBL3128042,RZXMIHOUHYSGJO-UHFFFAOYSA-N,,,Q9P286,SERINE/THREONINE-PROTEIN KINASE PAK7,PAK7,,,24432870.0,IC50,=,126.0,NM,,,,,,,,,,,,,,Inhibition of PAK5 (unknown origin),Back Pocket Flexibility Provides Group II p21-Activated Kinase (PAK) Selectivity for Type I 1/2 Kinase Inhibitors.,J. Med. Chem.,PUBLICATION,
4483519,CHEMBL1322336,UQBMHYREWDMIHR-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2665545,CHEMBL1523955,MEUITMQIYLGTIX-AATRIKPKSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,7307.8,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3333579,CHEMBL270584,PAGUEXPGJGKHKX-UHFFFAOYSA-N,,,P25963,NF-KAPPAB INHIBITOR ALPHA,NFKBIA,,,18024113.0,EC50,,,,,cell_based,,,,,,,,,,,,Induction of human IkappaBalpha stabilization in OCI-Ly3 cells by green light emiting IkappaBalpha-fused luciferase reporter gene assay,Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4856751,CHEMBL1611838,WEHXFVLLFFYCDF-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
4178556,CHEMBL2030608,SPAGUFALSCAYAY-UHFFFAOYSA-N,,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,22607683.0,RATIO IC50,=,3.1,,,,,,,,,,,,,,,Competitive inhibition of Epac2 using fluorescent nucleotide analog 8-NBD-cAMP by fluorescence analysis relative to cAMP,"5-Cyano-6-oxo-1,6-dihydro-pyrimidines as potent antagonists targeting exchange proteins directly activated by cAMP.",Bioorg. Med. Chem. Lett.,PUBLICATION,
150660,CHEMBL1466745,AOYJRVHCUFBQQB-UHFFFAOYSA-N,DNDI1417648,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16353.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1917928,CHEMBL1350043,JASULDRJKSUGFU-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,8912.51,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2089538,CHEMBL1530832,JTUINJHDTNXECT-OWHBQTKESA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,=,3162.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
29267,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P15917,ANTHRAX LETHAL FACTOR,,,,19170530.0,IC50,=,5000.0,NM,,,,,,,,,,,,,,,,,,
3980849,CHEMBL1427699,RSUNVBITOJEYPG-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
185313,CHEMBL1514498,ASRHTHREVUNIPN-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,14689.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. InCell qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Hit Validation. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4761112,CHEMBL286586,VTXPJLWYFJDDQR-UHFFFAOYSA-N,,,P22748,CARBONIC ANHYDRASE IV,CA4,,,11229775.0,KI,=,6.0,NM,,,,,,,,,,,,,,"Inhibition of cloned isozyme, human carbonic anhydrase IV",Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
680832,CHEMBL1603037,CVKRKMOEZUKTSZ-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
963938,CHEMBL1340393,DZVJIXOOKHHJSO-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
545661,CHEMBL2012244,CGGSZBTXQJLOGP-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,22318156.0,INHIBITION,=,41.0,%,,,,,,,,,,,,,,Inhibition of human ERG at 30 uM,"Discovery and hit-to-lead optimization of pyrrolopyrimidines as potent, state-dependent Na(v)1.7 antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3490208,CHEMBL1709810,PRKYYRSNDWFECB-GRSHGNNSSA-N,,,P51452,DUAL SPECIFICITY PROTEIN PHOSPHATASE 3,DUSP3,,,,IC50,=,13400.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR VHR1 Fluorescent Assay for In Vitro dose response studies. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1654, AID1661, AID1878, AID1992, AID2004, AID2070, AID2085]",PUBCHEM BIOASSAY DATA SET,,DATASET,
729632,CHEMBL243664,DANYIYRPLHHOCZ-UHFFFAOYSA-N,ACACETIN,,Q16665,HYPOXIA-INDUCIBLE FACTOR 1 ALPHA,HIF1A,,,,POTENCY,=,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
910708,CHEMBL1606429,DUBXLRJWMBQVJY-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
49548,CHEMBL415856,ADNPLDHMAVUMIW-UHDHWGDKSA-N,,,P14600,NEUROKININ 1 RECEPTOR,,,,,INHIBITION,=,98.0,%,,,,,,,,,,,,,,Inhibition of 500 nM [125I]BHSP binding to the rat central tachykinin (NK1) receptor.,,Bioorg. Med. Chem. Lett.,PUBLICATION,
796601,CHEMBL3677480,DHYULOSNSAMDNF-UHFFFAOYSA-N,,,P11150,HEPATIC LIPASE,LIPC,,,,IC50,=,11.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Biological Assay. Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artificial vesicle containing DMPG (Avanti Polar Lipids) as the excipient. Vesicles were prepared by combining 571 uL of 29 mM DMPG in a 1:1 mixture of MeOH and CHCl3 with 2000 uL of 1 mM A10070 in a 1:1 mixture of MeOH and CHCl3. The mixture was dried under nitrogen in multiple vials then resuspended in 20 mL total volume of 50 mM HEPES pH 8.0 buffer containing 50 mM NaCl and 0.2 mM EDTA. The sample was allowed to sit at room temperature for 15 min and then was sonicated 3x4 mins on ice with a Branson Sonicator using duty cycle 1. This preparation provides vesicles with a mole fraction of 0.11 for the FRET substrate.The enzymatic assay was measured using 384-well white Optiplates. Each well contained 20 uL of assay buffer (50 mM HEPES pH 8.0, 50 mM NaCl and 1 mM CaCl2) and 0.25 uL of a DMSO solution containing a compound.","Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase",,PATENT,
2804913,CHEMBL1893843,MULXTQKDWYBJMO-KYNMMFKBSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
689981,CHEMBL295692,CWHZBYXJYJKQAZ-UHFFFAOYSA-N,,,"P19490, P19493, P19491, P19492","GLUTAMATE RECEPTOR IONOTROPIC, AMPA",,,,8648608.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]AMPA binding to Ionotropic glutamate receptor AMPA.,Synthesis and pharmacology of highly selective carboxy and phosphono isoxazole amino acid AMPA receptor antagonists.,J. Med. Chem.,PUBLICATION,
5642249,CHEMBL2177551,ZLLCEWCZDFPICU-UHFFFAOYSA-N,,,P36544,NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN ALPHA-7 SUBUNIT,CHRNA7,,,23025891.0,KI,=,3.6,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]epibatidine from human alpha7 nAChR expressed in human HEK/RIC3 cells,Structure-Activity Studies of 7-Heteroaryl-3-azabicyclo[3.3.1]non-6-enes: A Novel Class of Highly Potent Nicotinic Receptor Ligands.,J. Med. Chem.,PUBLICATION,
2308974,CHEMBL1261,KRKNYBCHXYNGOX-UHFFFAOYSA-N,CITRIC ACID,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,,KI,,,,,,,,,,Chem-1,,,,,,,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),DrugMatrix in vitro pharmacology data,,DATASET,
3609558,CHEMBL231013,QEYUQXQAUUYZDC-UHFFFAOYSA-N,GSK605714A,,P51817,SERINE/THREONINE-PROTEIN KINASE PRKX,PRKX,,,,INHIBITION,=,3.27,%,,,,,,,,,,,,,,GSK_PKIS: PRKX mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4068555,CHEMBL1916132,SCPJKGGAIWBYON-UHFFFAOYSA-N,,,P11541,PHOSPHODIESTERASE 6A,,,,21988093.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Inhibition of recombinant bovine PDE6A using [3H]cGMP after 1 hr by scintillation proximity assay,"Highly potent, selective, and orally active phosphodiesterase 10A inhibitors.",J. Med. Chem.,PUBLICATION,
3679152,CHEMBL82949,QMNYVASLMSOSFP-UHFFFAOYSA-N,,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4654477,CHEMBL268145,VICQQBALNUQPGD-VJCCQZEDSA-N,,,P41146,NOCICEPTIN RECEPTOR,OPRL1,,,11689089.0,EMAX,=,12.0,%,,,,,,,,,,,,,,Efficacy for human ORL1 receptor expressing HEK293 cell membrane,Structure-activity studies on nociceptin analogues: ORL1 receptor binding and biological activity of cyclic disulfide-containing analogues of nociceptin peptides.,J. Med. Chem.,PUBLICATION,
4439342,CHEMBL1418788,ULCYXPPTGZCIBH-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2993979,CHEMBL1421354,NOWOGPABUNPLDU-UHFFFAOYSA-N,,,Q9H3R0,LYSINE-SPECIFIC DEMETHYLASE 4C,KDM4C,,,,AC50,=,3961.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: GASC-1 histone demethylase dose retest Measured in Cell-Free Homogeneous System Using Plate Reader - 2043-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2123],PUBCHEM BIOASSAY DATA SET,,DATASET,
2682592,CHEMBL1086105,MGPIMNVSULKFFK-UHFFFAOYSA-N,,,Q9H3N8,HISTAMINE H4 RECEPTOR,HRH4,,,20452213.0,KI,=,3.3,NM,,,,,,,,,,,,,,Displacement of [3H]histamine from human recombinant histamine H4 receptor,Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1106319,CHEMBL3197348,FPPSBYQFUZCPJI-LZYBPNLTSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1800370,CHEMBL231623,INRJBVLMKPWSHK-UHFFFAOYSA-N,GSK620503A,,P10721,STEM CELL GROWTH FACTOR RECEPTOR,KIT,,,,INHIBITION,=,1.74,%,,,,,,,,,,,,,,GSK_PKIS: KIT (V560G mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1919492,CHEMBL1451872,JAWQCJJCRLCIHN-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5292548,CHEMBL1966204,XZONYYFHQICDAM-UHFFFAOYSA-N,,,Q13188,SERINE/THREONINE-PROTEIN KINASE MST2,STK3,,,,KI,=,3162.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK3,PUBCHEM BIOASSAY DATA SET,,DATASET,
4727171,CHEMBL1429579,VQAQCBVUQYIIBN-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5131690,CHEMBL1613023,XHYPQEOTYKNCKN-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2793929,CHEMBL1243064,MTDYVCJCWISUMJ-UHFFFAOYSA-N,,,Q9NPH5,NADPH OXIDASE 4,NOX4,,,20731357.0,IC50,=,1000.0,NM,,cell_based,,,,,HEK293,,,,,,,Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay,Small-molecule inhibitors of NADPH oxidase 4.,J. Med. Chem.,PUBLICATION,
2232979,CHEMBL1864280,KJLVVKZJBBVONY-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2606411,CHEMBL1484094,LYEDBPASHCFCAC-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3237235,CHEMBL1406278,OPSZFVXGHUWYNQ-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1388540,CHEMBL1369462,GUYNXRMVGOLOQV-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3195933,CHEMBL487497,OLHVMYLPYPPJJK-UHFFFAOYSA-N,,,P25099,ADENOSINE A1 RECEPTOR,,,,24164628.0,KI,=,107.0,NM,,,,,,,,,,,,,,Binding affinity to rat recombinant adenosine A1 receptor,Adenosine A2A receptor as a drug discovery target.,J. Med. Chem.,PUBLICATION,
5714015,CHEMBL1161243,ZTGRCBLDCZAEFO-GFOCRRMGSA-N,,,P20456,INOSITOL-1(OR 4)-MONOPHOSPHATASE 1,,,,,IC50,>,300000.0,NM,,,,,,,,,,,,,,Compound was tested for inhibitory activity against myo-inositol-1-phosphatase; weak inhibitor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
3878728,CHEMBL374453,RHTXWIKPNGROHZ-UHFFFAOYSA-N,GSK-299115A,,P43250,G PROTEIN-COUPLED RECEPTOR KINASE 6,GRK6,,,,INHIBITION,=,7.35,%,,,,,,,,,,,,,,GSK_PKIS: GRK6 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5486609,CHEMBL2382082,YURMAOFMJXJEJG-HJOGWXRNSA-N,,,P25774,CATHEPSIN S,CTSS,,,23562595.0,KI,=,8500.0,NM,,,,,,,,,,,,,,Inhibition of recombinant cathepsin-S (unknown origin) using Z-Val-Arg-AMC as substrate by fluorescence assay,Identification of new peptide amides as selective cathepsin L inhibitors: The first step towards selective irreversible inhibitors?,Bioorg. Med. Chem. Lett.,PUBLICATION,
2937654,CHEMBL1365075,NIRJFBXWESODKG-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1684423,CHEMBL391737,IAUZEBLXCOCAFL-JSGCOSHPSA-N,,,P00734,THROMBIN,F2,,,17336062.0,KI,=,17.0,NM,,,,,,,,,,,,,,Inhibition of thrombin by fluorogenic assay,Sulfonamide-related conformational effects and their importance in structure-based design.,Bioorg. Med. Chem. Lett.,PUBLICATION,
964933,CHEMBL180040,DZZBYASQGXWJGZ-UHFFFAOYSA-N,,,"Q8WWL7, P06493, P14635, O95067",CYCLIN-DEPENDENT KINASE 1/CYCLIN B,"CCNB1, CCNB2, CCNB3, CDK1",,,15780638.0,IC50,=,9260.0,NM,,,,,,,,,,,,,,Inhibitory concentration against human Cyclin B-cyclin-dependent kinase 1 was observed,"Structure-based design of a new class of highly selective aminoimidazo[1,2-a]pyridine-based inhibitors of cyclin dependent kinases.",Bioorg. Med. Chem. Lett.,PUBLICATION,
840190,CHEMBL135873,DMPPIAONRCOHOK-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,9435894.0,RATIO,=,108.0,,,,,,,,,,,,,,,Ratio of the binding affinity to low affinity state (D2 low) to high affinity state (D2 high),New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromans.,J. Med. Chem.,PUBLICATION,
1247873,CHEMBL1549290,GFHWGLZCBJSBAL-QPJJXVBHSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,29092.9,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
703294,CHEMBL1730111,CXVHGJRNODOUOK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,183.6,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4280224,CHEMBL260311,TUASFNZQWJGIHZ-UHFFFAOYSA-N,NSC-234945,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5006122,CHEMBL71001,WURKOHONKFWQNR-UHFFFAOYSA-N,,,P25100,ALPHA-1D ADRENERGIC RECEPTOR,ADRA1D,,,12014961.0,KI,=,7585.78,NM,,,,,,,,,,,,,,Affinity to human Alpha-1D adrenergic receptor determined by radioligand binding techniques from rat-1 fibroblasts membranes,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,PUBLICATION,
1037361,CHEMBL1533277,FHYSENNAGROFEP-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
742557,CHEMBL488868,DBZONAUQFSBVIB-UHFFFAOYSA-N,,,O00519,ANANDAMIDE AMIDOHYDROLASE,FAAH,,,18693015.0,IC50,=,320.0,NM,,,,,,,,,,,,,,Inhibition of human FAAH preincubated for 10 mins,Thiadiazolopiperazinyl ureas as inhibitors of fatty acid amide hydrolase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
965708,CHEMBL366591,FAAVTENFCLADRE-PHDIDXHHSA-N,,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,1825117.0,IC50,=,777.0,NM,,,,,,,,,,,,,,"In vitro binding affinity against N-methyl-D-aspartate glutamate receptor using [3H]CGS-19,755 ligand",4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.,J. Med. Chem.,PUBLICATION,
5292998,CHEMBL3359958,XZPXPOMFAVMLND-UHFFFAOYSA-N,,,P05093,CYTOCHROME P450 17A1,CYP17A1,,,25462231.0,INHIBITION,=,2.0,%,,,,,,,,,,,,,,Inhibition of human CYP17 expressed in Escherichia coli using [3H]-progesterone substrate pre-incubated for 5 mins at 2.5 uM in presence of rat P450 reductase by HPLC method,Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11ß-hydroxylase.,Eur. J. Med. Chem.,PUBLICATION,
2492108,CHEMBL1321322,LLXIZQPQLYREPB-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5315462,CHEMBL1418126,YBRVBNDJOVPVFV-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4313740,CHEMBL1550389,TXOPRTPXOSUEJC-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
167849,CHEMBL576989,AQTGJJPOCBCGFT-UHFFFAOYSA-N,,,O75116,RHO-ASSOCIATED PROTEIN KINASE 2,ROCK2,,,19716697.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of ROCK-2 at 10 uM,The discovery of thienopyridine analogues as potent IkappaB kinase beta inhibitors. Part II.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5576622,CHEMBL2171332,ZEDVBWFTUWXMCH-VQHVLOKHSA-N,,,O42275,ACETYLCHOLINESTERASE,,,,22512543.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of eel AChE using acetylthiocholine iodide as substrate after 5 mins by Ellman's method,"Tacrine-Ferulic Acid-Nitric Oxide (NO) Donor Trihybrids as Potent, Multifunctional Acetyl- and Butyrylcholinesterase Inhibitors.",J. Med. Chem.,PUBLICATION,
1042168,CHEMBL448620,FIIXCJGBCCCOQQ-UHFFFAOYSA-N,SNAP-5089,,P35368,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,,,7752182.0,KI,=,410.0,NM,,,,,,,,,,,,,,Ability to displace [3H]prazosin from cloned human Alpha-1B adrenergic receptor,Discovery of alpha 1a-adrenergic receptor antagonists based on the L-type Ca2+ channel antagonist niguldipine.,J. Med. Chem.,PUBLICATION,
656412,CHEMBL2133641,CSZQKCTXBHMMOJ-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5513846,CHEMBL235241,YXPOTYIIRALLPH-UHFFFAOYSA-N,TCMDC-123921,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,10.65,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
523700,CHEMBL1684662,CDVMXMZPDJHSCC-UHFFFAOYSA-N,,,P06213,INSULIN RECEPTOR,INSR,wild_type,,21316219.0,INHIBITION,=,88.0,%,inhibition,cell_free,functional,enzyme_activity,competitive_inhibitor,radiometry,,0.1-1,uM,33P+ATP,,10.0,uM,Inhibition of IR at 0.1 uM,Optimisation of ITK inhibitors through successive iterative design cycles.,Bioorg. Med. Chem. Lett.,PUBLICATION,Kinase concentration change (supplementry material)
3104837,CHEMBL1895450,OBMZKUNRGPCSLT-UHFFFAOYSA-N,GSK-2220400A,,P42681,TYROSINE-PROTEIN KINASE TXK,TXK,,,,INHIBITION,=,1.5,%,,,,,,,,,,,,,,GSK_PKIS: TXK mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3686212,CHEMBL3192002,QNJLPGAFPHKGCU-ODCIPOBUSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
4795244,CHEMBL12531,VXTKXGKPBOLHRY-UHFFFAOYSA-N,CLAMIKALANT,,"Q09428, Q14654","SULFONYLUREA RECEPTOR 1, KIR6.2","ABCC8, KCNJ11",,,11297455.0,INHIBITION,=,5.0,%,,cell_based,,,,,CHO,,,,,,,Antiarrhythmic effect in hSUR1/hKir6.2 (pancreatic KATP channel) transfected in CHO cells at a dose of 0.1 uM,Cardioselective K(ATP) channel blockers derived from a new series of m-anisamidoethylbenzenesulfonylthioureas.,J. Med. Chem.,PUBLICATION,
5744350,CHEMBL386974,ZWTVVWUOTJRXKM-HZCBDIJESA-N,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,17125264.0,KI,=,6410.0,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]ZM-241385 from human adenosine A2A receptor expressed in HEK cells,Potent and orally bioavailable 8-bicyclo[2.2.2]octylxanthines as adenosine A1 receptor antagonists.,J. Med. Chem.,PUBLICATION,
5710837,CHEMBL1990383,ZSVXXHYMGRQADR-LFVJCYFKSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5857666,CHEMBL3828646,,,,P00915,CARBONIC ANHYDRASE I,CA1,,,27396930.0,Ki,=,2954.0,NM,,,,,,,,,,,,,,Inhibition of human CA1 preincubated for 15 mins by stopped flow CO2 hydration assay,Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties.,Bioorg. Med. Chem.,PUBLICATION,
3016469,CHEMBL1643307,NRHYNEFJUMPQKN-UHFFFAOYSA-N,,,P00918,CARBONIC ANHYDRASE II,CA2,,,21145236.0,KI,=,8.9,NM,,,,,,,,,,,,,,Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by stopped-flow CO2 hydrase assay,Inhibition of ß-carbonic anhydrases with ureido-substituted benzenesulfonamides.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2516832,CHEMBL1744448,LOLFAJUUOFBGSF-KYIYJVAASA-N,BLEOMYCIN A2,,P08575,LEUKOCYTE COMMON ANTIGEN,PTPRC,,,,KI,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Tyrosine Phosphatase, PTPRC (CD45) enzyme inhibition (substrate: DiFMUP)",DrugMatrix in vitro pharmacology data,,DATASET,
1274508,CHEMBL3309997,GIAVVFIPFBOBRR-UHFFFAOYSA-N,,,P09619,PLATELET-DERIVED GROWTH FACTOR RECEPTOR BETA,PDGFRB,,,24980703.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of PDGFR (unknown origin),Fragment-based hit discovery and structure-based optimization of aminotriazoloquinazolines as novel Hsp90 inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
2570360,CHEMBL1569831,LUDAHOMSVXVMRU-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4923097,CHEMBL173465,WLIQAZXJDQKSEC-UHFFFAOYSA-N,,,P24530,ENDOTHELIN RECEPTOR ET-B,EDNRB,,,12617929.0,IC50,=,903.0,NM,,cell_based,,,,,CHO,,,,,,,In vitro inhibitory concentration required against [125I]ET1 binding to membranes of CHO cells expressing human ETB receptor,The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4637822,CHEMBL1509112,VGHUNHMCOJGJSJ-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
2122770,CHEMBL1395936,JXGRALGMTGUYBG-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4728255,CHEMBL1352093,VQEIGFJGSMWILL-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,32629.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5062338,CHEMBL1401280,XAODGRCKBVFBPM-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1267856,CHEMBL1488410,GHHKWUQQBBBNQI-JQWIXIFHSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
1934755,CHEMBL1342516,JCLDOBGFWWINRX-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4593083,CHEMBL3589165,VBMFXGFCLWKXEL-UHFFFAOYSA-N,,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,25987372.0,IC50,=,48.0,NM,,,,,,,,,,,,,,Inhibition of JAK3 (unknown origin),9H-Carbazole-1-carboxamides as potent and selective JAK2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4525690,CHEMBL1503729,UUKXQRCKOJRJOL-UHFFFAOYSA-N,DNDI1417601,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1574097,CHEMBL421778,HONVEEQHGVXUMK-UHFFFAOYSA-N,,,P32238,CHOLECYSTOKININ A RECEPTOR,CCKAR,,,,IC50,=,3162.28,NM,,cell_based,,,,,CHO-K1,,,,,,,Tested for the 50% displacement of [125I]CCK-8 from membrane preparation isolated from CHO-K1 cells stably transfected with the cDNA of human Cholecystokinin type A receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
3387029,CHEMBL1552487,PGKONKQRSVJMQA-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3775356,CHEMBL1708683,QWYMRYCHPFRXHZ-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
5091282,CHEMBL74071,XDUYFOWMTMCCEI-UHFFFAOYSA-N,,,P35348,ALPHA-1A ADRENERGIC RECEPTOR,ADRA1A,,,12014961.0,MAX,=,70.0,%,,,,,,,,,,,,,,Efficacy as % of the maximal effect observed for nonselective agonist phenylephrine in rat-1 fibroblasts expressing human Alpha-1 adrenergic receptor,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,PUBLICATION,
1894880,CHEMBL1558558,IYHJVUCDSQJZGM-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4907460,CHEMBL1501,WJOHZNCJWYWUJD-IUGZLZTKSA-N,FLUOCINONIDE,,P12530,ARACHIDONATE 15-LIPOXYGENASE,,,,,IC50,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Lipoxygenase 15-LO enzyme inhibition (substrate: Linoleic acid),DrugMatrix in vitro pharmacology data,,DATASET,
446089,CHEMBL237347,BVHZLDLRNBQWRF-UHFFFAOYSA-N,GW559768X,,P16591,TYROSINE-PROTEIN KINASE FER,FER,,,,INHIBITION,=,18.53,%,,,,,,,,,,,,,,GSK_PKIS: FER mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3499646,CHEMBL1386964,PSKCFUZRZWBLFM-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
271138,CHEMBL1306387,BCBWOAAFWNQNCC-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1665684,CHEMBL1875557,HYWCZXUPQZAEEE-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,14581.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5521313,CHEMBL1456851,YYKVLRQUTRJDFZ-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,5.8,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3671299,CHEMBL414749,QLVKKYGVIQGKCF-SEYGNWCUSA-N,,,P30872,SOMATOSTATIN RECEPTOR 1,SSTR1,,,11405660.0,IC50,=,15.0,NM,,,,,,,,,,,,,,Tested for ability to bind to 20 uM thick cryostat sections of a membrane pellet of cells transfected with human cloned somatostatin (sst) receptor subtype 1.,Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1).,J. Med. Chem.,PUBLICATION,
2042506,CHEMBL206031,JORVRJNILJXMMG-OLNQLETPSA-N,BRECANAVIR,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,17664327.0,INHIBITION,=,50.0,%,,cell_based,,,,,,,,,,,,Inhibition of human MDR1-dependent accumulation of calcein-AM expressed in MDCK2 cells at 20 uM,Effects of human immunodeficiency virus protease inhibitors on the intestinal absorption of tenofovir disoproxil fumarate in vitro.,Antimicrob. Agents Chemother.,PUBLICATION,
963189,CHEMBL400144,DZTFRDMOGLIUFL-UHFFFAOYSA-N,,,P30304,DUAL SPECIFICITY PHOSPHATASE CDC25A,CDC25A,,,18714978.0,IC50,=,3280.0,NM,,,,,,,,,,,,,,Inhibition of Cdc25A (336-523) expressed in Escherichia coli,Discovery of novel Cdc25 phosphatase inhibitors with micromolar activity based on the structure-based virtual screening.,J. Med. Chem.,PUBLICATION,
5256003,CHEMBL7927,XVPRVMIFXXOEFR-UHFFFAOYSA-N,FAUC 113,,P21917,DOPAMINE D4 RECEPTOR,DRD4,,,11495580.0,KI,=,3.6,NM,,,,,,,,,,,,,,Binding affinity against human dopamine receptor D4.4 using radioligand [3H]spiperone,"Rationally based efficacy tuning of selective dopamine d4 receptor ligands leading to the complete antagonist 2-[4-(4-chlorophenyl)piperazin-1-ylmethyl]pyrazolo[1,5-a]pyridine (FAUC 213).",J. Med. Chem.,PUBLICATION,
3680826,CHEMBL1485647,QMTFEMGWCBZTJN-UHFFFAOYSA-N,,,P11308,TRANSCRIPTIONAL REGULATOR ERG,ERG,,,,POTENCY,,125.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction: HTRF assay against cherry picks. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5483516,CHEMBL1521598,YUHPHFGUQNCJJC-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
4966681,CHEMBL1564356,WQGXGQWAEKQCRY-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1563838,CHEMBL1578821,HNKMMWNZUCJYTD-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1884952,CHEMBL1333878,IXECRYIURURBIM-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,16944.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2879377,CHEMBL1328919,NCKMMSIFQUPKCK-UHFFFAOYSA-N,CLOROPHENE,,P04792,HEAT SHOCK PROTEIN BETA-1,HSPB1,,,,POTENCY,,29847.0,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay for small molecule activators of the heat shock response signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3006293,CHEMBL1727470,NQEHSYQGSYNZOJ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4916461,CHEMBL1542017,WKNHHNNDRZBVHK-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5834719,CHEMBL1909054,,CARBOXYMETHYLCELLULOSE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,,,,,,,MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
1113334,CHEMBL2024087,FQIJPHXWIONJLF-JKOKRWQUSA-N,,,"P12392, P12389",NEURONAL ACETYLCHOLINE RECEPTOR; ALPHA2/BETA4,,,,22171543.0,KI,=,249.0,NM,,,,,,,,,,,,,,Displacement of [3H] epibatidine from rat alpha2beta4 nAChR by beta scintillation counting,Chemistry and behavioral studies identify chiral cyclopropanes as selective a4ß2-nicotinic acetylcholine receptor partial agonists exhibiting an antidepressant profile.,J. Med. Chem.,PUBLICATION,
1524019,CHEMBL1220,HJLSLZFTEKNLFI-UHFFFAOYSA-N,TINIDAZOLE,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
999983,CHEMBL3653013,FDSQATWCNNIXSC-UHFFFAOYSA-N,,,O60563,CYCLIN T1,CCNT1,,,,IC50,=,0.00795,NM,,,,,,,,,,,,,,"BindingDB_Patents: IMAP Assay. Cdk9/cyclinT1 is purchased from Millipore, cat #14-685. The final total protein concentration in the assay 4 nM. The 5TAMRA-cdk7tide peptide substrate, 5TAMRA-YSPTSPSYSPTSPSYSTPSPS--COOH, is purchased from Molecular Devices, cat#R7352. The final concentration of peptide substrate is 100 nM. The ATP substrate (Adenosine-5'-triphosphate) is purchased from Roche Diagnostics, cat#1140965. The final concentration of ATP substrate is 6 uM. IMAP (Immobilized Metal Assay for Phosphochemicals) Progressive Binding reagent is purchased from Molecular Devices, cat#R8139. Fluorescence polarization (FP) is used for detection. The 5TAMRA-cdk7tide peptide is phosphorylated by Cdk9/cyclinT1 kinase using the ATP substrate. The Phospho-5TAMRA-cdk7tide peptide substrate is bound to the IMAP Progressive Binding Reagent.",Heteroaryl compounds and their uses,,PATENT,
674991,CHEMBL1608789,CURXKXUVNORFTO-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
85265,CHEMBL3198765,AHMIALFFIMLXQD-AFUMVMLFSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5659852,CHEMBL3431855,ZNMMBZHPEMZRNC-OAQYLSRUSA-N,,,P23786,CARNITINE PALMITOYLTRANSFERASE 2,CPT2,,,,IC50,=,6549.7,NM,,,,,,,,,,,,,,SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 2,Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752).,,DATASET,
1993607,CHEMBL1322745,JJDNRKHILPYOIF-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,1584.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3651225,CHEMBL1412092,QJOYKPASVOVSGN-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3156573,CHEMBL90555,OGWKCGZFUXNPDA-XQKSVPLYSA-N,VINCRISTINE,,P21447,P-GLYCOPROTEIN 3,,,,8667431.0,ACTIVITY,,,,,organism_based,,,,,,,,,,,,TP_TRANSPORTER: increase in brain concentration in mdr1a(-/-) mouse,Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.,J. Natl. Cancer Inst.,PUBLICATION,
5638799,CHEMBL1375246,ZLASPKKZJUOFFJ-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1829432,CHEMBL1340941,IQWCJTLTXGUVMF-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4662716,CHEMBL550970,VJEGSWJGTALRBW-SWLSCSKDSA-N,PUREALDIN L,,P00740,COAGULATION FACTOR IX,F9,,,19379003.0,INHIBITION,<,5.0,%,,,,,,,,,,,,,,Inhibition of factor 9a at 222 uM after 10 min,"Clavatadines C-E, guanidine alkaloids from the Australian sponge Suberea clavata.",J. Nat. Prod.,PUBLICATION,
1093945,CHEMBL1714761,FOEVREDQDHWIBE-BLIXFSHQSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3547901,CHEMBL1727803,PXVBSXMHHOOXJW-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1947943,CHEMBL1468537,JDWBBPSLVAZGRL-ZRDIBKRKSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1479273,CHEMBL3393195,HERYOHUMBQWYLK-UHFFFAOYSA-N,,,Q13370,PHOSPHODIESTERASE 3B,PDE3B,,,25592707.0,IC50,=,6540.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant PDE3B pre-incubated for 5 mins before [3H]cAMP substrate addition and measured 20 mins post substrate addition by scintillation proximity assay,Synthesis and in vitro characterization of cinnoline and benzimidazole analogues as phosphodiesterase 10A inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2681627,CHEMBL1888875,MGMFJQCNHZOCDZ-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,18887.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3404484,CHEMBL86097,PIDQUGWLJLCCGV-UHFFFAOYSA-N,,,Q13093,LDL-ASSOCIATED PHOSPHOLIPASE A2,PLA2G7,,,11086729.0,INHIBITION,=,10.0,%,,,,,,,,,,,,,,Inhibition of lipoprotein associated phospholipase A2 in rabbit plasma at 100 nM,"N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2589069,CHEMBL2018445,LWEJQWKYQBTESX-UHFFFAOYSA-N,,,Q13547,HISTONE DEACETYLASE 1,HDAC1,,,22165909.0,IC50,=,4640.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant HDAC1 using RHKKAc peptide as substrate incubated for 5 to mins prior to substrate addition measured after 2 hrs,Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells.,J. Med. Chem.,PUBLICATION,
4045564,CHEMBL1460155,SAAMDLFHGJROHF-UHFFFAOYSA-N,,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3683642,CHEMBL344535,QNAZZNDAFAAQKP-NTISSMGPSA-N,,,"P18084, P06756",INTEGRIN ALPHA-V/BETA-5,"ITGAV, ITGB5",,,12565960.0,IC50,=,6.4,NM,,cell_based,,,,,HT-29,,,,,,,Inhibition of vitronectin binding to HT-29 cells expressing integrin alphaV-beta5,Thiophene-based vitronectin receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5176944,CHEMBL3392026,XMURZXALJYXGTJ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4732271,CHEMBL1493233,VQQCWJOKBTWVIO-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5005940,CHEMBL520897,WURBVZBTWMNKQT-UHFFFAOYSA-N,TRIADIMEFON,,Q9R1A7,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 2,,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3225207,CHEMBL23250,OOJLJEDKMZDNKK-UHFFFAOYSA-N,TCMDC-137697,,Q27713,DIHYDROFOLATE REDUCTASE,,,,3100802.0,IC50,=,12.1,NM,,,,,,,,,,,,,,Inhibitory activity against dihydrofolate reductase (DHFR) of Plasmodium berghei,"2,4-Diamino-5-benzylpyrimidines as antibacterial agents. 7. Analysis of the effect of 3,5-dialkyl substituent size and shape on binding to four different dihydrofolate reductase enzymes.",J. Med. Chem.,PUBLICATION,
5841837,CHEMBL3805612,,,,P14625,ENDOPLASMIN,HSP90B1,,,27003516.0,Inhibition,=,94.8,%,,,,,,,,,,,,,,Displacement of FITC-GDA from Grp94 (unknown origin) at 25 uM after 24 hrs by fluorescence polarization assay,Development of Glucose Regulated Protein 94-Selective Inhibitors Based on the BnIm and Radamide Scaffold.,J. Med. Chem.,PUBLICATION,
398899,CHEMBL1313846,BPXYMJLKACNGEX-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
299833,CHEMBL378373,BFJBLHQIHXGRDD-VQCVYIJISA-N,,,Q7ZJM1,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE,,,,16539381.0,IC50,=,22000.0,NM,,,,,,,,,,,,,,Inhibition of HIV1 integrase 3'-processing activity in presence of MgCl2,"Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.",J. Med. Chem.,PUBLICATION,
3569778,CHEMBL145,QAIPRVGONGVQAS-DUXPYHPUSA-N,CAFFEIC ACID,,P06280,ALPHA-GALACTOSIDASE A,GLA,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3496023,CHEMBL1259112,PSBWDCHOGUBLQH-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,20857909.0,KI,=,1.4,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]prozosin from human cloned dopamine D2 receptor expressed in CHO cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
4321128,CHEMBL1464721,TYLPTGMQARBNQU-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2212105,CHEMBL3687476,KGZCVPZUCOCCCQ-FSKGLPCWSA-N,,,Q9P1W9,SERINE/THREONINE-PROTEIN KINASE PIM2,PIM2,,,,IC50,=,1.18,NM,,,,,,,,,,,,,,"BindingDB_Patents: AlphaScreen Assay. Pim 1, Pim 2  and  Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2,  and  Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",Ring-substituted N-pyridinyl amides as kinase inhibitors,,PATENT,
675593,CHEMBL3672816,CUTVEPHNALKITM-UHFFFAOYSA-N,,,A0A059UE90,GLYCOGEN SYNTHASE KINASE-3 BETA SPLICE VARIANT X1,,,,,IC50,=,260.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. A mixture containing 100 mM MES-sodium hydroxide (pH 6.5), 1 mM magnesium acetate, 0.5 mM EGTA, 5 mM, .beta.-mercaptoethanol, 0.02% Tween 20, 10% glycerol, 12 .mu.g/ml P-GS1, 41.7 .mu.M [.gamma.-.sup.32P] ATP (68 kBq/ml), bovine cerebral TPK1 and a compound shown in Table (a final mixture contained 1.7% DMSO deriving from a solution of a test compound prepared in the presence of 10% DMSO) was used as a reaction system. The phosphorylation was started by adding ATP, and the reaction was conducted at 25.degree. C. for 2 hours, and then stopped by adding 21% perchloric acid on ice cooling. The reaction mixture was centrifuged at 12,000 rpm for 5 minutes and adsorbed on P81 paper (Whatmann), and then the paper was washed four times with 75 mM phosphoric acid, three times with water and once with acetone. The paper was dried, and the residual radioactivity was measured using a liquid scintillation counter. The results are shown in the table below.",Pyrimidone derivatives,,PATENT,
1302107,CHEMBL1403357,GLCQITIFTZRCJR-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4303643,CHEMBL1577358,TWKOJWLKHVITTP-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,7304.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4839431,CHEMBL1406379,WCRGYCASNQYQHE-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3408261,CHEMBL1588411,PIMYSBWAQQENMR-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,707.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
1026932,CHEMBL520037,FGUYNCHKIOFPMS-UHFFFAOYSA-N,GW837331X,,Q9UPE1,SERINE/THREONINE-PROTEIN KINASE SRPK3,SRPK3,,,,INHIBITION,=,3.15,%,,,,,,,,,,,,,,GSK_PKIS: MSSK1 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3156600,CHEMBL90555,OGWKCGZFUXNPDA-XQKSVPLYSA-N,VINCRISTINE,,P13945,BETA-3 ADRENERGIC RECEPTOR,ADRB3,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol),DrugMatrix in vitro pharmacology data,,DATASET,
5749750,CHEMBL2059024,ZXJRIOIBPFUSJT-XZWHSSHBSA-N,,,Q02790,FK506 BINDING PROTEIN 4,FKBP4,,,22455444.0,IC50,=,2800.0,NM,,,,,,,,,,,,,,Binding affinity to FKBP52 FK1 domain by fluorescence polarization assay,Evaluation of Synthetic FK506 Analogues as Ligands for the FK506-Binding Proteins 51 and 52.,J. Med. Chem.,PUBLICATION,
1698316,CHEMBL505670,ICCFXXDUYSPKOL-UHFFFAOYSA-N,NSC-228155,,O15648,6-PHOSPHO-1-FRUCTOKINASE,,,,,POTENCY,,2685.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Tb PFK orthogonal confirmatory assay using ATP depletion (Kinase-Glo Plus) as an alternative measure of Tb PFK activity: Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768],PUBCHEM BIOASSAY DATA SET,,DATASET,
4016895,CHEMBL373056,RWXZZBVYJHEKRB-VAWYXSNFSA-N,,,P21554,CANNABINOID CB1 RECEPTOR,CNR1,,,16213718.0,KI,=,2800.0,NM,,,,,,,,,,,,,,Displacement of [3H]CP-55940 from human recombinant CB1 receptor,New metabolically stable fatty acid amide ligands of cannabinoid receptors: Synthesis and receptor affinity studies.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2556878,CHEMBL1404209,LSTQCMQSBHWXKZ-UHFFFAOYSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,=,501.19,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5540885,CHEMBL1698319,ZAOJGMLLBBVRIY-TUQFTLKDSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3054783,CHEMBL544152,NVSMPHKVKRYAAL-UHFFFAOYSA-N,,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,13678406.0,ACTIVITY,=,420.0,%,,cell_based,,,,,A9,,,,,,,Ability to stimulate biochemical responses in cell lines expressing muscarinic A9 L receptor sub types,"Synthesis and biological characterization of 1-methyl-1,2,5,6-tetrahydropyridyl-1,2,5-thiadiazole derivatives as muscarinic agonists for the treatment of neurological disorders.",J. Med. Chem.,PUBLICATION,
2816616,CHEMBL130811,MVMQGWXVSBNFLB-UHFFFAOYSA-N,,,"P54750, O76074, Q14123, Q01064","PHOSPHODIESTERASE, PDE1/PDE5","PDE1A, PDE1B, PDE1C, PDE5A",,,12213052.0,RATIO,>,50000.0,,,,,,,,,,,,,,,Selectivity for human heart PDE-1 and human corpus cavernosum PDE-5,Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction.,J. Med. Chem.,PUBLICATION,
5726858,CHEMBL1561389,ZUTRTSJRUYNUIH-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,9200.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1765094,CHEMBL3099636,IJWCPZKNDHYTTP-UHFFFAOYSA-N,,,P28074,PROTEASOME MACROPAIN SUBUNIT MB1,PSMB5,,,24321833.0,IC50,=,670.0,NM,,,,,,,,,,,,,,Inhibition of chymotrypsin-like activity of human 20S proteasome beta 5 subunit assessed as hydrolysis of succinyl-LLVY-AMC fluorogenic substrate measured for 1 hr by fluorometric analysis,"A novel tamoxifen derivative, ridaifen-F, is a nonpeptidic small-molecule proteasome inhibitor.",Eur. J. Med. Chem.,PUBLICATION,
3319960,CHEMBL488182,OYQFARLFBYSBDE-RLBRRGQKSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,18818089.0,INHIBITION,=,20.0,%,,cell_based,,,,,HeLa,,,,,,,Inhibition of EGFR expressed in human HeLa cells at 10 ug/mL by AP1-luciferase reporter gene assay relative to control,"Synthesis and antitumoral evaluation of indole alkaloid analogues containing an hexahydropyrrolo[1',2',3':1,9a,9]imidazo[1,2-a]indole skeleton.",Bioorg. Med. Chem.,PUBLICATION,
1496490,CHEMBL1549830,HGOIQPFXVPWZRF-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2145942,CHEMBL1974328,JZTOUVBEZONDKA-UHFFFAOYSA-N,,,Q00535,CYCLIN-DEPENDENT KINASE 5,CDK5,,,,KI,=,316.23,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK5,PUBCHEM BIOASSAY DATA SET,,DATASET,
4369780,CHEMBL3196682,UDOCLNVLVFZZBK-CXUHLZMHSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,177.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3866910,CHEMBL3618332,RGMCYARQJKEXRX-GOSISDBHSA-N,,,P97639,MELANIN-CONCENTRATING HORMONE RECEPTOR 1,,,,26386604.0,KI,=,5.5,NM,,,,,,,,,,,,,,"Displacement of [125I][Phe13,Tyr19]-MCH from rat MCHR1 by scintillation counting analysis",Non-basic azolotriazinone MCHR1 antagonists for the treatment of obesity: An empirical brain-exposures-driven candidate selection for in vivo efficacy studies.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2004753,CHEMBL1868534,JKOAIXBWVHYWRQ-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,11582.1,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2404226,CHEMBL1510188,LCECJARKRYULHK-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
768321,CHEMBL1572634,DEVINRKUZNGSBV-UHFFFAOYSA-N,,,Q94696,LUCIFERASE,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Counterscreen for Luciferase (Kinase-Glo TM) Inhibition. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1364138,CHEMBL4,GSDSWSVVBLHKDQ-UHFFFAOYSA-N,OFLOXACIN,,P08913,ALPHA-2A ADRENERGIC RECEPTOR,ADRA2A,,,,KI,,,,,,,,,,Sf9,,,,,,,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DrugMatrix in vitro pharmacology data,,DATASET,
2387375,CHEMBL1463212,LAEXBDWYYIHYKN-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1454967,CHEMBL1493578,HCIBOFMYCXRYNI-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4561681,CHEMBL519881,UYDANWBUSABCEA-UHFFFAOYSA-N,GW861893X,,Q15418,RIBOSOMAL PROTEIN S6 KINASE ALPHA 1,RPS6KA1,,,,INHIBITION,=,7.14,%,,,,,,,,,,,,,,GSK_PKIS: RSK1 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3018440,CHEMBL156413,NROFNXMIPRUFIY-WLHGVMLRSA-N,,,Q9QYN8,HISTAMINE H3 RECEPTOR,,,,10052966.0,KI,=,7.94,NM,,,,,,,,,,,,,,Activity against Histamine H3 receptor of rat cerebral cortex synaptosomes of rat cerebral cortex,"Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.",J. Med. Chem.,PUBLICATION,
50903,CHEMBL1409517,ADRASFMZVRWGLU-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
150657,CHEMBL3287723,AOYJKNKRKBOUAP-UHFFFAOYSA-N,,,P08172,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,CHRM2,,,24735492.0,INHIBITION,=,-1.0,%,,,,,,,,,,,,,,Binding affinity to human muscarinic M2 receptor at 10 uM by radioligand displacement assay,Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence.,J. Med. Chem.,PUBLICATION,
1265264,CHEMBL1210744,GHBJXDOCTOUSIE-FIRIVFDPSA-N,,,P46663,BRADYKININ B1 RECEPTOR,BDKRB1,,,20573508.0,IC50,=,9.7,NM,,,,,,,,,,,,,,Antagonist activity at human bradykinin B1 receptor assessed as inhibition of Lys-desArg9-BK-induced calcium flux,Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2752304,CHEMBL492444,MOEPMTDKDUFBNH-UHFFFAOYSA-N,,,P18825,ALPHA-2C ADRENERGIC RECEPTOR,ADRA2C,,,18578476.0,KI,=,1584.89,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]RS79948-197 from human recombinant adrenergic Alpha-2C receptor expressed in CHO cells,Alpha2-adrenoreceptors profile modulation. 4. From antagonist to agonist behavior.,J. Med. Chem.,PUBLICATION,
374186,CHEMBL1593269,BNBWGPORZJPMDH-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5635672,CHEMBL3192648,ZKTMNHHMFOBHAJ-UFFVCSGVSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
865657,CHEMBL410456,DPDZHVCKYBCJHW-UHFFFAOYSA-N,,,Q07912,TYROSINE KINASE NON-RECEPTOR PROTEIN 2,TNK2,wild_type,,22037377.0,ACTIVITY,=,103.2321685,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ABLTIDE ,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
415479,CHEMBL1465646,BRWRINOIVLGINF-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1807829,CHEMBL3133595,IOLMMMMSKJTZKV-UHFFFAOYSA-N,,,P21453,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-1,S1PR1,,,,EC50,=,89.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at S1P1 receptor (unknown origin) expressed in CHO cells preincubated for 2 hrs followed by D2-labeled IP1 and Ab-Cryp addition measured after 1 hr by fluorescence assay,,MedChemComm,PUBLICATION,
1090468,CHEMBL543736,FNWXELQBKRXOHZ-ZEDZUCNESA-N,,,P23977,DOPAMINE TRANSPORTER,,,,8632426.0,IC50,=,378.0,NM,,,,,,,,,,,,,,Inhibition of [3H]WIN-35428 binding to dopamine transporter using rat striatal tissue,Synthesis and pharmacology of potential cocaine antagonists. 2. Structure-activity relationship studies of aromatic ring-substituted methylphenidate analogs.,J. Med. Chem.,PUBLICATION,
4947340,CHEMBL1304434,WODOFYSHORIFHD-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
5007468,CHEMBL1613149,WUVNSGFOXOQEJT-UHFFFAOYSA-N,,,Q9HBX9,RELAXIN RECEPTOR 1,RXFP1,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4629903,CHEMBL2051948,VFKHECGAEJNAMV-LAHCRNKXSA-N,,,P28647,ADENOSINE A3 RECEPTOR,,,,7707320.0,DISPLACEMENT,=,24.0,%,,cell_based,,,,,CHO,,,,,,,Binding affinity determined by displacement of specific binding of [125I]N-(4-amino-3-iodophenethyl)-adenosine in membranes of CHO cells stably transfected with the rat Adenosine A3 receptor,Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors.,J. Med. Chem.,PUBLICATION,
2195920,CHEMBL53753,KFHMLBXBRCITHF-UHFFFAOYSA-N,PD-158780,,P36897,TGF-BETA RECEPTOR TYPE I,TGFBR1,wild_type,,23398362.0,ACTIVITY,=,87.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10,uM,"Millipore: Percentage of residual kinase activity of TGFBR1 at 1uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2096896,CHEMBL1994036,JUPQYTORKCHMOD-YBFXNURJSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5766333,CHEMBL228687,ZZEVNYNMIVJANK-UHFFFAOYSA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,17428659.0,KI,=,1028.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]diprenorphine from human KOP receptor expressed in CHO cell membranes,Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2312161,CHEMBL3415058,KRSAIDAGFIQHKH-UHFFFAOYSA-N,,,P00734,THROMBIN,F2,,,25874337.0,IC50,=,4.84,NM,,,,,,,,,,,,,,Inhibition of human thrombin using Ac-FVR-AMC as substrate incubated for 10 mins prior to substrate addition measured for 10 min by fluorescence assay,"Design, synthesis and structural exploration of novel fluorinated dabigatran derivatives as direct thrombin inhibitors.",Eur. J. Med. Chem.,PUBLICATION,
3899701,CHEMBL3644598,RJWJDXGGEANTKR-UHFFFAOYSA-N,,,P09874,POLY [ADP-RIBOSE] POLYMERASE-1,PARP1,,,,IC50,=,15.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. A convenient method to determine IC50 of a PARP inhibitor compound is a PARP assay using purified recombinant human PARP from Trevigan (Gaithersburg, Md.), as follows: The PARP enzyme assay is set up on ice in a volume of 100 microliters consisting of 100 mM Tris-HCl (pH 8.0), 1 mM MgCl2, 28 mM KCl, 28 mM NaCl, 3.0 µg/ml of DNase I-activated herring sperm DNA (Sigma, Mo.), 30 micromolar [3H]nicotinamide adenine dinucleotide (62.5 mci/mmole), 15 micrograms/ml PARP enzyme, and various concentrations of the compounds to be tested. The reaction is initiated by adding enzyme and incubating the mixture at 25° C. After 2 minutes of incubation, the reaction is terminated by adding 500 microliters of ice cold 30% (w/v) trichloroacetic acid. The precipitate formed is transferred onto a glass fiber filter (Packard Unifilter-GF/C) and washed three times with 70% ethanol. After the filter is dried, the radioactivity is determined by scintillation counting.","PARP inhibitor compounds, compositions and methods of use",,PATENT,
2208661,CHEMBL519894,KGPAYJZAMGEDIQ-KRWDZBQOSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
407832,CHEMBL263811,BQXOJMGGMXNMBL-UHFFFAOYSA-N,,,"Q14432, Q13370",PHOSPHODIESTERASE 3,"PDE3A, PDE3B",,,11472206.0,IC50,>,3162.28,NM,,,,,,,,,,,,,,Inhibitory activity of the against phosphodiesterase 3 (PDE3); No significant inhibitory activity at pIC50,Novel selective PDE4 inhibitors. 2. Synthesis and structure-activity relationships of 4-aryl-substituted cis-tetra- and cis-hexahydrophthalazinones.,J. Med. Chem.,PUBLICATION,
3809775,CHEMBL286721,RAMROQQYRRQPDL-HNNXBMFYSA-N,AMINOPURVALANOL,,Q15303,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-4,ERBB4,wild_type,,23398362.0,ACTIVITY,=,107.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15,uM,"Millipore: Percentage of residual kinase activity of ERBB4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 2.5 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
5501138,CHEMBL1513161,YWHBBBLMRFFIBX-BQYQJAHWSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3802271,CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P21917,DOPAMINE D4 RECEPTOR,DRD4,,,9871530.0,KI,=,47.0,NM,,cell_based,,,,,CHO,,,,,,,In vitro binding affinity at human D4 dopamine receptor in CHO cells by [3H]spiperone displacement.,"Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1185266,CHEMBL1436748,FYGPBRJJHQKZOE-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3937036,CHEMBL488,ROBVIMPUHSLWNV-UHFFFAOYSA-N,AMINOGLUTETHIMIDE,,P18089,ALPHA-2B ADRENERGIC RECEPTOR,ADRA2B,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DrugMatrix in vitro pharmacology data,,DATASET,
4008378,CHEMBL261582,RVXKJZPVVOOYLJ-UHFFFAOYSA-N,,,O95749,GERANYLGERANYL PYROPHOSPHATE SYNTHETASE,GGPS1,,,17905588.0,ACTIVITY,>,100000.0,NM,,cell_based,,,,,K562,,,,,,,Inhibition of human GGDPS-mediated Rap1a geranylgeranylation in human K562 cells after 24 hrs by Western blot,Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
860695,CHEMBL1911146,DORONXPGVMNNNC-NRFANRHFSA-N,,,P04150,GLUCOCORTICOID RECEPTOR,NR3C1,wild_type,,21899328.0,EMAX,=,13.0,%,activation,cell_based,functional,enzyme_activity,,spectrophotometry,,,,"TAT SUBSTRATE (POTASSIUM PHOSPHATE BUFFER, PH 7.6, TYROSINE SODIUM SALT, PYRIDOXAL 5′-PHOSPHATE, Α-KETOGLUTARATE)",=,"200MM, 5.4NM, 0.06MM, 10.8MM",,Transactivation activity at glucocorticoid receptor alpha human 13D3/Huh7 cells assessed as induction of TAT activity after 4 hrs by spectrophotometry relative to Dexamethasone,"Azaxanthene Based Selective Glucocorticoid Receptor Modulators: Design, Synthesis, and Pharmacological Evaluation of (S)-4-(5-(1-((1,3,4-Thiadiazol-2-yl)amino)-2-methyl-1-oxopropan-2-yl)-5H-chromeno[2,3-b]pyridin-2-yl)-2-fluoro-N,N-dimethylbenzamide (BMS-776532) and Its Methylene Homologue (BMS-791826).",J. Med. Chem.,PUBLICATION,
470936,CHEMBL1446073,BYFDYIHNLMBPDD-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,2612.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. InCell qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Hit Validation. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5399694,CHEMBL611733,YLBVEDBKVYZZNS-UHFFFAOYSA-O,,,Q965D5,ENOYL-ACYL-CARRIER PROTEIN REDUCTASE,,,,17477517.0,IC50,=,40000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of Plasmodium falciparum recombinant enoyl ACP reductase expressed in BL21 (DE3) cells,Discovery of a rhodanine class of compounds as inhibitors of Plasmodium falciparum enoyl-acyl carrier protein reductase.,J. Med. Chem.,PUBLICATION,
549372,CHEMBL2152035,CGPUSPDYHXPTBF-UHFFFAOYSA-N,,,Q9NR71,NEUTRAL CERAMIDASE,ASAH2,,,22989912.0,INHIBITION,,,,,cell_based,,,,,Sf9,,,,,,,Inhibition of recombinant human nCDase expressed in Sf9 cells using fluorescently-labeled acyl-NBD-C12-ceramide as substrate at 80 uM after 2 hrs by fluorescence assay,Novel amide- and sulfonamide-based aromatic ethanolamines: effects of various substituents on the inhibition of acid and neutral ceramidases.,Bioorg. Med. Chem.,PUBLICATION,
1747103,CHEMBL1599746,IHUQJNWWFPKMFR-QGOAFFKASA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4529684,CHEMBL1455,UUVWYPNAQBNQJQ-UHFFFAOYSA-N,ALTRETAMINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,KI,,,,,,,,,,MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
106163,CHEMBL1873639,AJXXMZKFJCZGSL-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5325576,CHEMBL83154,YCSBALJAGZKWFF-UHFFFAOYSA-N,2-AMINOANTHRACENE,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,17527.2,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2133861,CHEMBL1377973,JYMATOLOUZWCRG-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4517761,CHEMBL83623,UTNNZWWKLIJITH-LOSJGSFVSA-N,,,"P03372, Q92731",ESTROGEN RECEPTOR,"ESR1, ESR2",,,15109649.0,IC50,,,,,organism_based,,,,,HEK293,,,,,,,In vivo inhibition of human ERalpha/ERbeta co-expressed in HEK 293 cells; ND=Not determined,Estrogen receptor ligands. Part 3: The SAR of dihydrobenzoxathiin SERMs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
243812,CHEMBL215205,AYZRKFOEZQBUEA-OUKQBFOZSA-N,,,Q16816,PHOSPHORYLASE KINASE GAMMA SUBUNIT 1,PHKG1,,,21777997.0,ACTIVITY,=,29.0,%,,,,,,,,,,,,,,Inhibition of PHKG1 assessed as residual activity at 10 uM by radioactivity assay in presence of 50 uM ATP,The selective P-TEFb inhibitor CAN508 targets angiogenesis.,Eur. J. Med. Chem.,PUBLICATION,
3798098,CHEMBL1201001,QZIQJVCYUQZDIR-UHFFFAOYSA-N,MECHLORETHAMINE HYDROCHLORIDE,,P04150,GLUCOCORTICOID RECEPTOR,NR3C1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of glucocorticoid receptor signaling. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
559,CHEMBL1600410,AABJEMQLIHBZAW-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2159946,CHEMBL1325264,KBHWWBGJCKYLMT-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1859342,CHEMBL3310016,IUEJRPNRKWUJEV-NRFANRHFSA-N,,,P21397,MONOAMINE OXIDASE A,MAOA,,,24986657.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Reversible inhibition of human MAOA expressed in baculovirus-infected BTI insect cells pre-incubated for 1 hr followed by centrifugation-ultrafiltration by resorufin dye based fluorimetry,Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2187084,CHEMBL273312,KEHDGXFGMIOLCR-UHFFFAOYSA-N,,,P35348,ALPHA-1A ADRENERGIC RECEPTOR,ADRA1A,,,12643939.0,MAX RESPONSE,=,39.0,%,,,,,,,,,,,,,,Maximal response assayed via calcium mobilization to the human alpha-1A adrenergic receptor compared the percent of the 40 mM phenylephrine response,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: alpha1a subtype selective 2'-heteroaryl compounds.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2583875,CHEMBL2375456,LVOTYHYJWWIIGB-YMLAAAECSA-N,,,P18031,PROTEIN-TYROSINE PHOSPHATASE 1B,PTPN1,,,23531458.0,IMAX,=,64.75,%,,,,,,,,,,,,,,Inhibition of PTP1B (unknown origin) expressed in Escherichia coli expression system using p-nitrophenyl phosphate as substrate assessed as release of p-nitrophenol at 10 ug/mL incubated for 10 mins prior to substrate addition measured after 30 mins relative to control,Synthesis and biological evaluation of oleanolic acid derivatives as PTP1B inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
3580886,CHEMBL1609054,QBPWXUQYOYYVHP-BUHFOSPRSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3129220,CHEMBL1802485,ODZGYELAMAOARP-UHFFFAOYSA-N,,,P23443,RIBOSOMAL PROTEIN S6 KINASE 1,RPS6KB1,wild_type,,23398362.0,ACTIVITY,=,62.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15,uM,"Millipore: Percentage of residual kinase activity of RPS6KB1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
600753,CHEMBL2218931,CMKMGFAUKPAOMG-CQSZACIVSA-N,,,P42681,TYROSINE-PROTEIN KINASE TXK,TXK,wild_type,,23398362.0,ACTIVITY,=,91.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of TXK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2960350,CHEMBL1453188,NLENUXQYGCDSNE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4224225,CHEMBL1324995,STWAQHZZBCQKST-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1652167,CHEMBL1448447,HXKIXANWEUKUOS-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
3201841,CHEMBL1546211,OLVFOFYIPMTXTH-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2427650,CHEMBL1303681,LEVUICRLFJDCDL-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
225778,CHEMBL305477,AWYYOUZTURFIFO-FOKLQQMPSA-N,GW829874X,,P06239,TYROSINE-PROTEIN KINASE LCK,LCK,,,,INHIBITION,=,8.97,%,,,,,,,,,,,,,,GSK_PKIS: LCK mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1505201,CHEMBL219146,HHJUWIANJFBDHT-KOTLKJBCSA-N,VINDESINE,,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,,IC50,,,,,,,,,,MDCK,,,,,,,DRUGMATRIX: Norepinephrine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
4175878,CHEMBL297626,SOTLBUKMGXVUFG-UHFFFAOYSA-N,,,Q05769,CYCLOOXYGENASE-2,,,,15026065.0,IC50,=,0.01,UG.ML-1,,,,,,,,,,,,,,Inhibitory concentration against prostaglandin G/H synthase 2 in mouse peritoneal macrophages,A prodrug approach to COX-2 inhibitors with methylsulfone.,Bioorg. Med. Chem. Lett.,PUBLICATION,
748756,CHEMBL1315683,DCRBHANWOMIVPT-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1236590,CHEMBL2007377,GEAGDHRIXNWKKF-CVKSISIWSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
651845,CHEMBL1905341,CSKMTXOWMSAOQU-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4633058,CHEMBL1490960,VFSWRVCQVBVRTK-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,75193.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4598284,CHEMBL3330466,VCCZBPRISWIBNC-ZFWWWQNUSA-N,,,P00742,COAGULATION FACTOR X,F10,,,25179681.0,IC50,=,8080.0,NM,,,,,,,,,,,,,,"Inhibition of human factor 10a using N-Z-D-Arg-Gly-Arg-pNA, S-2765 chromogenic substrate","Design, synthesis, and structure-activity and structure-pharmacokinetic relationship studies of novel [6,6,5] tricyclic fused oxazolidinones leading to the discovery of a potent, selective, and orally bioavailable FXa inhibitor.",J. Med. Chem.,PUBLICATION,
1494404,CHEMBL1980889,HGHXQEAQLCPUAU-AWNIVKPZSA-N,,,P07378,"PHOSPHOGLYCERATE KINASE, GLYCOSOMAL",,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4581085,CHEMBL1350444,VAGIFARZJYAPQL-SFHVURJKSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,37933.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3479494,CHEMBL165861,PQFPGVBGDZEYHR-UHFFFAOYSA-N,,,"P35563, Q9JJ16",SEROTONIN 3 (5-HT3) RECEPTOR,,,,9513601.0,KI,>,17000.0,NM,,,,,,,,,,,,,,Ability to displace [3H]granisetron specifically bound to 5-hydroxytryptamine 3 receptor in rat cortical membrane,Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 1. Mapping the central 5-HT3 receptor binding site by arylpiperazine derivatives.,J. Med. Chem.,PUBLICATION,
5719874,CHEMBL1439983,ZTXOKDSGOJNDCH-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,37933.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
363302,CHEMBL1801495,BLYHNNQBGAYJIW-UHFFFAOYSA-N,,,P29475,"NITRIC-OXIDE SYNTHASE, BRAIN",NOS1,,,20931971.0,EC50,=,520.0,NM,,cell_based,,,,,HEK293,,,,,,,"Inhibition of human nNOS expressed in HEK293 cells assessed as inhibition ionomycin induced nitric oxide production incubated for 24 hrs measured after 18 hrs of ionomycin challenge using 2,3-diaminonaphthalene by fluorescence assay","Discovery of dual inducible/neuronal nitric oxide synthase (iNOS/nNOS) inhibitor development candidate 4-((2-cyclobutyl-1H-imidazo[4,5-b]pyrazin-1-yl)methyl)-7,8-difluoroquinolin-2(1H)-one (KD7332) part 2: identification of a novel, potent, and selective series of benzimidazole-quinolinone iNOS/nNOS dimerization inhibitors that are orally active in pain models.",J. Med. Chem.,PUBLICATION,
505195,CHEMBL271843,CBXVHMLTAMBOAT-UHFFFAOYSA-N,GW275944X,,P49841,GLYCOGEN SYNTHASE KINASE-3 BETA,GSK3B,,,,INHIBITION,=,1.9,%,,,,,,,,,,,,,,GSK_PKIS: GSK3B mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2114753,CHEMBL1585002,JWMGIIIMPAQNFY-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2394951,CHEMBL1306749,LBCWZIMQKJWBFB-UHFFFAOYSA-N,,,C4YTQ8,ATP-DEPENDENT MOLECULAR CHAPERONE HSP82,,,,,EC50,=,7030.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence Cell-Based Secondary Assay to Identify Inhibitors of Resistant C. albicans Growth in the Presence of Fluconazole. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1979, AID2007]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5500272,CHEMBL1485255,YWFPDXYLTQTWFD-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4306482,CHEMBL1403937,TWSVURCWPHWPRC-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,1768.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1207735,CHEMBL553025,GBABOYUKABKIAF-IELIFDKJSA-N,VINORELBINE BASE,,P41597,C-C CHEMOKINE RECEPTOR TYPE 2,CCR2,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Chemokine CCR2B radioligand binding (ligand: [125I] MCP-1),DrugMatrix in vitro pharmacology data,,DATASET,
4112665,CHEMBL19315,SHLQXYASXAHMIS-UHFFFAOYSA-N,,,Q99720,SIGMA OPIOID RECEPTOR,SIGMAR1,,,8164264.0,KI,=,0.32,NM,,,,,,,,,,,,,,Binding affinity against sigma-1 receptor of guinea pig brain membranes using [3H]pentazocine as radioligand,Structural features important for sigma 1 receptor binding.,J. Med. Chem.,PUBLICATION,
852926,CHEMBL1716176,DNYNSYBKTMCOAB-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,89.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
418451,CHEMBL1578804,BSGVXZDUDZQJNU-UHFFFAOYSA-N,,,Q4R6F8,T-COMPLEX PROTEIN 1 SUBUNIT BETA,,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991],PUBCHEM BIOASSAY DATA SET,,DATASET,
3419990,CHEMBL1539,PJSFRIWCGOHTNF-UHFFFAOYSA-N,SULFADOXINE,,P00918,CARBONIC ANHYDRASE II,CA2,,,,IC50,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DrugMatrix in vitro pharmacology data,,DATASET,
5465707,CHEMBL597561,YSCJZJPYACVLEA-UHFFFAOYSA-N,,,P97612,ANANDAMIDE AMIDOHYDROLASE,,,,20143779.0,INHIBITION,=,100.0,%,,tissue,,,,,,,,,,,,Inhibition of FAAH-mediated [3H]AEA hydrolysis in rat brain homogenate by liquid scintillation spectroscopy relative to control,Synthesis and evaluation of paracetamol esters as novel fatty acid amide hydrolase inhibitors.,J. Med. Chem.,PUBLICATION,
2273538,CHEMBL1516336,KNVMUAIXPPLLMD-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3771677,CHEMBL1611267,QWMMYDYTKDDDCJ-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1612199,CHEMBL151214,HSYOVYMEIHEOMC-UHFFFAOYSA-N,,,Q64640,ADENOSINE KINASE,,,,14613327.0,IC50,=,5.0,NM,,tissue,,,,,,,,,,,,Inhibition adenosine kinase activity in rat brain in vitro,"5,6,7-trisubstituted 4-aminopyrido[2,3-d]pyrimidines as novel inhibitors of adenosine kinase.",J. Med. Chem.,PUBLICATION,
1995542,CHEMBL1766361,JJJYLXJYOQSRKD-UHFFFAOYSA-N,,,"Q9BVA1, Q9BUF5, Q9BQE3, Q6PEY2, Q13885, P68363, Q13509, P68371, Q71U36, P07437, Q3ZCM7, P04350, Q9H4B7, P68366, Q13748",TUBULIN,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",,,21402478.0,INHIBITION,,,,,cell_based,,,,,A549,,,,,,,Inhibition of tubulin polymerization in human A549 cells assessed as disrupted microtubule organization at 1 uM after 48 hrs by immunohistochemistry,"Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.",Bioorg. Med. Chem.,PUBLICATION,
1073375,CHEMBL1490041,FMABFSDXQZDQEM-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,,7943.28,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Quantitative High-Throughput Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Summary. (Class of assay: summary) [Related pubchem assays (depositor defined):AID1471, AID1688, AID2669, AID2672, AID2673, AID2713]",PUBCHEM BIOASSAY DATA SET,,DATASET,
708258,CHEMBL3675928,CYJPVTPYPTUQAC-AGQSAPNSSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,IC50,=,186.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 µM ATP, 10 µM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 4 nM Jak2 in a total volume of 20 µL. Human Jak2 kinase domain comprising amino acids 808-1132 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV4210).","Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors",,PATENT,
5379831,CHEMBL1462157,YIXKWRRUVCLCCE-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3238309,CHEMBL1477654,OPXCUUJACRRYMC-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
2457855,CHEMBL3144951,LIJDRSPSHXYFCW-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5361230,CHEMBL1867956,YGSFROAXHAMMHQ-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2482437,CHEMBL1438442,LLDCQQMMXZBMKN-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3294584,CHEMBL405618,OVVIBUHLQIYUEU-IWIISZHXSA-N,ANALOG OF DYNORPHIN A,,,&#954; opioid receptor (KOR Q115A),,,,24121503.0,KI,=,120.0,NM,,,,,,,,,,,,,,,,,,
1892596,CHEMBL3693743,IYADGYDKRDAQFR-UHFFFAOYSA-N,,,Q9UBN7,HISTONE DEACETYLASE 6,HDAC6,,,,IC50,=,85.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assays. Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were diluted in assay buffer (50 mM HEPES, pH 7.4, 100 mM KCl, 0.001% Tween-20, 0.05% BSA, 20 uM TCEP) to 6 fold their final concentration. The HDAC enzymes (purchased from BPS Biosciences) were diluted to 1.5 fold their final concentration in assay buffer. The tripeptide substrate and trypsin at 0.05 uM final concentration were diluted in assay buffer at 6 fold their final concentration. The final enzyme concentrations used in these assays were 3.3 ng/ml (HDAC1), 0.2 ng/ml (HDAC2), 0.08 ng/ml (HDAC3) and 2 ng/ml (HDAC6). The final substrate concentrations used were 16 uM (HDAC1), 10 uM (HDAC2), 17 uM (HDAC3) and 14 uM (HDAC6).",Reverse amide compounds as protein deacetylase inhibitors and methods of use thereof,,PATENT,
1198347,CHEMBL553856,FZWFTTQDIUWUHE-LJAQVGFWSA-N,,,Q9H244,PURINERGIC RECEPTOR P2Y12,P2RY12,,,19604694.0,KI,=,69.0,NM,,cell_based,,,,,CHO,,,,,,,Binding affinity to human recombinant P2Y12 receptor expressed in CHO cells,Piperazinyl-glutamate-pyridines as potent orally bioavailable P2Y12 antagonists for inhibition of platelet aggregation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4399831,CHEMBL222419,UHCHLTQBLNUYRT-GFCCVEGCSA-N,GSK-237701A,,Q9UQM7,CAM KINASE II ALPHA,CAMK2A,,,,INHIBITION,=,7.42,%,,,,,,,,,,,,,,GSK_PKIS: CAMK2A mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1464562,CHEMBL1703767,HDFPELQVEWDRJZ-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2554761,CHEMBL1602164,LSOUOZODHCGMCX-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3086507,CHEMBL1582384,NZHKTPOMUKMKPW-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,18356.4,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
482524,CHEMBL20,BZKPWHYZMXOIDC-UHFFFAOYSA-N,ACETAZOLAMIDE,,P00918,CARBONIC ANHYDRASE II,CA2,,,17482815.0,KM,=,9300000.0,NM,,,,,,,,,,,,,,Activity of human CA2 at pH 7.5 by CO2 hydration assay,Carbonic anhydrase inhibitors: the beta-carbonic anhydrase from Helicobacter pylori is a new target for sulfonamide and sulfamate inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4601378,CHEMBL611,VCKUSRYTPJJLNI-UHFFFAOYSA-N,TERAZOSIN,,Q12809,HERG,KCNH2,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Potassium Channel HERG radioligand binding (ligand: [3H] Astemizole),DrugMatrix in vitro pharmacology data,,DATASET,
1583462,CHEMBL1535572,HPQNRFINRZQSMY-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2779520,CHEMBL1410486,MRHOWXODTULEDY-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,5.2,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3595858,CHEMBL428496,QDLHCMPXEPAAMD-QAIWCSMKSA-N,WORTMANNIN,,Q16512,PROTEIN KINASE N1,PKN1,wild_type,,22037377.0,ACTIVITY,=,94.22924316,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,GLYCOGEN ,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2466723,CHEMBL3210578,LJKIDKSBUMUGSD-ZCXUNETKSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3180559,CHEMBL1485048,OJMNTWPPFNMOCJ-UHFFFAOYSA-M,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1896471,CHEMBL441897,IYKCWOIZNVHUMI-GUYCJALGSA-N,,,P05129,PROTEIN KINASE C GAMMA,PRKCG,,,17977729.0,KI,=,1510.0,NM,,,,,,,,,,,,,,Displacement of [3H]PDBu from PKCgamma C1A domain,Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.,Bioorg. Med. Chem.,PUBLICATION,
5605279,CHEMBL84391,ZHGQWUUWKIQCDS-UHFFFAOYSA-N,,,P34158,CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR,,,,12852954.0,ACTIVITY,=,45.0,%,,,,,,,,,,,,,,Percent activity against CFTR (cystic fibrosis transmembrane conductance regulator) in rat relative to UCCF-152(50 uM),3-(2-Benzyloxyphenyl)isoxazoles and isoxazolines: synthesis and evaluation as CFTR activators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2418023,CHEMBL373751,LDTAHRLHGHFHKP-UHFFFAOYSA-N,GSK-319347A,,Q9UM73,ALK TYROSINE KINASE RECEPTOR,ALK,,,,INHIBITION,=,9.85,%,,,,,,,,,,,,,,GSK_PKIS: ALK mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3409638,CHEMBL522892,PIQCTGMSNWUMAF-UHFFFAOYSA-N,DOVITINIB,,Q16620,NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 2,NTRK2,wild_type,,22037378.0,KD,=,720.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for TRKB kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
1401913,CHEMBL1415738,GWLNJRGKUHEFCC-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3670440,CHEMBL1415756,QLSMRFDUKLEGJW-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1777869,CHEMBL495698,ILIWVAFIMXCJTB-UHFFFAOYSA-N,,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,18752952.0,KI,=,0.1,NM,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at human histamine H3 receptor expressed in HEK293 cells assessed as reversal of N-alpha-methylhistamine-induced inhibition of forskolin-stimulated cAMP formation,Benzimidazole-substituted (3-phenoxypropyl)amines as histamine H3 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2716212,CHEMBL1311227,MKPRBADKSRGHDI-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2809376,CHEMBL1359903,MUYBWNBRPJJRMK-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23099.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4477008,CHEMBL1563861,UPHYVKGODXLYCF-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1237225,CHEMBL1517028,GECDNJNYMZBVBU-LBPRGKRZSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
240096,CHEMBL2442239,AYOQZYIGBZUOIH-VHEIIQRDSA-N,,,P56817,BETA-SECRETASE 1,BACE1,,,23993670.0,INHIBITION,=,58.0,%,,,,,,,,,,,,,,Inhibition of recombinant human BACE1 at 2 uM by FRET analysis,Novel BACE1 inhibitors with a non-acidic heterocycle at the P1' position.,Bioorg. Med. Chem.,PUBLICATION,
508400,CHEMBL1352117,CCHYDEOHCJSSKW-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5508378,CHEMBL3702054,YXBKCKHBHRIXQX-UHFFFAOYSA-N,,,P11802,CYCLIN-DEPENDENT KINASE 4,CDK4,,,,IC50,=,33.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Assay. The Cdk4 and Cdk6 inhibitory activity of the compounds is measured with a kinase inhibition assay using recombinant Cdk4/CyclinD1 or Cdk6/CyclinD3 protein complexes. The protein substrate used in the assay is the retinoblastoma protein (Rb). The kinase reactions are carried out in a 96-well filter plate (MSDV N6B50, Millipore). Compounds are serially diluted in kinase buffer (20 mM Tris-HCl, pH 7.4, 50 mM NaCl, 1 mM DTT, 1 mg/ml BSA) and added to the reaction mixture containing 2.5 ng/ml Cdk4/CyclinD1 or Cdk6/CyclinD3, 25 µM ATP, 10 µCi/ml [33P]-ATP, 0.1 µg/ml Rb in the kinase buffer. The mixture is incubated at room temperature for 1 hour and the proteins precipitated with an equal volume of 20% TCA. The plates are washed with 10% TCA according to the manufacturer's instruction and dried at room temperature. The amount of the phosphorylated Rb is determined with a TopCount (PerkinElmer).","Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors",,PATENT,
1802991,CHEMBL2326954,INVUNGLLMHOUEN-UHFFFAOYSA-N,,,P42336,PI3-KINASE P110-ALPHA SUBUNIT,PIK3CA,,,23410005.0,IC50,=,56.0,NM,,,,,,,,,,,,,,Inhibition of PI3K p110alpha (unknown origin),"Synthesis and cancer stem cell-based activity of substituted 5-morpholino-7H-thieno[3,2-b]pyran-7-ones designed as next generation PI3K inhibitors.",J. Med. Chem.,PUBLICATION,
1770254,CHEMBL238154,IKLPEMFMSKFWMF-UHFFFAOYSA-N,,,Q01727,MELANOCORTIN RECEPTOR 1,,,,17618123.0,KI,=,1700.0,NM,,cell_based,,,,,B16,,,,,,,Displacement of [125I]NDP-MSH from MC1 receptor in mouse B16 cells,Design and synthesis of a library of tertiary amides: evaluation as mimetics of the melanocortins' active core.,Bioorg. Med. Chem.,PUBLICATION,
1901553,CHEMBL1538113,IYWZVSXMWXGDFG-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,674.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4425908,CHEMBL381738,UJNGZMPNPWMTDP-UHFFFAOYSA-N,,,Q9UM73,ALK TYROSINE KINASE RECEPTOR,ALK,,,16451066.0,IC50,=,1300.0,NM,,,,,,,,,,,,,,Inhibitory activity against ALK,Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase.,J. Med. Chem.,PUBLICATION,
5675179,CHEMBL1497629,ZPDNERUPJPVOLW-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1957774,CHEMBL10839,JFDLROYLPHDXTE-QFIPXVFZSA-N,,,"P06756, P05106",INTEGRIN ALPHA-V/BETA-3,"ITGAV, ITGB3",,,12643914.0,KI,=,11.0,NM,,,,,,,,,,,,,,Binding affinity towards vitronectin receptor (alpha V-beta3) was determined,Biphenyls as potent vitronectin receptor antagonists. Part 2: biphenylalanine ureas.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5009825,CHEMBL1864200,WUZDMLIXHIFWLR-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4813044,CHEMBL1579275,VZSHRQFJGUVAAB-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,1584.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5829145,CHEMBL3751978,,,,P29275,ADENOSINE A2B RECEPTOR,ADORA2B,,,26638043.0,Inhibition,=,1.0,%,,,,,,,,,,,,,,Antagonist activity at human A2B receptor expressed in CHO cells assessed as inhibition of NECA-stimulated cAMP production at 1 uM by scintillation counting method,"Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor.",Eur. J. Med. Chem.,PUBLICATION,
1531573,CHEMBL1416702,HKFOBKHXPHNEOD-UHFFFAOYSA-N,,,"Q01196, Q13951",RUNT-RELATED TRANSCRIPTION FACTOR 1/CORE-BINDING FACTOR SUBUNIT BETA,"CBFB, RUNX1",,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4826425,CHEMBL1314602,WBFBUSAZALVWJQ-UHFFFAOYSA-N,,,Q57TT1,PUTATIVE UNCHARACTERIZED PROTEIN,,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2302995,CHEMBL1462819,KQWCMWVHCFJFCN-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
760679,CHEMBL1328036,DDWSMYWTXCCWEV-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,446.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5753950,CHEMBL1432251,ZXUIHBQNPSDKNZ-FOCLMDBBSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1586415,CHEMBL38874,HPZJMUBDEAMBFI-WTNAPCKOSA-N,DAMGO,,P35372,MU OPIOID RECEPTOR,OPRM1,,,7815359.0,KI,=,1.4,NM,,,,,,,,,,,,,,,,,,
4587018,CHEMBL1542649,VAVVIAOWQRDAPK-UHFFFAOYSA-N,,,Q9GZV3,HIGH-AFFINITY CHOLINE TRANSPORTER,SLC5A7,,,,IC50,,15865.74,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose responses of compounds that inhibit the Choline Transporter (CHT) - 5 point CRC. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488975, AID488997, AID493221, AID493222]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5370311,CHEMBL1595632,YHVCBUHGIBCVTQ-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
320808,CHEMBL1563370,BHMAAIAPZUZRTC-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3810418,CHEMBL1501153,RANFNRWGTXIDKI-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
4966930,CHEMBL1551314,WQIBSMVWPSPDQF-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4091610,CHEMBL1956867,SFFYVRPLWQGRDX-UHFFFAOYSA-L,,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,22342268.0,KI,=,0.251,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]-Bradykinin from human bradykinin B2 receptor expressed in CHO cells membrane after 60 mins by scintillation counting,"Design and synthesis of novel sulfonamide-containing bradykinin hB(2) receptor antagonists. Synthesis and structure-relationships of a,a-tetrahydropyranylglycine.",Bioorg. Med. Chem.,PUBLICATION,
2240550,CHEMBL1381951,KKHUOFVHGUYCDB-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4550451,CHEMBL1327403,UXBAABFGZBLQNS-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
188814,CHEMBL1366525,ASYZOADETZSQIW-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2658239,CHEMBL259888,MDYRCEZNRQFYDB-UHFFFAOYSA-N,,,P18031,PROTEIN-TYROSINE PHOSPHATASE 1B,PTPN1,,,24185377.0,INHIBITION,=,57.46,%,,,,,,,,,,,,,,Inhibition of recombinant human PTP1B at 10 uM by malachite green assay relative to control,"Design, synthesis and molecular modelling studies of novel 3-acetamido-4-methyl benzoic acid derivatives as inhibitors of protein tyrosine phosphatase 1B.",Eur. J. Med. Chem.,PUBLICATION,
2599156,CHEMBL98802,LXIJGOPVTSVKPS-DYVMYPEFSA-N,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,12270178.0,KI,=,2420.0,NM,,,,,,,,,,,,,,Receptor binding affinity for the adenosine A2A receptor were determined using [3H]ZM-241385 as a radioligand in pig,Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2438347,CHEMBL1512803,LGDULKPAXYPOIO-UHFFFAOYSA-N,,,P10828,THYROID HORMONE RECEPTOR BETA-1,THRB,,,,POTENCY,=,100.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3967682,CHEMBL1766626,RRICXSUQKJIROQ-UHFFFAOYSA-N,,,P27338,MONOAMINE OXIDASE B,MAOB,,,24169316.0,ACTIVITY,=,-10.4,%,,,,,,,,,,,,,,Inhibition of MAO-B (unknown origin) assessed as residual activity,Chromenylchalcones with inhibitory effects on monoamine oxidase B.,Bioorg. Med. Chem.,PUBLICATION,
2295375,CHEMBL1890170,KQDRHIRVZUQUFL-UHFFFAOYSA-N,,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5203296,CHEMBL1976317,XPUVYFAZUFZFKC-PTGBLXJZSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2824330,CHEMBL1453700,MWJQXHZIUSMPSJ-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2032422,CHEMBL1938643,JNNQSTULXLHQBB-UHFFFAOYSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,22087750.0,RATIO IC50,=,127.0,,,cell_based,,,,,,,,,,,,Ratio of IC50 for JAK2 expressed in Ba/F3 cells by AlphaScreen assay to IC50 for human recombinant JAK2 by TR-FRET assay,Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors.,J. Med. Chem.,PUBLICATION,
729429,CHEMBL1964275,DANPUZSWWCDWEM-UHFFFAOYSA-N,,,Q02763,TYROSINE-PROTEIN KINASE TIE-2,TEK,wild_type,,19035792.0,ACTIVITY,,,,inhibition,physiochemical,binding,binding_reversible,competitive_inhibitor,qPCR,,10000,NM,,,,,Binding affinity to human TIE2 at 10 uM relative to control,Assessment of chemical coverage of kinome space and its implications for kinase drug discovery.,J. Med. Chem.,PUBLICATION,"IN THIS ASSAY, 0% MEANS PHAGE/KINASE-FUSION WAS POTENTLY DISPLACED BY THE DRUG, WHICH MEANS THE DRUG IS VERY EFFECTIVE. CONVERSELY, 100% MEANS ALL PHAGE REMAINED BOUND, WHICH SIGNIFIES THE DRUG HAD NO EFFECT = NO BINDING TO THE KINASE"
3005868,CHEMBL57,NQDJXKOVJZTUJA-UHFFFAOYSA-N,NEVIRAPINE,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3799543,CHEMBL1330957,QZNVRCIXEYLABT-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,POTENCY,=,316.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2216087,CHEMBL169873,KHNWJDINXUXFHT-DCWSAZFOSA-N,,,P30968,GONADOTROPIN-RELEASING HORMONE RECEPTOR,GNRHR,,,11859012.0,IC50,=,43.9,NM,,,,,,,,,,,,,,Inhibition of gonadotropin-releasing hormone receptor-stimulated [3H]inositol phosphate hydrolysis,2-Arylindoles as gonadotropin releasing hormone (GnRH) antagonists: optimization of the tryptamine side chain.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5593745,CHEMBL128593,ZFZUYTCCHMWWTD-UHFFFAOYSA-N,,,"P15823, P22909, P43140, P19328, P22086, P23944",ADRENERGIC RECEPTOR ALPHA,,,,7562941.0,MAX,=,95.0,MMHG,,,,,,,,,,,,,,"Alpha adrenergic activity was evaluated as maximal pressure response caused by agonist, expressed in mmHg (the maximum obtained with phenylephrine is 150 mmHg).","Design, synthesis, and structure-activity relationships of a new series of alpha-adrenergic agonists: spiro[(1,3-diazacyclopent-1-ene)-5,2'-(1',2',3',4'- tetrahydronaphthalene)].",J. Med. Chem.,PUBLICATION,
1568788,CHEMBL7364,HOAREJUGBLUUJD-MJSJRNKMSA-N,,,"P22612, P17612, P22694",CAMP-DEPENDENT PROTEIN KINASE (PKA),"PRKACA, PRKACB, PRKACG",,,9871700.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of protein kinase A at 240 uM (No inhibition),Design of new inhibitors for cdc2 kinase based on a multiple pseudosubstrate structure.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1833243,CHEMBL1354734,IRHXGOXEBNJUSN-OMGRJGNGSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,12589.25,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
9693,CHEMBL1456349,AAVYQEIAQDJKNU-UHFFFAOYSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,11193.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1168635,CHEMBL1573443,FWKVMPPPEFOQLK-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,1412.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
713335,CHEMBL75880,CYXKNKQEMFBLER-UHFFFAOYSA-N,PERHEXILINE,,P32198,CARNITINE PALMITOYLTRANSFERASE 1A,,,,21504156.0,IC50,=,77000.0,NM,,,,,,,,,,,,,,Inhibition of CPT1 in rat cardiac mitochondria using [3H]carnitine by radiometric method,Carnitine Palmitoyltransferase (CPT) Modulators: A Medicinal Chemistry Perspective on 35 Years of Research.,J. Med. Chem.,PUBLICATION,
5818418,CHEMBL3764518,,,,P39898,PLASMEPSIN 1,,,,26670264.0,IC50,=,9400.0,NM,,,,,,,,,,,,,,Inhibition of Plasmodium falciparum plasmepsin 1 preincubated for 30 mins followed by DABCYL-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-EDANS substrate addition by FRET assay,"Fragment-Based Discovery of 2-Aminoquinazolin-4(3H)-ones As Novel Class Nonpeptidomimetic Inhibitors of the Plasmepsins I, II, and IV.",J. Med. Chem.,PUBLICATION,
3803451,CHEMBL1509368,QZVGIRSOKOZOLV-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2293094,CHEMBL302196,KPXVCGPCRXEDLT-OAHLLOKOSA-N,A-304121,,P25021,HISTAMINE H2 RECEPTOR,HRH2,,,12606603.0,KI,=,10000.0,NM,,,,,,,,,,,,,,,,,,
4766255,CHEMBL1301598,VUNXUJWCGQLSKJ-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3814,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,ERLOTINIB,,Q15759,MAP KINASE P38 BETA,MAPK11,,,15711537.0,KD,,,,,,,,,,,,,,,,,Average Binding Constant for p38-beta; NA=Not Active at 10 uM,A small molecule-kinase interaction map for clinical kinase inhibitors.,Nat. Biotechnol.,PUBLICATION,
5576467,CHEMBL1359609,ZEDCDLQHBHXSFT-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,6745.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2281521,CHEMBL1471932,KOTHBZNIJDYYPY-SXGWCWSVSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2069263,CHEMBL1351362,JRQPHAYPLDKISU-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
2854878,CHEMBL184702,MZRCRDHXYKYBSB-UHFFFAOYSA-N,,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,15501042.0,IC50,,,,,,,,,,,,,,,,,inhibitory concentration required to inhibit Ab1 tyrosine kinase was not determined,Urea derivatives of STI571 as inhibitors of Bcr-Abl and PDGFR kinases.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1253134,CHEMBL1501707,GFUIVIGQVGIYEU-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
120713,CHEMBL1391421,ALNDHUQPXHHNON-JXMROGBWSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,18887.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2203064,CHEMBL1370664,KFWUMUYBEZOXTE-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4726060,CHEMBL1489273,VPWXRXYKNADFAY-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5185334,CHEMBL1553604,XNTCJOYWOBRSFN-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1140427,CHEMBL352257,FTDRSCZZEUAAIP-UHFFFAOYSA-N,ME-3221,,P34976,ANGIOTENSIN II TYPE 1A (AT-1A) RECEPTOR,,,,21071232.0,KD,=,1.51,NM,,,,,,,,,,,,,,Antagonist activity at angiotensin AT1 receptor in rabbit aorta assessed as reduction of angiotensin 2-induced contractile response,Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists--a perspective.,Bioorg. Med. Chem.,PUBLICATION,
5759765,CHEMBL1440078,ZYKBYMVWSFCXRR-NTEUORMPSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3465762,CHEMBL103871,PORLBUSMWVWYQB-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,9016321.0,KI,=,254.0,NM,,cell_based,,,,,CHO,,,,,,,Binding affinity on human Dopamine receptor D2 expressed in CHO cells using radioligand [3H]-YM 09151,2-Phenyl-4(5)-[[4-(pyrimidin-2-yl)piperazin-1-yl]methyl]imidazole. A highly selective antagonist at cloned human D4 receptors.,J. Med. Chem.,PUBLICATION,
4769271,CHEMBL447571,VUXDSWRSGDQYRJ-TWGQIWQCSA-N,,,Q9P1W9,SERINE/THREONINE-PROTEIN KINASE PIM2,PIM2,,,19072652.0,IC50,=,4400.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant Pim2 by ATP depletion assay,Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases.,J. Med. Chem.,PUBLICATION,
1311531,CHEMBL1435698,GMBJJMHTWIGFPH-HXUWFJFHSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3129306,CHEMBL1802485,ODZGYELAMAOARP-UHFFFAOYSA-N,,,P07332,TYROSINE-PROTEIN KINASE FES,FES,wild_type,,23398362.0,ACTIVITY,=,94.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,45,uM,"Millipore: Percentage of residual kinase activity of FES at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1403566,CHEMBL1519798,GWQHZKXQGNKXCL-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4651871,CHEMBL1731765,VHUCADWRIQJDHP-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3878551,CHEMBL374453,RHTXWIKPNGROHZ-UHFFFAOYSA-N,GSK-299115A,,Q96L34,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 4,MARK4,,,,INHIBITION,=,-0.78,%,,,,,,,,,,,,,,GSK_PKIS: MARK4 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4226813,CHEMBL1534171,SUDZVHVERINPDZ-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4922928,CHEMBL1483562,WLIAEGLNJRYXSH-AQTBWJFISA-N,,,P30989,NEUROTENSIN RECEPTOR 1,NTSR1,,,,EC50,=,6690.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of Image-Based HTS for Selective Agonists for NTR1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493036, AID493055]",PUBCHEM BIOASSAY DATA SET,,DATASET,
265055,CHEMBL3431530,BBJVILCGKJKEIO-LJQANCHMSA-N,,,P18886,CARNITINE PALMITOYLTRANSFERASE 2,,,,,IC50,=,82834.4,NM,,,,,,,,,,,,,,SUPPLEMENTARY: Inhibition of Carnitine palmitoyltransferase 2,Roche carnitine palmitoyltransferase modulator screening data (supplementary data associated with the publication CHEMBL2216752).,,DATASET,
950443,CHEMBL1609603,DYKVNHBLLHDFTK-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4854925,CHEMBL1684952,WEDRCRAFXXEUCP-GOSISDBHSA-N,,,Q9P0X4,VOLTAGE-GATED T-TYPE CALCIUM CHANNEL ALPHA-1I SUBUNIT,CACNA1I,,,21316226.0,IP,=,21.0,NM,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at Cav3.3 alpha1i expressed in HEK293 cells by depolarized FLIPR assay,Pyridyl amides as potent inhibitors of T-type calcium channels.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1676652,CHEMBL1399109,HZYXVMMMXAIHQN-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5546675,CHEMBL1493816,ZBGCANJOCPQRGP-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
586203,CHEMBL482326,CKYDKNBLVBVPCS-UHFFFAOYSA-N,GSK-1030062A,,Q9BUB5,MAP KINASE-INTERACTING SERINE/THREONINE-PROTEIN KINASE MNK1,MKNK1,,,,INHIBITION,=,3.31,%,,,,,,,,,,,,,,GSK_PKIS: MKNK1 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2115138,CHEMBL180022,JWNPDZNEKVCWMY-VQHVLOKHSA-N,NERATINIB,,Q9UQ88,PITSLRE SERINE/THREONINE-PROTEIN KINASE CDC2L2,CDK11A,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for CDC2L2 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
1358275,CHEMBL1422002,GRMVBQHMQJJCSH-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3566471,CHEMBL1459573,QAASAWDDTWBBSV-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4841900,CHEMBL1527769,WCXGFTJSDASEPR-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1184317,CHEMBL1613312,FYDXGXXZTIAQSP-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2345075,CHEMBL1451972,KVFCHIJEEKLLLO-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
3093871,CHEMBL3098404,OAFMURWKCFITFM-UHFFFAOYSA-N,,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,24332652.0,INHIBITION,=,1.0,%,,cell_based,,,,,,,,,,,,Displacement of [3H]-MRE-3008-F20 from human adenosine A3 receptor expressed in CHO cell membranes at 10 uM by scintillation counting analysis relative to control,Synthesis and biological evaluation of novel 2-amino-3-aroyl-4-neopentyl-5-substituted thiophene derivatives as allosteric enhancers of the A1 adenosine receptor.,Bioorg. Med. Chem.,PUBLICATION,
2471512,CHEMBL1326250,LJYYYUZEIDNFJR-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2451385,CHEMBL1476773,LHOUIHSOKXTJSF-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1721991,CHEMBL1430080,IESPXOJBGIZSPC-NXVVXOECSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1368921,CHEMBL1732352,GSTQCRMDSMTGDM-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,32642.7,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1201914,CHEMBL1325167,GAHVFJPZNZTMMQ-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
481393,CHEMBL2324209,BZKOMDWHRRVIDX-DFZCOPKLSA-N,,,P14735,INSULIN-DEGRADING ENZYME,IDE,,,23437776.0,KI,=,73.3,NM,,,,,,,,,,,,,,Inhibition of human recombinant IDE-mediated FRET1 degradation,Optimization of Peptide hydroxamate inhibitors of insulin-degrading enzyme reveals marked substrate-selectivity.,J. Med. Chem.,PUBLICATION,
4128661,CHEMBL1447931,SJGVTEGJFJMYJZ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
818686,CHEMBL1897878,DKIYHSXYZRYVQM-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1770605,CHEMBL164,IKMDFBPHZNJCSN-UHFFFAOYSA-N,MYRICETIN,,P31941,PROBABLE DNA DC->DU-EDITING ENZYME APOBEC-3A,APOBEC3A,,,,IC50,=,17500.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of APOBEC3G DNA Deaminase Inhibitors via a A3A counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493012, AID493028]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4685284,CHEMBL581044,VLSZBFXLXHWWLO-ZHACJKMWSA-N,GNF-PF-321,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2284413,CHEMBL281948,KOZFSFOOLUUIGY-SOLYNIJKSA-N,K-252A,,O15111,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE ALPHA SUBUNIT,CHUK,wild_type,,23398362.0,ACTIVITY,=,2.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of CHUK at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4130730,CHEMBL218708,SJNURYXTMIYOKB-WOJGMQOQSA-N,,,P49286,MELATONIN RECEPTOR 1B,MTNR1B,,,19193160.0,KI,=,2.5,NM,,cell_based,,,,,MT2,,,,,,,Displacement of 2-[125I]iodomelatonin from human MT2 receptor expressed in CHO cells,"2-[(2,3-dihydro-1H-indol-1-yl)methyl]melatonin analogues: a novel class of MT2-selective melatonin receptor antagonists.",J. Med. Chem.,PUBLICATION,
2507987,CHEMBL1325458,LNNUEUIEHHLWCO-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3013438,CHEMBL476520,NQXRCLOMDZLNSQ-UHFFFAOYSA-N,,,P32238,CHOLECYSTOKININ A RECEPTOR,CCKAR,,,18614364.0,ACTIVITY,=,100.0,%,,,,,,,,,,,,,,Agonist activity against human CCK1 receptor assessed as receptor activation at 10000 nM,Discovery of imidazole carboxamides as potent and selective CCK1R agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4025600,CHEMBL1558255,RXZLFESEYCCPPE-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3974334,CHEMBL267797,RSDHWPCDLAICEZ-RTWAWAEBSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,16824755.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibition of CYP2D6,Synthesis and structure-activity relationships of retro bis-aminopyrrolidine urea (rAPU) derived small-molecule antagonists of the melanin-concentrating hormone receptor-1 (MCH-R1). Part 2.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1054020,CHEMBL1200825,FJQXCDYVZAHXNS-UHFFFAOYSA-N,METHADONE HYDROCHLORIDE,,"P33533, P34975, Q9R0C9, P33535",OPIOID RECEPTOR,,,,209186.0,IC50,=,51.0,NM,,,,,,,,,,,,,,Displacement of [3H]naloxone from Sprague-Dawley rat cerebellum opioid receptor assessed as relative receptor affinity by scintillation counting,"Conformation of 2,9-dimethyl-3'-hydroxy-5-phenyl-6,7-genzomorphan and its relation to other analgetics and enkephalin.",J. Med. Chem.,PUBLICATION,
4255417,CHEMBL1356366,SXLCDNBUYFLDNG-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
5627735,CHEMBL428730,ZJTXSGLJNBAMJS-UHFFFAOYSA-N,,,P49019,HM74 NICOTINIC ACID GPCR,HCAR3,,,17804224.0,EC50,=,11748.98,NM,,cell_based,,,,,,,,,,,,Agonist activity at human GPR109b expressed in human adipocytes assessed as decrease in intracellular cAMP level by HTRF assay,Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4569962,CHEMBL1881600,UZAKTCJEVNQJLK-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5348147,CHEMBL3310483,YFFZLXAPKOKACC-UHFFFAOYSA-N,,,Q01959,DOPAMINE TRANSPORTER,SLC6A3,,,24974340.0,INHIBITION,=,87.0,%,,cell_based,,,,,,,,,,,,Inhibition of DA reuptake at human DAT expressed in HEK293 cells at 0.1 uM after 15 mins by fluorescence neurotransmitter transporter assay,Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3518888,CHEMBL2354596,PUOCWGUMERCRQW-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3386326,CHEMBL1474198,PGHRVWFIJGTNSS-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1638583,CHEMBL2130752,HVYIAHCCVHYWJC-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5279925,CHEMBL3182647,XYFPWWZEPKGCCK-UHFFFAOYSA-N,,,P07948,TYROSINE-PROTEIN KINASE LYN,LYN,,,,Ki,=,14.0,NM,,,,,,,,,,,,,,BindingDB_Patents: In Vitro Inhibition Assay. Btk kinase activity was determined using a time-resolved fluorescence resonance energy transfer (TR-FRET) methodology.,Inhibitors of Bruton's tyrosine kinase,,PATENT,
415826,CHEMBL1532563,BRXUYAZRQGXKPF-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2393485,CHEMBL1550422,LAYGSBQLNPJVMR-WYMLVPIESA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2492499,CHEMBL2143644,LLYTXRFVIPOTSI-MWALGVAMSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5566090,CHEMBL562994,ZDABWPALDQUMFM-UHFFFAOYSA-N,,,P43115,PROSTANOID EP3 RECEPTOR,PTGER3,,,19487124.0,KI,=,25.12,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human EP3 receptor expressed in cells assessed as mobilization of intracellular calcium by FLIPR assay,Discovery of novel aminothiadiazole amides as selective EP(3) receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4933601,CHEMBL1455476,WMPFNUWVGCJGHG-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1840881,CHEMBL1969843,ISEDKXOMRIKZPK-UHFFFAOYSA-N,,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,,KI,>,3162.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MET,PUBCHEM BIOASSAY DATA SET,,DATASET,
1809075,CHEMBL1407979,IOPUFELJULDOMM-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5505113,CHEMBL1717084,YWRKVGDAQUZAQX-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1891737,CHEMBL275242,IXXJXRFQXXILRP-UHFFFAOYSA-N,,,P20272,CANNABINOID CB1 RECEPTOR,,,,9804691.0,KI,=,707945.78,NM,,,,,,,,,,,,,,Cannabinoid receptor 1 binding affinity by measuring its ability to displace [3H]WIN-55212-2 in rat forebrain membranes,Three-dimensional quantitative structure-activity relationship study of the cannabimimetic (aminoalkyl)indoles using comparative molecular field analysis.,J. Med. Chem.,PUBLICATION,
3342064,CHEMBL1934357,PBEGXDUDGVNPPT-GOSISDBHSA-N,,,Q12809,HERG,KCNH2,,,22172695.0,INHIBITION,=,65.0,%,,,,,,,,,,,,,,Inhibition of human ERG at 3 uM by patch-clamp assay,Identification of biaryl sulfone derivatives as antagonists of the histamine H3 receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916).,Bioorg. Med. Chem. Lett.,PUBLICATION,
1155294,CHEMBL55939,FUUQBCXGSJUNAU-UHFFFAOYSA-N,,,P25104,ANGIOTENSIN II TYPE 1A (AT-1A) RECEPTOR,,,,,IC50,=,4000.0,NM,,,,,,,,,,,,,,Binding affinity for angiotensin II receptor of bovine adrenal cortex,,Bioorg. Med. Chem. Lett.,PUBLICATION,
3529332,CHEMBL1488931,PVRHIOQTEXYCLW-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1935180,CHEMBL1390578,JCMQQNRPYKUQNS-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
125159,CHEMBL149518,AMDGKLWVCUXONP-UHFFFAOYSA-N,,,P08246,LEUKOCYTE ELASTASE,ELANE,,,7853347.0,[I],=,6000.0,NM,,,,,,,,,,,,,,Inhibition of human leukocyte elastase.,Mechanism-based isocoumarin inhibitors for human leukocyte elastase. Effect of the 7-amino substituent and 3-alkoxy group in 3-alkoxy-7-amino-4-chloroisocoumarins on inhibitory potency.,J. Med. Chem.,PUBLICATION,
2775657,CHEMBL185939,MQWZYEDJGHLFFI-UHFFFAOYSA-N,GW828525X,,P23443,RIBOSOMAL PROTEIN S6 KINASE 1,RPS6KB1,,,,INHIBITION,=,2.06,%,,,,,,,,,,,,,,GSK_PKIS: p70s6K1 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5597830,CHEMBL119148,ZGISQAAIGWPLSR-UHFFFAOYSA-N,,,"P08514, P05106",INTEGRIN ALPHA-IIB/BETA-3,"ITGA2B, ITGB3",,,9057858.0,IC50,=,11.0,NM,,,,,,,,,,,,,,Binding affinity for soluble GPIIb/IIIa captured on fibrinogen coated microtiter plate,"From peptide to non-peptide. 3. Atropisomeric GPIIbIIIa antagonists containing the 3,4-dihydro-1H-1,4-benzodiazepine-2,5-dione nucleus.",J. Med. Chem.,PUBLICATION,
5811523,CHEMBL3729390,,,,P49683,PROLACTIN-RELEASING PEPTIDE RECEPTOR,PRLHR,,,,Ki,=,33.0,NM,,,,,,,,,,,,,,Displacement of [3H]-PrRP from human GPR10 receptor expressed in HEK293 cell membranes incubated for 90 mins by liquid scintillation counting method,Heterocyclic compounds for the treatment of stress-related conditions,,PATENT,
605123,CHEMBL154,CMWTZPSULFXXJA-VIFPVBQESA-N,NAPROXEN,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
1356906,CHEMBL2206289,GRHRNWSXMRDJHN-UAPYVXQJSA-N,,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,21928839.0,KI,=,8.7,NM,,,,,,,,,,,,,,Displacement of [3H]-n-alpha-methylhistamine from human histamine H3 receptor homogenate after 60 mins by scintillation counting,Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764).,J. Med. Chem.,PUBLICATION,
508842,CHEMBL1528529,CCIVPPJSMAQGMQ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1623524,CHEMBL1323700,HUHOCBLDMJJPER-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2390175,CHEMBL1559901,LAOIDZXLMACBIW-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1003720,CHEMBL1560722,FEDJIXSTQIHTPD-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5530713,CHEMBL1356013,YZJUPPHFTGOIMM-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3854353,CHEMBL1468403,RFEIWHMQKOIPCS-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2913898,CHEMBL1323799,NGHKDTZHRCAVFD-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3465000,CHEMBL1881705,POPNGLHPEKTRJY-UHFFFAOYSA-N,,,P07550,BETA-2 ADRENERGIC RECEPTOR,ADRB2,,,,EC50,=,64.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose response for HTS for Beta-2AR agonists via FAP method from CP1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485366, AID492947, AID504448]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5476023,CHEMBL207995,YTIZDTKSGSSUMG-UHFFFAOYSA-N,,,Q9Y243,SERINE/THREONINE-PROTEIN KINASE AKT3,AKT3,wild_type,,21336281.0,KI,<,10000.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
5771680,CHEMBL103098,ZZTJLVZEYMOZSD-UHFFFAOYSA-N,SB-738482,,Q9HBH9,MAP KINASE SIGNAL-INTEGRATING KINASE 2,MKNK2,,,,INHIBITION,=,6.29,%,,,,,,,,,,,,,,GSK_PKIS: MNK2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5268159,CHEMBL1387227,XXDAOQJKQSUZNK-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3500681,CHEMBL293994,PSNUXVHTFCBHQG-LJAQVGFWSA-N,,,P08588,BETA-1 ADRENERGIC RECEPTOR,ADRB1,,,11052788.0,IC50,=,1700.0,NM,,cell_based,,,,,CHO,,,,,,,Binding affinity was evaluated on chinese hamster ovary (CHO) cells expressing the cloned human beta-1 adrenergic receptor in the presence of [125I]- iodocyanopindolol.,"Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide.",J. Med. Chem.,PUBLICATION,
2162723,CHEMBL1562587,KBQXOIQZLUEAHN-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1223081,CHEMBL1491773,GCMVZWZLMVMYSB-UHFFFAOYSA-N,,,P54132,BLOOM SYNDROME PROTEIN,BLM,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM). (Class of assay: confirmatory) [Related pubchem assays: 593 (Fluorescein region spectral profiling screen), 2386 (Probe Development Summary for Inhibitors of Bloom&apos;s syndrome helicase (BLM)), 594 (Rhodamine region spectral profiling screen), 2364 (qHTS Validation Assay for Inhibitors of Bloom&apos;s syndrome helicase (BLM))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4088176,CHEMBL3193113,SEYAPTRPGUOMQI-FYJGNVAPSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,10322.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3720739,CHEMBL509032,QQWUGDVOUVUTOY-UHFFFAOYSA-N,TAE-684,,Q9Y243,SERINE/THREONINE-PROTEIN KINASE AKT3,AKT3,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for AKT3 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
5027297,CHEMBL247622,WWXHPAOSNLSCAI-NRFANRHFSA-N,,,P32246,C-C CHEMOKINE RECEPTOR TYPE 1,CCR1,,,17720492.0,INHIBITION,<,30.0,%,,,,,,,,,,,,,,Inhibition of CCR1 at 10 uM,Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).,Bioorg. Med. Chem. Lett.,PUBLICATION,
4514365,CHEMBL3289109,UTEHUKGJDLVHIH-UHFFFAOYSA-N,,,O95271,TANKYRASE-1,TNKS,,,27163581.0,IC50,=,346.0,NM,,,,,,,,,,,,,,Inhibition of TNKS-1 (unknown origin) using histone as substrate incubated for 30 mins by colorimetric assay,Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases.,Eur. J. Med. Chem.,PUBLICATION,
3624867,CHEMBL2011824,QGNAUHRUBJPYAG-WJOKGBTCSA-N,,,Q92847,GHRELIN RECEPTOR,GHSR,,,22305493.0,IC50,=,79.0,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human GHSR1a receptor assessed as intracellular Ca2+ concentration by aequorin luminescent assay,Discovery of a new class of ghrelin receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
722096,CHEMBL590830,CZSNUKITORTJBZ-UHFFFAOYSA-N,,,P05067,BETA AMYLOID A4 PROTEIN,APP,,,19959359.0,EC50,=,180.0,NM,,cell_based,,,,,CHO-K1,,,,,,,Inhibition of human recombinant APP expressed in CHO-K1 cells assessed as reduction of amyloid beta level by ELISA,"Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1738915,CHEMBL1538796,IGVASXQFZVWRKR-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,16360.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5744672,CHEMBL1305289,ZWUWBGUOTKETDL-WYMLVPIESA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,37685.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3227819,CHEMBL418400,OOSNQRWJSKYKEL-KLKADRCKSA-N,,,P10649,GLUTATHIONE S-TRANSFERASE MU 1,,,,3612687.0,SPECIFIC ACTIVITY,=,2.24,UM MIN-1 (MG OF PROTEIN)-1,,,,,,,,,,,,,,"GST activity in the cytosols of liver of ICR/Ha mice, using 1-Chloro-2,4-dinitrobenzene as substrate",Effects of derivatives of kahweol and cafestol on the activity of glutathione S-transferase in mice.,J. Med. Chem.,PUBLICATION,
1842709,CHEMBL3207943,ISJXOZSPGKAMMF-WSDLNYQXSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2479978,CHEMBL1528893,LKVRUAHOVWEHOG-UHFFFAOYSA-N,,,P87108,MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE SUBUNIT TIM10,,,,,IC50,=,16600.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS small molecule inhibitors of tim10-1 yeast via a luminescent assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463190, AID463194, AID504542, AID504544]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3141100,CHEMBL14490,OFFGOUURBVXUDV-UHFFFAOYSA-N,,,"P10980, P08911, P08485, P08482, P08483",MUSCARINIC ACETYLCHOLINE RECEPTOR,,,,2319559.0,RATIO,=,1.8,,,,,,,,,,,,,,,The ratio of Kapp([3H]-NMS) / Kapp([3H]-OXO-M) was determined,Novel quinuclidine-based ligands for the muscarinic cholinergic receptor.,J. Med. Chem.,PUBLICATION,
3242220,CHEMBL1353658,OQHFLDSVCLZTSJ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23099.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3494570,CHEMBL2218335,PRXIPCHXQZPQRW-UHFFFAOYSA-N,,,Q99572,P2X PURINOCEPTOR 7,P2RX7,,,,IC50,=,50.12,NM,,,,,,,,,,,,,,SUPPLEMENTARY: Inhibition of human P2X7 receptor assessed as inhibition of ethidium bromide accumulation. Same assay as CHEMBL1103860,Structure-activity relationship data for chemical series of antagonists of the P2X7 receptor (Supplementary Bioactivity Data for publication CHEMBL1157114),,DATASET,
2222844,CHEMBL1445654,KIIANFDRGBARDY-UHFFFAOYSA-N,,,O40947,ORF 73,,,,,AC50,=,171461.0,NM,,biochemical,,,,,,,,,,,,PUBCHEM_BIOASSAY: C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504431],PUBCHEM BIOASSAY DATA SET,,DATASET,
4883470,CHEMBL415690,WHGYBXFWUBPSRW-FOUAGVGXSA-N,BETADEX,,P04035,HMG-COA REDUCTASE,HMGCR,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: HMG-CoA Reductase enzyme inhibition (substrate: [14C]HMG-CoA),DrugMatrix in vitro pharmacology data,,DATASET,
2076307,CHEMBL1349632,JSHIGTIDHUCMNI-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4506474,CHEMBL1495924,USIUFCSLBYEOHA-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
2327915,CHEMBL1568059,KTIXKAUXLVIDQB-UHFFFAOYSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,,IC50,>,32000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR Analysis of Antagonists of the DOR Receptor using an Image-Based Assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1785, AID1786, AID1966, AID2133, AID2136, AID2284, AID2285, AID2498]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2551373,CHEMBL2203397,LSFSILMVQQMGRP-OPRSCSRJSA-N,,,P37059,ESTRADIOL 17-BETA-DEHYDROGENASE 2,HSD17B2,,,24328103.0,INHIBITION,=,7.0,%,,cell_based,,,,,,,,,,,,Inhibition of 17-beta HSD2 (unknown origin) transfected in HEK293 cells using [14C]E2 as substrate at 10 uM,Discovery of a non-estrogenic irreversible inhibitor of 17ß-hydroxysteroid dehydrogenase type 1 from 3-substituted-16ß-(m-carbamoylbenzyl)-estradiol derivatives.,J. Med. Chem.,PUBLICATION,
5729949,CHEMBL1348507,ZVCUZQFIYYBURH-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2022167,CHEMBL1884527,JMKFJBUIOSPNNA-UHFFFAOYSA-N,,,P11021,78 KDA GLUCOSE-REGULATED PROTEIN,HSPA5,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3776518,CHEMBL1552965,QXBAVHFEBJFXBD-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3832734,CHEMBL1445046,RCXKOJGUNGMBIN-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4261417,CHEMBL1488449,SYCOPHPNXJABFS-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
3925475,CHEMBL1612774,RMRMZYPGKLMUFK-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
546656,CHEMBL6,CGIGDMFJXJATDK-UHFFFAOYSA-N,INDOMETHACIN,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1995.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3211072,CHEMBL2010994,OMYTZYUGUKDESE-UHFFFAOYSA-N,,,P00915,CARBONIC ANHYDRASE I,CA1,,,22440859.0,KD,=,1.9,NM,,,,,,,,,,,,,,Binding affinity to human recombinant carbonic anhydrase-1 by thermal shift assay,Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases.,Eur. J. Med. Chem.,PUBLICATION,
2840554,CHEMBL1543125,MYKFXDBIHNIJAK-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3441833,CHEMBL1685032,PMDSJEXWWAYJPT-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,23778.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1931123,CHEMBL116529,JCBQQIGSXUEVIL-UHFFFAOYSA-N,,,P22894,MATRIX METALLOPROTEINASE 8,MMP8,,,9464365.0,KI,=,36000.0,NM,,,,,,,,,,,,,,"Inhibition of Matrix metalloprotease-8 (Human neutrophil collagenase, MMP-8)",Design and synthesis of malonic acid-based inhibitors of human neutrophil collagenase (MMP8).,J. Med. Chem.,PUBLICATION,
2392370,CHEMBL1575107,LAUOWRVPALCKDC-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3376932,CHEMBL2251844,PFFIDZXUXFLSSR-UHFFFAOYSA-N,PENTHIOPYRAD,,"D0VWV4, A5GZW8",SUCCINATE-UBIQUINONE OXIDOREDUCTASE,,,,25841198.0,IC50,=,527.0,NM,,,,,,,,,,,,,,Inhibition of porcine heart SQR in SCR complex assessed as reduction in ubiquinol-cytochrome c reductase (complex 3) activity by measuring cytochrome c level using succinate and DCIP substrate at 23 degC by spectrophotometry,Discovery of N-benzoxazol-5-yl-pyrazole-4-carboxamides as nanomolar SQR inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
5307510,CHEMBL1566094,YAWISMKQAPRZFW-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3126566,CHEMBL3289537,ODURLPUYPXNJAO-UHFFFAOYSA-N,,,P08913,ALPHA-2A ADRENERGIC RECEPTOR,ADRA2A,,,24908653.0,KI,=,676.08,NM,,,,,,,,,,,,,,Displacement of [3H]RX821002 from alpha2-adrenergic receptor in prefrontal cortex of human brain after 30 mins by liquid scintillation spectrometric analysis,Guanidine-based a2-adrenoceptor ligands: Towards selective antagonist activity.,Eur. J. Med. Chem.,PUBLICATION,
4467246,CHEMBL1562360,UOFDUGZZJBYOJI-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,1412.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3036065,CHEMBL1554242,NTPSRXLKKKQBCH-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
868715,CHEMBL1591079,DPLVYADYWAAXLO-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1168976,CHEMBL1581675,FWMDMFADWUBUJV-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1357215,CHEMBL1698250,GRIWYQPNDWVZJE-PMACEKPBSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1864197,CHEMBL2001239,IUUVJFSKAMMCEA-UHFFFAOYSA-N,,,O75582,RIBOSOMAL PROTEIN S6 KINASE ALPHA 5,RPS6KA5,,,,KI,=,1000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KA5,PUBCHEM BIOASSAY DATA SET,,DATASET,
790710,CHEMBL1507250,DHHSTKVDKKUOTI-UHFFFAOYSA-N,,,P35639,DNA DAMAGE-INDUCIBLE TRANSCRIPT 3 PROTEIN,,,,,IC50,=,160.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: CHOP dose-response primary assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2732, AID493217]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5554386,CHEMBL1456075,ZBUUVLJZBJLQAR-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,7307.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3303119,CHEMBL1215805,OWVOXVUWUMLQMP-UHFFFAOYSA-N,,,Q14242,P-SELECTIN GLYCOPROTEIN LIGAND 1,SELPLG,,,20718494.0,IC50,=,175000.0,NM,,,,,,,,,,,,,,Inhibition of recombinant PSGL-1 by surface plasmon resonance assay,"Discovery of 2-[1-(4-chlorophenyl)cyclopropyl]-3-hydroxy-8-(trifluoromethyl)quinoline-4-carboxylic Acid (PSI-421), a P-selectin inhibitor with improved pharmacokinetic properties and oral efficacy in models of vascular injury.",J. Med. Chem.,PUBLICATION,
945545,CHEMBL1332072,DXVUOUZEFCKESJ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
56675,CHEMBL1598944,AEJUHQARWADPLL-OEAKJJBVSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4188550,CHEMBL431295,SQALAXQIIVTRQA-UHFFFAOYSA-N,,,P19327,SEROTONIN 1A (5-HT1A) RECEPTOR,,,,2898533.0,KI,=,37.0,NM,,tissue,,,,,,,,,,,,In vitro inhibition of [3H]spiperone binding to 5-hydroxytryptamine 1A receptor from rat hippocampal tissue.,Polycyclic aryl- and heteroarylpiperazinyl imides as 5-HT1A receptor ligands and potential anxiolytic agents: synthesis and structure-activity relationship studies.,J. Med. Chem.,PUBLICATION,
4739001,CHEMBL1517142,VRNQPCARTXBASB-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1704010,CHEMBL1406804,ICSOJTRMPMCHHH-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,,30131.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for antagonists of the Thyroid Stimulation Hormone Receptor: Hit Validation in Primary Screen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3705528,CHEMBL1392391,QPKGVDAMABIDCW-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2527820,CHEMBL3211686,LPMXSHXJDGRBIP-CIAFOILYSA-N,,,"P63316, P45379, P19429","TROPONIN, CARDIAC MUSCLE","TNNC1, TNNI3, TNNT2",,,,EC50,>,71472.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence-based biochemical high throughput dose response assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493008, AID493018, AID504382, AID504383]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3343203,CHEMBL1528882,PBIGZFXZDWCSRR-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,35338.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with MMS Viability. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2991429,CHEMBL1451220,NOOQIZVANABYFI-UHFFFAOYSA-N,,,Q57TT1,PUTATIVE UNCHARACTERIZED PROTEIN,,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3170135,CHEMBL69170,OIJCKALHPUHDSY-UHFFFAOYSA-N,,,P11597,CHOLESTERYL ESTER TRANSFER PROTEIN,CETP,,,17604633.0,IC50,=,700.0,NM,,,,,,,,,,,,,,Inhibition of CETP,2D Quantitative structure-activity relationship studies on a series of cholesteryl ester transfer protein inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
5245762,CHEMBL1487,XUKUURHRXDUEBC-KAYWLYCHSA-N,ATORVASTATIN,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
3813132,CHEMBL145806,RARPYAVALSABGF-UHFFFAOYSA-N,,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,1361582.0,IC50,=,2600.0,NM,,,,,,,,,,,,,,The compound was tested for its affinity against N-methyl-D-aspartate glutamate receptor in rats using [3H]CPP as radioligand,"Bioisosteric replacement of the alpha-amino carboxylic acid functionality in 2-amino-5-phosphonopentanoic acid yields unique 3,4-diamino-3-cyclobutene-1,2-dione containing NMDA antagonists.",J. Med. Chem.,PUBLICATION,
3209874,CHEMBL1376513,OMVBRPANJTYVJZ-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4380911,CHEMBL1990821,UEWCRBHXCIZHHV-UHFFFAOYSA-N,,,Q9NYL2,MIXED LINEAGE KINASE 7,ZAK,,,,KI,=,2511.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ZAK,PUBCHEM BIOASSAY DATA SET,,DATASET,
3357293,CHEMBL3263695,PDAASAKPBNZZQB-UHFFFAOYSA-N,,,Q13133,LXR-ALPHA,NR1H3,,,24685544.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human GAL4-fused LXRalpha expressed in HEK293 cells assessed as transcriptional activity after 5 hrs by luciferase reporter gene assay,Identification of tertiary sulfonamides as RORc inverse agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4248715,CHEMBL1476909,SWPZJCZUXVEZBC-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Permissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3970631,CHEMBL1611832,RRSRBHCVBHVKSV-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
809554,CHEMBL1541241,DJJCSPMUERTOAV-LCYFTJDESA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4832992,CHEMBL1548227,WBYRTEWWUGFVLP-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6513.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4909168,CHEMBL169154,WJTYCLQDZFRNQT-OZLKFZLXSA-M,,,P62593,BETA-LACTAMASE TEM,,,,10853646.0,IC50,,,,,,,,,,,,,,,,,The compound was evaluated for inhibition against Class A TEM-1 beta-lactamase derived from Enterobacter cloacae; Not tested,The synthesis and evaluation of 3-substituted-7-(alkylidene)cephalosporin sulfones as beta-lactamase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4628649,CHEMBL1440535,VFGMEMBJAIXGTA-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5446081,CHEMBL1927262,YPULTKAHHAYKOE-UHFFFAOYSA-N,,,Q14012,CAM KINASE I ALPHA,CAMK1,,,22137457.0,ACTIVITY,=,75.0,%,,,,,,,,,,,,,,Inhibition of CAMK1 assessed as residual activity at 10 uM using [33P-ATP] by radiometric filter binding assay,Fragment based lead discovery of small molecule inhibitors for the EPHA4 receptor tyrosine kinase.,Eur. J. Med. Chem.,PUBLICATION,
3018981,CHEMBL2172299,NRPQUZCFMRCDRJ-UHFFFAOYSA-N,,,P19793,RETINOID X RECEPTOR ALPHA,RXRA,,,22712432.0,EC50,=,20910.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human RXRalpha expressed in african green monkey COS1 cells assessed as induction of RXRE transcriptional activity after 12 hrs by luciferase reporter gene assay,"Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventive agents.",J. Med. Chem.,PUBLICATION,
2768160,CHEMBL539053,MQAQKHCMPMBWIS-UKOKCHKQSA-N,DX-9065A HYDROCHLORIDE HYDRATE,,P00742,COAGULATION FACTOR X,F10,,,15887966.0,KI,=,41.0,NM,,,,,,,,,,,,,,Inhibitory concentration against human Coagulation factor X,Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.,J. Med. Chem.,PUBLICATION,
4828018,CHEMBL3330401,WBKWIGZIJLEGEF-UHFFFAOYSA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,,,25043312.0,INHIBITION,=,-1.0,%,,,,,,,,,,,,,,Inhibition of human IGF-1R at 1 uM by radiometric Assay,Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.,Bioorg. Med. Chem.,PUBLICATION,
4747768,CHEMBL1331192,VSOBPFOLLXMZMM-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
11420,CHEMBL2218926,ABBADGFSRBWENF-UHFFFAOYSA-N,,,P16234,PLATELET-DERIVED GROWTH FACTOR RECEPTOR ALPHA,PDGFRA,wild_type,,23398362.0,ACTIVITY,=,106.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,120.0,uM,"Millipore: Percentage of residual kinase activity of PDGFRA at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4652327,CHEMBL64391,VHVPQPYKVGDNFY-UHFFFAOYSA-N,ITRAZOLE,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,1995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1106867,CHEMBL1409540,FPRFPKKBBMYQFO-UHFFFAOYSA-N,,,P10696,ALKALINE PHOSPHATASE PLACENTAL-LIKE,ALPPL2,,,,EC50,=,999000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Luminescent assay for HTS discovery of chemical activators of placental alkaline phosphatase. (Class of assay: confirmatory) [Related pubchem assays: 518 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2783626,CHEMBL1369478,MRWNESHUWGQEMM-UHFFFAOYSA-N,,,Q9XUB2,ZINC FINGER PROTEIN MEX-5,,,,,EC50,>,300000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescent Polarization Homogeneous Dose Response HTS to Identify Inhibitors of Mex-5 Binding to TCR-2. (Class of assay: confirmatory) [Related pubchem assays: 1833 (Project Summary), 1832 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4468259,CHEMBL77456,UOHFCPXBKJPCAD-UHFFFAOYSA-N,TYRPHOSTIN 1,,P51817,SERINE/THREONINE-PROTEIN KINASE PRKX,PRKX,wild_type,,23398362.0,ACTIVITY,=,95.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of PRKX at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
5427297,CHEMBL1511665,YNXTZYIYTKKIAZ-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,26854.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
785052,CHEMBL1366408,DGQLVPJVXFOQEV-NGOCYOHBSA-N,CARMINE,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2532062,CHEMBL220244,LPZDPCXVCBSYEC-AATRIKPKSA-N,GW427984X,,Q9UHD2,SERINE/THREONINE-PROTEIN KINASE TBK1,TBK1,,,,INHIBITION,=,1.36,%,,,,,,,,,,,,,,GSK_PKIS: TBK1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3482199,CHEMBL1597878,PQOONWXYKHRVJH-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
535024,CHEMBL1608398,CFCACPFQQNBFKU-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5577366,CHEMBL1897268,ZEGJMPAEHOQTLE-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
138967,CHEMBL1301519,ANVDJDPTKMXAED-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4085886,CHEMBL1449334,SERAYZIPJKSYSO-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,84921.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2933166,CHEMBL1549735,NIHAVSQKGMJQLB-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2394097,CHEMBL1609249,LAZYDYIOIRRDSG-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
844088,CHEMBL1601264,DMZGRAIMZVQKKA-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3491906,CHEMBL1339143,PRPKDAOJFGGIEJ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,82.0,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
402258,CHEMBL3289348,BQIVJOPYYORORN-UHFFFAOYSA-N,,,O14684,PROSTAGLANDIN E SYNTHASE,PTGES,,,24794772.0,INHIBITION,=,37.0,%,,,,,,,,,,,,,,Inhibition of mPGES-1 in interleukin-1 beta-stimulated human A549 cell microsomes assessed as reduction in PGE2 production using PGH2 as substrate at 10 uM treated for 15 mins prior to substrate addition measured after 1 min by RP-HPLC analysis,Exploration of the dihydropyrimidine scaffold for the development of new potential anti-inflammatory agents blocking prostaglandin E2 synthase-1 enzyme (mPGES-1).,Eur. J. Med. Chem.,PUBLICATION,
5038218,CHEMBL1576910,WYDGONOUVKWYOA-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
742234,CHEMBL1427955,DBYNKHJNYGHMPU-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
5206059,CHEMBL1399154,XQEPRBSXMBWBMG-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
5165671,CHEMBL578502,XLQDLTNRQJXBOY-UHFFFAOYSA-N,SJ000154295,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,1584.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2575771,CHEMBL1560247,LUQDQFMVTUQBBV-HTLJXXAVSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,398.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2386471,CHEMBL314987,LACILEXWDGRNHN-HZCBDIJESA-N,,,P61169,DOPAMINE D2 RECEPTOR,,,,9003524.0,KI,=,83.0,NM,,,,,,,,,,,,,,In vitro binding affinity for dopamine receptor D2 on rat striatal membranes by [3H]spiperone displacement.,3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonists.,J. Med. Chem.,PUBLICATION,
5295451,CHEMBL1431,XZWYZXLIPXDOLR-UHFFFAOYSA-N,METFORMIN,,P22303,ACETYLCHOLINESTERASE,ACHE,,,,KI,,,,,cell_based,,,,,HEK293,,,,,,,DRUGMATRIX: Acetylcholinesterase enzyme inhibition (substrate: acetylthiocholine),DrugMatrix in vitro pharmacology data,,DATASET,
2905959,CHEMBL1971613,NFLMKMJDUCVJOE-HEHNFIMWSA-N,,,Q14191,WERNER SYNDROME ATP-DEPENDENT HELICASE,WRN,,,,POTENCY,,6065.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of WRN Helicase: Confirmatory Assay for Cherry-picked Compounds..   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5161211,CHEMBL3211514,XLFUBOKRKLGTMU-KYIGKLDSSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
960279,CHEMBL1385603,DZNNYKSTICIHAR-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5475197,CHEMBL501235,YTFVRYKNXDADBI-SNAWJCMRSA-N,SINAPIC ACID METHYL ETHER,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5422618,CHEMBL1607263,YNKXUMMWJICJAZ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3554526,CHEMBL1613004,PYPBLOIYODUALV-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,9466.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1244382,CHEMBL1418145,GEYQVKFQQIYITE-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,46945.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) [Related pubchem assays: 1490 (qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase)), 1819 (Probe Development Summary of Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1924402,CHEMBL457916,JBJWQTGIRWWVAW-UHFFFAOYSA-N,,,P04757,NEURONAL ACETYLCHOLINE RECEPTOR SUBUNIT ALPHA-3,,,,18989912.0,EC50,=,7943.28,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at rat alpha-3-beta-4 nAChR expressed in HEK293 cells by FMP assay,Novel acetylcholine and carbamoylcholine analogues: development of a functionally selective alpha4beta2 nicotinic acetylcholine receptor agonist.,J. Med. Chem.,PUBLICATION,
3584546,CHEMBL2368367,QCATUPVGQKLFCK-KZOVSVDNSA-N,,,P29275,ADENOSINE A2B RECEPTOR,ADORA2B,,,15771421.0,ACTIVATION,,,,,,,,,,,,,,,,,Relative activation of human Adenosine A2B receptor after 10 uM treatment compared to 10 uM Cl-IB-MECA; Not determined,"(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.",J. Med. Chem.,PUBLICATION,
569386,CHEMBL257922,CJCCEOMVGVWFDI-VGQJWJISSA-N,SALVINORIN B 1-ETHOXYETHYL ETHER,,P32300,DELTA OPIOID RECEPTOR,,,,17981041.0,KI,>,1000.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]diprenorphine from mouse delta opioid receptor expressed in CHO cells,Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers.,Bioorg. Med. Chem.,PUBLICATION,
2921811,CHEMBL1887816,NHCJFOUAXKDSOS-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2403209,CHEMBL1458986,LCAYWDANTWYSBO-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3218194,CHEMBL3276413,ONQKWJRMNBAMQN-UHFFFAOYSA-M,,,Q9N1N9,BUTYRYLCHOLINESTERASE,,,,592327.0,KI,=,6400.0,NM,,,,,,,,,,,,,,Reversible mixed-type inhibition of horse serum butyrylcholinesterase using acetylcholine bromide as substrate by Lineweaver-Burk plot analysis,Potent reversible anticholinesterase agents. Bis- and mono-N-substituted benzoquinolinium halides.,J. Med. Chem.,PUBLICATION,
3833654,CHEMBL1386831,RDAUQKXHXWTLKA-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,11917.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4938412,CHEMBL2205157,WNFCPRXLLMTDPX-UHFFFAOYSA-N,,,Q9Y5Y4,G PROTEIN-COUPLED RECEPTOR 44,PTGDR2,,,22651823.0,IC50,>,1000.0,NM,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]PGD2 from recombinant human CRTH2 receptor expressed in CHO-K1 cells after 30 min by FRET method,"Diazine Indole Acetic Acids as Potent, Selective, and Orally Bioavailable Antagonists of Chemoattractant Receptor Homologous Molecule Expressed on Th2 Cells (CRTH2) for the Treatment of Allergic Inflammatory Diseases.",J. Med. Chem.,PUBLICATION,
511435,CHEMBL1885746,CCPYQRYMNOYXGL-UHFFFAOYSA-N,GW561436X,,Q8TDX7,SERINE/THREONINE-PROTEIN KINASE NEK7,NEK7,,,,INHIBITION,=,2.38,%,,,,,,,,,,,,,,GSK_PKIS: NEK7 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
315165,CHEMBL260662,BGVFZHIFEQILLB-UHFFFAOYSA-N,,,P49840,GLYCOGEN SYNTHASE KINASE-3 ALPHA,GSK3A,,,12941332.0,IC50,=,6.0,NM,,,,,,,,,,,,,,Inhibitory activity to human glycogen synthase kinase-3 alpha (GSK-3alpha) was determined,"6-aryl-pyrazolo[3,4-b]pyridines: potent inhibitors of glycogen synthase kinase-3 (GSK-3).",Bioorg. Med. Chem. Lett.,PUBLICATION,
1118480,CHEMBL1305880,FQTINIQTRUAUNA-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2711921,CHEMBL3189522,MKBDRKARLHCCCT-VCHYOVAHSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,730.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4991931,CHEMBL351042,WTDRDQBEARUVNC-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1912096,CHEMBL1400873,JABXTGIFAPKHLO-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5561108,CHEMBL261131,ZCNBZFRECRPCKU-UHFFFAOYSA-N,DIACYLGLYCEROL KINASE INHIBITOR II,,Q96NX5,CAM KINASE I GAMMA,CAMK1G,wild_type,,22037377.0,ACTIVITY,=,103.5855944,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,AUTOCAMTIDE 2 + CA-CAM,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2631260,CHEMBL313493,MBABOKRGFJTBAE-UHFFFAOYSA-N,METHANESULFONIC ACID METHYL ESTER,,P32241,VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1,VIPR1,,,,IC50,,,,,,,,,,HT-29,,,,,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),DrugMatrix in vitro pharmacology data,,DATASET,
5153243,CHEMBL1361995,XKKTXLIECSWCQE-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2253455,CHEMBL1909376,KLJXDQVVVCKVLJ-UHFFFAOYSA-N,SB-759335B,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,INHIBITION,=,3.22,%,,,,,,,,,,,,,,GSK_PKIS: EGFR (L861Q mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1975053,CHEMBL1534465,JGYWMWQPWWEUGL-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,3662.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators: Hit Validation in Primary Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
493451,CHEMBL1551800,CAQOKRCESWEGAH-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3203246,CHEMBL3609220,OLZRHVFWMXZNMK-PXWFKLNNSA-N,,,Q09470,VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT KV1.1,KCNA1,,,26288216.0,IC50,=,0.002,NM,,cell_based,,,,,,,,,,,,Antagonist activity at human Kv1.1 expressed in HEK293 cells assessed as inhibition of potassium currents after 10 mins by IonWorks Quattro patch clamp electrophysiology assay,"Pharmaceutical Optimization of Peptide Toxins for Ion Channel Targets: Potent, Selective, and Long-Lived Antagonists of Kv1.3.",J. Med. Chem.,PUBLICATION,
3961834,CHEMBL1593142,RQTLNWKKMJXDEL-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,1995.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1546893,CHEMBL1430138,HLMAAXQVSYQPOP-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3082958,CHEMBL1574561,NYXUNUSKQCQQKJ-XBXARRHUSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5048089,CHEMBL366429,WZCSMILXZLIZGL-UHFFFAOYSA-N,,,P35354,CYCLOOXYGENASE-2,PTGS2,,,9083488.0,INHIBITION,=,68.0,%,,,,,,,,,,,,,,Inhibition of human Prostaglandin G/H synthase 2 at 10 ug/mL expressed as mean percent inhibition of control PGE-2 production,Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.,J. Med. Chem.,PUBLICATION,
5324409,CHEMBL101253,YCOYDOIWSSHVCK-UHFFFAOYSA-N,VATALANIB,,P07949,TYROSINE-PROTEIN KINASE RECEPTOR RET,RET,,,,KI,>,2511.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RET,PUBCHEM BIOASSAY DATA SET,,DATASET,
203900,CHEMBL1376948,AUPGBNCDKJBECS-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
14824,CHEMBL1309404,ABLYHHAPJOFYQH-YHYXMXQVSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5283902,CHEMBL1519432,XYRDNQOCDBOFKP-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5292229,CHEMBL1998639,XZNYIBDRNJIFES-SSDVNMTOSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
5332643,CHEMBL1589024,YDOROBHXWNAUHM-GDNBJRDFSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
2791920,CHEMBL1537563,MSXWDGSTENQXBT-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,115.8,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
648860,CHEMBL1584316,CSBRSIUFWLEHLD-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2596015,CHEMBL427060,LXAYJWRAXDNSOJ-UHFFFAOYSA-N,,,Q14242,P-SELECTIN GLYCOPROTEIN LIGAND 1,SELPLG,,,17201408.0,ACTIVITY,,,,,cell_based,,,,,CHO,,,,,,,Inhibition of human recombinant P-selectin expressed in CHO cells by Biacore assay at 1 mM,Synthesis and biological evaluation of quinoline salicylic acids as P-selectin antagonists.,J. Med. Chem.,PUBLICATION,
4633740,CHEMBL1736370,VFVGBVPQAQRPJT-UHFFFAOYSA-N,,,P11308,TRANSCRIPTIONAL REGULATOR ERG,ERG,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1802595,CHEMBL417799,INVGWHRKADIJHF-UHFFFAOYSA-N,SANGUINARIUM,,P25094,PERIPHERAL MYELIN PROTEIN 22,,,,,POTENCY,,15836.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3193588,CHEMBL526,OLBCVFGFOZPWHH-UHFFFAOYSA-N,PROPOFOL,,P25024,INTERLEUKIN-8 RECEPTOR A,CXCR1,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Chemokine CXCR1 (IL-8A),DrugMatrix in vitro pharmacology data,,DATASET,
4334384,CHEMBL1359534,TZWXWLKDADPAOC-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3124164,CHEMBL574738,ODPGGGTTYSGTGO-UHFFFAOYSA-N,AST-487,,P24941,CYCLIN-DEPENDENT KINASE 2,CDK2,,,18183025.0,KD,=,760.0,NM,,,,,,,,,,,,,,Binding constant for full-length CDK2,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4335620,CHEMBL1362868,UAAAHVSYSDWUIX-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20587.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4363725,CHEMBL679,UCTWMZQNUQWSLP-VIFPVBQESA-N,EPINEPHRINE,,P22734,CATECHOL O-METHYLTRANSFERASE,,,,1246034.0,VMAX,=,19.8,NMOL/MG/MIN,,,,,,,,,,,,,,Activity of Sprague-Dawley rat liver COMT using [14CH3]-SAM as methyl group donor after 10 mins by scintillation spectrophotometric analysis,"Synthesis and biological activity of 2- and 4-substituted 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines.",J. Med. Chem.,PUBLICATION,
930732,CHEMBL1570913,DWJJOPMDTHBMAX-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3285883,CHEMBL1540636,OUWDMQMZKLXMKQ-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5167119,CHEMBL1362068,XLURVOPEHLTVFE-UHFFFAOYSA-N,,,O75604,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2,USP2,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
147137,CHEMBL1312974,AOOHZDHSYHNXKM-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
2855024,CHEMBL2017853,MZRTXTPBAYMJCA-UHFFFAOYSA-N,,,P18031,PROTEIN-TYROSINE PHOSPHATASE 1B,PTPN1,,,22424978.0,KI,=,300.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant PTP1B expressed in Escherichia coli using para-nitrophenyl phosphate as substrate preincubated for 30 mins followed by substrate addition measured by fluorescence analysis,Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5405079,CHEMBL2441943,YLPKGKXMWHVALE-UHFFFAOYSA-N,,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,24140447.0,KD,=,10.0,NM,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human histamine H3 receptor expressed in CHO cells assessed as inhibition of forskolin/R-alpha-methylhistamine-induced cAMP accumulation after 1.5 hrs by TR-FRET immunoassay,Synthesis and evaluation of N-alkyl-S-[3-(piperidin-1-yl)propyl]isothioureas: high affinity and human/rat species-selective histamine H(3) receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2418709,CHEMBL586051,LDTQDFBNNNCIHE-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,19848404.0,IC50,=,130.0,NM,,,,,,,,,,,,,,Inhibition of human mTOR by DELFIA assay,Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase.,J. Med. Chem.,PUBLICATION,
778128,CHEMBL1530806,DFWHRROVOOHMBS-UHFFFAOYSA-N,,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3792924,CHEMBL55436,QYYXITIZXRMPSZ-UHFFFAOYSA-N,,,P49880,ECDYSONE RECEPTOR,,,,12749904.0,EC50,=,440.0,NM,,,,,,,,,,,,,,Effective concentration for ecdysone-dependent transactivation in mammalian cell line expressing Aedes aegypti ecdysone receptor,"Synthesis and SAR of cis-1-benzoyl-1,2,3,4-tetrahydroquinoline ligands for control of gene expression in ecdysone responsive systems.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1602228,CHEMBL1551116,HRUQZCSOTNXABO-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
301432,CHEMBL1407126,BFNYWCBWRCTEMR-LICLKQGHSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
779032,CHEMBL1441842,DFZLVDRZKMKTHD-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,115.8,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4268918,CHEMBL1079304,SYZGOUOZLCZRJD-QGAUECBJSA-N,ALSTOYUNINE E,,P23219,CYCLOOXYGENASE-1,PTGS1,,,19775092.0,INHIBITION,=,41.76,%,,,,,,,,,,,,,,Inhibition of COX1 at 100 uM after 15 mins,Monoterpenoid indole alkaloids from Alstonia yunnanensis.,J. Nat. Prod.,PUBLICATION,
131472,CHEMBL1455045,AMWSWALKGNCXCX-UHFFFAOYSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,,EC50,>,32000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: HTS Image-Based Screen for Agonists of the DOR Receptor. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1786, AID2133]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2195108,CHEMBL349515,KFFUJJZHHFGBET-CZNDPXEESA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,14736255.0,EC50,=,8.0,NM,,,,,,,,,,,,,,"Agonistic potency towards human melanocortin 4 receptor, determined by 50% maximum cAMP release",Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptor.,J. Med. Chem.,PUBLICATION,
2941194,CHEMBL1702335,NIYZOMKRAISURD-UHFFFAOYSA-N,,,O95977,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-6,S1PR4,,,22119461.0,EC50,,,,,cell_based,,,,,U2OS,,,,,,,Agonist activity at human S1P4R expressed in human U2OS cells containing EDG6 gene co-expressing GAL4-VP16 and beta-arrestin/TEV protease assessed as migration of VP16-GAL4 into nucleus up to 25 uM by FERT based beta-lactamase reporter gene assay,"Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1041585,CHEMBL2326274,FIHGGDIQXZHBEV-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,23406429.0,KI,>,20000.0,NM,,,,,,,,,,,,,,"Displacement of [3H]CP-55,940 from CB2 receptor (unknown origin) after 1 hr by scintillation counting analysis","Novel triaryl sulfonamide derivatives as selective cannabinoid receptor 2 inverse agonists and osteoclast inhibitors: discovery, optimization, and biological evaluation.",J. Med. Chem.,PUBLICATION,
3971753,CHEMBL1731037,RRWHQPHUNIVKCP-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2978327,CHEMBL1363255,NNAVYBDNKPZJMW-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2441836,CHEMBL1909408,LGOFDYJCRIMGHI-ZHEQYFEDSA-N,GSK-200398A,,Q9UM73,ALK TYROSINE KINASE RECEPTOR,ALK,,,,INHIBITION,=,-0.47,%,,,,,,,,,,,,,,GSK_PKIS: ALK mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1049547,CHEMBL365604,FJFHOUORJSHHRE-GRSHGNNSSA-N,,,Q7ZJM1,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE,,,,16250669.0,IC50,=,70.0,NM,,,,,,,,,,,,,,In vitro concentration required to inhibit the HIV-1 integrase strand transfer,Pharmacophore-based design of HIV-1 integrase strand-transfer inhibitors.,J. Med. Chem.,PUBLICATION,
4233630,CHEMBL1559206,SUXSUICLDFDAHR-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,10322.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5668275,CHEMBL1503613,ZOIZKDTYLJOHIP-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5055949,CHEMBL1342938,WZVCVWIYUKEBFF-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
4639200,CHEMBL1358928,VGLKOZVJDDZBMT-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
499231,CHEMBL473773,CBIAKDAYHRWZCU-UHFFFAOYSA-N,WHI-P154,,Q9Y6E0,SERINE/THREONINE-PROTEIN KINASE 24,STK24,wild_type,,23398362.0,ACTIVITY,=,43.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15,uM,"Millipore: Percentage of residual kinase activity of STK24 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3357547,CHEMBL1165152,PDBFFXOPMVKXDS-VQHVLOKHSA-N,,,P03956,MATRIX METALLOPROTEINASE-1,MMP1,,,23375794.0,IC50,=,4712.73,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP1 using succinylated gelatin as substrate incubated for 30 mins prior to substrate addition measured after 60 mins,Synthesis and structure-activity relationship analysis of caffeic acid amides as selective matrix metalloproteinase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2868614,CHEMBL1209377,NBGOOZKZGUKSAS-UHFFFAOYSA-N,,,P25774,CATHEPSIN S,CTSS,,,20594841.0,IC50,=,13.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant cathepsin S,2-Phenyl-9H-purine-6-carbonitrile derivatives as selective cathepsin S inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5069107,CHEMBL6273,XBJBPGROQZJDOJ-UHFFFAOYSA-N,FLEROXACIN,,P15207,ANDROGEN RECEPTOR,,,,,IC50,,,,,,,,,,,,,,,,,DRUGMATRIX: Androgen (Testosterone) AR radioligand binding (ligand: [3H] Mibolerone),DrugMatrix in vitro pharmacology data,,DATASET,
4254551,CHEMBL1308129,SXIDTKNMFJLQRQ-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1915430,CHEMBL1585931,JAMCNYIBSTYVKI-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5496468,CHEMBL321783,YVVLLDVGGVLRHN-UHFFFAOYSA-N,,,"P10980, P08911, P08485, P08482, P08483",MUSCARINIC ACETYLCHOLINE RECEPTOR,,,,2231611.0,INHIBITION,=,12.0,%,,,,,,,,,,,,,,Inhibitory effect on muscarinic acetylcholine receptor binding affinity at a concentration of (10e -6)M,"Synthesis and antiarrhythmic activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines.",J. Med. Chem.,PUBLICATION,
4169099,CHEMBL1341078,SNWGXXRJYSNHPG-UHFFFAOYSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
5278865,CHEMBL163704,XYCPEHAPRMZWKX-MKUMLKGRSA-N,,,"P41143, P41145, P35372",OPIOID RECEPTORS; MU/KAPPA/DELTA,"OPRD1, OPRK1, OPRM1",,,2153826.0,CONTROL,=,100.0,%,,,,,,,,,,,,,,Irreversible inhibition of 0.5 nM [3H]bremazocine binding against Opioid receptors from washed bovine caudate membranes at 100 nM in presence of NaCl,Conjugate addition ligands of opioid antagonists. Methacrylate esters and ethers of 6 alpha- and 6 beta-naltrexol.,J. Med. Chem.,PUBLICATION,
1662037,CHEMBL1793928,HYKBICDYDPTWDJ-SLICBABFSA-N,,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,9216842.0,IC50,=,880.0,NM,,,,,,,,,,,,,,Inhibition of binding to Endothelin A receptor of rabbit renal vascular smooth muscle cells,"Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe]Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties.",J. Med. Chem.,PUBLICATION,
4830748,CHEMBL1532928,WBTCERKLDKQMFI-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3222877,CHEMBL1478511,OOBSMPJMRSRYTN-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4387863,CHEMBL1559463,UFQNJXZUPXSBCZ-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1950129,CHEMBL259324,JEDNMNJCJIIYJR-NJDSBKIZSA-N,,,Q8WTS6,HISTONE-LYSINE N-METHYLTRANSFERASE SETD7,SETD7,,,18348515.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant SET7 assessed as histone H3 protein methylation at 100 uM,"epigenetic multiple ligands: mixed histone/protein methyltransferase, acetyltransferase, and class III deacetylase (sirtuin) inhibitors.",J. Med. Chem.,PUBLICATION,
5189778,CHEMBL1404173,XOHDBTHGCAJFHY-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4935946,CHEMBL1575715,WMWFQZNCWFRHPR-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3363894,CHEMBL95692,PDTYLGXVBIWRIM-UHFFFAOYSA-N,SB-242235,,Q5VT25,SERINE/THREONINE-PROTEIN KINASE MRCK-A,CDC42BPA,wild_type,,21336281.0,KI,<,10000.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
4312488,CHEMBL59492,TXJVJGOVBNVZNM-UHFFFAOYSA-N,,,P51681,C-C CHEMOKINE RECEPTOR TYPE 5,CCR5,,,15055994.0,IC50,,,,,cell_based,,,,,L1.2,,,,,,,Migration of compound was evaluated in cell migration assay with C-C chemokine receptor type 5-transfected L1.2 cells or activated human peripheral blood lymphocytes; nd denotes not determined,Orally bioavailable competitive CCR5 antagonists.,J. Med. Chem.,PUBLICATION,
5173996,CHEMBL1165530,XMKZYRQJHAXBPO-UHFFFAOYSA-N,,,P35575,GLUCOSE-6-PHOSPHATASE,G6PC,,,20471838.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of glucose-6-phosphatase assessed as inositol phosphate release at 100 uM after 30 mins,"Design and synthesis of 2,4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents.",Bioorg. Med. Chem.,PUBLICATION,
1926331,CHEMBL1307207,JBMKSILOCSVHGX-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,21331.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1983225,CHEMBL1340521,JHZGTKAFPZSVRY-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
354786,CHEMBL1426734,BLDQOOUOTLORKG-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3603898,CHEMBL1318943,QEKYDTGXFOVMRB-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
4159483,CHEMBL1729178,SMXPLLCJICLNDP-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2576923,CHEMBL1376135,LUUPXNBEMVUQRQ-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5045087,CHEMBL762,WYWIFABBXFUGLM-UHFFFAOYSA-N,OXYMETAZOLINE,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,,KI,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Dopamine D3 radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
443412,CHEMBL2205773,BVAIASCEGGMUQD-UHFFFAOYSA-N,,,P42338,PI3-KINASE P110-BETA SUBUNIT,PIK3CB,,,22726925.0,IC50,=,39810717.06,NM,,,,,,,,,,,,,,Inhibition of PI3Kbeta assessed as change in pIC50 by kinobeads assay,"Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5840730,CHEMBL1909079,,STANNOUS FLUORIDE,,P15127,INSULIN RECEPTOR,,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Insulin radioligand binding (ligand: [125I] Insulin),DrugMatrix in vitro pharmacology data,,DATASET,
2800263,CHEMBL347167,MTXWTNUNMLDZTE-UHFFFAOYSA-N,,,P19327,SEROTONIN 1A (5-HT1A) RECEPTOR,,,,15914001.0,IC50,=,1.59,NM,,,,,,,,,,,,,,Inhibitory concentration against 5-hydroxytryptamine 1A receptor in rat hippocampus membrane using [3H]-8-OH-DPAT as radioligand,"New piperidinyl- and 1,2,3,6-tetrahydropyridinyl-pyrimidine derivatives as selective 5-HT1A receptor agonists with highly potent anti-ischemic effects.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3952781,CHEMBL524057,RPRZAINAFJBVOV-UHFFFAOYSA-N,GW683768X,,P42680,TYROSINE-PROTEIN KINASE TEC,TEC,,,,INHIBITION,=,3.41,%,,,,,,,,,,,,,,GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1709386,CHEMBL218969,IDHOIXYTISLBFT-BQYQJAHWSA-N,GW445015X,,P07333,MACROPHAGE COLONY STIMULATING FACTOR  RECEPTOR,CSF1R,,,,INHIBITION,=,4.09,%,,,,,,,,,,,,,,GSK_PKIS: FMS mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3291389,CHEMBL1590876,OVMSOCFBDVBLFW-SSXYINQQSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4778074,CHEMBL1909407,VVZKVERLAIBFRB-UHFFFAOYSA-N,SB-220025A,,Q16288,NT-3 GROWTH FACTOR RECEPTOR,NTRK3,,,,INHIBITION,=,-1.78,%,,,,,,,,,,,,,,GSK_PKIS: TRKC mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1142314,CHEMBL1380884,FTIJNRLFGFYJME-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3950150,CHEMBL1701096,RPLNVBYDJXCAAU-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,2592.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
748638,CHEMBL569721,DCQUEYKYABNNDA-SECBINFHSA-N,,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,19857966.0,IC50,>,30000.0,NM,,,,,,,,,,,,,,Inhibition of JAK3 using 5 mM ATP as a substrate,Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1074908,CHEMBL47940,FMETVQKSDIOGPX-UHFFFAOYSA-N,,,Q9NQU5,SERINE/THREONINE-PROTEIN KINASE PAK6,PAK6,wild_type,,23398362.0,ACTIVITY,=,63.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of PAK6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1520854,CHEMBL300516,HJBXFPFTLNZSRF-UHFFFAOYSA-N,,,"Q95323, Q3SZX4, P00921, P18915",CARBONIC ANHYDRASE,,,,3761301.0,INHIBITION,=,53.0,%,,,,,,,,,,,,,,Evaluated for the inhibition of carbonic anhydrase enzyme at 0.5 g/L concentration,Synthesis and inhibitory activity on carbonic anhydrase of some new sulpiride analogues studied by means of a new method.,J. Med. Chem.,PUBLICATION,
3631373,CHEMBL1613678,QHHAGKKNDWKSAB-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4044309,CHEMBL1315944,RZWICVKPMKJLJR-UHFFFAOYSA-N,,,Q13627,DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REGULATED KINASE 1A,DYRK1A,,,21450467.0,IC50,=,3152.0,NM,,,,,,,,,,,,,,Inhibition of Dyrk1A kinase using ATP as substrate by 33P radiolabeled kinase assay,Potent and selective small molecule inhibitors of specific isoforms of Cdc2-like kinases (Clk) and dual specificity tyrosine-phosphorylation-regulated kinases (Dyrk).,Bioorg. Med. Chem. Lett.,PUBLICATION,
2225125,CHEMBL410893,KIQFUORWRVZTHT-OPTMKGCMSA-N,,,,Ubiquitin-specific peptidase 2a (USP2a),,,,28343940.0,IC50,=,33100.0,NM,,,,,,,,,,,,,,,,,,
402941,CHEMBL1318936,BQJPOUCEBYMCNU-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4379186,CHEMBL252719,UEQUQVLFIPOEMF-GOSISDBHSA-N,(S)-MIANSERIN,,P41595,SEROTONIN 2B (5-HT2B) RECEPTOR,HTR2B,,,10821800.0,KI,=,19.95,NM,,,,,,,,,,,,,,,,,,
2021708,CHEMBL1585818,JMIZIAKUBBDMRO-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2549822,CHEMBL1527473,LSBCOVVXPPHMML-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,446.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1032623,CHEMBL3335153,FHLJVZAGXXPSEH-WKILWMFISA-N,,,P11309,SERINE/THREONINE-PROTEIN KINASE PIM1,PIM1,,,25198388.0,ACTIVITY,=,13.0,%,,,,,,,,,,,,,,Inhibition of PIM1 (unknown origin) assessed as residual enzyme activity at 10 uM,The design and synthesis of potent and selective inhibitors of Trypanosoma brucei glycogen synthase kinase 3 for the treatment of human african trypanosomiasis.,J. Med. Chem.,PUBLICATION,
1848587,CHEMBL481491,ITAJXWHXKVYGCF-UHFFFAOYSA-N,,,O96017,SERINE/THREONINE-PROTEIN KINASE CHK2,CHEK2,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
552013,CHEMBL1489416,CGZHSLYTYIXHQY-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2039104,CHEMBL1970522,JOIUJUJSHIHBDT-UHFFFAOYSA-N,,,Q5VT25,SERINE/THREONINE-PROTEIN KINASE MRCK-A,CDC42BPA,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA,PUBCHEM BIOASSAY DATA SET,,DATASET,
5594840,CHEMBL1343864,ZGCWMNNVCZKFJA-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1650286,CHEMBL253969,HXHAJRMTJXHJJZ-UHFFFAOYSA-N,OSI-632,,Q02763,TYROSINE-PROTEIN KINASE TIE-2,TEK,,,18308565.0,IC50,=,18.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant TIE2 by HTRF assay,"Design and synthesis of dihydroindazolo[5,4-a]pyrrolo[3,4-c]carbazole oximes as potent dual inhibitors of TIE-2 and VEGF-R2 receptor tyrosine kinases.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5226994,CHEMBL264406,XSHQBIXMLULFEV-UHFFFAOYSA-N,,,Q9P286,SERINE/THREONINE-PROTEIN KINASE PAK7,PAK7,,,17850214.0,ACTIVITY,=,73.0,%,activation,biochemical,functional,enzyme_activity,competitive_inhibitor,radiometry,,1,uM,ATP,=,20.0,uM,Percentage PAK5 activity remaining in the presence of 1uM inhibitor,The selectivity of protein kinase inhibitors: a further update.,Biochem. J.,PUBLICATION,
5293608,CHEMBL222579,XZRPKQLMWUXWPM-JYBLDVITSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,15588100.0,ACTIVITY,=,90.0,%,,cell_based,,,,,CHO,,,,,,,Activity at human recombinant delta opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay relative to DPDPE,"Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.",J. Med. Chem.,PUBLICATION,
3600889,CHEMBL1271266,QEAYLNJEDDOYNQ-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2173052,CHEMBL1794059,KCVNXJLUFNZAMY-LCYFTJDESA-N,GW275616X,,P04049,SERINE/THREONINE-PROTEIN KINASE RAF,RAF1,,,,INHIBITION,=,-0.16,%,,,,,,,,,,,,,,GSK_PKIS: CRAF mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3426968,CHEMBL1559278,PKNMGNVMKCLCTL-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1778.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2617213,CHEMBL2420562,LZLQWVSFCFCTJH-NJDAHSKKSA-N,,,P50750,CYCLIN-DEPENDENT KINASE 9,CDK9,,,23916259.0,INHIBITION,<,35.0,%,,,,,,,,,,,,,,Inhibition of CDK9 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,"Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2758606,CHEMBL214844,MOYFDFLARKLAIW-UHFFFAOYSA-N,,,P48058,"GLUTAMATE RECEPTOR IONOTROPIC, AMPA 4",GRIA4,,,16872827.0,EC50,=,1143.0,NM,,cell_based,,,,,HEK293,,,,,,,Activity at human recombinant iGluR4 flip expressed in HEK293 cells measured as change in intracellular calcium ion concentration in presence of glutamate by FLIPR assay,"A novel class of positive allosteric modulators of AMPA receptors: design, synthesis, and structure-activity relationships of 3-biphenyl-4-yl-4-cyano-5-ethyl-1-methyl-1H-pyrrole-2-carboxylic acid, LY2059346.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3751237,CHEMBL79990,QUFMDMYSYWGKMF-UHFFFAOYSA-N,,,P35348,ALPHA-1A ADRENERGIC RECEPTOR,ADRA1A,,,12161153.0,KI,=,297.0,NM,,,,,,,,,,,,,,Displacement of [125I]HEAT from human Alpha-1A adrenergic receptor,Arylpiperazine substituted heterocycles as selective alpha(1a) adrenergic antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3671553,CHEMBL128427,QLWDRAMFFJADEJ-UHFFFAOYSA-N,,,P25099,ADENOSINE A1 RECEPTOR,,,,9767637.0,DISPLACEMENT,=,16.0,%,,,,,,,,,,,,,,Antagonist activity by displacement of specific [3H]DPCPX binding in rat cortical membrane (Adenosine A1 receptor) at a Conc of 10 mM.,A novel class of adenosine A3 receptor ligands. 2. Structure affinity profile of a series of isoquinoline and quinazoline compounds.,J. Med. Chem.,PUBLICATION,
4356066,CHEMBL1353409,UBZUGODTEUOBAO-UHFFFAOYSA-M,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5706604,CHEMBL1651906,ZSJLQEPLLKMAKR-YDEIVXIUSA-N,STREPTOZOTOCIN,,Q16539,MAP KINASE P38 ALPHA,MAPK14,,,,IC50,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Serine/Threonine Kinase, p38alpha enzyme inhibition (substrate: Myelin Basic Protein)",DrugMatrix in vitro pharmacology data,,DATASET,
2785166,CHEMBL2181441,MSBJVIBAZGDWFI-XYOGLKKJSA-M,,,P49682,C-X-C CHEMOKINE RECEPTOR TYPE 3,CXCR3,,,23150943.0,RATIO,=,0.36,,,cell_based,,,,,HEK293,,,,,,,Agonist activity at CXCR3 expressed in HEK293 cells by [35S]GTPgamma binding assay relative to CXCL11,Chemical Subtleties in Small-Molecule Modulation of Peptide Receptor Function: The Case of CXCR3 Biaryl-Type Ligands.,J. Med. Chem.,PUBLICATION,
695275,CHEMBL590615,CWYDYWFZPBTTIM-UHFFFAOYSA-N,,,Q01959,DOPAMINE TRANSPORTER,SLC6A3,,,19954972.0,KI,=,137.0,NM,,,,,,,,,,,,,,Binding affinity to DAT,"Oxo-bridged isomers of aza-trishomocubane sigma (sigma) receptor ligands: Synthesis, in vitro binding, and molecular modeling.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4966675,CHEMBL1564356,WQGXGQWAEKQCRY-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3793437,CHEMBL215152,QYZOGCMHVIGURT-UHFFFAOYSA-N,AZD-1152-HQPA,,Q09013,MYOTONIN-PROTEIN KINASE,DMPK,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for DMPK kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4155556,CHEMBL1765905,SMKUWLPJDRLBCV-GDNBJRDFSA-N,,,P09917,ARACHIDONATE 5-LIPOXYGENASE,ALOX5,,,22551629.0,IC50,=,1930.0,NM,,cell_based,,,,,,,,,,,,Inhibition of 5-lipoxygenase in human polynuclear leukocytes assessed as inhibition of A23187-stimulated 5-LO product formation preincubated for 15 mins measured after 10 mins by HPLC analysis,Synthesis and biological evaluation of a class of 5-benzylidene-2-phenyl-thiazolinones as potent 5-lipoxygenase inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
504229,CHEMBL1608545,CBVHOIKBOHZGSA-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
349000,CHEMBL3687981,BKMVBDOZLBKNIT-LJQANCHMSA-N,,,P27487,DIPEPTIDYL PEPTIDASE IV,DPP4,,,,IC50,=,13.5,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Inhibition Assay. DPP4 activity was measured using a continuous fluorometric assay. The substrate, Gly-Pro-AMC, was cleaved by DPP4 to release the fluorescent AMC group. The reaction was monitored at the excitation wavelength of 360 nm and emission wavelength of 460 nm in a black 384-well plate using a PHERAstar Plus plate reader (BMG Labtech., Inc.) set at 37 C. The 30 ul assay solution contained 20 pM recombinant human DPP4 and 50 uM Gly-Pro-AMC substrate in assay buffer (100 mM HEPES, 100 mM NaCl, 0.1 mg/ml BSA, pH 7.5). The reaction was linear for at least 30 min (initial velocity) after addition of the substrate (no inhibitor control). All materials and reagents were pre-incubated at 37 C. prior to start of the experiment. Test compounds were serially diluted (3-fold) in 100% DMSO to avoid solubility issues; working solutions in 3% DMSO were prepared using assay buffer. 10 ul each of enzyme and compound solutions were mixed and pre-incubated at 37 C. for 30 minutes.",Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors,,PATENT,
1693983,CHEMBL3211064,IBRJIFVOHPIBLC-DJKKODMXSA-N,,,Q9HBX9,RELAXIN RECEPTOR 1,RXFP1,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2405715,CHEMBL1973937,LCGSWTFWYNYUKS-UHFFFAOYSA-N,,,P68400,CASEIN KINASE II ALPHA,CSNK2A1,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK2A1,PUBCHEM BIOASSAY DATA SET,,DATASET,
3160012,CHEMBL414778,OHFMRHZLQMSCRN-VKYCMGGFSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,15771429.0,MAXIMAL EFFECT,=,16.0,%,,cell_based,,,,,HEK293,,,,,,,Maximal effect on human melanocortin 4 receptor expressing HEK 293 cells,Novel 3D pharmacophore of alpha-MSH/gamma-MSH hybrids leads to selective human MC1R and MC3R analogues.,J. Med. Chem.,PUBLICATION,
5738183,CHEMBL1130,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,DOXIFLURIDINE,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DrugMatrix in vitro pharmacology data,,DATASET,
4731417,CHEMBL1542684,VQODOCJEYQFDIX-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3801064,CHEMBL1669276,QZSRDKWUUVVBAE-UHFFFAOYSA-N,,,P07858,CATHEPSIN B,CTSB,,,21227690.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of human cathepsin B,"1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors: separation of desired cellular activity from undesired tissue accumulation through optimization of basic nitrogen pka.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4019510,CHEMBL1304583,RXGWHWRZNGEZOH-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3000245,,NPNXPJMTHYXCHW-UHFFFAOYSA-N,SURECN9660473,,P08912,MUSCARINIC ACETYLCHOLINE RECEPTOR M5,CHRM5,,,2704370.0,KI,=,2.0,NM,,,,,,,,,,,,,,,,,,
2283133,CHEMBL3195171,KOYGLTLBUXYMNL-AFUMVMLFSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2348153,CHEMBL254895,KVPNOQAXVUMKFJ-UHFFFAOYSA-N,,,P04629,NERVE GROWTH FACTOR RECEPTOR TRK-A,NTRK1,,,18055203.0,IC50,=,0.6,NM,,,,,,,,,,,,,,Inhibition of TrkA,Identification of 2-amino-5-(thioaryl)thiazoles as inhibitors of nerve growth factor receptor TrkA.,Bioorg. Med. Chem. Lett.,PUBLICATION,
562132,CHEMBL1440860,CIDWMBFGIDEDKO-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4190080,CHEMBL1405664,SQFIJFCIFAVGEG-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3392749,CHEMBL440765,PGZRDDYTKFZSFR-ONTIZHBOSA-N,U-69593,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,8114680.0,KI,=,1000.0,NM,,,,,,,,,,,,,,,,,,
464896,CHEMBL3189231,BXMQWUCCYTZOND-FCQUAONHSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18348.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1314137,CHEMBL1429415,GMICJYWRBUKYCK-UHFFFAOYSA-N,,,P15917,ANTHRAX LETHAL FACTOR,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3253905,CHEMBL485,OROGSEYTTFOCAN-DNJOTXNNSA-N,CODEINE,,P33535,MU OPIOID RECEPTOR,,,,2831361.0,KP,=,11.4,,,,,,,,,,,,,,,Binding constant for the antagonist state was measured for its ability to displace [3H]naloxone from opioid mu 1 receptor buffered homogenate of rat brain membranes,Structure-activity relationships for drugs binding to the agonist and antagonist states of the primary morphine receptor.,J. Med. Chem.,PUBLICATION,
1162847,CHEMBL2133248,FVRNNYJGQUROJN-GJBCSVNNSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
691618,CHEMBL1398936,CWOJHKDXIMRASK-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5431478,CHEMBL1332346,YOHQXMCAKJZZPA-XRCYRVQWSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
244249,CHEMBL1429646,AZAPTLTZCLSCIW-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
4625019,CHEMBL1420065,VEYUTGFIBSSMPK-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,112.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
1677687,CHEMBL1732159,IACBXMJNYCONGZ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16353.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1773870,CHEMBL511765,IKWHWJFNGWUVIJ-UHFFFAOYSA-N,GSK-2213727A,,Q06187,TYROSINE-PROTEIN KINASE BTK,BTK,,,,INHIBITION,=,0.16,%,,,,,,,,,,,,,,GSK_PKIS: BTK mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
790403,CHEMBL3581050,DHGZFNINOOBXHZ-UHFFFAOYSA-N,,,Q15858,SODIUM CHANNEL PROTEIN TYPE IX ALPHA SUBUNIT,SCN9A,,,25466191.0,KI,=,650.0,NM,,,,,,,,,,,,,,Inhibition of Nav1.7 (unknown origin) by electrophysiological assay,Dibenzazepines and dibenzoxazepines as sodium channel blockers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
924500,CHEMBL215943,DVRSTRMZTAPMKO-UHFFFAOYSA-N,,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,16970394.0,IC50,=,72.0,NM,,,,,,,,,,,,,,Inhibition of Jak3 by HTRF kinase assay,"Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.",J. Med. Chem.,PUBLICATION,
2263985,CHEMBL1383967,KMQIYGBEGPWIJH-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,6510.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1954248,CHEMBL529593,JERMOQNJLJHILS-UHFFFAOYSA-N,TCMDC-124553,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,0.97,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
5563361,CHEMBL3093830,ZCSQHWMSYZNFAX-UHFFFAOYSA-N,,,P81908,CHOLINESTERASE,,,,24148835.0,IC50,=,6120.0,NM,,,,,,,,,,,,,,Inhibition of equine serum BChE using butylthiocholine chloride as substrate incubated for 15 mins prior to substrate addition by Ellman's method,"Design, synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents.",Bioorg. Med. Chem.,PUBLICATION,
5339142,CHEMBL1988163,YEHCNYAQEBQCCS-UHFFFAOYSA-N,,,Q13188,SERINE/THREONINE-PROTEIN KINASE MST2,STK3,,,,KI,=,79.43,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: STK3,PUBCHEM BIOASSAY DATA SET,,DATASET,
1546616,CHEMBL3211816,HLKYTGVSIPJJGD-PTGBLXJZSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2835606,CHEMBL1309683,MXUJAKDFMUGPHN-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5375683,CHEMBL1442543,YIKIHFZNZOMKRG-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2036254,CHEMBL1558656,JNZXGFSUVHHLKG-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,IC50,=,9770.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of small molecule APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493012, AID493028]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1379467,CHEMBL1560318,GTZTULFSOSTURT-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
548633,CHEMBL249017,CGNLCPXSULXNCO-UHFFFAOYSA-N,,,P00742,COAGULATION FACTOR X,F10,,,17881231.0,KAPP,=,650.0,10^6L/MOL,,,,,,,,,,,,,,Binding affinity to F10a,D-phenylglycinol-derived non-covalent factor Xa inhibitors: effect of non-peptidic S4 linkage elements on affinity and anticoagulant activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2346591,CHEMBL1406985,KVKMSOGAETTWON-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
1990251,CHEMBL1520312,JIVCISAVUBTQRK-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3722073,CHEMBL1542074,QQXUHMOOSXZQGF-UHFFFAOYSA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,,IC50,>,31500.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: uHTS identification of small molecule antagonists of the kappa opioid receptor via a luminescent beta-arrestin assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1785, AID1786, AID1966, AID2136, AID2285, AID2495, AID434981, AID463105, AID488826, AID488935]",PUBCHEM BIOASSAY DATA SET,,DATASET,
516600,CHEMBL1869664,CDGWQGPJQZDZLA-UHFFFAOYSA-N,"4,5,6-TRIMETHOXYCOUMARANONE",,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4827476,CHEMBL1391718,WBIJZIRNVLZQHN-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4994403,CHEMBL1372269,WTLQYVNZNOFSGL-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,4.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2660, AID2666, AID2667, AID2668, AID2681, AID504465]",PUBCHEM BIOASSAY DATA SET,,DATASET,
905613,CHEMBL2112814,DTMNXUIEZZDGTK-OAHLLOKOSA-N,,,P30543,ADENOSINE A2A RECEPTOR,,,,11101355.0,INHIBITION,=,47.0,%,,,,,,,,,,,,,,Binding affinity against adenosine A2A receptor in rat striatal membrane preparations using [3H]CGS-21680 at 10 uM,7-Deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists.,J. Med. Chem.,PUBLICATION,
1151874,CHEMBL1986943,FUMCKNCUEAQHCV-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,,KI,=,251.19,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,PUBCHEM BIOASSAY DATA SET,,DATASET,
4142855,CHEMBL1335851,SKZKTUMFJUGQNK-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1959445,CHEMBL290106,JFIOVJDNOJYLKP-UHFFFAOYSA-N,BITHIONOL,,P50052,ANGIOTENSIN II TYPE 2 (AT-2) RECEPTOR,AGTR2,,,,KI,,,,,cell_based,,,,,CHO-K1,,,,,,,DRUGMATRIX: Angiotensin AT2 radioligand binding (ligand: [125I] CGP-42112A),DrugMatrix in vitro pharmacology data,,DATASET,
2652454,CHEMBL1560217,MDGXWVLZIHZDCE-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5623336,CHEMBL1456412,ZJFOXBNOYKAJHK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,1636.0,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
867729,CHEMBL611945,DPIYTCQGFANXRZ-UHFFFAOYSA-N,,,Q16539,MAP KINASE P38 ALPHA,MAPK14,,,19969459.0,IC50,=,16.3,NM,,,,,,,,,,,,,,Inhibition of p38 alpha,Continued exploration of the triazolopyridine scaffold as a platform for p38 MAP kinase inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4683314,CHEMBL1602921,VLNVQTMRPSWICN-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3977624,CHEMBL160937,RSOMSYHDLLNJGQ-UHFFFAOYSA-N,SB-390527,,Q86V86,SERINE/THREONINE-PROTEIN KINASE PIM3,PIM3,,,,INHIBITION,=,-0.32,%,,,,,,,,,,,,,,GSK_PKIS: PIM3 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
933808,CHEMBL1542969,DWSIOSHAIVWFOQ-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,316.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1242528,CHEMBL1406725,GERZIBJSNHFDPD-ZZAQZTKVSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
583124,CHEMBL1409168,CKOLIABRVFHOPI-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1936370,CHEMBL1162220,JCQYPCOLVFCIRV-MIGAEMFTSA-N,,,P53686,NAD-DEPENDENT DEACETYLASE HST2,,,,17951578.0,KD,=,3300.0,NM,,,,,,,,,,,,,,Binding affinity to Saccharomyces cerevisiae Hst2 by isothermal titration calorimetry,Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.,J. Biol. Chem.,PUBLICATION,
3705645,CHEMBL3198492,QPKPUHZRQCMNLP-CIAFOILYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2599887,CHEMBL1506353,LXJYWAVEMQWCNP-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3154119,CHEMBL1430546,OGPPFBNXBNVDLK-BJMVGYQFSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
708747,CHEMBL1741914,CYKSIGMPZBAPCK-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,=,28183.83,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3597907,CHEMBL1736170,QDRBVCQGVAHXBS-JQASONJCSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2708271,CHEMBL156924,MJPRHOCGAAJSMO-UHFFFAOYSA-N,,,O19045,COAGULATION FACTOR X,,,,11266160.0,KI,=,0.08,NM,,,,,,,,,,,,,,Binding affinity towards Rabbit Coagulation factor X in a rabbit arterio-venous (A-V) shunt model,Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5533999,CHEMBL579369,YZTRDTVSKPACHB-UHFFFAOYSA-N,GNF-PF-5131,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1536400,CHEMBL1360921,HKSDYVVCYJKCRE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3386120,CHEMBL1558931,PGHALHMYKSQSBZ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5050873,CHEMBL1541191,WZISKAGWGCOEDW-HNNXBMFYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,354.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2719438,CHEMBL1419718,MKXQZGCRTNDUKF-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4105390,CHEMBL6966,SGTNSNPWRIOYBX-UHFFFAOYSA-N,VERAPAMIL,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,16309318.0,INHIBITION,=,95.0,%,,cell_based,,,,,A2780,,,,,,,Inhibition of P-glycoprotein-mediated multidrug resistance in adriamycin-resistant human A2780 cells assessed as calcein accumulation at 2.5 ug/ml after 15 mins relative to control,Bioactive tetrahydrofuran lignans from Peperomia dindygulensis.,J. Nat. Prod.,PUBLICATION,
4664694,CHEMBL1447554,VJJQBKMQAKBKDC-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5340512,CHEMBL1490680,YEICHOBCEQKGNQ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3585614,CHEMBL1594093,QCEHWNYVFVSDFZ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
684889,CHEMBL1534013,CVUIMTMTLKYPHV-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,28100.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with MMS Viability. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3509727,CHEMBL1413072,PTNNZVXQWGIVTC-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5623175,CHEMBL2218932,ZJFMARHFPUZEKI-KMKOMSMNSA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,wild_type,,23398362.0,ACTIVITY,=,106.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of IGF1R at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 50 mM Tris pH 7.5, 0.1 mM EGTA, 0.1 mM Na3VO4, 0.1% ?-mercaptoethanol",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4912187,CHEMBL1373658,WKBMJLABMRWBRG-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4893763,CHEMBL361894,WIIIHAKKVLVGJX-UHFFFAOYSA-N,GW806290X,,P51817,SERINE/THREONINE-PROTEIN KINASE PRKX,PRKX,,,,INHIBITION,=,1.25,%,,,,,,,,,,,,,,GSK_PKIS: PRKX mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1465953,CHEMBL1572120,HDKLDDWHIQFXHF-QINSGFPZSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,2238.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1701007,CHEMBL1396364,ICJQXOSVTSBBTA-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1225834,CHEMBL1379224,GCWIBWLLOHLHLN-FNORWQNLSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4098481,CHEMBL1453396,SGBJDXQVWTUNJO-UHFFFAOYSA-N,,,P11021,78 KDA GLUCOSE-REGULATED PROTEIN,HSPA5,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4607691,CHEMBL41275,VDALIBWXVQVFGZ-UHFFFAOYSA-N,TAK-779,,P41597,C-C CHEMOKINE RECEPTOR TYPE 2,CCR2,,,17715128.0,INHIBITION,=,90.7,%,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [125I]MCP1 from CCR2/CXCR4 expressed in CHOK1 cells,Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers.,J. Biol. Chem.,PUBLICATION,
5316763,CHEMBL2326972,YBVOPGZDZNWRKJ-FNFCYJGBSA-N,,,O60880,SH2 DOMAIN-CONTAINING PROTEIN 1A,SH2D1A,,,23470190.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of recombinant 6-His-tagged SLAM associated protein SH2 domain (unknown origin) expressed in Escherichia coli BL21(DE3) binding to biotinyl-KKSLTIpYAQVQK-NH2 attached to NeutrAvidin-coated plates using p-nitrophenyl phosphate as substrate at 100 uM after 1 hr,Development and Evaluation of Novel Phosphotyrosine Mimetic Inhibitors Targeting the Src Homology 2 Domain of Signaling Lymphocytic Activation Molecule (SLAM) Associated Protein.,J. Med. Chem.,PUBLICATION,
1692571,CHEMBL1318004,IBOBEXDBNVGMKY-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3963032,CHEMBL1308357,RQWXBPMJZHPGEX-BQYQJAHWSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2925103,CHEMBL505734,NHKCCADZVLTPPO-UHFFFAOYSA-N,NOCARDAMINE,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
891914,CHEMBL1384373,DRXXNHVPDYGFPX-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
5655269,CHEMBL404391,ZMXKPCHQLHYTHY-IMFSECDYSA-N,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,18177012.0,ACTIVITY,=,111.0,%,,cell_based,,,,,,,,,,,,Inhibition of P-glycoprotein-mediated multidrug resistance in human 2780AD cells assessed as calcein accumulation at 0.25 ug/mL relative to control,Bioactive triterpene saponins from the roots of Phytolacca americana.,J. Nat. Prod.,PUBLICATION,
5849485,CHEMBL1316468,,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,37933.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2013773,CHEMBL1429104,JLOJSXAPTCXIKQ-MOSHPQCFSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2394995,CHEMBL1431637,LBCZSJPUOWSJJS-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3604284,CHEMBL33051,QELSIJXWEROXOE-UHFFFAOYSA-N,,,P37136,ACETYLCHOLINESTERASE,,,,17924614.0,ACTIVITY,=,4.0,%,,tissue,,,,,,,,,,,,Reactivation activity of tabun-inhibited AChE in rat brain at 10 uM after 30 mins,Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203).,J. Med. Chem.,PUBLICATION,
3242514,CHEMBL459730,OQIBXTHHXDTIBJ-OAQYLSRUSA-N,,,P19020,DOPAMINE D3 RECEPTOR,,,,18754613.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Displacement of [3H]NMSP from rat cloned dopamine D3 receptor,"Discovery and labeling of high-affinity 3,4-diarylpyrazolines as candidate radioligands for in vivo imaging of cannabinoid subtype-1 (CB1) receptors.",J. Med. Chem.,PUBLICATION,
1645876,CHEMBL477979,HWUIKJWOZNTZQM-UHFFFAOYSA-N,GW785974X,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,AC50,=,,,,,,,,,,,,,,,,GSK_PKIS: Inhibition of Firefly Luciferase (Data from PubChem: AID 652016) [NIH NCATS],"Data associated with the publication PLoS ONE, 8(3), e57888, (2013) PMID: 23505445. Compounds: GSK PKIS; Assays: NIH NCATS",,DATASET,
1417016,CHEMBL1307205,GYFTYGRYVYKBQJ-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,119.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3255961,CHEMBL1864744,ORUXVPGCSZCDTB-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4216622,CHEMBL1301811,SSYYFONFBSKVFR-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3398389,CHEMBL1497324,PHMWWUXKFJMFGL-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1462396,CHEMBL1168,HDACQVRGBOVJII-JBDAPHQKSA-N,RAMIPRIL,,P21452,NEUROKININ 2 RECEPTOR,TACR2,,,,KI,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),DrugMatrix in vitro pharmacology data,,DATASET,
1873181,CHEMBL1593952,IVWAKVKHUXEHAS-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3969892,CHEMBL3685301,RRQJOXSKCRZHNK-UHFFFAOYSA-N,,,O14965,SERINE/THREONINE-PROTEIN KINASE AURORA-A,AURKA,,,,IC50,=,3.8,NM,,,,,,,,,,,,,,BindingDB_Patents: Enzyme Assay. The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.,Amino azaheterocyclic carboxamides,,PATENT,
1169663,CHEMBL1338804,FWOMHORVBSHZTK-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3654072,CHEMBL2058781,QJYBFPPSYZFEAR-ODLFYWEKSA-N,,,,D-lactate dehydrogenase,,,,15123280.0,KI,=,42.0,NM,,,,,,,,,,,,,,,,,,
4671382,CHEMBL3261381,VKGGBLHFFRIHKZ-UHFFFAOYSA-N,,,P14174,MACROPHAGE MIGRATION INHIBITORY FACTOR,MIF,,,24712915.0,INHIBITION,=,157.0,%,,cell_based,,,,,,,,,,,,Inhibition of recombinant MIF (unknown origin)-mediated glucocorticoid overriding activity in LPS-stimulated mouse RAW264.7 cells assessed as inhibition of dexamethasone-induced intracellular TNF-alpha production at 20 uM preincubated for 30 mins followed by LPS challenge measured at 4 hrs by ELISA relative to control,Discovery of novel inhibitors targeting the macrophage migration inhibitory factor via structure-based virtual screening and bioassays.,J. Med. Chem.,PUBLICATION,
2389256,CHEMBL3639673,LALJURXWRABUQR-UHFFFAOYSA-N,,,P50750,CYCLIN-DEPENDENT KINASE 9,CDK9,,,,IC50,=,45.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: LANCE ULight TR-FRET Kinase Assay. CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode.","Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors",,PATENT,
904126,CHEMBL1564792,DTHUVVNJGCENDO-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2561620,CHEMBL557959,LTGOPTWEELVVIO-CXUHLZMHSA-N,,,P21397,MONOAMINE OXIDASE A,MAOA,,,23807114.0,IC50,=,6630.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human MAO-A assessed as oxidation of kynuramine to 4-hydroxyquinoline after 20 mins by spectrofluorometric analysis,"Exploring 4-substituted-2-thiazolylhydrazones from 2-, 3-, and 4-acetylpyridine as selective and reversible hMAO-B inhibitors.",Eur. J. Med. Chem.,PUBLICATION,
3145064,CHEMBL33273,OFQRSSBIOOSTFD-UHFFFAOYSA-N,,,P16257,PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR,,,,8182701.0,IC50,,,,,,,,,,,,,,,,,Displacement of [3H]-PK 11195 from peripheral (mitochondrial) benzodiazepine receptor (Not tested),"Novel ligands specific for mitochondrial benzodiazepine receptors: 6-arylpyrrolo[2,1-d][1,5]benzothiazepine derivatives. Synthesis, structure-activity relationships, and molecular modeling studies.",J. Med. Chem.,PUBLICATION,
5159449,CHEMBL1392257,XKZUXXSJJHVVCD-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2187838,CHEMBL3264142,KEJSIFQISWZRTF-UHFFFAOYSA-N,,,"P24864, P24941",CYCLIN-DEPENDENT KINASE 2/CYCLIN E1,"CCNE1, CDK2",,,24742150.0,INHIBITION,=,56.0,%,,,,,,,,,,,,,,Inhibition of CDK2/CycE (unknown origin) using FAM labeled peptide as substrate at 10 uM by IMAP FAM FP assay,"Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors.",J. Med. Chem.,PUBLICATION,
4823728,CHEMBL70740,WAXAHQBOIDNYSY-UHFFFAOYSA-N,,,P18089,ALPHA-2B ADRENERGIC RECEPTOR,ADRA2B,,,12014961.0,KI,<,6309.57,NM,,cell_based,,,,,CHO,,,,,,,Affinity to human Alpha-1B adrenergic receptor determined by radioligand binding techniques from chinese hamster ovary (CHO) cells,2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: the discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues.,J. Med. Chem.,PUBLICATION,
1484844,CHEMBL318728,HFICAVMUTYFODG-UHFFFAOYSA-N,GW549390X,,Q04759,PROTEIN KINASE C THETA,PRKCQ,,,,INHIBITION,=,1.93,%,,,,,,,,,,,,,,GSK_PKIS: PKC-theta mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3975832,CHEMBL361427,RSIJFBWODLEWFF-UHFFFAOYSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,15603954.0,MAXIMAL ACTIVATION,,,,,,,,,,,,,,,,,In vitro maximal activation of human Peroxisome proliferator activated receptor gamma in COS-1 cell transactivation assay at 3 uM; Not done,Benzoyl 2-methyl indoles as selective PPARgamma modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2622073,CHEMBL307346,LZZYPRNAOMGNLH-UHFFFAOYSA-M,CETRIMONIUM BROMIDE,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,61130.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3147140,CHEMBL1309876,OFWGWRCVTONDAC-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4000172,CHEMBL1468019,RUZNNFFRWPDTFQ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
827184,CHEMBL1334427,DLFGPGNUOGHRME-CPNJWEJPSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2328214,CHEMBL168114,KTJZAXFDNXGQDU-SNVBAGLBSA-N,,,P09810,TRYPTOPHAN 5-MONOOXYGENASE 1,,,,2522991.0,ACTIVITY,=,44.0,NG G-1,,,,,,,,,,,,,,Compound was tested for its effect on NSD 1015 induced accumulation of 5-HTP(ng/g) in rats in corpus striatum at a dosage of 10 umol/kg,"Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.",J. Med. Chem.,PUBLICATION,
4740203,CHEMBL1489292,VRROYWXDROBNNL-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5026730,CHEMBL3235056,WWVQOPCDGDSZNA-GFCCVEGCSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,25556098.0,EC50,=,33.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulation after 30 mins,Selective CB2 receptor agonists. Part 1: the identification of novel ligands through computer-aided drug design (CADD) approaches.,Bioorg. Med. Chem. Lett.,PUBLICATION,
742764,CHEMBL3186763,DCAMTBFFNOHDAW-DYTRJAOYSA-N,,,P49146,NEUROPEPTIDE Y RECEPTOR TYPE 2,NPY2R,,,25244572.0,INHIBITION,=,-6.1,%,,,,,,,,,,,,,,Displacement of [125I]Peptide YY from human neuropeptide Y Y2 receptor at 10 uM,"Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus.",J. Med. Chem.,PUBLICATION,
1882124,CHEMBL1704279,IWVVMBKSZBJCJF-ZEQRLZLVSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
631638,CHEMBL3208560,CQAZDAVDFAYGFS-XDHOZWIPSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5706997,CHEMBL1735421,ZSJXMDKBNBDTHX-WRLHONTGSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4294500,CHEMBL1353290,TVKCFCZANTZCSU-OYRHEFFESA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2674391,CHEMBL1415388,MFPLDJKNBZRCBS-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
916316,CHEMBL510801,DUTLYPZZJJBEAJ-QISMNGAHSA-N,HEMOPRESSIN,,P08913,ALPHA-2A ADRENERGIC RECEPTOR,ADRA2A,,,18077343.0,ACTIVITY,=,0.92,,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at alpha2A adrenergic receptor expressed in HEK293 cells assessed as blockade of secreted alkaline phosphatase activity at 1 uM after 6 hrs relative to control,Hemopressin is an inverse agonist of CB1 cannabinoid receptors.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
4925447,CHEMBL3672154,WLNOXYPHSLDGRE-MGPUTAFESA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,IC50,=,52.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: LC-MS Biochemical Assay. Mutant IDH1 R132H catalytic activity was monitored using the quantitative liquid chromatography/mass spectrometry (LC-MS) detection of 2-HG, a product of the NADPH-dependent alpha-KG reduction reaction.More specifically, the biochemical reactions were performed at room temperature in 384-well Greiner flat-bottom plates (Costar, Cat. No. 781201) using a final reaction volume of 30 uL and the following assay buffer conditions: 50 mM HEPES pH 7.4, 10 mM MgCl2, 50 mM KCl, 1 mM DTT, 0.02% BSA, 5 uM NADPH and 100 uM alpha-KG.The final reaction mixture contained 3.3% DMSO and inhibitors with concentrations ranging 0.02-50 uM. The IDH1 enzyme was used at a final concentration of 0.25 nM. Following 45 minutes incubation, the reaction mixtures were quenched by the addition of 10 uL of 16% formic acid containing 800 nM of 5-carbon labeled 13C-2-HG). The protein was then precipitated by the addition of 2.5 volumes of acetonitrile followed by centrifugation (3000xg, 20 minutes).",3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH,,PATENT,
2583860,CHEMBL1372937,LVOROODZGSJCJA-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5816440,CHEMBL3728698,,,,P41743,PROTEIN KINASE C IOTA,PRKCI,,,,IC50,=,100.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human PKC-iota kinase domain expressed in Sf21 cells using FAM-PKCs pseudopeptide derived peptide substrate and 25 uM ATP by fluorescence polarization based IMAP assay,Thienopyrimidine inhibitors of atypical protein kinase C,,PATENT,
3743919,CHEMBL379093,QTJJFCPBQRQZAR-UHFFFAOYSA-N,GW651576X,,"Q15303, P21860, P04626, P00533",EPIDERMAL GROWTH FACTOR RECEPTOR,"EGFR, ERBB2, ERBB3, ERBB4",,,-103.0,PKD,=,7.3565473235138095,-LOG(10) M,inhibition,biochemical,binding,enzyme_activity,,qPCR,,1,UM,,,,,KINOMESCAN BEADS,,,,EGFR
2180526,CHEMBL1508593,KDMSACVVPBXINL-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4749301,CHEMBL2237843,VSPLHTQKPKXSIY-UHFFFAOYSA-N,,,P21836,ACETYLCHOLINESTERASE,,,,,ACTIVITY,=,59.0,NMOL/MIN,,,,,,,,,,,,,,Inhibition of AChE in Mus musculus (mouse) brain homogenate assessed as residual activity measuring acetylthiocholine iodide hydrolysis per mg protein at 10 uM after 5 min by Ellman method,,Med Chem Res,PUBLICATION,
1730391,CHEMBL1561133,IFTAUFOEDCOUKF-QJOMJCCJSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2616585,CHEMBL1398481,LZKAWWQLQSNKFF-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3803886,CHEMBL290578,QZWHWHNCPFEXLL-UHFFFAOYSA-N,CAMBENDAZOLE,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,4252.7,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1191177,CHEMBL1407409,FYXLANAMYDYSCN-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
81066,CHEMBL1970074,AGYRJOAGMDIFKL-UHFFFAOYSA-N,,,P51957,SERINE/THREONINE-PROTEIN KINASE NEK4,NEK4,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: NEK4,PUBCHEM BIOASSAY DATA SET,,DATASET,
4905637,CHEMBL1331471,WJHCIHDFLMOZGH-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2561026,CHEMBL178909,LTESPEAYFMUEAV-HHHXNRCGSA-N,,,Q07869,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA,PPARA,,,15950464.0,EC50,=,420.0,NM,,,,,,,,,,,,,,Agonist activity against human PPARalpha in COS-1 cell Gal4 assay,(2R)-2-methylchromane-2-carboxylic acids: discovery of selective PPARalpha agonists as hypolipidemic agents.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1611101,CHEMBL23,HSUGRBWQSSZJOP-RTWAWAEBSA-N,DILTIAZEM,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,19128860.0,IC50,=,217270.12,NM,,,,,,,,,,,,,,Inhibition of CYP3A4,"Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques.",Eur. J. Med. Chem.,PUBLICATION,
1676568,CHEMBL1371777,HZYOUKHXCBYDBT-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1099690,CHEMBL1381264,FOUCUCMUTILNFC-ZJMWYTODSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
925871,CHEMBL1988805,DVWFMBFZDOBWAD-UHFFFAOYSA-N,,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,,,,KI,>,3162.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT3,PUBCHEM BIOASSAY DATA SET,,DATASET,
1639747,CHEMBL3645915,HWDAPNZBEKEDCW-UHFFFAOYSA-N,,,P42336,PI3-KINASE P110-ALPHA SUBUNIT,PIK3CA,,,,IC50,=,109.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Filter-Binding-Assay. PI3Kalpha assay described herein provides IC50 values indicating the activity of the compounds inhibiting PI3 kinase alpha activity Inhibition of PI3 kinase is expected to be indicative of activity in treating conditions of excessive or anomalous cell proliferation, such as cancers. See also J. A. Engelman, Nature Reviews Cancer, 2009, 9, 550-562; A. Carnero, Expert Opin. Investig. Drugs, 2009, 18, 1265-1277 and P. Liu et al., Nature Reviews Drug Discovery, 2009, 8, 627-64.",5-alkynyl-pyrimidines,,PATENT,
715536,CHEMBL266325,CZDUJGOCEPWCNA-UHFFFAOYSA-N,,,Q8TDX7,SERINE/THREONINE-PROTEIN KINASE NEK7,NEK7,wild_type,,22037377.0,ACTIVITY,=,95.52467136,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,MBP,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
1927540,CHEMBL304087,JBPUGFODGPKTDW-SFHVURJKSA-N,MERIMEPODIB,,P12268,INOSINE-5'-MONOPHOSPHATE DEHYDROGENASE 2,IMPDH2,,,12565969.0,IC50,=,10.0,NM,,,,,,,,,,,,,,Inhibitory activity against inosine monophosphate dehydrogenase IMPDH II,"Quinolone-based IMPDH inhibitors: introduction of basic residues on ring D and SAR of the corresponding mono, di and benzofused analogues.",Bioorg. Med. Chem. Lett.,PUBLICATION,
417184,CHEMBL1603549,BSCUBEPIPZPMGN-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
1559075,CHEMBL1539811,HMWJBAVBAXUCPT-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4228840,CHEMBL1886005,SUJAHRJENFILIB-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3821543,CHEMBL1329349,RBQRHNVNUNTQNU-UHFFFAOYSA-N,TDR77582,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,1122.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2605286,CHEMBL1417197,LYAVSQAXRGJZJX-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2447274,CHEMBL1578561,LHCKVTPMAGSYGW-FMIVXFBMSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
1752950,CHEMBL1779375,IIJWQBDPICTUBI-OAQYLSRUSA-N,,,P49137,MAP KINASE-ACTIVATED PROTEIN KINASE 2,MAPKAPK2,,,21565498.0,EC50,=,2300.0,NM,,,,,,,,,,,,,,Inhibition of MK2 in LPS-stimulated human THP1 cells assessed as inhibition of Hsp27 phosphorylation pretreated 60 mins before LPS challenge measured after 10 mins,Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4919730,CHEMBL1492819,WKXGDKXWDPBUFH-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4962898,CHEMBL1275918,WPZJZIUTEZTIJI-UHFFFAOYSA-N,,,P00807,BETA-LACTAMASE,,,,11182316.0,KI,=,13800.0,NM,,,,,,,,,,,,,,,,,,
5309131,CHEMBL1399,YBBLVLTVTVSKRW-UHFFFAOYSA-N,ANASTROZOLE,,P56937,3-KETO-STEROID REDUCTASE,HSD17B7,wild_type,,19772289.0,INHIBITION,=,0.3,%,inhibition,cell_based,functional,enzyme_activity,,label_free_technology,HEK293,,,14C- ESTRONE,,150,NM,Inhibition of human 17beta-HSD7 expressed in HEK293 cells assessed as inhibition of reduction of [14C]estrone into [14C]estradiol at 3 uM after 7 hrs,"Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.",J. Med. Chem.,PUBLICATION,
2856025,CHEMBL3194203,MZUWLSVORLNYBL-SRZZPIQSSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2931176,CHEMBL524508,NICCTCZINAGVPL-CVEARBPZSA-N,,,Q14994,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP I MEMBER 3,NR1I3,,,18983136.0,ACTIVITY,,,,,cell_based,,,,,HEK293,,,,,,,Increase in human nuclear co-repressor receptor binding to human CAR-LBD expressed in HEK293 cells by yeast two-hybrid assay,Insights into ligand-elicited activation of human constitutive androstane receptor based on novel agonists and three-dimensional quantitative structure-activity relationship.,J. Med. Chem.,PUBLICATION,
3019286,CHEMBL1390859,NRQUSSPHVLYWNP-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
893554,CHEMBL21283,DSEJCLDJIFTPPH-FMIVXFBMSA-N,JNJ-5207787,,P49146,NEUROPEPTIDE Y RECEPTOR TYPE 2,NPY2R,,,24365162.0,IC50,=,100.0,NM,,,,,,,,,,,,,,Displacement of [125I]-NPY from NPYY2 receptor (unknown origin),Ligands of the neuropeptide Y Y2 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
971299,CHEMBL1508521,FAODIJVFNDXZLK-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4651888,CHEMBL1716803,VHUCUYKGQSNJNF-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,707.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
287751,CHEMBL1356472,BDZHSHQYEHRWAJ-UHFFFAOYSA-M,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1996856,CHEMBL1882406,JJOPBSQQDMRVAW-UHFFFAOYSA-N,,,Q14191,WERNER SYNDROME ATP-DEPENDENT HELICASE,WRN,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1413742,CHEMBL1326682,GXWZOOGNJIZESN-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1122.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4966970,CHEMBL218682,WQIJMZYASPFYIG-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,16931010.0,KI,>,2000.0,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]dofetilide from human ERG potassium channel expressed in HEK293 cells,Inhibitory effect of carboxylic acid group on hERG binding.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2163791,CHEMBL1326467,KBUGOUFFTMZFKA-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2511957,CHEMBL1879856,LNZYJVLBKAJRTB-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3030593,CHEMBL478891,NSYWWSFCQSTAPB-UHFFFAOYSA-N,,,"P08238, P07900",HEAT SHOCK PROTEIN HSP90,"HSP90AA1, HSP90AB1",,,18762423.0,IC50,=,28000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of Hsp90 in human SKBR3 cells assessed as interaction with Cy3b-conjugated geldanamycin by FP assay,Synthesis and SAR study of N-(4-hydroxy-3-(2-hydroxynaphthalene-1-yl)phenyl)-arylsulfonamides: heat shock protein 90 (Hsp90) inhibitors with submicromolar activity in an in vitro assay.,Bioorg. Med. Chem. Lett.,PUBLICATION,
716741,CHEMBL1613641,CZFRBNRMYDNMLM-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1984593,CHEMBL1364045,JICUURALAJFCDA-UHFFFAOYSA-N,,,P06280,ALPHA-GALACTOSIDASE A,GLA,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate. (Class of assay: confirmatory) [Related pubchem assays: 1472, 1467 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1572311,CHEMBL1445899,HOJDDYGJUZIWJT-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,1299.5,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5008830,CHEMBL273348,WUWFMDMBOJLQIV-UHFFFAOYSA-N,TOSUFLOXACIN,,P28335,SEROTONIN 2C (5-HT2C) RECEPTOR,HTR2C,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2C radioligand binding (ligand: [3H] Mesulergine),DrugMatrix in vitro pharmacology data,,DATASET,
26545,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P35346,SOMATOSTATIN RECEPTOR 5,SSTR5,,,10598788.0,KI,=,3.98,NM,,,,,,,,,,,,,,,,,,
2762038,CHEMBL1836722,MPIPGSFQCMGNRK-UHFFFAOYSA-N,,,P41279,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 8,MAP3K8,,,21862328.0,IC50,=,7100.0,NM,,,,,,,,,,,,,,Inhibition of TPL2,"Identification and SAR of a new series of thieno[3,2-d]pyrimidines as Tpl2 kinase inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
316350,CHEMBL1705766,BGWZZQHBKDDJJE-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,14581.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
356082,CHEMBL31410,BLGXFZZNTVWLAY-DKJBZYCGSA-N,CORYNANTHEINE,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
5517592,CHEMBL3092779,YYCBPQHVOAJHLZ-QAQDUYKDSA-N,,,Q12866,PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER,MERTK,,,24195762.0,IC50,=,83.0,NM,,,,,,,,,,,,,,Inhibition of Mer kinase (unknown origin) using 5-FAM-EFPIYDFLPAKKK-CONH2 as substrate after 180 mins by microfluidic capillary electrophoresis assay,Pseudo-cyclization through intramolecular hydrogen bond enables discovery of pyridine substituted pyrimidines as new Mer kinase inhibitors.,J. Med. Chem.,PUBLICATION,
2594693,CHEMBL1376492,LWWZLNVHDFYGAS-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,23934.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Eta: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3271633,CHEMBL1394226,OTLREVDELLDVEY-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,9528.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
162021,CHEMBL412142,AQGNHMOJWBZFQQ-UHFFFAOYSA-N,CHIR-99021,CHIR99021,Q9BZL6,SERINE/THREONINE-PROTEIN KINASE D2,PRKD2,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKD2,PUBCHEM BIOASSAY DATA SET,,DATASET,
3013118,CHEMBL1330764,NQWRSILGEXNJIT-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1622561,CHEMBL445916,HUDYYTCJRPYVSA-MTJSOVHGSA-N,,,P27338,MONOAMINE OXIDASE B,MAOB,,,,IC50,>,1000000.0,NM,,,,,,,,,,,,,,Compound was tested for inhibition of monoamine oxidase-B (MAO-B).,,Bioorg. Med. Chem. Lett.,PUBLICATION,
3201815,CHEMBL1146,OLVCFLKTBJRLHI-AXAPSJFSSA-N,CEFAMANDOLE,,O35956,SOLUTE CARRIER FAMILY 22 MEMBER 6,,,,10411577.0,ACTIVITY,,,,,cell_based,,,,,Oocyte,,,,,,,"TP_TRANSPORTER: inhibition of PAH uptake (PAH: 2 uM, Cefamandole: 2000 uM) in Xenopus laevis oocytes",The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.,J. Pharmacol. Exp. Ther.,PUBLICATION,
730676,CHEMBL1459332,DARDLSOHWBBFCG-BQYQJAHWSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5722975,CHEMBL1908073,ZUGCDOZAVASBQT-SLVREZFOSA-N,2-HYDROXYESTRIOL,,P16662,UDP-GLUCURONOSYLTRANSFERASE 2B7,UGT2B7,,,10836148.0,ACTIVITY,=,101.0,TOTAL PICOMOLES,,,,,,,,,,,,,,Specific activity of expressed human recombinant UGT2B7,"Human UDP-glucuronosyltransferases: metabolism, expression, and disease.",Annual Review of Pharmacology and Toxicology,PUBLICATION,
5158729,CHEMBL1491294,XKYYWVKEJCKOJU-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
139588,CHEMBL14112,ANWALZPQHPAZFO-UHFFFAOYSA-N,SB-210313,,P24723,PROTEIN KINASE C ETA,PRKCH,,,,INHIBITION,=,-1.13,%,,,,,,,,,,,,,,GSK_PKIS: PKC-eta mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
81559,CHEMBL453991,AHANXAKGNAKFSK-PDBXOOCHSA-N,"CIS-11,14,17-EICOSATRIENOICACID",,P13726,COAGULATION FACTOR III,F3,,,9834151.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,Inhibition of amidolytic activity of human tissue factor/human factor 7a,Inhibitory activity of unsaturated fatty acids and anacardic acids toward soluble tissue factor-factor VIIa complex.,J. Nat. Prod.,PUBLICATION,
3917895,CHEMBL1428594,RLUGGYIDYDDQGW-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2992337,CHEMBL110091,NORGAKNCZQAZKT-UHFFFAOYSA-N,,,Q72547,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE,,,,11462972.0,KI,=,20.0,NM,,,,,,,,,,,,,,Inhibition of HIV-1 Mutant HIV-1 RT enzymes containing the single amino acid substitution V106A,Quinoxalinylethylpyridylthioureas (QXPTs) as potent non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors. Further SAR studies and identification of a novel orally bioavailable hydrazine-based antiviral agent.,J. Med. Chem.,PUBLICATION,
4102320,CHEMBL1386859,SGLWQDBRNZJMGO-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,44.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3524813,CHEMBL1370161,PVGWHHNCDLILBX-NTMALXAHSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1353811,CHEMBL1504738,GQXAAZWBUIPYAF-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5322479,CHEMBL1336882,YCNINHOOCHJQLG-UHFFFAOYSA-N,,,O15648,6-PHOSPHO-1-FRUCTOKINASE,,,,,POTENCY,,15101.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5564557,CHEMBL534,ZCVMWBYGMWKGHF-UHFFFAOYSA-N,KETOTIFEN,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,KI,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 1A2 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
4981692,CHEMBL3233191,WSANIYPIWXGLEG-CUPIEXAXSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,24613457.0,EC50,,,,,cell_based,,,,,,,,,,,,Agonist activity at GFP-fused delta opioid receptor (unknown origin) expressed in HEK293 cells assessed as recruitment of beta-arrestin-2 after 10 mins by BRET assay,Endomorphin analogues with mixed µ-opioid (MOP) receptor agonism/d-opioid (DOP) receptor antagonism and lacking ß-arrestin2 recruitment activity.,Bioorg. Med. Chem.,PUBLICATION,
2138412,CHEMBL3144979,JZBBMXYAROGVTC-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2250709,CHEMBL1334129,KLCKOWUTOXPCEW-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4496125,CHEMBL1484025,URFBPCUSVFCNSQ-UHFFFAOYSA-N,,,Q9I194,PVDQ,,,,,AC50,=,5399.0,NM,,biochemical,,,,,,,,,,,,PUBCHEM_BIOASSAY: Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488968],PUBCHEM BIOASSAY DATA SET,,DATASET,
1629658,CHEMBL1458082,HUZAFIBIRYKODU-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2092240,CHEMBL411476,JUBBNHGBNYSGEP-UHFFFAOYSA-N,,,P32246,C-C CHEMOKINE RECEPTOR TYPE 1,CCR1,,,18329267.0,IC50,=,1850.0,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]MIP1-alpha from human CCR1 receptor expressed in THP1 cells,Identification of novel series of human CCR1 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4591074,CHEMBL29898,VBHKTXLEJZIDJF-UHFFFAOYSA-N,QUINALIZARIN,,P35503,UDP-GLUCURONOSYLTRANSFERASE 1-3,UGT1A3,,,10836148.0,ACTIVITY,=,749.0,PM/MIN/MG,,,,,,,,,,,,,,Specific activity of expressed human recombinant UGT1A3,"Human UDP-glucuronosyltransferases: metabolism, expression, and disease.",Annual Review of Pharmacology and Toxicology,PUBLICATION,
3060601,CHEMBL1300394,NWIUDDSHTSZVPH-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
307515,CHEMBL1575837,BGDPUOVLEVAHCH-VAWYXSNFSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1303807,CHEMBL266707,GLHFDXWSDZWRNN-UHFFFAOYSA-N,SKF-86055,,Q15349,RIBOSOMAL PROTEIN S6 KINASE ALPHA 2,RPS6KA2,,,,INHIBITION,=,2.43,%,,,,,,,,,,,,,,GSK_PKIS: RSK3 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2637994,CHEMBL1376600,MBSXRUSJFAEHRG-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1214495,CHEMBL1497694,GBUMEGLMTNAXOM-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,756.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1361228,CHEMBL1375885,GRWGCNYYLRFRIY-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1267278,CHEMBL218932,GHHDPZAABUUQIX-AATRIKPKSA-N,GW432441X,,Q9Y5S2,SERINE/THREONINE-PROTEIN KINASE MRCK BETA,CDC42BPB,,,,INHIBITION,=,0.52,%,,,,,,,,,,,,,,GSK_PKIS: MRCKB mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3804146,CHEMBL1306553,QZXDXUVEIDSDQQ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6513.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5248591,,XUTNSSYTUKBUHU-UHFFFAOYSA-N,,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,2.96,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1379025,CHEMBL1507210,GTYFWBJCFFHMIA-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
677337,CHEMBL1409532,CUZBACHHWQECIQ-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
284820,CHEMBL1335869,BDPKMKPXVKPVIV-UHFFFAOYSA-N,,,O14727,APOPTOTIC PROTEASE-ACTIVATING FACTOR 1,APAF1,,,,IC50,>,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response validation of Inhibitors of Apaf-1 using a Fluorescent Interference Counterscreen assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID489030, AID492945]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2083666,CHEMBL1372382,JTCVRLSGGUJXGK-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1552620,CHEMBL2165037,HMCXLHKQRBBRRQ-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,IC50,=,534.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Inhibition Assay. The Invitrogen (Carlsbad, Calif.) mammalian target of rapamycin (mTOR) Lanthascreen assay can be used to quantitate mTOR kinase activity in an in vitro setting. Active mTOR phosphorylates eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) on residue threonine 46. This phosphorylation event can be detected with a phospho-specific terbium (Tb) labeled Ab, in turn bringing the Tb label in close proximity to the GFP tagged 4E-BP1 and allowing for time-resolved fluorescence resonance energy transfer (TR-FRET), which correlates 4E-BP1 phosphorylation levels with mTOR kinase activity.",Inhibitors of PI3 kinase and/or mTOR,,PATENT,
3916043,CHEMBL1511909,RLOGZEHDXBZHTN-HVMFNXBNSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3745421,CHEMBL2114973,QTNMNMYCLZOFFQ-DOTFVSGYSA-M,,,"P08173, P11229, P08912, P20309, P08172",MUSCARINIC ACETYLCHOLINE RECEPTOR,"CHRM1, CHRM2, CHRM3, CHRM4, CHRM5",,,3411598.0,KD,=,169.82,NM,,,,,,,,,,,,,,Antagonist activity against Muscarinic acetylcholine receptor of guinea pig heart.,"Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides.",J. Med. Chem.,PUBLICATION,
2282861,CHEMBL3193761,KOXBMNHXCXHWIV-RQZCQDPDSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1558961,CHEMBL3213404,HMVYUZKHUJKBLT-LVWGJNHUSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3148422,CHEMBL1404255,OFZXMOVBMDFXCD-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5321869,CHEMBL1426665,YCLAQLTVHNAEEQ-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1722369,CHEMBL35492,IEUDFLVLULWXJM-ZEQRLZLVSA-N,,,Q9WTR4,NOREPINEPHRINE TRANSPORTER,,,,3039136.0,KI,=,41.3,NM,,,,,,,,,,,,,,Inhibition of uptake of tritiated norepinephrine (NE) in rat synaptosomes,Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.,J. Med. Chem.,PUBLICATION,
2480720,CHEMBL1715928,LKXSUAQVHKZUHU-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,6510.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1763829,CHEMBL1440833,IJSAGNZMJWEPAS-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,2238.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3481083,CHEMBL609383,PQLOPNDFAZZBHL-BHNWBGBOSA-N,,,P0A6D3,5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE,,,,,KI,=,7400.0,NM,,,,,,,,,,,,,,Inhibition of the EPSP synthase by the compound expressed as weak apparent value,,Bioorg. Med. Chem. Lett.,PUBLICATION,
4954358,CHEMBL255937,WOZZEGNZSHRTMV-UHFFFAOYSA-N,,,P25100,ALPHA-1D ADRENERGIC RECEPTOR,ADRA1D,,,18400496.0,EC50,>,10000.0,NM,,cell_based,,,,,CHO,,,,,,,Agonist activity at human cloned adrenergic Alpha-1D receptor expressed in CHO cells assessed as calcium mobilization by FLIPR,Novel 2-imidazoles as potent and selective alpha1A adrenoceptor partial agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4750881,CHEMBL1375052,VSUUOVOIPALBSG-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5687940,CHEMBL1992645,ZQJVVICZLBJUTJ-UHFFFAOYSA-N,,,Q00535,CYCLIN-DEPENDENT KINASE 5,CDK5,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK5,PUBCHEM BIOASSAY DATA SET,,DATASET,
1496534,CHEMBL1980396,HGOOQGKPUKXHGF-BSYVCWPDSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
728925,CHEMBL1568572,DAMOOGIJYSKQLK-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2304988,CHEMBL201241,KRAYBRNWGRIQNM-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,16420061.0,KI,>,10000.0,NM,,cell_based,,,,,HEK293,,,,,,,Inhibition of binding to human D2L receptor expressed in HEK 293 cells by functional calcium assay,"Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.",J. Med. Chem.,PUBLICATION,
5151927,CHEMBL1528877,XKGLHMIHUYUAGH-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3676267,CHEMBL7463,QMGUOJYZJKLOLH-UHFFFAOYSA-N,GF-109203,,O15530,3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1,PDPK1,wild_type,,23398362.0,ACTIVITY,=,63.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1687075,CHEMBL101489,IBABLALBTRLAOY-UHFFFAOYSA-N,,,Q95214,ACYL-COA:CHOLESTEROL ACYLTRANSFERASE,,,,8411011.0,IC50,=,370.0,NM,,,,,,,,,,,,,,In vitro inhibition of Acyl coenzyme A:cholesterol acyltransferase in intestinal microsomes isolated from cholesterol-fed rabbits,Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agents.,J. Med. Chem.,PUBLICATION,
1891202,CHEMBL1447889,IXVRMFMEWSBNHX-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,354.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
285320,CHEMBL1445985,BDRDWDBBQLQURQ-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1690409,CHEMBL1571553,IBHMZLPZYKPFAF-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
565440,CHEMBL31293,CIPQGGYPCPIDBB-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,281.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3334869,CHEMBL1349572,PAKIGZJNNCHKSX-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4432519,CHEMBL1393813,UKHAMZBIMNTOHU-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5624722,CHEMBL462192,ZJJZCHNTRMUXMT-UHFFFAOYSA-N,,,P50750,CYCLIN-DEPENDENT KINASE 9,CDK9,,,18996007.0,ACTIVITY,=,12.0,NM,,,,,,,,,,,,,,Inhibition of CDK9,"The discovery of AZD5597, a potent imidazole pyrimidine amide CDK inhibitor suitable for intravenous dosing.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5096775,CHEMBL3207664,XEKZXEDRWZTAEU-XBXARRHUSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
248979,CHEMBL1455663,AZOLWIFGYAOYTE-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1578978,CHEMBL1097347,HPDGUUSJXUKDGG-HSTGIYNWSA-N,,,P56817,BETA-SECRETASE 1,BACE1,,,20347593.0,KI,=,14.0,NM,,,,,,,,,,,,,,Inhibition oh BACE1,"Piperazine sulfonamide BACE1 inhibitors: design, synthesis, and in vivo characterization.",Bioorg. Med. Chem. Lett.,PUBLICATION,
264924,CHEMBL1307689,BBJHCWYVJLCXTK-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4750364,CHEMBL3697460,VSSWHHCPMGVOTL-LJAQVGFWSA-N,,,Q15910,HISTONE-LYSINE N-METHYLTRANSFERASE EZH2,EZH2,,,,IC50,=,29.58,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use. Compounds in 100% DMSO (1 uL) were spotted into polypropylene 384-well V-bottom plates (Greiner) using a Platemate 2x3 outfitted with a 384-channel pipet head (Thermo). DMSO (1 uL) was added to columns 11, 12, 23, 24, rows A-H for the maximum signal control, and SAH, a known product and inhibitor of PRC2 (1 uL) was added to columns 11, 12, 23, 24, rows I-P for the minimum signal control, A cocktail (40 uL) containing the wild-type PRC2 enzyme and H3K27me0 peptide or any of the Y641 mutant enzymes and H3K27me2 peptide was added by Multidrop Combi (Thermo). The compounds were allowed to incubate with PRC2 for 30 min at 25 C., then a cocktail (10 uL) containing a mixture of non-radioactive and 3H-SAM was added to initiate the reaction (final volume=51 uL).",Aryl- or heteroaryl-substituted benzene compounds,,PATENT,
39125,CHEMBL266339,ACOVNTWZIJRSIM-OHOMDISFSA-N,,,Q8BZP8,NEUROPEPTIDE S RECEPTOR,,,,17696420.0,EMAX,=,14.0,%,,cell_based,,,,,HEK293,,,,,,,Agonist activity at mouse recombinant NPSR expressed in HEK293 cells assessed as calcium mobilization relative to baseline,Conformation-activity relationship of neuropeptide S and some structural mutants: helicity affects their interaction with the receptor.,J. Med. Chem.,PUBLICATION,
1877358,CHEMBL236752,IWJWKIXKIBPVSL-XMMPIXPASA-N,,,"P35030, P07478, P07477",TRYPSIN,"PRSS1, PRSS2, PRSS3",,,17914785.0,KI,>,3000.0,NM,,,,,,,,,,,,,,Inhibition of human trypsin,"Discovery of 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide (apixaban, BMS-562247), a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa.",J. Med. Chem.,PUBLICATION,
3694877,CHEMBL1412100,QOFCWXZJKNLFGI-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,28.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1880395,CHEMBL3696489,IWSITJSGTRUVTC-CXAGYDPISA-N,,,P98170,INHIBITOR OF APOPTOSIS PROTEIN 3,XIAP,,,,IC50,=,1500.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In vitro Competitive Displacement Binding Assays. Modified SMAC peptides and compounds were tested for their ability to displace the fluorescent tracer from either XIAP, clAP-1 or clAP-2. BIR3 domains of clAP-1 , clAP-2 and XIAP were incubated with test compounds or SMAC based peptides and their respective peptide probes (Peptide Protein Research) in assay buffer (50mM Hepes pH 7.5, 0.025% Tween-20, 0.01 % BSA, and 1 mM DTT). Positive controls consisted of BIR3 proteins and tracer (no inhibition) and negative controls contained tracer only (100% inhibition). The samples were incubated at room temperature for 1 hr (XIAP and clAP-2) or 3hrs (clAP-1 ) prior to being read in the BMG Pherastar in Fluorescence Polarization mode (FP 485nm, 520nm, 520nm).",Bicyclic heterocycle compounds and their uses in therapy,,PATENT,
2576496,CHEMBL1708506,LUSPGDHXDJRBCX-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4242230,CHEMBL1800381,SVUUYQJCKFMOIW-UHFFFAOYSA-N,,,Q13547,HISTONE DEACETYLASE 1,HDAC1,,,21696956.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of recombinant HDAC1 assessed as inhibition of fluorogenic aminocoumarin release from substrate by trypsin-coupled biochemical assay,A novel HDAC inhibitor with a hydroxy-pyrimidine scaffold.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3408358,CHEMBL47244,PIMZUZSSNYHVCU-YKWPQBAZSA-N,PICROTOXININ,,P29476,"NITRIC-OXIDE SYNTHASE, BRAIN",,,,,IC50,,,,,tissue,,,,,,,,,,,,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",DrugMatrix in vitro pharmacology data,,DATASET,
4183743,CHEMBL1289494,SPMVMDHWKHCIDT-UHFFFAOYSA-N,TIVOZANIB,,Q07912,TYROSINE KINASE NON-RECEPTOR PROTEIN 2,TNK2,wild_type,,23398362.0,ACTIVITY,=,6.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,70.0,uM,"Millipore: Percentage of residual kinase activity of TNK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3881576,CHEMBL3323517,RIBPNVGFVDGCPR-UHFFFAOYSA-N,,,Q60492,SIGMA-1 RECEPTOR,,,,25062506.0,INHIBITION,=,21.0,%,,,,,,,,,,,,,,Displacement of [3H]-(+)-pentazocine from sigma-1 receptor in guinea pig brain cortex membranes at 10 uM,Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted ¿-opioid receptor agonists.,J. Med. Chem.,PUBLICATION,
5273214,CHEMBL1417929,XXPFGRVEANGYDQ-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2848409,CHEMBL1445498,MYWOSNLJTUDLIP-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5402707,CHEMBL95,YLJREFDVOIBQDA-UHFFFAOYSA-N,TACRINE,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4956177,CHEMBL361957,WPEHFDALSJCGER-NRFANRHFSA-N,,,"P21554, P34972",CANNABINOID RECEPTOR,"CNR1, CNR2",,,15664857.0,SELECTIVITY,=,1.2,,,,,,,,,,,,,,,Selectivity of cannabinoid receptor 2 over cannabinoid receptor 1,Triaryl bis-sulfones as a new class of cannabinoid CB2 receptor inhibitors: identification of a lead and initial SAR studies.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2531295,CHEMBL1519191,LPXXLDUTBILXBZ-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,16360.1,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5207491,CHEMBL1520647,XQIFLVAOUNFAAK-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2092802,CHEMBL476744,JUCXEQYBGUEGFL-UHFFFAOYSA-N,,,P04818,THYMIDYLATE SYNTHASE,TYMS,,,18605720.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Inhibition of human thymidylate synthase at >12 uM,"The effect of 5-alkyl modification on the biological activity of pyrrolo[2,3-d]pyrimidine containing classical and nonclassical antifolates as inhibitors of dihydrofolate reductase and as antitumor and/or antiopportunistic infection agents.",J. Med. Chem.,PUBLICATION,
1441766,CHEMBL517082,HAZCKIILVLDGRW-ODGPQVTHSA-N,,,P07711,CATHEPSIN L,CTSL,,,19124252.0,KI,=,31000.0,NM,,,,,,,,,,,,,,Inhibition of human cathepsin L by fluorescence assay,Solid-phase parallel synthesis and SAR of 4-amidofuran-3-one inhibitors of cathepsin S: effect of sulfonamides P3 substituents on potency and selectivity.,Bioorg. Med. Chem.,PUBLICATION,
4066985,CHEMBL3197678,SCKXXMPRDJDAED-RGVLZGJSSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1756942,CHEMBL78211,IIVLGLJKIYHOOI-ZRDIBKRKSA-N,,,P30543,ADENOSINE A2A RECEPTOR,,,,,KI,=,7.4,NM,,,,,,,,,,,,,,In vitro binding affinity against Adenosine A2a receptor in rat forebrain membranes by [3H]NECA (+CPA) displacement.,,Bioorg. Med. Chem. Lett.,PUBLICATION,
1513719,CHEMBL748,HIGSLXSBYYMVKI-UHFFFAOYSA-N,PRALIDOXIME CHLORIDE,,P22303,ACETYLCHOLINESTERASE,ACHE,,,2913310.0,KHOX,=,482.0,M-1 MIN-1,,cell_based,,,,,,,,,,,,Effective rate constant for reactivation of GD-inhibited AChE in human erythrocytes,Quaternary salts of 2-[(hydroxyimino)methyl]imidazole. 2. Preparation and in vitro and in vivo evaluation of 1-(alkoxymethyl)-2-[(hydroxyimino)methyl]-3-methylimida zolium halides for reactivation of organophosphorus-inhibited acetylcholinesterases.,J. Med. Chem.,PUBLICATION,
1884145,CHEMBL222167,IXBJGIDDOVBBHA-UHFFFAOYSA-N,,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,17266207.0,KD,=,5.01,NM,,cell_based,,,,,,,,,,,,Antagonist potency at human bradykinin B2 receptor assessed as effect on inositol monophosphate accumulation in CHOdhfr- cells,"Design and synthesis of novel sulfonamide-containing bradykinin hB2 receptor antagonists. 2. Synthesis and structure-activity relationships of alpha,alpha-cycloalkylglycine sulfonamides.",J. Med. Chem.,PUBLICATION,
4077681,CHEMBL359542,SDUIHZXGXLYNPJ-ZENAZSQFSA-N,,,P55210,CASPASE-7,CASP7,,,15686936.0,IC50,>,10.0,NM,,,,,,,,,,,,,,Inhibitory concentration against recombinant human caspase-7 in neuronal precursor (NT2) cells,Novel pyrazinone mono-amides as potent and reversible caspase-3 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4979744,CHEMBL514162,WRWFZZDBIJLBIJ-UHFFFAOYSA-N,GW852849X,,P10721,STEM CELL GROWTH FACTOR RECEPTOR,KIT,,,,INHIBITION,=,8.11,%,,,,,,,,,,,,,,GSK_PKIS: KIT (T6701 mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2165186,CHEMBL1521805,KBYOKASRLQCUKP-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
340431,CHEMBL1868702,BJJXHLWLUDYTGC-ANULTFPQSA-N,GESTRINONE,,P10275,ANDROGEN RECEPTOR,AR,,,7966160.0,RELATIVE BINDING AFFINITY,=,83.0,,,,,,,,,,,,,,,Relative binding affinity to the testosterone receptor.,PRO_LIGAND: an approach to de novo molecular design. 2. Design of novel molecules from molecular field analysis (MFA) models and pharmacophores.,J. Med. Chem.,PUBLICATION,
3299183,CHEMBL540485,OWJWKROFVJCUFG-UHFFFAOYSA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,,,19394223.0,IC50,=,36.0,NM,,,,,,,,,,,,,,Inhibition of GST-tagged human IGF1R expressed in Sf9-baculovirus system,"Discovery of 3,5-disubstituted-1H-pyrrolo[2,3-b]pyridines as potent inhibitors of the insulin-like growth factor-1 receptor (IGF-1R) tyrosine kinase.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3185197,CHEMBL1541,OKBVVJOGVLARMR-QSWIMTSFSA-N,CEFIXIME,,Q9NXA8,"NAD-DEPENDENT PROTEIN DEACYLASE SIRTUIN-5, MITOCHONDRIAL",SIRT5,,,,AC50,,17860.0,NM,,biochemical,,,,,,,,,,,,PubChem BioAssay. MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_Dose_CherryPick_Activity_Set5.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
574798,CHEMBL3670669,CJPQHCIMSKHOBF-UHFFFAOYSA-N,,,Q9UBN7,HISTONE DEACETYLASE 6,HDAC6,,,,IC50,=,0.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. The reactions were carried out in a 96-well microplate for fluorometry in a 50 uL reaction volume. After the deacetylation reaction, Fluor-de-Lys-Developer (BioMol Cat. # KI-105) was added to each well to digest the deacetylated substrate, thus producing the fluorescent signal. The reaction was allowed to develop for 45 minutes at 30degrees C. with 5% CO2; then the fluorescent signal was measured with an excitation wavelength at 360 nm and an emission wavelength at 460 nm in a microplate-reading fluorometer (GeminiXS; Molecular Devices, Sunnyvale, Calif.). A curve of Deacetylated Standard (Biomol, Cat. # KI-142; made from 100 uM with 1:2 dilution and 10-doses, 6 uL) allowed the conversion of fluorescent signal into micromoles of deacetylated product. ",Histone deacetylase inhibitors based simultaneously on trisubstituted 1H-pyrroles and aromatic and heteroaromatic spacers,,PATENT,
52714,CHEMBL1418920,ADWWPPKGPXDZOR-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5257498,CHEMBL1489824,XVUPONBBOMLUHA-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3527051,CHEMBL103104,PVLOKYREDKFWTF-UHFFFAOYSA-N,GW831090X,,Q14164,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE EPSILON SUBUNIT,IKBKE,,,,INHIBITION,=,-3.0,%,,,,,,,,,,,,,,GSK_PKIS: IKK-epsilon % inhibition at 1 uM [UNC Frye lab],Compounds: GSK PKIS; Assays: UNC Frye lab,,DATASET,
611108,CHEMBL1569566,CNRPDCKHCGUKDK-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
543547,CHEMBL1327384,CFYXDOGIFLBAFR-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
446996,CHEMBL1420521,BVJWCLJAFSANEC-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3753162,CHEMBL1434325,QULWOLRVNPEZBR-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4829146,CHEMBL1547612,WBNVDKYUZBTIEW-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3951819,CHEMBL1377450,RPPKJHAAFXVMHH-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4468213,CHEMBL77456,UOHFCPXBKJPCAD-UHFFFAOYSA-N,TYRPHOSTIN 1,,P57059,SERINE/THREONINE-PROTEIN KINASE SIK1,SIK1,wild_type,,23398362.0,ACTIVITY,=,18.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,45.0,uM,"Millipore: Percentage of residual kinase activity of SIK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
4787759,CHEMBL1967395,VWYKBRYDSJBXQE-MRCUWXFGSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
623580,CHEMBL305160,CPDXTLZUFAYJLD-UHFFFAOYSA-N,,,P09237,MATRIX METALLOPROTEINASE 7,MMP7,,,11454461.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Matrix metalloprotease-7,The development of new carboxylic acid-based MMP inhibitors derived from a cyclohexylglycine scaffold.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4537791,CHEMBL1357247,UVSVTDVJQAJIFG-SOFGYWHQSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,15848.93,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1224784,CHEMBL1435625,GCSUBZUGWVEHNP-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4402152,CHEMBL1404855,UHFVJQGZHPYPME-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2794773,CHEMBL1611333,MTGQGBKKBSMQCF-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
825177,CHEMBL1703193,DKZUUWUNCPYXNK-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3706909,CHEMBL1934861,QPOPDJJHKWFMOW-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,22182575.0,FC,=,4.5,,,cell_based,,,,,CHO,,,,,,,Binding affinity to recombinant human A1 adenosine receptor allosteric site expressed in CHO cells assessed as [3H]CCPA Bmax shift at 10 uM after 90 mins relative to control,Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A1 adenosine receptor.,Bioorg. Med. Chem.,PUBLICATION,
3221713,CHEMBL393267,ONYNFACZHHCTDA-QHCPKHFHSA-N,,,P51677,C-C CHEMOKINE RECEPTOR TYPE 3,CCR3,,,17720492.0,IC50,>,10000.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells,Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).,Bioorg. Med. Chem. Lett.,PUBLICATION,
238975,CHEMBL371124,AYLBCUKRYLCKCA-NSCUHMNNSA-N,,,"P66936, Q932M0",DNA GYRASE,,,,15857125.0,IC50,=,664.0,UG.ML-1,,,,,,,,,,,,,,Inhibitory concentration against DNA gyrase of Staphylococcus aureus,"Synthesis and antibacterial activity of 1-(2-fluorovinyl)-7-substituted-4-quinolone-3-carboxylic acid derivatives, conformationally restricted analogues of fleroxacin.",J. Med. Chem.,PUBLICATION,
5857990,CHEMBL3780324,,,,P00740,COAGULATION FACTOR IX,F9,,,27073051.0,Ki,>,34860.0,NM,,,,,,,,,,,,,,Inhibition of human coagulation factor 9a assessed as reduction in release of p-nitroaniline after 10 to 120 mins by Michaelis-Menten equation analysis,Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group.,Bioorg. Med. Chem.,PUBLICATION,
361988,CHEMBL136123,BLUONAREVSMXCN-UHFFFAOYSA-N,,,"P23944, P43140, P15823",ADRENERGIC RECEPTOR ALPHA-1,,,,9986714.0,IC50,=,85.0,NM,,,,,,,,,,,,,,Inhibition of Alpha-1 adrenergic receptor in rat cortex membrane,"Synthesis, pharmacological evaluation, and structure-activity relationship and quantitative structure-activity relationship studies on novel derivatives of 2,4-diamino-6,7-dimethoxyquinazoline alpha1-adrenoceptor antagonists.",J. Med. Chem.,PUBLICATION,
2862646,CHEMBL1333880,NAPPFVHLAYZRPZ-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,8436.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3968042,CHEMBL14276,RRJLJKRFFRZRAF-UHFFFAOYSA-N,SB-228357,,P15917,ANTHRAX LETHAL FACTOR,,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2262826,CHEMBL1433371,KMMPNSFLIOYVAZ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
428589,CHEMBL14762,BTIHMVBBUGXLCJ-OAHLLOKOSA-N,SELICICLIB,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for EGFR(S752-I759del) kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2046418,CHEMBL1969483,JPCWMTOYDYYXLS-UHFFFAOYSA-N,,,P49841,GLYCOGEN SYNTHASE KINASE-3 BETA,GSK3B,,,,KI,>,3981.07,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B,PUBCHEM BIOASSAY DATA SET,,DATASET,
3292662,CHEMBL1468449,OVPXXZVAKBLIPX-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2147995,CHEMBL1303610,JZYWFBSSDYCXDG-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4118457,CHEMBL2048769,SICNKSFIKGNNPV-KJYTXNCISA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,22439881.0,KI,=,230.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]-naltrindole from human delta opioid receptor expressed in CHO cells after 3 hrs by scintillation counting,"Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.",J. Med. Chem.,PUBLICATION,
2682743,CHEMBL1699680,MGPZSXULPILEJV-UHFFFAOYSA-N,,,"Q00975, Q02410",VOLTAGE-GATED N-TYPE CALCIUM CHANNEL ALPHA-1B SUBUNIT/AMYLOID BETA A4 PRECURSOR PROTEIN-BINDING FAMILY A MEMBER 1,"APBA1, CACNA1B",,,,IC50,>,56800.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR analysis of small molecule inhibitors of Mint-PDZ and N-type Ca2+ channel carboxyl-terminal peptide association using HTRF. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2073, AID2091, AID2093, AID434980]",PUBCHEM BIOASSAY DATA SET,,DATASET,
131201,CHEMBL1456386,AMVQKYZUUAAEMJ-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2908103,CHEMBL2420585,NFSLUNNYNIQGSX-HAQNSBGRSA-N,,,Q9Y5S2,SERINE/THREONINE-PROTEIN KINASE MRCK BETA,CDC42BPB,,,23916259.0,INHIBITION,<,35.0,%,,,,,,,,,,,,,,Inhibition of MRCKbeta in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,"Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1746756,CHEMBL1500869,IHTKCDIXTXILJD-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20587.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4491345,CHEMBL1873141,UQWJPWFCSFVFKR-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3319295,CHEMBL450786,OYONTEXKYJZFHA-SSHUPFPWSA-N,PHA-665752,,O43318,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7,MAP3K7,wild_type,,22037378.0,KD,=,5300.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for TAK1 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2879098,CHEMBL1484303,NCJWLUPKNXOHDR-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2639403,CHEMBL1346417,MBXHULDEJNNQLN-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,446.7,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5761784,CHEMBL605685,ZYQCLNAQWLOZJU-VDXVPGQCSA-N,,,P30543,ADENOSINE A2A RECEPTOR,,,,7739005.0,EC50,=,3290.0,NM,,,,,,,,,,,,,,Functional activity against adenosine A2a receptor from rat aorta.,2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists.,J. Med. Chem.,PUBLICATION,
108603,CHEMBL1348803,AKFXQYMORAUSBD-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2397406,CHEMBL1376043,LBKVWLLUUVVCQF-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4287096,CHEMBL1339697,TUSPHNIBXFMXQW-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
290127,CHEMBL1611023,BEHPDWUBHLTQQO-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5214723,CHEMBL1419529,XRBXAMRZIUEYNE-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5837937,CHEMBL3526555,,,,P20815,CYTOCHROME P450 3A5,CYP3A5,,,21123164.0,COMPOUND RECOVERY,,,,,,,,,,,,,,,,,Drug metabolism assessed as human CYP3A5-mediated compound formation from 20 uM [14C]boceprevir after 120 mins by LC-MS/FSA method relative to total [14C]boceprevir,"Characterization of human liver enzymes involved in the biotransformation of boceprevir, a hepatitis C virus protease inhibitor.",Drug Metab. Dispos.,PUBLICATION,
3269134,CHEMBL3208358,OTFSSODKJATZQV-OQLLNIDSSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,5804.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4823949,CHEMBL1407583,WAXWLEFHHHVFSL-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2372399,CHEMBL1454890,KYKRDWMFIVDTJX-MSUUIHNZSA-N,,,P04406,GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE LIVER,GAPDH,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen confirmation. (Class of assay: confirmatory) [Related pubchem assays: 2451, 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3582188,CHEMBL2006338,QBUJNSNDZCHEPL-SSDVNMTOSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2584930,CHEMBL1487498,LVRGSACCABYUQI-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5494868,CHEMBL520971,YVQQGBFEGSGJII-UHFFFAOYSA-N,CER-0263971,,P05129,PROTEIN KINASE C GAMMA,PRKCG,,,18479119.0,INHIBITION,=,2.0,%,,,,,,,,,,,,,,Inhibition of PKCgamma at 10 uM by HTRF assay relative to control,Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.,J. Med. Chem.,PUBLICATION,
2030224,CHEMBL1453036,JNHHXBDSHUEQCL-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
726204,CHEMBL1399690,DADKJZNZOPSAEI-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4780,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,ERLOTINIB,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,,,25172421.0,IC50,=,200.0,NM,,cell_based,,,,,,,,,,,,Inhibition of histidine-tagged recombinant HER2 (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,"Design, synthesis and molecular modeling of biquinoline-pyridine hybrids as a new class of potential EGFR and HER-2 kinase inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
957266,CHEMBL1589179,DZESWQADJGZDFL-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2878883,CHEMBL1887824,NCJCTPWFPUZQLN-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,562341.3,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4320646,CHEMBL1522988,TYKHMTOCAPVWBF-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1436870,CHEMBL1503706,HAMZZMBVWRGPBJ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,23109.3,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
459575,CHEMBL203665,BWYBBMQLUKXECQ-GIVPXCGWSA-N,RELACATIB,,P07711,CATHEPSIN L,CTSL,,,18226527.0,IC50,=,2.0,NM,,cell_based,,,,,HepG2,,,,,,,Inhibition of cathepsin L in human HepG2 cells,"The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2985098,CHEMBL534821,NNVUIGRLEXSZBS-UHFFFAOYSA-N,TCMDC-124938,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,-1.92,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2947015,CHEMBL3657092,NJRPTSMHENYHER-UHFFFAOYSA-N,,,Q00987,P53-BINDING PROTEIN MDM-2,MDM2,,,,IC50,=,0.252,NM,,,,,,,,,,,,,,"BindingDB_Patents: Time Resolved Fluorescence Energy Transfer (TR-FRET) Assay. The inhibition of p53-MDM2 and p53-MDM4 interactions is measured by time resolved fluorescence energy transfer (TR-FRET). Fluorescence energy transfer (or Foerster resonance energy transfer) describes an energy transfer between donor and acceptor fluorescent molecules. For this assay, human MDM2 protein (amino acids 2-188) and human MDM4 protein (amino acids 2-185), tagged with a C-terminal biotin moiety, are used in combination with a Europium labeled streptavidin (Perkin Elmer, Inc., Waltham, Mass., USA) serving as the donor fluorophore. The p53 derived, Cy5 labeled peptide Cy5-TFSDLWKLL (p53 aa18-26) is the energy acceptor. Upon excitation of the donor molecule at 340 nm, binding interaction between MDM2 or MDM4 and the p53 peptide induces energy transfer and enhanced response at the acceptor emission wavelength at 665 nm.","Substituted pyrrolo[3,4-D]imidazoles for the treatment of MDM2/4 mediated diseases",,PATENT,
1263259,CHEMBL880,GGXKWVWZWMLJEH-UHFFFAOYSA-N,FAMCICLOVIR,,P21397,MONOAMINE OXIDASE A,MAOA,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,DRUGMATRIX: Monoamine Oxidase MAO-A enzyme inhibition (substrate: Kynuramine),DrugMatrix in vitro pharmacology data,,DATASET,
1582467,CHEMBL866,HPNSFSBZBAHARI-RUDMXATFSA-N,MYCOPHENOLIC ACID,,P49146,NEUROPEPTIDE Y RECEPTOR TYPE 2,NPY2R,,,,KI,,,,,,,,,,KAN-TS,,,,,,,DRUGMATRIX: Neuropeptide Y Y2 radioligand binding (ligand: [125I] Peptide YY),DrugMatrix in vitro pharmacology data,,DATASET,
3039758,CHEMBL1447074,NTYUSFDHFJNKEC-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
199212,CHEMBL1341925,AUAZFCHKRGVFTE-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3739325,CHEMBL1880357,QSYQKHKEMTXGLH-WIOPSUGQSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
981143,CHEMBL1682,FBPFZTCFMRRESA-JGWLITMVSA-N,SORBITOL,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
1190851,CHEMBL1425809,FYWAUYOJEICEFP-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5048807,CHEMBL1413350,WZENEEQIBOWOOQ-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,37685.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
404130,CHEMBL1714107,BQNCJGIWXCJMIC-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,50456.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Counterscreen Assay for Enhancers of SMN2 Splice Variant Expression: Interaction with Luciferase Reporter for Further Probe SAR. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1474],PUBCHEM BIOASSAY DATA SET,,DATASET,
3458498,CHEMBL1491846,PNWPVJRAOUNGON-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5377882,CHEMBL1331644,YIQWXZCKYSISSR-ISKFKSNPSA-N,,,Q4R6F8,T-COMPLEX PROTEIN 1 SUBUNIT BETA,,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991],PUBCHEM BIOASSAY DATA SET,,DATASET,
3344171,CHEMBL1027,PBJUNZJWGZTSKL-MRXNPFEDSA-N,TIAGABINE,,P31649,GABA TRANSPORTER 3,,,,18395300.0,ACTIVITY,=,64.0,%,,cell_based,,,,,,,,,,,,Inhibition of [3H]GABA uptake at mouse GAT3 expressed in HEK cells assessed as remaining [3H]GABA uptake at 100 uM relative to control,Synthesis and biological evaluation of aminomethylphenol derivatives as inhibitors of the murine GABA transporters mGAT1-mGAT4.,Eur. J. Med. Chem.,PUBLICATION,
4946987,CHEMBL1389712,WOCRQHOHYUGKML-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2730302,CHEMBL610667,MLRGVBGIMDLKTE-NRKRKGKXSA-N,"N6,N6'-PENTANEDIYLBIS-ADENOSINE",,"P00558, P07205",PHOSPHOGLYCERATE KINASE,"PGK1, PGK2",,,11063610.0,IC50,,,,,,,,,,,,,,,,,Inhibition of Trypanosoma brucei Phosphoglycerate kinase (PGK).,Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.,J. Med. Chem.,PUBLICATION,
4771683,CHEMBL1348092,VVFGFLFZBRPQFD-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,891.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5630207,CHEMBL1424778,ZKCKJUQEFZPWRE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4180162,CHEMBL1358338,SPFBFHIKDVTYOA-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3607524,CHEMBL104899,QEUKHXXNKFPKOL-OFNKIYASSA-N,,,P13945,BETA-3 ADRENERGIC RECEPTOR,ADRB3,,,11714606.0,KI,=,147.0,NM,,cell_based,,,,,CHO,,,,,,,Binding affinity to CHO cells expressing the cloned human beta-3 adrenergic receptor in the presence of [125I]iodocyanopindolol,BMS-196085: a potent and selective full agonist of the human beta(3) adrenergic receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2849130,CHEMBL1397327,MYYRFPHNWHRJPQ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,366.3,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1107847,CHEMBL1408113,FPUXKXIZEIDQKW-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4152332,CHEMBL1545614,SMBHSWVYWYNDSD-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3333435,CHEMBL1474940,PAGFFZPHKSETMD-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3297324,CHEMBL1523876,OWENTRAVNDRYKC-UHFFFAOYSA-M,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
76279,CHEMBL1378945,AGKAAJMNNVUNDK-UHFFFAOYSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,177.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1151884,CHEMBL1986943,FUMCKNCUEAQHCV-UHFFFAOYSA-N,,,P24941,CYCLIN-DEPENDENT KINASE 2,CDK2,,,,KI,=,12.59,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
164317,CHEMBL30,AQIXAKUUQRKLND-UHFFFAOYSA-N,CIMETIDINE,,"P10980, P08911, P08485, P08482, P08483",MUSCARINIC ACETYLCHOLINE RECEPTOR,,,,3351856.0,INHIBITION,=,2.0,%,,,,,,,,,,,,,,Percentage inhibition for muscarinic acetylcholine receptor at concentration 10e-6 M.,"Synthesis and antiulcer activity of 5,11-dihydro[1]benzoxepino[3,4-b]pyridines.",J. Med. Chem.,PUBLICATION,
1538714,CHEMBL388978,HKSZLNNOFSGOKW-FYTWVXJKSA-N,STAUROSPORINE,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,mutated,EGFR(S752-I759del),22037378.0,KD,=,290.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for EGFR(S752-I759del) kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
3901843,CHEMBL1866899,RKEBYCQSMAJQGM-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1114710,CHEMBL462523,FQMPYBCEABTPIK-UHFFFAOYSA-N,,,P09917,ARACHIDONATE 5-LIPOXYGENASE,ALOX5,,,19053751.0,IC50,=,2000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant 5-LO expressed in Escherichia coli by cell-free assay,Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.,J. Med. Chem.,PUBLICATION,
1897383,CHEMBL1708918,IYNKTAHDZXZCSQ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4693472,CHEMBL1612004,VMPITZXILSNTON-UHFFFAOYSA-N,,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),DrugMatrix in vitro pharmacology data,,DATASET,
3573080,CHEMBL1352779,QASASMSJCWGFMV-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3685554,CHEMBL297251,QNHKZDQLUUKJBH-UHFFFAOYSA-N,,,P04070,VITAMIN K-DEPENDENT PROTEIN C,PROC,,,12039583.0,IC50,>,11000.0,NM,,,,,,,,,,,,,,Inhibitory activity against activated protein C,"Design, synthesis and biological activity of novel non-amidine factor Xa inhibitors. Part 1: P(1) structure-activity relationships of the substituted 1-(2-Naphthyl)-1H-pyrazole-5-carboxylamides.",Bioorg. Med. Chem. Lett.,PUBLICATION,
885301,CHEMBL473392,DRDSZZCLAHXSAE-BQIDRLATSA-N,ROBOTNIKININ,,Q62226,SONIC HEDGEHOG PROTEIN,,,,19151731.0,INHIBITION,,,,,cell_based,,,,,Shh Light II,,,,,,,Inhibition of N-palmitoylated Shh in mouse Shh Light2 cells at 6.3 to 50 uM after 30 hrs by firefly luciferase reporter assay in presence of 100 nM Smo agonist SAG,A small molecule that binds Hedgehog and blocks its signaling in human cells.,Nat. Chem. Biol.,PUBLICATION,
5317265,CHEMBL1308358,YBXAQSUCNHMZIA-UHFFFAOYSA-N,,,P9WHJ3,PROTEIN RECA,,,,,EC50,=,16500.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2097, AID2223, AID489010, AID492950]",PUBCHEM BIOASSAY DATA SET,,DATASET,
479498,CHEMBL1447828,BZEQRMREWARERO-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1563510,CHEMBL1411979,HNJJXZKZRAWDPF-UHFFFAOYSA-N,METHAPYRILENE,,P08588,BETA-1 ADRENERGIC RECEPTOR,ADRB1,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DrugMatrix in vitro pharmacology data,,DATASET,
3735924,CHEMBL1734081,QSNSXXYUVFWBMF-UHFFFAOYSA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,,EC50,=,15300.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR analysis of small molecule agonists of the kappa opioid receptor via a luminescent beta-arrestin assay - Set 3. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1777, AID1785, AID1786, AID1966, AID2133, AID2136, AID2284, AID2500]",PUBCHEM BIOASSAY DATA SET,,DATASET,
63430,CHEMBL1299291,AEZZDPHKXMCIQN-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,794.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1529374,CHEMBL1596405,HJYNECMBYSJLFK-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4177646,CHEMBL190029,SOYGWDUWIWWWAW-IRXDYDNUSA-N,,,Q6V1X1,DIPEPTIDYL PEPTIDASE VIII,DPP8,,,15927466.0,IC50,=,71.0,NM,,,,,,,,,,,,,,Inhibitory concentration against Dipeptidylpeptidase 8,Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2315193,CHEMBL1735420,KSAWHSSJCNJZHL-FCDUAZGNSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5506635,CHEMBL1610203,YWVPGMVSJHJYKJ-UHFFFAOYSA-N,,,Q27686,PYRUVATE KINASE,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3378280,CHEMBL1574944,PFJVIRXHQLNIJN-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
644571,CHEMBL1717766,CROREQCUPPQWJP-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18348.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
708156,CHEMBL3199897,CYJFBURBBCQKBM-HZHRSRAPSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3351254,CHEMBL3415064,PCHLJHIZYCJIRV-UHFFFAOYSA-N,,,P00734,THROMBIN,F2,,,26690913.0,IC50,=,5.622999999999999,NM,,,,,,,,,,,,,,Inhibition of thrombin (unknown origin),"Molecular modeling studies, synthesis and biological evaluation of dabigatran analogues as thrombin inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
72806,CHEMBL1504294,AGAHBUGKJJYNCW-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5139013,CHEMBL617,XIURVHNZVLADCM-IUODEOHRSA-N,CEPHALOTHIN,,D1MEN9,METALLO-BETA-LACTAMASE VIM-2,,,,18362187.0,KM,=,6200.0,NM,,,,,,,,,,,,,,Activity at Pseudomonas aeruginosa COL-1 metallo-beta lactamase VIM-2 by spectrometry,Biochemical characterization of metallo-beta-lactamase VIM-11 from a Pseudomonas aeruginosa clinical strain.,Antimicrob. Agents Chemother.,PUBLICATION,
543941,CHEMBL472959,CGAJHTAPHFZAKU-UHFFFAOYSA-N,,,P12931,TYROSINE-PROTEIN KINASE SRC,SRC,,,18722033.0,KI,=,6309.57,NM,,,,,,,,,,,,,,Inhibition of c-Src,"Docking, 3D-QSAR studies and in silico ADME prediction on c-Src tyrosine kinase inhibitors.",Eur. J. Med. Chem.,PUBLICATION,
1618748,CHEMBL3680551,HTRVDWTYRAEJCW-UHFFFAOYSA-N,,,O14965,SERINE/THREONINE-PROTEIN KINASE AURORA-A,AURKA,,,,IC50,=,0.74,NM,,,,,,,,,,,,,,BindingDB_Patents: Enzyme Assay. The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.,Amino azaheterocyclic carboxamides,,PATENT,
1912877,CHEMBL464859,JADDQZYHOWSFJD-FLNNQWSLSA-N,NECA,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,EC50,>,112219.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Luminescence Biochemical Dose Response HTS to Identify Inhibitors of Luciferase. (Class of assay: confirmatory) [Related pubchem assays: 1663 (Primary HTS), 1678 (Summary of Project)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3163210,CHEMBL1515640,OHNSEVZFYIKRGX-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4018189,CHEMBL1434743,RXCDPCNEXSCJHL-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3197786,CHEMBL1420321,OLNNUFFSADAYPY-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3291919,CHEMBL521031,OVOUDWSXPLANNM-QXAKKESOSA-N,,,Q60492,SIGMA-1 RECEPTOR,,,,19081725.0,KI,=,4030.0,NM,,,,,,,,,,,,,,Displacement of [3H](+)-pentazocine from opioid sigma1 receptor in guinea pig brain homogenate,"Relationships between the structure of 6-allyl-6,8-diazabicyclo[3.2.2]nonane derivatives and their sigma receptor affinity and cytotoxic activity.",Bioorg. Med. Chem.,PUBLICATION,
1869991,CHEMBL482488,IVMFPVCOTJWHCR-UHFFFAOYSA-N,CER-0263252,,P05129,PROTEIN KINASE C GAMMA,PRKCG,,,18479119.0,INHIBITION,=,14.0,%,,,,,,,,,,,,,,Inhibition of PKCgamma at 10 uM by HTRF assay relative to control,Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.,J. Med. Chem.,PUBLICATION,
2680978,CHEMBL336196,MGJXIOXOKWLZFS-UHFFFAOYSA-N,,,Q02880,DNA TOPOISOMERASE II BETA,TOP2B,,,3005575.0,MIC,>,100.0,UG.ML-1,,,,,,,,,,,,,,Antibacterial activity against Pseudomonas aeruginosa (UI-18),New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.,J. Med. Chem.,PUBLICATION,
687670,CHEMBL1532102,CWAYDDYERJEKHI-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3280929,CHEMBL1376432,OUKJGAWIOGKKPM-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
667656,CHEMBL1585864,CUAAOUQGDUPYKX-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,4775.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
679819,CHEMBL1096869,CVHWKCBSOHTLIK-UHFFFAOYSA-N,,,P81908,CHOLINESTERASE,,,,20361801.0,INHIBITION,=,50.0,%,,,,,,,,,,,,,,Inhibition of equine serum BChE at 10 uM by modified Ellman's method,Bivalent beta-carbolines as potential multitarget anti-Alzheimer agents.,J. Med. Chem.,PUBLICATION,
4529949,CHEMBL3085439,UUWIYANOKPHUQZ-NTZARQNWSA-N,,,P08246,LEUKOCYTE ELASTASE,ELANE,,,,KREACT,=,3.7e-05,S-1,,,,,,,,,,,,,,Compound was evaluated for the inhibitory activity against Human leukocyte elastase (HLE),,Bioorg. Med. Chem. Lett.,PUBLICATION,
2551900,CHEMBL1447592,LSHQMFOYBDSNJK-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
838440,CHEMBL127,DMJNNHOOLUXYBV-PQTSNVLCSA-N,MEROPENEM,,O08498,CARBAPENEM-HYDROLYZING BETA-LACTAMASE BLAB-1,,,,19651915.0,KCAT/KM,=,7.6,10'5/M/S,,,,,,,,,,,,,,Ratio of Kcat to Km for Chryseobacterium meningosepticum CCUG 4310 beta-lactamase BlaB1 expressed in Escherichia coli DH5alpha by Michaelis-Menten equation,"IND-6, a highly divergent IND-type metallo-beta-lactamase from Chryseobacterium indologenes strain 597 isolated in Burkina Faso.",Antimicrob. Agents Chemother.,PUBLICATION,
287417,CHEMBL101907,BDYFDDGUXXUNJN-UHFFFAOYSA-N,,,"P03372, Q92731",ESTROGEN RECEPTOR,"ESR1, ESR2",,,9464360.0,IC50,=,1037.0,NM,,cell_based,,,,,CV-1,,,,,,,Antagonistic activity was determined in Human estrogen receptor(hER) of CV-1 cells in cotransfection assay.,"5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.",J. Med. Chem.,PUBLICATION,
158446,CHEMBL1723975,APVAXVZXAPIPNR-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1146969,CHEMBL32571,FTVWIRXFELQLPI-UHFFFAOYSA-N,,,P22748,CARBONIC ANHYDRASE IV,CA4,,,22299585.0,KI,=,1120.0,NM,,,,,,,,,,,,,,,,,,
4240424,CHEMBL95207,SVRAGOOKTLUHES-UHFFFAOYSA-N,SB-220455,,Q14680,MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE,MELK,,,,INHIBITION,=,2.15,%,,,,,,,,,,,,,,GSK_PKIS: MELK mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4842750,CHEMBL1711567,WDADCPCNAFTPRZ-UHFFFAOYSA-N,,,P34707,PROTEIN SKINHEAD-1,,,,,IC50,>,100000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response Confirmation of SKN-1 Inhibitor hits in a fluorescence ratio assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4133499,CHEMBL1568053,SJWBQWLPKMFBKI-CJLVFECKSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2855731,CHEMBL3357630,MZTUFMTZBFIKDQ-ZOCIIQOWSA-N,,,P21980,PROTEIN-GLUTAMINE GAMMA-GLUTAMYLTRANSFERASE,TGM2,,,25333388.0,RATIO,=,2.9,,,,,,,,,,,,,,,Inhibition of human transglutaminase 2 using ((benzyloxy)carbony l)-L-glutaminylglycine peptide substrate assessed as Kinh/Ki ratio by GDH coupled assay,Discovery of potent and specific dihydroisoxazole inhibitors of human transglutaminase 2.,J. Med. Chem.,PUBLICATION,
4995597,CHEMBL1419192,WTQCHZRJUNESPR-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,819.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3132047,CHEMBL1328311,OEFWIJZKAIUFBL-UHFFFAOYSA-N,,,Q14289,PROTEIN TYROSINE KINASE 2 BETA,PTK2B,,,,IC50,=,4281.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: TR-FRET counterscreen for FAK inhibitors: dose-response biochemical high throughput screening assay to identify inhibitors of Proline-rich tyrosine kinase 2 (Pyk2). (Class of assay: confirmatory) [Related pubchem assays: 794, 727, 810 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2570624,CHEMBL2449326,LUDUBZUOROCVBO-VNQPRFMTSA-N,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,,EC50,=,102329.3,NM,,cell_based,,,,,CCRF-CEM/VCR-1000,,,,,,,SUPPLEMENTARY: Inhibition of P-glycoprotein expressed in MDR CCRF vcr1000 cells by daunorubicin efflux assay.  Same assay as CHEMBL914418,Structure-activity data for a series of P-glycoprotein inhibitors (Supplementary Data to CHEMBL1142990),,DATASET,
1683249,CHEMBL414810,IARAAMMRAOTQKW-XOMXTNSMSA-N,,,"P08419, P00772",PANCREATIC ELASTASE,,,,10866385.0,KI',=,1.2,MM,,,,,,,,,,,,,,Inhibition constant for uncompetitive inhibition of Suc-AAPA and Pancreatic elastase,Mass spectrometry reveals elastase inhibitors from the reactive centre loop of alpha1-antitrypsin.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1734786,CHEMBL1456780,IGHACNHFXFQMMR-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
484070,CHEMBL1570272,BZMXBHLBYNEVBH-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5168842,CHEMBL1485573,XLZMKXRPULOGJY-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2284763,CHEMBL1562945,KPAJBGDOAXZQTM-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
329673,CHEMBL422897,BIIVYFLTOXDAOV-UHFFFAOYSA-N,,,O14757,SERINE/THREONINE-PROTEIN KINASE CHK1,CHEK1,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CHEK1,PUBCHEM BIOASSAY DATA SET,,DATASET,
2634520,CHEMBL1269449,MBHSGJGKSYZBPV-HGZPNADKSA-N,,,Q12809,HERG,KCNH2,,,20869254.0,INHIBITION,=,90.0,%,,,,,,,,,,,,,,Inhibition of human ERG at 300 uM,9-Dihydroerythromycin ethers as motilin agonists--developing structure-activity relationships for potency and safety.,Bioorg. Med. Chem.,PUBLICATION,
4473726,CHEMBL2420570,UOWIBRHHTRGSJK-MXVIHJGJSA-N,,,P15735,PHOSPHORYLASE KINASE GAMMA SUBUNIT 2,PHKG2,,,23916259.0,INHIBITION,<,35.0,%,,,,,,,,,,,,,,Inhibition of PHKgamma2 in human PC3 cell lysates at 10 uM using desthiobiotin-tagged ATP probe AX9989 followed by trypsinization by LC/MS analysis,"Hit-to-lead optimization and kinase selectivity of imidazo[1,2-a]quinoxalin-4-amine derived JNK1 inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1559269,CHEMBL1488126,HMWUPEBWYBVNQB-ULPIOCOXSA-N,,,P06280,ALPHA-GALACTOSIDASE A,GLA,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3111830,CHEMBL1606251,OCGRAYOBSHCJQP-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
765592,CHEMBL1080892,DENRRAMLWBYAGF-AWEZNQCLSA-N,,,P24941,CYCLIN-DEPENDENT KINASE 2,CDK2,,,20137932.0,IC50,=,198.0,NM,,,,,,,,,,,,,,Inhibition of CDK2,2-Aminothiadiazole inhibitors of AKT1 as potential cancer therapeutics.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5121330,CHEMBL267495,XGZZHZMWIXFATA-UEZBDDGYSA-N,NALFURAFINE,,P35372,MU OPIOID RECEPTOR,OPRM1,,,25283554.0,EMAX,=,70.4,%,,cell_based,,,,,,,,,,,,Agonist activity at human mu opioid receptor expressed in CHO cells by [35S]GTPgammaS binding assay relative to DAMGO,"Design, synthesis, and structure-activity relationship of novel opioid ¿ receptor selective agonists: a-Iminoamide derivatives with an azabicyclo[2.2.2]octene skeleton.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1821586,CHEMBL1485905,IQAONXATWUITBO-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4370984,CHEMBL1477352,UDSVOHWDGMFOHN-HWKANZROSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,14575.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
165536,CHEMBL391951,AQMDQWAARXFGOY-UHFFFAOYSA-N,,,P31391,SOMATOSTATIN RECEPTOR 4,SSTR4,,,19786348.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Displacement of SST14 from human recombinant SST4 receptor,Benzoxazole piperidines as selective and potent somatostatin receptor subtype 5 antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1635274,CHEMBL3408972,HVRAZCWNURIUQB-UHFFFAOYSA-N,,,P16257,PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR,,,,25725375.0,RATIO KI,=,1.3,,,,,,,,,,,,,,,"Potency index, ratio of Ki for DPA-713 to Ki for compound for displacement of [3H]PK11195 from TSPO in Wistar rat kidney mitochondrial fractions incubated for 90 mins by liquid scintillation counting method",Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO).,Eur. J. Med. Chem.,PUBLICATION,
4652000,CHEMBL2252807,VHUJNJPWVLFIFI-UHFFFAOYSA-N,AMINO(2-FLUOROPHENYL)METHYLPHOSPHONIC ACID,,P25462,"GLUTAMINE SYNTHETASE, CHLOROPLASTIC",,,,19697446.0,IC50,=,10092528.86,NM,,,,,,,,,,,,,,Inhibition of Zea mays cv. Jeff (maize) leaf glutamine synthetase using L-glutamate as substrate assessed as inorganic phosphate production after 20 min by malachite green assay relative to control,Effectiveness and mode of action of phosphonate inhibitors of plant glutamine synthetase.,Pest Manag Sci,PUBLICATION,
3984673,CHEMBL1456,RTGDFNSFWBGLEC-SYZQJQIISA-N,MYCOPHENOLATE MOFETIL,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 3A4 enzyme inhibition (substrate: 7-Benzyloxy-4-(trifluoromethyl)-coumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
2743609,CHEMBL2372699,MNFGRPPMYAFNSV-IBDPFQGXSA-N,,,P35346,SOMATOSTATIN RECEPTOR 5,SSTR5,,,11931620.0,IC50,=,91.0,NM,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity of human Somatostatin receptor type 5 (hsst5) by the displacement of [125I]- Tyr11 somatostatin-14 in CHO-K1 cells,Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units.,J. Med. Chem.,PUBLICATION,
4456625,CHEMBL1201356,UNBRKDKAWYKMIV-QWQRMKEZSA-N,METHYLERGONOVINE,,P21452,NEUROKININ 2 RECEPTOR,TACR2,,,,KI,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Tachykinin NK2 radioligand binding (ligand: [3H] SR-48968),DrugMatrix in vitro pharmacology data,,DATASET,
145533,CHEMBL1331327,AOJZWEQDQUMIRD-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2536765,CHEMBL2206290,LQOGSAVOXSCLHL-RZDIXWSQSA-N,,,Q9QYN8,HISTAMINE H3 RECEPTOR,,,,21928839.0,KI,=,21.0,NM,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at rat histamine H3 receptor expressed in human HEK293 cells assessed as inhibition of forskolin-induced cAMP release pretreated 10 mins prior forskolin stimulation measured after 4.5 hrs by spectrofluorimetric analysis,Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764).,J. Med. Chem.,PUBLICATION,
3781801,CHEMBL1448248,QXQWOPCFNQHMRO-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2168962,CHEMBL1986499,KCKXYZOBGBJZEG-UHFFFAOYSA-N,,,P49841,GLYCOGEN SYNTHASE KINASE-3 BETA,GSK3B,,,,KI,=,12.59,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: GSK3B,PUBCHEM BIOASSAY DATA SET,,DATASET,
4048929,CHEMBL1521627,SALSYBKMNINXEC-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3598106,CHEMBL1990742,QDRSIQDHEDWBCQ-CIAFOILYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,26679.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3862315,CHEMBL1605746,RGBLLCPMCSEYBC-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3381717,CHEMBL1733701,PFTSMVYWKFQVQY-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4260708,CHEMBL1398012,SYAIRAPJWGZHRK-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
1756835,CHEMBL1468878,IIVFJKDZRRBGGY-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5213259,CHEMBL269959,XQYFTHHWGHOOSS-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,19560918.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [3H]dofetilide from human ERG channel by scintillation proximity assay,Dopamine D3 receptor antagonists: the quest for a potentially selective PET ligand. Part one: lead identification.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4721619,CHEMBL2132423,VPLGAORAGIUNQM-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1216056,CHEMBL1536469,GBYLGUKGHHCSMR-UHFFFAOYSA-N,,,O00167,EYES ABSENT HOMOLOG 2,EYA2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939],PUBCHEM BIOASSAY DATA SET,,DATASET,
2610683,CHEMBL3675650,LYQWROUQCSVXLE-UHFFFAOYSA-N,,,Q9Y233,PHOSPHODIESTERASE 10A,PDE10A,,,,IC50,=,10000.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: IMAP TR-FRET Assay. IMAP TR-FRET progressive binding system, FAM-cAMP substrate were from Molecular Devices (Sunnyvale, Calif.). The PDE IMAP assay was conducted in a 384-well black Greiner polypropylene plate (Sigma, St. Louis, Mo.). PDE inhibitors were serial diluted in 100% DMSO and dispensed into assay plate at 200 mL per well using Echo® Liquid Handling System from LABCYTE. Ten µL of PDE enzyme in IMAP reaction buffer (10 mM Tris-HCl, pH 7.2, 10 mM MgCl2, 0.05% NaN3, and 0.01% Tween-20) was added into the assay wells. The PDE enzyme concentration used was based on each lot of enzyme activity, to ensure enzyme reaction falls in a linear range under assay condition. 1.4 nM of PDE2 or 8 µM PDE10 were used in the assay system. Enzyme was pre-incubated with inhibitors for 60 minutes at room temperature before addition of 10 uL of substrate addition, which results in 100 nM of FAM-cAMP in the reaction.",Azetidine and piperidine compounds useful as PDE10 inhibitors,,PATENT,
4020450,CHEMBL2372364,RXKJZSUWKRMCHT-IVVHDTBISA-N,,,P35377,NOCICEPTIN RECEPTOR,,,,17490886.0,EMAX,=,88.0,%,,,,,,,,,,,,,,Agonist activity at NOP receptor in Swiss mouse vas deferens assessed as effect on electrically stimulated contractions,"Synthesis and biological activity of nociceptin/orphanin FQ analogues substituted in position 7 or 11 with Calpha,alpha-dialkylated amino acids.",Bioorg. Med. Chem.,PUBLICATION,
5390171,CHEMBL1344007,YKCPJOFNMLHJSR-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4374579,CHEMBL1328820,UEFUMHWCAZACNK-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3852788,CHEMBL563556,REZVMBRTPXAZNR-UHFFFAOYSA-N,,,P15917,ANTHRAX LETHAL FACTOR,,,,19359184.0,IC50,=,28000.0,NM,,,,,,,,,,,,,,Inhibition of Bacillus anthracis lethal factor assessed as cleavage of MAPKK by fluorescence peptide cleavage assay,Structure-activity relationship studies of a novel series of anthrax lethal factor inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
2835486,CHEMBL1735580,MXTYZDLGGBHMKJ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3844112,CHEMBL316711,RECMLZUYXVOJLP-UHFFFAOYSA-N,,,"P33533, P34975, Q9R0C9, P33535",OPIOID RECEPTOR,,,,8411007.0,IC50,>,1000.0,NM,,tissue,,,,,,,,,,,,Inhibition of [3H]naxolone binding to opiate receptors in rat brain,"Chemistry, binding affinities, and behavioral properties of a new class of ""antineophobic"" mitochondrial DBI receptor complex (mDRC) ligands.",J. Med. Chem.,PUBLICATION,
3959443,CHEMBL1888142,RQLWEWIMGMJJKK-WKAQUBQDSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3446681,CHEMBL530860,PMSGTYOSJRRXOQ-UHFFFAOYSA-N,TCMDC-132997,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,2.06,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1808100,CHEMBL1610550,IOMPRSGMGRXDKH-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3960831,CHEMBL1351688,RQQJGRPBADURDQ-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,84921.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3447610,CHEMBL86943,PMUJUSJUVIXDQC-LCYFTJDESA-N,,,Q15208,SERINE/THREONINE-PROTEIN KINASE 38,STK38,wild_type,,22037377.0,ACTIVITY,=,101.48551040000001,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
4202996,CHEMBL1231533,SRLVNYDXMUGOFI-YWEYNIOJSA-N,,,P36897,TGF-BETA RECEPTOR TYPE I,TGFBR1,wild_type,,22037377.0,ACTIVITY,=,102.05437309999999,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,CASEIN ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
4759208,CHEMBL1483688,VTSTYWHECDLJQV-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5415280,CHEMBL1409084,YMSYXWPCDBRESY-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
886882,CHEMBL1391437,DRIGLOHKSIRHTN-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
333354,CHEMBL1895678,BIRZSADKIXHCHN-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5161555,CHEMBL3659579,XLGKEXZOGVNKFN-VUWPPUDQSA-N,,,Q93LQ9,BETA-LACTAMASE,,,,,IC50,=,260.0,NM,,,,,,,,,,,,,,BindingDB_Patents: Spectrophotometric Assay. Enzyme activities were measured in the presence of the test inhibitor in spectrophotometric assay.,Œ=-lactamase inhibitors,,PATENT,
2851476,CHEMBL1439569,MZEXRCSVJIGQQE-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5666433,CHEMBL101326,ZOCSXAVNDGMNBV-UHFFFAOYSA-N,FIPRONIL,,P25094,PERIPHERAL MYELIN PROTEIN 22,,,,,POTENCY,,10181.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element firefly luciferase assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1563373,CHEMBL1411979,HNJJXZKZRAWDPF-UHFFFAOYSA-N,METHAPYRILENE,,P37288,VASOPRESSIN V1A RECEPTOR,AVPR1A,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),DrugMatrix in vitro pharmacology data,,DATASET,
4041612,CHEMBL1766586,RZPCAEILZXDTRZ-UHFFFAOYSA-N,,,"P60903, P07355",ANNEXIN A2/S100-A10,"ANXA2, S100A10",,,21375334.0,IC50,=,100000.0,NM,,,,,,,,,,,,,,Inhibition of Cy3-labeled annexin A2(1-14)-Cy5- labeled S100A10 interaction after 5 mins by FRET assay,"Design, synthesis, and structure-activity relationship exploration of 1-substituted 4-aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-one analogues as inhibitors of the annexin A2-S100A10 protein interaction.",J. Med. Chem.,PUBLICATION,
2822384,CHEMBL239732,MWCZKKARWNYYQC-UHFFFAOYSA-N,CYCLONOVOBIOCIC ACID,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,15811.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3634818,CHEMBL1320459,QHMVSANQVSVVDE-UHFFFAOYSA-N,,,O00167,EYES ABSENT HOMOLOG 2,EYA2,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939],PUBCHEM BIOASSAY DATA SET,,DATASET,
2719259,CHEMBL806,MKXKFYHWDHIYRV-UHFFFAOYSA-N,FLUTAMIDE,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,KI,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
4216730,CHEMBL1326231,SSZDQYOVOQZKDY-TWGQIWQCSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3530,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,ERLOTINIB,,Q9H2G2,SERINE/THREONINE-PROTEIN KINASE 2,SLK,,,,KI,=,50.12,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SLK,PUBCHEM BIOASSAY DATA SET,,DATASET,
942705,CHEMBL1852345,DXQCCZNEUHNYEV-UHFFFAOYSA-N,,,P28335,SEROTONIN 2C (5-HT2C) RECEPTOR,HTR2C,,,,IC50,=,130.0,NM,,cell_based,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. For serotonin 5-HT2A binding, an aliquot of human recombinant serotonin 5-HT2A receptor (PerkinElmer Life and Analytical Sciences, USA) expressed in CHO-K1 cells (5 ug/well) and 1 nM [3H]Ketanserin (PerkinElmer) were used in the presence of mianserin (20 uM) as a nonspecific. The reaction mixture was incubated for 60 min at 27Â° C. using 50 mM Tris-HCl (pH 7.4) buffer containing 4 mM CaCl2 and 0.1% ascorbic acid, and harvested through filtermate A glass fiber filter (Wallac, Finland) presoaked in 0.5% polyethyleneimine (PEI) by microbeta filtermate-96 harvester (PerkinElmer) to terminate the reaction, and then washed with ice cold 50 mM Tris-HCl buffer solution (pH 7.4). The filter was then covered with MeltiLex, sealed in a sample bag, dried in an oven. The radioactivity retained in the filter was finally counted using MicroBeta Plus (Wallac). For serotonin 5-HT2C binding, frozen membranes from stable CHO-K1 cell line expressing the human recombinant 5-HT2C receptor.",Arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same,,PATENT,
3981119,CHEMBL1706985,RSVDXQLBOVERCX-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5296435,CHEMBL1588140,XZYGHTWJILHRLO-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,2238.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5670915,CHEMBL38490,ZORPUEVHWCIKLW-UHFFFAOYSA-N,,,"P28473, P28471, P23574, P15431, P63079, O09028, P30191, Q91ZM7, P18508, P62813, P20236, P19969, P23576, P63138, Q9ES14, P18506",GABA-A RECEPTOR; ANION CHANNEL,,,,10386933.0,GS,=,1.5,,,,,,,,,,,,,,,GABA shift which is the ratio of binding in the absence and presence of GABA (1 mM) was determined,"Potential anxiolytic agents. 3. Novel A-ring modified pyrido[1,2-a]benzimidazoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1502574,CHEMBL259084,HHFBDROWDBDFBR-UHFFFAOYSA-N,MLN-8054,,Q15759,MAP KINASE P38 BETA,MAPK11,,,17360485.0,ACTIVITY,=,95.0,%,,,,,,,,,,,,,,Activity of human SAPK2b kinase at 1 uM,"Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase.",Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
1169412,CHEMBL1892805,FWNRLHMZWCSDSM-QLODZENZSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
701380,CHEMBL1230609,CXQHYVUVSFXTMY-UHFFFAOYSA-N,FORETINIB,,Q15418,RIBOSOMAL PROTEIN S6 KINASE ALPHA 1,RPS6KA1,,,22037378.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for RSK1(Kin.Dom.1-N-terminal) kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
3776151,CHEMBL1365675,QXAITBQSYVNQDR-ZIOPAAQOSA-N,AMITRAZ,,P25021,HISTAMINE H2 RECEPTOR,HRH2,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Histamine H2 radioligand binding (ligand: [125I] Aminopotentidine),DrugMatrix in vitro pharmacology data,,DATASET,
5783177,CHEMBL3727597,,,,Q9EQC5,N-TERMINAL KINASE-LIKE PROTEIN,,,,,Ratio,=,1.37,,,,,,,,,,,,,,,Inhibition of Scyl1 in mouse BetaTC6 cells assessed as ratio of insulin release at 10 uM incubated for 2 hrs by ELISA relative to DMSO (Rvb = 1 No_unit),Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5,,PATENT,
1388299,CHEMBL3189712,GUXSDTCRRCSSAE-CNHKJKLMSA-N,,,P07900,HEAT SHOCK PROTEIN HSP 90-ALPHA,HSP90AA1,,,,AC50,=,2096.0,NM,,organism_based,,,,,,,,,,,,PUBCHEM_BIOASSAY: HsHsp90 Counterscreen Measured in Microorganism System Using Plate Reader - 2121-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596],PUBCHEM BIOASSAY DATA SET,,DATASET,
934540,CHEMBL1651208,DWTYHCYVKJONSP-UHFFFAOYSA-N,,,P07550,BETA-2 ADRENERGIC RECEPTOR,ADRB2,,,23009245.0,INHIBITION,=,8.0,%,,,,,,,,,,,,,,Inhibition of radioligand binding to human adrenergic beta2 receptor at 10 uM,Orally Active Metabotropic Glutamate Subtype 2 Receptor Positive Allosteric Modulators: Structure-Activity Relationships and Assessment in a Rat Model of Nicotine Dependence.,J. Med. Chem.,PUBLICATION,
5073790,CHEMBL9883,XBWWFMWPJCKVEN-UHFFFAOYSA-N,,,P43119,PROSTANOID IP RECEPTOR,PTGIR,,,15013022.0,KI,=,79.43,NM,,,,,,,,,,,,,,"Binding affinity towards prostacyclin receptor on rat NG-108-15 neuroblastoma cells, using [3H]iloprost as a radioligand",Discovery and SAR development of 2-(phenylamino) imidazolines as prostacyclin receptor antagonists [corrected].,Bioorg. Med. Chem. Lett.,PUBLICATION,
4025466,CHEMBL1214185,RXZBMPWDPOLZGW-XMRMVWPWSA-N,ROXITHROMYCIN,,P05181,CYTOCHROME P450 2E1,CYP2E1,,,,KI,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2E1 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
2276298,CHEMBL220465,KODFUVBIVXFWPF-UHFFFAOYSA-N,GSK-248233A,,P07333,MACROPHAGE COLONY STIMULATING FACTOR  RECEPTOR,CSF1R,,,,INHIBITION,=,-0.02,%,,,,,,,,,,,,,,GSK_PKIS: FMS mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
902435,CHEMBL94940,DTCPBMNVODXPJH-UHFFFAOYSA-N,,,P30994,SEROTONIN 2B (5-HT2B) RECEPTOR,,,,8709108.0,-LOG KB,=,9.06,,,,,,,,,,,,,,,Binding affinity analysed for 5-HT 2B receptor in rat stomach fundus,"Potent, selective tetrahydro-beta-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus.",J. Med. Chem.,PUBLICATION,
5718217,CHEMBL275168,ZTUCRQHYVRNKFG-UHFFFAOYSA-N,SB-278539,,P41743,PROTEIN KINASE C IOTA,PRKCI,,,,INHIBITION,=,1.87,%,,,,,,,,,,,,,,GSK_PKIS: PKC-iota mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2036872,CHEMBL2131248,JOBNSMMJJGRSBT-UBKPWBPPSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
480878,CHEMBL3401983,BZIKSZZVJAQWMC-SBBZOCNPSA-N,,,O00329,PI3-KINASE P110-DELTA SUBUNIT,PIK3CD,,,25827523.0,KI,=,1900.0,NM,,,,,,,,,,,,,,Inhibition of PI3Kdelta (unknown origin),Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3879577,CHEMBL1419328,RHVPYGDUORFUQO-VOTSOKGWSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2974052,CHEMBL1463601,NMPDXYBFWKGUIG-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4227085,CHEMBL385482,SUEUOYXWDYAPQY-STNYYUMZSA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,17004724.0,KI,=,0.32,NM,,cell_based,,,,,C6,,,,,,,Displacement of [3H]diprenorphine from human mu opioid receptor expressed in C6 cells,Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effects of changes to the chain linking of the C14-amino group to the aryl ring.,J. Med. Chem.,PUBLICATION,
2355070,CHEMBL1470626,KWHQMDCQGGHVJP-PJABCKPXSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,4775.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4970413,CHEMBL1393647,WQTGYDDIUWXLHC-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5176513,CHEMBL1335068,XMTGLCZMWMPEAN-UHFFFAOYSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
457580,CHEMBL1613346,BWRJKFFSFLZLBE-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4674856,CHEMBL1465780,VKNWWBXHQYHQJF-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4806098,CHEMBL1455014,VYXKATGJKODPQR-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4037064,CHEMBL118,RZEKVGVHFLEQIL-UHFFFAOYSA-N,CELECOXIB,,P12822,ANGIOTENSIN-CONVERTING ENZYME,,,,,IC50,,,,,tissue,,,,,,,,,,,,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",DrugMatrix in vitro pharmacology data,,DATASET,
2497755,CHEMBL1438807,LMONDBIHNXOFHP-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
290780,CHEMBL248685,BEJMIGRFXPOEAU-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,17827014.0,EMAX,<,2.0,%,,,,,,,,,,,,,,Agonist activity at human GLP1 assessed as stimulation of cAMP relative to cAMP,Small molecule ago-allosteric modulators of the human glucagon-like peptide-1 (hGLP-1) receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2275776,CHEMBL1397721,KOCRHITXIVDAFW-CQSZACIVSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
5505341,CHEMBL340269,YWSKAQWSPONVPP-UHFFFAOYSA-N,,,P00378,DIHYDROFOLATE REDUCTASE,,,,7990119.0,KD,=,5100.0,NM,,,,,,,,,,,,,,Tested for the apparent dissociation constant for binding of compound to binary NADPH complex with chicken dihydrofolate reductase using equations 11 and 12,Structure-activity relationships and pH dependence of binding of 8-alkyl-N5-deazapterins to dihydrofolate reductase.,J. Med. Chem.,PUBLICATION,
1616355,CHEMBL2381202,HTLMWVUYXHRUOF-UHFFFAOYSA-N,,,P20393,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP D MEMBER 1,NR1D1,,,23656296.0,TIME,=,0.0,HR,,cell_based,,,,,,,,,,,,Agonist activity at REV-ERBalpha in human U2OS cells assessed as delay of peak of second cycle at 20 uM by luciferase reporter gene assay relative to DMSO-treated control,Optimized chemical probes for REV-ERBa.,J. Med. Chem.,PUBLICATION,
3383523,CHEMBL289668,PFZIJAVARPSGTC-UHFFFAOYSA-N,,,P00734,THROMBIN,F2,,,12668009.0,INHIBITION,=,32.0,%,,,,,,,,,,,,,,Inhibitory activity against thrombin at concentration 400 nM,High-throughput synthesis and optimization of thrombin inhibitors via urazole alpha-addition and Michael addition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3566834,CHEMBL179453,QAAZSECJUMWUTP-UHFFFAOYSA-N,GW622055X,,P27361,MAP KINASE ERK1,MAPK3,,,,INHIBITION,=,1.66,%,,,,,,,,,,,,,,GSK_PKIS: MAPK3 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5822899,CHEMBL3740691,,,,P34969,SEROTONIN 7 (5-HT7) RECEPTOR,HTR7,,,,Ki,=,49.0,NM,,,,,,,,,,,,,,Displacement of [3H]-5-carboxyamidotryptamine from human serotonin 5-HT7B receptor expressed in HEK293 cells after 1 hr by microplate reader based assay,Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7receptor antagonists and their psychotropic properties,MedChemComm,PUBLICATION,
111922,CHEMBL1383367,AKNBMTLPQVUEPW-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
673011,CHEMBL1358903,CUMODTAOJFPLAW-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,335.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2380630,CHEMBL1596187,KZKVIYAMJGKZFL-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4709181,CHEMBL1530220,VOCKHRGRLWCBLC-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
765366,CHEMBL2313214,DENHKCMZPFZGQV-UHFFFAOYSA-N,,,P35354,CYCLOOXYGENASE-2,PTGS2,,,23237838.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of COX-2 (unknown origin) at 5 uM,Synthesis and biological activity of aminophthalazines and aminopyridazines as novel inhibitors of PGE2 production in cells.,Bioorg. Med. Chem. Lett.,PUBLICATION,
396138,CHEMBL1327627,BPOJTSJPTIZJSW-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2005302,CHEMBL133469,JKPIHCSBJFLPKX-UHFFFAOYSA-N,,,Q72547,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 REVERSE TRANSCRIPTASE,,,,10514284.0,IC50,=,2600.0,NM,,,,,,,,,,,,,,Inhibition of Reverse transcriptase (Y181C) using poly(rA)600:oligo(dT)10 as template primer.,Synthesis and structure-activity relationships of the (alkylamino)piperidine-containing BHAP class of non-nucleoside reverse transcriptase inhibitors: effect of 3-alkylpyridine ring substitution.,J. Med. Chem.,PUBLICATION,
4555014,CHEMBL1399979,UXNPKIAJFNEKGZ-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1140697,CHEMBL1316317,FTEBWIBRQIFYOX-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9. (Class of assay: confirmatory) [Related pubchem assays: 885, 884, 410 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1742024,CHEMBL1584634,IHFWDNOFDRSICE-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4745181,CHEMBL1711391,VSHMRTHYBWLVBB-LTRPCDOLSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
5778242,CHEMBL3785443,,,,Q9UGL1,LYSINE-SPECIFIC DEMETHYLASE 5B,KDM5B,,,26710088.0,EC50,=,530.0,NM,,,,,,,,,,,,,,Inhibition of KDM5B in human PC9 cells assessed as reduction in demethylation of H3K4me3 after 120 hrs by AlphaLisa assay,RECENT PROGRESS IN HISTONE DEMETHYLASE INHIBITORS.,J. MED. CHEM.,PUBLICATION,
3345661,CHEMBL1495434,PBNWZMPSMRXQGO-UHFFFAOYSA-N,,,O97447,"PUTATIVE FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE",,,,,POTENCY,=,22334.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia. (Class of assay: confirmatory) [Related pubchem assays: 2472, 2464 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5387497,CHEMBL1573186,YJUKWTYRJQOSHV-VAWYXSNFSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
1796924,CHEMBL862,INJOMKTZOLKMBF-UHFFFAOYSA-N,GUANFACINE,,P25100,ALPHA-1D ADRENERGIC RECEPTOR,ADRA1D,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DrugMatrix in vitro pharmacology data,,DATASET,
553721,CHEMBL24236,CHEPGSNAEUFBIL-UHFFFAOYSA-N,,,"P25115, P30729, P19020, P18901, P61169",DOPAMINE RECEPTOR,,,,,ED50,=,30.0,MG.KG-1,,organism_based,,,,,,,,,,,,Dopamine receptor antagonist activity expressed as ability to inhibit apomorphine-induced climbing behavior in rat on subcutaneous administration.,,Bioorg. Med. Chem. Lett.,PUBLICATION,
4286278,CHEMBL1243003,TUQGOHBCIDWLPB-UHFFFAOYSA-N,,,P06493,CYCLIN-DEPENDENT KINASE 1,CDK1,,,20638755.0,IC50,=,830.0,NM,,,,,,,,,,,,,,Inhibition of CDK1,"Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay.",Eur. J. Med. Chem.,PUBLICATION,
3932298,CHEMBL77275,RNNKRPICXJIOPQ-UHFFFAOYSA-N,,,"P35355, Q63921",CYCLOOXYGENASE,,,,2115589.0,IC50,>,1000000.0,NM,,,,,,,,,,,,,,Inhibitory activity against Prostaglandin G/H synthase,Antiinflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid.,J. Med. Chem.,PUBLICATION,
2703580,CHEMBL3209592,MJCRUGNTUHDFME-QGMBQPNBSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,=,15848.93,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3870323,CHEMBL2447974,RGVHPHLMJAJFPO-UHFFFAOYSA-N,,,Q9WTR4,NOREPINEPHRINE TRANSPORTER,,,,6134833.0,IC50,=,910.0,NM,,,,,,,,,,,,,,Effect on synaptosomal uptake inhibition of Noradrenaline (NA),Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.,J. Med. Chem.,PUBLICATION,
288007,CHEMBL1334441,BEAFQOMWRHXVLL-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,3264.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1007038,CHEMBL1315988,FENQHHJSVVATIX-SAPNQHFASA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1603615,CHEMBL1578872,HRZMERPUIOFDKD-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4714341,CHEMBL1538787,VOTMRGAEXRLYEO-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,125.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2500998,CHEMBL1880739,LMXYVLFTZRPNRV-UHFFFAOYSA-N,GW305074X,,Q15139,PROTEIN KINASE C MU,PRKD1,,,,INHIBITION,=,3.52,%,,,,,,,,,,,,,,GSK_PKIS: PRKD1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5406390,CHEMBL1588575,YLTSPFWGOFPTFJ-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5796259,CHEMBL3214665,,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,33491.5,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
832074,CHEMBL1439895,DLRUGRPGYYZBIG-WJDWOHSUSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,23778.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4120820,CHEMBL3214362,SIIYIFFQXBUHDX-MHWRWJLKSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,=,15848.93,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1519404,CHEMBL1672621,HIXMVSBRCJHLQW-UHFFFAOYSA-N,,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,,KI,,,,,cell_based,,,,,HeLa,,,,,,,Displacement of [3H]NECA from human adenosine A3 receptor expressed in HeLa cells after 3 hrs by filtration binding assay,,ACS Med. Chem. Lett.,PUBLICATION,
4275209,CHEMBL295416,SZRPDCCEHVWOJX-UHFFFAOYSA-N,PIRINIXIC ACID,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,19952.62,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4199084,CHEMBL1603087,SRBIHKSWFZJZFZ-UHFFFAOYSA-N,,,"P08238, P07900",HEAT SHOCK PROTEIN HSP90,"HSP90AA1, HSP90AB1",,,,IC50,>,50000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cell-based secondary assay for identifying Hsp90 inhibitors that degrade Hsp90 client protein Her2. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
188411,CHEMBL2381091,ASXNPNYNZNCONJ-KRWDZBQOSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,23535328.0,INHIBITION,<,57.0,%,,,,,,,,,,,,,,Inhibition of human recombinant CYP2D6 at 1 uM by fluorimetric assay,"Discovery, synthesis, selectivity modulation and DMPK characterization of 5-azaspiro[2.4]heptanes as potent orexin receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2891175,CHEMBL1309460,NDTTVQJRZOMEFE-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3835915,CHEMBL1909357,RDHBGCDZTMPHGL-UHFFFAOYSA-N,GW410563A,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,,INHIBITION,=,36.13,%,,,,,,,,,,,,,,GSK_PKIS: ABL1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3767111,CHEMBL114,QWAXKHKRTORLEM-UGJKXSETSA-N,SAQUINAVIR,,P43140,ALPHA-1A ADRENERGIC RECEPTOR,,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),DrugMatrix in vitro pharmacology data,,DATASET,
5839144,CHEMBL1909056,,COBALT(II) ACETYLACETONATE,,P18089,ALPHA-2B ADRENERGIC RECEPTOR,ADRA2B,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DrugMatrix in vitro pharmacology data,,DATASET,
3036601,CHEMBL2205830,NTRDOPDLDNCOHJ-UHFFFAOYSA-N,,,Q01959,DOPAMINE TRANSPORTER,SLC6A3,,,23981939.0,KI,,,,,cell_based,,,,,,,,,,,,"Displacement of [3H]-WIN-35,428 from human DAT expressed in HEK cell membranes","N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
59407,CHEMBL1173017,AEQHEVDDTLOOMD-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,20481570.0,KI,=,3800.0,NM,,cell_based,,,,,HEK293,,,,,,,Binding affinity to human ERG expressed in HEK293 cells,Discovery of bishomo(hetero)arylpiperazines as novel multifunctional ligands targeting dopamine D(3) and serotonin 5-HT(1A) and 5-HT(2A) receptors.,J. Med. Chem.,PUBLICATION,
1785722,CHEMBL1473085,IMGNXIJXSJRBRR-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,2930.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2660, AID2666, AID2667, AID2668, AID2681, AID504465]",PUBCHEM BIOASSAY DATA SET,,DATASET,
582934,CHEMBL1518174,CKNPFYGGJKEFSF-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4357641,CHEMBL1334062,UCEGDYDPOSBUTP-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,1191.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Polymerase Iota: Confirmatory Assay for Cherry-picked Compounds.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1404102,CHEMBL3127761,GWRRSDYREVCXHH-UHFFFAOYSA-N,,,P09467,"FRUCTOSE-1,6-BISPHOSPHATASE",FBP1,,,24530031.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant FBPase expressed in Escherichia coli BL21(DE3) by phosphoglucose isomerase and glucose-6-phosphate dehydrogenase coupled assay,"Design, synthesis and biological evaluation of 7-nitro-1H-indole-2-carboxylic acid derivatives as allosteric inhibitors of fructose-1,6-bisphosphatase.",Bioorg. Med. Chem.,PUBLICATION,
5655754,CHEMBL450121,ZMYQRHSOVRDQDL-CPPDSBOHSA-N,LEUCOSCEPTOSIDE A,,O42713,TYROSINASE,,,,17287127.0,INHIBITION,=,21.65,%,,,,,,,,,,,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.051 mM,Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.,Bioorg. Med. Chem.,PUBLICATION,
5062806,CHEMBL1533320,XAPUHHALCZTLTF-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,89125.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4203883,CHEMBL222556,SRNPMQHYWVKBAV-UHFFFAOYSA-N,"3',4'-DIHYDROXYFLAVONE",,P15907,"BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE 1",ST6GAL1,,,,IC50,=,7100.0,NM,,,,,,,,,,,,,,Inhibition of human ST6Gal1,,MedChemComm,PUBLICATION,
2883947,CHEMBL1579130,NCYCYZXNIZJOKI-HWCYFHEPSA-N,13-CIS-RETINAL,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5773487,CHEMBL657,ZZVUWRFHKOJYTH-UHFFFAOYSA-N,DIPHENHYDRAMINE,,P08912,MUSCARINIC ACETYLCHOLINE RECEPTOR M5,CHRM5,,,,KI,=,116.0,NM,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M5 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
1810662,CHEMBL1328003,IOUSNEFHJKZMFR-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1125003,CHEMBL332141,FRMQZSOWTABKHV-MUWNOXIOSA-N,,,Q14416,METABOTROPIC GLUTAMATE RECEPTOR 2,GRM2,,,9464366.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,"Ability to block 1S,3R-ACPD-induced inhibition of forskolin stimulated cyclic-AMP in non-neuronal cell line expressing human Metabotropic glutamate receptor 2","2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution.",J. Med. Chem.,PUBLICATION,
4337368,CHEMBL1484580,UAECCVTYKLPSEX-UHFFFAOYSA-N,,,Q4R6F8,T-COMPLEX PROTEIN 1 SUBUNIT BETA,,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991],PUBCHEM BIOASSAY DATA SET,,DATASET,
5592502,CHEMBL558161,ZFWXTIRTVJJPDT-QOCTXULSSA-N,,,P30874,SOMATOSTATIN RECEPTOR 2,SSTR2,,,19351180.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,"Displacement of [125I] Des-AA1,4-6,10,12,13-[DTyr2,DAgl(NMe,2naphthoyl)8,IAmp9]-SRIF-Thr-NH2 from sst2 receptor in human tumor cells by autoradiography","Novel, potent, and radio-iodinatable somatostatin receptor 1 (sst1) selective analogues.",J. Med. Chem.,PUBLICATION,
4608189,CHEMBL1459895,VDCHPLSPMDXGPN-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5407233,CHEMBL1218,YLXDSYKOBKBWJQ-LBPRGKRZSA-N,RAMELTEON,,P49286,MELATONIN RECEPTOR 1B,MTNR1B,,,12213063.0,KI,=,0.045,NM,,,,,,,,,,,,,,Binding affinity against human Melatonin receptor type 1B (MT2),Synthesis of a novel series of tricyclic indan derivatives as melatonin receptor agonists.,J. Med. Chem.,PUBLICATION,
226981,CHEMBL3699290,AXCZPENGSHNULO-LLVKDONJSA-N,,,P68400,CASEIN KINASE II ALPHA,CSNK2A1,,,,IC50,=,7.54,NM,,,,,,,,,,,,,,"BindingDB_Patents: Kinase Assay. The effectiveness of compounds of the present invention as inhibitors of protein kinases can be readily tested by assays known to those skilled in the art. For example, in vitro protein kinase assays may be conducted with a relevant purified protein kinase and an appropriate synthetic substrate to determine the inhibitory activity of the compounds. Assays for inhibition of CK2 by the instant compounds were performed in 384-well plates with reaction mixtures containing 10 uM of peptide substrate (RRRADDSDDDDD-NH2), [gamma-33P]ATP (10 uCi) at 25 uM (CK2A1) or 5 uM (CK2A2), 20 mM Hepes (pH 7.4), 100 mM NaCl, 10 mM MgCl2, 0.25 mM dithiothreitol, Brij-35 at 0.015%, and recombinant CK2A1 (10 nM, Invitrogen) or CK2A2 (5 nM, Upstate Biotechnology). Reaction mixtures were incubated at 30 C. for 1 hour, and reaction products were captured by binding to phosphocellulose (P81) filter plates.",Imidazotriazinecarbonitriles useful as kinase inhibitors,,PATENT,
1096631,CHEMBL1330983,FONBFLZXBNXWCN-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,14083.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS screen for small molecules that inhibit ELG1-dependent DNA repair: Hit Confirmation with Unstimulated Viability Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1683828,CHEMBL1393200,IASZFBVEIXGSES-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5200961,CHEMBL223228,XPOQHMRABVBWPR-ZDUSSCGKSA-N,EFAVIRENZ,,,HIV-1 Reverse Transcriptase Mutant (Y181C),,,,15670903.0,IC50,=,4.0,NM,,,,,,,,,,,,,,,,,,
2234784,CHEMBL1450008,KJQLFFHRDREFOS-UHFFFAOYSA-N,,,P46063,ATP-DEPENDENT DNA HELICASE Q1,RECQL,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4797092,CHEMBL7995,VXXUBJWBUJJPCS-HNCPQSOCSA-M,,,P05364,BETA-LACTAMASE,,,,7699694.0,IC50,>,20000.0,NM,,,,,,,,,,,,,,The concentration of compound to inhibit beta-lactamase was measured on Enterobacter cloacae SC 12368,Synthesis and biological activity of 7-alkylidenecephems.,J. Med. Chem.,PUBLICATION,
1038995,CHEMBL1465522,FIBFCFXKLQHQRC-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,7307.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4315601,CHEMBL1822145,TXUPRVNNKMSBLZ-UHFFFAOYSA-N,,,Q16539,MAP KINASE P38 ALPHA,MAPK14,,,21813278.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibition of recombinant p38alpha Thr69/71 of ATF-2 as substrate preincubated for 15 mins measured after 60 mins by TR-FRET assay,Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration.,Bioorg. Med. Chem. Lett.,PUBLICATION,
867220,CHEMBL3589376,DPGTVVMMQHTXDT-UHFFFAOYSA-N,,,P48736,PI3-KINASE P110-GAMMA SUBUNIT,PIK3CG,,,26037808.0,IC50,=,18480.0,NM,,,,,,,,,,,,,,Inhibition of His-tagged p110gamma (unknown origin) expressed in Sf9/Baculovirus system using [gamma-33P]ATP by scintillation proximity assay,"Design, synthesis and biological evaluation of novel condensed pyrrolo[1,2-c]pyrimidines featuring morpholine moiety as PI3Ka inhibitors.",Eur. J. Med. Chem.,PUBLICATION,
4990966,CHEMBL210249,WTBUEOBCBVKJHP-UHFFFAOYSA-N,,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,,,16580199.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of FLT3,Identification of 2-acylaminothiophene-3-carboxamides as potent inhibitors of FLT3.,Bioorg. Med. Chem. Lett.,PUBLICATION,
539995,CHEMBL2158062,CFODIQZSRVSRRB-CYBMUJFWSA-N,,,P27815,PHOSPHODIESTERASE 4A,PDE4A,,,21456625.0,IC50,=,2400.0,NM,,,,,,,,,,,,,,Inhibition of full-length PDE4A4 using cAMP as substrate by two-step radiochemical assay,"Elucidation of a Structural Basis for the Inhibitor-Driven, p62 (SQSTM1)-Dependent Intracellular Redistribution of cAMP Phosphodiesterase-4A4 (PDE4A4).",J. Med. Chem.,PUBLICATION,
1705755,CHEMBL1698371,ICYMYYFELNPZJJ-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4864199,CHEMBL1871056,WFFNKLOIFRGGQP-DNVJHFABSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4773865,CHEMBL1835561,VVLTXYYNPMMNKQ-LSDHHAIUSA-N,,,P78536,ADAM17,ADAM17,,,21963348.0,INHIBITION,=,58.5,%,,,,,,,,,,,,,,Inhibition of TACE in human whole blood assessed as reduction of of LPS-induced TNFalpha production at 1 uM pretreated 15 mins before LPS challenge measured 5 hrs post LPS challenge,"Synthesis, preliminary biological evaluation and molecular modeling of some new heterocyclic inhibitors of TACE.",Eur. J. Med. Chem.,PUBLICATION,
980017,CHEMBL268920,FBOPVIWMYMFESR-YOZOHBORSA-N,,,"Q8TCU5, Q14957, Q12879, O15399, Q13224, Q05586, O60391",GLUTAMATE [NMDA] RECEPTOR,"GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, GRIN3A, GRIN3B",,,11909726.0,IC50,=,9.7,NM,,,,,,,,,,,,,,"In vitro inhibitory activity at 1 uM concentration against N-methyl-D-aspartate glutamate receptor, using [3H]CGP-39653 binding assay","5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition.",Bioorg. Med. Chem. Lett.,PUBLICATION,
51129,CHEMBL1339144,ADRRAQOVZYHAOI-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4774978,CHEMBL1309272,VVPPEWSHABGJGH-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2118778,CHEMBL1490258,JWWHLDSWTPNVCQ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23099.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1570500,CHEMBL3237625,HOFKXNBVTNUDSH-UHFFFAOYSA-N,,,P16070,CD44 ANTIGEN,CD44,,,24606063.0,IC50,,,,,,,,,,,,,,,,,Inhibition of recombinant human hyaluronan binding domain of CD44 binding to immobilized polymeric hyaluronan by surface plasmon resonance assay,Fragment-based identification of an inducible binding site on cell surface receptor CD44 for the design of protein-carbohydrate interaction inhibitors.,J. Med. Chem.,PUBLICATION,
5427013,CHEMBL1444947,YNWZLOKZBJTEJA-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,1000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
564523,CHEMBL1559348,CIMJIDMSZBBZGL-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1871585,CHEMBL267160,IVRLAVIATUXSQY-UHFFFAOYSA-N,CID 667285,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5229240,CHEMBL284969,XSMYYYQVWPZWIZ-IDTAVKCVSA-N,,,P25099,ADENOSINE A1 RECEPTOR,,,,8201607.0,EC50,=,8.2,NM,,,,,,,,,,,,,,Negative chronotropic activity via A1 Adenosine receptor was tested in spontaneously beating rat atria,2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation.,J. Med. Chem.,PUBLICATION,
5449917,CHEMBL1378091,YQFQKZQXIWYPPX-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3519877,CHEMBL3664425,PUQFRMPEHMXFJI-GOSISDBHSA-N,,,P33316,DUTP PYROPHOSPHATASE,DUT,,,,IC50,=,90.0,NM,,,,,,,,,,,,,,BindingDB_Patents: Inhibition Assay. The inhibitory activity of the compound against human dUTPase was determined by measuring the production of [5-3H]deoxyuridine monophosphate from [5-3H]deoxyuridine triphosphate.,Uracil compound or salt thereof having human deoxyuridine triphosphatase inhibitory activity,,PATENT,
1248536,CHEMBL3191017,GFJVYQLTCMVKEU-CXUHLZMHSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2753361,CHEMBL1339905,MOICTNVFTWFQIG-HMMYKYKNSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4288072,CHEMBL573339,TUVCWJQQGGETHL-UHFFFAOYSA-N,PI-103,,Q96KB5,PDZ-BINDING KINASE,PBK,,,18077363.0,THERMAL MELTING CHANGE,=,0.5,DEGREES C,,,,,,,,,,,,,,Delta TM value showing the stabilisation of PBK produced by compound binding,A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
4706083,CHEMBL540578,VNUDTMJJQPMVFB-UHFFFAOYSA-N,,,"Q02152, P35363, P34968",SEROTONIN 2 (5-HT2) RECEPTOR,,,,1360026.0,KI,=,272.0,NM,,,,,,,,,,,,,,In vitro binding affinity for serotonin 5-hydroxytryptamine (5-HT) 2 receptors,Novel piperidine sigma receptor ligands as potential antipsychotic drugs.,J. Med. Chem.,PUBLICATION,
4727690,CHEMBL1386579,VQCJXPKDVQEPEC-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2045516,CHEMBL1518119,JOZHWTKZRYCORB-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,26854.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4781376,CHEMBL1299327,VWHYJSXMYUFBNR-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5700639,CHEMBL581370,ZRTGTHGCFHZHIJ-UHFFFAOYSA-N,TCMDC-136934,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,0.15,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2006864,CHEMBL1476656,JKUAYJSYPMLKMU-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
954783,CHEMBL99287,DYYJCAJRBQEMSD-IBGZPJMESA-N,,,"P08514, P05106",INTEGRIN ALPHA-IIB/BETA-3,"ITGA2B, ITGB3",,,11738566.0,IC50,=,7100.0,NM,,,,,,,,,,,,,,Inhibition of rate of ADP-stimulated gel-filtered human platelet aggregation mediated by integrin alphaIIb beta-3 in PLAGGIN assay,Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4959663,CHEMBL1308726,WPOXCOWNWBQQCW-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5303585,CHEMBL1208976,YAMLXUWLQZQANA-UHFFFAOYSA-N,,,P07858,CATHEPSIN B,CTSB,,,20598883.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human cathepsin B by fluorescence assay,"6-Phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile as cathepsin S inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2967312,CHEMBL219272,NLYHQDXERCUYHP-POFDKVPJSA-N,,,Q00788,VASOPRESSIN V2 RECEPTOR,,,,17300166.0,KI,=,76.0,NM,,,,,,,,,,,,,,Displacement of [3H]AVP from vasopressin V2 receptor in rat kidney membranes,Design and synthesis of the first selective agonists for the rat vasopressin V(1b) receptor: based on modifications of deamino-[Cys1]arginine vasopressin at positions 4 and 8.,J. Med. Chem.,PUBLICATION,
1870915,CHEMBL1391707,IVPNWBGGWKSMFF-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,631.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4538376,CHEMBL581187,UVUCEFFMTRFLDP-UHFFFAOYSA-N,MMV020490,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,8.75,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2529264,CHEMBL404,LPQZKKCYTLCDGQ-WEDXCCLWSA-N,TAZOBACTAM,,P41968,MELANOCORTIN RECEPTOR 3,MC3R,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Melanocortin MC3 radioligand binding (ligand: [125I] NDP-alpha-MSH),DrugMatrix in vitro pharmacology data,,DATASET,
5675250,,ZPDRTCQTMQVUEM-UHFFFAOYSA-N,,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,0.54,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
36719,CHEMBL540930,ACHAGBFZZOHGJZ-UHFFFAOYSA-N,,,Q99705,MELANIN-CONCENTRATING HORMONE RECEPTOR 1,MCHR1,,,19500979.0,IC50,=,6.0,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [125I]MCH from human MCHR1 expressed in HEK293 cells,Optimization of 2-piperidin-4-yl-acetamides as melanin-concentrating hormone receptor 1 (MCH-R1) antagonists: Designing out hERG inhibition.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2338945,CHEMBL2205814,KULMFBVVFDTVNX-UHFFFAOYSA-N,,,P28222,SEROTONIN 1B (5-HT1B) RECEPTOR,HTR1B,,,22959245.0,KI,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT1B receptor,"A s(1) receptor pharmacophore derived from a series of N-substituted 4-azahexacyclo[5.4.1.0(2,6).0(3,10).0(5,9).0(8,11)]dodecan-3-ols (AHDs).",Bioorg. Med. Chem. Lett.,PUBLICATION,
2920595,CHEMBL1767108,NGZJITNNZBCMAC-UHFFFAOYSA-N,,,Q96S37,SOLUTE CARRIER FAMILY 22 MEMBER 12,SLC22A12,,,21449597.0,INHIBITION,=,99.6,%,,,,,,,,,,,,,,Inhibition of human URAT1 expressed in xenopus oocyte assessed as inhibition of [14C]-labelled urate uptake at 50 uM after 60 mins by liquid scintillation counting,Developing Potent Human Uric Acid Transporter 1 (hURAT1) Inhibitors.,J. Med. Chem.,PUBLICATION,
4862146,CHEMBL2140233,WEXZBWKKUZLIBN-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3881632,CHEMBL3359197,RIBWEGLQTVTLTI-LBPRGKRZSA-N,,,P55212,CASPASE-6,CASP6,,,25358116.0,IC50,=,500000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant caspase 6 using Ac-VEID-AMC substrate assessed as accumulation of cleaved fluorogenic product,Synthesis of 7-halogenated isatin sulfonamides: nonradioactive counterparts of caspase-3/-7 inhibitor-based potential radiopharmaceuticals for molecular imaging of apoptosis.,J. Med. Chem.,PUBLICATION,
3480526,CHEMBL397750,PQJGXJKQGVLLQQ-VWLOTQADSA-N,,,P41597,C-C CHEMOKINE RECEPTOR TYPE 2,CCR2,,,18258426.0,IC50,=,14.45,NM,,,,,,,,,,,,,,Antagonist activity at human CCR2b receptor,QSAR studies on CCR2 antagonists with chiral sensitive hologram descriptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2390015,CHEMBL1338961,LANQSYRZYXGMKA-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2514547,CHEMBL605003,LOGJQOUIVKBFGH-YBEGLDIGSA-N,SU-6656,,P51813,TYROSINE-PROTEIN KINASE BMX,BMX,wild_type,,23398362.0,ACTIVITY,=,60.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,45.0,uM,"Millipore: Percentage of residual kinase activity of BMX at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2781425,CHEMBL1974381,MRNRDFOQXNZICL-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2377240,CHEMBL1519976,KYYMYUIAHXUHIT-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2517444,CHEMBL1224524,LOMHDTDKMKKMKY-UHFFFAOYSA-N,,,Q12809,HERG,KCNH2,,,20709552.0,INHIBITION,=,75.0,%,,,,,,,,,,,,,,Displacement of radiolabeled MK-0499 from human ERG at 1 uM,"Substituted biaryl oxazoles, imidazoles, and thiazoles as sodium channel blockers.",Bioorg. Med. Chem. Lett.,PUBLICATION,
619546,CHEMBL1357022,COQVUPJCIBMVIQ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
226598,CHEMBL1730974,AXBQRFCKHZGXSI-UHFFFAOYSA-N,,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2688661,CHEMBL1901032,MHIBDQBBZKDNIR-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
57797,CHEMBL1706549,AEMJFGSKZPGQOV-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,730.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1286901,CHEMBL1350167,GJKULARCJCZGPA-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1984172,CHEMBL97664,JIBPEZNZJOOEKR-UHFFFAOYSA-N,,,P00742,COAGULATION FACTOR X,F10,,,15857135.0,KI,=,4531.0,NM,,,,,,,,,,,,,,Binding affinity towards human Coagulation factor X,"Structural requirements for factor Xa inhibition by 3-oxybenzamides with neutral P1 substituents: combining X-ray crystallography, 3D-QSAR, and tailored scoring functions.",J. Med. Chem.,PUBLICATION,
2254303,CHEMBL1413903,KLMQTENCLYVRHF-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
679491,CHEMBL3190031,CVGPNVWUBSDWKD-RQZCQDPDSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2741765,CHEMBL475620,MMZFKVNBNHUWDT-UHFFFAOYSA-N,UR-PI182,,P25021,HISTAMINE H2 RECEPTOR,HRH2,,,19317445.0,ACTIVITY,=,0.51,,,cell_based,,,,,,,,,,,,Intrinsic activity at human H2 receptor expressed in insect Sf9 cells co-expressing GsalphaS fusion protein assessed as gamma[32P]GTP binding at 10 uM by liquid scintillation counting relative to histamine,N(G)-acylated imidazolylpropylguanidines as potent histamine H4 receptor agonists: selectivity by variation of the N(G)-substituent.,J. Med. Chem.,PUBLICATION,
4571502,CHEMBL230592,UZFISAOOMRYRDS-UHFFFAOYSA-N,GSK-635416A,,Q13177,SERINE/THREONINE-PROTEIN KINASE PAK 2,PAK2,,,,INHIBITION,=,1.46,%,,,,,,,,,,,,,,GSK_PKIS: PAK2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4313214,CHEMBL336313,TXMKWLMXNSUAPQ-UHFFFAOYSA-N,,,P23977,DOPAMINE TRANSPORTER,,,,8960553.0,IC50,=,55.0,NM,,,,,,,,,,,,,,Inhibition of [3H]dopamine uptake at the dopamine transporter in rat striatal tissue,Halogenated mazindol analogs as potential inhibitors of the cocaine binding site at the dopamine transporter.,J. Med. Chem.,PUBLICATION,
5755814,CHEMBL3196066,ZXYJCYBGAOGFFM-OQLLNIDSSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5219817,CHEMBL1466148,XRNNWZJOVKMVCY-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5580491,CHEMBL306208,ZEOHVQFWFVMPGM-UHFFFAOYSA-N,,,P31652,SEROTONIN TRANSPORTER,,,,11078197.0,KI,=,4.0,NM,,,,,,,,,,,,,,Inhibition of 0.2 nM [3H]paroxetine binding to Serotonin transporter,3alpha-(4-Substituted phenyl)nortropane-2beta-carboxylic acid methyl esters show selective binding at the norepinephrine transporter.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4904014,CHEMBL1908391,WJEOLQLKVOPQFV-UHFFFAOYSA-N,MASITINIB,,Q9H3Y6,TYROSINE-PROTEIN KINASE SRMS,SRMS,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for SRMS kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
564961,CHEMBL1323151,CIOAJOQLXNPPEI-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
515314,CHEMBL1447019,CDCOCBUMCDJEIO-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5651617,CHEMBL197603,ZMNWFTYYYCSSTF-SOAUALDESA-N,A-770041,,Q9Y6E0,SERINE/THREONINE-PROTEIN KINASE 24,STK24,wild_type,,21336281.0,KI,<,1584.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
24148,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,Q07820,INDUCED MYELOID LEUKEMIA CELL DIFFERENTIATION PROTEIN MCL-1,MCL1,,,23603658.0,IC50,=,68000.0,NM,,,,,,,,,,,,,,,,,,
5640039,CHEMBL2062215,ZLERIZZWJGASNU-UHFFFAOYSA-N,TCMDC-141071,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,1.49,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4674581,CHEMBL1327117,VKMXQSOHQMSBAR-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
990789,CHEMBL1517209,FCQSGXANJRIIHV-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5861594,CHEMBL3785951,,,,O75116,RHO-ASSOCIATED PROTEIN KINASE 2,ROCK2,,,26951753.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibition of ROCK2 (unknown origin) in presence of [gamma33P]ATP,Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
272000,CHEMBL135192,BCEKUFMALFETIP-UKRRQHHQSA-N,,,"P23944, P43140, P15823",ADRENERGIC RECEPTOR ALPHA-1,,,,9767652.0,IC50,,,,,,,,,,,,,,,,,Inhibition of specific binding of [3H]prazosin to Alpha-1 adrenergic receptor in rat cortical membranes; NA=Not active up to a concentration of 5 uM,N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies.,J. Med. Chem.,PUBLICATION,
1565717,CHEMBL526613,HNOZAQDXKCDBCV-UHFFFAOYSA-N,TCMDC-135429,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,5.1,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2021106,CHEMBL1398247,JMHJUJVEHJETMD-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4646456,CHEMBL478,VHFVKMTVMIZMIK-UHFFFAOYSA-N,CHLOROPHENYLPIPERAZINE,,P28335,SEROTONIN 2C (5-HT2C) RECEPTOR,HTR2C,,,23537943.0,EC50,=,8.1,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at serotonin-activated human recombinant 5HT-2C receptor expressed in HEK293 cells assessed as increase in intracellular calcium level after 5 mins measured for 1 min by fluorescence assay,Novel pyrimidoazepine analogs as serotonin 5-HT2A and 5-HT2C receptor ligands for the treatment of obesity.,Eur. J. Med. Chem.,PUBLICATION,
1743014,CHEMBL1438732,IHIUCLFYIRIBAI-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,25929.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
46508,CHEMBL272026,ADGOSWMTFHSWDE-UHFFFAOYSA-N,GW290597X,,Q9HBH9,MAP KINASE SIGNAL-INTEGRATING KINASE 2,MKNK2,,,,INHIBITION,=,3.98,%,,,,,,,,,,,,,,GSK_PKIS: MNK2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3383462,CHEMBL92569,PFZBZEAIVHQPHF-UHFFFAOYSA-N,,,P08172,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,CHRM2,,,11133078.0,KI,=,5.07,NM,,cell_based,,,,,CHO,,,,,,,Binding affinity at human cloned acetylcholine receptor M2 in CHO cells.,Benzylidene ketal derivatives as M2 muscarinic receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5182469,CHEMBL1990223,XNKYXYWPDUHBSC-UHFFFAOYSA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,,,,KI,>,2511.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: IGF1R,PUBCHEM BIOASSAY DATA SET,,DATASET,
3749748,CHEMBL3319641,QTZIMOLBWBGHEB-UHFFFAOYSA-N,,,P42338,PI3-KINASE P110-BETA SUBUNIT,PIK3CB,,,24992874.0,IC50,=,17.0,NM,,cell_based,,,,,,,,,,,,Inhibition of PI3Kbeta in human MAD-MB-468 cells assessed as inhibition of Ser473 Akt phosphorylation by cellular potency assay,"Discovery of 9-(1-anilinoethyl)-2-morpholino-4-oxo-pyrido[1,2-a]pyrimidine-7-carboxamides as PI3Kß/d inhibitors for the treatment of PTEN-deficient tumours.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5438599,CHEMBL1389247,YOXUSOWSCCYRSN-NTEUORMPSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,1258.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4229002,CHEMBL2326345,SUJSKPRKWODNFZ-UHFFFAOYSA-N,,,P00766,ALPHA-CHYMOTRYPSIN,,,,23451707.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of bovine alpha-chymotrypsin assessed as residual protease activity at 500 uM after 10 mins by spectrophotometry,Discovery of Allosteric Modulators of Factor XIa by Targeting Hydrophobic Domains Adjacent to Its Heparin-Binding Site.,J. Med. Chem.,PUBLICATION,
3758587,CHEMBL1564782,QVCRZZHRIYFRIS-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2017719,CHEMBL3325550,JLXFCNWPMMNUMM-YOEHRIQHSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,25176194.0,INHIBITION,=,25.0,%,,,,,,,,,,,,,,Inhibition of CYP3A4 (unknown origin) using midazolam substrate at 10 uM,The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Na(v)1.7.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3917963,CHEMBL2262482,RLULKMKEGYFYFB-UHFFFAOYSA-N,,,P31389,HISTAMINE H1 RECEPTOR,,,,,INHIBITION,=,57.3,%,,,,,,,,,,,,,,Inhibition of H1 receptor in Cavia porcellus Hartley (guinea pig) ileum assessed as inhibition of histamine-induced spasms incubated at 10 '-5 M 2 min prior histamine-challenge,,Med Chem Res,PUBLICATION,
2676173,CHEMBL1447929,MFUXLQTVWABVBF-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4480645,CHEMBL1020,UPSPUYADGBWSHF-UHFFFAOYSA-N,TOLMETIN,,P18825,ALPHA-2C ADRENERGIC RECEPTOR,ADRA2C,,,,KI,,,,,,,,,,Sf9,,,,,,,DRUGMATRIX: Adrenergic Alpha-2C radioligand binding (ligand: [3H] MK-912),DrugMatrix in vitro pharmacology data,,DATASET,
4383550,CHEMBL589419,UFDWCHMFGTWGGU-UHFFFAOYSA-N,,,O42275,ACETYLCHOLINESTERASE,,,,20158205.0,IC50,=,10.72,NM,,,,,,,,,,,,,,Inhibition of electric eel AChE by Ellman's method,Hybrid molecules from xanomeline and tacrine: enhanced tacrine actions on cholinesterases and muscarinic M1 receptors.,J. Med. Chem.,PUBLICATION,
4256933,CHEMBL1539808,SXPOYFMLXFUVSN-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3678434,CHEMBL1999630,QMMIFWYVGNVUCF-YYADALCUSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1687148,CHEMBL1567799,IBAJPBSHLMSDGL-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4329286,CHEMBL3210352,TZIINHOWTVNJHE-JMIUGGIZSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4356861,CHEMBL1726275,UCBHOMJDYHTNAN-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2233650,CHEMBL1420205,KJOLGVIFRDVCIG-RRAHZORUSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1092801,CHEMBL1596531,FOBPIYMSXDFDAQ-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2016457,CHEMBL1379008,JLTIGXCDZJXQTH-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1765217,CHEMBL1596823,IJWMNGVIDBEGCE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4425770,CHEMBL1583308,UJMRSCBULSTLMM-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1845543,CHEMBL1945264,ISTSLSXDZDEWGJ-UHFFFAOYSA-N,,,Q96EB6,NAD-DEPENDENT DEACETYLASE SIRTUIN 1,SIRT1,,,22304848.0,FC,=,1.2,,,cell_based,,,,,,,,,,,,Inhibition of SirT1 in human ARN8 cells assessed as p53 activation at 10 uM by beta-galactosidase reporter gene assay relative to control,Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins.,Bioorg. Med. Chem.,PUBLICATION,
237682,CHEMBL1531439,AYGOPVWFLVEGFG-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4252774,CHEMBL403431,SXCMSCHMAVFUOD-YGPDHOBYSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,18294847.0,KI,=,190.0,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [125]NDPMSH from human MC4 receptor expressed in HEK293 cells,Design and synthesis of 3-arylpyrrolidine-2-carboxamide derivatives as melanocortin-4 receptor ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5850607,CHEMBL307261,,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,26741854.0,Papp,=,27.97,10'-6 CM/S,,,,,,,,,,,,,,Activity at MDR1 (unknown origin) expressed in MDCK cells assessed as permeability across apical to basolateral after 90 mins by LC-MS/MS analysis,Combating P-glycoprotein-mediated multidrug resistance with 10-O-phenyl dihydroartemisinin ethers in MCF-7 cells.,Eur. J. Med. Chem.,PUBLICATION,
822129,CHEMBL2000335,DKSNLQYRZJKYOC-UHFFFAOYSA-N,,,P11309,SERINE/THREONINE-PROTEIN KINASE PIM1,PIM1,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM1,PUBCHEM BIOASSAY DATA SET,,DATASET,
1495160,CHEMBL1450479,HGKNJHZXDJWTAY-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,1584.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4829089,CHEMBL2207207,WBNQNCMIKFGMCR-UHFFFAOYSA-N,,,Q9UHD2,SERINE/THREONINE-PROTEIN KINASE TBK1,TBK1,,,23099093.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Inhibition of TBK1 by radiometry,Synthesis and structure-activity relationships of a novel series of pyrimidines as potent inhibitors of TBK1/IKKe kinases.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3149721,CHEMBL553028,OGDYFTNOLZTFCD-XDKWHASVSA-N,,,P22756,GLUTAMATE RECEPTOR IONOTROPIC KAINATE 1,,,,19588945.0,EC50,=,794.33,NM,,cell_based,,,,,HEK293,,,,,,,Agonist activity at rat recombinant GluR5(Q) RNA-edited isoform expressed in HEK293 cells assessed as increase in intracellular calcium level by Fluo-4/AM assay,"The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.",J. Med. Chem.,PUBLICATION,
1915783,CHEMBL2048773,JAMOJAWCNGJKHW-WYMJOSIYSA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,22439881.0,ACTIVITY,,,,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human kappa opioid receptor expressed in CHO cells assessed as inhibition of U50488-induced [33S]GTPgammaS binding after 60 mins by scintillation counting,"Synthesis, binding affinity, and functional in vitro activity of 3-benzylaminomorphinan and 3-benzylaminomorphine ligands at opioid receptors.",J. Med. Chem.,PUBLICATION,
108370,CHEMBL3189762,AKFFIZBZJYPMQQ-NTEUORMPSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,37685.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2212561,CHEMBL3605416,KHAQNNMTWYYNDF-OAQYLSRUSA-N,,,P02768,SERUM ALBUMIN,ALB,,,26287310.0,PB,=,91.0,%,,,,,,,,,,,,,,Binding affinity to human serum albumin,Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.,J. Med. Chem.,PUBLICATION,
4912077,CHEMBL1584408,WKAZEFFSTWKBSF-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2746647,CHEMBL1356659,MNMOQMBKFNOIDH-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,631.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
48894,CHEMBL1604269,ADMVBZDDROIZEM-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1010811,CHEMBL1701990,FEXSLYNDJSERQP-UHFFFAOYSA-N,,,Q14191,WERNER SYNDROME ATP-DEPENDENT HELICASE,WRN,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4200127,CHEMBL1715778,SREMEMVZOAKQTR-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3743586,CHEMBL1301089,QTIIUQCSZDWTJC-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1984929,CHEMBL1450185,JIEFLMYTOPJVES-UHFFFAOYSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3516118,CHEMBL355905,PUHRPYOPXGWCTE-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,14584934.0,IC50,=,24200.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human Cytochrome P450 2C9,"Identification of a potent and selective 5-HT(6) antagonist: one-step synthesis of (E)-3-(benzenesulfonyl)-2- (methylsulfanyl)pyrido[1,2-a]pyrimidin-4-ylidenamine from 2-(benzenesulfonyl)-3,3-bis(methylsulfanyl)acrylonitrile.",J. Med. Chem.,PUBLICATION,
3844603,CHEMBL1491512,REECKKLIOHBMCU-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1884749,CHEMBL1812091,IXDMGXAOUDSJSQ-ZDUSSCGKSA-N,,,P33905,TRANSCRIPTIONAL ACTIVATOR PROTEIN TRAR,,,,21798746.0,ACTIVITY,=,0.0,%,,,,,,,,,,,,,,Agonist activity at Agrobacterium tumefaciens WCF (pCF372) TraR at 10 uM after 8 hrs by beta-galactosidase reporter gene assay relative to OdDHL,Thiolactone modulators of quorum sensing revealed through library design and screening.,Bioorg. Med. Chem.,PUBLICATION,
1583832,CHEMBL468590,HPRRSGUVFUNSCJ-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1416563,CHEMBL1320175,GYEIPKBACHQJHT-UHFFFAOYSA-N,,,Q9HBX9,RELAXIN RECEPTOR 1,RXFP1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4725308,CHEMBL405759,VPVLEBIVXZSOMQ-UHFFFAOYSA-N,TWS-119,,P42681,TYROSINE-PROTEIN KINASE TXK,TXK,wild_type,,23398362.0,ACTIVITY,=,3.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of TXK at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
5680072,CHEMBL1488501,ZPOBFBGXGLHTPU-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4857645,CHEMBL1372303,WEKYVNZJKJRZGI-UHFFFAOYSA-N,,,P11308,TRANSCRIPTIONAL REGULATOR ERG,ERG,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2456853,CHEMBL1333946,LIFSWYYOPMJCHE-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4192793,CHEMBL504433,SQMXIYKGSSMYER-UHFFFAOYSA-N,,,P14925,PEPTIDYL-GLYCINE ALPHA-AMIDATING MONOOXYGENASE,,,,18952446.0,KIS,=,2600.0,NM,,,,,,,,,,,,,,Inhibition of rat recombinant peptidylglycine alpha-amidating monooxygenase assessed as inhibition of N-dansyl-Tyr-Val-Gly amidation,Substituted hippurates and hippurate analogs as substrates and inhibitors of peptidylglycine alpha-hydroxylating monooxygenase (PHM).,Bioorg. Med. Chem.,PUBLICATION,
5197868,CHEMBL1603724,XPHPDCDWKNWBIS-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4985524,CHEMBL542512,WSLHBIAPEPTROH-UHFFFAOYSA-N,,,Q8VH26,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,,,,10602706.0,PKB,=,5.63,,,tissue,,,,,,,,,,,,Antagonistic activity against Muscarinic acetylcholine receptor M3 from Guinea pig ileum longitudinal muscle,"Design, synthesis, and biological evaluation of symmetrically and unsymmetrically substituted methoctramine-related polyamines as muscular nicotinic receptor noncompetitive antagonists.",J. Med. Chem.,PUBLICATION,
2131830,CHEMBL1576243,JYFMRYBMIWHKPO-NRFANRHFSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4943626,CHEMBL262623,WNTAZUFBXXQBAO-UHFFFAOYSA-N,,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,wild_type,,21336281.0,KI,<,19952.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
1443054,CHEMBL247368,HBDDEVHKKBWEQT-FKBYEOEOSA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,17350835.0,KI,=,12.0,NM,,,,,,,,,,,,,,Displacement of [3H]diprenorphine from human cloned mu opioid receptor,Further studies of tyrosine surrogates in opioid receptor peptide ligands.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2242271,CHEMBL1794066,KKMDOYLDYOJWIA-UHFFFAOYSA-N,GSK-619487A,,Q9P286,SERINE/THREONINE-PROTEIN KINASE PAK7,PAK7,,,,INHIBITION,=,80.08,%,,,,,,,,,,,,,,GSK_PKIS: PAK5 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2751848,CHEMBL3211932,MODFXPWHEAJGBB-CSKARUKUSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5777348,CHEMBL1581034,,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
739809,CHEMBL1547495,DBRPQQMAOMTRMK-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
243549,CHEMBL1579886,AYYZBKVHEDPSCQ-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
628754,CHEMBL1321,CPTBDICYNRMXFX-UHFFFAOYSA-N,PROCARBAZINE,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,,IC50,,,,,,,,,,HEK293,,,,,,,"DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)",DrugMatrix in vitro pharmacology data,,DATASET,
86850,CHEMBL3401894,AHQJFHONHNOTEL-UHFFFAOYSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,25819333.0,IC50,=,3700.0,NM,,,,,,,,,,,,,,Inhibition of recombinant TDP1 (unknown origin) assessed as increase in fluorescence,Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety.,Bioorg. Med. Chem.,PUBLICATION,
2141716,CHEMBL1688923,JZJXBBRJALGDAW-QHCPKHFHSA-N,,,P52732,KINESIN-LIKE PROTEIN 1,KIF11,,,21344920.0,KI,<,50.0,NM,,,,,,,,,,,,,,Inhibition of C-terminal His6-tagged human Eg5 basal ATPase activity,Structure-activity relationship and multidrug resistance study of new S-trityl-L-cysteine derivatives as inhibitors of Eg5.,J. Med. Chem.,PUBLICATION,
4211751,CHEMBL1083401,SSLQXNFBHFVQQV-UHFFFAOYSA-N,,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,20483599.0,INTRINSIC ACTIVITY,=,51.0,%,,cell_based,,,,,CHO,,,,,,,Intrinsic activity at human muscarinic M1 receptor expressed in CHO cells assessed as effect on acetylcholine-induced intracellular calcium level by FLIPR assay relative to acetylcholine,2' biaryl amides as novel and subtype selective M1 agonists. Part II: Further optimization and profiling.,Bioorg. Med. Chem. Lett.,PUBLICATION,
492136,CHEMBL1425350,CAMDZOMVTGRKAN-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,1412.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4775346,CHEMBL1992536,VVQQRUZZQQSDEI-UHFFFAOYSA-N,,,Q13464,RHO-ASSOCIATED PROTEIN KINASE 1,ROCK1,,,,KI,=,501.19,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ROCK1,PUBCHEM BIOASSAY DATA SET,,DATASET,
4684943,CHEMBL1477602,VLSINZIVCYNFRO-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5687335,CHEMBL3208300,ZQHWIPXRYHYYEJ-OGLMXYFKSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
1131383,CHEMBL1311451,FSIBSJDCMPEBNN-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,44.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3744633,CHEMBL1391547,QTKRLZDSHXZXNP-IIYDPXPESA-N,,,Q4GZG4,PHOSPHOGLYCERATE KINASE,,,,,POTENCY,,16343.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for inhibitors of Phosphogylcerate Kinase: Hit Validation Screen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1961031,CHEMBL118611,JFMMOXZUHXDFEQ-UHFFFAOYSA-N,,,P00492,HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE,HPRT1,,,6991691.0,ACTIVITY,,,,,,,,,,,,,,,,,Ability to inhibit hypoxanthine-guanine phosphoribosyltransferase in crude extracts of H.Ep.-2 cells.,Synthesis of potential inhibitors of hypoxanthine-guanine phosphoribosyltransferase for testing as antiprotozoal agents. 1. 7-Substituted 6-oxopurines.,J. Med. Chem.,PUBLICATION,
745588,CHEMBL1082596,DCJWZIGHKBTFDW-OXHPVDPFSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,20557054.0,FC,=,1.21,,,,,,,,,,,,,,,Binding affinity to recombinant beta-glucocerebrosidase assessed as enzymatic activity at 0.5 uM after 40 mins by thermal stabilization assay relative to control,Click chemistry approach to new N-substituted aminocyclitols as potential pharmacological chaperones for Gaucher disease.,J. Med. Chem.,PUBLICATION,
2345082,CHEMBL164964,KVFFKWIKILEIPC-UHFFFAOYSA-N,,,P35346,SOMATOSTATIN RECEPTOR 5,SSTR5,,,11266182.0,KI,=,430.0,NM,,,,,,,,,,,,,,Inhibitory constant on human somatostatin receptor 5,Synthesis of substituted imidazopyrazines as ligands for the human somatostatin receptor subtype 5.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3950298,CHEMBL1605077,RPLZBWWAWOUPBL-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
68907,CHEMBL1550670,AFPQJEYVQPKFNF-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4407248,CHEMBL24828,UHTHHESEBZOYNR-UHFFFAOYSA-N,VANDETANIB,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,,KI,=,6.31,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,PUBCHEM BIOASSAY DATA SET,,DATASET,
2160629,CHEMBL1477485,KBJUIEIYGDHCEY-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5558078,CHEMBL164660,ZCCUUQDIBDJBTK-UHFFFAOYSA-N,PSORALEN,,P56817,BETA-SECRETASE 1,BACE1,,,22222157.0,INHIBITION,=,19.3,%,,,,,,,,,,,,,,Inhibition of recombinant human BACE1 using Rh-EVNLDAEFK as substrate at 500 uM after 60 mins by fluorescence quenching assay,Structure-activity relationships for naturally occurring coumarins as ß-secretase inhibitor.,Bioorg. Med. Chem.,PUBLICATION,
32060,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P00915,CARBONIC ANHYDRASE I,CA1,,,28043719.0,KI,=,0.4053,NM,,,,,,,,,,,,,,,,,,
1464706,CHEMBL1613013,HDGDSXNJKJMZOA-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
2379074,CHEMBL583066,KZEWGAHUIUQCHU-MYHRABSESA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,19788201.0,EFFICACY,=,93.0,%,,cell_based,,,,,CHO,,,,,,,Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTPgammaS binding at 10 uM after 1 hr by liquid scintillation counting relative to U69593,Pentapeptides displaying mu opioid receptor agonist and delta opioid receptor partial agonist/antagonist properties.,J. Med. Chem.,PUBLICATION,
4658086,CHEMBL1516445,VIOLUUILROGECM-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4247865,CHEMBL1361855,SWMNSABUWYKPAU-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3724566,CHEMBL1300803,QRGKWXHZWFMTHW-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
517184,CHEMBL1365108,CDJFAUMDUMUUDI-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3187341,CHEMBL1514417,OKGACCULAUEFPX-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1334227,CHEMBL1725604,GOTAIPBZIBLSEC-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5850380,CHEMBL3828041,,,,P08253,MATRIX METALLOPROTEINASE-2,MMP2,,,27452283.0,IC50,=,209.89,NM,,,,,,,,,,,,,,Inhibition of human recombinant MMP2 by colorimetric analysis,Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.,Bioorg. Med. Chem.,PUBLICATION,
3786221,CHEMBL1328133,QYFDWTZVAPUJBO-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5761562,CHEMBL1573031,ZYPOYBGIGVWBFK-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2145739,CHEMBL3109832,JZSYNTDQZVHCDU-UHFFFAOYSA-N,,,Q9EQU3,TOLL-LIKE RECEPTOR 9,,,,24228757.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of TLR9 in BALB/c mouse BMDM assessed as downregulation of CpG-stimulated IL-12p40 level at 5 ug/ml preincubated for 18 hrs followed by CpG challenge measured after 24 hrs by ELISA relative to control,Designing anti-inflammatory drugs from parasitic worms: a synthetic small molecule analogue of the Acanthocheilonema viteae product ES-62 prevents development of collagen-induced arthritis.,J. Med. Chem.,PUBLICATION,
3188431,CHEMBL1223837,OKJJBTUOKCQSPH-PWRODBHTSA-N,,,P07998,RIBONUCLEASE PANCREATIC,RNASE1,,,20692173.0,KB,=,6.76,10'4/M,,,,,,,,,,,,,,Inhibition of RNase A by spectrophotometry,Synthesis and ribonuclease A inhibition activity of resorcinol and phloroglucinol derivatives of catechin and epicatechin: Importance of hydroxyl groups.,Bioorg. Med. Chem.,PUBLICATION,
4710207,CHEMBL3182447,VOGIWUFDXLFNKS-KNKQGSTJSA-N,,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4296208,CHEMBL1091260,TVPBFWGWHNPLGD-KRWDZBQOSA-N,,,Q16539,MAP KINASE P38 ALPHA,MAPK14,,,20346659.0,IC50,=,45.0,NM,,,,,,,,,,,,,,Inhibition of human p38alpha assessed as gamma-[32P]ATP incorporation after 60 mins by scintillation counting,"Amide-based inhibitors of p38alpha MAP kinase. Part 2: design, synthesis and SAR of potent N-pyrimidyl amides.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1751919,CHEMBL1364621,IIHDTJRXBMXFDL-UHFFFAOYSA-N,,,Q9GZU7,CARBOXY-TERMINAL DOMAIN RNA POLYMERASE II POLYPEPTIDE A SMALL PHOSPHATASE 1,CTDSP1,,,,IC50,=,44537.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493091, AID493120]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2441852,CHEMBL1909408,LGOFDYJCRIMGHI-ZHEQYFEDSA-N,GSK-200398A,,Q9P0L2,SERINE/THREONINE-PROTEIN KINASE MARK1,MARK1,,,,INHIBITION,=,0.33,%,,,,,,,,,,,,,,GSK_PKIS: MARK1 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5515907,CHEMBL1507467,YXWIINFMPNXYSU-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,=,28183.83,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1785971,CHEMBL1988153,IMHKMKWSWHFKTM-UHFFFAOYSA-N,,,Q9NR20,DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 4,DYRK4,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: DYRK4,PUBCHEM BIOASSAY DATA SET,,DATASET,
3294657,CHEMBL405618,OVVIBUHLQIYUEU-IWIISZHXSA-N,ANALOG OF DYNORPHIN A,,P34975,KAPPA OPIOID RECEPTOR,,,,10753461.0,KI,=,3.4,NM,,cell_based,,,,,,,,,,,,"Binding constant against D216N,D217N,E218Q EL-2 Opioid receptor kappa 1 using [3H]diprenorphine as radioligand expressed in HEK cells",Isosteric replacement of acidic with neutral residues in extracellular loop-2 of the kappa-opioid receptor does not affect dynorphin A(1-13) affinity and function.,J. Med. Chem.,PUBLICATION,
2161651,CHEMBL1574021,KBNGFJXOWGLOQH-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3767644,CHEMBL1301754,QWBPNZKTEGVGJK-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,84921.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5223713,CHEMBL1612381,XRYPMVLEDGPSQH-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3803738,CHEMBL3196832,QZWAXTKQEOEKLZ-WOJGMQOQSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
240648,CHEMBL3193678,AYQGIUZZVJRRQN-BUVRLJJBSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1256285,CHEMBL1303216,GGGCXCRVXOZWCJ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1065981,CHEMBL2131333,FLDACYHRSIBDFA-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1814830,CHEMBL3099500,IPFFEMHJNMAEKB-YQOHNZFASA-N,,,P22303,ACETYLCHOLINESTERASE,ACHE,,,,KI,=,1.48,NM,,,,,,,,,,,,,,Inhibition of human acetylcholine esterase,,ACS Med. Chem. Lett.,PUBLICATION,
326573,CHEMBL1486854,BIAPDPDGWQHFTO-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3310141,CHEMBL1306586,OXPWPEKTXJVXIX-UHFFFAOYSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
4621586,CHEMBL1575608,VEPVZEPUAQGDGI-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1204923,CHEMBL1385800,GAQRALDWRVQHTN-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
715235,CHEMBL1469737,CZDHUFYOXKHLME-DFWYDOINSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
4478749,CHEMBL1337182,UPNRZEIUEBUTFM-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,2393.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
351000,CHEMBL1470588,BKSWQGPNTNYZEH-VAWYXSNFSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,1584.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1531486,CHEMBL3189582,HKFJXVWFHGANRS-MDWZMJQESA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,446.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3182941,CHEMBL1414645,OJUVDWYGAYBTIO-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3004323,CHEMBL3196459,NPYSSQZXRXNSQT-UITAMQMPSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5435277,CHEMBL1476419,YOOSYBMZEBWGMZ-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,656.1,NM,,,,,,,,,,,,,,PubChem BioAssay. Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in WT MEF Cells: Hit Validation. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1167853,CHEMBL1077444,FWIAKJCGLTYNRM-QWRGUYRKSA-N,,,P14756,PSEUDOLYSIN,,,,19773163.0,KI,=,37000.0,NM,,,,,,,,,,,,,,Inhibition of Pseudomonas aeruginosa LasB by fluorimetric assay in buffer of pH 7.2,Inhibitor profiling of the Pseudomonas aeruginosa virulence factor LasB using N-alpha mercaptoamide template-based inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2880927,CHEMBL1588335,NCPGCIWQFAKYKF-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,23109.3,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2629579,CHEMBL482910,MAUOZAHVKXMLMV-UHFFFAOYSA-N,CER-0262839,,Q9UQM7,CAM KINASE II ALPHA,CAMK2A,,,18479119.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Inhibition of CaMK2alpha at 10 uM by HTRF assay relative to control,Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.,J. Med. Chem.,PUBLICATION,
4547047,CHEMBL147845,UWSDSQVGPVPJRF-UHFFFAOYSA-N,,,P19793,RETINOID X RECEPTOR ALPHA,RXRA,,,10585206.0,TRANSCRIPTIONAL ACTIVATION,,,,,,,,,,,,,,,,,Transcriptional activation of Retinoid X receptor RXR alpha; NA is Not Active,Structure-activity relationship studies of novel heteroretinoids: induction of apoptosis in the HL-60 cell line by a novel isoxazole-containing heteroretinoid.,J. Med. Chem.,PUBLICATION,
3922544,CHEMBL2135606,RMIAKFOIJKCOJD-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1987276,CHEMBL222704,JILRUXVVISWBOM-DYZJZLFBSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,15588100.0,EC50,=,10.3,NM,,cell_based,,,,,CHO,,,,,,,Activity at human recombinant delta opioid receptor expressed in CHO cells by [35S]GTP-gamma-S binding assay,"Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.",J. Med. Chem.,PUBLICATION,
709189,CHEMBL2207948,CYMAADFHFNZTMW-GXDHUFHOSA-N,,,P00690,PANCREATIC ALPHA-AMYLASE,,,,23102653.0,IC50,=,22960.0,NM,,,,,,,,,,,,,,Inhibition of porcine pancreatic alpha amylase using starch as substrate by Bernfeld method,"Synthesis and glycosidase inhibitory activity of novel (2-phenyl-4H-benzopyrimedo[2,1-b]-thiazol-4-yliden)acetonitrile derivatives.",Bioorg. Med. Chem. Lett.,PUBLICATION,
147912,CHEMBL1534798,AOQDRODZYPYLLO-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
2490986,CHEMBL1651629,LLUQYJRYJAPGMA-QKPAOTATSA-N,,,Q9HCG7,BETA-GLUCOSIDASE,GBA2,,,,IC50,=,40.0,NM,,,,,,,,,,,,,,Inhibition of recombinant GBA2 preincubated with compound for 30 mins using 4-methylumbelliferyl-B-glucoside substrate by fluorimetric assay,,ACS Med. Chem. Lett.,PUBLICATION,
5804517,CHEMBL3818599,,,,Q04609,GLUTAMATE CARBOXYPEPTIDASE II,FOLH1,,,27074627.0,IC50,=,97.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant GCP2 expressed in Schneider 2 cells preincubated for 15 mins using [3H]-NAAG/NAAG as substrate measured after 20 mins by liquid scintillation counting,Unprecedented Binding Mode of Hydroxamate-Based Inhibitors of Glutamate Carboxypeptidase II: Structural Characterization and Biological Activity.,J. Med. Chem.,PUBLICATION,
1325362,CHEMBL1510764,GNRNJFUGLZNHPF-JLHYYAGUSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Nrf2 Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1013362,CHEMBL1470954,FFEYGVPRULMULX-QHHAFSJGSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3098307,CHEMBL1310231,OATDPCNSANACJZ-UHFFFAOYSA-N,,,Q38C91,"METHIONYL-TRNA SYNTHETASE, PUTATIVE",,,,,IC50,,14411.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Luminescence-based biochemical high throughput dose response assay for inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4376067,CHEMBL3651395,UEJFQMOMDBQXQK-KBKYJPHKSA-N,,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,,IC50,=,3.0,NM,,,,,,,,,,,,,,BindingDB_Patents: Kinase Assay. The kinase assay is based on the LanthaScreen technology. LanthaScreen is the detection of Time-Resolved Fluorescence Resonance Energy Transfer (TR-FRET) using lanthanide chelates to measure interactions between various binding partners.,Heterocyclic oxime compounds,,PATENT,
5684963,CHEMBL405042,ZQAZHQLWCKQXTD-GDNBJRDFSA-N,GW335962X,,Q8NE63,HOMEODOMAIN-INTERACTING PROTEIN KINASE 4,HIPK4,,,,INHIBITION,=,2.56,%,,,,,,,,,,,,,,GSK_PKIS: HIPK4 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4703,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,ERLOTINIB,,P07333,MACROPHAGE COLONY STIMULATING FACTOR  RECEPTOR,CSF1R,wild_type,,21336281.0,KI,<,2511.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
480115,CHEMBL1307910,BZFYMVNNVFSVCX-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2112223,CHEMBL1548907,JWEMAIXAXWGFFA-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1101326,CHEMBL1723547,FOZTVZJJHHNHRK-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2510881,CHEMBL1609552,LNWUZNFUKXOTNK-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,1778.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1568353,CHEMBL1422976,HNZGQEGSNWJQGB-UHFFFAOYSA-N,,,P16050,ARACHIDONATE 15-LIPOXYGENASE,ALOX15,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5569323,CHEMBL1714401,ZDKCFRVWYIVUNG-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3536433,CHEMBL1313647,PWMLTDZXAYBHCF-PFONDFGASA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1280364,CHEMBL3260795,GIQNFCNDIZCJAU-UHFFFAOYSA-N,,,P41595,SEROTONIN 2B (5-HT2B) RECEPTOR,HTR2B,,,24704027.0,KI,>,30000.0,NM,,,,,,,,,,,,,,Binding affinity to 5-HT2B receptor (unknown origin),Lactam and oxazolidinone derived potent 5-hydroxytryptamine 6 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5603993,CHEMBL1454068,ZHCSJVBGPYDOEC-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1083654,CHEMBL1490169,FNESYDFRCQEEKA-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5081084,CHEMBL463860,XCSLRYGWAPFQHW-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,19010671.0,EFFICACY,=,95.0,%,,cell_based,,,,,,,,,,,,Agonist activity at human CB2 receptor expressed in yeast cells assessed as degradation of FDGlu to fluorescein after 24 hrs relative to HU210,Pyridine-3-carboxamides as novel CB(2) agonists for analgesia.,Bioorg. Med. Chem. Lett.,PUBLICATION,
409423,CHEMBL116864,BRCOHFWXLLNYRS-PBBVDAKRSA-N,,,P25929,NEUROPEPTIDE Y RECEPTOR TYPE 1,NPY1R,,,11814791.0,IC50,=,176.0,NM,,cell_based,,,,,SK-N-MC,,,,,,,Inhibition of I-PYY binding to Nueopeptide Y1 receptor expressed in human neuroblastoma SK-N-MC cells,Novel dihydropyrazine analogues as NPY antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1831562,CHEMBL1417340,IRDCYHWGZWHFDM-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2903016,CHEMBL1018,NFDFQCUYFHCNBW-SCGPFSFSSA-N,DIENESTROL,,Q16665,HYPOXIA-INDUCIBLE FACTOR 1 ALPHA,HIF1A,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway. (Class of assay: confirmatory) [Related pubchem assays: 915 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4376123,CHEMBL558551,UEJJHQNACJXSKW-SECBINFHSA-N,(R)-THALIDOMIDE,,P37288,VASOPRESSIN V1A RECEPTOR,AVPR1A,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),DrugMatrix in vitro pharmacology data,,DATASET,
3612171,CHEMBL1729483,QFFVPUMEHLKREQ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2678061,CHEMBL1526367,MFZQWORLZAHWRL-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,4775.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4607445,CHEMBL117589,VCZPXCAFIGMLIM-UHFFFAOYSA-N,,,P16257,PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR,,,,8784441.0,KI,=,1.8,NM,,,,,,,,,,,,,,Binding affinity against peripheral-type benzodiazepine receptor (PBR) from rat cortex homogenate using [3H]-PK 11195 as radioligand,"Synthesis, biological activity, and SARs of pyrrolobenzoxazepine derivatives, a new class of specific ""peripheral-type"" benzodiazepine receptor ligands.",J. Med. Chem.,PUBLICATION,
3478641,CHEMBL1316401,PQCZLFZLWVVYDJ-JZRQUBEPSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2777071,CHEMBL597,MRBDMNSDAVCSSF-UHFFFAOYSA-N,PHENTOLAMINE,,Q01959,DOPAMINE TRANSPORTER,SLC6A3,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55),DrugMatrix in vitro pharmacology data,,DATASET,
570146,CHEMBL1597476,CJDGUAJAZWPYEA-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1005351,CHEMBL1320314,FEISWSCUSGUOQO-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3058921,CHEMBL1730812,NWELMRUSUDLLMJ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1151082,CHEMBL1669208,FUJPPJWHQDRORA-HSRBSRBISA-N,,,P08246,LEUKOCYTE ELASTASE,ELANE,,,21216608.0,RATIO,=,5900.0,/M/S,,,,,,,,,,,,,,Inhibition of human neutrophil elastase after 15 mins,Phosphonic pseudopeptides as human neutrophil elastase inhibitors--a combinatorial approach.,Bioorg. Med. Chem.,PUBLICATION,
952137,CHEMBL3323105,DYQBWKPHLQJDJC-UHFFFAOYSA-N,,,Q01959,DOPAMINE TRANSPORTER,SLC6A3,,,,Ki,=,300.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. In order to evaluate the relative affinity of the various compounds at the NE, DA and 5HT transporters, HEK293E cell lines were developed to express each of the three human transporters. cDNAs containing the complete coding regions of each transporter were amplified by PCR from human brain libraries. The cDNAs contained in pCRII vectors were sequenced to verify their identity and then subcloned into an Epstein-Barr virus based expression plasmid (Shen et al., Gene 156:235-239 (1995), which is hereby incorporated by reference in its entirety). This plasmid containing the coding sequence for one of the human transporters was transfected into HEK93E cells. Successful transfection was verified by the ability of known reuptake blockers to inhibit the uptake of tritiated NE, DA or 5HT.For binding, cells were homogenized, centrifuged, and then resuspended in incubation buffer (5 mM Tris, 120 mM NaCl, 5 mM KCl, pH 7.4). Then, the appropriate radioligand was added.","Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin",,PATENT,
5013924,CHEMBL306498,WVMANZPBOBRWCB-UHFFFAOYSA-N,ALOISINE,,Q9P0L2,SERINE/THREONINE-PROTEIN KINASE MARK1,MARK1,wild_type,,23398362.0,ACTIVITY,=,76.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of MARK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
2976951,CHEMBL1584524,NMWUAZBKUCUGGK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2946105,CHEMBL1452671,NJPHIHDNVLWHKY-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,562.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3918928,CHEMBL1383774,RLXVZUCZLUPPLJ-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,14581.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of TGF-b: Confirmation of Cherry Picks.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4240978,CHEMBL72712,SVRPBUFBZVAMNK-UHFFFAOYSA-N,,,P47747,HISTAMINE H2 RECEPTOR,,,,1613748.0,RELATIVE POTENCY,=,245.0,%,,,,,,,,,,,,,,Inhibition of the positive chronotropic response (histamine H2 receptor antagonism) of guinea pig right atrium relative to cimetidine.,Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.,J. Med. Chem.,PUBLICATION,
4084785,CHEMBL1588737,SENQRZNAZUBHRQ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5663752,CHEMBL573108,ZNSULAZTNWFKEW-UHFFFAOYSA-N,BX-320,,O15530,3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1,PDPK1,,,22119465.0,IC50,=,39.0,NM,,,,,,,,,,,,,,Inhibition of PDK1 using [gamma33P]-ATP as substrate after 30 mins by scintillation counting,Structure-based design of PDK1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1773628,CHEMBL1361999,IKWCHHWCTUGXIN-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3888090,CHEMBL3234273,RISZJEPZUYFOAI-UHFFFAOYSA-N,,,P51449,NUCLEAR RECEPTOR ROR-GAMMA,RORC,,,24704616.0,IMAX,<,20.0,%,,cell_based,,,,,,,,,,,,Antagonist activity at Gal4-fused RORgamma (unknown origin) expressed in 293T cells at 10 uM after 24 hrs by luciferase reporter gene assay relative to control,"Discovery of 2-oxo-1,2-dihydrobenzo[cd]indole-6-sulfonamide derivatives as new ROR¿ inhibitors using virtual screening, synthesis and biological evaluation.",Eur. J. Med. Chem.,PUBLICATION,
2723140,CHEMBL1336,MLDQJTXFUGDVEO-UHFFFAOYSA-N,SORAFENIB,,P21860,RECEPTOR TYROSINE-PROTEIN KINASE ERBB-3,ERBB3,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for ERBB3 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4465495,CHEMBL1311158,UOBPZFOFEWZPQK-XCVCLJGOSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4227238,CHEMBL1465811,SUFIZEKWHWMOTM-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1111263,CHEMBL126077,FQCPPVRJPILDIK-UHFFFAOYSA-N,INDIRUBIN-3-MONOXIME,,P22607,FIBROBLAST GROWTH FACTOR RECEPTOR 3,FGFR3,wild_type,,23398362.0,ACTIVITY,=,20.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15.0,uM,"Millipore: Percentage of residual kinase activity of FGFR3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3351539,CHEMBL3194429,PCIFCVSBLZZYFL-NKVSQWTQSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4072888,CHEMBL1311810,SDDYVQAWOVLJHR-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5225777,CHEMBL945,XSDQTOBWRPYKKA-UHFFFAOYSA-N,AMILORIDE,,P00918,CARBONIC ANHYDRASE II,CA2,,,,IC50,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Carbonic Anhydrase II enzyme inhibition (substrate: 4-Nitrophenyl acetate (4-NPA)),DrugMatrix in vitro pharmacology data,,DATASET,
2254117,CHEMBL1436694,KLLYGZDHTPSGKX-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5323907,CHEMBL101253,YCOYDOIWSSHVCK-UHFFFAOYSA-N,VATALANIB,,P53779,C-JUN N-TERMINAL KINASE 3,MAPK10,,,15711537.0,KD,,,,,,,,,,,,,,,,,Average Binding Constant for JNK3; NA=Not Active at 10 uM,A small molecule-kinase interaction map for clinical kinase inhibitors.,Nat. Biotechnol.,PUBLICATION,
5724545,CHEMBL2112619,ZUMCXPZUDNKPKF-FIXISWKDSA-N,,,P25099,ADENOSINE A1 RECEPTOR,,,,9371242.0,RATIO,=,4.3,,,,,,,,,,,,,,,GTP shift ratio of the apparent Ki values in the presence and absence of GTP.,N6-cyclopentyl-3'-substituted-xylofuranosyladenosines: a new class of non-xanthine adenosine A1 receptor antagonists.,J. Med. Chem.,PUBLICATION,
403923,CHEMBL1364119,BQMHPATXTVZSSW-PMACEKPBSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,29092.9,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5297776,CHEMBL558752,YABJJWZLRMPFSI-UHFFFAOYSA-N,CHIR-265,,Q96SB4,SERINE/THREONINE-PROTEIN KINASE SRPK1,SRPK1,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for SRPK1 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
5409515,CHEMBL1504786,YMDAKRSQXVSZQD-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4501846,CHEMBL50608,URUHKHGBRNTPGA-UHFFFAOYSA-N,,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,12182873.0,PKA,=,8.5,,,,,,,,,,,,,,,The compound was tested for its binding affinity against N-methyl-D-aspartate glutamate receptor using potentiometric method.,4-Aminoquinolines as a novel class of NR1/2B subtype selective NMDA receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4657015,CHEMBL1162,VIKNJXKGJWUCNN-XGXHKTLJSA-N,NORETHINDRONE,,P18089,ALPHA-2B ADRENERGIC RECEPTOR,ADRA2B,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Alpha-2B adrenergic receptor radioligand binding (ligand: Rauwolscine),DrugMatrix in vitro pharmacology data,,DATASET,
1454712,CHEMBL2147351,HCHBSQRARVRKLC-UHFFFAOYSA-N,,,P80147,GAMMA-AMINO-N-BUTYRATE TRANSAMINASE,,,,22944334.0,KM,=,1700000.0,NM,,,,,,,,,,,,,,Activity of pig GABA aminotransferase using alpha-ketoglutarate as substrate after 16 hrs by Hanes-Woolf plot analysis,Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.,Bioorg. Med. Chem.,PUBLICATION,
912190,CHEMBL796,DUGOZIWVEXMGBE-UHFFFAOYSA-N,METHYLPHENIDATE,,Q01959,DOPAMINE TRANSPORTER,SLC6A3,,,12672255.0,IC50,=,17.0,NM,,,,,,,,,,,,,,Inhibition of [3H]WIN-35428 Binding to the Dopamine Transporter in Rhesus (Macaca mulatta) orCynomolgus Monkey (Macaca fascicularis) Caudate-Putamen,Synthesis and evaluation of dopamine and serotonin transporter inhibition by oxacyclic and carbacyclic analogues of methylphenidate.,J. Med. Chem.,PUBLICATION,
4096677,CHEMBL1309656,SFVHGAPJVQGNSZ-UHFFFAOYSA-N,,,P07550,BETA-2 ADRENERGIC RECEPTOR,ADRB2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485366, AID485386, AID504448, AID504454, AID504459]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1558560,CHEMBL1475403,HMVAVEVINBNXTQ-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,25929.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
615010,CHEMBL1698046,COCOHJKFBVQVSD-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4414109,CHEMBL1359104,UIIASYYYEGJPET-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5311156,CHEMBL1402439,YBHKNPOLPRIBBG-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
334943,CHEMBL258844,BIWGYFZAEWGBAL-UHFFFAOYSA-N,AKT INHIBITOR VIII,,P54756,EPHRIN TYPE-A RECEPTOR 5,EPHA5,wild_type,,22037377.0,ACTIVITY,=,101.6303818,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,PEY + MN,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
5239397,CHEMBL1852458,XTUCGYCEOQKVGI-UMZWJABMSA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,23116124.0,EMAX,=,22.62,%,,cell_based,,,,,CHO,,,,,,,Agonist activity at mu opioid receptor expressed in CHO cells assessed as stimulation of [35S]-GTP-gammaS binding relative to DAMGO,"Design, Synthesis, and Biological Evaluation of 17-Cyclopropylmethyl-3,14ß-dihydroxy-4,5a-epoxy-6ß-[(4'-pyridyl)carboxamido]morphinan Derivatives as Peripheral Selective µ Opioid Receptor Agents.",J. Med. Chem.,PUBLICATION,
4169895,CHEMBL372434,SNZRAKOFDSGBRF-WYYIAQBKSA-N,,,Q04206,NUCLEAR FACTOR NF-KAPPA-B P65 SUBUNIT,RELA,,,16570920.0,IC100,=,20000.0,NM,,,,,,,,,,,,,,Inhibition of NF-kappaB DNA binding by EMSA,Development of a structural model for NF-kappaB inhibition of sesquiterpene lactones using self-organizing neural networks.,J. Med. Chem.,PUBLICATION,
3827146,CHEMBL1347279,RCGVPMFFTDNWMF-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,11582.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2120044,CHEMBL1536799,JWZXHNKCBPUKSX-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4671684,CHEMBL1276308,VKHAHZOOUSRJNA-GCNJZUOMSA-N,MIFEPRISTONE,,P32238,CHOLECYSTOKININ A RECEPTOR,CCKAR,,,,IC50,,,,,,,,,,1321-N1,,,,,,,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",DrugMatrix in vitro pharmacology data,,DATASET,
3954205,CHEMBL167223,RPUXCIYWJSVFFV-UHFFFAOYSA-N,,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,12593665.0,KI,=,151.36,NM,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity towards cloned human muscarinic acetylcholine receptor M1 stably expressed in CHO-K1 cells using [3H]N-methylscopolamine,Structure-activity relationships of dimethindene derivatives as new M2-selective muscarinic receptor antagonists.,J. Med. Chem.,PUBLICATION,
3020978,CHEMBL1456701,NRUIJZZBQQZHSB-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1350644,CHEMBL1909368,GQMGDJGIMHECBU-UHFFFAOYSA-N,GW683134A,,P45984,C-JUN N-TERMINAL KINASE 2,MAPK9,,,,INHIBITION,=,2.67,%,,,,,,,,,,,,,,GSK_PKIS: JNK2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1529577,CHEMBL1427821,HJZFLWXZAVYJJO-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
21666,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,,Microtubule-associated protein Tau isoform 2N4R (Tau 2N4R),,,,24072703.0,IC50,=,8940.0,NM,,,,,,,,,,,,,,,,,,
5098588,CHEMBL1507752,XEQLOETVRJXVHG-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3447026,CHEMBL1164113,PMTNHFJQZHFLNV-UHFFFAOYSA-N,,,Q2XUH7,ANGIOTENSIN TYPE II RECEPTOR,,,,20493713.0,KI,=,3.2,NM,,,,,,,,,,,,,,Displacement of [125I]angiotensin 2 from AT2 receptor in pig uterus membrane after 1.5 hrs by gamma counting,Selective angiotensin II AT(2) receptor agonists with reduced CYP 450 inhibition.,Bioorg. Med. Chem.,PUBLICATION,
3574520,CHEMBL1380270,QAWRKXTYLIAHNC-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,125892.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5019442,CHEMBL442449,WVXZZGALNSGPLY-XNTDXEJSSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
3477782,CHEMBL1443635,PQAPPBPANKMKHC-UHFFFAOYSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
3590795,CHEMBL1870721,QCUBIVMFCWHQOX-QRIZJJBVSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,6513.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of TGF-b: Confirmation of Cherry Picks.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
402429,CHEMBL70,BQJCRHHNABKAKU-KBQPJGBKSA-N,MORPHINE,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,17887741.0,EC50,=,484.0,NM,,cell_based,,,,,CHO,,,,,,,Agonist activity at human kappa opioid receptor expressed in CHO cells assessed as stimulation of [35S]GTP-gamma-S binding,"Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.",J. Med. Chem.,PUBLICATION,
1721186,CHEMBL1443892,IEPPBIBXFCQZJN-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1631830,CHEMBL1723218,HVFLGTSDWSLJHN-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1229478,CHEMBL296411,GDHNBPHYVRHYCC-SNAWJCMRSA-N,TRISMETHOXYRESVERATROL,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,11754588.0,IC50,=,6200.0,NM,,,,,,,,,,,,,,Inhibition of ethoxyresorufin O-deethylation (EROD) in bicistronic bacterial membranes expressing human cytochrome P450 1A2,"Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.",J. Med. Chem.,PUBLICATION,
5749355,CHEMBL1361261,ZXIHZWGGBAWQEA-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,141.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of Cruzain. (Class of assay: confirmatory) [Related pubchem assays: 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1476 (cruzain qHTS without detergent), 1478 (cruzain qHTS with detergent)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4075906,CHEMBL277034,SDOJFPSFHFRQPP-PKTNWEFCSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,9526559.0,IC50,=,114.82,NM,,,,,,,,,,,,,,Inhibitory activity against HIV-1 protease.,Comparative binding energy analysis of HIV-1 protease inhibitors: incorporation of solvent effects and validation as a powerful tool in receptor-based drug design.,J. Med. Chem.,PUBLICATION,
3397835,CHEMBL2001923,PHMQDWBSDYUPSP-UHFFFAOYSA-N,,,P23443,RIBOSOMAL PROTEIN S6 KINASE 1,RPS6KB1,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: RPS6KB1,PUBCHEM BIOASSAY DATA SET,,DATASET,
5466572,CHEMBL1365191,YSEVVXWMFVPJDE-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,EC50,h=,3670.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counter Screen for Luciferase-based Assay Positives. (Class of assay: confirmatory) [Related pubchem assays: 620, 618, 411 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2197059,CHEMBL1562405,KFJNGIKNWQUZAN-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2761732,CHEMBL1316962,MPHPQIYWMBXTST-UHFFFAOYSA-N,,,P10828,THYROID HORMONE RECEPTOR BETA-1,THRB,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2391711,CHEMBL90454,LASSXLIBWVEMIH-UHFFFAOYSA-N,,,"O96020, P24941, P24864",CYCLIN-DEPENDENT KINASE 2/CYCLIN E,"CCNE1, CCNE2, CDK2",,,,IC50,=,500.0,NM,,,,,,,,,,,,,,Inhibitory concentration against cyclin dependent kinase-2 (CDK2)/Cyclin E,,Bioorg. Med. Chem. Lett.,PUBLICATION,
5069420,CHEMBL1572558,XBJWJLBOSJUSKB-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,6513.1,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
920338,CHEMBL30379,DVDMKLDPYXVOQQ-UHFFFAOYSA-N,,,"Q08499, P27815, Q07343, Q08493",PHOSPHODIESTERASE 4,"PDE4A, PDE4B, PDE4C, PDE4D",,,9767640.0,IC50,=,900.0,NM,,,,,,,,,,,,,,Inhibitory activity against phosphodiesterase 4 isolated from guinea pig ventricular tissue,"Design, synthesis, and biological activities of new thieno[3,2-d] pyrimidines as selective type 4 phosphodiesterase inhibitors.",J. Med. Chem.,PUBLICATION,
1560347,CHEMBL3675397,HNAFGFOVDGEYQN-OAHLLOKOSA-N,,,O14965,SERINE/THREONINE-PROTEIN KINASE AURORA-A,AURKA,,,,IC50,=,48.0,NM,,,,,,,,,,,,,,BindingDB_Patents: Enzyme Assay. The Aurora assays described here are performed on two Caliper Life Sciences systems: the LC3000 and the Desktop Profiler. These provide data on enzyme activity via measurement of the relative amounts of phosphorylated or unphosphorylated fluorescently labelled substrate peptide at the end of an enzymatic reaction. These different states of peptide are resolved by applying a potential difference across the sample. The presence of the charged phosphate group on the product (as opposed to the substrate) causes a different peptide mobility between the two peptides. This is visualized by excitation of the fluorescent label on the substrate and product peptides and represented as peaks within the analysis software.,Amino azaheterocyclic carboxamides,,PATENT,
2080754,CHEMBL3209782,JSTBBLDUEFOWTR-AFUMVMLFSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4095399,CHEMBL1484922,SFRBUUOSVDJYFY-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
1031833,CHEMBL1411277,FHIJWWDEXOXMOX-TWJUONSBSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2904920,CHEMBL26424,NFIXBCVWIPOYCD-UHFFFAOYSA-N,TESMILIFENE,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,=,25118.86,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4859932,CHEMBL1701329,WESXUSXALICULW-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2287348,CHEMBL3673333,KPJAUMQJYMYINR-UHFFFAOYSA-N,,,P48067,GLYCINE TRANSPORTER 1,SLC6A9,,,,KI,<,10000.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. Radioligand binding to human GlyT1c transporter-expressing membranes was carried out as described in Mezler et al., Molecular Pharmacology 74:1705-1715, 2008.","Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy",,PATENT,
4823528,CHEMBL1712891,WAWPKBCGSAFTHC-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
5498250,CHEMBL1393731,YVYUSCHLRYEEBG-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2788281,CHEMBL1414890,MSKNCRMLUUGTDB-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
4349272,CHEMBL1462945,UBKVGMKTRIFDBG-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,84921.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5401572,CHEMBL1346859,YLHNXEFEKGQGGX-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2321488,CHEMBL1432841,KSTYBZSIRSTAHC-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1692506,CHEMBL1330324,IBNVFHOFSRSVAS-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4525265,CHEMBL1717323,UUJZAPVGHSXVSM-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3995295,CHEMBL1516070,RUKFQFDSWPNHGL-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1190143,CHEMBL1905163,FYTJZJYWLSJQSR-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5386447,CHEMBL1424378,YJRCWYDHPHLQFB-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
635802,CHEMBL3645120,CQNHZTVKOGLVDJ-ZDUSSCGKSA-N,,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,,,,Kd,=,3.0,NM,,,,,,,,,,,,,,BindingDB_Patents: Binding Assay. ATP-site dependent competition binding assay using Ambit KinomeScan Screening kit.,Inhibitors of protein kinases,,PATENT,
4848717,CHEMBL1582760,WDOIQXLSUHZAMD-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
4969750,CHEMBL1442059,WQRLNZZYGAZFKQ-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
3531712,CHEMBL11417,PVYJZLYGTZKPJE-UHFFFAOYSA-N,STREPTONIGRIN,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,1000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF. (Class of assay: confirmatory) [Related pubchem assays: 995 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5560791,CHEMBL198436,ZCMMWOVFLLUFDU-UHFFFAOYSA-N,,,P00734,THROMBIN,F2,,,16137886.0,KI,=,2.3,NM,,,,,,,,,,,,,,Inhibitory constant against thrombin,Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimization.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3567509,CHEMBL487313,QACKOGCLOZIDSF-UHFFFAOYSA-N,,,P28221,SEROTONIN 1D (5-HT1D) RECEPTOR,HTR1D,,,18507369.0,KI,>,1000.0,NM,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [3H]5-hydroxytryptamine from human cloned 5HT1D receptor expressed in CHOK1 cells by liquid scintillation counting,"Designing selective, high affinity ligands of 5-HT1D receptor by covalent dimerization of 5-HT1F ligands derived from 4-fluoro-N-[3-(1-methyl-4-piperidinyl)-1H-indol-5-yl]benzamide.",J. Med. Chem.,PUBLICATION,
5787650,CHEMBL3715171,,,,Q96KB5,PDZ-BINDING KINASE,PBK,,,,IC50,=,630.0,NM,,,,,,,,,,,,,,Inhibition of N-terminal GST-tagged full-length human PBK (1 to 322 residues) using FITC-labeled histone-H3 peptide substrate incubated for 0.5 hrs by fluorescence polarization based assay,7-Hydroxy-benzoimidazole-4-yl-methanone Derivatives and PBK Inhibitors Containing the Same,,PATENT,
518144,CHEMBL10,CDMGBJANTYXAIV-UHFFFAOYSA-N,SB-203580,,Q9UIK4,DEATH-ASSOCIATED PROTEIN KINASE 2,DAPK2,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for DAPK2 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
1030250,CHEMBL1760035,FHDPQTHZTKXVCW-UHFFFAOYSA-N,,,P06213,INSULIN RECEPTOR,INSR,,,21414779.0,IC50,=,3.0,NM,,,,,,,,,,,,,,Inhibition of INSR,"Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
431480,CHEMBL528734,BTQQRTVTLFERGV-UHFFFAOYSA-N,TCMDC-125603,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,1458.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5803414,CHEMBL3740851,,,,"Q07869, Q03181, P37231",PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR,"PPARA, PPARD, PPARG",,,26616289.0,FC,=,3.0,,,,,,,,,,,,,,,Agonist activity at PPAR in human THP1 cells assessed as induction of ABCG1 expression at 20 uM after 24 hrs by Western blot analysis relative to control,Identification of dual PPAR/ agonists and their effects on lipid metabolism.,Bioorg. Med. Chem.,PUBLICATION,
2484610,CHEMBL1241348,LLGDPTDZOVKFDU-XUHJSTDZSA-N,FALDAPREVIR,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,20823284.0,INHIBITION,=,2.0,%,,,,,,,,,,,,,,Inhibition of human adenosine A1 receptor at 10 uM,"Preclinical characterization of BI 201335, a C-terminal carboxylic acid inhibitor of the hepatitis C virus NS3-NS4A protease.",Antimicrob. Agents Chemother.,PUBLICATION,
2608751,CHEMBL1435183,LYLNBNUSVNWGJG-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1096255,CHEMBL3217774,FOLYTFBHRHGMMG-UHFFFAOYSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells at 1 uM by immunoblot analysis,,MedChemComm,PUBLICATION,
1777933,CHEMBL1528883,ILJCNGSHKONNGT-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4194240,CHEMBL1538274,SQQAUFNKYVYIFS-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4985553,CHEMBL3114531,WSLLFUZFPYVTFT-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,24461289.0,EC50,=,1973.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human CB2 receptor expressed in CHO-K1 cells assessed as forskolin-induced cAMP accumulation after 1 hr,"Benzimidazole CB2 agonists: Design, synthesis and SAR.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4557702,CHEMBL365905,UXWAVVXCMUJGHD-UHFFFAOYSA-N,,,P78536,ADAM17,ADAM17,,,15357971.0,IC50,=,867.0,NM,,,,,,,,,,,,,,Effect on TNF-Alpha release in LPS-stimulated human whole blood assay,Synthesis and structure-activity relationship of a novel sulfone series of TNF-alpha converting enzyme inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1204644,CHEMBL1708020,GAPPGYVPJUGIHP-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,2909.3,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4247863,CHEMBL1361855,SWMNSABUWYKPAU-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1839263,CHEMBL3190943,IRZLLOQNQDTOFR-FYWRMAATSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3710675,CHEMBL196748,QPYOIXLXNCRGLA-UHFFFAOYSA-N,,,P00602,PHOSPHOLIPASE A2 ISOZYME CM-I,,,,15837334.0,KI,=,55000.0,NM,,,,,,,,,,,,,,Inhibitory activity against phospholipase A2,QSAR for phospholipase A2 inhibitions by 1-acyloxy-3-N-n-octylcarbamyl-benzenes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
963248,CHEMBL139008,DZTHNMBIWFXTLC-HMMYKYKNSA-N,,,P00742,COAGULATION FACTOR X,F10,,,9484495.0,IC50,=,580.0,NM,,,,,,,,,,,,,,Inhibitory activity against human Coagulation factor X,Identification and initial structure-activity relationships of a novel class of nonpeptide inhibitors of blood coagulation factor Xa.,J. Med. Chem.,PUBLICATION,
4483973,CHEMBL1556692,UQCSLAKDGBJQHP-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,9200.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5637731,CHEMBL104264,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,H89,,Q96SB4,SERINE/THREONINE-PROTEIN KINASE SRPK1,SRPK1,wild_type,,22037377.0,ACTIVITY,=,110.20694950000001,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,RS PEPTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
1951944,CHEMBL3210347,JEJOFLLEIGRTCH-FOKLQQMPSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
691667,CHEMBL3216476,CWOMCLVWSXLYKC-HGKUZVQUSA-N,,,P33533,DELTA OPIOID RECEPTOR,,,,21235243.0,KI,=,0.64,NM,,,,,,,,,,,,,,"Displacement of [3H][Ile5,6]deltorphin 2 from delta opioid receptor in Sprague-Dawley rat brain membrane by liquid scintillation counting","Synthesis and pharmacological activities of 6-glycine substituted 14-phenylpropoxymorphinans, a novel class of opioids with high opioid receptor affinities and antinociceptive potencies.",J. Med. Chem.,PUBLICATION,
920848,CHEMBL34704,DVEXZJFMOKTQEZ-JYFOCSDGSA-N,U-0126,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4686962,CHEMBL1812109,VLWKSABCDXFRCV-UHFFFAOYSA-N,,,P25084,TRANSCRIPTIONAL ACTIVATOR PROTEIN LASR,,,,21798749.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Antagonist activity at Pseudomonas aeruginosa PAO1 MW1 (pUM15) LasR assessed as inhibition of N-(3-oxo)-dodecanoyl HL-induced quorum sensing activation at 10 uM relative to untreated control,"Design, synthesis, and biological evaluation of abiotic, non-lactone modulators of LuxR-type quorum sensing.",Bioorg. Med. Chem.,PUBLICATION,
920549,CHEMBL3214019,DVEKULLBTKAXNM-KEBDBYFISA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1180024,CHEMBL1572809,FXRIMHMLPNSELN-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,1122.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
258397,CHEMBL120185,BARFMAOTOPEJFY-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,15177482.0,IC50,>,2000.0,NM,,,,,,,,,,,,,,Inhibition of human cytochrome P450 2C9,Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5803567,CHEMBL3828232,,,,Q07869,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA,PPARA,,,27326332.0,IC50,=,1563.0,NM,,,,,,,,,,,,,,Binding affinity to human GST-tagged PPAR-alpha LBD expressed in Escherichia coli BL21 (DE3) PlysS after 30 mins in presence of fluorescein ligand FLA-A by fluorescence polarization assay,"Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPAR Selective Agonist.",ACS Med. Chem. Lett.,PUBLICATION,
4150631,CHEMBL1046,SLXKOJJOQWFEFD-UHFFFAOYSA-N,AMINOCAPROIC ACID,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,,IC50,,,,,,,,,,Chem-1,,,,,,,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),DrugMatrix in vitro pharmacology data,,DATASET,
2055431,CHEMBL27163,JQFCHNQFJRJNTL-UHFFFAOYSA-N,,,Q9H4A4,AMINOPEPTIDASE B,RNPEP,,,7909847.0,KI,=,11.0,NM,,,,,,,,,,,,,,Inhibition of arginylaminopeptidase (aminopeptidase B),Investigation of the active site of aminopeptidase A using a series of new thiol-containing inhibitors.,J. Med. Chem.,PUBLICATION,
2463025,CHEMBL1567102,LIXUVYCCJGEZQK-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4009165,CHEMBL1388629,RWAJJRZLHXZLNG-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
827958,CHEMBL1573305,DLHKVNXJHQYCSK-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1552318,CHEMBL1438626,HMCBGXYFLYODIR-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5490533,CHEMBL1445846,YVELSDDXFCIBLA-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4321232,CHEMBL1684721,TYLVBPUBYJRUFS-UHFFFAOYSA-N,,,Q13258,PROSTANOID DP RECEPTOR,PTGDR,,,21316222.0,IC50,>,50000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]PGD2 from human DP1 receptor expressed in HEK293 cell membranes,Thienopyrrole acetic acids as antagonists of the CRTH2 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2443003,CHEMBL1448694,LGQKIMQROHFJGL-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,562.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
5090374,CHEMBL55,XDRYMKDFEDOLFX-UHFFFAOYSA-N,PENTAMIDINE,,O75751,SOLUTE CARRIER FAMILY 22 MEMBER 3,SLC22A3,,,23241029.0,IC50,=,9500.0,NM,,cell_based,,,,,HEK293,,,,,,,Inhibition of human OCT3-mediated ASP+ uptake expressed in HEK293 cells after 3 mins by fluorescence assay,"Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.",J. Med. Chem.,PUBLICATION,
5208424,CHEMBL1591518,XQLGYPKQVXSJTO-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,32642.7,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5833348,CHEMBL3727792,,,,P25090,LIPOXIN A4 RECEPTOR,FPR2,,,,EC50,=,213.0,NM,,,,,,,,,,,,,,Agonist activity at human recombinant ALX receptor expressed in HEK293 cells co-expressing G-protein Galpha16 assessed as effect on calcium response by Fluo-4-AM dye based FLIPR assay,Bridged spiro [2.4] heptane derivatives as alx receptor and/or fprl2 agonists,,PATENT,
5680371,CHEMBL1478870,ZPOVQBOFTXCRKF-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3666117,CHEMBL1922939,QLEJNCAOFVEXSA-QHCPKHFHSA-N,,,P47871,GLUCAGON RECEPTOR,GCGR,,,22030028.0,IC50,=,44.0,NM,,cell_based,,,,,CHO,,,,,,,Antagonist activity at human glucagon receptor expressed in CHO cells assessed as inhibition of forskolin/glucagon-induced cAMP production preincubated for 30 mins before glucagon challenge measured after 30 mins using [125I]-cAMP by liquid scintillation counting,Discovery of N-aryl-2-acylindole human glucagon receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1701438,CHEMBL3212760,ICKUWLDXBAHOLN-OVCLIPMQSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5284376,CHEMBL1343297,XYSRHOKREWGGFE-UHFFFAOYSA-N,,,P35236,PROTEIN-TYROSINE PHOSPHATASE LC-PTP,PTPN7,,,,IC50,>,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: HTS Discovery of Chemical Inhibitors of HePTP, a Leukemia Target. Inhibition of phosphatase activity by colorimetric assay of released free phosphate (BioMol green). Secondary Screen (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3781877,CHEMBL436047,QXRBKLSXANWSNZ-UHFFFAOYSA-N,,,Q15722,LEUKOTRIENE B4 RECEPTOR 1,LTB4R,,,7699700.0,IC50,=,26.0,NM,,,,,,,,,,,,,,Binding affinity for Leukotriene B4 (LTB4) receptor,Second-generation leukotriene B4 receptor antagonists related to SC-41930: heterocyclic replacement of the methyl ketone pharmacophore.,J. Med. Chem.,PUBLICATION,
2812909,CHEMBL1171987,MVDKLMQNQSJYHJ-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,20550118.0,IC50,=,1520.0,NM,,,,,,,,,,,,,,Inhibition of CYP3A4 expressed in baculovirus infected insect microsomes,Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors.,J. Med. Chem.,PUBLICATION,
2365616,CHEMBL243677,KXPQYWKYYDYOCQ-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1967249,CHEMBL1503012,JGDVEASUBBNKOX-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,501.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
908000,CHEMBL1399878,DTTQMQQILNEQGU-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
69357,CHEMBL1548306,AFRQJOVCRXENOE-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
786143,CHEMBL1609752,DGTPXSQAQYUKNA-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5116741,CHEMBL374584,XGMNRALXOWECNG-UHFFFAOYSA-N,,,P18825,ALPHA-2C ADRENERGIC RECEPTOR,ADRA2C,,,20925410.0,INTRINSIC ACTIVITY,=,1.15,,,cell_based,,,,,CHO,,,,,,,Agonist activity at human Alpha-2C adrenoceptor expressed in CHO cells assessed as induction of extracellular acidification by microphysiometry relative to (-)noradrenaline,Fruitful adrenergic a(2C)-agonism/a(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence.,J. Med. Chem.,PUBLICATION,
1616439,CHEMBL127101,HTLUBFSSIMOABR-UHFFFAOYSA-N,,,Q9H2K2,TANKYRASE-2,TNKS2,,,27163581.0,Inhibition,=,97.0,%,,,,,,,,,,,,,,Inhibition of N-terminal GST-tagged human TNKS-2 (849 to 1166 residues) expressed in in insect sf21 cells at 100 nM preincubated for 2 hrs followed by substrate addition measured after 30 mins,Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases.,Eur. J. Med. Chem.,PUBLICATION,
1164501,CHEMBL94091,FVWWHXXCNJDXHS-PPTMTGTBSA-N,,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,15139756.0,IC50,=,221.0,NM,,cell_based,,,,,CHO,,,,,,,Antagonist activity towards human recombinant Endothelin A receptor expressed in chinese hamster ovary (CHO) cells determined using [125I]ET1 as radioligand,"Novel benzo[1,4]diazepin-2-one derivatives as endothelin receptor antagonists.",J. Med. Chem.,PUBLICATION,
2413383,CHEMBL1509129,LDDJGQKLJHFNQV-CWTOASCOSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4430137,CHEMBL1348374,UKAFKKJTWPITNK-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,=,14125.38,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5687379,CHEMBL46399,ZQHYKVKNPWDQSL-UHFFFAOYSA-N,PHENAZOCINE,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,6313921.0,RELATIVE POTENCY,=,0.4,,,,,,,,,,,,,,,Relative potency to induce 50% of maximal effect in rabbit vas deferens expressing Opioid receptor kappa 1,"Synthesis and pharmacological characterization of (+/-)-5,9 alpha-dimethyl-2-[2-(4-fluorophenyl)ethyl]-2'-hydroxy-6,7-benzomorphan (fluorophen), a ligand suitable for visualization of opiate receptors in vivo.",J. Med. Chem.,PUBLICATION,
3392292,CHEMBL3703143,PGYSOMADUOJSOK-UHFFFAOYSA-N,,,P31751,SERINE/THREONINE-PROTEIN KINASE AKT2,AKT2,,,,IC50,=,95.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: TR-FRET Assay. For the assay 50 nl of a 100 fold concentrated solution of the test compound in DMSO was pipetted into a black low volume 384 well microtiter plate (Greiner Bio-One, Frickenhausen, Germany), 2 ul of a solution of Akt2 in assay buffer [50 mM TRIS/HCl pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 0.02% (v/v) Triton X-100 (Sigma)] were added and the mixture was incubated for 15 min at 22 C. to allow prebinding of the test compounds to the enzyme before the start of the kinase reaction. Then the kinase reaction was started by the addition of 3 ul of a solution of adenosine-tri-phosphate (ATP, 16.7 uM=>final conc. in the 5 ul assay volume is 10 uM) and substrate (1.67 uM=>final conc. in the 5 ul assay volume is 1 uM) in assay buffer and the resulting mixture was incubated for a reaction time of 60 min at 22 C. The concentration of Akt2 in the assay was adjusted depending of the activity of the enzyme lot.","Substituted imidazo[1,2-a]pyrimidines and ‚Äîpyridines",,PATENT,
3529076,CHEMBL1524172,PVQMZFZHUWKIEU-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2133390,CHEMBL1223232,JYKMELCLGQMDDG-OJKZWRJASA-N,,,P31391,SOMATOSTATIN RECEPTOR 4,SSTR4,,,20666484.0,IC50,>,1000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]-[LTT] SIRF-28 from human SST4 receptor expressed in human CCL39 cells by autoradiography,Novel octreotide dicarba-analogues with high affinity and different selectivity for somatostatin receptors.,J. Med. Chem.,PUBLICATION,
4463250,CHEMBL1497156,UNUVJFMMLVCOQB-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,819.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4560097,CHEMBL1762230,UXYOZHSRSIIWTB-FJXKBIBVSA-N,,,P07607,THYMIDYLATE SYNTHASE,,,,21330014.0,IC50,=,3600.0,NM,,cell_based,,,,,L1210,,,,,,,Inhibition of thymidylate synthase in mouse L1210 cells assessed as inhibition of tritium release from [5-3H]deoxyuridine after preincubation for 4 hrs by liquid scintillation counting,Synthesis and biological evaluation of unsaturated keto and exomethylene D-arabinopyranonucleoside analogs: novel 5-fluorouracil analogs that target thymidylate synthase.,Eur. J. Med. Chem.,PUBLICATION,
4241701,CHEMBL327592,SVTHOVFACRERMT-UHFFFAOYSA-N,,,"P51164, P20648",POTASSIUM-TRANSPORTING ATPASE,"ATP4A, ATP4B",,,10522698.0,IC50,=,17000.0,NM,,,,,,,,,,,,,,Compound was tested in vitro for H+/K+ ATPase activity in rabbit stomach preparations,"Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2902317,CHEMBL711,NFBAXHOPROOJAW-UHFFFAOYSA-N,PHENINDIONE,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4499236,CHEMBL1435228,URMXLVMRDVBPIA-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2451541,CHEMBL3581545,LHPJLIOBTGASHY-UHFFFAOYSA-N,,,P51449,NUCLEAR RECEPTOR ROR-GAMMA,RORC,,,25815138.0,EC50,=,14.0,NM,,,,,,,,,,,,,,Agonist activity at N-terminal 6xHis-tagged human RORc ligand binding domain (241 to 486) expressed in bacterial expression system assessed as activation of SRC1 co-activator peptide recruitment after 3 hrs by TR-FRET analysis,,ACS Med. Chem. Lett.,PUBLICATION,
5656881,CHEMBL1823528,ZNCMDFNYYJAFKI-UHFFFAOYSA-N,,,P27338,MONOAMINE OXIDASE B,MAOB,,,21777011.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of human recombinant MAO-B expressed in BTI-TN-5B1-4 insect cells at 100 uM using p-tyramine substrate by Amplex Red MAO assay,"3-Acetyl-2,5-diaryl-2,3-dihydro-1,3,4-oxadiazoles: a new scaffold for the selective inhibition of monoamine oxidase B.",J. Med. Chem.,PUBLICATION,
4256445,CHEMBL3087613,SXOKDPSXOOUEDU-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,24189187.0,INHIBITION,=,11.5,%,,,,,,,,,,,,,,"Inhibition of VEGFR2 (unknown origin) using poly (Glu, Tyr)4:1 as substrate preincubated at 10 uM for 5 mins measured after 30 mins by immunoassay","Synthesis and biological evaluation of substituted 1,2,3-benzotriazines and pyrido[3,2-d]-1,2,3-triazines as inhibitors of vascular endothelial growth factor receptor-2.",Bioorg. Med. Chem.,PUBLICATION,
1522861,CHEMBL66027,HJIZKRPOTBXWRI-UHFFFAOYSA-N,,,Q9H244,PURINERGIC RECEPTOR P2Y12,P2RY12,,,8336341.0,IC50,=,4300.0,NM,,,,,,,,,,,,,,In vitro inhibitory activity against ADP-induced human platelet aggregation,Synthesis and biological evaluation of antiplatelet 2-aminochromones.,J. Med. Chem.,PUBLICATION,
2218571,CHEMBL1501643,KHTCIJIPWGMLEV-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
574749,CHEMBL434577,CJPNXLZTRUTXTI-UHFFFAOYSA-N,,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,15588074.0,IC50,=,50.0,NM,,cell_based,,,,,,,,,,,,Activity at human ERalpha expressed in HAECT1 cells assessed as inhibition of NF-kappaB transcription,Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid arthritis.,J. Med. Chem.,PUBLICATION,
5569690,CHEMBL1531024,ZDLBOEFLSKKESG-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5458080,CHEMBL1304382,YRDYFBHQVLDZFF-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1664915,CHEMBL2347763,HYTLBVVBBREIBV-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,23360475.0,INHIBITION,=,1.0,%,,,,,,,,,,,,,,Inhibition of human recombinant CYP3A4 at 10 uM incubated for 30 mins at 37 degC using 7-benzyloxy-4-(trifluoromethyl)coumarin substrate,"Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.",J. Nat. Prod.,PUBLICATION,
2345623,CHEMBL1222233,KVHFVGMFACJKKD-UHFFFAOYSA-N,,,P28335,SEROTONIN 2C (5-HT2C) RECEPTOR,HTR2C,,,20655748.0,IC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]mesulergine from human 5HT2C expressed in CHOKI cells,Synthesis and SAR of (piperazin-1-yl-phenyl)-arylsulfonamides: a novel series of atypical antipsychotic agents.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4971930,CHEMBL151449,WQYJPEHBLXPHHJ-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,14640550.0,IC50,=,570.0,NM,,,,,,,,,,,,,,Concentration required to inhibit cytochrome P450 1A2.,"Pyrazole and isoxazole derivatives as new, potent, and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors.",J. Med. Chem.,PUBLICATION,
2750542,CHEMBL3693274,MNZFNMJZWDCKKG-UHFFFAOYSA-N,,,O00408,PHOSPHODIESTERASE 2A,PDE2A,,,,IC50,=,1118.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Fluorescence Polarization Assay. The inhibition of PDE 2A or 10 enzyme activity was assessed using IMAP-Phosphodiesterase-cAMP fluorescence labeled substrate (Molecular Devices, Order No. R7506), IMAP TR-FRET screening express (Molecular Devices, Order No. R8160, the TR-FRET component will not be used) and PDE 2A or PDE10 protein expressed upon baculovirus infection in SF9 cells. The cells were incubated after infection for ~3 days and protein production was confirmed by Western Blot. The cells were collected by centrifugation and the pellet frozen in liquid nitrogen before it was resuspended in PBS containing 1% Triton X-100 and protease inhibitors. After 45 min incubation on ice, the cell debris was removed by centrifugation (13.000 rpm, 30 min). Since SF 9 cells do not express cAMP hydrolyzing enzymes to a high extent, no further purification of the protein was needed.All reactions were performed in 384 well plates, Perkin Elmer black optiplates and IMAP reaction buffer with 0.1% Tween20 (kit component).","Substituted pyrido[3,2-E][1,2,4]-triazolo[4,3-A]pyrazines for the treatment of central nervous system disorders",,PATENT,
2732678,CHEMBL1966918,MLYQSWJIORZOBV-ONUWXRSBSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for inhibitors of Vif-A3F interactions: Cherry picks. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2110207,CHEMBL1715631,JVYSYYFTOSKRRY-ZXRBMNSTSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3556672,CHEMBL374440,PYVMYBZZIWFCPE-UHFFFAOYSA-N,,,Q14164,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE EPSILON SUBUNIT,IKBKE,,,16997559.0,IC50,=,251.19,NM,,,,,,,,,,,,,,Inhibition of human recombinant IKKepsilon by TR-FRET assay,"5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-epsilon kinase.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3988537,CHEMBL2407268,RTOMUFLVUUQGRB-UHFFFAOYSA-N,,,P23907,MAJOR PRION PROTEIN,,,,,EC50,=,861.0,NM,,cell_based,,,,,,,,,,,,Antiprion activity against sheep prion infected in mouse ScN2a-cl3 cells assessed as reduction in PrPSc level after 5 days by ELISA,,ACS Med. Chem. Lett.,PUBLICATION,
1287598,CHEMBL1306569,GJMUQXWQPXQMPA-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2748961,CHEMBL2206676,MNTZQPYJSPFTGX-KBUPBQIOSA-N,,,P0CS83,CANDIDAPEPSIN-2,,,,23123016.0,IC50,=,890.0,NM,,,,,,,,,,,,,,Inhibition of candida albicans SAP2 using 0.05% BSA as substrate by spectrophotometric analysis,Bicyclic peptidomimetics targeting secreted aspartic protease 2 (SAP2) from Candida albicans reveal a constrained inhibitory chemotype.,Bioorg. Med. Chem.,PUBLICATION,
2944208,CHEMBL2001224,NJKBCVHYFWYIIQ-UHFFFAOYSA-N,,,Q5VT25,SERINE/THREONINE-PROTEIN KINASE MRCK-A,CDC42BPA,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC42BPA,PUBCHEM BIOASSAY DATA SET,,DATASET,
4589532,CHEMBL1893747,VBCRGLYLZRPTEN-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,2685.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2213846,CHEMBL1460663,KHEXJXSMUQSDGM-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1148983,CHEMBL106737,FUCGAUZSWYLMRK-UHFFFAOYSA-N,,,"P22909, P19328, P22086",ADRENERGIC RECEPTOR ALPHA-2,,,,8101878.0,KI,=,593.0,NM,,,,,,,,,,,,,,Binding affinity against alpha-2 adrenergic receptor by measuring displacement of [3H]clonidine from rat brain cortex membranes (in vitro).,"Studies on quinazolines. 5. 2,3-dihydroimidazo[1,2-c]quinazoline derivatives: a novel class of potent and selective alpha 1-adrenoceptor antagonists and antihypertensive agents.",J. Med. Chem.,PUBLICATION,
5049891,CHEMBL1441920,WZHJKEUHNJHDLS-HARLFGEKSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,28.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1889117,CHEMBL608699,IXQZKZKVGGJPMS-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
4870057,CHEMBL1557059,WFUHAMNOWNMQSC-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3866372,CHEMBL2180567,RGLOPKARGYDSMG-WKILWMFISA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,,,23098137.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of IGF1R at 10 uM in presence of ATP at Km level by kinase profiler method,"Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties.",J. Med. Chem.,PUBLICATION,
1759416,CHEMBL1457727,IJDVDZUKMOBGCV-XFXZXTDPSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2492942,CHEMBL1885759,LMAVJQPNUFSEQP-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,29092.9,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
637032,CHEMBL1546723,CQRLNXCCTFVTCR-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3883863,CHEMBL506153,RIIYKHQJSKRYKG-UHFFFAOYSA-N,GW876790X,,P68400,CASEIN KINASE II ALPHA,CSNK2A1,,,,INHIBITION,=,2.99,%,,,,,,,,,,,,,,GSK_PKIS: CK2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
977027,CHEMBL1461498,FBEVDZYOBTWNOJ-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
517860,CHEMBL1457525,CDLNNHFGJJAHSX-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
3946326,CHEMBL3310774,ROZPXEFLRGERGS-UHFFFAOYSA-N,,,P25025,INTERLEUKIN-8 RECEPTOR B,CXCR2,,,24974342.0,INHIBITION,>,50.0,%,,cell_based,,,,,,,,,,,,Antagonist activity against human recombinant CXCR2 receptor expressed in CHO cell membranes at 10 uM by SPA based [35S]GTPgammaS binding assay,"The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5099130,CHEMBL120432,XESORVDKNANWAB-IBGZPJMESA-N,,,P30969,GONADOTROPIN-RELEASING HORMONE RECEPTOR,,,,14505682.0,KI,=,4.0,NM,,,,,,,,,,,,,,Binding affinity towards rat Gonadotropin-releasing hormone receptor,"Synthesis and structure-activity relationships of thieno[2,3-d]pyrimidine-2,4-dione derivatives as potent GnRH receptor antagonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4444608,CHEMBL1505280,ULSMDANCDQHIGT-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2890433,CHEMBL200514,NDRKLRUEEPVRJG-UHFFFAOYSA-N,,,Q965D5,ENOYL-ACYL-CARRIER PROTEIN REDUCTASE,,,,16198563.0,IC50,=,1200.0,NM,,,,,,,,,,,,,,Inhibition of PfENR enzymatic activity,"Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4'-substituted triclosan derivatives.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5360361,CHEMBL1784776,YGQLHBBLHAXKIS-JMMIECQRSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,21574625.0,IC50,=,7100.0,NM,,,,,,,,,,,,,,Inhibition of BRCA1 by fluorescence polarization assay,Structure-activity relationship studies to probe the phosphoprotein binding site on the carboxy terminal domains of the breast cancer susceptibility gene 1.,J. Med. Chem.,PUBLICATION,
5221859,CHEMBL1412478,XRTSIORUDZRRLY-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4310338,CHEMBL1410469,TXDONRRSHXDVTK-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3655416,CHEMBL1329328,QKBNPRMECRQFOQ-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2669738,CHEMBL475761,MFBTVPWNHQVGPL-UHFFFAOYSA-N,GW784684X,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,19111461.0,IC50,=,5.0,NM,,,,,,,,,,,,,,Inhibition of EGFR,Thienopyrimidine-based dual EGFR/ErbB-2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2151382,CHEMBL1447513,KAJBCQTZGNCAND-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5455624,CHEMBL1536795,YQWOXKDXMBLRCK-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4271386,CHEMBL1889729,SZFPNRWEOPEYLA-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,73.1,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2089090,CHEMBL3646512,JTSTWKIGATWXTF-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,IC50,>,10000.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Inhibition Assay. The Invitrogen (Carlsbad, Calif.) mammalian target of rapamycin (mTOR) Lanthascreen assay can be used to quantitate mTOR kinase activity in an in vitro setting. Active mTOR phosphorylates eukaryotic translation initiation factor 4E binding protein 1 (4E-BP1) on residue threonine 46. This phosphorylation event can be detected with a phospho-specific terbium (Tb) labeled Ab, in turn bringing the Tb label in close proximity to the GFP tagged 4E-BP1 and allowing for time-resolved fluorescence resonance energy transfer (TR-FRET), which correlates 4E-BP1 phosphorylation levels with mTOR kinase activity.",Inhibitors of PI3 kinase and/or mTOR,,PATENT,
4971554,CHEMBL1418334,WQWSRQOIGLOXTM-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5604352,CHEMBL3358944,ZHDQJPLHDTXEKR-UHFFFAOYSA-N,,,P04150,GLUCOCORTICOID RECEPTOR,NR3C1,,,25516791.0,EMAX,=,91.0,%,,cell_based,,,,,,,,,,,,Agonist activity at GR in HFF cells assessed as suppression of IL-1-induced IL-6 production at 2 uM relative to dexamethasone,Optimization of drug-like properties of nonsteroidal glucocorticoid mimetics and identification of a clinical candidate.,ACS Med. Chem. Lett.,PUBLICATION,
307446,CHEMBL3099720,BGDLETKJFQIBLX-QFIPXVFZSA-N,,,P53355,DEATH-ASSOCIATED PROTEIN KINASE 1,DAPK1,,,,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of DAPK1 (unknown origin) at 1 uM after 1 hr,,ACS Med. Chem. Lett.,PUBLICATION,
3453742,CHEMBL1559999,PNJABCDGUHWOMR-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3316569,CHEMBL1394404,OYHSNNIYCVGTJL-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2791672,CHEMBL1370550,MSXHZMFIPHCLKN-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1744246,CHEMBL2031900,IHKWHSZSPBFQEP-UHFFFAOYSA-N,,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,22320327.0,IC50,=,71.2,NM,,cell_based,,,,,,,,,,,,Inhibition of HGF-mediated c-Met autophosphorylation in human PC3 cells after 10 mins by quantitative electrochemiluminescent immunoassay,Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series.,J. Med. Chem.,PUBLICATION,
4135718,CHEMBL411297,SKDXNKDCRIQAKF-UHFFFAOYSA-N,,,P36897,TGF-BETA RECEPTOR TYPE I,TGFBR1,,,18314943.0,IC50,=,85.0,NM,,cell_based,,,,,Sf9,,,,,,,Inhibition of TGFbeta type receptor 1 ALK5 (T204D) expressed in Sf9 cells,Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agent.,J. Med. Chem.,PUBLICATION,
596048,CHEMBL289177,CLYPHAMMJJIYFU-UHFFFAOYSA-N,,,"O08537, P19785",ESTROGEN RECEPTOR,,,,3735317.0,ACTIVITY,=,60.0,,,,,,,,,,,,,,,Estrogenic effect in uterotrophic assay in immature mice at 100 ug dose,"2-Alkyl-substituted 1,1-bis(4-acetoxyphenyl)-2-phenylethenes. Estrogen receptor affinity, estrogenic and antiestrogenic properties, and mammary tumor inhibiting activity.",J. Med. Chem.,PUBLICATION,
5095983,CHEMBL196691,XEHXGRZQFPFESG-UHFFFAOYSA-N,,,P05067,BETA AMYLOID A4 PROTEIN,APP,,,16134939.0,INHIBITION,=,2.0,%,,cell_based,,,,,,,,,,,,Percent inhibition against beta-amyloid-42 (Abeta42) secretion was evaluated in human neuroglioma cells (H4-APP695NL) at 100 uM,Synthesis and biological activity of flurbiprofen analogues as selective inhibitors of beta-amyloid(1)(-)(42) secretion.,J. Med. Chem.,PUBLICATION,
3600006,CHEMBL1571070,QDXOYHGNVOZOOK-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
925376,CHEMBL1486253,DVVFBWOFBXMYAZ-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,562.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5834003,CHEMBL3804862,,,,P25021,HISTAMINE H2 RECEPTOR,HRH2,,,27007611.0,Kb,>,10000.0,NM,,,,,,,,,,,,,,Antagonist activity at human histamine H2 receptor expressed in sf9 cell membrane co-expressing Gsalphas assessed as inhibition of histamine-induced [35S]GTPgammaS binding incubated for 90 mins,Conformational Restriction and Enantioseparation Increase Potency and Selectivity of Cyanoguanidine-Type Histamine H4 Receptor Agonists.,J. Med. Chem.,PUBLICATION,
4861920,CHEMBL97702,WEXHXYWFZRDROO-UHFFFAOYSA-N,,,"P19490, P19493, P19491, P19492","GLUTAMATE RECEPTOR IONOTROPIC, AMPA",,,,,DISPLACEMENT,=,49.0,%,,,,,,,,,,,,,,Binding affinity for Ionotropic glutamate receptor AMPA was determined by the ability to displace [3H]AMPA in rat cortical membranes at 10 uM,,Bioorg. Med. Chem. Lett.,PUBLICATION,
5556772,CHEMBL91829,ZCBUQCWBWNUWSU-SFHVURJKSA-N,RUBOXISTAURIN,,Q16513,PROTEIN KINASE N2,PKN2,,,18183025.0,KD,=,1500.0,NM,,,,,,,,,,,,,,Binding constant for PKN2 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
3824656,CHEMBL1232074,RBZQWZODGBMNHX-USACIQFYSA-N,,,P45452,MATRIX METALLOPROTEINASE 13,MMP13,,,20965620.0,KI,=,1.7,NM,,,,,,,,,,,,,,Inhibition of MMP13 by fluorimetric assay,"Structure-based approach to nanomolar, water soluble matrix metalloproteinases inhibitors (MMPIs).",Eur. J. Med. Chem.,PUBLICATION,
3896588,CHEMBL1499111,RJQCDBSTSVHQLN-ATVHPVEESA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
489257,CHEMBL1502397,CADJXJZULCWBCH-ZHZULCJRSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
570664,CHEMBL1867452,CJEHVFDOGIJZJE-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5776086,CHEMBL3746159,,,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,26690914.0,Ki,=,412.0,NM,,,,,,,,,,,,,,Displacement of [3H]-Nalpha-methylhistamine from human recombinant histamine H3 receptor expressed in HEK293 cells after 90 mins,Chlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agents.,Bioorg. Med. Chem.,PUBLICATION,
794922,CHEMBL3194164,DHUMZMCCYVOXHN-QGMBQPNBSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5157995,CHEMBL1318784,XKWSCPZVMRRPBK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,1158.2,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5176369,CHEMBL1479538,XMSVFGRBSHYYAY-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
29141,,ABZSPJVXTTUFAA-UHFFFAOYSA-N,,,P17706,T-CELL PROTEIN-TYROSINE PHOSPHATASE,PTPN2,,,16407290.0,IC50,=,1600.0,NM,,,,,,,,,,,,,,,,,,
5856517,CHEMBL3808601,,,,P02769,SERUM ALBUMIN,,,,27089212.0,K,=,1.2,10'4/M,,,,,,,,,,,,,,Binding affinity to bovine serum albumin assessed as binding constant in absorption spectra by Benesie-Hildebrand plot analysis,Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin.,Eur. J. Med. Chem.,PUBLICATION,
2760443,CHEMBL499397,MPDHKCCXYPNZRH-PLBPPWJTSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,18950150.0,RATIO IC50,=,56.2,,,cell_based,,,,,CHO,,,,,,,Ratio of IC50 for drug to GLP1 for human GLP1R expressed in CHO cells by [125I]exendin(9-39) displacement assay,Influence of selective fluorination on the biological activity and proteolytic stability of glucagon-like peptide-1.,J. Med. Chem.,PUBLICATION,
1944676,CHEMBL1468335,JDMUFUINJWKLBE-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
545721,CHEMBL189643,CGGYRECKAHVGKU-WUFINQPMSA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,15863335.0,KI,=,1.3,NM,,,,,,,,,,,,,,Inhibitory constant against human Opioid receptor kappa using [3H]diprenorphine as radio ligand,Arylacetamide kappa opioid receptor agonists with reduced cytochrome P450 2D6 inhibitory activity.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4768651,CHEMBL2069988,VUVPTOUJAZYNDM-UHFFFAOYSA-N,,,"Q14432, Q13370",PHOSPHODIESTERASE 3,"PDE3A, PDE3B",,,22897945.0,INHIBITION,=,79.45,%,,,,,,,,,,,,,,Inhibition of PDE3 at 500 uM by Biomol Green quantizyme assay system,Synthesis and evaluation of novel 2-pyridone derivatives as inhibitors of phosphodiesterase3 (PDE3): a target for heart failure and platelet aggregation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2864744,CHEMBL281594,NAUWTFJOPJWYOT-UHFFFAOYSA-N,VANOXERINE,,O35505,VOLTAGE-DEPENDENT L-TYPE CALCIUM CHANNEL SUBUNIT ALPHA-1C,,,,22761000.0,IC50,=,320.0,NM,,cell_based,,,,,Ventricular myocyte,,,,,,,Inhibition of L-type calcium channel measured using whole-cell patch clamp in guinea pig ventricular myocytes,,Journal of Applied Toxicology,PUBLICATION,
4530446,CHEMBL416768,UUXLOYTVROETTQ-UHFFFAOYSA-N,,,P49286,MELATONIN RECEPTOR 1B,MTNR1B,,,9089668.0,KI,=,9.6,NM,,,,,,,,,,,,,,,,,,
240545,CHEMBL1385690,AYPWDUGRNFDGTN-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,562.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
1799450,CHEMBL1451302,INPPHCDHMWZOBY-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
662025,CHEMBL1645213,CTNKZIPRPHMVLZ-UHFFFAOYSA-N,WMS-1824,,Q60492,SIGMA-1 RECEPTOR,,,,21126878.0,KI,=,32.0,NM,,,,,,,,,,,,,,Displacement of [3H]-(+)-pentazocine from sigma1 receptor in guinea pig brain membrane by scintillation counting,"Synthesis, pharmacological activity and structure affinity relationships of spirocyclic s(1) receptor ligands with a (2-fluoroethyl) residue in 3-position.",Bioorg. Med. Chem.,PUBLICATION,
5040556,CHEMBL3677435,WYKWKTOTYQGRII-UHFFFAOYSA-N,,,Q9Y5X9,ENDOTHELIAL LIPASE,LIPG,,,,IC50,=,70.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Biological Assay. Endothelial lipase (EL) and hepatic lipase (HL) activities were measured using a fluorescent substrate, A10070, (Invitrogen, CA) doped into an artificial vesicle containing DMPG (Avanti Polar Lipids) as the excipient. Vesicles were prepared by combining 571 uL of 29 mM DMPG in a 1:1 mixture of MeOH and CHCl3 with 2000 uL of 1 mM A10070 in a 1:1 mixture of MeOH and CHCl3. The mixture was dried under nitrogen in multiple vials then resuspended in 20 mL total volume of 50 mM HEPES pH 8.0 buffer containing 50 mM NaCl and 0.2 mM EDTA. The sample was allowed to sit at room temperature for 15 min and then was sonicated 3x4 mins on ice with a Branson Sonicator using duty cycle 1. This preparation provides vesicles with a mole fraction of 0.11 for the FRET substrate.The enzymatic assay was measured using 384-well white Optiplates. Each well contained 20 uL of assay buffer (50 mM HEPES pH 8.0, 50 mM NaCl and 1 mM CaCl2) and 0.25 uL of a DMSO solution containing a compound.","Amide, urea or sulfone amide linked benzothiazole inhibitors of endothelial lipase",,PATENT,
4350690,CHEMBL1605776,UBNMTCZOZUIUHM-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3258385,CHEMBL1601549,OSCXEQXDSDJNKX-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
4372057,CHEMBL1594896,UDWLPPBHVNQRBL-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2724470,CHEMBL1990254,MLGGUGPIWDHBAI-UHFFFAOYSA-N,,,Q9H2G2,SERINE/THREONINE-PROTEIN KINASE 2,SLK,,,,KI,=,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: SLK,PUBCHEM BIOASSAY DATA SET,,DATASET,
42019,CHEMBL3213230,ACUQMMALPPXTQV-NTUHNPAUSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
134755,CHEMBL318409,ANIOYQXTAMMUKZ-UHFFFAOYSA-N,,,P06401,PROGESTERONE RECEPTOR,PGR,,,9464361.0,EC50,=,6.9,NM,,cell_based,,,,,CV-1,,,,,,,Agonistic activity was measured for modulation of hPR-B (human progesterone receptor) in co-transfected CV-1 cells.,"5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.",J. Med. Chem.,PUBLICATION,
3881660,CHEMBL3195316,RICBSTFZGAJTFJ-JJPRUIFNSA-N,,,P10145,INTERLEUKIN-8,CXCL8,,,,IC50,,79000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose Response confirmation of uHTS small molecule hits for cystic fibrosis induced NFkb Inhibitors in a TNFa-induced IL8 counterscreen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1957826,CHEMBL1518238,JFDSWNVPWSBOMS-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2403868,CHEMBL3326556,LCDAETYKSLPKDG-UHFFFAOYSA-N,,,Q86V86,SERINE/THREONINE-PROTEIN KINASE PIM3,PIM3,,,25087047.0,ACTIVITY,=,8.0,%,,,,,,,,,,,,,,Inhibition of full-length human PIM3 using RSRHSSYPAGT as substrate assessed as residual kinase activity at 1 uM after 30 mins in presence of [gamma-33P]ATP,"Synthesis of pyrazolo[4,3-a]phenanthridines, a new scaffold for Pim kinase inhibition.",Bioorg. Med. Chem.,PUBLICATION,
435181,CHEMBL1515540,BUAWUYUQLBPGDW-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1913903,CHEMBL37883,JAHHZJFOTROQSY-UHFFFAOYSA-N,,,P43140,ALPHA-1A ADRENERGIC RECEPTOR,,,,12672251.0,PKB,=,6.16,,,,,,,,,,,,,,,Inhibition of (-)-noradrenaline-induced contraction of rat prostatic vas deferens (alpha1A receptor),"1,3-dioxolane-based ligands as a novel class of alpha1-adrenoceptor antagonists.",J. Med. Chem.,PUBLICATION,
883762,CHEMBL3416539,DRAKQXYVTUXDED-UHFFFAOYSA-N,,,Q07794,HISTONE ACETYLTRANSFERASE RTT109,,,,25634295.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of Vps75-stimulated recombinant Saccharomyces cerevisiae histone acetyltransferase Rtt109 assessed as H3K56 acetylated product at 125 uM after 45 mins by Slot bolt inhibiton assay,PAINS in the assay: chemical mechanisms of assay interference and promiscuous enzymatic inhibition observed during a sulfhydryl-scavenging HTS.,J. Med. Chem.,PUBLICATION,
5598109,CHEMBL239049,ZGJRZDNEIXHOTP-UHFFFAOYSA-N,,,P35557,HEXOKINASE TYPE IV,GCK,,,19758809.0,FC,=,1.15,,,,,,,,,,,,,,,Activation of human glucokinase expressed in Escherichia coli BL21(DE3) at 10 uM by G6PDH-coupled spectrometry relative to untreated control,Benzamide derivatives as dual-action hypoglycemic agents that inhibit glycogen phosphorylase and activate glucokinase.,Bioorg. Med. Chem.,PUBLICATION,
2031240,CHEMBL1482875,JNKVVULKSRWDGT-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,67455.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2136679,CHEMBL2035070,JYVHKHHKUPLYOZ-UHFFFAOYSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,22534184.0,EC50,>,10000.0,NM,,cell_based,,,,,,,,,,,,Transactivation activity at human PPARgamma expressed in african green monkey CV1 cells after 24 hrs by luciferase reporter gene assay,"Discovery, design and synthesis of Y-shaped peroxisome proliferator-activated receptor d agonists as potent anti-obesity agents in vivo.",Eur. J. Med. Chem.,PUBLICATION,
271139,CHEMBL1306387,BCBWOAAFWNQNCC-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,251.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3838107,CHEMBL1459302,RDNAXDDXGRTCSE-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
887447,CHEMBL1338130,DRJKQVBCCZPBQB-UHFFFAOYSA-N,,,"Q01196, Q13951",RUNT-RELATED TRANSCRIPTION FACTOR 1/CORE-BINDING FACTOR SUBUNIT BETA,"CBFB, RUNX1",,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1389902,CHEMBL1585646,GVDHYLXQXGOMBI-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4528689,CHEMBL1742079,UUTDWTOZAWFKFW-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5727401,CHEMBL1570069,ZUVPLKVDZNDZCM-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,37650.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5811210,CHEMBL3797492,,,,"P49810, Q9NZ42, Q92542, Q96BI3, P49768, Q8WW43",GAMMA-SECRETASE,"APH1A, APH1B, NCSTN, PSEN1, PSEN2, PSENEN",,,27038496.0,Inhibition,=,90.0,%,,,,,,,,,,,,,,Inhibition of human gamma-secretase assessed as inhibition of amyloid beta 40 production using recombinant APP C100FLAG as substrate at 100 uM after 4 hrs by ELISA relative to control,Part 3: Notch-sparing -secretase inhibitors: SAR studies of 2-substituted aminopyridopyrimidinones.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5017310,CHEMBL1421059,WVUKBGUNJPPZKT-UHFFFAOYSA-N,,,P15917,ANTHRAX LETHAL FACTOR,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5731941,CHEMBL1576852,ZVHTWMGONKMROW-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5199257,CHEMBL13485,XPLJEFSRINKZLC-ATVHPVEESA-N,SU-11652,,Q13554,CAM KINASE II BETA,CAMK2B,wild_type,,22037377.0,ACTIVITY,=,27.25849592,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,AUTOCAMTIDE 2 + CA-CAM,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2598018,CHEMBL577623,LXESHIPCIIXEDS-GTZBIZLUSA-N,,,P03372,ESTROGEN RECEPTOR ALPHA,ESR1,,,20031420.0,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]estradiol from human recombinant ERalpha by liquid scintillation counting,Click synthesis of estradiol-cyclodextrin conjugates as cell compartment selective estrogens.,Bioorg. Med. Chem.,PUBLICATION,
1979991,CHEMBL131963,JHNZWHOSOLPGTO-UHFFFAOYSA-N,,,P10275,ANDROGEN RECEPTOR,AR,,,10743937.0,IC50,=,675.0,NM,,cell_based,,,,,CV-1,,,,,,,Inhibitory concentration against human androgen receptor (AR) dependent transcriptional activity in co-transfected mammalian CV-1 cells,"Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1064244,CHEMBL1390789,FKWLZMUXZBBGAF-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,2592.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5819388,CHEMBL3785410,,,,P36544,NEURONAL ACETYLCHOLINE RECEPTOR PROTEIN ALPHA-7 SUBUNIT,CHRNA7,,,26994846.0,EC50,>,20000.0,NM,,,,,,,,,,,,,,Agonist activity at human alpha7 nAChR expressed in xenopus oocytes preincubated for 10 mins followed by acetylcholine addition by patch clamp electrophysiological assay,Synthesis and biological activities of indolizine derivatives as alpha-7 nAChR agonists.,Eur. J. Med. Chem.,PUBLICATION,
1221850,CHEMBL1395,GCKMFJBGXUYNAG-HLXURNFRSA-N,METHYLTESTOSTERONE,,P20309,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M3 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
5684122,CHEMBL3192339,ZPYNAHTZNISFMM-LSHDLFTRSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18348.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2536636,CHEMBL1475996,LQNVTQFKSNPGPJ-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1503625,CHEMBL3189239,HHFNQUCCEKLAEU-LKUDQCMESA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5829764,CHEMBL3799104,,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,27161878.0,Inhibition,=,1.0,%,,,,,,,,,,,,,,Displacement of [3H]-ZM241385 from human adenosine A2A receptor expressed in CHO cell membranes at 1 uM after 60 mins by scintillation counting method relative to control,"Exploring the 2- and 5-positions of the pyrazolo[4,3-d]pyrimidin-7-amino scaffold to target human A1 and A2A adenosine receptors.",Bioorg. Med. Chem.,PUBLICATION,
872749,CHEMBL1604821,DPYHNEPEJIWDCT-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3660906,CHEMBL262433,QKPLUKMJEKRAJD-UHFFFAOYSA-N,,,Q9Y6M4,CASEIN KINASE I ISOFORM GAMMA-3,CSNK1G3,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CSNK1G3,PUBCHEM BIOASSAY DATA SET,,DATASET,
3362597,CHEMBL3215572,PDPOGRRGKZVQCR-UHFFFAOYSA-N,,,P56817,BETA-SECRETASE 1,BACE1,,,19663388.0,INHIBITION,=,14.5,%,,,,,,,,,,,,,,Inhibition of human recombinant BACE1 at 2.5 uM by fluorimetric assay,"Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds.",J. Med. Chem.,PUBLICATION,
4193370,CHEMBL1501516,SQOPDKUJMANOTR-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5333242,CHEMBL23865,YDPOZFIBKFKFMB-UHFFFAOYSA-N,4-FLUOROPHENYL SULFAMATE,,P00918,CARBONIC ANHYDRASE II,CA2,,,19632111.0,KINACT,=,74.0,NM,,,,,,,,,,,,,,Inhibition of human CA2 by stopped flow CO2 hydration assay,Carbonic anhydrase inhibitors; fluorinated phenyl sulfamates show strong inhibitory activity and selectivity for the inhibition of the tumor-associated isozymes IX and XII over the cytosolic ones I and II.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1711916,CHEMBL1215643,IDPLIEOQLDDUNY-UHFFFAOYSA-N,,,Q15139,PROTEIN KINASE C MU,PRKD1,,,20684591.0,IC50,=,2.0,NM,,,,,,,,,,,,,,Inhibition of PKD1 by TR-FRET assay,Identification of orally available naphthyridine protein kinase D inhibitors.,J. Med. Chem.,PUBLICATION,
2847703,CHEMBL1389849,MYUGDVSOIJKJHT-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3802090,CHEMBL42,QZUDBNBUXVUHMW-UHFFFAOYSA-N,CLOZAPINE,,P28223,SEROTONIN 2A (5-HT2A) RECEPTOR,HTR2A,,,9225287.0,KI,=,10.96,NM,,,,,,,,,,,,,,,,,,
3508595,CHEMBL129542,PTKHFRNHJULJKT-UHFFFAOYSA-N,JNJ-5207852,,Q9Y5N1,HISTAMINE H3 RECEPTOR,HRH3,,,16300945.0,KD,=,0.8320000000000001,NM,,cell_based,,,,,SK-N-MC,,,,,,,Activity against human histamine H3 receptor by histamine induced inhibition of forskolin stimulated cAMP accumulation in SK-N-MC cells,Aplysamine-1 and related analogs as histamine H3 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3542029,CHEMBL2172522,PXCULAPXMKABRM-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,26141910.0,FC,=,8.7,,,cell_based,,,,,,,,,,,,Binding affinity to human adenosine A1 receptor expressed in CHO cells assessed as fold Ki shift of CCPA at 10 uM after 90 mins by [3H]-CCPA displacement assay relative to control,Synthesis and biological evaluation of a new series of 2-amino-3-aroyl thiophene derivatives as agonist allosteric modulators of the A1 adenosine receptor. A position-dependent effect study.,Eur. J. Med. Chem.,PUBLICATION,
243022,CHEMBL2031858,AYXUGNAPZHLRMC-TWCSMJBVSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,22579420.0,EMAX,,,,,cell_based,,,,,,,,,,,,Transactivation of human PPARgamma expressed in african green monkey CV1 cells at 30 uM by luciferase reporter gene assay relative to troglitazole,Total synthesis and dual PPARa/¿ agonist effects of Amorphastilbol and its synthetic derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2936119,CHEMBL3234570,NINLJGBDNUJAET-OAQYLSRUSA-N,,,Q8TDU6,G-PROTEIN COUPLED BILE ACID RECEPTOR 1,GPBAR1,,,24666203.0,EC50,=,1.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human TGR5 expressed in Jurkat cells assessed as intracellular cAMP level after 1 hr by HTRF assay,"Discovery of trifluoromethyl(pyrimidin-2-yl)azetidine-2-carboxamides as potent, orally bioavailable TGR5 (GPBAR1) agonists: structure-activity relationships, lead optimization, and chronic in vivo efficacy.",J. Med. Chem.,PUBLICATION,
1299553,CHEMBL1771,GKTWGGQPFAXNFI-HNNXBMFYSA-N,CLOPIDOGREL,,P08311,CATHEPSIN G,CTSG,,,,IC50,,,,,tissue,,,,,,,,,,,,"DRUGMATRIX: Protease, Cathepsin G enzyme inhibition (substrate: Suc-Ala-Ala-Pro-Phe-AMC)",DrugMatrix in vitro pharmacology data,,DATASET,
4612935,CHEMBL1431783,VDTIAGVTHWFQKM-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2323614,CHEMBL1323090,KTBHDQNJXBFQRU-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2906187,CHEMBL329706,NFMADGYJLRYPSL-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1792366,CHEMBL382590,IMYVCWQAHSYYOO-UHFFFAOYSA-N,ANILINOQUINAZOLINE1,,Q9NWZ3,INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4,IRAK4,wild_type,,23398362.0,ACTIVITY,=,115.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of IRAK4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1388083,CHEMBL1515006,GUXBRDJSKMCQOX-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4930545,CHEMBL134888,WMFDFSMUXDGMBY-VUCKYWBMSA-N,,,P52020,SQUALENE MONOOXYGENASE,,,,8308869.0,IC50,=,0.87,NM,,,,,,,,,,,,,,Tested in vitro in rat liver squalene synthase assay (RLSS),Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition.,J. Med. Chem.,PUBLICATION,
4896278,CHEMBL1542930,WIMYONIKOLZLBM-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
37303,CHEMBL1461353,ACIVJTXNWZWPJR-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1740605,CHEMBL383705,IHBAVXVTGLANPI-QMMMGPOBSA-N,,,P27487,DIPEPTIDYL PEPTIDASE IV,DPP4,,,14584950.0,IC50,=,4000.0,NM,,,,,,,,,,,,,,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),"Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.",J. Med. Chem.,PUBLICATION,
4166720,CHEMBL585656,SNPULDFVHOUJEE-UHFFFAOYSA-N,GNF-PF-4300,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3312212,CHEMBL1441191,OXVDQYDHDVMVMK-PTNGSMBKSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,23934.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2193342,CHEMBL1331734,KFAKESMKRPNZTM-UHFFFAOYSA-N,,,O00141,SERINE/THREONINE-PROTEIN KINASE SGK1,SGK1,wild_type,,23398362.0,ACTIVITY,=,82.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,90.0,uM,"Millipore: Percentage of residual kinase activity of SGK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
396078,CHEMBL1407282,BPODIEMZYKITCO-QIROLCGISA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,12995.3,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4043273,CHEMBL1436501,RZTUWNMVPPLKQE-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4345116,CHEMBL3192381,UAZWHAJIINOVKI-VXLYETTFSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,26679.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
919959,CHEMBL3198453,DVCFPZMWHDJJJB-LICLKQGHSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2699384,,MIPHERPUAFQKEK-UHFFFAOYSA-N,,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,3.03,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1670974,CHEMBL381948,HZJPBOLTWHOKEL-UHFFFAOYSA-N,GW680975X,,Q12851,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 2,MAP4K2,,,,INHIBITION,=,1.6,%,,,,,,,,,,,,,,GSK_PKIS: MAP4K2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3347175,CHEMBL1598969,PBTUWXCLUPICOD-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2670560,CHEMBL3641071,MFDJOPKRSLEWGD-UHFFFAOYSA-N,,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,,IC50,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: kinase Assay. The final concentration of DMSO is 5%. 10 µL of the B-Raf (V600E)-kinase solution are pipetted in (containing 0.5 ng B-Raf (V600E)-kinase in 20 mM Tris-HCl pH 7.5, 0.1 mM EDTA, 0.1 mM EGTA, 0.286 mM sodium orthovanadate, 10% glycerol, 1 mg/mL bovine serum albumin, 1 mM dithiothreitol) and the mixture is incubated for 24 h at RT under with shaking. The kinase reaction is started by the addition of 20 µL ATP solution [final concentration: 250 µM ATP, 30 mM Tris-HCl pH 7.5, 0.02% Brij, 0.2 mM sodium orthovanadate, 10 mM magnesium acetate, 0.1 mM EGTA, phosphatase cocktail (Sigma, # P2850, dilution recommended by the manufacturer), 0.1 mM EGTA] and 10 µL MEK1 solution [containing 50 ng biotinylated MEK1 (prepared from purified MEK1 according to standard procedure, e.g. with EZ-Link Sulpho-NHS-LC-Biotin reagent, Pierce, #21335) and carried out for 60 min at RT with constant shaking.","Pyrido [5, 4-D] pyrimidines as cell proliferation inhibitors",,PATENT,
2691724,CHEMBL2003420,MHRZYVYAAMLZJC-UHFFFAOYSA-N,,,P53778,MAP KINASE P38 GAMMA,MAPK12,,,,KI,>,6309.57,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK12,PUBCHEM BIOASSAY DATA SET,,DATASET,
4539295,CHEMBL1515189,UVXWXLKXIYWKRS-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,2909.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5114134,CHEMBL343951,XGFSECKOYNLTFU-AQHLSBRRSA-N,N-2-METHYLNAPHTHYL STRYCHNINE IODIDE,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,9986715.0,COOPERATIVITY,=,2.0,,,,,,,,,,,,,,,Cooperativity with NMS at human muscarinic acetylcholine receptor M1,Allosteric interactions of quaternary strychnine and brucine derivatives with muscarinic acetylcholine receptors.,J. Med. Chem.,PUBLICATION,
2402725,CHEMBL1421793,LBZGPEASBGJRIL-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,6745.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3303173,CHEMBL1477069,OWVXBNHIVJRULJ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
527479,CHEMBL1437588,CEIMEGAMWXIDKU-UHFFFAOYSA-N,,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,,26121.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Acumen qHTS Assay for Inhibitors of the mTORC1 Signaling Pathway in MEF (Tsc2-/-, p53-/-) Cells: Sytravon. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2660, AID2666, AID2667, AID2668, AID2681, AID504465]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4452194,CHEMBL1443026,UMPZHICSSNFKIL-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2042000,CHEMBL2413097,JOPUUEPBDBDCNF-CXUHLZMHSA-N,,,O42275,ACETYLCHOLINESTERASE,,,,23810675.0,IC50,=,19054.61,NM,,,,,,,,,,,,,,Inhibition of electric eel AChE using acetylthiocholine iodide as substrate preincubated for 20 mins prior to substrate addition by Ellman's method,"Synthesis, evaluation and molecular dynamics study of some new 4-aminopyridine semicarbazones as an antiamnesic and cognition enhancing agents.",Bioorg. Med. Chem.,PUBLICATION,
1570467,CHEMBL1504645,HOFHTNOKYKHYFH-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,22.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5411946,CHEMBL1429838,YMJKWKQWOMYDND-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4848621,CHEMBL3250956,WDOCIKSRUBWQFT-REOHCLBHSA-N,,,P49088,ASPARAGINE SYNTHETASE,,,,22754.0,INHIBITION,=,25.8,%,,,,,,,,,,,,,,Inhibition of asparagine synthetase isolated from rat bearing Novikoff hepatoma cells using [14C]-L-aspartic acid as substrate at 2 mM incubated 15 mins prior to substrate addition measured after 30 mins,Potential inhibitors of L-asparagine biosynthesis. 4. Substituted sulfonamide and sulfonylhydrazide analogues of L-asparagine.,J. Med. Chem.,PUBLICATION,
3951994,CHEMBL1609117,RPQAFSUOQKXFMS-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
244550,CHEMBL1706390,AZBPIUIVISPLQZ-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3401103,CHEMBL445,PHVGLTMQBUFIQQ-UHFFFAOYSA-N,NORTRIPTYLINE,,Q690N0,PROGESTERONE RECEPTOR,,,,,IC50,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Progesterone radioligand binding (ligand: [3H] R-5020),DrugMatrix in vitro pharmacology data,,DATASET,
4744098,CHEMBL1337907,VSDOZKUBBYNSHF-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,1995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 1467, 2100, 2112, 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5356924,CHEMBL575228,YGGFBJKJOQHWKO-UHFFFAOYSA-N,,,P32397,PROTOPORPHYRINOGEN OXIDASE,,,,19540767.0,KI,=,4786.3,NM,,,,,,,,,,,,,,Inhibition of Bacillus subtilis Protoporphyrinogen oxidase by capillary electrophoresis,"Bioactive conformation analysis of cyclic imides as protoporphyrinogen oxidase inhibitor by combining DFT calculations, QSAR and molecular dynamic simulations.",Bioorg. Med. Chem.,PUBLICATION,
3048441,CHEMBL355001,NVBFHJWHLNUMCV-UHFFFAOYSA-N,SULFAMIDE,,B5SU02,ALPHA CARBONIC ANHYDRASE,,,,21208801.0,KI,=,0.01,NM,,,,,,,,,,,,,,Inhibition of Stylophora pistillata carbonic anhydrase by stopped-flow CO2 hydration assay,Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5570038,CHEMBL3310023,ZDMISNIHKZAHFI-RQLCIQNHSA-N,,,P27338,MONOAMINE OXIDASE B,MAOB,,,24986657.0,KI,=,520.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human MAOB expressed in baculovirus-infected BTI insect cells assessed as H2O2 production by resorufin dye based fluorimetric method,Synthesis of some novel hydrazone and 2-pyrazoline derivatives: monoamine oxidase inhibitory activities and docking studies.,Bioorg. Med. Chem. Lett.,PUBLICATION,
589560,CHEMBL484521,CLEZOYKYQIRFRF-ZENAZSQFSA-N,CER-0263706,,P45984,C-JUN N-TERMINAL KINASE 2,MAPK9,,,18479119.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Inhibition of JNK2 at 10 uM by HTRF assay relative to control,Development and experimental validation of a docking strategy for the generation of kinase-targeted libraries.,J. Med. Chem.,PUBLICATION,
4011797,CHEMBL214205,RWIVICVCHVMHMU-UHFFFAOYSA-N,2-MORPHOLINOETHANAMINE,,P00918,CARBONIC ANHYDRASE II,CA2,,,23294703.0,KA,=,190.0,NM,,,,,,,,,,,,,,Activation of human recombinant CA2 by stopped flow CO2 hydrase method,"The extremo-a-carbonic anhydrase (CA) from Sulfurihydrogenibium azorense, the fastest CA known, is highly activated by amino acids and amines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
5334784,CHEMBL531611,YDVUTDAMJFFBOB-UHFFFAOYSA-N,MMV665927,,O77239,CDK-RELATED PROTEIN KINASE 6,,,,,IC50,>,1000.0,NM,,,,,,,,,,,,,,"MMV: PK6 Protein kinase inhibition assay using recombinant PfPK6, Myelin Basic Protein (MBP) substrate, ATP and KinaseGlo to measure % inhibition at 1 uM MMV box compound. Final concentrations were 1.5 µM ATP, 5 mM MnCl2, and 15 µg/ml PK6 in a buffer of 100 mM Tris-HCl (pH 7.5). 50 µg/mL MBP was provided as the substrate; 10 µM staurosporine was used as a control inhibitor. Incubation time was 3 hours and 40 minutes.The catalytic activity of each kinase was considered proportional to ATP consumed, as determined from measurements of residual [ATP] with the luciferase-based reagent Kinase-Glo (Promega) following incubation. Luminescence (proportional to residual [ATP]) was measured on the plate readers FLx800 (BioTek Instruments, Winooski, VT, USA) and MicroBeta2.",MMV Box screening against Plasmodium falciparum protein kinases and aminoacyl tRNA synthetases.,,DATASET,
2021463,CHEMBL1536878,JMIHJEGISAXHQH-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4950997,CHEMBL1333387,WOPYYPZSSDEEGF-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2953701,CHEMBL3329684,NKKNQMFHKZEGQU-KQWNVCNZSA-N,,,P12931,TYROSINE-PROTEIN KINASE SRC,SRC,,,25089810.0,INHIBITION,=,20.0,%,,,,,,,,,,,,,,Inhibition of c-Src (unknown origin) at 1 uM,Novel acylureidoindolin-2-one derivatives as dual Aurora B/FLT3 inhibitors for the treatment of acute myeloid leukemia.,Eur. J. Med. Chem.,PUBLICATION,
458566,CHEMBL489943,BWURKXKNKUNIAG-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,316.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3223379,CHEMBL3426468,OODLQVULCFDNPD-VEOUJPFZSA-N,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,25856545.0,ACTIVITY,=,101.2,,,cell_based,,,,,,,,,,,,Inhibition of P-gp in human MCF7/ADR cells assessed as side scatter count of cells at 10 uM pre-treated for 1 hr at 37 degC followed by incubation with Rh123 for 1 hr by flow cytometry (Rvb = 100.6 No unit),Lathyrol diterpenes as modulators of P-glycoprotein dependent multidrug resistance: structure-activity relationship studies on Euphorbia factor L3 derivatives.,J. Med. Chem.,PUBLICATION,
485391,CHEMBL1580137,BZRPVXSNCKPEGC-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4052214,CHEMBL3660083,SAVPCTYZGZDSSO-HOCLYGCPSA-N,,,O70444,SERINE/THREONINE-PROTEIN KINASE PIM-3,,,,,IC50,=,248.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: PIM-3 Enzyme Assay. The assay for the determination of PIM activity is based on the incorporation of [33P] ATP into PIM2tide substrate and capture of the radiolabeled peptide onto a Whatman P81 (phosphocellulose) filter plate. Assay mixtures contained 30 uM [gamma-33P] ATP (20 uCi/mL), 3.75 uM PIM2tide and 0.5 nM recombinant rat PIM-3 in place of PIM-1.",Triazolopyridine compounds as PIM kinase inhibitors,,PATENT,
4577599,CHEMBL1451573,UZWYUGMPNWKWFC-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,56.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3837973,CHEMBL1312504,RDMPFGRXTJLVOB-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4170007,CHEMBL1582133,SNZYTTZBDBQBPN-UHFFFAOYSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
1633153,CHEMBL1488499,HVKBDHDQWGYXTP-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,1258.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5365943,CHEMBL2348675,YHHNVBABVWLSCW-UHFFFAOYSA-N,,,Q1A7N1,TRANSIENT RECEPTOR POTENTIAL M8 PROTEIN,,,,23411075.0,IC50,=,11.0,NM,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at dog TRPM8 expressed in HEK293 cells assessed as inhibition of icilin-induced calcium influx incubated for 5 mins prior to icilin induction measured after 5 mins by fluorescence assay,Arylglycine derivatives as potent transient receptor potential melastatin 8 (TRPM8) antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2525174,CHEMBL3545154,LPFWVDIFUFFKJU-UHFFFAOYSA-N,POZIOTINIB,,P42346,SERINE/THREONINE-PROTEIN KINASE MTOR,,wild_type,,21732342.0,IC50,>,10000.0,NM,inhibition,biochemical,functional,enzyme_activity,,,,,,,,,,INHIBITION OF RECOMBINANT HUMAN GST-TAGGED MTOR (1360 TO 2549 RESIDUES) CATALYTIC DOMAIN EXPRESSED IN BACULOVIRUS EXPRESSION SYSTEM,,INT J CANCER.,,
4282561,CHEMBL577752,TUESBQKXFVYGKJ-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5304681,CHEMBL1521619,YAPYNCGECVXNED-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4137152,CHEMBL3194929,SKIPNWLPMRDSBV-LFYBBSHMSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5067827,CHEMBL53400,XBGGUPMXALFZOT-VIFPVBQESA-N,GLY-TYR,,P46059,OLIGOPEPTIDE TRANSPORTER SMALL INTESTINE ISOFORM,SLC15A1,,,16759105.0,RATIO,=,870.0,,,,,,,,,,,,,,,Ratio of %GSmax to EC50 for human PEPT1 activation,Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.,J. Med. Chem.,PUBLICATION,
4569687,CHEMBL1579393,UYZKTGWOCRUXSU-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for inhibitors of Vif-A3G interactions: Cherry picks counterscreen. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3254873,CHEMBL3233841,ORRRPUSEMSKTEW-NEPJUHHUSA-N,,,P27487,DIPEPTIDYL PEPTIDASE IV,DPP4,,,24617858.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of DPP4 purified from human seminal plasma using Gly-Pro-p-nitroanilide as substrate by spectrophotometry,Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP).,J. Med. Chem.,PUBLICATION,
4499329,CHEMBL1347322,URNHOWGTBDZMBN-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2095986,CHEMBL8171,JUMVVVACUIUKIE-UHFFFAOYSA-N,,,P54833,BETA-2 ADRENERGIC RECEPTOR,,,,3001305.0,ID50,>,1.0,MG.KG-1,,,,,,,,,,,,,,The compound was tested for beta-2 adrenergic receptor blocking activity in dogs,[p-[(Thienylcarbonyl)amino]phenoxy]propanolamines derivatives as diuretic and beta-adrenergic receptor blocking agents.,J. Med. Chem.,PUBLICATION,
1274716,CHEMBL2151630,GIBMGWTWPPGMRU-INIZCTEOSA-N,,,P41594,METABOTROPIC GLUTAMATE RECEPTOR 5,GRM5,,,22975301.0,EC50,=,1200.0,NM,,cell_based,,,,,HEK293,,,,,,,Positive allosteric modulation of human mGluR5 expressed in recombinant HEK293 cells by FLIPR assay,Azetidinyl oxadiazoles as potent mGluR5 positive allosteric modulators.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5680404,CHEMBL1582111,ZPOXHEZPUFKFGC-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4300667,CHEMBL3622506,TWBAAPGODFMHCM-UHFFFAOYSA-N,,,O75173,ADAMTS4,ADAMTS4,,,26288689.0,IC50,=,8500.0,NM,,,,,,,,,,,,,,Inhibition of recombinant human ADAMTS4 (213 to 575 amino acid residues) using WAAG-3R as substrate preincubated for 15 mins followed by substrate addition measured every 30 secs for 1 hr,,ACS Med. Chem. Lett.,PUBLICATION,
4964604,CHEMBL38262,WQEPZBNLBWDIRZ-UHFFFAOYSA-N,,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,9873377.0,KI,=,2682.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]spiperone from human Dopamine receptor D3 expressed in CHO cells,Isoindolinone enantiomers having affinity for the dopamine D4 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2611723,CHEMBL1364193,LYUBETMMBKVDRM-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5168256,CHEMBL273916,XLXYOWSUVOIWNA-KAPZOZIZSA-N,,,P56817,BETA-SECRETASE 1,BACE1,,,16220977.0,KI,=,1129.0,NM,,,,,,,,,,,,,,Binding affinity for beta-secretase,"Hydroxyethylene sulfones as a new scaffold to address aspartic proteases: design, synthesis, and structural characterization.",J. Med. Chem.,PUBLICATION,
3632864,CHEMBL278041,QHKYPYXTTXKZST-UHFFFAOYSA-N,SB-202190,,Q16659,MITOGEN-ACTIVATED PROTEIN KINASE 6,MAPK6,,,18077363.0,THERMAL MELTING CHANGE,=,0.2,DEGREES C,,,,,,,,,,,,,,Delta TM value showing the stabilisation of ERK3 produced by compound binding,A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
3201118,CHEMBL50894,OLUKILHGKRVDCT-UHFFFAOYSA-N,ALSTERPAULLONE,,P22607,FIBROBLAST GROWTH FACTOR RECEPTOR 3,FGFR3,wild_type,,22037377.0,ACTIVITY,=,90.53309058,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,PEY + MN,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
805724,CHEMBL2419455,DIXPIAYWNUKBHL-UHFFFAOYSA-N,,,Q9NR97,TOLL-LIKE RECEPTOR 8,TLR8,,,23899291.0,ACTIVITY,,,,,cell_based,,,,,HEK293,,,,,,,Modulation of human TLR8 expressed in HEK293 cells co-transfected with MD2 and sAP assessed as induction of NF-kappaB activity by reporter gene assay,"Exquisite selectivity for human toll-like receptor 8 in substituted furo[2,3-c]quinolines.",J. Med. Chem.,PUBLICATION,
4224125,CHEMBL3213053,STVUQYNUZOQKKO-LSHDLFTRSA-N,,,Q27686,PYRUVATE KINASE,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
658382,CHEMBL1164211,CTDJEYYLCBZVFQ-HALQZYIMSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,20452225.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at VDR in human SCC4 cells assessed as induction of CYP24 gene expression at 1 uM after 5 to 10 mins by RT-PCR analysis,Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids.,Bioorg. Med. Chem.,PUBLICATION,
181004,CHEMBL1789962,ASFADYMEYHSSND-UHFFFAOYSA-N,GW643971X,,P51813,TYROSINE-PROTEIN KINASE BMX,BMX,,,,INHIBITION,=,2.02,%,,,,,,,,,,,,,,GSK_PKIS: BMX mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
228083,CHEMBL1803078,AXGOMSKWSVKSPC-XFXZXTDPSA-N,,,"Q15078, Q00535",CYCLIN-DEPENDENT KINASE 5/CDK5 ACTIVATOR 1,"CDK5, CDK5R1",,,21615147.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant CDK5/p25 at 10 uM,"Leucettines, a class of potent inhibitors of cdc2-like kinases and dual specificity, tyrosine phosphorylation regulated kinases derived from the marine sponge leucettamine B: modulation of alternative pre-RNA splicing.",J. Med. Chem.,PUBLICATION,
3533600,CHEMBL1342330,PWDXMUGOYSJNDS-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2068987,CHEMBL1381251,JRPVSVZSUPSYOM-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4235912,CHEMBL394003,SVFGAFGHEBEAJE-UHFFFAOYSA-N,,,P78536,ADAM17,ADAM17,,,17606376.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibition of human TACE in human whole blood,Structure-based design of TACE selective inhibitors: manipulations in the S1'-S3' pocket.,Bioorg. Med. Chem.,PUBLICATION,
3161645,CHEMBL1481439,OHJVPEIXMPTHAG-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4205253,CHEMBL206946,SRQOBFXQILTASR-JTQLQIEISA-N,,,Q8JXU8,HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE,,,,16722622.0,IC50,>,20000.0,NM,,,,,,,,,,,,,,Inhibition of HCV NS5B RNA dependent RNA polymerase,Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site.,J. Med. Chem.,PUBLICATION,
3803125,CHEMBL3647382,QZUMZUIOXMTRMY-YQOPPWPCSA-N,,,O60502,BIFUNCTIONAL PROTEIN NCOAT,MGEA5,,,,KI,=,1.43,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acetyl-ß-D-glucosaminide dihydrate (Sigma M2133) dissolved in ddH2O, as a substrate. The amount of purified human O-GlcNAcase enzyme used in the reaction is 0.7 nM. Test compound of varying concentrations is added to the enzyme prior to initiation of the reaction. The reaction is performed at room temperature in a 96-well plate and is initiated with the addition of substrate. The production of fluorescent product is measured every 60 sec for 45 min with a Tecan Infinite M200 plate-reader with excitation at 355 nM and emission detected at 460 nM, with 4-Methylumbelliferone (Sigma M1381) used to produce a standard curve. The slope of product production is determined for each concentration of compound tested and plotted, using standard curve fitting algorithms for sigmoidal dose response curves.",Selective glycosidase inhibitors and uses thereof,,PATENT,
2737590,CHEMBL454791,MMNFZCWXLBJTKN-WJOKGBTCSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,18665579.0,ACTIVITY,>,30000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant CYP1A2 expressed in insect microsomes,"Discovery of (R)-4-(8-fluoro-2-oxo-1,2-dihydroquinazolin-3(4H)-yl)-N-(3-(7-methyl-1H-indazol-5-yl)-1-oxo-1-(4-(piperidin-1-yl)piperidin-1-yl)propan-2-yl)piperidine-1-carboxamide (BMS-694153): a potent antagonist of the human calcitonin gene-related peptide receptor for migraine with rapid and efficient intranasal exposure.",J. Med. Chem.,PUBLICATION,
792681,CHEMBL527996,DHNLBEMZYYHAJS-UHFFFAOYSA-N,TCMDC-125493,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,1.45,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2390064,CHEMBL29712,LANUFFUDCPUKAX-UHFFFAOYSA-N,,,B0BL08,DIHYDROFOLATE REDUCTASE,,,,3290487.0,KI,=,1.69824365246175e+16,NM,,,,,,,,,,,,,,Inhibition constant against binding of Escherichia coli dihydrofolate reductase,The hypothetical active site lattice. An approach to modelling active sites from data on inhibitor molecules.,J. Med. Chem.,PUBLICATION,
3061969,CHEMBL1342204,NWNVJUVZTWOJHG-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
110973,CHEMBL535844,AKLFWARHTOZNAH-UHFFFAOYSA-N,,,P41145,KAPPA OPIOID RECEPTOR,OPRK1,,,17428659.0,KI,=,295.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]diprenorphine from human KOP receptor expressed in CHO cell membranes,Synthesis and structure-activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
34364,CHEMBL160876,ACBZAFIQJQQSBY-UHFFFAOYSA-N,SB-360741,,P07948,TYROSINE-PROTEIN KINASE LYN,LYN,,,,INHIBITION,=,-2.02,%,,,,,,,,,,,,,,GSK_PKIS: LYN B (splice variant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1944716,CHEMBL1601518,JDMVKIDVDBNUND-UHFFFAOYSA-N,,,P55789,FAD-LINKED SULFHYDRYL OXIDASE ALR,GFER,,,,AC50,=,25784.0,NM,,biochemical,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488787],PUBCHEM BIOASSAY DATA SET,,DATASET,
1822618,CHEMBL1423723,IQEAIXDYKIYSCN-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
215215,CHEMBL1349935,AVQOOBAITMINRK-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
1752277,CHEMBL153594,IIIAAMCKBYJVOM-HXUWFJFHSA-N,,,P07872,PALMITOYL-COA OXIDASE,,,,14698201.0,INHIBITION,=,40.0,%,,,,,,,,,,,,,,Inhibition of rat heart mitochondrial Palmitoyl-CoA oxidation at 30 uM,New fatty acid oxidation inhibitors with increased potency lacking adverse metabolic and electrophysiological properties.,Bioorg. Med. Chem. Lett.,PUBLICATION,
696068,CHEMBL1709527,CXAYOCVHDCXPAI-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2152013,CHEMBL1987679,KAKGFGCTONHQJW-UHFFFAOYSA-N,,,P51955,SERINE/THREONINE-PROTEIN KINASE NEK2,NEK2,,,,KI,>,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: NEK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
457247,CHEMBL312717,BWQAEQBADOVIBT-UHFFFAOYSA-N,,,Q07869,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA,PPARA,,,15546740.0,EC50,=,69.0,NM,,,,,,,,,,,,,,Transactivation activity for human Peroxisome proliferator activated receptor alpha,Conversion of human-selective PPARalpha agonists to human/mouse dual agonists: a molecular modeling analysis.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3399003,CHEMBL425534,PHOBNPDRNIKURV-UHFFFAOYSA-N,KYS-05050,,O43497,VOLTAGE-GATED T-TYPE CALCIUM CHANNEL ALPHA-1G SUBUNIT,CACNA1G,,,15603940.0,INHIBITION,=,83.8,%,,cell_based,,,,,HEK293,,,,,,,Percent inhibition of T-type [Ca2+] channel (alpha1G) expressed in HEK293 cells at 10 uM,"Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4692777,CHEMBL566360,VMNZUPVQRSMAAG-UHFFFAOYSA-N,,,P32239,CHOLECYSTOKININ B RECEPTOR,CCKBR,,,19811913.0,KI,=,398.11,NM,,,,,,,,,,,,,,Displacement of [125I]-CCK-8S from CCK2R after 100 mins by liquid scintillation counting,Anthranilic sulfonamide CCK1/CCK2 dual receptor antagonists I: discovery of CCKR1 selectivity in a previously CCKR2-selective lead series.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4677630,CHEMBL1423893,VKWCYZQYOGYGDV-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5222221,CHEMBL169587,XRUWVGMEGYVABH-UHFFFAOYSA-N,,,P97266,MU OPIOID RECEPTOR,,,,1847432.0,IC50,=,1600.0,NM,,,,,,,,,,,,,,In vitro binding activity against opioid receptor mu using [3H]DAGO) as radioligand,New 1-(heterocyclylalkyl)-4-(propionanilido)-4-piperidinyl methyl ester and methylene methyl ether analgesics.,J. Med. Chem.,PUBLICATION,
873814,CHEMBL1794073,DQBBVXOEACBXDP-UHFFFAOYSA-N,GW770220A,,Q06418,TYROSINE-PROTEIN KINASE RECEPTOR TYRO3,TYRO3,,,,INHIBITION,=,6.07,%,,,,,,,,,,,,,,GSK_PKIS: TYRO3 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2296303,CHEMBL1570364,KQFRMXRIJMTJPE-JXMROGBWSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4534990,CHEMBL1733081,UVKYDVGLOHTBMI-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,6309.6,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5146526,CHEMBL1418096,XJQWNXKLHDLZNT-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
464749,CHEMBL1402286,BXMFBVSLAAZQII-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
902776,CHEMBL1545399,DTDLLIWDDAEFBA-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1007647,CHEMBL1483639,FEPNJXLNQAAQTH-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1892624,CHEMBL1420135,IYAGELTYGVQHSV-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4897762,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,SUNITINIB,,P23458,TYROSINE-PROTEIN KINASE JAK1,JAK1,,,15711537.0,KD,=,9.2,NM,,,,,,,,,,,,,,Average Binding Constant for JAK1 (Kin.Dom. 1); NA=Not Active at 10 uM,A small molecule-kinase interaction map for clinical kinase inhibitors.,Nat. Biotechnol.,PUBLICATION,
2242574,CHEMBL1794066,KKMDOYLDYOJWIA-UHFFFAOYSA-N,GSK-619487A,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,,INHIBITION,=,4.12,%,,,,,,,,,,,,,,GSK_PKIS: BRAF (V599E mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5592960,CHEMBL190,ZFXYFBGIUFBOJW-UHFFFAOYSA-N,THEOPHYLLINE,,P29477,"NITRIC OXIDE SYNTHASE, INDUCIBLE",,,,,IC50,,,,,,,,,,,,,,,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",DrugMatrix in vitro pharmacology data,,DATASET,
3572998,CHEMBL16068,QARVLSVVCXYDNA-UHFFFAOYSA-N,BROMOBENZENE,,P08173,MUSCARINIC ACETYLCHOLINE RECEPTOR M4,CHRM4,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M4 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
641413,CHEMBL1367220,CRDWYIKYCUCPDM-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1189559,CHEMBL1090090,FYSRKRZDBHOFAY-UHFFFAOYSA-N,VX-702,,Q96RG2,PAS DOMAIN-CONTAINING SERINE/THREONINE-PROTEIN KINASE,PASK,wild_type,,22037377.0,ACTIVITY,=,103.0380091,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ZIPTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
5600520,CHEMBL2420507,ZGRZTJZRHOLFOO-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,23859074.0,IC50,>,200000.0,NM,,,,,,,,,,,,,,Inhibition of APE-1 (unknown origin) using double-stranded AP-site containing DNA as substrate after 30 mins by fluorescence assay,Toxoflavins and deazaflavins as the first reported selective small molecule inhibitors of tyrosyl-DNA phosphodiesterase II.,J. Med. Chem.,PUBLICATION,
1528997,CHEMBL1488035,HJXOIRIPJDWFBS-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2531992,CHEMBL1425684,LPYYRMZUHXFWBP-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2732738,CHEMBL160544,MLYWUDPUFFMOQV-BKUYFWCQSA-N,,,P17252,PROTEIN KINASE C ALPHA,PRKCA,,,14736244.0,KI,=,736.0,NM,,,,,,,,,,,,,,"Displacement of [20-3H]-phorbol 12,13-dibutyrate (PDBU) from protein kinase C alpha with phosphatidylserine","Conformationally constrained analogues of diacylglycerol. 20. The search for an elusive binding site on protein kinase C through relocation of the carbonyl pharmacophore along the sn-1 side chain of 1,2-diacylglycerol lactones.",J. Med. Chem.,PUBLICATION,
2461876,CHEMBL1459647,LIUGTYRLGGLNLO-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2117614,CHEMBL1597566,JWSXUZMEZMZHNO-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3918082,CHEMBL1577578,RLVDDIKGFIABJY-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3111505,CHEMBL1334179,OCFSEPBSLYJRJI-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2215804,CHEMBL1730768,KHMZGAATZFHXNK-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,398.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
600882,CHEMBL2218931,CMKMGFAUKPAOMG-CQSZACIVSA-N,,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,wild_type,,23398362.0,ACTIVITY,=,106.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of ABL1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1969038,CHEMBL589389,JGJNEIOIBJGSFV-UHFFFAOYSA-N,,,P35367,HISTAMINE H1 RECEPTOR,HRH1,,,19945877.0,IC50,=,104.0,NM,,cell_based,,,,,SK-N-SH,,,,,,,Antagonist activity at histamine H1 receptor in human SK-N-SH cells assessed as histamine-induced maximum intracellular calcium spike at phase 1 treated 10 to 15 seconds before histamine challenge,"Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indoles.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4460836,CHEMBL202891,UNNVAVXBYOPNHR-UHFFFAOYSA-N,GW679410X,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,INHIBITION,=,1.51,%,,,,,,,,,,,,,,GSK_PKIS: EGFR (L858R mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3053437,CHEMBL208840,NVONLYUUKCINFL-UHFFFAOYSA-N,,,P04150,GLUCOCORTICOID RECEPTOR,NR3C1,,,16821781.0,PIC50,,,,,cell_based,,,,,A549,,,,,,,Activity at GR assessed as ability to antagonize dexamethasone-induced MMTV luciferase reporter gene transactivation in human A549 cells,Dissociated nonsteroidal glucocorticoid receptor modulators; discovery of the agonist trigger in a tetrahydronaphthalene-benzoxazine series.,J. Med. Chem.,PUBLICATION,
1099764,CHEMBL1492059,FOUKFXNAPADHSF-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5531705,CHEMBL1450241,YZMLAJBOSVHFEW-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1635216,CHEMBL1472282,HVQSTRGEJFIASM-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3783526,CHEMBL243508,QXWBRFSVARVGTR-UHFFFAOYSA-N,,,P18031,PROTEIN-TYROSINE PHOSPHATASE 1B,PTPN1,,,17705360.0,KI,=,1700.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant PTP1B,Structure-based optimization of protein tyrosine phosphatase 1B inhibitors: from the active site to the second phosphotyrosine binding site.,J. Med. Chem.,PUBLICATION,
4842200,CHEMBL3330255,WCYCISQGDVZZOB-UHFFFAOYSA-N,,,P45984,C-JUN N-TERMINAL KINASE 2,MAPK9,,,25043312.0,INHIBITION,=,29.0,%,,,,,,,,,,,,,,Inhibition of human JNK2alpha2 at 1 uM by radiometric Assay,Discovery of inhibitors of the mitotic kinase TTK based on N-(3-(3-sulfamoylphenyl)-1H-indazol-5-yl)-acetamides and carboxamides.,Bioorg. Med. Chem.,PUBLICATION,
4460915,CHEMBL1360013,UNNVTXBVIMHXGU-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3819949,CHEMBL363424,RBLCSCFFNCADJO-XZATXCMXSA-N,,,P14780,MATRIX METALLOPROTEINASE 9,MMP9,,,16107143.0,KI,=,5.05,NM,,,,,,,,,,,,,,Inhibition of MOCAc-Pro-Leu-Gly-Leu-A2p (Dnp)-Ala-Arg-NH2 binding to human matrix metalloprotease-9 (MMP-9),"A combination of docking, QM/MM methods, and MD simulation for binding affinity estimation of metalloprotein ligands.",J. Med. Chem.,PUBLICATION,
1313229,CHEMBL1338772,GMFOBNBUCAYWBU-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3223744,CHEMBL331382,OOEMZCZWZXHBKW-SCFUHWHPSA-N,METRIFUDIL,,P28647,ADENOSINE A3 RECEPTOR,,,,15771421.0,KI,=,38.0,NM,,cell_based,,,,,CHO,,,,,,,Inhibition of [125I]AB-MECA binding to rat Adenosine A3 receptor expressed in CHO cells,"(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists.",J. Med. Chem.,PUBLICATION,
1780005,CHEMBL177577,ILOIOIGZFHGSMS-UHFFFAOYSA-N,OL-135,,P97612,ANANDAMIDE AMIDOHYDROLASE,,,,24456116.0,INHIBITION,,,,,,,,,,,,,,,,,Reversible inhibition of recombinant rat FAAH expressed in Escherichia coli assessed as remaining activity at IC80 preincubated for 3 hrs followed by 370 fold dilution measured after 18 hrs,"Design, Synthesis, and Characterization of a-Ketoheterocycles That Additionally Target the Cytosolic Port Cys269 of Fatty Acid Amide Hydrolase.",J. Med. Chem.,PUBLICATION,
2128552,CHEMBL1503549,JXXAXBSNOJUDFU-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1743443,CHEMBL266240,IHJCXVZDYSXXFT-UHFFFAOYSA-N,,,Q16790,CARBONIC ANHYDRASE IX,CA9,,,17540563.0,KINACT,=,39.0,NM,,,,,,,,,,,,,,Inhibition of human CA9 catalytic domain,"Carbonic anhydrase inhibitors: inhibition of human, bacterial, and archaeal isozymes with benzene-1,3-disulfonamides--solution and crystallographic studies.",Bioorg. Med. Chem. Lett.,PUBLICATION,
521689,CHEMBL1583319,CDPXZYGHQMCKPO-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2045178,CHEMBL462547,JOYRKODLDBILNP-UHFFFAOYSA-N,URETHANE,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,,KI,,,,,,,,,,Chem-1,,,,,,,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),DrugMatrix in vitro pharmacology data,,DATASET,
4897188,CHEMBL535,WINHZLLDWRZWRT-ATVHPVEESA-N,SUNITINIB,,Q02763,TYROSINE-PROTEIN KINASE TIE-2,TEK,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for TIE2 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4706331,CHEMBL1323208,VNVDPAPNZKLPEU-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
489659,CHEMBL3198860,CAEZKMVXBNAAGV-CVKSISIWSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1472085,CHEMBL217406,HEAUFJZALFKPBA-JPQUDPSNSA-N,NEUROKININ A,,P14600,NEUROKININ 1 RECEPTOR,,,,,IC50,=,31.0,NM,,,,,,,,,,,,,,Binding affinity towards Tachykinin receptor 1 in rat cerebral cortex membranes was determined by using 125 [I]-BHSP as radioligand,,Bioorg. Med. Chem. Lett.,PUBLICATION,
1119090,CHEMBL1384121,FQUYQZIFBQYCNB-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1678009,CHEMBL139598,IACZHXNOMCVUJH-UHFFFAOYSA-N,,,P30122,CHOLESTEROL ESTERASE,,,,,KI,=,9000.0,NM,,,,,,,,,,,,,,Dissociation constant (KI) for the Pancreatic cholesterol esterase-catalyzed hydrolysis of 4-nitrophenyl butyrate,,Bioorg. Med. Chem. Lett.,PUBLICATION,
2057103,CHEMBL1722269,JQIPTJVRSOKQHT-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,4610.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3399511,CHEMBL1084597,PHPQEIFINWDHDD-UHFFFAOYSA-N,,,O75116,RHO-ASSOCIATED PROTEIN KINASE 2,ROCK2,,,20471253.0,IC50,=,6.0,NM,,,,,,,,,,,,,,Inhibition of ROCK2 by luciferase based ATP detection assay,"Substituted 2H-isoquinolin-1-ones as potent Rho-kinase inhibitors: part 3, aryl substituted pyrrolidines.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2356776,CHEMBL1500751,KWNHPLRWRWAJHX-KRXBUXKQSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2539613,CHEMBL1473658,LQXMFIJCDCJSIO-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4315671,CHEMBL1645620,TXUYISCBMIUUDE-AXMZGBSTSA-N,,,Q02401,LACTASE-GLYCOSYLCERAMIDASE,,,,21185187.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of Wistar rat small intestine lactase at 1000 uM after 30 mins,"The synthesis and biological evaluation of 1-C-alkyl-l-arabinoiminofuranoses, a novel class of a-glucosidase inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3429547,CHEMBL342059,PKVBGKUACUZPER-UHFFFAOYSA-N,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,19501513.0,KI,=,2.8,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]NECA from human adenosine A2A receptor expressed in CHO cells,Combining selectivity and affinity predictions using an integrated Support Vector Machine (SVM) approach: An alternative tool to discriminate between the human adenosine A(2A) and A(3) receptor pyrazolo-triazolo-pyrimidine antagonists binding sites.,Bioorg. Med. Chem.,PUBLICATION,
4979742,CHEMBL514162,WRWFZZDBIJLBIJ-UHFFFAOYSA-N,GW852849X,,P10721,STEM CELL GROWTH FACTOR RECEPTOR,KIT,,,,INHIBITION,=,2.57,%,,,,,,,,,,,,,,GSK_PKIS: KIT (T6701 mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4943306,CHEMBL542972,WNSINUWAJFLIDC-UHFFFAOYSA-N,,,P08172,MUSCARINIC ACETYLCHOLINE RECEPTOR M2,CHRM2,,,1447741.0,KB,=,1899.0,NM,,,,,,,,,,,,,,Antimuscarinic activity to muscarinic acetylcholine receptor M2 from atria of guinea pig.,"Synthesis and antimuscarinic properties of some N-substituted 5-(aminomethyl)-3,3-diphenyl-2(3H)-furanones.",J. Med. Chem.,PUBLICATION,
5372485,CHEMBL1735619,YIAYGHSLPZOVGO-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,14575.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3966156,CHEMBL1577744,RREMDFFQJTXIGH-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
74297,CHEMBL1891085,AGEKBMLRLTVUGG-QGZVFWFLSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2850812,CHEMBL269941,MZDNYCYPYVLIBI-UHFFFAOYSA-N,,,P25963,NF-KAPPAB INHIBITOR ALPHA,NFKBIA,,,18024113.0,EFFICACY,=,50.0,%,,cell_based,,,,,,,,,,,,Induction of human IkappaBalpha stabilization in OCI-Ly3 cells by green light emiting IkappaBalpha-fused luciferase reporter gene assay relative to control,Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
676566,CHEMBL1334163,CUWXJFCSNROABJ-UHFFFAOYSA-N,,,P04406,GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE LIVER,GAPDH,,,,IC50,>,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: GAPDH Dose Response Colorimetric Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5003441,CHEMBL1375218,WULVWVCDFTYVOT-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,AC50,=,45350.0,NM,,biochemical,,,,,,,,,,,,PUBCHEM_BIOASSAY: JMJD2A counterscreen for GASC1 inhibitors Measured in Biochemical System Using Plate Reader - 2043-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2123],PUBCHEM BIOASSAY DATA SET,,DATASET,
536424,CHEMBL1478676,CFEYMTMIFIDHRN-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,1995.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
697672,CHEMBL92887,CXGGCNYHKKNQGW-UHFFFAOYSA-N,,,P21396,MONOAMINE OXIDASE A,,,,23353756.0,KI,>,630957.34,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]Ro 41-1049 from rat MAO-A receptor expressed in HEK293 cells,"Synthesis, pharmacological evaluation and QSAR modeling of mono-substituted 4-phenylpiperidines and 4-phenylpiperazines.",Eur. J. Med. Chem.,PUBLICATION,
2109639,CHEMBL365663,JVXFJMXCRSAZFH-UHFFFAOYSA-N,GW780159X,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,,INHIBITION,=,20.23,%,,,,,,,,,,,,,,GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3281231,CHEMBL3133038,OULBSCBVCFKZBI-UHFFFAOYSA-N,,,Q62226,SONIC HEDGEHOG PROTEIN,,,,,IC50,=,5.0,NM,,cell_based,,,,,,,,,,,,Inhibition of SHh in mouse LIGHT2 cells,,MedChemComm,PUBLICATION,
5415608,CHEMBL672,YMTINGFKWWXKFG-UHFFFAOYSA-N,FENOFIBRATE,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DrugMatrix in vitro pharmacology data,,DATASET,
1394415,CHEMBL109400,GVQANTPXHISKAG-PSWAGMNNSA-N,,,P33535,MU OPIOID RECEPTOR,,,,12852751.0,KI,=,399.0,NM,,tissue,,,,,,,,,,,,Binding affinity for Opioid receptor mu 1 using [3H]DAGO in rat brain P2 synaptosomal preparation,Unique high-affinity synthetic mu-opioid receptor agonists with central- and systemic-mediated analgesia.,J. Med. Chem.,PUBLICATION,
4871593,CHEMBL1309295,WFYQUXUBUIVSHZ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,25929.0,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1382570,CHEMBL1520507,GUHCWPAQANNICY-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
3019371,CHEMBL1503962,NRQZRFXIQMRNMR-UHFFFAOYSA-N,,,P18054,ARACHIDONATE 12-LIPOXYGENASE,ALOX12,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1474650,CHEMBL1602369,HEGDVHBPSHHNFL-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1114420,CHEMBL1605353,FQLWPRIXQKTKDA-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4125101,CHEMBL1305220,SIWDNRSKMNOEEX-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4089638,CHEMBL1526420,SFBIOLLOMCGUCC-LPRJTOQXSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
813143,CHEMBL1331045,DJTGGIYZQHHLGJ-RTBURBONSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4080962,CHEMBL1351232,SEDIYFLCPNQLEM-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2762998,CHEMBL1682315,MPLIZXJUJHPEKV-UHFFFAOYSA-N,,,P14174,MACROPHAGE MIGRATION INHIBITORY FACTOR,MIF,,,21277206.0,INHIBITION,=,83.0,%,,,,,,,,,,,,,,Inhibition of MIF in human PBMC assessed as MIF secretion at 100 uM after 5 hrs by ELISA,Synthesis and biological activity of novel MIF antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5237118,CHEMBL92318,XTLWXRWZKDAMBY-UHFFFAOYSA-N,,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,,IC50,=,2603.0,NM,,,,,,,,,,,,,,Compound was tested for binding affinity against Endothelin A receptor,,Bioorg. Med. Chem. Lett.,PUBLICATION,
439822,CHEMBL1370717,BUOFJLCNFUBXDR-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
678256,CHEMBL1332240,CVBYCSIAIVHEFX-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5090789,CHEMBL3133765,XDTLROCWMUHOGN-UHFFFAOYSA-N,,,Q13627,DUAL-SPECIFICITY TYROSINE-PHOSPHORYLATION REGULATED KINASE 1A,DYRK1A,,,26048785.0,INHIBITION,=,0.4,%,,,,,,,,,,,,,,Inhibition of Dyrk1A (unknown origin) using Woodtide as substrate at 0.5 uM after 30 mins by P81 membrane assay in presence of [33P]-g-ATP relative to control,Meridianin derivatives as potent Dyrk1A inhibitors and neuroprotective agents.,Bioorg. Med. Chem. Lett.,PUBLICATION,
425084,CHEMBL3589279,BTBIESGZHJNUQC-UHFFFAOYSA-N,,,Q9H2K2,TANKYRASE-2,TNKS2,,,26026769.0,INHIBITION,=,17.0,%,,,,,,,,,,,,,,Inhibition of human TNKS2 catalytic activity at 1 uM,"Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases.",Bioorg. Med. Chem.,PUBLICATION,
3492773,CHEMBL435324,PRRYSNSLFNBYDL-IGBKUBFESA-N,MEN-11558,,P21452,NEUROKININ 2 RECEPTOR,TACR2,,,11063600.0,KD,=,48.0,,,,,,,,,,,,,,,Compound was evaluated for Kd value against [3H]-SR- 48968 on the Tyr266Phe mutated human NK-2 receptor,Discovery of potent cyclic pseudopeptide human tachykinin NK-2 receptor antagonists.,J. Med. Chem.,PUBLICATION,
2737981,CHEMBL1537267,MMOPLUDAOXDRCY-UHFFFAOYSA-N,,,"Q01196, Q13951",RUNT-RELATED TRANSCRIPTION FACTOR 1/CORE-BINDING FACTOR SUBUNIT BETA,"CBFB, RUNX1",,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5083945,CHEMBL1872168,XCZVUQFWDYDGNG-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5661469,CHEMBL1408078,ZNPDQQQWUBOSSC-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
904743,CHEMBL1439006,DTJRCIGKNRVIKA-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
952009,CHEMBL1923393,DYPMFOVODKWNAU-PZBSVLGOSA-N,,,P06213,INSULIN RECEPTOR,INSR,,,22004721.0,KCAT,=,1.09,/S,,,,,,,,,,,,,,Activity of pre-activated human GST-His6-tagged InsR assessed as compound phosphorylation measured every 2 mins for 60 mins by ADP-Quest assay,Substrate profiling of IGF-1R and InsR: identification of a potent pentamer substrate.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3816801,CHEMBL167071,RBCPNDRFXKBOQT-CUNXSJBXSA-N,,,P29466,CASPASE-1,CASP1,,,16023344.0,IC50,=,6190.0,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human Caspase-1,Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4750993,CHEMBL1392179,VSVFHKKAQQVYDX-UHFFFAOYSA-N,,,O00167,EYES ABSENT HOMOLOG 2,EYA2,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939],PUBCHEM BIOASSAY DATA SET,,DATASET,
3098622,CHEMBL329609,OAUGIJWXGIUSTE-SRYIDKSASA-N,,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,7636842.0,IC50,=,320.0,NM,,,,,,,,,,,,,,Binding affinity against endothelin A receptor from rabbit renal vascular smooth muscles,Structure-activity relationships of the potent combined endothelin-A/endothelin-B receptor antagonist Ac-DDip16-Leu-Asp-Ile-Ile-Trp21: development of endothelin-B receptor selective antagonists.,J. Med. Chem.,PUBLICATION,
2998372,CHEMBL1427062,NPIUBZZUZQJJJE-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,9200.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1378076,CHEMBL280074,GTVPOLSIJWJJNY-UHFFFAOYSA-N,OLOMOUCINE,,,Cyclin-Dependent Kinase 1 (CDK1),,,,10465404.0,IC50,=,7000.0,NM,,,,,,,,,,,,,,,,,,
4631441,CHEMBL3357366,VFNTWLNLWCSFDA-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,25499880.0,EC50,=,9.6,NM,,cell_based,,,,,,,,,,,,Agonist activity at human CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production,"Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4936915,CHEMBL445420,WMZYZYFPPQOFKY-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5478140,CHEMBL370581,YTPUQGNBJYGJTB-UHFFFAOYSA-N,,,P50579,METHIONINE AMINOPEPTIDASE 2,METAP2,,,20621724.0,IC50,=,28000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human MetAP2 expressed in baculovirus infected Sf9 cells,Subtype-selectivity of metal-dependent methionine aminopeptidase inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1184894,CHEMBL1553178,FYFKITKMIROERM-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,29081.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2024731,CHEMBL111990,JMRDRIITSWYAPV-UHFFFAOYSA-N,,,"Q08499, P27815, Q07343, Q08493",PHOSPHODIESTERASE 4,"PDE4A, PDE4B, PDE4C, PDE4D",,,9379444.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibitory activity against Phosphodiesterase 4 from heart.,Selective inhibitors of cyclic AMP-specific phosphodiesterase: heterocycle-condensed purines.,J. Med. Chem.,PUBLICATION,
2287578,CHEMBL1340362,KPJSSYRKHIOJOK-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3646684,CHEMBL1576904,QJAMXYFLUKVTII-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
1319761,CHEMBL394619,GMYYMEOGFRKSFS-UHFFFAOYSA-N,,,Q96SB4,SERINE/THREONINE-PROTEIN KINASE SRPK1,SRPK1,wild_type,,21336281.0,KI,<,6309.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
3358153,CHEMBL101815,PDDBTWXLNJNICS-UHFFFAOYSA-N,"5-NITRO-[1,10]PHENANTHROLINE",,P05227,HISTIDINE-RICH PROTEIN,,,,15139771.0,INHIBITION,=,,,,,,,,,,,,,,,,Inhibition of beta-hematin formation; Not active,"In vitro antimalarial activity of a series of cationic 2,2'-bipyridyl- and 1,10-phenanthrolineplatinum(II) benzoylthiourea complexes.",J. Med. Chem.,PUBLICATION,
2447708,CHEMBL1311539,LHDYNGFEVDDAGP-YBEGLDIGSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
904445,CHEMBL446342,DTIOXMCBTYZRGU-NNRVVCJVSA-N,,,P25929,NEUROPEPTIDE Y RECEPTOR TYPE 1,NPY1R,,,19053784.0,KD,=,1.1,NM,,cell_based,,,,,SK-N-MC,,,,,,,Binding affinity to neuropeptide Y1 receptor in human SK-N-MC cells by kinetic experiment,Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist.,J. Med. Chem.,PUBLICATION,
3554882,CHEMBL1568108,PYQHFPSJUYBZLZ-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,5011.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4147659,CHEMBL1466003,SLPIRABVJGYWDC-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
492915,CHEMBL2369758,CAOPMDVFFKIBHG-WKHKIOIGSA-N,,,P30872,SOMATOSTATIN RECEPTOR 1,SSTR1,,,11312929.0,KI,=,1000.0,NM,,cell_based,,,,,CHO,,,,,,,Ability to displace [125 I]labelled Tyr11-somatostatin from human hsst-1 receptor expressed on CHO cells,Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.,J. Med. Chem.,PUBLICATION,
5852660,CHEMBL3764798,,,,P07333,MACROPHAGE COLONY STIMULATING FACTOR  RECEPTOR,CSF1R,,,26810260.0,Inhibition,=,10.56,%,,,,,,,,,,,,,,Inhibition of human FMS at 10 uM,"Discovery of highly selective CRAF inhibitors, 3-carboxamido-2H-indazole-6-arylamide: In silico FBLD design, synthesis and evaluation.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3572654,CHEMBL1593665,QARJYELLWUULEM-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3695194,CHEMBL1316514,QOGLSUYGRBMWCT-AZQJCYAJSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4277271,CHEMBL1522874,SZYIAAQXOVZXAH-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5096570,CHEMBL501882,XEKHYAPKOUIALX-UHFFFAOYSA-N,,,Q9QYN8,HISTAMINE H3 RECEPTOR,,,,,Ki,=,7.41,NM,,cell_based,,,,,,,,,,,,"BindingDB_Patents: Competition Binding Assay. The rat H3 receptor was cloned and expressed in cells, and competition binding assays carried out, according to methods previously described (see Esbenshade, et al. Journal of Pharmacology and Experimental Therapeutics 2005, 313, 165-175; Esbenshade et al., Biochemical Pharmacology 2004, 68, 933-945; and Krueger, et al. Journal of Pharmacology and Experimental Therapeutics 2005, 314, 271-281). Membranes were prepared from C6 or HEK293 cells, expressing the rat histamine H3 receptor, by homogenization on ice in TE buffer (50 mM Tris-HCl buffer, pH 7.4, containing 5 mM EDTA), 1 mM benzamidine, 2 ug/ml aprotinin, 1 ug/ml leupeptin, and 1 ug/ml pepstatin. The homogenate was centrifuged at 40,000 g for 20 minutes at 4 C. This step was repeated, and the resulting pellet was resuspended in TE buffer. Aliquots were frozen at -70 C. until needed. On the day of assay, membranes were thawed and diluted with TE buffer.",4-substituted-2-amino-pyrimidine derivatives,,PATENT,
3248090,CHEMBL1729967,OQXWBQJXLRLGSS-ACRUOGEOSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2793189,CHEMBL1466856,MTCDQQWJRCDICU-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3071766,CHEMBL189353,NXPQZPWXVHIWGN-UHFFFAOYSA-N,GW809897X,,P08922,PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS,ROS1,,,,INHIBITION,=,33.46,%,,,,,,,,,,,,,,GSK_PKIS: ROS mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
98476,CHEMBL214029,AIZMFPJJDXEQKC-SXLOSVNLSA-N,,,P20309,MUSCARINIC ACETYLCHOLINE RECEPTOR M3,CHRM3,,,16970392.0,KI,=,0.48,NM,,cell_based,,,,,CHO,,,,,,,Inhibition of [3H]NMS binding to human cloned M3 receptor expressed in CHO cells,Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.,J. Med. Chem.,PUBLICATION,
3340926,CHEMBL1511467,PBBZKOQKNMRGPM-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16353.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4955298,CHEMBL1505082,WPBKAZMLTNYKBR-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4414795,CHEMBL1481524,UIKBJBCURGBPCV-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1108393,CHEMBL1441532,FPWPWYBWMYTWFT-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
475613,CHEMBL318457,BYTNEISLBIENSA-MDZDMXLPSA-N,,,Q96RI1,BILE ACID RECEPTOR FXR,NR1H4,,,21256005.0,ACTIVITY,,,,,,,,,,,,,,,,,Binding affinity to human FXR by X-ray crystallography,Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.,Bioorg. Med. Chem. Lett.,PUBLICATION,
81797,CHEMBL1477307,AHBGDSREPWVVFA-UHFFFAOYSA-N,,,P00748,COAGULATION FACTOR XII,F12,,,,IC50,,92.45,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Factor XIIa 1536 HTS Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID800],PUBCHEM BIOASSAY DATA SET,,DATASET,
5760125,,ZYLFIDXHMVREOC-OAHLLOKOSA-N,BI00047804,,P48736,"PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE 3-KINASE CATALYTIC SUBUNIT GAMMA",None,,,-103.0,PKD,=,8.95860731484177,-LOG(10) M,inhibition,biochemical,binding,enzyme_activity,,qPCR,,1,UM,,,,,KINOMESCAN BEADS,,,,PIK3CG
2181263,CHEMBL1463293,KDPDDKZGQVSUKS-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5188248,CHEMBL3700181,XODPXIFFMUGEMP-ZRYLAOAESA-N,,,Q99558,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 14,MAP3K14,,,,KI,=,39.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. The ability of the nuclear factor-kappa B (NF-kB)-inducing kinase (NIK) to catalyze the hydrolysis of adenosine-5'-triphosphate (ATP) was monitored using the Transcreener ADP (adenosine-5'-diphosphate) assay (BellBrook Labs). Purified NIK (0.2-1 nM) derived from a baculovirus-infected insect cell expression system was incubated with test compounds for 1-3.5 hours in 50 mM 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid buffer (pH 7.2) containing 10 mM MgCl.sub.2, 2 mM dithiothreitol, 10 uM ATP, 0.01% Triton X-100, 0.1% gamma-globulins from bovine blood, 1% dimethylsulfoxide (DMSO), 12 ug/mL ADP antibody and 4 nM ADP-AlexaFluor.RTM. 633 tracer. Reactions were quenched by the addition of 20 mM 2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetic acid and 0.01% Brij 35. The tracer bound to the antibody was displaced by the ADP generated during the NIK reaction, which causes a decrease in fluorescence polarization that was measured by laser excitation.",Tricyclic compounds and methods of use therefor,,PATENT,
4462602,CHEMBL1313499,UNSQDIJMOQODPG-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,1584.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
619813,CHEMBL561511,CORRNILCUDTMSS-UHFFFAOYSA-N,D-331,,P19020,DOPAMINE D3 RECEPTOR,,,,19427222.0,KI,=,5.18,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]spiperone from rat dopamine D3 receptor expressed in HEK293 cells,"Investigation of various N-heterocyclic substituted piperazine versions of 5/7-{[2-(4-aryl-piperazin-1-yl)-ethyl]-propyl-amino}-5,6,7,8-tetrahydro-naphthalen-2-ol: effect on affinity and selectivity for dopamine D3 receptor.",Bioorg. Med. Chem.,PUBLICATION,
2172755,CHEMBL1794059,KCVNXJLUFNZAMY-LCYFTJDESA-N,GW275616X,,Q7KZI7,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2,MARK2,,,,INHIBITION,=,2.99,%,,,,,,,,,,,,,,GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1132471,CHEMBL312929,FSKOAKSLUAJDDL-QHCPKHFHSA-N,,,"P06756, P05106",INTEGRIN ALPHA-V/BETA-3,"ITGAV, ITGB3",,,15109653.0,IC50,=,0.057999999999999996,NM,,,,,,,,,,,,,,Inhibitory activity was determined against human vitronectin receptor (alpha V beta 3),Discovery of a potent and selective alpha v beta 3 integrin antagonist with strong inhibitory activity against neointima formation in rat balloon injury model.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4514307,CHEMBL1577238,UTDXHEHIDDGBFV-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3726155,CHEMBL1095789,QRLAIUSGKUVHBM-XMMPIXPASA-N,,,P21554,CANNABINOID CB1 RECEPTOR,CNR1,,,20423086.0,INHIBITION,,,,,cell_based,,,,,CHO,,,,,,,Inverse agonist activity at human recombinant cannabinoid CB1 receptor expressed in CHO cellssassessed as inhibition of forskolin-stimulated increase in intracellular cAMP level,"Discovery of N-[(4R)-6-(4-chlorophenyl)-7-(2,4-dichlorophenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridin-4-yl]-5-methyl-1H-pyrazole-3-carboxamide (MK-5596) as a novel cannabinoid-1 receptor (CB1R) inverse agonist for the treatment of obesity.",J. Med. Chem.,PUBLICATION,
1151241,CHEMBL385717,FUKIMKAXNJAMDX-UHFFFAOYSA-N,,,Q8NER1,VANILLOID RECEPTOR,TRPV1,,,16870426.0,IC50,=,168.0,NM,,,,,,,,,,,,,,Antagonist activity against capsaicin-activated human VR1 by FLIPR assay,"From arylureas to biarylamides to aminoquinazolines: discovery of a novel, potent TRPV1 antagonist.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2003243,CHEMBL280660,JKIWMIGBZFKLHT-XVNBXDOJSA-N,,,"P20701, P05362, P05107","INTERCELLULAR ADHESION MOLECULE (ICAM-1), INTEGRIN ALPHA-L/BETA-2","ICAM1, ITGAL, ITGB2",,,11312920.0,IC50,=,1200.0,NM,,,,,,,,,,,,,,Inhibition of JY-8 cell adhesion via leukocyte function associated antigen 1 (LFA-1) to ICAM-1,Novel p-arylthio cinnamides as antagonists of leukocyte function-associated antigen-1/intracellular adhesion molecule-1 interaction. 2. Mechanism of inhibition and structure-based improvement of pharmaceutical properties.,J. Med. Chem.,PUBLICATION,
4723940,CHEMBL1590748,VPTAPVOKQQWWRX-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3963623,CHEMBL577394,RQYQDVZKXQROMJ-UHFFFAOYSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,19800790.0,EC50,=,133.0,NM,,,,,,,,,,,,,,Agonist activity at human delta opioid receptor by GTP[gamma]35S binding assay,Delta agonist hydroxy bioisosteres: the discovery of 3-((1-benzylpiperidin-4-yl){4-[(diethylamino)carbonyl]phenyl}amino)benzamide with improved delta agonist activity and in vitro metabolic stability.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4951342,CHEMBL1433385,WOQWZOVLUYFODG-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1931568,CHEMBL998,JCCNYMKQOSZNPW-UHFFFAOYSA-N,LORATADINE,,P21917,DOPAMINE D4 RECEPTOR,DRD4,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Dopamine D4.2 radioligand binding (ligand: [3H] Spiperone),DrugMatrix in vitro pharmacology data,,DATASET,
2329853,CHEMBL1515289,KTPIQPFYFJEKGJ-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,30131.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4171624,CHEMBL1611627,SOEISDFVBHRXPC-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
356670,CHEMBL15245,BLGXFZZNTVWLAY-SCYLSFHTSA-N,YOHIMBINE,,P11229,MUSCARINIC ACETYLCHOLINE RECEPTOR M1,CHRM1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Muscarinic M1 radioligand binding (ligand: [3H] N-Methylscopolamine),DrugMatrix in vitro pharmacology data,,DATASET,
4643734,CHEMBL1392132,VGYCHSOZFBOOKO-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5277628,CHEMBL3427180,XXZCJMWSTWCVLY-SECBINFHSA-N,,,P08069,INSULIN-LIKE GROWTH FACTOR I RECEPTOR,IGF1R,,,25768698.0,ACTIVITY,=,62.0,%,,,,,,,,,,,,,,Inhibition of IGF-1R (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control,Luciferin and derivatives as a DYRK selective scaffold for the design of protein kinase inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
161398,CHEMBL3342481,AQEDHLQMBLGFJJ-ICDZXHCJSA-N,,,P03469,NEURAMINIDASE,,,,25255388.0,IC50,>,200.0,NM,,,,,,,,,,,,,,Inhibition of Influenza A virus A/duck/china/1206/2012(H5N1) Neuraminidase,Discovery of N-substituted oseltamivir derivatives as potent and selective inhibitors of H5N1 influenza neuraminidase.,J. Med. Chem.,PUBLICATION,
2873394,CHEMBL1393246,NBVJIVWPYQSSJG-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4419742,CHEMBL1436771,UIZVFFBLFONNHM-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
1954931,CHEMBL1564425,JETUPENNJQBNKK-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
199033,CHEMBL1440549,AUAHLIBWGDCGLY-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,50.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4180831,CHEMBL1566796,SPGNCUNYEIQSPX-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3289400,CHEMBL1467045,OVGMLGUDHKCYNI-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3346250,CHEMBL3264635,PBQQMXSGXHWZMB-UHFFFAOYSA-N,,,Q96RI1,BILE ACID RECEPTOR FXR,NR1H4,,,24775917.0,INHIBITION,=,95.0,%,,,,,,,,,,,,,,Antagonist activity at human GST-tagged FXR at 493 nM after 20 mins by TR-FRET assay relative to control,Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor.,Bioorg. Med. Chem.,PUBLICATION,
4882317,CHEMBL86066,WHDJEAZLMYPLGL-UHFFFAOYSA-N,,,Q96SB4,SERINE/THREONINE-PROTEIN KINASE SRPK1,SRPK1,wild_type,,21336281.0,KI,<,6309.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
5146834,CHEMBL580615,XJRUXZMCKCREGD-UHFFFAOYSA-N,TCMDC-136958,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,1.08,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
5615679,CHEMBL595373,ZIJIMHMKDXTURQ-UHFFFAOYSA-N,,,P09769,TYROSINE-PROTEIN KINASE FGR,FGR,wild_type,,19692247.0,ACTIVITY,=,6.0,%,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,radiometry,,1,uM,Protein/peptide,,,,Residual activity of FGR at 1 uM by microplate scintillation counting,Substituted 2-arylbenzothiazoles as kinase inhibitors: hit-to-lead optimization.,Bioorg. Med. Chem.,PUBLICATION,
3449305,CHEMBL23327,PMXCMJLOPOFPBT-HNNXBMFYSA-N,PURVALANOLA,,P51817,SERINE/THREONINE-PROTEIN KINASE PRKX,PRKX,wild_type,,22037377.0,ACTIVITY,=,97.35649629,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,KEMPTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
1790660,CHEMBL1497998,IMTVMNYHZDXPGX-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
108471,CHEMBL1612834,AKFPHXCDBVJHSP-UVTDQMKNSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
3360387,CHEMBL1709426,PDJZHFUCHLOXMQ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1978443,CHEMBL1498938,JHIPASCAAQGZNS-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4103785,CHEMBL1392892,SGPQZLYYQVUELY-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
196031,CHEMBL1510548,ATRHFXRGWPUVPR-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,=,12589.25,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4063130,CHEMBL558267,SBZHDIQQBIXXRZ-UHFFFAOYSA-N,,,Q96RI1,BILE ACID RECEPTOR FXR,NR1H4,,,19586769.0,ACTIVITY,=,90.0,%,,,,,,,,,,,,,,Induction of SRC1 coactivator peptide binding to ligand binding domain of human FXR by FRET assay relative to GW-4064,FXR agonist activity of conformationally constrained analogs of GW 4064.,Bioorg. Med. Chem. Lett.,PUBLICATION,
284196,CHEMBL1327721,BDNBQEJUOYJFPM-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
131529,CHEMBL1462311,AMXAMOVUVIWCME-DHZHZOJOSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,23778.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2835937,CHEMBL1421889,MXVWQEQAIWUYLQ-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2462763,CHEMBL1576186,LIXCDBOWGMGWSF-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
357158,CHEMBL1324640,BLHVSLNMKSONKB-UHFFFAOYSA-N,,,P9WHJ3,PROTEIN RECA,,,,,EC50,=,1550.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of RecA-Intein Splicing Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2097, AID2223, AID489010, AID492950]",PUBCHEM BIOASSAY DATA SET,,DATASET,
824220,CHEMBL1720979,DKYOPQCZOIKEOD-UHFFFAOYSA-N,,,"P63316, P45379, P19429","TROPONIN, CARDIAC MUSCLE","TNNC1, TNNI3, TNNT2",,,,EC50,>,71475.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence-based biochemical high throughput dose response assay for activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493008, AID493018, AID504382, AID504383]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3305608,CHEMBL995,OXCMYAYHXIHQOA-UHFFFAOYSA-N,LOSARTAN POTASSIUM,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,794.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3341334,CHEMBL1243,PBCZLFBEBARBBI-UHFFFAOYSA-N,SULFABENZAMIDE,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,,KI,,,,,cell_based,,,,,Sf9,,,,,,,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),DrugMatrix in vitro pharmacology data,,DATASET,
5707045,CHEMBL1450384,ZSJZMRMJGIXWMO-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4551845,CHEMBL1445359,UXFNGZSHEPJXEF-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2792128,CHEMBL1522332,MSYQTUROBYMOKW-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3023825,CHEMBL3593941,NSDDRJXKROCWRZ-UHFFFAOYSA-N,,,Q8NER1,VANILLOID RECEPTOR,TRPV1,,,26263397.0,EC50,,,,,cell_based,,,,,,,,,,,,Activation of human TRPV1 expressed in TREx-HEK cells by Fluo-4 AM dye-based Ca2+ imaging assay,"Structure-Activity Relationship Study on Isothiocyanates: Comparison of TRPA1-Activating Ability between Allyl Isothiocyanate and Specific Flavor Components of Wasabi, Horseradish, and White Mustard.",J. Nat. Prod.,PUBLICATION,
195334,CHEMBL1345454,ATPHABLFTZNQPT-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
274945,CHEMBL1730138,BCIUNHJJUFMWCQ-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,125892.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2069348,CHEMBL277475,JRQRKFDFHAPMGQ-UHFFFAOYSA-N,,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,2544728.0,I,=,10.0,%,,,,,,,,,,,,,,"NMDA receptor antagonistic ability of 100 uM of compound was assessed from the ability to displace [3H]CPP29,30 from rat cortical membranes.",Exploration of phenyl-spaced 2-amino-(5-9)-phosphonoalkanoic acids as competitive N-methyl-D-aspartic acid antagonists.,J. Med. Chem.,PUBLICATION,
3357071,CHEMBL503,PCZOHLXUXFIOCF-BXMDZJJMSA-N,LOVASTATIN,,P06241,TYROSINE-PROTEIN KINASE FYN,FYN,,,,IC50,,,,,cell_based,,,,,Insect cells,,,,,,,"DRUGMATRIX: Protein Tyrosine Kinase, Fyn enzyme inhibition (substrate: Poly(Glu:Tyr))",DrugMatrix in vitro pharmacology data,,DATASET,
3242068,CHEMBL1589520,OQGVDLGWSSRUEF-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3907377,CHEMBL1965660,RKUKAACYUCUJEE-UHFFFAOYSA-N,,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,,KI,>,630.96,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: ABL1,PUBCHEM BIOASSAY DATA SET,,DATASET,
171540,CHEMBL528350,AREMJBFZAIBNQU-UHFFFAOYSA-N,TCMDC-137763,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,68.89,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
3263786,CHEMBL3338802,OSQRKWSIYAVQQD-UHFFFAOYSA-N,,,Q9H0K1,SERINE/THREONINE-PROTEIN KINASE SIK2,SIK2,,,25247770.0,ACTIVITY,=,106.0,%,,,,,,,,,,,,,,Inhibition of SIK2 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay,Synthesis and preliminary mechanistic evaluation of 5-(p-tolyl)-1-(quinolin-2-yl)pyrazole-3-carboxylic acid amides with potent antiproliferative activity on human cancer cell lines.,Eur. J. Med. Chem.,PUBLICATION,
3123845,CHEMBL574738,ODPGGGTTYSGTGO-UHFFFAOYSA-N,AST-487,,Q13470,NON-RECEPTOR TYROSINE-PROTEIN KINASE TNK1,TNK1,,,18183025.0,KD,=,60.0,NM,,,,,,,,,,,,,,Binding constant for full-length TNK1,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4986865,CHEMBL2380643,WSPHZWFOMITWJU-RLOPOPLLSA-N,,,P28845,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,HSD11B1,,,23478147.0,IC50,=,50.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant 11beta-HSD1 by scintillation proximity assay,"Discovery of SAR184841, a potent and long-lasting inhibitor of 11ß-hydroxysteroid dehydrogenase type 1, active in a physiopathological animal model of T2D.",Bioorg. Med. Chem. Lett.,PUBLICATION,
723059,CHEMBL136669,CZVATJJPBCSTOP-UHFFFAOYSA-N,,,O42275,ACETYLCHOLINESTERASE,,,,8978837.0,IC50,=,69100.0,NM,,,,,,,,,,,,,,Inhibitory activity against Acetylcholinesterase,Structure-based alignment and comparative molecular field analysis of acetylcholinesterase inhibitors.,J. Med. Chem.,PUBLICATION,
5685301,CHEMBL405042,ZQAZHQLWCKQXTD-GDNBJRDFSA-N,GW335962X,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,,INHIBITION,=,13.58,%,,,,,,,,,,,,,,GSK_PKIS: ABL1 (Q252H mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2863999,CHEMBL1445388,NATPEGQTQIDEOV-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1000094,CHEMBL2424948,FDSXIKAYJSIQIL-UHFFFAOYSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,,IMAX,=,51.0,%,,,,,,,,,,,,,,Binding affinity to PPARgamma (unknown origin) at 10 uM by Polarscreen competitor assay relative to rosiglitazone,,Med Chem Res,PUBLICATION,
452984,CHEMBL186213,BWBYKJFTJZIURF-UHFFFAOYSA-N,GW827105X,,P24723,PROTEIN KINASE C ETA,PRKCH,,,,INHIBITION,=,0.87,%,,,,,,,,,,,,,,GSK_PKIS: PKC-eta mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1730582,CHEMBL1333742,IFTQTIBCRQQXMJ-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3928338,CHEMBL87549,RNAPBKRIXYBLAL-NVQSTNCTSA-N,,,Q920D2,DIHYDROFOLATE REDUCTASE,,,,11472209.0,IC50,=,3830.0,NM,,,,,,,,,,,,,,Inhibitory activity against dihydrofolate reductase DHFR in rat liver,"Structural studies on bioactive compounds. 34. Design, synthesis, and biological evaluation of triazenyl-substituted pyrimethamine inhibitors of Pneumocystis carinii dihydrofolate reductase.",J. Med. Chem.,PUBLICATION,
996228,CHEMBL1468163,FDGHERCWMGVBHT-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
390576,CHEMBL1371254,BOYNXPGAJNXHJS-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1997199,CHEMBL1344433,JJPWCZTVMILYRL-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1507512,CHEMBL1724867,HHQRZBNJANFRNX-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,4610.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2877021,CHEMBL478112,NCFADVGMVIJELQ-BEEDKBRMSA-N,,,Q4Q5W4,"FARNESYLTRANSFERASE, PUTATIVE",,,,17709461.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Inhibition of Leishmania major recombinant squalene synthase expressed in Escherichia coli by liquid scintillation counter,Quinuclidine derivatives as potential antiparasitics.,Antimicrob. Agents Chemother.,PUBLICATION,
2221190,CHEMBL1373665,KICCTNVHWVLFLA-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4064241,CHEMBL3676178,SCCSYDABXJGYAW-UHFFFAOYSA-N,,,O00408,PHOSPHODIESTERASE 2A,PDE2A,,,,IC50,<,6.79,NM,,,,,,,,,,,,,,"BindingDB_Patents: Scintillation Proximity Assay. In the present assay, the activity of the test substances on human full-length PDE2A3 enzyme was determined using the [3H]-cGMP scintillation proximity assay (SPA) modified from the Amersham TRKQ7100 instructions (GE Healthcare, Arlington Heights, Ill., USA). PDE2A3 protein was obtained from FLAG purification of sf21 insect cells using standard affinity purification procedures for this tag (anti-FLAG M2, Sigma Aldrich, St. Louis, Mo., USA). Briefly, the SPA assays were performed using PDE SPA yttrium silicate beads (Perkin Elmer RPNQ0024; PerkinElmer, Inc., Waltham, Mass., USA) which bind preferentially to the linear nucleotide, GMP, compared to the cyclic nucleotide, cGMP. The, 3H-GMP product was detected using a Wallac MicroBeta scintillation counter. The reaction time was chosen with respect to the amount of time in which 10-20% of substrate was hydrolyzed by the enzyme. The assay was validated using PDE2-selective literature compounds.","Pyrazolo[3,4-d]pyrimidine compounds and their use as PDE2 inhibitors and/or CYP3A4 inhibitors",,PATENT,
5225201,CHEMBL1363708,XSDFYVVDWHCQJK-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,10322.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4205919,CHEMBL1405203,SRRXZDLALXNSBQ-UHFFFAOYSA-N,,,P51452,DUAL SPECIFICITY PROTEIN PHOSPHATASE 3,DUSP3,,,,IC50,=,942.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response selectivity of inhibitors of STriatal-Enriched Phosphatase (STEP) in the dual-specificity protein-tyrosine phosphatase VHR Inhibition Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2064248,CHEMBL1610421,JRCNQNRNXXORHG-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16353.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
454667,CHEMBL308201,BWHBHEZPFOLODC-YNCDLQQUSA-N,,,Q7ZJM1,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE,,,,10841789.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibitory activity against HIV-1 integrase at 200 uM,Developing a dynamic pharmacophore model for HIV-1 integrase.,J. Med. Chem.,PUBLICATION,
2419108,CHEMBL3632825,LDVISLLDEAZEMG-UHFFFAOYSA-N,,,P00915,CARBONIC ANHYDRASE I,CA1,,,26497049.0,KI,=,77.0,NM,,,,,,,,,,,,,,Inhibition of human carbonic anhydrase-1 assessed as CO2 hydration activity by stopped-flow method,"Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors.",J. Med. Chem.,PUBLICATION,
3745912,CHEMBL1423270,QTPPCOYBDXFASS-UHFFFAOYSA-N,,,P10520,STREPTOKINASE A,,,,,EC50,=,217.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity. (Class of assay: confirmatory) [Related pubchem assays: 1677 (Project Summary), 1662 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3111970,CHEMBL1576924,OCHFAZCCFZCRGP-UHFFFAOYSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5275791,CHEMBL1996376,XXUIZAYXUCISNF-GHRIWEEISA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,12493.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4554903,CHEMBL1704861,UXNIRSLJTHESJA-UHFFFAOYSA-N,,,Q9QUQ5,SHORT TRANSIENT RECEPTOR POTENTIAL CHANNEL 4,,,,,EC50,,10590.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation dose response assay for compounds that activate transient receptor potential cation channel C4 (TRPC4). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2237, AID2259]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1182878,CHEMBL1447883,FXZFKGDBRDZYRV-UHFFFAOYSA-N,,,Q27686,PYRUVATE KINASE,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1977950,CHEMBL244707,JHGZYXRWZXMYBZ-UHFFFAOYSA-N,"7,8,2'-TRIHYDROXYFLAVONE",,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2945163,CHEMBL376856,NJMNLVKBTMXWRA-RZYZSWTKSA-N,,,P34914,EPOXIDE HYDRATASE,,,,16908134.0,IC50,=,33000.0,NM,,,,,,,,,,,,,,Inhibition of mouse recombinant soluble Epoxide hydrolase,Peptidyl-urea based inhibitors of soluble epoxide hydrolases.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2096397,CHEMBL1321197,JUNXWBRPUPOZHW-RMKNXTFCSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1476 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
411953,CHEMBL1470382,BRKQRBLCDHWCTI-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4331244,CHEMBL548223,TZOMVAGZLDMDFN-UHFFFAOYSA-N,TCMDC-140480,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,3.32,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1344299,CHEMBL1388974,GPTVBNSMSNATQA-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2381220,CHEMBL177571,KZMUMHSHQDFMSC-UHFFFAOYSA-N,,,P29274,ADENOSINE A2A RECEPTOR,"ADORA2A, SPECC1L-ADORA2A",,,15771447.0,DISPLACEMENT,=,13.0,%,,cell_based,,,,,CHO,,,,,,,Percent displacement of [3H]-ZM 241385 binding to human adenosine A2A receptor expressed in CHO cells at 1 uM,A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor.,J. Med. Chem.,PUBLICATION,
4783514,,VWPHRPNLRAQASD-UHFFFAOYSA-N,,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,-1.25,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4460799,CHEMBL202891,UNNVAVXBYOPNHR-UHFFFAOYSA-N,GW679410X,,P07949,TYROSINE-PROTEIN KINASE RECEPTOR RET,RET,,,,INHIBITION,=,4.29,%,,,,,,,,,,,,,,GSK_PKIS: RET (V804L mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3395548,CHEMBL1519205,PHIPFFIOAKIXKT-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3148945,CHEMBL1316893,OGBDUOFXOQKFNV-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3667250,CHEMBL1562110,QLJGQLPHQVQVJE-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1551872,CHEMBL2003657,HMBDNAGIIDHKKM-UHFFFAOYSA-N,,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,,,,KI,>,2511.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT3,PUBCHEM BIOASSAY DATA SET,,DATASET,
5503384,CHEMBL522237,YWNFBFMORHLUGP-UHFFFAOYSA-N,,,Q15761,NEUROPEPTIDE Y RECEPTOR TYPE 5,NPY5R,,,19464889.0,IC50,=,3.4,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]PYY from human recombinant NPY Y5 receptor expressed in mouse LMtk- cells,Aryl urea derivatives of spiropiperidines as NPY Y5 receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2072129,CHEMBL189231,JRYCXZUZWFHQPB-UHFFFAOYSA-N,SB-734117,,Q9UHD2,SERINE/THREONINE-PROTEIN KINASE TBK1,TBK1,,,,INHIBITION,=,37.0,%,,,,,,,,,,,,,,GSK_PKIS: TBK1 % inhibition at 1 uM [UNC Frye lab],Compounds: GSK PKIS; Assays: UNC Frye lab,,DATASET,
535596,CHEMBL426800,CFCWMGRWMVZFQN-UHFFFAOYSA-N,GW785404X,,P06213,INSULIN RECEPTOR,INSR,,,,INHIBITION,=,5.22,%,,,,,,,,,,,,,,GSK_PKIS: INSR mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
911608,CHEMBL270015,DUEOGLDPZSDHOJ-DURBRWELSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,18032040.0,INTRINSIC ACTIVITY,=,72.0,%,,cell_based,,,,,CHO,,,,,,,Intrinsic activity at human MC4 receptor expressed in CHO cells assessed as accumulation of cAMP production relative to alphaMSH,Identification and characterization of pyrrolidine diastereoisomers as potent functional agonists and antagonists of the human melanocortin-4 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2147113,CHEMBL1531200,JZWAGBPUWIHJST-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2894767,CHEMBL3244684,NEGPUHDTBFUPPD-UHFFFAOYSA-N,,,Q91XF0,PYRIDOXINE-5'-PHOSPHATE OXIDASE,,,,557561.0,ID50,=,2.5,NM,,cell_based,,,,,,,,,,,,Inhibition of pyridoxine phosphate oxidase in mouse TA3 cells assessed as inhibition of 1 x 10'-7 M pyridoxal-induced cell growth,4-Halovinyl- and 4-ethynyl-4-deformylpyridoxal derivatives and related analogues as potentially irreversible antagonists of vitamin B6.,J. Med. Chem.,PUBLICATION,
5351597,CHEMBL1323357,YFPGFGQWWLYWNO-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5859928,CHEMBL3824159,,,,O95838,GLUCAGON-LIKE PEPTIDE 2 RECEPTOR,GLP2R,,,26986178.0,EC50,=,0.1,NM,,,,,,,,,,,,,,Agonist activity at human GLP2R expressed in HEK293 cells after 5 hrs by luciferase reporter gene assay,Synthesis and Pharmacological Characterization of Novel Glucagon-like Peptide-2 (GLP-2) Analogues with Low Systemic Clearance.,J. Med. Chem.,PUBLICATION,
4507018,CHEMBL1494968,USKFLYHRAPETSM-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
9133,CHEMBL1469863,AAUCFFHULPLITE-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
4162631,CHEMBL1428429,SNHRATKOAXSECW-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5738918,CHEMBL2432045,ZWCQZHOWEDKJBN-CAUKCHDASA-N,,,P08912,MUSCARINIC ACETYLCHOLINE RECEPTOR M5,CHRM5,,,23981939.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of muscarinic M5 receptor (unknown origin) at 10 uM by PDSP assay relative to control,"N-substituted 8-aminopentacyclo[5.4.0.0(2,6).0(3,10).0(5,9)]undecanes as s receptor ligands with potential neuroprotective effects.",Bioorg. Med. Chem.,PUBLICATION,
2045926,CHEMBL1335130,JPAWHIGGTVOTJC-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1293539,CHEMBL302171,GKDJCOLVXBCNNK-HNNXBMFYSA-N,,,P61169,DOPAMINE D2 RECEPTOR,,,,7783153.0,KI,=,17.0,NM,,cell_based,,,,,CHO-K1,,,,,,,Binding affinity rat Dopamine receptor D2 expressed in CHO-K1 cells by [3H]U-86170 displacement.,"Structure-activity relationships in the 8-amino-6,7,8,9-tetrahydro-3H-benz[e]indole ring system. 2. Effects of 8-amino nitrogen substitution on serotonin receptor binding and pharmacology.",J. Med. Chem.,PUBLICATION,
4295752,CHEMBL1559608,TVNLGPSJSIOPSJ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
583402,CHEMBL1388030,CKPQQFHSOGQYLA-UHFFFAOYSA-N,,,P43367,CALPAIN 2,,,,,IC50,>,50000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Dose Response Confirmation for Calpain Inhibitors. (Class of assay: confirmatory) [Related pubchem assays: 1236 (Primary screen preceding this confirmatory assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
2002684,CHEMBL1470780,JKHDNQYWEPIBQS-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2642625,CHEMBL1889443,MCDYZLDVCBRFNY-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2215548,CHEMBL1457810,KHLUOAZWYONYCR-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,177.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5777654,CHEMBL3824130,,,,Q9UM73,ALK TYROSINE KINASE RECEPTOR,ALK,,,27144831.0,IC50,=,0.72,NM,,,,,,,,,,,,,,Inhibition of human ALK using poly[Glu:Tyr] (4:1) as substrate and [gamma-33P]ATP measured after 1 hr,"Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase.",J. Med. Chem.,PUBLICATION,
2553006,CHEMBL1529890,LSLBZAFVKUEBJS-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,17.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4850452,CHEMBL3586644,WDSQNMSWLYROHT-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,26111355.0,FC,=,12.67,,,cell_based,,,,,,,,,,,,Activation of Nrf2 in human HepG2-ARE-C8 cells assessed as upregulation of ARE level at 2 uM after 12 hrs by luciferase reporter gene assay relative to control,"Discovery and Modification of in Vivo Active Nrf2 Activators with 1,2,4-Oxadiazole Core: Hits Identification and Structure-Activity Relationship Study.",J. Med. Chem.,PUBLICATION,
646426,CHEMBL537357,CRTYVJVWHSONBI-UHFFFAOYSA-N,TCMDC-139914,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,15.92,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4906076,CHEMBL1515643,WJIVITYQJZIOCB-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,631.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1282435,CHEMBL3670899,GIXNFUDXKSHSST-IZEXYCQBSA-N,,,Q9YQ30,HIV-1 PROTEASE,,,,,IC50,=,4.12,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzymatic Assay. This is a fluorometric assay based on the cleavage by protease of a substrate carrying a donor group (EDANS) and an acceptor group (DABCYL) on each side of the cleavage site, interacting together through fluorescence resonance energy transfer (FRET) as described by Matayoshi et al. (Science 247:954-954, 1990).",Protease inhibitors,,PATENT,
4827555,CHEMBL154225,WBIROJVEMHKQCB-INIZCTEOSA-N,,,Q6B856,TUBULIN BETA CHAIN,,,,2299625.0,IC50,=,1700.0,NM,,,,,,,,,,,,,,Inhibitory effect on the polymerization of purified bovine brain tubulin.,"Antitubulin effects of derivatives of 3-demethylthiocolchicine, methylthio ethers of natural colchicinoids, and thioketones derived from thiocolchicine. Comparison with colchicinoids.",J. Med. Chem.,PUBLICATION,
478252,CHEMBL1505755,BZAXRXGZDUKFCA-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3185127,CHEMBL1365415,OKBRSHSCBXYHHB-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): Confirmation of Cherrypicks. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4394959,CHEMBL1575188,UGMFPJNRJGALCL-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,89125.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5197234,CHEMBL918,XPFRXWCVYUEORT-UHFFFAOYSA-N,PHENACEMIDE,,P28482,MAP KINASE ERK2,MAPK1,,,,IC50,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DrugMatrix in vitro pharmacology data,,DATASET,
2939358,CHEMBL3609371,NIVBGOGCJSMNMG-KRWDZBQOSA-N,,,Q13153,SERINE/THREONINE-PROTEIN KINASE PAK 1,PAK1,,,26191365.0,IC50,=,18.0,NM,,,,,,,,,,,,,,Inhibition of wild type dephosphorylated form of PAK1 (249 to 545) (unknown origin) expressed in Escherichia coli using 5-Fluo-Ahx-AKRRRLSSLRA-COOH as substrate preincubated for 60 mins followed by substrate addition measured after 60 mins by Caliper assay,,ACS Med. Chem. Lett.,PUBLICATION,
4748853,CHEMBL274064,VSPFURGQAYMVAN-UHFFFAOYSA-N,SB-220025,,P35916,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3,FLT4,wild_type,,23398362.0,ACTIVITY,=,69.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of FLT4 at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1359873,CHEMBL1341586,GRSJGSCGJJWSBD-DEDYPNTBSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,100.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
2647179,CHEMBL1564747,MCPKSFINULVDNX-UHFFFAOYSA-N,DROMETRIZOLE,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,5308.0,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3592992,CHEMBL110247,QDBZAAWPKCEIBY-HDICACEKSA-N,,,P35462,DOPAMINE D3 RECEPTOR,DRD3,,,11543687.0,KI,>,8000.0,NM,,,,,,,,,,,,,,Binding affinity at dopamine receptor D3,"Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.",J. Med. Chem.,PUBLICATION,
428980,CHEMBL370976,BTIKBNRXWBVMSS-UHFFFAOYSA-N,,,"Q8WWL7, P06493, P14635, O95067",CYCLIN-DEPENDENT KINASE 1/CYCLIN B,"CCNB1, CCNB2, CCNB3, CDK1",,,15801830.0,IC50,>,5000.0,NM,,,,,,,,,,,,,,Inhibition of [32P]ATP binding to Cyclin dependent kinase 1-cyclin B,"Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4.",J. Med. Chem.,PUBLICATION,
4840399,CHEMBL1575652,WCULIEIRSKSHDQ-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5311334,CHEMBL1994431,YBHVETPUSQZDTB-UHFFFAOYSA-N,,,P11308,TRANSCRIPTIONAL REGULATOR ERG,ERG,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
540319,CHEMBL508102,CFOYWRHIYXMDOT-UHFFFAOYSA-N,CARBIMAZOLE,,P30411,BRADYKININ B2 RECEPTOR,BDKRB2,,,,IC50,,,,,,,,,,Chem-1,,,,,,,DRUGMATRIX: Bradykinin B2 radioligand binding (ligand: [3H] Bradykinin),DrugMatrix in vitro pharmacology data,,DATASET,
1927805,CHEMBL1538465,JBQWAJVJFOCKLV-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2104157,CHEMBL1433464,JVHUVQVECYYYSO-UHFFFAOYSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,=,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1829614,CHEMBL1480154,IQWLLHGKLYRABO-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5427348,CHEMBL1722878,YNXXKXKBXVCTHU-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,16360.1,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4943795,CHEMBL272942,WNTGYJSOUMFZEP-UHFFFAOYSA-N,MECOPROP,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2472592,CHEMBL1718090,LKBVWATVFXCMRO-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1326483,CHEMBL383011,GNUXGVDZLWXMPV-UHFFFAOYSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,16384704.0,IC50,,,,,,,,,,,,,,,,,Binding affinity to human PPAR gamma,Design and synthesis of potent and subtype-selective PPARalpha agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2247175,CHEMBL1591163,KKUJUVOEUPSRQJ-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,1158.2,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4025642,CHEMBL564829,RXZMYLDMFYNEIM-UHFFFAOYSA-N,MILCICLIB,,Q9Y2K2,SERINE/THREONINE-PROTEIN KINASE SIK3,SIK3,,,29191878.0,KDAPP,=,265.84,NM,inhibition,cell_free,binding,binding_reversible,,label_free_technology,"K-562, COLO 205, MV-4-11, SK-N-BE(2)",3-30,NM-UM,,,,,LC-MS/MS BASED KINOBEADS COMPETITIVE PULL-DOWN ASSAY,THE TARGET LANDSCAPE OF CLINICAL KINASE DRUGS,SCIENCE,,
719365,CHEMBL1367364,CZNDCWPMEWXZST-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2502445,CHEMBL1594911,LNAZFNROEFHGSW-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3801179,CHEMBL1299393,QZTCKOHOSODJKQ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20587.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3953546,CHEMBL305228,RPTJRADKZYANBI-ZRTHHSRSSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,8667359.0,RATIO,=,170.0,,,,,,,,,,,,,,,Ability to increase whole-cell antiviral efficacy through better translation defined as the ratio between IC90 and Ki,Preparation and structure-activity relationship of novel P1/P1'-substituted cyclic urea-based human immunodeficiency virus type-1 protease inhibitors.,J. Med. Chem.,PUBLICATION,
362574,CHEMBL1441974,BLWLRMDLVBFWRZ-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1286431,CHEMBL252923,GJJFMKBJSRMPLA-HIFRSBDPSA-N,"1R,2S-MILNACIPRAN",,P23975,NOREPINEPHRINE TRANSPORTER,SLC6A2,,,14744476.0,KI,=,22.0,NM,,,,,,,,,,,,,,,,,,
1283571,CHEMBL1704210,GJAJDMJVIYHOBG-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4419282,CHEMBL580728,UIXYKGQBZISOJI-UHFFFAOYSA-N,TCMDC-139329,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,7.03,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
3634725,CHEMBL1347400,QHMMWOZHZQJXNV-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2923292,CHEMBL1583076,NHGLRJZOSKWTRG-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
5200071,CHEMBL1559605,XPLZCBAQKAMBHT-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,1584.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1168385,CHEMBL1508830,FWKAEGXSBJKQFT-UHFFFAOYSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,891.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1279329,CHEMBL1566780,GININQDBFYGKGX-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4879193,CHEMBL1438503,WGVLTEVDNJRKCG-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4621315,CHEMBL1499360,VEPLLMTXNHFDMM-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5846104,CHEMBL1351,,CARBOPLATIN,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2411483,CHEMBL1574845,LCYOKOVCOOCWTM-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3429585,CHEMBL1085322,PKVDODLSCSUTRW-OAHLLOKOSA-N,,,P31645,SEROTONIN TRANSPORTER,SLC6A4,,,20462211.0,INHIBITION,=,65.0,%,,cell_based,,,,,JAR,,,,,,,Inhibition of SERT-mediated serotonin uptake in human JAR cells at 6 uM,"Discovery of novel selective norepinephrine reuptake inhibitors: 4-[3-aryl-2,2-dioxido-2,1,3-benzothiadiazol-1(3H)-yl]-1-(methylamino)butan-2-ols (WYE-103231).",J. Med. Chem.,PUBLICATION,
4920326,CHEMBL1461620,WKZDHDBRHPLMAM-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2406652,CHEMBL1299667,LCKCLJIDKCZHPN-SDNWHVSQSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1038169,CHEMBL278789,FHZPGIUBXYVUOY-VWGYHWLBSA-N,DERMORPHIN,,P33533,DELTA OPIOID RECEPTOR,,,,9288177.0,KI,=,82.5,NM,,,,,,,,,,,,,,Opioid receptor delta 1 binding affinity by displacement of radioligand [3H][D-Pen]-enkephalin (DPDPE) from rat brain membrane synaptosomes,Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides.,J. Med. Chem.,PUBLICATION,
1577772,CHEMBL279940,HOYYGGIWRKOTDQ-UHFFFAOYSA-N,,,P11511,CYTOCHROME P450 19A1,CYP19A1,,,8176705.0,RELATIVE POTENCY,=,49.0,,,,,,,,,,,,,,,Potency relative to AG(IC50 37 uM),"Aromatase inhibitors. Syntheses and structure-activity studies of novel pyridyl-substituted indanones, indans, and tetralins.",J. Med. Chem.,PUBLICATION,
5499304,CHEMBL1465409,YWCFGOMDCLQCBM-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1013238,CHEMBL1567662,FFEPHEJMIVWUQF-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5218125,CHEMBL222102,XRKYMMUGXMWDAO-UHFFFAOYSA-N,KU-55933,,Q15139,PROTEIN KINASE C MU,PRKD1,wild_type,,22037377.0,ACTIVITY,=,83.40848840000001,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,GLYCOGEN ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2556897,CHEMBL1319241,LSTQFCLDGQRHFH-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,4610.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
429736,CHEMBL147393,BTKWJOHVYLHIQC-UHFFFAOYSA-N,,,"P22909, P19328, P22086",ADRENERGIC RECEPTOR ALPHA-2,,,,2894465.0,DISPLACEMENT,=,79.3,%,,,,,,,,,,,,,,Binding affinity for alpha-2 adrenergic receptor by displacement of [3H]clonidine at 10e-6 M from rat brain homogenate preparation,"2,4-Diamino-6,7-dimethoxyquinazolines. 4. 2-[4-(substituted oxyethoxy) piperidino] derivatives as alpha 1-adrenoceptor antagonists and antihypertensive agents.",J. Med. Chem.,PUBLICATION,
2459759,CHEMBL95835,LIOTZVIDBXLBAC-UHFFFAOYSA-N,,,Q13547,HISTONE DEACETYLASE 1,HDAC1,,,14613312.0,IC50,=,15.0,NM,,,,,,,,,,,,,,Inhibitory concentration against recombinant human Histone deacetylase 1,Histone deacetylase inhibitors.,J. Med. Chem.,PUBLICATION,
446202,CHEMBL237347,BVHZLDLRNBQWRF-UHFFFAOYSA-N,GW559768X,,O95819,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 4,MAP4K4,,,,INHIBITION,=,35.06,%,,,,,,,,,,,,,,GSK_PKIS: MAP4K4 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2529044,CHEMBL183619,LPQLYZKOKVZVSN-WDJPJFJCSA-N,,,P42574,CASPASE-3,CASP3,,,16023344.0,IC50,=,16.0,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human Caspase-3,Lipophilic versus hydrogen-bonding effect in P3 on potency and selectivity of valine aspartyl ketones as caspase 3 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4631193,CHEMBL1537984,VFNINUYXEVKMLY-UHFFFAOYSA-M,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,1778.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1002131,CHEMBL1461905,FDZJWKFFTIJLKJ-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
5645457,CHEMBL147707,ZLUVBHBXQYRUJC-UHFFFAOYSA-N,,,P00734,THROMBIN,F2,,,9836616.0,KI,>,100000.0,NM,,,,,,,,,,,,,,The inhibition constant against human thrombin,Tetrahydro-isoquinoline-based factor Xa inhibitors.,J. Med. Chem.,PUBLICATION,
3463712,,POMAUPQMWDUMCT-UHFFFAOYSA-N,SURECN6483752,,,Phosphopantetheine adenylyltransferase (PPAT),,,,20486930.0,IC50,=,230000.0,NM,,,,,,,,,,,,,,,,,,
4781377,CHEMBL1299327,VWHYJSXMYUFBNR-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,30131.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2251077,CHEMBL1321705,KLEDTLVOOOTPRV-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4757681,CHEMBL3104299,VTOUJCOSUXDNJF-UHFFFAOYSA-N,,,,Butyrylcholinesterase,,,,25462625.0,IC50,=,49600.0,NM,,,,,,,,,,,,,,,,,,
1755841,CHEMBL418971,IISBACLAFKSPIT-UHFFFAOYSA-N,BISPHENOL A,,P12822,ANGIOTENSIN-CONVERTING ENZYME,,,,,KI,,,,,tissue,,,,,,,,,,,,"DRUGMATRIX: Peptidase, Angiotensin Converting Enzyme enzyme inhibition (substrate: FAPGG)",DrugMatrix in vitro pharmacology data,,DATASET,
1197778,CHEMBL1492286,FZTYZXJTCPYTRO-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3561710,CHEMBL8163,PZKMVVUAVPOFPD-UHFFFAOYSA-N,,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,8151612.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),"Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase.",J. Med. Chem.,PUBLICATION,
357813,CHEMBL499,BLJRIMJGRPQVNF-JTQLQIEISA-N,TIMOLOL,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,15993593.0,IC50,=,11000.0,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human Cytochrome P450 2D6 (CYP2D6) after incubated for 45 minutes,A 3D-QSAR model for CYP2D6 inhibition in the aryloxypropanolamine series.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1409078,CHEMBL1582708,GXHGAHVWGLLXOX-FNORWQNLSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3655768,CHEMBL305545,QKCWUYHXHMXOLG-UHFFFAOYSA-N,,,Q14790,CASPASE-8,CASP8,,,11384246.0,KI,>,50000.0,NM,,,,,,,,,,,,,,Inhibitory activity against Caspase-8,Potent and selective nonpeptide inhibitors of caspases 3 and 7.,J. Med. Chem.,PUBLICATION,
1225369,CHEMBL2140543,GCUUKUTYMNHSJY-UHFFFAOYSA-N,,,P07947,TYROSINE-PROTEIN KINASE YES,YES1,,,,POTENCY,,244.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for small molecule inhibitors of Yes1 kinase: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4296998,CHEMBL2337499,TVRYULRVVKKIMV-GNAZCLTHSA-N,,,P28223,SEROTONIN 2A (5-HT2A) RECEPTOR,HTR2A,,,23177783.0,INTRINSIC ACTIVITY,=,0.8,,,cell_based,,,,,,,,,,,,Intrinsic activity at 5-HT2A receptor in HEK293E cells assessed as elevation of intracellular calcium level measured for 90 secs by FLIPR assay relative to serotonin,"Synthesis and SAR of 2,3,3a,4-tetrahydro-1H-pyrrolo[3,4-c]isoquinolin-5(9bH)-ones as 5-HT2C receptor agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
996174,CHEMBL587634,FDGAQPLGUDZVND-UHFFFAOYSA-N,TCMDC-133623,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,0.95,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
1787205,CHEMBL270822,IMKXYXBHFRRSCC-PWOSISDISA-N,,,P56817,BETA-SECRETASE 1,BACE1,,,17980584.0,IC50,=,219.0,NM,,,,,,,,,,,,,,Inhibition of BACE1,Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5526273,CHEMBL3700532,YYWNHCHJPUHQLK-UHFFFAOYSA-N,,,P68400,CASEIN KINASE II ALPHA,CSNK2A1,,,,IC50,=,224.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: In Vitro Cell-Free Assay. Test compounds in aqueous solution were added at a volume of 10 microliters, to a reaction mixture comprising 10 microliters Assay Dilution Buffer (ADB; 20 mM MOPS, pH 7.2, 25 mM beta-glycerolphosphate, 5 mM EGTA, 1 mM sodium orthovanadate and 1 mM dithiothreitol), 10 microliters of substrate peptide (RRRDDDSDDD, dissolved in ADB at a concentration of 1 mM), 10 microliters of recombinant human CK2 (25 ng dissolved in ADB; Upstate). Reactions were initiated by the addition of 10 microliters of ATP Solution (90% 75 mM MgCl2, 75 micromolar ATP dissolved in ADB; 10% [gamma-33P]ATP (stock 1 mCi/100 ul; 3000 Ci/mmol (Perkin Elmer) and maintained for 10 minutes at 30 degrees C. The reactions were quenched with 100 microliters of 0.75% phosphoric acid, then transferred to and filtered through a phosphocellulose filter plate (Millipore). After washing each well 5 times with 0.75% phosphoric acid, the plate was dried under vacuum for 5 min.",Fused tricyclic compounds as serine-threonine protein kinase and PARP modulators,,PATENT,
389513,CHEMBL427216,BOVGTQGAOIONJV-UHFFFAOYSA-N,GLICLAZIDE,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4225067,CHEMBL1605275,STZKTXRCRFJHCP-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5064213,CHEMBL346988,XAUNJOUEWQWLCP-AONDRMHESA-N,,,"P21554, P34972",CANNABINOID RECEPTOR,"CNR1, CNR2",,,7086846.0,RELATIVE POTENCY,=,375.0,,,,,,,,,,,,,,,Capability to induce convulsions in tetrahydrocannabinol-seizure susceptible (THC-SS) rabbit,Use of a potential rabbit model for structure--behavioral activity studies of cannabinoids.,J. Med. Chem.,PUBLICATION,
3979189,CHEMBL258721,RSQPNXBTPUXMQN-UHFFFAOYSA-N,RGB-286147,,P17612,CAMP-DEPENDENT PROTEIN KINASE ALPHA-CATALYTIC SUBUNIT,PRKACA,wild_type,,23398362.0,ACTIVITY,=,90.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10,uM,"Millipore: Percentage of residual kinase activity of PRKACA at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3481459,CHEMBL1611736,PQMSUELGQATRIZ-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3081054,CHEMBL2443195,NYRNFJQJOXIJHL-UHFFFAOYSA-N,,,O43570,CARBONIC ANHYDRASE XII,CA12,,,24103428.0,KD,=,3700.0,NM,,,,,,,,,,,,,,Binding affinity to human recombinant carbonic anhydrase 12 by thermal shift assay,"Benzenesulfonamides with pyrimidine moiety as inhibitors of human carbonic anhydrases I, II, VI, VII, XII, and XIII.",Bioorg. Med. Chem.,PUBLICATION,
5538216,CHEMBL320970,ZAGFXUMBSUVWFZ-UHFFFAOYSA-N,,,Q9QYN8,HISTAMINE H3 RECEPTOR,,,,8809168.0,KI,=,14.0,NM,,,,,,,,,,,,,,Rat Histamine H3 receptor antagonism determined by [K+] - evoked depolarization-induced release of [3H]histamine from rat cerebral cortex synaptosomes,A novel series of (phenoxyalkyl)imidazoles as potent H3-receptor histamine antagonists.,J. Med. Chem.,PUBLICATION,
4789713,CHEMBL292507,VXEVTWMFMKSFLP-UHFFFAOYSA-N,,,P29475,"NITRIC-OXIDE SYNTHASE, BRAIN",NOS1,,,10987430.0,INHIBITION,=,59.0,%,,,,,,,,,,,,,,Inhibitory activity against Neuronal nitric oxide synthase,Substituted 2-aminopyridines as inhibitors of nitric oxide synthases.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4748850,CHEMBL274064,VSPFURGQAYMVAN-UHFFFAOYSA-N,SB-220025,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,,KI,=,5011.87,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: KDR,PUBCHEM BIOASSAY DATA SET,,DATASET,
4244261,CHEMBL339006,SWCOEJVKWRSAKV-UHFFFAOYSA-M,,,P46002,PLATELET ACTIVATING FACTOR RECEPTOR,,,,1992139.0,ID50,>,5.0,MG.KG-1,,,,,,,,,,,,,,Activity expressed as the dose required to reduce the lowering of the arterial blood pressure caused by PAF by 50%,Disubstituted tetrahydrofurans and dioxolanes and PAF antagonists.,J. Med. Chem.,PUBLICATION,
1438935,CHEMBL1482500,HASPBBZZYQNEOX-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,18356.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1407121,CHEMBL553371,GXCXFFVKHNZFCN-UHFFFAOYSA-N,,,"Q14432, Q13370",PHOSPHODIESTERASE 3,"PDE3A, PDE3B",,,11405657.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Inhibitory activity against canine heart Phosphodiesterase 3 (PDE3),"Novel, potent, and selective phosphodiesterase 5 inhibitors: synthesis and biological activities of a series of 4-aryl-1-isoquinolinone derivatives.",J. Med. Chem.,PUBLICATION,
2822972,CHEMBL544605,MWFCPVMUWACMFB-UHFFFAOYSA-N,,,P37136,ACETYLCHOLINESTERASE,,,,10514292.0,IC50,=,89.4,NM,,,,,,,,,,,,,,"Inhibition of acetylcholinesterase activity in rat cerebral cortex homogenate, in the presence of a specific butyrylcholinesterase (BChE) inhibitor; ethopropazine",Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.,J. Med. Chem.,PUBLICATION,
4184915,CHEMBL1585792,SPOZCEKGUJQEHP-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,1122.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1363798,CHEMBL33,GSDSWSVVBLHKDQ-JTQLQIEISA-N,LEVOFLOXACIN,,P15823,ALPHA-1B ADRENERGIC RECEPTOR,,,,,IC50,,,,,,,,,,,,,,,,,DRUGMATRIX: Alpha-1B adrenergic receptor radioligand binding (ligand: prazosin),DrugMatrix in vitro pharmacology data,,DATASET,
2808349,CHEMBL219998,MUUMAOMIQCDWLM-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,17343372.0,IC50,=,26.0,NM,,,,,,,,,,,,,,Inhibition of KDR by HTRF assay,"Discovery of N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea (ABT-869), a 3-aminoindazole-based orally active multitargeted receptor tyrosine kinase inhibitor.",J. Med. Chem.,PUBLICATION,
357458,CHEMBL1571801,BLJDNNFXOCIXOL-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3190603,CHEMBL1472258,OKRJXIUTMOHKLC-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1329092,CHEMBL1580574,GOCPOHGCCWYZTA-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1684865,CHEMBL1909380,IAVGAAAFEZBPEV-UHFFFAOYSA-N,GW282449A,,P15735,PHOSPHORYLASE KINASE GAMMA SUBUNIT 2,PHKG2,,,,INHIBITION,=,2.67,%,,,,,,,,,,,,,,GSK_PKIS: PHKG2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5838438,CHEMBL3717945,,,,P19793,RETINOID X RECEPTOR ALPHA,RXRA,,,,Ki,=,3000.0,NM,,,,,,,,,,,,,,Displacement of [3H]9-cis-retinoic acid from RXRalpha (unknown origin) by radioligand binding assay,Hepatocyte nuclear factor 4alpha modulator compounds,,PATENT,
5365643,CHEMBL1374808,YHGKENNQDVSAOI-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5619184,CHEMBL116438,ZIUSSTSXXLLKKK-KOBPDPAPSA-N,CURCUMIN,,P80457,XANTHINE DEHYDROGENASE,,,,19388706.0,ACTIVITY,=,150.0,NM/S,,,,,,,,,,,,,,Inhibition of bovine xanthine oxidase assessed as reduction of cytochrome c at 20 uM,"Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin.",J. Nat. Prod.,PUBLICATION,
3187132,CHEMBL194062,OKFOIEMZTIOWQH-UHFFFAOYSA-N,GW572399X,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,INHIBITION,=,2.73,%,,,,,,,,,,,,,,GSK_PKIS: EGFR (L861Q mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1340959,CHEMBL601142,GPLAIZANQYKUPM-UHFFFAOYSA-N,GNF-PF-52,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4856638,CHEMBL1490810,WEHLZKKFOHRWSM-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
527323,CHEMBL395047,CEIFRCHESJYGAV-SBKWZQTDSA-N,,,Q9WTR4,NOREPINEPHRINE TRANSPORTER,,,,17350257.0,IC50,=,33.0,NM,,,,,,,,,,,,,,Inhibition of [3H]5-HT uptake at NE transporter in Wistar rat synaptosomes,"Synthesis of enantiomerically pure milnacipran analogs and inhibition of dopamine, serotonin, and norepinephrine transporters.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4601029,CHEMBL1613675,VCKFIUBWADXSCI-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,33587.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3501325,CHEMBL249697,PSPFQEBFYXJZEV-UHFFFAOYSA-N,BMS-345541,,Q8N752,CASEIN KINASE I ISOFORM ALPHA-LIKE,CSNK1A1L,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for CSNK1A1L kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
3378896,CHEMBL172145,PFLZCIVRHONVAM-HZPDHXFCSA-N,,,Q7ZJM1,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INTEGRASE,,,,8568830.0,INHIBITION,<,5.0,%,,,,,,,,,,,,,,Inhibitory activity against 3'-processing by HIV-1 Integrase at 100 uM,(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase.,J. Med. Chem.,PUBLICATION,
141070,CHEMBL279382,ANZXGPZNXUHRNO-UHFFFAOYSA-N,,,"P14867, P47870, P18507",GABA-A RECEPTOR; ALPHA-1/BETA-2/GAMMA-2,"GABRA1, GABRB2, GABRG2",,,10197957.0,CHANGE IN CL- CURRENT,=,1.1,,,cell_based,,,,,HEK293,,,,,,,In vitro GABA-mediated chloride current in A293 cells expressing GABA-A benzodiazepine receptor alpha-1-beta-2-gamma-2 subunits at 5 uM,"Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.",J. Med. Chem.,PUBLICATION,
4091292,CHEMBL1500453,SFEXZCUXCBCCLF-SSZFMOIBSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4441629,CHEMBL1339991,ULJGQGAPJVFAKD-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2951774,CHEMBL143221,NKFYFKVMXRDNEH-UHFFFAOYSA-N,,,"P23944, P43140, P15823",ADRENERGIC RECEPTOR ALPHA-1,,,,9888831.0,KI,>,10000.0,NM,,,,,,,,,,,,,,In vitro binding affinity was evaluated on alpha-1 adrenergic receptor from rat cerebral cortex by using [3H]prazosin as radioligand,"Synthesis and structure-activity relationships of a new model of arylpiperazines. 4. 1-[omega-(4-Arylpiperazin-1-yl)alkyl]-3-(diphenylmethylene) - 2, 5-pyrrolidinediones and -3-(9H-fluoren-9-ylidene)-2, 5-pyrrolidinediones: study of the steric requirements of the terminal amide fragment on 5-HT1A affinity/selectivity.",J. Med. Chem.,PUBLICATION,
4768320,CHEMBL1404449,VUUZSNPFXXSXSN-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,562.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5236517,CHEMBL3659933,XTJXCYWSPWJKOC-UHFFFAOYSA-N,,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,,IC50,=,1457.0,NM,,,,,,,,,,,,,,BindingDB_Patents: Kinase Assay. In vitro kinase assay.,"Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases",,PATENT,
1229135,CHEMBL1704270,GDGCNJMFHOCJEH-UHFFFAOYSA-N,,,P55055,LXR-BETA,NR1H2,,,,EC50,,67439.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based dose response assay to identify agonists of the Liver-X-Receptor (LXR)..   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2675204,CHEMBL1307185,MFSKFEMERYYCSZ-BQYQJAHWSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3591905,CHEMBL1922849,QCXZLPPMMJTYLV-SNVBAGLBSA-N,,,Q9KM66,CAI-1 AUTOINDUCER SENSOR KINASE/PHOSPHATASE CQSS,,,,22001326.0,EMAX,=,48.0,%,,,,,,,,,,,,,,"Agonist activity at CqsS receptor in cqsA-deficient, luxQ-deficient Vibrio cholerae MM920 harboring cosmid pBB1 carrying Vibrio harveyi luxCDABE gene assessed as quorum sensing regulated bioluminescence after 4 hrs by scintillation counting relative to (S)-CAI-1",Small molecule probes of the receptor binding site in the Vibrio cholerae CAI-1 quorum sensing circuit.,Bioorg. Med. Chem.,PUBLICATION,
5803037,CHEMBL3734823,,,,Q09472,HISTONE ACETYLTRANSFERASE P300,EP300,,,26505788.0,IC50,=,320.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant Histone acetyltransferase p300 catalytic domain (1284-1672 residues) using [3H]Acetyl-CoA and histone H3 substrate at 50 uM after 1 hr by liquid scintillation counting,Enzyme kinetics and inhibition of histone acetyltransferase KAT8.,Eur. J. Med. Chem.,PUBLICATION,
5304179,CHEMBL2178508,YAOKZMJVVGYFMH-ZNMIVQPWSA-N,,,Q8I4S1,"THYMIDYLATE KINASE, PUTATIVE",,,,23240776.0,KI,=,159000.0,NM,,,,,,,,,,,,,,Inhibition of recombinant Plasmodium falciparum TMPK using TMP as substrate by pyruvate kinase and lactate dehydrogenase enzyme coupled assay,Synthesis and evaluation of a-thymidine analogues as novel antimalarials.,J. Med. Chem.,PUBLICATION,
215147,CHEMBL149073,AVQJNCBAUVLRRN-ZSOIEALJSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,10602697.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibitory activity of compound against VEGF induced cell proliferation,"Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases.",J. Med. Chem.,PUBLICATION,
2801235,CHEMBL208213,MUAWNZBLKUQMAM-HMSDUJDUSA-N,,,P48443,RETINOID X RECEPTOR GAMMA,RXRG,,,16364638.0,EC50,=,322.0,NM,,cell_based,,,,,,,,,,,,Transactivation of RXRgamma in CV1 cells by cotransfection assay,Aza-retinoids as novel retinoid X receptor-specific agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
277123,CHEMBL3199597,BCQYODJBQLOHEE-AWQFTUOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1904259,CHEMBL932,IZEKFCXSFNUWAM-UHFFFAOYSA-N,DIPYRIDAMOLE,,P29476,"NITRIC-OXIDE SYNTHASE, BRAIN",,,,,IC50,,,,,tissue,,,,,,,,,,,,"DRUGMATRIX: Nitric Oxide Synthase, Neuronal (nNOS) radioligand binding (ligand: [3H]L-Arginine)",DrugMatrix in vitro pharmacology data,,DATASET,
5276070,CHEMBL485549,XXUXXCZCUGIGPP-WLRTZDKTSA-N,NIFURSOL,,P43140,ALPHA-1A ADRENERGIC RECEPTOR,,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Alpha-1A adrenergic receptor radioligand binding (ligand: prazosin),DrugMatrix in vitro pharmacology data,,DATASET,
2093350,CHEMBL1340286,JUECNSKYWLRYQE-UHFFFAOYSA-N,,,Q8IUX4,DNA DC->DU-EDITING ENZYME APOBEC-3F,APOBEC3F,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Vif-A3F Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
49990,CHEMBL1381722,ADOVMKXWNWCKIX-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
234088,CHEMBL1574127,AXXFEWVWZFNYQV-XGICHPGQSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3038920,CHEMBL1872457,NTXCGRMMYZSAGT-DEDYPNTBSA-N,,,Q9Y253,DNA POLYMERASE ETA,POLH,,,,POTENCY,,1995.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Eta. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588636],PUBCHEM BIOASSAY DATA SET,,DATASET,
5733344,CHEMBL2325945,ZVMCUUWFJNJCDC-UHFFFAOYSA-N,,,Q07912,TYROSINE KINASE NON-RECEPTOR PROTEIN 2,TNK2,,,,IC50,=,369.4,NM,,,,,,,,,,,,,,BindingDB_Patents: AlphaScreen Assay. AlphaScreen (amplified luminescent proximity homogeneous assay) assay was used to test for ACK1 inhibitory activity.,Substituted imidazopyr- and imidazotri-azines,,PATENT,
1066133,CHEMBL1883643,FLDRLXJNISEWNZ-UHFFFAOYSA-N,,,P37840,ALPHA-SYNUCLEIN,SNCA,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of alpha-syn Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4358160,CHEMBL84,UCFGDBYHRUNTLO-QHCPKHFHSA-N,TOPOTECAN,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Adenosine A3 radioligand binding (ligand: AB-MECA),DrugMatrix in vitro pharmacology data,,DATASET,
3356788,CHEMBL503,PCZOHLXUXFIOCF-BXMDZJJMSA-N,LOVASTATIN,,Q9Y271,CYSTEINYL LEUKOTRIENE RECEPTOR 1,CYSLTR1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Cysteinyl leukotriene receptor 1 radioligand binding (ligand: [3H]LTD4),DrugMatrix in vitro pharmacology data,,DATASET,
2496869,CHEMBL2381631,LMMCDIDKKPPLQO-UHFFFAOYSA-N,,,Q9H2K2,TANKYRASE-2,TNKS2,,,23672613.0,IC50,=,310.0,NM,,,,,,,,,,,,,,Inhibition of auto-PARsylation of GST-tagged TNKS2 PARP domain (947 to 1162) (unknown origin) expressed in Escherichia coli BL21(DE3) after 2 hrs by LC/MS analysis,Fragment-based ligand design of novel potent inhibitors of tankyrases.,J. Med. Chem.,PUBLICATION,
1975268,CHEMBL1386262,JGZSGXTUCLJOMX-UHFFFAOYSA-N,,,Q9HBX9,RELAXIN RECEPTOR 1,RXFP1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
129961,CHEMBL1425034,AMRPAMSVFKIGHT-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4133119,CHEMBL1519626,SJUZAHHEAOSAMG-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3555637,CHEMBL1366064,PYSXPMVOUHMGEC-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,29092.9,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
482055,CHEMBL20,BZKPWHYZMXOIDC-UHFFFAOYSA-N,ACETAZOLAMIDE,,P37288,VASOPRESSIN V1A RECEPTOR,AVPR1A,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),DrugMatrix in vitro pharmacology data,,DATASET,
488646,CHEMBL453116,CABYYOSJFIVJAB-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,19215089.0,IC50,=,5400.0,NM,,,,,,,,,,,,,,Inhibition of luciferin binding site of Photinus pyralis luciferase by competitive inhibition assay,A basis for reduced chemical library inhibition of firefly luciferase obtained from directed evolution.,J. Med. Chem.,PUBLICATION,
3142202,CHEMBL1095626,OFIHBQUKIUHAHV-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,19894727.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibition of ERK2,"Discovery of 4-morpholino-6-aryl-1H-pyrazolo[3,4-d]pyrimidines as highly potent and selective ATP-competitive inhibitors of the mammalian target of rapamycin (mTOR): optimization of the 6-aryl substituent.",J. Med. Chem.,PUBLICATION,
353812,CHEMBL1336238,BLAXFQZKXNVGPM-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1346931,CHEMBL1927010,GQCGTFZJPSNMME-JOCHJYFZSA-N,,,P51681,C-C CHEMOKINE RECEPTOR TYPE 5,CCR5,,,22033460.0,RATIO IC50,=,3.0,,,cell_based,,,,,HeLa,,,,,,,Antagonist activity against human CCR5 assessed as ratio of inhibition of HIV1 gp120-induced cell-cell fusion between human HeLa P4/R5 cells and CHO-tat10 cells expressing HIV-1JRFL viral envelop protein after 20 hrs by beta-galactosidase reporter gene assay in presence of 1 mg/ml of alpha-acid-glycoprotein relative to CCR5 inhibition in absence of alpha-acid-glycoprotein,Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1732356,CHEMBL1577975,IGABRTJMXKNZKJ-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2932501,CHEMBL3196509,NIEVELUOOLCEPO-PYCFMQQDSA-N,,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,,IC50,=,371.24,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Estrogen Receptor-beta Coactivator Binding Inhibitors ELISA Secondary Assay. (Class of assay: confirmatory) [Related pubchem assays: 633 (Primary screen preceding this ELISA dose response confirmation assay.), 733 (Primary dose response assay preceding this ELISA dose response confirmation assay.)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5742460,CHEMBL535259,ZWOBGADPHYRYGM-UHFFFAOYSA-N,TCMDC-132211,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,2.56,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
3402920,CHEMBL1436807,PHYSTVRQRSKHIT-UHFFFAOYSA-N,,,P10828,THYROID HORMONE RECEPTOR BETA-1,THRB,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5861396,CHEMBL1304774,,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
5565210,CHEMBL3415576,ZCXKNMJBIIVQIS-UHFFFAOYSA-N,,,P81908,CHOLINESTERASE,,,,25621991.0,IC50,=,1059.0,NM,,,,,,,,,,,,,,Inhibition of equine serum BuChE after 5 mins by Ellman's method,"Development of multifunctional, heterodimeric isoindoline-1,3-dione derivatives as cholinesterase and ß-amyloid aggregation inhibitors with neuroprotective properties.",Eur. J. Med. Chem.,PUBLICATION,
37149,CHEMBL1462825,ACIJLVMBHSTHLJ-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5238613,CHEMBL591091,XTRKHZOUCWZBMT-UHFFFAOYSA-N,,,P06239,TYROSINE-PROTEIN KINASE LCK,LCK,,,19945867.0,IC50,=,5.4,NM,,,,,,,,,,,,,,Inhibition of GST-tagged human LCK by scintillation counting,"Ring-fused pyrazole derivatives as potent inhibitors of lymphocyte-specific kinase (Lck): Structure, synthesis, and SAR.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4468478,CHEMBL77456,UOHFCPXBKJPCAD-UHFFFAOYSA-N,TYRPHOSTIN 1,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
4915027,CHEMBL66292,WKJFLAJZSWRICW-FOKLQQMPSA-N,PYRAZOLOPYRIMIDINE 2,,P24941,CYCLIN-DEPENDENT KINASE 2,CDK2,,,,INHIBITION,=,41.56,%,,,,,,,,,,,,,,GSK_PKIS: CDK2/cyclinE mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4664066,CHEMBL2152387,VJJLDGVIEMEYDL-AFARHQOCSA-N,,,P45983,C-JUN N-TERMINAL KINASE 1,MAPK8,,,,EC50,=,14000.0,NM,,,,,,,,,,,,,,Inhibition of JNK1-mediated c-jun phosphorylation in TNF-alpha stimulated human HK-2 cells after 30 mins by TR-FRET assay,,ACS Med. Chem. Lett.,PUBLICATION,
726721,CHEMBL1392747,DAEWGUFSMBYFKG-INIZCTEOSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1298558,CHEMBL1574898,GKRCTNRJSDOOJR-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,9200.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
933272,CHEMBL3192255,DWRAVFZEXVWHDO-UZYVYHOESA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
851973,CHEMBL1528120,DNWZVECWNMRCAF-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1566064,CHEMBL569224,HNQFIUIKKNSDAO-XUZLZKRQSA-N,,,Q99808,EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1,SLC29A1,,,19632836.0,BMAX,=,2.6,MFU,,cell_based,,,,,,,,,,,,Binding affinity to human ENT1 in SK-PC1 cells by flow cytometry,Towards to hENT1-nucleoside transporter selective imaging agents. Synthesis and in vitro evaluation of the radiolabeled SAENTA analogues.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2729782,CHEMBL1329052,MLPXDRONNNYCQN-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4099734,CHEMBL487417,SGEWCQFRYRRZDC-VPRICQMDSA-N,VITEXIN,,P03468,NEURAMINIDASE,,,,20116898.0,LOGIC50,=,1.32,,,,,,,,,,,,,,,Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors.,Eur. J. Med. Chem.,PUBLICATION,
1151764,CHEMBL2367916,FUMBLBJFVJXVBV-VWMXVWASSA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,12593663.0,KI,=,5.2,NM,,,,,,,,,,,,,,Binding affinity towards Opioid receptor delta 1 from guinea pig brain using [3H]naltrindole as radioligand,"Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.",J. Med. Chem.,PUBLICATION,
2872074,CHEMBL1335615,NBQJKNSAKITVLO-UHFFFAOYSA-N,,,O75604,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2,USP2,,,,POTENCY,,13091.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2281, AID463106, AID463254]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2816817,CHEMBL611434,MVNIBXTXVYCLEI-IFKAHUTRSA-N,,,P97266,MU OPIOID RECEPTOR,,,,14998329.0,EC50,=,660.0,NM,,,,,,,,,,,,,,"Agonistic activity towards Opioid receptor mu 1 was determined in [35S]GTP-gamma-S, binding assay in guinea pig caudate","Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone].",J. Med. Chem.,PUBLICATION,
4727720,CHEMBL1499952,VQCOJXZDTNIMJW-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
827954,CHEMBL586462,DLHJJPUYXNYLSG-UHFFFAOYSA-N,TCMDC-139126,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,1.18,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
963106,CHEMBL1362829,DZSZJGUENGYDGV-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
4582431,CHEMBL1511324,VAKDCLHBTCOOBU-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,794.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
367563,CHEMBL608533,BMGQWWVMWDBQGC-IIFHNQTCSA-N,MIDOSTAURIN,,P10721,STEM CELL GROWTH FACTOR RECEPTOR,KIT,,,18183025.0,KD,=,150.0,NM,,,,,,,,,,,,,,"Binding constant for KIT(V559D,T670I) kinase domain",A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2112413,CHEMBL1733022,JWFGZIXJXWDMJF-TWUWCHPWSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3247698,CHEMBL521179,OQWZIAVXCYIZNN-UHFFFAOYSA-N,SR-3677,,P15735,PHOSPHORYLASE KINASE GAMMA SUBUNIT 2,PHKG2,,,18834107.0,INHIBITION,<,10.0,%,,,,,,,,,,,,,,Inhibition of PHKG2 at 3 uM,Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors.,J. Med. Chem.,PUBLICATION,
1066308,CHEMBL1241473,FLEAYYMORDPWAJ-UHFFFAOYSA-N,,,Q13131,"AMP-ACTIVATED PROTEIN KINASE, ALPHA-1 SUBUNIT",PRKAA1,,,,KI,=,7.94,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1,PUBCHEM BIOASSAY DATA SET,,DATASET,
758978,CHEMBL2367892,DDTDNCYHLGRFBM-YZEKDTGTSA-N,TEICOPLANIN,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,,IC50,,,,,cell_based,,,,,Sf9,,,,,,,DRUGMATRIX: Estrogen ERbeta radioligand binding (ligand: [3H] Estradiol),DrugMatrix in vitro pharmacology data,,DATASET,
4665330,CHEMBL3314525,VJLIVOQJQIHFHR-BDAKNGLRSA-N,,,Q63120,CANALICULAR MULTISPECIFIC ORGANIC ANION TRANSPORTER 1,,,,24959892.0,IC50,>,200000.0,NM,,,,,,,,,,,,,,Inhibition of ATPase activity of rat Mrp2 assessed as inorganic phosphate,Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099).,J. Med. Chem.,PUBLICATION,
1404323,CHEMBL1498688,GWSLTGYFILICHT-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,2059.6,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5606456,CHEMBL63728,ZHJIZOYQFUOCHV-FBCYGCLPSA-N,GW644007X,,Q86V86,SERINE/THREONINE-PROTEIN KINASE PIM3,PIM3,,,,INHIBITION,=,7.74,%,,,,,,,,,,,,,,GSK_PKIS: PIM3 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1167915,CHEMBL1519748,FWIHOYMHAFKCEN-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2193047,CHEMBL1331734,KFAKESMKRPNZTM-UHFFFAOYSA-N,,,Q04759,PROTEIN KINASE C THETA,PRKCQ,wild_type,,23398362.0,ACTIVITY,=,81.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15.0,uM,"Millipore: Percentage of residual kinase activity of PRKCQ at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1389230,CHEMBL1710470,GVBGICSSPRFALD-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2761015,CHEMBL1419866,MPFHRVMIBWXYQB-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,6012.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4996341,CHEMBL1374947,WTSNADCCDZTFBO-JXAWBTAJSA-N,,,Q9HC16,DNA DC->DU-EDITING ENZYME APOBEC-3G,APOBEC3G,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Vif-A3G Interactions: qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3817905,CHEMBL1309773,RBFUKUAUBFQAIK-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3580464,CHEMBL1385652,QBOTWFVWVPZZJH-PTNGSMBKSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,15848.9,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3940453,CHEMBL1536931,ROIFFXPIWZMQPU-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4496121,CHEMBL221753,UREZNYTWGJKWBI-UHFFFAOYSA-M,BENZETHONIUM CHLORIDE,,A6XA80,LEUKOTRIENE C4 SYNTHASE,,,,,KI,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Leukotriene LTC4 Synthase enzyme inhibition (substrate: LTA4),DrugMatrix in vitro pharmacology data,,DATASET,
1316207,CHEMBL1391801,GMOUXONDTOYBTR-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2429517,CHEMBL1588866,LFBMKXWDSPGPGD-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3336994,CHEMBL1729715,PAQLZQGQCRLEPE-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2318672,CHEMBL59277,KSKVIZXIXFRARN-SANMLTNESA-N,,,P43235,CATHEPSIN K,CTSK,,,12781182.0,IC50,=,1000.0,NM,,,,,,,,,,,,,,Inhibitory activity against recombinant human cathepsin K activity using fluorescence assay,Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1113495,CHEMBL1631536,FQIVPUNKUNABAV-UHFFFAOYSA-N,,,P28222,SEROTONIN 1B (5-HT1B) RECEPTOR,HTR1B,,,21053897.0,KI,=,3.98,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]5-HT from human recombinant 5-HT1B receptor expressed in CHO cells,"Discovery of 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone (GSK163090), a Potent, Selective, and Orally Active 5-HT1A/B/D Receptor Antagonist.",J. Med. Chem.,PUBLICATION,
69274,CHEMBL3427580,AFRLJFGHZHGNMZ-KRWDZBQOSA-N,,,P26358,DNA (CYTOSINE-5)-METHYLTRANSFERASE 1,DNMT1,,,25801160.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of recombinant DNMT1 (unknown origin) after 90 mins by fluorescence assay,Developing new chemical tools for DNA methyltransferase 1 (DNMT 1): a small-molecule activity-based probe and novel tetrazole-containing inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
5179,CHEMBL1339161,AAKOJKQMPSAJIG-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
3348149,CHEMBL586599,PBXNQYHPZXPXJF-UHFFFAOYSA-N,TCMDC-125745,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,2.45,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
3776381,CHEMBL1373162,QXAPWJIDMMHYCM-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,7307.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
197447,CHEMBL2178869,ATULJSMRIAVHMJ-SFHVURJKSA-N,,,"P11230, P02708, P07510, Q07001",ACETYLCHOLINE RECEPTOR; ALPHA1/BETA1/DELTA/GAMMA,"CHRNA1, CHRNB1, CHRND, CHRNG",,,23092294.0,EC50,>,1000.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human alpha1beta1gammadelta nAChR expressed in human TE671/RD cells assessed as stimulation of 86Rb+ efflux preincubated for 10 mins by liquid scintillation counting,Discovery of Highly Potent and Selective a4ß2-Nicotinic Acetylcholine Receptor (nAChR) Partial Agonists Containing an Isoxazolylpyridine Ether Scaffold that Demonstrate Antidepressant-like Activity. Part II.,J. Med. Chem.,PUBLICATION,
263284,CHEMBL2419089,BBFDZJDATHTFBI-UHFFFAOYSA-N,,,Q06124,PROTEIN-TYROSINE PHOSPHATASE 2C,PTPN11,,,23942421.0,IC50,,,,,,,,,,,,,,,,,Inhibition of SHP2 (unknown origin),The first synthesis of natural disulfide bruguiesulfurol and biological evaluation of its derivatives as a novel scaffold for PTP1B inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3881212,CHEMBL1491466,RIARXAWNBLLEEJ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23109.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4826727,CHEMBL1333510,WBGBOQGUFPAFOW-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4766987,CHEMBL1711063,VUQCERQBHNFUMV-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3590972,CHEMBL290305,QCUSNVPGCDPMDE-UHFFFAOYSA-N,,,P18031,PROTEIN-TYROSINE PHOSPHATASE 1B,PTPN1,,,10649970.0,KIS,=,750000.0,NM,,,,,,,,,,,,,,Inhibitory activity against protein tyrosine phosphatases (PTP1B) (Kis=slope inhibitory constant),Structure-based discovery of small molecule inhibitors targeted to protein tyrosine phosphatase 1B.,J. Med. Chem.,PUBLICATION,
3204372,CHEMBL1356516,OMDQCAMJVDGWCZ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2307394,CHEMBL1725279,KRIUNPBAQZGFQA-UHFFFAOYSA-N,SP-600125,,Q9H2K8,SERINE/THREONINE-PROTEIN KINASE TAO3,TAOK3,wild_type,,23398362.0,ACTIVITY,=,69.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15,uM,"Millipore: Percentage of residual kinase activity of TAOK3 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 200 mM NaCl, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1099974,CHEMBL1491052,FOVBZNFCLJMWOL-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5020730,CHEMBL3137854,WWBDYIVCOYXHMT-OGRGGCPISA-N,,,P37058,ESTRADIOL 17-BETA-DEHYDROGENASE 3,HSD17B3,,,16078844.0,IC50,,,,,cell_based,,,,,HEK293,,,,,,,Inhibition of type-3 17 beta-hydroxysteroid dehydrogenase expressed in HEK293 cells at 37 degree C pH 7.4; Not determined,Androsterone 3alpha-ether-3beta-substituted and androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship.,J. Med. Chem.,PUBLICATION,
5178846,CHEMBL95050,XNAKHOOLFRTEOY-PGRDOPGGSA-N,,,P42866,MU OPIOID RECEPTOR,,,,8410998.0,AD50,=,0.19,MG KG-1,,organism_based,,,,,,,,,,,,Antagonism of opioid analgesia using a mouse writhing model to block morphine (2.5 mg/kg) induced mu-opioid receptor (subcutaneously dosed),"Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptors.",J. Med. Chem.,PUBLICATION,
3174499,CHEMBL92176,OIUDSIHLHKLLBT-UHFFFAOYSA-N,TCMDC-142338,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,1.13,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2642780,CHEMBL1712166,MCEQXUDYUWVRQT-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1752500,CHEMBL1374814,IIIQJAKHUZXUHB-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1436571,CHEMBL586876,HAMLMUFPMMDFDR-UHFFFAOYSA-N,TCMDC-138135,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,-2.06,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4570891,CHEMBL1474461,UZDOBCBBIPFXGU-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2925566,CHEMBL560556,NHMACPMXYHTADL-UHFFFAOYSA-N,,,Q96GD4,SERINE/THREONINE-PROTEIN KINASE AURORA-B,AURKB,,,19447622.0,KI,=,153.0,NM,,,,,,,,,,,,,,Inhibition of Aurora-B,The discovery of the potent aurora inhibitor MK-0457 (VX-680).,Bioorg. Med. Chem. Lett.,PUBLICATION,
4234977,CHEMBL1863773,SVCRRZWVGDMNJA-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,1000.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
826644,CHEMBL560919,DLDOVDSFVAFCQE-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3733752,CHEMBL2113348,QSGPKQOEFRHVCP-OULLVITASA-N,,,P28221,SEROTONIN 1D (5-HT1D) RECEPTOR,HTR1D,,,10794704.0,KI,=,100.0,NM,,,,,,,,,,,,,,Binding activity against human 5-hydroxytryptamine 1D receptor,"Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the rat.",J. Med. Chem.,PUBLICATION,
5176710,CHEMBL2064660,XMUDTSDEEPCGFL-HDFRBTCWSA-N,MRS-5679,,Q60613,ADENOSINE A2A RECEPTOR,,,,22559880.0,INHIBITION,=,6.0,%,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]I-AB-MECA from mouse adenosine A2A receptor expressed in HEK293 cells at 10 uM after 60 mins by liquid scintillation counting,Structure-Guided Design of A(3) Adenosine Receptor-Selective Nucleosides: Combination of 2-Arylethynyl and Bicyclo[3.1.0]hexane Substitutions.,J. Med. Chem.,PUBLICATION,
1008018,CHEMBL1392033,FEQNTUXIYYKDDE-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5320221,CHEMBL1371864,YCGPEXYEZIEOKG-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2065044,CHEMBL178126,JRFGDLNYJGJONH-UHFFFAOYSA-N,,,Q8JXU8,HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA POLYMERASE,,,,15999993.0,IC50,=,59.0,NM,,,,,,,,,,,,,,Inhibitory activity against by hepatitis C virus NS5B polymerase,Potent inhibitors of subgenomic hepatitis C virus RNA replication through optimization of indole-N-acetamide allosteric inhibitors of the viral NS5B polymerase.,J. Med. Chem.,PUBLICATION,
396168,CHEMBL3220951,BPOLLSANJOHJRS-UHFFFAOYSA-N,,,Q14330,N-ARACHIDONYL GLYCINE RECEPTOR,GPR18,,,,INHIBITION,=,0.0,%,,cell_based,,,,,,,,,,,,Antagonist activity against human GPR18 expressed in CHO cells assessed as reduction in delta9-THC-induced beta-arrestin recruitment at 10 uM by beta-galactosidase enzyme fragment complementation method,,MedChemComm,PUBLICATION,
1053484,CHEMBL3104578,FJOVWJCCWUEVCA-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,24374270.0,MAX ACTIVATION,,,,,,,,,,,,,,,,,Activation of PKM2 (unknown origin) assessed as PEP conversion to pyruvate by luminescence assay relative to FBP,Discovery of 3-(trifluoromethyl)-1H-pyrazole-5-carboxamide activators of the M2 isoform of pyruvate kinase (PKM2).,Bioorg. Med. Chem. Lett.,PUBLICATION,
1133044,CHEMBL289184,FSLQUWVSSNAKHE-MPKDPQEWSA-N,,,P42574,CASPASE-3,CASP3,,,14998341.0,K2,,,,,,,,,,,,,,,,,Second-order inhibition rate of caspase-3 was determined by progress curve method; No inhibition,"Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8.",J. Med. Chem.,PUBLICATION,
4889053,CHEMBL575060,WHUUTDBJXJRKMK-VKHMYHEASA-N,L-GLUTAMATE,,O00222,METABOTROPIC GLUTAMATE RECEPTOR 8,GRM8,,,15603952.0,IC50,=,5.7,NM,,,,,,,,,,,,,,Inhibitory concentration against [3H]1 binding to recombinant human Metabotropic glutamate receptor 8,"(2S,1'S,2'R,3'R)-2(2'-Carboxy-3'-hydroxymethylcyclopropyl)glycine-[3H], a potent and selective radioligand for labeling group 2 and 3 metabotropic glutamate receptors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1172263,CHEMBL211500,FWXXCSISWQQOGS-NSHDSACASA-N,,,P42892,ENDOTHELIN-CONVERTING ENZYME 1,ECE1,,,16821800.0,IC50,>,3000.0,NM,,,,,,,,,,,,,,Inhibition of human ECE1,Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides.,J. Med. Chem.,PUBLICATION,
2883316,CHEMBL3194311,NCWZBKKOWLSMFW-LPYMAVHISA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
850866,CHEMBL1371672,DNTZIYOFPLYQIC-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4837837,CHEMBL1462270,WCLUYDXOSFFFQJ-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2782341,CHEMBL1703732,MRRFERVJRVFBGQ-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
4753342,CHEMBL1714153,VTBZRRWYRWPFGT-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2974944,CHEMBL397753,NMSAVNXFCXMJJY-LBPRGKRZSA-N,,,P18825,ALPHA-2C ADRENERGIC RECEPTOR,ADRA2C,,,20925410.0,KI,=,537.03,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]RX821002 from human Alpha-2C adrenoceptor expressed in CHO cells,Fruitful adrenergic a(2C)-agonism/a(2A)-antagonism combination to prevent and contrast morphine tolerance and dependence.,J. Med. Chem.,PUBLICATION,
964495,CHEMBL1389769,DZXIBQMNEDTISW-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3919113,CHEMBL1594376,RLYGJKUXWYDHLJ-WYMLVPIESA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,5358.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5449318,CHEMBL1409264,YQEKOWIWTHUKPX-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1699293,CHEMBL1909347,ICEJPUIRDWMBNZ-BTJKTKAUSA-N,SB-732881H,,Q13237,CGMP-DEPENDENT PROTEIN KINASE 2,PRKG2,,,,INHIBITION,=,4.33,%,,,,,,,,,,,,,,GSK_PKIS: PRKG2 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
586402,CHEMBL482326,CKYDKNBLVBVPCS-UHFFFAOYSA-N,GSK-1030062A,,P36888,FMS RELATED TYROSINE KINASE 3,None,,,-100.0,INHIBITION,=,99.3,%,inhibition,biochemical,binding,,,qPCR,,1,UM,,,,,KINOMESCAN BEADS,,,,FLT3
1480578,CHEMBL1427265,HEVFAHVHSVMJRM-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
1093734,CHEMBL524195,FOEBLBGFGWQSRQ-UHFFFAOYSA-N,,,P40763,SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3,STAT3,,,18578470.0,ACTIVITY,,,,,cell_based,,,,,HeLa,,,,,,,Inhibition of STAT3 Y705 phosphorylation in human HeLa cells by Western blot analysis,"Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters.",J. Med. Chem.,PUBLICATION,
5545152,CHEMBL1509483,ZBCOZCVPNSNSKF-CMDGGOBGSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4224683,CHEMBL1593294,STXRBEDTXBMQLL-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
1555557,CHEMBL1472748,HMLUQJWWHLUSRR-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1827639,CHEMBL1388922,IQPWJPPZXNWEIA-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1081383,CHEMBL3414865,FMWWGWLFONHVSV-UHFFFAOYSA-N,,,Q9WKE8,REVERSE TRANSCRIPTASE,,mutated,"Q9WJQ2(L100I,K103N)",25522204.0,IC50,=,1000.0,NM,,,,,,,,,,,,,,Inhibition of HIV1 reverse transcriptase L100I/K103N mutant associated RNase H domain activity assessed as reduction in reduction in DNA 3' end directed cleavage using HTS-1 RNA/DNA duplex substrate by fluorescence assay,"Design, synthesis, biochemical, and antiviral evaluations of C6 benzyl and C6 biarylmethyl substituted 2-hydroxylisoquinoline-1,3-diones: dual inhibition against HIV reverse transcriptase-associated RNase H and polymerase with antiviral activities.",J. Med. Chem.,PUBLICATION,
4837954,CHEMBL1560904,WCMHNCDTWUKZIH-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3254055,CHEMBL2313590,OROQOIOMQUSZJD-WOJGMQOQSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,23262035.0,IC50,,,,,,,,,,,,,,,,,Inhibition of pure alpha-glucosidase (unknown origin) assessed as para-nitrophenol release at 420 nm OD,"Synthesis, crystal structure and antidiabetic activity of substituted (E)-3-(Benzo [d]thiazol-2-ylamino) phenylprop-2-en-1-one.",Eur. J. Med. Chem.,PUBLICATION,
4362184,CHEMBL1436746,UCQLKMJOEIRRRB-YDCVZUCISA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
4285637,CHEMBL1447144,TUOHAIMSYDWAQE-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
5151659,CHEMBL1981047,XKFTZKGMDDZMJI-UHFFFAOYSA-N,,,P06493,CYCLIN-DEPENDENT KINASE 1,CDK1,,,,KI,=,3162.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDC2,PUBCHEM BIOASSAY DATA SET,,DATASET,
1563295,CHEMBL1430604,HNJGSVLTNYDANM-UHFFFAOYSA-N,,,Q9Y256,PRENYL PROTEIN SPECIFIC PROTEASE,RCE1,,,,AC50,=,5200.0,NM,,biochemical,,,,,,,,,,,,PUBCHEM_BIOASSAY: Human Ras-Converting Enzyme Inhibition Assay Measured in Biochemical System Using Plate Reader - 2034-04_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2618],PUBCHEM BIOASSAY DATA SET,,DATASET,
357678,CHEMBL499,BLJRIMJGRPQVNF-JTQLQIEISA-N,TIMOLOL,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,,IC50,,,,,,,,,,HEK293,,,,,,,"DRUGMATRIX: Opiate delta1 (OP1, DOP) radioligand binding (ligand: [3H] Naltrindole)",DrugMatrix in vitro pharmacology data,,DATASET,
2086500,CHEMBL67396,JTKZGJJIAMQERE-UHFFFAOYSA-M,,,P21556,PLATELET ACTIVATING FACTOR RECEPTOR,,,,7783144.0,IC50 RATIO,=,144.0,,,,,,,,,,,,,,,Competitive inhibition of PAF-induced platelet aggregation was measured as IC50 ratio is (1000 x the IC50 of the test compound divided by the IC50 of a standard),Development of a novel series of trialkoxyaryl derivatives as specific and competitive antagonists of platelet activating factor.,J. Med. Chem.,PUBLICATION,
5841102,CHEMBL3798256,,,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,27085672.0,Activity,=,6.4,%,,,,,,,,,,,,,,Inhibition of partial length wild type human BRAF expressed in mammalian system assessed as enzyme activity at 1 uM relative to control,Purinylpyridinylamino-based DFG-in/C-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling.,Bioorg. Med. Chem.,PUBLICATION,
1303849,CHEMBL266707,GLHFDXWSDZWRNN-UHFFFAOYSA-N,SKF-86055,,Q12851,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 2,MAP4K2,,,,INHIBITION,=,1.02,%,,,,,,,,,,,,,,GSK_PKIS: MAP4K2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
365859,CHEMBL3675662,BMFNCADIGSOVGK-UHFFFAOYSA-N,,,Q9Y5Y4,G PROTEIN-COUPLED RECEPTOR 44,PTGDR2,,,,IC50,=,53.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Calcium Flux Assay. Calcium Flux Assay Using Fluorometric Imaging Plate Reader (FLIPR). Buffer containing dye (from the FLIPR® Calcium 3 Assay Kit from Molecular Devices, a division of MDS Analytical Technologies and MDS Inc.) was prepared by dissolving the contents of one bottle into 200 mL Hank's Balanced Salt Solution containing 20 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) and 2.5 mM probenecid. Growth media was removed from the cell plates and 25 µL of Hank's Balanced Salt Solution (HBSS) containing 20 mM HEPES, 0.05% BSA and 2.5 mM probenecid was added to each well followed by 25 µL of diluted dye using a Multidrop dispenser. The plates were then incubated for 1 hour at 37° C.",Piperidinyl naphthylacetic acids,,PATENT,
658198,CHEMBL1366123,CTCQPEXAXPGKMY-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3689108,CHEMBL1357018,QNQZGEQPXVSUOZ-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3232390,CHEMBL1334340,OPIFKWJRFLXODB-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5714928,CHEMBL1572214,ZTJNWWANFGWTCN-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2886799,CHEMBL38954,NDENPPYDSJTEJR-MYHRABSESA-N,,,P00797,RENIN,REN,,,2187994.0,IC50,=,2.8,NM,,,,,,,,,,,,,,In vitro inhibition of human plasma renin.,"Potent, low molecular weight renin inhibitors containing a C-terminal heterocycle: hydrogen bonding at the active site.",J. Med. Chem.,PUBLICATION,
1199082,CHEMBL1499578,FZZDVSIOIPMZDH-UHFFFAOYSA-N,,,Q07440,BCL-2-RELATED PROTEIN A1,,,,,IC50,>,20000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response confirmation of UBC13 Polyubiquitin Inhibitors using a Bfl-1 counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485273, AID485343]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3751063,CHEMBL1326123,QUERFNZEBZXEQK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2212109,CHEMBL3687476,KGZCVPZUCOCCCQ-FSKGLPCWSA-N,,,P11309,SERINE/THREONINE-PROTEIN KINASE PIM1,PIM1,,,,IC50,=,1.18,NM,,,,,,,,,,,,,,"BindingDB_Patents: AlphaScreen Assay. Pim 1, Pim 2 & Pim 3 AlphaScreen assays using high ATP (11-125.times. ATP Km) were used to determine the biochemical activity of the inhibitors. The activity of Pim 1, Pim 2, & Pim 3 is measured using a homogeneous bead based system quantifying the amount of phosphorylated peptide substrate resulting from kinase-catalyzed phosphoryl transfer to a peptide substrate. Compounds to be tested are dissolved in 100% DMSO and directly distributed to a white 384-well plate at 0.25 .mu.l per well. To start the reaction, 5 .mu.l of 100 nM Bad peptide (Biotin-AGAGRSRHSSYPAGT-OH (SEQ ID NO:1)) and ATP (concentrations described below) in assay buffer (50 mM Hepes, pH=7.5, 5 mM MgCl.sub.2, 0.05% BSA, 0.01% Tween-20, 1 mM DTT) is added to each well. This is followed by the addition of 5 .mu.l/well of Pim 1, Pim 2 or Pim 3 kinase in assay buffer (concentrations described below). Final assay concentrations (described below) are in 2.5% DMSO. The reactions are performed for .about.2 hours.",Ring-substituted N-pyridinyl amides as kinase inhibitors,,PATENT,
3900423,CHEMBL589029,RJYOQAPRXIFRHT-UHFFFAOYSA-N,TCMDC-132766,,P11166,GLUCOSE TRANSPORTER,SLC2A1,,,,INHIBITION,=,9.29,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGLUT1 that are glucose transport deficient and complemented with the human glucose transporter GLUT1. Activity is measured by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
3955134,,RPYFPONCOKUOBA-UHFFFAOYSA-N,,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,1.85,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4606267,CHEMBL1492860,VCWHAQDKDBHXOX-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
99395,CHEMBL2140365,AJCMVEOGETUASH-UHFFFAOYSA-N,,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2099706,CHEMBL429023,JUVIOZPCNVVQFO-HBGVWJBISA-N,ROTENONE,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Validation of Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5363801,CHEMBL1535579,YHALUMYXIPMSON-SAPNQHFASA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
4498259,CHEMBL716,URKOMYMAXPYINW-UHFFFAOYSA-N,QUETIAPINE,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,12629531.0,KI,=,245.0,NM,,,,,,,,,,,,,,,,,,
4363968,CHEMBL1345029,UCUCHEUQKVFIMZ-UHFFFAOYSA-N,,,Q14191,WERNER SYNDROME ATP-DEPENDENT HELICASE,WRN,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2166825,CHEMBL1705260,KCEIVWKDBLAQKL-UHFFFAOYSA-N,,,Q9UBT6,DNA POLYMERASE KAPPA,POLK,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],PUBCHEM BIOASSAY DATA SET,,DATASET,
5011054,CHEMBL1316714,WVDBMMCTLMMZAL-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2325304,CHEMBL601719,KTEIFNKAUNYNJU-GFCCVEGCSA-N,CRIZOTINIB,,Q9H2G2,SERINE/THREONINE-PROTEIN KINASE 2,SLK,,,29191878.0,KDAPP,=,3470.28,NM,inhibition,cell_free,binding,binding_reversible,,label_free_technology,"K-562, COLO 205, MV-4-11, SK-N-BE(2)+CAKI-1",3-30,NM-UM,,,,,LC-MS/MS BASED KINOBEADS COMPETITIVE PULL-DOWN ASSAY,THE TARGET LANDSCAPE OF CLINICAL KINASE DRUGS,SCIENCE,,
858108,CHEMBL372474,DOKIBWCVABZHOH-UHFFFAOYSA-N,GW678313X,,P21802,FIBROBLAST GROWTH FACTOR RECEPTOR 2,FGFR2,,,,INHIBITION,=,29.33,%,,,,,,,,,,,,,,GSK_PKIS: FGFR2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
139234,CHEMBL1464306,ANVVHXVNYURAKK-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5322515,CHEMBL1524717,YCNKYQGKKLOHRJ-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3196675,CHEMBL470998,OLJRAFPOAGIZKX-XGBBNYNSSA-N,,,P05627,TRANSCRIPTION FACTOR AP-1,,,,24831826.0,RATIO,=,2.38,,,,,,,,,,,,,,,Inhibition of AP-1-mediated transcriptional activation in lipopolysaccharide-stimulated mouse RAW 264.7 cells assessed ratio of luciferase activity normalized to Renilla luciferase activity by luciferase reporter gene assay,Small molecule inhibitors targeting activator protein 1 (AP-1).,J. Med. Chem.,PUBLICATION,
1465535,CHEMBL1558065,HDIRLWYGQMZPSK-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,4109.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of TGF-b: CCL64 Cells Orthogonal Assay for Cherry Picks.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4753733,CHEMBL1928681,VTCZIOVOFULZNG-UHFFFAOYSA-N,,,O96017,SERINE/THREONINE-PROTEIN KINASE CHK2,CHEK2,,,22111927.0,IC50,=,16000.0,NM,,,,,,,,,,,,,,Competitive inhibition of human CHK2 using ATP as substrate by DELFIA,Structure-guided evolution of potent and selective CHK1 inhibitors through scaffold morphing.,J. Med. Chem.,PUBLICATION,
2171552,CHEMBL1419414,KCSCYIVJVSRGFZ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20587.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
545170,CHEMBL2029902,CGEOTWGXFRJZLW-UHFFFAOYSA-N,,,O14965,SERINE/THREONINE-PROTEIN KINASE AURORA-A,AURKA,,,22607669.0,IC50,=,38.0,NM,,,,,,,,,,,,,,Inhibition of aurora A kinase,"Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3065439,CHEMBL378178,NXADGRVVCCIRJO-UHFFFAOYSA-N,,,P37136,ACETYLCHOLINESTERASE,,,,18976927.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of acetylcholinesterase in Wistar rat brain homogenate at upto 10 uM by Ellman's method,Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity.,Bioorg. Med. Chem.,PUBLICATION,
5372201,CHEMBL1557335,YHZQXRRMJQRBAK-XBXARRHUSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1982335,CHEMBL3702939,JHVXIHFNMGGWOB-CDMKHQONSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,IC50,=,17.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: HTRF Assay. The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAK1 #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 mL of diluted compounds in DMSO were dispensed into the wells of a dry 384-well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser. Subsequent reagent additions employed an Agilent Bravo. Next, 18 uL of 1.11x enzyme and 1.11x substrate in 1x assay buffer (Invitrogen kinase buffer #PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at ambient temperature to allow compound binding to equilibrate. After equilibration, 2 uL of 10xATP in 1x assay buffer was added to initiate the kinase reaction.",Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors,,PATENT,
4814547,CHEMBL1442232,VZXSAJUGGVLVHT-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5008096,CHEMBL276711,WUWDLXZGHZSWQZ-WQLSENKSSA-N,SEMAXANIB,,Q13554,CAM KINASE II BETA,CAMK2B,wild_type,,22037377.0,ACTIVITY,=,93.98169238,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,AUTOCAMTIDE 2 + CA-CAM,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
4374025,CHEMBL27842,UEDNQLLZQOYYJJ-JYPDZDFGSA-N,,,P08473,NEPRILYSIN,MME,,,,IC50,=,10000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of neutral endopeptidase in human umbilical vein endothelial cells,,Bioorg. Med. Chem. Lett.,PUBLICATION,
2041552,CHEMBL1287853,JOOXLOJCABQBSG-UHFFFAOYSA-N,FEDRATINIB,,P42336,PI3-KINASE P110-ALPHA SUBUNIT,PIK3CA,,,22037378.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for PIK3CA(H1047Y) kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
5795446,CHEMBL3822883,,,,Q16790,CARBONIC ANHYDRASE IX,CA9,,,27144971.0,Ki,=,1.7,NM,,,,,,,,,,,,,,Inhibition of human recombinant carbonic anhydrase 9 preincubated for 15 mins prior to testing by stopped-flow CO2 hydration assay,PEGylated Bis-Sulfonamide Carbonic Anhydrase Inhibitors Can Efficiently Control the Growth of Several Carbonic Anhydrase IX-Expressing Carcinomas.,J. Med. Chem.,PUBLICATION,
2423817,CHEMBL3277958,LEKPSSVKGMCAIY-VWJPMABRSA-N,,,P21964,CATECHOL O-METHYLTRANSFERASE,COMT,,,1271409.0,INHIBITION,=,20.0,%,,,,,,,,,,,,,,Inhibition of catechol O-methyltransferase (unknown origin) using 1 mM SAM as substrate at 1.2 mM,Analogues of S-adenosylhomocysteine as potential inhibitors of biological transmethylation. Synthesis of analogues with modifications at the 5'-thioether linkage.,J. Med. Chem.,PUBLICATION,
3647637,CHEMBL1403203,QJEPBPOSGCYKCI-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1169610,CHEMBL1893769,FWOGBNQBGXLBMH-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
565874,CHEMBL1899777,CIROQNKWSTZEED-SFHVURJKSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3403128,CHEMBL361033,PHZQHCMEUDDSTI-DQEYMECFSA-N,,,P33533,DELTA OPIOID RECEPTOR,,,,16483774.0,KI,=,0.3,NM,,tissue,,,,,,,,,,,,Displacement of [3H]DPDPE from delta opioid receptor in rat brain,Identification of potent phenyl imidazoles as opioid receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3071302,CHEMBL475599,NXPQOKLTKBGJEH-UHFFFAOYSA-N,GSK-300014A,,P08922,PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ROS,ROS1,,,,INHIBITION,=,6.34,%,,,,,,,,,,,,,,GSK_PKIS: ROS mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4548843,CHEMBL3216654,UWWYFQYAIHDLFL-UHFFFAOYSA-N,,,P10828,THYROID HORMONE RECEPTOR BETA-1,THRB,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Concentration Response Confirmation Assay for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) [Related pubchem assays: 1469 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
499616,CHEMBL473773,CBIAKDAYHRWZCU-UHFFFAOYSA-N,WHI-P154,,P52333,TYROSINE-PROTEIN KINASE JAK3,JAK3,wild_type,,22037377.0,ACTIVITY,=,100.27123979999999,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,JAK3TIDE,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3133791,CHEMBL783,OELFLUMRDSZNSF-BRWVUGGUSA-N,NATEGLINIDE,,P35372,MU OPIOID RECEPTOR,OPRM1,,,,IC50,,,,,,,,,,CHO-K1,,,,,,,"DRUGMATRIX: Opiate mu (OP3, MOP) radioligand binding (ligand: [3H] Diprenorphine)",DrugMatrix in vitro pharmacology data,,DATASET,
2869125,CHEMBL531708,NBIAOKINFSSRSS-UHFFFAOYSA-N,TCMDC-132031,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,9.98,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
2648927,CHEMBL1975179,MCUTVQUXLJEKAW-LNVKXUELSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
805915,CHEMBL1428544,DIYIKDXJMWOYSW-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1945772,CHEMBL1461287,JDQNOEQHJFRTMF-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1677593,CHEMBL1514563,IABOJROXRNMYKA-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3204396,CHEMBL1534364,OMDUQRRMUBRFAN-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3201005,CHEMBL50894,OLUKILHGKRVDCT-UHFFFAOYSA-N,ALSTERPAULLONE,,P35916,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 3,FLT4,wild_type,,23398362.0,ACTIVITY,=,32.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of FLT4 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1895750,CHEMBL512076,IYINYGZMZPUBOK-TZIWHRDSSA-N,GSK-192082A,,Q15349,RIBOSOMAL PROTEIN S6 KINASE ALPHA 2,RPS6KA2,,,,INHIBITION,=,0.86,%,,,,,,,,,,,,,,GSK_PKIS: RSK3 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1405348,CHEMBL3354601,GWVWQDNOLXCQAG-LZNUSVCISA-N,,,P30518,VASOPRESSIN V2 RECEPTOR,AVPR2,,,24874785.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Antagonist activity at human vasopressin V2 expressed in AVP-stimulated HEK293 cells after 5 hrs by firefly luciferase reporter gene assay,"New, potent, and selective peptidic oxytocin receptor agonists.",J. Med. Chem.,PUBLICATION,
3805031,CHEMBL7009,QZZWDAILXQWHAG-UHFFFAOYSA-N,,,"P28473, P28471, P23574, P15431, P63079, O09028, P30191, Q91ZM7, P18508, P62813, P20236, P19969, P23576, P63138, Q9ES14, P18506",GABA-A RECEPTOR; ANION CHANNEL,,,,8390574.0,KI,=,6.3,NM,,,,,,,,,,,,,,Binding affinity for Diazepam sensitive (DS) isoform of the benzodiazepine (Bz) binding site on GABAA receptors,"Synthetic and computer-assisted analysis of the structural requirements for selective, high-affinity ligand binding to diazepam-insensitive benzodiazepine receptors.",J. Med. Chem.,PUBLICATION,
1579922,CHEMBL54089,HPGJAAUNPHKECF-UHFFFAOYSA-N,,,Q95136,DOPAMINE D1 RECEPTOR,,,,7912735.0,IC50,=,40000.0,NM,,,,,,,,,,,,,,Binding affinity towards dopamine receptor D1 in calf striatum,"3,4-Dihydro-3-amino-2H-1-benzopyran derivatives as 5-HT1A receptor ligands and potential anxiolytic agents. 1. Synthesis and structure--activity relationship studies.",J. Med. Chem.,PUBLICATION,
5823958,CHEMBL1909075,,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
4185322,CHEMBL1532664,SPQSKMYHXVDLAW-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,1778.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4883332,CHEMBL415690,WHGYBXFWUBPSRW-FOUAGVGXSA-N,BETADEX,,P32238,CHOLECYSTOKININ A RECEPTOR,CCKAR,,,,KI,,,,,,,,,,1321-N1,,,,,,,"DRUGMATRIX: Cholecystokinin CCKA radioligand binding (ligand: [3H] L-364,718)",DrugMatrix in vitro pharmacology data,,DATASET,
1241337,CHEMBL1315812,GEOPKSGLHGUJHX-UHFFFAOYSA-N,,,P06746,DNA POLYMERASE BETA,POLB,,,,POTENCY,=,2238.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4650719,CHEMBL1417107,VHRKOEQPJGNZTC-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1577111,CHEMBL1337405,HOWZRYWHMPRDLI-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4849103,CHEMBL121022,WDPFPUDFLXNFFG-UHFFFAOYSA-N,,,Q64640,ADENOSINE KINASE,,,,12166937.0,IC50,=,45.0,NM,,,,,,,,,,,,,,Evaluated in vitro for inhibitory activity against Adenosine kinase (AK),"Design, synthesis, and structure-activity relationship of 6-alkynylpyrimidines as potent adenosine kinase inhibitors.",J. Med. Chem.,PUBLICATION,
2025075,CHEMBL393270,JMSIJLPYNMYLMV-UHFFFAOYSA-N,,,"O75899, Q9UBS5",GABA-B RECEPTOR,"GABBR1, GABBR2",,,17884493.0,EFFICACY,=,36.0,%,,cell_based,,,,,CHO-K1,,,,,,,Activity at GABAB 1b/2 receptor expressed in CHO-K1 cells assessed as effect on glutamate-induced [35S]GTP-gamma-S binding at 2.5 uM,Syntheses and optimization of new GS39783 analogues as positive allosteric modulators of GABA B receptors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5202716,CHEMBL3208807,XPTCAERUJHIROD-YDZHTSKRSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1962844,CHEMBL1613216,JFQIUEJMDJFBSH-UHFFFAOYSA-N,,,P38398,BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN,BRCA1,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3172041,CHEMBL441160,OIPFVCJQBKDETB-FBSWEULCSA-N,,,P47871,GLUCAGON RECEPTOR,GCGR,,,17201415.0,IC50,=,2429.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human cloned glucagon receptor expressed in BHK cells,New beta-alanine derivatives are orally available glucagon receptor antagonists.,J. Med. Chem.,PUBLICATION,
1863455,CHEMBL246127,IUSJINNBGHLFTG-UHFFFAOYSA-N,,,P31645,SEROTONIN TRANSPORTER,SLC6A4,,,17127059.0,KI,=,4.7,NM,,,,,,,,,,,,,,Binding affinity at human SERT,Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1033249,CHEMBL1362100,FHNBKGNZARSYOB-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
5269571,CHEMBL1346000,XXHQQBJZACLQPR-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1527707,CHEMBL247925,HJUKWDHJEFRHJW-UHFFFAOYSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,17292606.0,IC50,=,227.0,NM,,,,,,,,,,,,,,Displacement of fluorescein labeled ligand from PPARgamma receptor by fluorescence polarization assay,Discovery of tertiary aminoacids as dual PPARalpha/gamma agonists-I.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3917967,CHEMBL1373510,RLULOOJYAHJVIZ-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3797861,CHEMBL448473,QZHZKQMPXMKFSY-UHFFFAOYSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,16169215.0,KI,=,90.0,NM,,,,,,,,,,,,,,Inhibition of [125I]-NDP MSH binding to human Melanocortin 4 receptor,Privileged structure based ligands for melanocortin receptors--substituted benzylic piperazine derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4293579,CHEMBL568714,TVHJFFWRCNFNLY-UHFFFAOYSA-N,,,P49841,GLYCOGEN SYNTHASE KINASE-3 BETA,GSK3B,,,20030405.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of human recombinant GSK3-beta at 1 uM by ELISA,"Benzo[e]isoindole-1,3-diones as potential inhibitors of glycogen synthase kinase-3 (GSK-3). Synthesis, kinase inhibitory activity, zebrafish phenotype, and modeling of binding mode.",J. Med. Chem.,PUBLICATION,
2761926,CHEMBL2206014,MPIHOJMBMIMKAJ-KMKOMSMNSA-N,,,O15111,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE ALPHA SUBUNIT,CHUK,,,25219901.0,ACTIVITY,=,95.0,%,,,,,,,,,,,,,,Inhibition of human recombinant IKKalpha expressed Sf21 cells using Ulight-IkappaB-alpha substrate assessed as remaining enzyme activity at 1 uM after 30 mins relative to control,Indolinone based LRRK2 kinase inhibitors with a key hydrogen bond.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1702866,CHEMBL1340323,ICOSHNBUIVFXOY-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5503677,CHEMBL493326,YWNUJKWNTHEOIR-GFCCVEGCSA-N,GSK-317314A,,Q7KZI7,MAP/MICROTUBULE AFFINITY-REGULATING KINASE 2,MARK2,,,,INHIBITION,=,-0.63,%,,,,,,,,,,,,,,GSK_PKIS: PAR-1Balpha mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
1536592,CHEMBL1363802,HKSXFXSXWZQLQM-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,32642.7,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5377637,CHEMBL1533212,YIQJYGJDOYPHQS-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
3482901,CHEMBL1317429,PQQMVRKCOWHMOE-SFOWLQBLSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2195675,CHEMBL53753,KFHMLBXBRCITHF-UHFFFAOYSA-N,PD-158780,,Q9BYP7,SERINE/THREONINE-PROTEIN KINASE WNK3,WNK3,wild_type,,23398362.0,ACTIVITY,=,91.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200,uM,"Millipore: Percentage of residual kinase activity of WNK3 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1671213,CHEMBL381948,HZJPBOLTWHOKEL-UHFFFAOYSA-N,GW680975X,,P00533,EPIDERMAL GROWTH FACTOR RECEPTOR ERBB1,EGFR,,,,INHIBITION,=,7.94,%,,,,,,,,,,,,,,GSK_PKIS: EGFR (L861Q mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
141019,CHEMBL1407257,ANZQRJDEQQATQH-UHFFFAOYSA-N,,,Q9UBT6,DNA POLYMERASE KAPPA,POLK,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],PUBCHEM BIOASSAY DATA SET,,DATASET,
5501907,CHEMBL1480814,YWJBCJIGKJNRLN-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,2591.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3329782,CHEMBL1500938,OZVUEEWLSMZGAU-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
705812,CHEMBL1317602,CYCMCGJPKRYQDF-PCWBSFAKSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,354.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
636263,CHEMBL299613,CQOQDQWUFQDJMK-SSTWWWIQSA-N,2-METHOXYESTRADIOL,,P42345,SERINE/THREONINE-PROTEIN KINASE MTOR,MTOR,,,,POTENCY,=,5211.9,NM,,cell_based,,,,,MEF,,,,,,,PUBCHEM_BIOASSAY: Cytometry Cell-Based qHTS for Inhibitors of the mTORC1 Signaling Pathway in MEF cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3772118,CHEMBL281772,QWNXFTSHAHDZAF-CVEARBPZSA-N,,,O76074,PHOSPHODIESTERASE 5A,PDE5A,,,18045743.0,IC50,=,6.31,NM,,,,,,,,,,,,,,Inhibition of PDE5,Bioactivities of a series of phosphodiesterase type 5 (PDE-5) inhibitors as modelled by MIA-QSAR.,Eur. J. Med. Chem.,PUBLICATION,
1172931,CHEMBL1454202,FWZOTNIGAMRXHS-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18348.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
174809,CHEMBL3309678,ARLQMQGVVFXZCW-IRXDYDNUSA-N,,,Q04609,GLUTAMATE CARBOXYPEPTIDASE II,FOLH1,,,24954515.0,KI,=,0.0449,NM,,,,,,,,,,,,,,Inhibition of human recombinant N-terminal Avi-tagged glutamate carboxypeptidase 2 extracellular domain (44 to 750 amino acids) using pteroyl-di-L-glutamate substrate by HPLC method,Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery.,Bioorg. Med. Chem.,PUBLICATION,
3487077,CHEMBL413043,PRDKVDXHWLLADO-ZKKLFSJWSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,18088090.0,IC50,>,10000.0,NM,,cell_based,,,,,HEK293,,,,,,,"Displacement of [125I][Nle4,D-Phe7]alpha-MSH from human MC4 receptor expressed in HEK293 cells",Structure-activity relationships of cyclic lactam analogues of alpha-melanocyte-stimulating hormone (alpha-MSH) targeting the human melanocortin-3 receptor.,J. Med. Chem.,PUBLICATION,
1687251,CHEMBL522502,IBAKVEUZKHOWNG-UHFFFAOYSA-N,,,Q9P1W9,SERINE/THREONINE-PROTEIN KINASE PIM2,PIM2,wild_type,,23398362.0,ACTIVITY,=,136.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15.0,uM,"Millipore: Percentage of residual kinase activity of PIM2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3198270,CHEMBL1501146,OLPHFGSIFLMGPB-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5033993,CHEMBL2006039,WXSWASZSRDEVLW-MHWRWJLKSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
615944,CHEMBL2152236,COFQAKCKCHDGNW-TUTDZANASA-N,,,P50172,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,,,,,IC50,=,97.0,NM,,,,,,,,,,,,,,Inhibition of mouse 11betaHSD1 by scintillation proximity assay,,ACS Med. Chem. Lett.,PUBLICATION,
1516660,CHEMBL1785004,HIPGWLDSFHGAAY-UHFFFAOYSA-N,SB-253228,,Q12866,PROTO-ONCOGENE TYROSINE-PROTEIN KINASE MER,MERTK,,,,INHIBITION,=,1.13,%,,,,,,,,,,,,,,GSK_PKIS: MER mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5147288,CHEMBL1597227,XJSQQLPTQXPXSA-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
94483,CHEMBL1369865,AINSTPYBZSXWHP-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4621914,CHEMBL277474,VEQOALNAAJBPNY-UHFFFAOYSA-N,ANTIPYRINE,,P32241,VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1,VIPR1,,,,KI,,,,,,,,,,HT-29,,,,,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),DrugMatrix in vitro pharmacology data,,DATASET,
3417431,CHEMBL1788297,PJMHJXPXCJMDEB-PKLMIRHRSA-N,,,P19643,MONOAMINE OXIDASE B,,,,12431053.0,IC50,=,12000.0,NM,,,,,,,,,,,,,,In vitro inhibitory concentration against Monoamine oxidase B of rat brain homogenates; value ranges from 5-28,Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease.,J. Med. Chem.,PUBLICATION,
899026,CHEMBL504760,DSSYKIVIOFKYAU-XCBNKYQSSA-N,CAMPHOR,,P37288,VASOPRESSIN V1A RECEPTOR,AVPR1A,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Vasopressin V1A radioligand binding (ligand: [125I] PhenylacetylTyr(Me)PheGlnAsnArgProArgTyr),DrugMatrix in vitro pharmacology data,,DATASET,
3790707,CHEMBL1042,QYSXJUFSXHHAJI-YRZJJWOYSA-N,CHOLECALCIFEROL,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,42163.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1625194,CHEMBL1572888,HUMMRZFRSWRRRQ-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1339400,CHEMBL3193059,GPHKFILHCIUMLK-ODLFYWEKSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
786870,CHEMBL1319821,DGVXLHAJVRRLGV-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,21331.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3625855,CHEMBL1573690,QGPFSAWVISDZSY-HAVVHWLPSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
2851653,CHEMBL1606886,MZFVOAWLTVMEPG-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,1412.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
418788,CHEMBL261129,BSHCILRNXWKQAL-UHFFFAOYSA-N,SB-732881,,P28482,MAP KINASE ERK2,MAPK1,,,,INHIBITION,=,12.09,%,,,,,,,,,,,,,,GSK_PKIS: MAPK1 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
360636,CHEMBL1520896,BLSFWWQNJIEODB-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5128545,CHEMBL1505751,XHOVLENLNHKFLW-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,84921.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
415109,CHEMBL1766033,BRUZEIBVPXFMPA-WPSZSDGUSA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,21351746.0,KI,=,130.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]DAMGO from human mu opioid receptor expressed in CHO cells after 60 mins by scintillation counting,Aminothiazolomorphinans with mixed ¿ and µ opioid activity.,J. Med. Chem.,PUBLICATION,
3573591,CHEMBL1987073,QATMNAAQTUISJK-UHFFFAOYSA-N,,,P11309,SERINE/THREONINE-PROTEIN KINASE PIM1,PIM1,,,,KI,>,5011.87,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PIM1,PUBCHEM BIOASSAY DATA SET,,DATASET,
2671603,CHEMBL1533459,MFHDEYXRRYOWCK-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1370612,CHEMBL170487,GSZLRKKRTKNCQK-UHFFFAOYSA-N,,,P35353,CORTICOTROPIN RELEASING FACTOR RECEPTOR 1,,,,10072680.0,KI,=,222.0,NM,,,,,,,,,,,,,,Binding affinity was determined against corticotropin releasing factor receptor 1,Corticotropin-releasing hormone receptor antagonists: framework design and synthesis guided by ligand conformational studies.,J. Med. Chem.,PUBLICATION,
4156129,CHEMBL1473749,SMNLROLRLDZISW-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4648024,CHEMBL250699,VHKBTPQDHDSBSP-UHFFFAOYSA-N,A-803467,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,17483457.0,IC50,>,10000.0,NM,,,,,,,,,,,,,,Displacement of [125I]endothelin-1 from endothelin ETA receptor,"A-803467, a potent and selective Nav1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the rat.",Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
4930222,CHEMBL1347556,WMEAOFQKCCTHIO-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,1258.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
378564,CHEMBL1096979,BNQDCRGUHNALGH-UHFFFAOYSA-N,BENSERAZIDE,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,5972.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
2505849,CHEMBL476297,LNGLYCRNFZVESN-UHFFFAOYSA-N,,,P32238,CHOLECYSTOKININ A RECEPTOR,CCKAR,,,18614364.0,IC50,=,22.0,NM,,,,,,,,,,,,,,Inhibition of human CCK1 receptor,Discovery of imidazole carboxamides as potent and selective CCK1R agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
187860,CHEMBL26998,ASXGJMSKWNBENU-CQSZACIVSA-N,,,P97697,INOSITOL MONOPHOSPHATASE 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium. (Class of assay: confirmatory) [Related pubchem assays: 901 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
1787901,CHEMBL1784915,IMMOUXZOUPDXQI-UHFFFAOYSA-N,,,P11509,CYTOCHROME P450 2A6,CYP2A6,,,,INHIBITION,=,21.89,%,,,,,,,,,,,,,,Inhibition of human CYP2A6 at 10 uM,,ACS Med. Chem. Lett.,PUBLICATION,
5662828,CHEMBL56564,ZNRGQMMCGHDTEI-ITGUQSILSA-N,TROPISETRON,,P25100,ALPHA-1D ADRENERGIC RECEPTOR,ADRA1D,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Alpha-1D adrenergic receptor radioligand binding (ligand: prazosin),DrugMatrix in vitro pharmacology data,,DATASET,
4655790,CHEMBL1322040,VIHKEUDJKJYPLJ-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
1703275,CHEMBL3605415,ICQCMPQEFWZGRJ-OAQYLSRUSA-N,,,Q9UBN7,HISTONE DEACETYLASE 6,HDAC6,,,26287310.0,INHIBITION,=,78.0,%,,,,,,,,,,,,,,Inhibition of His-flagged recombinant HDAC6 (unknown origin) at 20 uM pre-incubated for 1 hr before substrate addition by homogeneous fluorogenic HDAC assay,Potent and Selective Inhibitors of Histone Deacetylase-3 Containing Chiral Oxazoline Capping Groups and a N-(2-Aminophenyl)-benzamide Binding Unit.,J. Med. Chem.,PUBLICATION,
1308749,CHEMBL1340749,GLWDKUGOBKLPAM-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1998072,CHEMBL1468038,JJTBQQQQMUTHSW-UHFFFAOYSA-N,,,"P08238, P07900",HEAT SHOCK PROTEIN HSP90,"HSP90AA1, HSP90AB1",,,,IC50,>,50000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Tumor Hsp90 Inhibitors Dose Response Confirmation. (Class of assay: confirmatory) [Related pubchem assays: 429 (Primary screen preceding this dose response confirmation assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
2748895,CHEMBL3218114,MNTWNPZVEDQTQO-UHFFFAOYSA-N,,,Q9ERZ8,TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 4,,,,,EC50,>,1000.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at rat TRPV4 expressed in CHOK1 cells assessed as changes in intracellular calcium level measured for 5 mins by FLIPR assay,,MedChemComm,PUBLICATION,
12686,CHEMBL1315419,ABFLQNFYUZSMJY-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
774570,CHEMBL1319170,DFMJGFACXUQYMN-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2704653,CHEMBL1381495,MJHGCBSPSLDUBM-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4335810,CHEMBL1579257,UAAMSNDIULCJJA-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1813140,CHEMBL588025,IPBCHSLQJORNHZ-UHFFFAOYSA-N,GW770249A,,P16591,TYROSINE-PROTEIN KINASE FER,FER,,,,INHIBITION,=,29.39,%,,,,,,,,,,,,,,GSK_PKIS: FER mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
12744,CHEMBL3209047,ABFWCJHIHKBIMJ-MXAYSNPKSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,31622.8,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3348472,CHEMBL1392912,PBYPMIYXQVBEMV-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3792808,CHEMBL1602080,QYYRMJQYFOYCRF-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
892528,CHEMBL1396515,DSAFSORWJPSMQS-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
4205309,CHEMBL3698990,SRQRRBLLTSGSRF-UHFFFAOYSA-N,,,P11103,POLY [ADP-RIBOSE] POLYMERASE-1,,,,,Kd,=,40.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Biochemical Assay. The assay is based on the use of a probe of formula (IP) that binds to the NAD binding pocket and takes advantage of the significant change in the polarization signal observed upon binding of the probe to PARP-1, -2 and -3.The probe of formula (IP) was tested for its ability to bind FL PARP-1, -2 and -3 in a titration experiment. The assay performances were then evaluated (ZÃ¢ factor) as well as the displacement of the probe by its scaffold and known commercially available PARP inhibitors. In all of the experiments, the polarization signal was measured using a Saphire2 plate reader (Tecan). Data analysis was performed using Dynafit software. In particular, titration data were fitted to the following equilibria: Enzyme+probe <==> Complex Enzyme-probe, while displacement data were fitted to the following equilibria: Enzyme+probe <==> Complex Enzyme-probe, Enzyme+Compound <==> Complex Enzyme-Compound, whereby binding of probe and compound on the enzyme are mutually exclusive.","3-oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP inhibitors",,PATENT,
1317403,CHEMBL1464571,GMSMBWMTBLESFN-UHFFFAOYSA-N,,,O43614,OREXIN RECEPTOR 2,HCRTR2,,,,IC50,>,50000.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen assay for antagonists of the orexin 1 receptor (OX1R; HCRTR1): Homogeneous Time Resolved Fluorescence (HTRF)-based cell-based dose response assay for antagonists of the orexin 2 receptor (OX2R; HCRTR2), run by assay provider. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3911768,CHEMBL3145210,RLCOFUWQEYTTHE-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,42284.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2267046,CHEMBL1518,KNAHARQHSZJURB-UHFFFAOYSA-N,PROPYLTHIOURACIL,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
2240695,CHEMBL274866,KKIMDKMETPPURN-UHFFFAOYSA-N,,,P28222,SEROTONIN 1B (5-HT1B) RECEPTOR,HTR1B,,,1565658.0,KI,=,64.0,NM,,,,,,,,,,,,,,,,,,
1881454,CHEMBL425336,IWUZBEMTCWTZBF-UHFFFAOYSA-N,,,P12530,ARACHIDONATE 15-LIPOXYGENASE,,,,15713402.0,IC50,=,340.0,NM,,,,,,,,,,,,,,Inhibitory concentration against rabbit reticulocyte 15-lipoxygenase with substrate arachidonic acid,Tryptamine and homotryptamine-based sulfonamides as potent and selective inhibitors of 15-lipoxygenase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2281586,CHEMBL1491145,KOTJYSOBVFDHCA-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4127408,CHEMBL1979357,SJDGHXXYFFXVPE-UHFFFAOYSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: JAK2,PUBCHEM BIOASSAY DATA SET,,DATASET,
479300,CHEMBL1561180,BZEDIFHRAGQVGN-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,25929.0,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
618183,CHEMBL1562494,COMIFAFOSRUICX-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2487343,CHEMBL1588686,LLKQEBREARMLHO-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5224227,CHEMBL539947,XRZYELWZLNAXGE-KPKJPENVSA-N,TYRPHOSTIN AG 879,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,3981.07,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5412708,CHEMBL1406308,YMMCTQWBDUNXJU-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,3981.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1711840,CHEMBL1257226,IDPGDKXBQTZRGW-KBMWQNTOSA-N,,,P35372,MU OPIOID RECEPTOR,OPRM1,,,20727752.0,IC50,>,24383.0,NM,,,,,,,,,,,,,,Antagonist activity at human mu opioid receptor assessed as inhibition of DAMGO-stimulated [35S]GTPgammaS binding,Discovery of 8-azabicyclo[3.2.1]octan-3-yloxy-benzamides as selective antagonists of the kappa opioid receptor. Part 1.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5595897,CHEMBL508928,ZGDSBEUMPIMXBM-UHFFFAOYSA-N,,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,wild_type,,21336281.0,KI,<,1584.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
186003,CHEMBL365544,ASTLYMNMTDERKI-IMUKZWIGSA-N,,,Q13133,LXR-ALPHA,NR1H3,,,16125384.0,EC50,=,1.0,NM,,,,,,,,,,,,,,Effective concentration in recombinant human LXRalpha ligand binding domain in homogeneous time-resolved fluorescence assay ,"Design, synthesis, and structure-activity relationship of podocarpic acid amides as liver X receptor agonists for potential treatment of atherosclerosis.",Bioorg. Med. Chem. Lett.,PUBLICATION,
411689,CHEMBL2441263,BRJRXEOBLQQTQY-UHFFFAOYSA-N,,,P34972,CANNABINOID CB2 RECEPTOR,CNR2,,,24125850.0,KI,=,101.0,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]-CP55940 from human CB2 receptor expressed in HEK293 cells after 1.5 hrs by microbeta liquid scintillation counting analysis,Mastering tricyclic ring systems for desirable functional cannabinoid activity.,Eur. J. Med. Chem.,PUBLICATION,
506601,CHEMBL1314034,CCBYJZRNPGFCJA-YZWUSWNESA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,2238.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5079989,CHEMBL1401102,XCOSVABQYGBEQG-KNTRCKAVSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5741852,CHEMBL1486297,ZWMGFYJOQWRFLA-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,819.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
147106,CHEMBL1312974,AOOHZDHSYHNXKM-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2366654,CHEMBL1465297,KXSZSABXZNPBQV-IZZDOVSWSA-N,,,P46063,ATP-DEPENDENT DNA HELICASE Q1,RECQL,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Confirmation qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1) - Round 2 Cherry Picks. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2367, AID593, AID594]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4188445,CHEMBL234338,SPZXXUUDYMHBSG-UHFFFAOYSA-N,"5,6,7,8,4'-PENTAHYDROXYFLAVONE",,Q14191,WERNER SYNDROME ATP-DEPENDENT HELICASE,WRN,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5572649,CHEMBL1584493,ZDSHJOVCTYCHHH-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20587.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2483647,CHEMBL157258,LLELAEGDEATZFN-UHFFFAOYSA-N,SB-390523,,P49840,GLYCOGEN SYNTHASE KINASE-3 ALPHA,GSK3A,,,,INHIBITION,=,16.4,%,,,,,,,,,,,,,,GSK_PKIS: GSK3A mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
646889,CHEMBL1539830,CRVPYKQWIRPDDN-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,=,1778.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
2540179,CHEMBL1403827,LQZITMLQRDSZDB-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
67395,CHEMBL378349,AFLJKKMTBWNZFE-AWEZNQCLSA-N,,,"P11230, P02708, P07510, Q07001",ACETYLCHOLINE RECEPTOR; ALPHA1/BETA1/DELTA/GAMMA,"CHRNA1, CHRNB1, CHRND, CHRNG",,,16821801.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of alpha-1-beta-1-gamma-delta nAChR expressed in TE671cells by FLIPR assay,"Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship.",J. Med. Chem.,PUBLICATION,
2470192,CHEMBL1643144,LJULQZCTWLGECQ-UHFFFAOYSA-N,BAS00416436,,O14965,SERINE/THREONINE-PROTEIN KINASE AURORA-A,AURKA,,,21194953.0,IC50,=,16720.0,NM,,cell_based,,,,,,,,,,,,Inhibition of human recombinant His-tagged Aurora A kinase expressed in insect cells,Computational approach to the identification of novel Aurora-A inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
4869624,CHEMBL1430061,WFTCAGFDWSMYSY-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,23934.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
89350,CHEMBL200680,AHYXGZDCECWMIM-IZZDOVSWSA-N,,,P32246,C-C CHEMOKINE RECEPTOR TYPE 1,CCR1,,,16198561.0,IC50,,,,,cell_based,,,,,,,,,,,,Antagonistic activity at human CCR1 by inhibition of MIP-1alpha induced calcium mobilization in THP1 cells,Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4318905,CHEMBL1470189,TYDLBYKMMQYLSJ-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
241533,CHEMBL202930,AYSXURJZVXBSRV-WJDWOHSUSA-N,A-432411,,"Q9BVA1, Q9BUF5, Q9BQE3, Q6PEY2, Q13885, P68363, Q13509, P68371, Q71U36, P07437, Q3ZCM7, P04350, Q9H4B7, P68366, Q13748",TUBULIN,"TUBA1A, TUBA1B, TUBA1C, TUBA3C, TUBA3D, TUBA3E, TUBA4A, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8",,,17887662.0,IC50,=,130.0,NM,,,,,,,,,,,,,,Displacement of [3H]colchicine from tubulin by scintillation proximity assay,An investigation into the cytotoxicity and mode of action of some novel N-alkyl-substituted isatins.,J. Med. Chem.,PUBLICATION,
3901217,CHEMBL458705,RKBFVIHBRHJYKX-TWGQIWQCSA-N,,,Q9HUY3,ARYLAMINE N-ACETYLTRANSFERASE,,,,19059786.0,INHIBITION,<,40.0,%,,,,,,,,,,,,,,Inhibition of Pseudomonas aeruginosa recombinant NAT using isoniazid as substrate at 30 uM,"Selective small molecule inhibitors of the potential breast cancer marker, human arylamine N-acetyltransferase 1, and its murine homologue, mouse arylamine N-acetyltransferase 2.",Bioorg. Med. Chem.,PUBLICATION,
4823605,CHEMBL1259203,WAWSGWZTHJAPIA-UHFFFAOYSA-N,,,P18130,ALPHA-1A ADRENERGIC RECEPTOR,,,,20857909.0,KI,=,0.52,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]prozosin from bovine cloned Alpha-1A receptor expressed in BHK cells,Exploring the neuroleptic substituent in Octoclothepin: potential ligands for positron emission tomography with subnanomolar affinity for a(1)-adrenoceptors.,J. Med. Chem.,PUBLICATION,
3566375,CHEMBL509001,QAAKLCLCIMZXGO-UHFFFAOYSA-N,,,P28190,ADENOSINE A1 RECEPTOR,,,,17418915.0,KI,=,19952623.15,NM,,,,,,,,,,,,,,Binding affinity to bovine adenosine A1 receptor,QSAR study on a novel series of 8-azaadenine analogues proposed as A1 adenosine receptor antagonists.,Eur. J. Med. Chem.,PUBLICATION,
1308103,CHEMBL1425,GLVAUDGFNGKCSF-UHFFFAOYSA-N,MERCAPTOPURINE,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,,KI,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Adenosine A1 radioligand binding (ligand: DPCPX),DrugMatrix in vitro pharmacology data,,DATASET,
2108934,CHEMBL1557894,JVWKQCOSIPNOKD-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5522720,CHEMBL434729,YYNPIMSTDPEJPS-UHFFFAOYSA-N,GW829906X,,Q9H0K1,SERINE/THREONINE-PROTEIN KINASE SIK2,SIK2,,,,INHIBITION,=,1.03,%,,,,,,,,,,,,,,GSK_PKIS: SNF1LK2 (QIK) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4556899,CHEMBL1369048,UXTNPNLYIOMMHB-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3765748,CHEMBL1388262,QVXSMTHKFBACMS-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2762159,CHEMBL3190800,MPJBPWFCWDGQDX-OVCLIPMQSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
705011,CHEMBL338383,CYAAOSBKNSIHNT-BNIKKZEQSA-N,,,P70536,OXYTOCIN RECEPTOR,,,,8258821.0,IC50,=,18.0,NM,,,,,,,,,,,,,,Inhibition of radioligand [3H]oxytocin binding at the oxytocin (OT) receptor in rat uterine tissue,"Nanomolar-affinity, non-peptide oxytocin receptor antagonists.",J. Med. Chem.,PUBLICATION,
4893796,CHEMBL361894,WIIIHAKKVLVGJX-UHFFFAOYSA-N,GW806290X,,P42681,TYROSINE-PROTEIN KINASE TXK,TXK,,,,INHIBITION,=,4.21,%,,,,,,,,,,,,,,GSK_PKIS: TXK mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3732560,CHEMBL574934,QSCFUZBKDKOVCC-UHFFFAOYSA-N,,,O35949,ELONGATION OF VERY LONG CHAIN FATTY ACIDS PROTEIN 3,,,,19596583.0,IC50,=,717.0,NM,,cell_based,,,,,,,,,,,,Inhibition of C-terminal V5-epitope-tagged mouse ELOVL3 expressed in african green monkey COS7 cells,Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
4692739,CHEMBL1329962,VMNXPUCTWIHZCR-UHFFFAOYSA-N,,,Q03137,EPHRIN TYPE-A RECEPTOR 4,,,,,IC50,=,2260.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Colorimetric assay for HTS discovery of chemical inhibitors of EphA4 receptor antagonists. Secondary screen (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3541153,CHEMBL1455056,PWZUZESHLMHRJI-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
4755301,CHEMBL1368578,VTJCQKDJERZXFP-RVDMUPIBSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2774432,CHEMBL529,MQTOSJVFKKJCRP-BICOPXKESA-N,AZITHROMYCIN,,P04626,RECEPTOR PROTEIN-TYROSINE KINASE ERBB-2,ERBB2,,,,IC50,,,,,cell_based,,,,,Insect cells,,,,,,,"DRUGMATRIX: Protein Tyrosine Kinase, ERBB2 (HER2) enzyme inhibition (substrate: Poly(Glu:Tyr))",DrugMatrix in vitro pharmacology data,,DATASET,
5280802,CHEMBL30908,XYICAUUIDRUWQX-UHFFFAOYSA-N,,,"Q14432, Q13370",PHOSPHODIESTERASE 3,"PDE3A, PDE3B",,,2822926.0,IC50,=,3500.0,NM,,,,,,,,,,,,,,Inhibitory concentration against cAMP PDE III enzyme in guinea pig,"Cardiotonic agents. 7. Inhibition of separated forms of cyclic nucleotide phosphodiesterase from guinea pig cardiac muscle by 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds. Structure-activity relationships and correlation with in vivo positive inotropic activity.",J. Med. Chem.,PUBLICATION,
1911985,CHEMBL1643462,JABANGKXVZEAJQ-UHFFFAOYSA-N,,,"P24941, P78396, P20248",CYCLIN-DEPENDENT KINASE 2/CYCLIN A,"CCNA1, CCNA2, CDK2",,,21094608.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,Inhibition of CDK2/cyclin A,"Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3545236,CHEMBL1562410,PXMMRSQLVRINIS-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
966058,CHEMBL1375338,FABYEEIARBZBHO-UHFFFAOYSA-N,,,Q932Y6,BETA LACTAMASE,,,,,IC50,=,27351.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen for inhibitors of TLR9-MyD88 binding: fluorescence-based cell-based high throughput dose response assay to identify non-selective inhibitors of the beta-lactamase enzyme (BLA). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504734, AID504750, AID540250, AID540251]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3799929,CHEMBL1525617,QZPCXTLTYHADQC-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
937874,CHEMBL3676095,DXCATLCGJNNZIB-QZTJIDSGSA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,IC50,>,1000.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. Compounds of Formula I were screened for their ability to inhibit Jak2 using the general enzyme inhibition assay method, in which the assay mixture contained 500 µM ATP, 10 µM Omnia Y7 peptide (Catalog # IVGN KNZ3071C, Invitrogen Corporation, Carlsbad, Calif.) and 4 nM Jak2 in a total volume of 20 µL. Human Jak2 kinase domain comprising amino acids 808-1132 was purchased from Invitrogen Corporation, Carlsbad, Calif. (catalog # IVGN PV4210).","Substituted pyrazolo[1,5-a]pyrimidine compounds as Trk kinase inhibitors",,PATENT,
698276,CHEMBL1464740,CXHSQLAKNRISGA-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1386561,CHEMBL3193224,GURLBPOZCBFOIA-VGOFMYFVSA-N,,,"Q01196, Q13951",RUNT-RELATED TRANSCRIPTION FACTOR 1/CORE-BINDING FACTOR SUBUNIT BETA,"CBFB, RUNX1",,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3351041,CHEMBL1544675,PCGUNDLOWPHDLM-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,16360.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3269517,CHEMBL1488375,OTHDYAZZMMEYNJ-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
2696439,CHEMBL436381,MIGREITXIMIAAD-UHFFFAOYSA-N,,,Q9H3N8,HISTAMINE H4 RECEPTOR,HRH4,,,12954048.0,KI,=,15.0,NM,,,,,,,,,,,,,,Displacement of [3H]- histamine from the recombinant human histamine H4 receptor,The first potent and selective non-imidazole human histamine H4 receptor antagonists.,J. Med. Chem.,PUBLICATION,
569851,CHEMBL459,CJCSPKMFHVPWAR-JTQLQIEISA-N,METHYLDOPA,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,23778.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
2486483,CHEMBL380071,LLJRXVHJOJRCSM-UHFFFAOYSA-N,,,Q8WTQ7,G PROTEIN-COUPLED RECEPTOR KINASE 7,GRK7,wild_type,,22037377.0,ACTIVITY,=,98.37244267,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,CASEIN,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2660430,CHEMBL604079,MEESNWIPVLGWFL-VWLOTQADSA-N,,,P00784,PAPAIN,,,,19913414.0,KI,=,6.3,NM,,,,,,,,,,,,,,Inhibition of Carica papaya papain by microtiter plate spectrofluorimetry,Antimalarial activity of azadipeptide nitriles.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4107376,CHEMBL1453492,SGXXNVKAZRUNAW-UHFFFAOYSA-N,,,Q57TT1,PUTATIVE UNCHARACTERIZED PROTEIN,,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4115754,CHEMBL1310906,SHTYTKCOCMRFDR-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
698735,CHEMBL3250738,CXJDIJUHGSFFHP-KQYNXXCUSA-N,,,P39069,ADENYLATE KINASE 1,,,,6286970.0,KM,=,2900000.0,NM,,,,,,,,,,,,,,Concentration of compound for half-maximal velocity to Adenylate kinase M isoenzyme,Species- or isozyme-specific enzyme inhibitors. 7. Selective effects in inhibitions of rat adenylate kinase isozymes by adenosine 5'-phosphate derivatives.,J. Med. Chem.,PUBLICATION,
4120840,CHEMBL1972659,SIIYWGTUMQUUKJ-UHFFFAOYSA-N,,,Q9H4B4,SERINE/THREONINE-PROTEIN KINASE PLK3,PLK3,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PLK3,PUBCHEM BIOASSAY DATA SET,,DATASET,
2597050,CHEMBL325372,LXCFILQKKLGQFO-UHFFFAOYSA-N,METHYLPARABEN,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,,IC50,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Melanocortin MC4 radioligand binding (ligand: [125I] NDP-alpha-MSH),DrugMatrix in vitro pharmacology data,,DATASET,
3033106,CHEMBL1474951,NTGIMUMGGGJCBL-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,4.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3591869,CHEMBL1424680,QCXXDKAQXWJZHU-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4071833,CHEMBL1387279,SDAIQTGEMBIVPX-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4058854,CHEMBL87445,SBMGFSCRPGXVOV-UHFFFAOYSA-N,,,P41146,NOCICEPTIN RECEPTOR,OPRL1,,,11101358.0,INHIBITION,=,32.9,%,,,,,,,,,,,,,,Percent inhibition of [3H]nociceptin ( 0.5 nM ) binding at 10 uM,4-Aminoquinolines: novel nociceptin antagonists with analgesic activity.,J. Med. Chem.,PUBLICATION,
4200644,CHEMBL1200961,SRGKFVAASLQVBO-BTJKTKAUSA-N,BROMPHENIRAMINE MALEATE,,O15648,6-PHOSPHO-1-FRUCTOKINASE,,,,,POTENCY,,756.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1457541,CHEMBL1698710,HCPCPTFKOFFNHU-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,21192.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3173659,CHEMBL1366791,OIRKHFPGGDPBLP-UHFFFAOYSA-N,,,O15648,6-PHOSPHO-1-FRUCTOKINASE,,,,,POTENCY,,19011.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1985468,CHEMBL108282,JIFUZIJTCAAWNY-QGZVFWFLSA-N,,,P21917,DOPAMINE D4 RECEPTOR,DRD4,,,12372513.0,KI,=,6.0,NM,,,,,,,,,,,,,,Binding affinity towards Dopamine type 4 receptor was determined by competitive displacement assays using [3H]-YM 09151 as the competitive ligand,Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 2: asymmetric synthesis and biological evaluation.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3317268,CHEMBL1369266,OYKGNQNESCZSHQ-UHFFFAOYSA-N,,,P15917,ANTHRAX LETHAL FACTOR,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Anthrax Lethal Toxin Internalization. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4070353,CHEMBL91420,SCWCDACSVVCEME-UHFFFAOYSA-N,,,P00918,CARBONIC ANHYDRASE II,CA2,,,10411484.0,KI,=,275.0,NM,,,,,,,,,,,,,,Inhibitory activity against human recombinant carbonic anhydrase II,"Carbonic anhydrase inhibitors. Synthesis of water-soluble, topically effective, intraocular pressure-lowering aromatic/heterocyclic sulfonamides containing cationic or anionic moieties: is the tail more important than the ring?",J. Med. Chem.,PUBLICATION,
3607300,CHEMBL1346837,QETHVGRWSOVJCW-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,23778.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
203743,CHEMBL2158126,AUOUXNQPFCJKKJ-UHFFFAOYSA-N,,,P81908,CHOLINESTERASE,,,,23000296.0,IC50,=,45.71,NM,,,,,,,,,,,,,,Inhibition of equine serum BuChE using butyrylthiocholine chloride substrate incubated for 5 mins before substrate addition measured at 3 min interval by Ellman method,"Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, ß-amyloid aggregation and Ca²¿ overload.",Bioorg. Med. Chem.,PUBLICATION,
2372961,CHEMBL213966,KYMLFJZPYAXAQW-UHFFFAOYSA-N,,,Q99705,MELANIN-CONCENTRATING HORMONE RECEPTOR 1,MCHR1,,,17125262.0,IC50,=,31.0,NM,,cell_based,,,,,CHO,,,,,,,Antagonist activity against human MCHR1 expressed in CHO cells by Gal4/Elk1-Luc reporter assay,"Potent, selective, and orally efficacious antagonists of melanin-concentrating hormone receptor 1.",J. Med. Chem.,PUBLICATION,
5636787,CHEMBL1834660,ZKXNIXASIHIFMC-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,21936542.0,IC50,=,1000.0,NM,,,,,,,,,,,,,,Inhibition of CYP3A4 using BFC as substrate,"Discovery of 3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea (NVP-BGJ398), A Potent and Selective Inhibitor of the Fibroblast Growth Factor Receptor Family of Receptor Tyrosine Kinase.",J. Med. Chem.,PUBLICATION,
4485103,CHEMBL437747,UQFRSHRWRKYNDE-UHFFFAOYSA-N,,,P06239,TYROSINE-PROTEIN KINASE LCK,LCK,wild_type,,21336281.0,KI,<,2511.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
5106594,CHEMBL1743803,XFPJZGUGGRESHD-PHJLCXHGSA-N,,,P31652,SEROTONIN TRANSPORTER,,,,3039136.0,KI,=,5.5,NM,,,,,,,,,,,,,,Inhibition the uptake of tritiated serotonin (5-HT) by the serotonin transporter SERT in rat synaptosomes,Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.,J. Med. Chem.,PUBLICATION,
819276,CHEMBL1496732,DKKYUXYUADHFGE-UHFFFAOYSA-N,,,P04608,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 TAT PROTEIN,,,,,IC50,,25360.0,NM,,,,,,,,,,,,,,PubChem BioAssay. An HIV-1 Tat-TAR Fluorescence Polarization (FP) Counter Screen to evaluate Inhibitors Targeting HIV-1 Vif-dependent Degradation of Human APOBEC3G.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
810861,CHEMBL1700954,DJMPDRJQNKEUOU-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,501.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
3431793,CHEMBL1493740,PLCQGRYPOISRTQ-AQTSZYAKSA-L,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
616160,CHEMBL1713609,COGJHWRZMOJNNH-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5133547,CHEMBL199049,XIFDEBVFTXMLPP-UHFFFAOYSA-N,,,P28222,SEROTONIN 1B (5-HT1B) RECEPTOR,HTR1B,,,16219465.0,ACTIVITY,,,,,,,,,,,,,,,,,Functional activity in in FLIPR assay for 5HT1B receptor,Synthesis and SAR of highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drugs.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2511699,CHEMBL3197501,LNYYGAZOBABHIB-PGACXJNKSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2269711,CHEMBL565,KNHUKKLJHYUCFP-UHFFFAOYSA-N,CLOFIBRATE,,P29477,"NITRIC OXIDE SYNTHASE, INDUCIBLE",,,,,IC50,,,,,,,,,,,,,,,,,"DRUGMATRIX: Nitric Oxide Synthase, Inducible (iNOS) enzyme inhibition (substrate: L-Arginine)",DrugMatrix in vitro pharmacology data,,DATASET,
3934601,CHEMBL1909355,RNVAYYNPHCMLEQ-UHFFFAOYSA-N,GW461104A,,Q8N4C8,MISSHAPEN-LIKE KINASE 1,MINK1,,,,INHIBITION,=,2.93,%,,,,,,,,,,,,,,GSK_PKIS: MINK mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2415528,CHEMBL3138561,LDKGCFTWQDANHW-UHFFFAOYSA-N,,,"Q14654, Q09428, Q15842, O60706",SULFONYLUREA RECEPTORS; K-ATP CHANNELS,"ABCC8, ABCC9, KCNJ11, KCNJ8",,,15163196.0,EC50,=,6760.83,NM,,,,,,,,,,,,,,Evaluated for K-ATP activity in terms of stable twitch response through field-stimulated landrace pig detrusor assay,"Synthesis and structure-activity relationships of a novel series of 2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide K(ATP) channel openers: discovery of (-)-(9S)-9-(3-bromo-4-fluorophenyl)-2,3,5,6,7,9- hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637), a potent K(ATP) opener that selectively inhibits spontaneous bladder contractions.",J. Med. Chem.,PUBLICATION,
5600131,CHEMBL2358447,ZGQIYHLNHANHNR-RVMAYGNISA-N,,,Q06710,PAIRED BOX PROTEIN PAX-8,PAX8,,,,AC50,=,17090.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. HTS for PAX8 inhibitors using PAX8 luciferase reporter gene assay in RMG-I cells Measured in Cell-Based System Using Plate Reader - 7054-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1634430,CHEMBL1363116,HVOFDEPSOOLGGX-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1040206,CHEMBL408565,FIFWWQUQNGQSLH-ZROIWOOFSA-N,,,Q9UEE5,SERINE/THREONINE-PROTEIN KINASE 17A,STK17A,,,18077363.0,THERMAL MELTING CHANGE,=,6.4,DEGREES C,,,,,,,,,,,,,,Delta TM value showing the stabilisation of DRAK1 produced by compound binding,A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
1117648,CHEMBL1521587,FQQPUUCQCAAOMA-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4511990,CHEMBL1488285,USZAEOZGEKRCQU-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature. (Class of assay: confirmatory) [Related pubchem assays: 902 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5010115,CHEMBL131693,WVAGWWGCPIPVSM-UHFFFAOYSA-N,,,O15111,INHIBITOR OF NUCLEAR FACTOR KAPPA B KINASE ALPHA SUBUNIT,CHUK,,,14698170.0,IC50,=,245.0,NM,,,,,,,,,,,,,,Inhibitory activity against IKK1,A novel series of potent and selective IKK2 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5580035,CHEMBL1341696,ZENCPPXDDPRLDV-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
102813,CHEMBL2158321,AJMZFXUDUORRMI-UHFFFAOYSA-N,,,P14920,D-AMINO-ACID OXIDASE,DAO,,,23683589.0,IC50,=,300.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant DAAO expressed in HEK293 cell lysate assessed as D-Serine conversion to H2O2 after 20 mins by spectrophotometric analysis,Synthesis of kojic acid derivatives as secondary binding site probes of D-amino acid oxidase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3918558,CHEMBL1305740,RLWNHKUMHXQPDW-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,35481.3,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4018673,CHEMBL523446,RXEANXJETHDITQ-VDAFUPJJSA-N,,,P15145,AMINOPEPTIDASE N,,,,19339187.0,IC50,=,43700.0,NM,,,,,,,,,,,,,,Inhibition of pig kidney microsomal aminopeptidase N after 30 mins by UV-VIS spectrophotometry,Novel aminopeptidase N inhibitors derived from antineoplaston AS2-5 (Part II).,Bioorg. Med. Chem.,PUBLICATION,
2089827,CHEMBL1404903,JTVCUAJIAFFQJI-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3721338,CHEMBL509032,QQWUGDVOUVUTOY-UHFFFAOYSA-N,TAE-684,,P45983,C-JUN N-TERMINAL KINASE 1,MAPK8,,,22335897.0,ACTIVITY,=,28.0,%,,,,,,,,,,,,,,Inhibition of JNK1 assessed as residual activity at 10 uM relative to control,Characterization of TAE684 as a potent LRRK2 kinase inhibitor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2621568,CHEMBL1343180,LZYDGSHJACEGJF-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4870382,CHEMBL2133002,WFVKDSQNAZYTRU-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3881512,CHEMBL3314937,RIBKOHFWGDNUSH-UMCMBGNQSA-N,,,Q9Y5L3,ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2,ENTPD2,,,24972256.0,INHIBITION,=,10.0,%,,cell_based,,,,,,,,,,,,Inhibition of recombinant human NTPDase2 transfected in COS-7 cells using ATP substrate at 100 uM relative to control,"2-Hexylthio-ß,¿-CH2-ATP is an effective and selective NTPDase2 inhibitor.",J. Med. Chem.,PUBLICATION,
2530682,CHEMBL1399481,LPVXJDJLLYCXRF-FKLOLKIJSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4906319,CHEMBL518506,WJJRVEFWXPKMQE-HSLMYDHPSA-N,,,O75469,PREGNANE X RECEPTOR,NR1I2,,,19053753.0,ACTIVITY,=,2.3,%,,cell_based,,,,,,,,,,,,Transactivation of human PXR transfected in HEK cells at 2 uM by luciferase reporter gene assay relative to 12.5 uM rifampin,"Further studies with the 2-amino-1,3-thiazol-4(5H)-one class of 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: reducing pregnane X receptor activity and exploring activity in a monkey pharmacodynamic model.",J. Med. Chem.,PUBLICATION,
4960853,CHEMBL1607580,WPTNWHKCTWYYNF-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
1790580,CHEMBL1302326,IMTLAJUSIIVOOU-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,9200.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3409878,CHEMBL522892,PIQCTGMSNWUMAF-UHFFFAOYSA-N,DOVITINIB,,P51812,RIBOSOMAL PROTEIN S6 KINASE ALPHA 3,RPS6KA3,wild_type,,22037378.0,KD,=,5600.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for RSK2(Kin.Dom.1-N-terminal) kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
812393,CHEMBL1798068,DJROYZFQFMCFLD-UHFFFAOYSA-N,,,A5A8K3,ENDOTHELIN RECEPTOR TYPE A,,,,21652209.0,INHIBITION,=,5.88,%,,,,,,,,,,,,,,Inhibition of endothelin A receptor in New Zealand white rabbit aortic rings assessed as inhibition of endothelin-1-induced vascular contraction at 10'-6 M,Synthesis and in vitro evaluation of ambrisentan analogues as potential endothelin receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5053496,CHEMBL158,WZPBZJONDBGPKJ-VEHQQRBSSA-N,AZTREONAM,,P32241,VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1,VIPR1,,,,IC50,,,,,,,,,,HT-29,,,,,,,DRUGMATRIX: Vasoactive Intestinal Peptide VIP1 radioligand binding (ligand: [125I] VIP),DrugMatrix in vitro pharmacology data,,DATASET,
2572793,CHEMBL1602976,LUJRGHLPIGTTJP-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
2403959,CHEMBL1462453,LCDJJENYZPCYIO-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
3742226,CHEMBL1418368,QTEUPVRQDQASMG-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,2238.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5330646,CHEMBL3662811,YDILSUBLFSBNBA-OXJNMPFZSA-N,,,P05771,PROTEIN KINASE C BETA,PRKCB,,,,KI,=,148.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Inhibition Assay. Protein Kinase C beta 2 (PKC beta II) catalyzes the production of ADP from ATP that accompanies the phosphoryl transfer to the PKC Pseudosubstrate peptide (A->S, RFARKGSLRQKNV). This transfer is coupled to the oxidation of p-NADH through the activities of Pyruvate Kinase (PK) and Lactate Dehydrogenase (LDH). (3-NADH conversion to NAD+ is monitored by the decrease in absorbance at 340 nm (e=6.22 cm-1 mM-1) using a Molecular Devices SPECTRA max PLUS spectrophotometer.A typical assay was carried out on a 96-well, clear microtiter plate in a Molecular Devices spectrophotometer for 20 minutes at 30 C. in 0.1 mL of assay buffer containing 50 mM HEPES, pH 7.4, 5 nM PKC, 23 units of pyruvate kinase, 33 units of lactate dehydrogenase, 0.15 mM peptide, 0.1 mM ATP, 1 mM DTT, 4 mM PEP, 8 mM MgCl2, 0.3 mM NADH, 60 mM CaCl2, 10 mg/mL PS, 50 ng/mL PMA, 7.5% DMSO and from about 10,000 nM to 0.169 nM compound inhibitor.","3-amido-pyrrolo[3,4-C]pyrazole-5(1H, 4H,6H) carbaldehyde derivatives",,PATENT,
329077,CHEMBL496664,BIIAUGOZAPCHMC-GTNKKZTPSA-N,,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,19356928.0,ACTIVITY,=,8.0,%,,,,,,,,,,,,,,Displacement of fluorescein-labeled estradiol from human recombinant ERbeta at 1 uM by fluorescence polarization assay,Biphenyl C-cyclopropylalkylamides: New scaffolds for targeting estrogen receptor beta.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1117634,CHEMBL189851,FQQPROZCOUSSJP-UHFFFAOYSA-N,,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,16000000.0,IC50,=,62.0,NM,,,,,,,,,,,,,,Inhibition of glutamate/tyrosine (4:1) copolymer phosphorylation by human VEGFR 2 in DELFIA assay,"Synthesis and structure-activity relationships of soluble 7-substituted 3-(3,5-dimethoxyphenyl)-1,6-naphthyridin-2-amines and related ureas as dual inhibitors of the fibroblast growth factor receptor-1 and vascular endothelial growth factor receptor-2 tyrosine kinases.",J. Med. Chem.,PUBLICATION,
1820839,CHEMBL1478342,IPYBHJWUFKCXRO-UHFFFAOYSA-N,,,Q99500,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-3,S1PR3,,,,IC50,=,4292.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose response cell-based high throughput screening assay for antagonists of the Sphingosine 1-Phosphate Receptor 3 (S1P3). (Class of assay: confirmatory) [Related pubchem assays: 1429, 485 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3563200,CHEMBL1965453,PZQNZFSGOVVLKX-CAOOACKPSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,3548.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5863895,CHEMBL3814554,,,,O15530,3-PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE-1,PDPK1,,,27217002.0,IC50,=,390.0,NM,,,,,,,,,,,,,,Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method,Discovery of novel 7-azaindoles as PDK1 inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4267948,CHEMBL1201010,SYWHXTATXSMDSB-GSLJADNHSA-N,FLUDROCORTISONE ACETATE,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,KI,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
3827395,CHEMBL1581498,RCHUVONGFCEQNK-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
816674,CHEMBL1949919,DKDKIXVBAAAELK-UHFFFAOYSA-N,,,P42338,PI3-KINASE P110-BETA SUBUNIT,PIK3CB,,,21985639.0,KI,=,43.0,NM,,,,,,,,,,,,,,Apparent binding affinity to PI3Kbeta using PIP3 as substrate after 30 mins by fluorescence polarization assay,Rational design of phosphoinositide 3-kinase a inhibitors that exhibit selectivity over the phosphoinositide 3-kinase ß isoform.,J. Med. Chem.,PUBLICATION,
1946207,CHEMBL1432352,JDSDZCCZMGTYQG-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5027550,CHEMBL1506369,WWYFUGXRLQKAHQ-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2398566,CHEMBL284237,LBOJYSIDWZQNJS-CVEARBPZSA-N,DIZOCILPINE,,"Q00959, Q62645, P35439, Q9R1M7, Q8VHN2, Q00961, Q00960",GLUTAMATE NMDA RECEPTOR,,,,1433216.0,INHIBITION,=,10.0,%,,,,,,,,,,,,,,Binding affinity against dextromethorpin binding site associated with N-methyl-D-aspartate glutamate receptor from rat brain determined at a concentration of 10e-5 M using [3H]1 as radioligand.,Synthesis and evaluation of 3-substituted 17-methylmorphinan analogs as potential anticonvulsant agents.,J. Med. Chem.,PUBLICATION,
1761411,CHEMBL1595938,IJKHKTVWSJFHPW-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,1258.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Agonists. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5118755,CHEMBL1604403,XGRYBDRIDFKQKK-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,4610.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3371072,CHEMBL458438,PEPOAPKYASCEKL-UHFFFAOYSA-N,GSK-1511931A,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,,INHIBITION,=,-1.9,%,,,,,,,,,,,,,,GSK_PKIS: MET mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3419860,CHEMBL1539,PJSFRIWCGOHTNF-UHFFFAOYSA-N,SULFADOXINE,,P28482,MAP KINASE ERK2,MAPK1,,,,KI,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DrugMatrix in vitro pharmacology data,,DATASET,
4860678,CHEMBL1543731,WEVNGTVNNVVTSN-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,16833.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1649821,CHEMBL419768,HXGDAZUUMWWNJY-UHFFFAOYSA-N,,,Q03181,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA,PPARD,,,14505666.0,IC50,>,50000.0,NM,,,,,,,,,,,,,,In vitro binding affinity was tested towards human Peroxisome proliferator activated receptor delta,Aryloxazolidinediones: identification of potent orally active PPAR dual alpha/gamma agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1426779,CHEMBL1461524,GZJBVAQVFHTCAD-QXMHVHEDSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2661122,CHEMBL3182355,MEHHPFQKXOUFFV-OWSLCNJRSA-N,,,Q03181,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA,PPARD,,,,POTENCY,,43342.3,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1271638,CHEMBL526214,GHSNRIDSNNBBFP-UHFFFAOYSA-N,TCMDC-123796,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1473, AID2293, AID2577, AID2578, AID2587, AID2588, AID2589, AID2590, AID2592, AID2593, AID2595, AID2596, AID2597, AID2613, AID2671, AID488845]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4475072,CHEMBL311014,UPBBTGBTRMORRK-UHFFFAOYSA-N,,,P35368,ALPHA-1B ADRENERGIC RECEPTOR,ADRA1B,,,9873563.0,KI,=,1650.0,NM,,cell_based,,,,,LM,,,,,,,Ability to displace beta ([125I]-iodo-4-hydroxyphenyl)-ethylamino methyl tetralone from human cloned Alpha-1b adrenergic receptor stably expressed in LM cells.,Design and synthesis of N-alkylated saccharins as selective alpha-1a adrenergic receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
505803,CHEMBL74801,CBZFZFCSCRFIEN-UHFFFAOYSA-N,,,"P28473, P28471, P23574, P15431, P63079, O09028, P30191, Q91ZM7, P18508, P62813, P20236, P19969, P23576, P63138, Q9ES14, P18506",GABA-A RECEPTOR; ANION CHANNEL,,,,2552115.0,GABA SHIFT,=,1.41,,,,,,,,,,,,,,,Ratio of binding affinity to the GABA-A receptor in the presence and absence of GABA,Novel benzodiazepine receptor partial agonists: oxadiazolylimidazobenzodiazepines.,J. Med. Chem.,PUBLICATION,
3234470,CHEMBL544140,OPNJBQKCHMICSO-UHFFFAOYSA-N,,,"P47869, Q16445, P18505, P18507, P47870, O00591, P34903, Q8N1C3, P78334, Q99928, P31644, O14764, P48169, P14867, P28472, Q9UN88",GABA-A RECEPTOR; ANION CHANNEL,"GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ",,,1331456.0,IC50,=,120.0,NM,,organism_based,,,,,,,,,,,,Binding affinity in vivo for gamma-aminobutyric-acid A receptor measured by its ability to displace [3H]-GABA agonist from rat brain preparations after iv injection.,Condensation of muscimol or thiomuscimol with aminopyridazines yields GABA-A antagonists.,J. Med. Chem.,PUBLICATION,
5056941,CHEMBL1367899,WZYFUROSSURMGZ-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
5520637,CHEMBL1361620,YYIDLQAYBASNCB-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,1995.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2451909,CHEMBL1409789,LHQHBNJJCLSSSC-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
356020,CHEMBL10347,BLGXFZZNTVWLAY-DIRVCLHFSA-N,RAUWOLSCINE,,"P23944, P43140, P15823",ADRENERGIC RECEPTOR ALPHA-1,,,,,KI,=,450.0,NM,,,,,,,,,,,,,,Evaluated for affinity at Alpha-1 adrenergic receptor of rat brain using [3H]prazosin as radioligand in radioligand binding assay,,Bioorg. Med. Chem. Lett.,PUBLICATION,
1824385,CHEMBL2058419,IQJBDRJDMXGXFH-OSNXYGPASA-N,,,P28221,SEROTONIN 1D (5-HT1D) RECEPTOR,HTR1D,,,24084296.0,KI,=,6835.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]5-CT from human recombinant 5HT1D receptor expressed in HEKT cells,In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.,Bioorg. Med. Chem.,PUBLICATION,
5537577,CHEMBL3342568,ZAEJFCCEYBSYJM-UHFFFAOYSA-N,,,P23219,CYCLOOXYGENASE-1,PTGS1,,,25313331.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant COX1 pre-incubated for 15 mins before fluorometric substrate addition by fluorescence based assay,Synthesis of Deuterated Benzopyran Derivatives as Selective COX-2 Inhibitors with Improved Pharmacokinetic Properties.,ACS Med. Chem. Lett.,PUBLICATION,
299500,CHEMBL1531317,BFHWGTMLVZHIPH-UHFFFAOYSA-N,,,Q9Y468,LETHAL(3)MALIGNANT BRAIN TUMOR-LIKE PROTEIN 1,L3MBTL1,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of L3MBTL1. (Class of assay: confirmatory) [Related pubchem assays: 485292 (Probe Development Summary for Inhibitors of L3MBTL1)],PUBCHEM BIOASSAY DATA SET,,DATASET,
1332234,CHEMBL1709116,GOLDTQVTSFGHKK-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5750871,CHEMBL1569933,ZXLGHUKKFPWWJW-UHFFFAOYSA-N,,,P04578,ENVELOPE POLYPROTEIN GP160,,,,,IC50,,67043.0,NM,,,,,,,,,,,,,,"PubChem BioAssay. TRFRET-based biochemical high throughput dose response assay for small molecules that bind to the HIV-1-gp120 binding antibody, PG9. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1108710,CHEMBL507522,FPXPIEZPAXSELW-RGNAGUPPSA-N,,,Q14833,METABOTROPIC GLUTAMATE RECEPTOR 4,GRM4,,,19469556.0,FC,=,7.0,,,cell_based,,,,,CHO,,,,,,,Activity at human mGluR4 expressed in CHO cells coexpressing Gqi5 protein assessed as fold shifting of glutamate-induced response to left at 30 uM,Synthesis and evaluation of a series of heterobiarylamides that are centrally penetrant metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulators (PAMs).,J. Med. Chem.,PUBLICATION,
1122534,CHEMBL1400788,FRENSWPRYDRYLT-IMKMYNEFSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,POTENCY,=,398.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2474240,CHEMBL1360351,LKFYGMKCUDNBOX-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,23778.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3224725,CHEMBL2134764,OOHQQTKNMCAKQZ-IRXDYDNUSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1328546,CHEMBL1466100,GOAPNQZJEWYVEH-UHFFFAOYSA-N,,,Q03164,HISTONE-LYSINE N-METHYLTRANSFERASE MLL,KMT2A,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)],PUBCHEM BIOASSAY DATA SET,,DATASET,
3220727,CHEMBL3215582,ONWNIWNJAJIPOS-UHFFFAOYSA-N,,,Q06418,TYROSINE-PROTEIN KINASE RECEPTOR TYRO3,TYRO3,,,19764794.0,ACTIVITY,=,84.0,%,,,,,,,,,,,,,,Inhibition of TYRO3 assessed as enzyme activity at 1 uM relative to untreated control,Selective inhibitors of the mutant B-Raf pathway: discovery of a potent and orally bioavailable aminoisoquinoline.,J. Med. Chem.,PUBLICATION,
2761233,CHEMBL578841,MPFXFPLOFFDVSF-MOPGFXCFSA-N,,,P31645,SEROTONIN TRANSPORTER,SLC6A4,,,19713106.0,IC50,=,266.0,NM,,cell_based,,,,,JAR,,,,,,,Inhibition of human SERT expressed in JAR cells,Structure-activity relationships of the 1-amino-3-(1H-indol-1-yl)-3-phenylpropan-2-ol series of monoamine reuptake inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4824417,CHEMBL16165,WAZHPOHPQXBJKI-UHFFFAOYSA-N,,,P35351,ANGIOTENSIN II TYPE 2 (AT-2) RECEPTOR,,,,,IC50,=,760.0,NM,,,,,,,,,,,,,,"Tested for its ability to displace the specific binding ligand [125I]-Sar 1,lle8-AlI from rat midbrain membrane (AT2 receptor)",,Bioorg. Med. Chem. Lett.,PUBLICATION,
3845275,CHEMBL50,REFJWTPEDVJJIY-UHFFFAOYSA-N,QUERCETIN,,Q9UBT6,DNA POLYMERASE KAPPA,POLK,,,,POTENCY,,199.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Kappa. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588638],PUBCHEM BIOASSAY DATA SET,,DATASET,
3734897,CHEMBL93678,QSLFOEUQWXCPOX-UHFFFAOYSA-N,,,P12527,ARACHIDONATE 5-LIPOXYGENASE,,,,1992126.0,IC50,=,820.0,NM,,tissue,,,,,,,,,,,,Reduction of lipid peroxide formed in rat brain homogenates.,Dual inhibitors of thromboxane A2 synthase and 5-lipoxygenase with scavenging activity of active oxygen species. Synthesis of a novel series of (3-pyridylmethyl)benzoquinone derivatives.,J. Med. Chem.,PUBLICATION,
2398419,CHEMBL1445109,LBNZBMZVSDLBMK-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5862959,CHEMBL3809966,,,,O43570,CARBONIC ANHYDRASE XII,CA12,,,27166574.0,Ki,=,5.5,NM,,,,,,,,,,,,,,Inhibition of recombinant human carbonic anhydrase 12 preincubated for 15 min to 72 hrs by stopped flow CO2 hydrase assay,Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII.,Bioorg. Med. Chem.,PUBLICATION,
259910,CHEMBL1344112,BAURRNRAFNHHFA-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,=,15848.93,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
868410,CHEMBL1549849,DPKZCBUDIJBTND-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4280707,CHEMBL522966,TUBUVORFIUBOSM-UHFFFAOYSA-M,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,19402665.0,RATIO,<,1.5,,,cell_based,,,,,,,,,,,,Induction of human histidine10-tagged MDR1 ATPase activity expressed in BHK cells relative to basal activity,"Rhodamine inhibitors of P-glycoprotein: an amide/thioamide ""switch"" for ATPase activity.",J. Med. Chem.,PUBLICATION,
3427689,CHEMBL423918,PKPCNUPLPQWEMV-UHFFFAOYSA-N,,,P30551,CHOLECYSTOKININ A RECEPTOR,,,,2153212.0,IC50,=,15000.0,NM,,,,,,,,,,,,,,Inhibition of binding of [125I]CCK-8 to Cholecystokinin type A receptor in rat pancreas,Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.,J. Med. Chem.,PUBLICATION,
5074655,CHEMBL1432522,XBZGNPPKPQINHK-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5028957,CHEMBL148702,WXBXZJWIPDOUMI-UHFFFAOYSA-N,,,P26684,ENDOTHELIN RECEPTOR ET-A,,,,9857090.0,KI,=,5900.0,NM,,,,,,,,,,,,,,Ability to inhibit binding of [125I]ET1 to membranes prepared from A10 rat thoracic aorta smooth muscle Endothelin A receptor,"Biphenylsulfonamide endothelin antagonists: structure-activity relationships of a series of mono- and disubstituted analogues and pharmacology of the orally active endothelin antagonist 2'-amino-N- (3,4-dimethyl-5-isoxazolyl)-4'-(2-methylpropyl)[1, 1'-biphenyl]-2-sulfonamide (BMS-187308).",J. Med. Chem.,PUBLICATION,
343740,CHEMBL1460711,BJUMEVUJYVPYFR-UHFFFAOYSA-N,,,O00167,EYES ABSENT HOMOLOG 2,EYA2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the Phosphatase Activity of Eya2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488939],PUBCHEM BIOASSAY DATA SET,,DATASET,
1105158,CHEMBL1332451,FPLRMRGLZGLYTI-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,1584.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
207412,CHEMBL2369193,AUYZAAGSGFULLW-WUXMJOGZSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,4107.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5291935,CHEMBL1898862,XZMYEIIKMSLVAL-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,141253.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2171881,CHEMBL1474545,KCSWQACVMHEKGA-VQHVLOKHSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,6309.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1431569,CHEMBL337319,GZVHEAJQGPRDLQ-UHFFFAOYSA-N,BENZOGUANAMINE,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2437161,CHEMBL1085431,LGAGDAIAGUTWEM-UHFFFAOYSA-N,,,P34998,CORTICOTROPIN RELEASING FACTOR RECEPTOR 1,CRHR1,,,20185312.0,KI,=,3300.0,NM,,cell_based,,,,,,,,,,,,Displacement of [125I]Tyr-o-CRF from human CRFR1 expressed in human IMR32 cells,"Design, synthesis and evaluation of constrained tetrahydroimidazopyrimidine derivatives as antagonists of corticotropin-releasing factor type 1 receptor (CRF1R).",Bioorg. Med. Chem. Lett.,PUBLICATION,
3556621,CHEMBL514988,PYVJEAZDEZTGIS-UBKPWBPPSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
5480690,CHEMBL2144558,YTXYCNCIMSWXHX-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5139863,CHEMBL1441897,XIXJFFXXLOPVMW-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3310135,CHEMBL1306586,OXPWPEKTXJVXIX-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23099.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3032690,CHEMBL1364829,NTEYDEZXIAKUDN-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,1122.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3754288,CHEMBL1411911,QUQGALBBEJXJRE-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,29092.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4286846,CHEMBL1429989,TURUGYAHLFATBO-UHFFFAOYSA-N,,,P17405,SPHINGOMYELIN PHOSPHODIESTERASE,SMPD1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1514769,CHEMBL1364328,HIJJKKBYPAMSIR-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,25918.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
704192,CHEMBL1307754,CXYDBMSOXLXDAC-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3396575,CHEMBL1473370,PHKGRPCYAUQONC-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
315810,CHEMBL408982,BGVLELSCIHASRV-QPEQYQDCSA-N,,,O96017,SERINE/THREONINE-PROTEIN KINASE CHK2,CHEK2,wild_type,,23398362.0,ACTIVITY,=,76.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,70.0,uM,"Millipore: Percentage of residual kinase activity of CHEK2 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1203531,CHEMBL3628628,GALXSGLZQVWBNV-UHFFFAOYSA-N,,,P15056,SERINE/THREONINE-PROTEIN KINASE B-RAF,BRAF,,,26455654.0,INHIBITION,=,43.64,%,,,,,,,,,,,,,,Inhibition of BRAF (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay,Crystal structures of human RIP2 kinase catalytic domain complexed with ATP-competitive inhibitors: Foundations for understanding inhibitor selectivity.,Bioorg. Med. Chem.,PUBLICATION,
1417280,CHEMBL1430391,GYGOURSCOXDJNU-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
3545957,CHEMBL1329452,PXPHJZKNDDKDFN-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3144696,CHEMBL1071,OFPXSFXSNFPTHF-UHFFFAOYSA-N,OXAPROZIN,,P07943,ALDOSE REDUCTASE,,,,,IC50,,,,,tissue,,,,,,,,,,,,DRUGMATRIX: Aldose Reductase enzyme inhibition (substrate: DL-Glyceraldehyde),DrugMatrix in vitro pharmacology data,,DATASET,
1572083,CHEMBL295458,HOIHZGNFCAITAJ-UHFFFAOYSA-N,,,"Q14654, Q09428, Q15842, O60706",SULFONYLUREA RECEPTORS; K-ATP CHANNELS,"ABCC8, ABCC9, KCNJ11, KCNJ8",,,12729655.0,EFFICACY,=,99.0,%,,,,,,,,,,,,,,Maximal efficacy was expressed in comparison to P1075 using KATP activity in pig bladder strips,Structure-activity relationship of a novel class of naphthyl amide KATP channel openers.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3009683,CHEMBL1086440,NQPDXQQQCQDHHW-UHFFFAOYSA-N,TRICLABENDAZOLE,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2836798,CHEMBL3668421,MXYFERHGZLMTPI-UHFFFAOYSA-N,,,P50750,CYCLIN-DEPENDENT KINASE 9,CDK9,,,,IC50,=,17.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: LANCE ULight TR-FRET Kinase Assay. CDK9 enzyme activities were measured using LANCE ULight TR-FRET kinase assay reagents (PerkinElmer, Waltham, Mass.). Compounds were directly added in 100% DMSO to white low volume assay plates (Perkin Elmer Proxiplate 6008289) using a Labcyte Echo acoustic dispenser. Assay reagents in serine/threonine kinase assay buffer containing 20 mM HEPES, 10 mM MgCl2, 100 mM Na3VO4, and 0.0075% Triton X-100. were added for final reaction mixture concentrations of 1000 uM ATP, 100 nM U-light MBP peptide (Perkin Elmer TRF0109M) and reaction initiated with 4 nM CDK9/Cyclin T1 (Carna Biosciences 04-110). The kinase reaction was carried out for 30 minutes before addition of stopping buffer to a final of 20 mM EDTA and 0.5 nM of LANCE Ultra Europium anti-phospho-MBP antibody (PerkinElmer TRF0201M) in LANCE detection buffer (PerkinElmer CR97-100). The reaction was equilibrated for 1 hour and the signal read in the Perkin Elmer Envision in TR-FRET mode.","Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors",,PATENT,
1766344,CHEMBL526571,IKAMABGFJPJJLC-UHFFFAOYSA-N,TCMDC-132120,,O61059,GLUCOSE TRANSPORTER,,,,,INHIBITION,=,8.14,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmGT2 that are glucose transport deficient and complemented with the L. Mexicana glucose transporter 2. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
3063596,CHEMBL1329849,NWTZRMJZOWWISN-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,5804.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3947443,CHEMBL1865593,RPDHUWLJRMPJDV-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,18356.4,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3998991,CHEMBL1323948,RUVDTNJZIMXZSL-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1306785,CHEMBL1481162,GLPYPNHIDCVDOQ-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,95283.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4454554,CHEMBL3194650,UMWAQZYZZVEAOD-FYWRMAATSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5173114,CHEMBL197127,XMHRXPMKDALTSG-RDCPFAOESA-N,,,P29466,CASPASE-1,CASP1,,,16216507.0,IC50,=,7.0,NM,,,,,,,,,,,,,,Inhibitory activity against Caspase 1,"Synthesis and evaluation of novel 8,6-fused bicyclic peptidomimetic compounds as interleukin-1beta converting enzyme inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
1607260,CHEMBL1975138,HSKVRPZJBMXFDX-UHFFFAOYSA-N,,,P50613,CYCLIN-DEPENDENT KINASE 7,CDK7,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: CDK7,PUBCHEM BIOASSAY DATA SET,,DATASET,
5756079,CHEMBL398518,ZXZABNZWYVFDLE-UHFFFAOYSA-N,,,P00742,COAGULATION FACTOR X,F10,,,17933529.0,KI,=,1400.0,NM,,,,,,,,,,,,,,Inhibition of human factor 10a,"Design, structure-activity relationship, and pharmacokinetic profile of pyrazole-based indoline factor Xa inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2350449,CHEMBL1097176,KVVHMNWUPDMNJO-UHFFFAOYSA-N,,,P16257,PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR,,,,20438080.0,ACTIVITY,,,,,,,,,,,,,,,,,Displacement of [3H]Ro5-4864 from TSPO in rat kidney mitochondrial membrane at 1 to 1000 nM,Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterization.,J. Med. Chem.,PUBLICATION,
2315745,CHEMBL1752,KSCFJBIXMNOVSH-UHFFFAOYSA-N,DYPHYLLINE,,P07550,BETA-2 ADRENERGIC RECEPTOR,ADRB2,,,,IC50,,,,,,,,,,CHO,,,,,,,DRUGMATRIX: Adrenergic beta2 radioligand binding (ligand: [3H] CGP-12177),DrugMatrix in vitro pharmacology data,,DATASET,
510800,CHEMBL108649,CCOQWVUQXNRKKP-SCZZXKLOSA-N,,,Q9H3N8,HISTAMINE H4 RECEPTOR,HRH4,,,21044842.0,EC50,=,7943.28,NM,,cell_based,,,,,SK-N-MC,,,,,,,Agonist activity at human histamine H4 receptor expressed in human SK-N-MC cells by CRE-beta galactosidase reporter gene assay,Histamine H4 receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2005914,CHEMBL1489969,JKRBEAJFHYFROT-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4964197,CHEMBL1519755,WQDDPMKUTXPILC-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
1636594,CHEMBL2326569,HVTXZTFXZTVZFY-WYYWQTAUSA-N,,,"P24941, P78396, P20248",CYCLIN-DEPENDENT KINASE 2/CYCLIN A,"CCNA1, CCNA2, CDK2",,,23323521.0,IC50,>,180000.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant CDK2/Cyclin A2 using fluoresceinyl-Ahx-Pro-Val-Lys-Arg-Arg-Leu-Phe-Gly tracer peptide as substrate after 45 mins by fluorescent polarization binding assay,Optimization of non-ATP competitive CDK/cyclin groove inhibitors through REPLACE-mediated fragment assembly.,J. Med. Chem.,PUBLICATION,
1613725,CHEMBL1540391,HTDCQHNWAWYCDX-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2555237,CHEMBL1462981,LSPXELCXNCFDKU-NTUHNPAUSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,14125.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4055046,CHEMBL1354000,SBASUYBMPLDSFM-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,177.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3375882,CHEMBL1301987,PFCNHZFSUQSEHE-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
3734252,CHEMBL1784539,QSIMIXYBWHIPOU-SSOJLPHTSA-N,CRYPEVEIC,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,21545152.0,KI,=,44000.0,NM,,,,,,,,,,,,,,Inhibition of human GST-tagged-Pin1 PPIase activity using Suc-AEPF-pNA as substrate by Michaelis-Menten equation,"Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1.",J. Med. Chem.,PUBLICATION,
659981,CHEMBL1449488,CTHYHHKEZHSLAV-UHFFFAOYSA-N,,,P46063,ATP-DEPENDENT DNA HELICASE Q1,RECQL,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1). (Class of assay: confirmatory) [Related pubchem assays: 594 (Rhodamine region spectral profiling screen), 593 (Fluorescein region spectral profiling screen), 2367 (Probe Development Summary for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1)), 2353 (qHTS Validation Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
833382,CHEMBL1164265,DLWMVUDMPMKGEE-UHFFFAOYSA-N,,,Q96PY6,SERINE/THREONINE-PROTEIN KINASE NEK1,NEK1,,,20483621.0,INHIBITION,<,50.0,%,,,,,,,,,,,,,,Inhibition of NEK1 at 1 uM,"Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase.",Bioorg. Med. Chem.,PUBLICATION,
2266288,CHEMBL3193367,KMYMCJIUHIGRCC-NTUHNPAUSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5744195,CHEMBL1518034,ZWTGBNXZKGJSFI-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
3633697,CHEMBL278041,QHKYPYXTTXKZST-UHFFFAOYSA-N,SB-202190,,P11309,SERINE/THREONINE-PROTEIN KINASE PIM1,PIM1,wild_type,,22037377.0,ACTIVITY,=,106.3929457,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,S6K/RSK2 PEPTIDE 2,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3381769,CHEMBL1578546,PFTVWYPBAGVJLZ-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1386441,CHEMBL3189786,GURFEJXMHQFUDX-NBVRZTHBSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2321403,CHEMBL1899238,KSTNMOVWNILYPW-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
700440,CHEMBL16,CXOFVDLJLONNDW-UHFFFAOYSA-N,PHENYTOIN,,P25101,ENDOTHELIN RECEPTOR ET-A,EDNRA,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Endothelin ETA radioligand binding (ligand: [125I] Endothelin-1),DrugMatrix in vitro pharmacology data,,DATASET,
738110,CHEMBL1732556,DBMOJKQLJLJRSN-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,5623.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1785872,CHEMBL386203,IMHADQMMGOEFNC-UHFFFAOYSA-N,,,"P13726, P08709",COAGULATION FACTOR VII/TISSUE FACTOR,"F3, F7",,,16870435.0,2PT,=,10900.0,NM,,,,,,,,,,,,,,Anticoagulant activity in human plasma measured as prothrombin time,"Preparation of 1-(3-aminobenzo[d]isoxazol-5-yl)-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-ones as potent, selective, and efficacious inhibitors of coagulation factor Xa.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3786250,CHEMBL1359801,QYFGBIBBYGFKBS-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
276765,CHEMBL1371241,BCPQUIDHAPLDOX-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,9200.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
251998,CHEMBL1386511,AZYBPQSWPOOMFP-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2190086,CHEMBL1305131,KEQSOUMJJLVRRL-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
3885413,CHEMBL2141119,RIKPMVDVTBSZOB-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,18356.4,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3192342,CHEMBL3189706,OKXGRFWXATZKHB-VCHYOVAHSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,20587.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5035477,CHEMBL1867864,WXUQVNPKFQFHGW-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
304349,CHEMBL1530045,BFVBRVUNWNTXRK-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1713920,CHEMBL1591499,IDVSKPCXHJOVQB-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1337457,CHEMBL1334784,GPAPPPVRLPGFEQ-UHFFFAOYSA-N,,,P10275,ANDROGEN RECEPTOR,AR,,,,POTENCY,,55148.2,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4934961,CHEMBL79236,WMTSGCIMPPZQLI-LZVMDTAVSA-N,,,Q72874,HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE,,,,12852968.0,IC50,=,0.07,NM,,,,,,,,,,,,,,Inhibitory activity against HIV-1 Protease from wild-type NL4-3 virus,HIV protease inhibitors with picomolar potency against PI-Resistant HIV-1 by extension of the P3 substituent.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5480603,CHEMBL235800,YTXMUOSDKIUWKU-UHFFFAOYSA-N,,,P04150,GLUCOCORTICOID RECEPTOR,NR3C1,,,18038970.0,EC50,=,61.66,NM,,cell_based,,,,,A549,,,,,,,Agonist activity at glucocorticoid receptor in human A549 cells by MMTV transactivation assay,Nonsteroidal glucocorticoid agonists: tetrahydronaphthalenes with alternative steroidal A-ring mimetics possessing dissociated (transrepression/transactivation) efficacy selectivity.,J. Med. Chem.,PUBLICATION,
1948280,CHEMBL1990355,JDXIZYHPMLDQPR-APSNUPSMSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2035866,CHEMBL1486844,JNYZYDBUKUVZSZ-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1764685,CHEMBL1443316,IJUZBFTYCOTAGJ-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,11577.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2088171,CHEMBL1257109,JTQJFSQQHGPLOX-UHFFFAOYSA-N,TELENZEPINE DIHYDROCHLORIDE,,"Q01196, Q13951",RUNT-RELATED TRANSCRIPTION FACTOR 1/CORE-BINDING FACTOR SUBUNIT BETA,"CBFB, RUNX1",,,,POTENCY,,89.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1484, AID504370, AID504374, AID504375]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1698290,CHEMBL505670,ICCFXXDUYSPKOL-UHFFFAOYSA-N,NSC-228155,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
3804712,CHEMBL38368,QZZAWDUEHAPFKB-UHFFFAOYSA-N,,,"P35354, P23219",CYCLOOXYGENASE,"PTGS1, PTGS2",,,11906292.0,RATIO,=,150.0,,,,,,,,,,,,,,,Selectivity ratio for COX-1 over COX-2,"4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1).",J. Med. Chem.,PUBLICATION,
888680,CHEMBL3194999,DRLYVZNTGWGBBO-JJIBRWJFSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2989540,CHEMBL1909361,NOIDWOQNGSHXOA-UHFFFAOYSA-N,GW830365A,,P00519,TYROSINE-PROTEIN KINASE ABL,ABL1,,,,INHIBITION,=,36.78,%,,,,,,,,,,,,,,GSK_PKIS: ABL1 (M351T mutant) mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4147209,CHEMBL1375575,SLNQFVQGUQPQCY-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1039528,CHEMBL1482353,FIDHBYQKLOEZPR-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,10322.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1236727,CHEMBL1726247,GEAQFHSSVRYART-MBPYSEENSA-N,,,Q8IL32,HSP90,,,,,AC50,=,1123.0,NM,,organism_based,,,,,,,,,,,,PUBCHEM_BIOASSAY: Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504596],PUBCHEM BIOASSAY DATA SET,,DATASET,
4384893,CHEMBL254760,UFICVEHDQUKCEA-UHFFFAOYSA-N,MGCD-265,,P08581,HEPATOCYTE GROWTH FACTOR RECEPTOR,MET,,,19211249.0,IC50,=,37.0,NM,,cell_based,,,,,,,,,,,,Inhibition of GST-fused recombinant c-Met catalytic domain expressed in baculovirus-infected Trichoplusia ni Hi5 cells after 30 mins by DELFIA assay,"N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitors.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4110687,CHEMBL38,SHGAZHPCJJPHSC-YCNIQYBTSA-N,TRETINOIN,,P00860,ORNITHINE DECARBOXYLASE,,,,,IC60,=,1.4,NM,,organism_based,,,,,,,,,,,,Inhibition of ornithine decarboxylase activity in hairless mouse skin in vivo,,Bioorg. Med. Chem. Lett.,PUBLICATION,
157016,CHEMBL137031,APRSOUNCXMPULQ-UHFFFAOYSA-N,,,O70536,ACYL COENZYME A:CHOLESTEROL ACYLTRANSFERASE 1,,,,8893833.0,DELTA TC,=,-39.0,%,,organism_based,,,,,,,,,,,,"Percent change in plasma total cholesterol in an acute cholesterol-fed rat model of hypercholesterolemia, dose at 30 mg/kg",Heterocyclic ureas: inhibitors of acyl-CoA:cholesterol O-acyltransferase as hypocholesterolemic agents.,J. Med. Chem.,PUBLICATION,
5207772,CHEMBL1515320,XQJFIVXBHHAYRS-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
653144,CHEMBL1599174,CSPKDLLEGKVEMG-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
5270608,CHEMBL491473,XXJWYDDUDKYVKI-UHFFFAOYSA-N,CEDIRANIB,,Q16620,NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 2,NTRK2,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for TRKB kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
4231945,CHEMBL1563943,SUSULHXCDDVZDI-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,1000.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
667926,CHEMBL136106,CUAUTGRQMYJPFC-UHFFFAOYSA-N,,,"P20786, Q05030",PLATELET-DERIVED GROWTH FACTOR RECEPTOR (PDGFR),,,,9784112.0,IC50,,,,,,,,,,,,,,,,,Inhibition of PDGF-stimulated Platelet-derived growth factor receptor autophosphorylation in rat aortic vascular smooth muscle cells (RAVSMCs) after 2 hr (not tested),"Synthesis and tyrosine kinase inhibitory activity of a series of 2-amino-8H-pyrido[2,3-d]pyrimidines: identification of potent, selective platelet-derived growth factor receptor tyrosine kinase inhibitors.",J. Med. Chem.,PUBLICATION,
1241886,CHEMBL1597892,GEQKMYHGSIUMMO-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,2511.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3939419,CHEMBL184238,ROFVXGGUISEHAM-UHFFFAOYSA-N,URB597,,O08914,ANANDAMIDE AMIDOHYDROLASE,,,,22651858.0,INHIBITION,,,,,cell_based,,,,,B16,,,,,,,Inhibition of FAAH in mouse B16 cells assessed as increase in N-acylethanlmine level after 8 hrs by isotope dilution HPLC-MS method,"Synthesis and pharmacological evaluation of 2,4-dinitroaryldithiocarbamate derivatives as novel monoacylglycerol lipase inhibitors.",J. Med. Chem.,PUBLICATION,
3766112,CHEMBL900,QVYRGXJJSLMXQH-UHFFFAOYSA-N,ORPHENADRINE,,P28564,SEROTONIN 1B (5-HT1B) RECEPTOR,,,,,KI,,,,,,,,,,,,,,,,,DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1B radioligand binding (ligand: [125I] Cyanopindolol),DrugMatrix in vitro pharmacology data,,DATASET,
160277,CHEMBL1342974,AQBKKIJDBGDJKV-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2985496,CHEMBL3344426,NNXHYPWIPVOCAK-INIZCTEOSA-N,,,P21453,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-1,S1PR1,,,25241927.0,EC50,>,5400.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human S1P1 receptor expressed in human EDG1-bla U2OS cells after 18 hrs by beta-arrestin recruitment assay,Piperazinyl-oxadiazoles as selective sphingosine-1-phosphate receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3031546,CHEMBL1377245,NTBXAEAPCVHXTB-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,891.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5425223,CHEMBL463931,YNSCKPCDFIDINW-UHFFFAOYSA-N,GSK-2163632A,,P07949,TYROSINE-PROTEIN KINASE RECEPTOR RET,RET,,,,INHIBITION,=,14.07,%,,,,,,,,,,,,,,GSK_PKIS: RET mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
3218811,CHEMBL1075723,ONSMHKKGSSTBGU-UHFFFAOYSA-N,,,Q07869,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA,PPARA,,,19928766.0,EC50,=,690.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human PPARalpha ligand binding domain expressed in human 293T cells co-transfected with Gal4-DBD by luciferase transactivation assay,Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists.,J. Med. Chem.,PUBLICATION,
1997890,CHEMBL1439143,JJSFUBKXHUGNPU-UHFFFAOYSA-N,,,O95398,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 3,RAPGEF3,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2593487,CHEMBL448350,LWTDZKXXJRRKDG-KXBFYZLASA-N,PHASEOLIN,,P0C6E9,SIALIDASE,,,,20363636.0,ACTIVITY,,,,,,,,,,,,,,,,,Inhibition of Vibrio cholerae neuraminidase assessed as inhibition of 4-MU-NANA hydrolysis after 30 mins by spectrofluorimetry,Prenylated pterocarpans as bacterial neuraminidase inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
4899511,CHEMBL292461,WIQYPYDXKSCUQF-UHFFFAOYSA-N,,,Q62758,SEROTONIN 4 (5-HT4) RECEPTOR,,,,9599243.0,RELAXATION,=,47.3,%,,,,,,,,,,,,,,Antagonistic activity by ability to block serotonin induced relaxation (mediated by activation of 5-hydroxytryptamine 4 receptor) in carbamylcholine (10e-6 M) contracted esophagus at a concentration of 10e-6 M.,Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.,J. Med. Chem.,PUBLICATION,
17345,CHEMBL319971,ABTWJNSIYNEABB-UHFFFAOYSA-N,,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,8863790.0,KI,=,14.6,NM,,cell_based,,,,,HEK293,,,,,,,In vitro binding affinity at human Adenosine A3 receptor from HEK293 cells by [125I]AB-MECA displacement.,Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype.,J. Med. Chem.,PUBLICATION,
4059724,CHEMBL1731111,SBOSMJHVWSRGAE-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1145673,CHEMBL1597967,FTSMFYCOJXCORG-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
85872,CHEMBL3699537,AHOGVSWNFFKKRI-UHOFOFEASA-N,,,O60674,TYROSINE-PROTEIN KINASE JAK2,JAK2,,,,IC50,=,2.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: HTRF Assay. The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAK1 #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 mL of diluted compounds in DMSO were dispensed into the wells of a dry 384-well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser. Subsequent reagent additions employed an Agilent Bravo. Next, 18 uL of 1.11x enzyme and 1.11x substrate in 1x assay buffer (Invitrogen kinase buffer #PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at ambient temperature to allow compound binding to equilibrate. After equilibration, 2 uL of 10xATP in 1x assay buffer was added to initiate the kinase reaction.",Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors,,PATENT,
3392858,CHEMBL1608839,PGZUVBKPWJZCQM-UHFFFAOYSA-N,,,Q9H0H5,RAC GTPASE-ACTIVATING PROTEIN 1,RACGAP1,,,,IC50,,66900.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Primary and Confirmatory Screens. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1292852,CHEMBL1597558,GKBSHHHDAPJWJO-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,7943.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4454145,CHEMBL13817,UMUPQWIGCOZEOY-JOCHJYFZSA-N,IBUTAMOREN,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,14761190.0,IC50,,,,,,,,,,,,,,,,,Inhibition against human melanocortin-4 (MC4) receptor; No binding detected,Recognition of privileged structures by G-protein coupled receptors.,J. Med. Chem.,PUBLICATION,
3203944,CHEMBL2114171,OMCCGYMNFCTGMB-JQMLSWRSSA-N,,,Q13258,PROSTANOID DP RECEPTOR,PTGDR,,,12773047.0,IC50,=,200.0,NM,,,,,,,,,,,,,,In vitro inhibition of [3H]- PGD-2 radioligand binding to prostaglandin D2 receptor on human platelet membrane,"Synthesis and biological activity of various derivatives of a novel class of potent, selective, and orally active prostaglandin D2 receptor antagonists. 1. Bicyclo[2.2.1]heptane derivatives.",J. Med. Chem.,PUBLICATION,
5809613,CHEMBL3718850,,,,P51686,C-C CHEMOKINE RECEPTOR TYPE 9,CCR9,,,,IC50,<,1000.0,NM,,,,,,,,,,,,,,Antagonist activity against CCR9 in human MOLT4 cells assessed as inhibition of human recombinant TECK-induced calcium response pre-treated before TECK stimulation by Flou-4-AM dye based FLIPR assay,Aryl sulfonamides,,PATENT,
1275310,CHEMBL1368414,GIDDINHJTQXZEA-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,3548.1,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2907638,CHEMBL1459194,NFQKVQHZKLUCOB-UYRXBGFRSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
5091536,CHEMBL277342,XDVQQOSTXHLNDZ-DCFHFQCYSA-N,,,P29466,CASPASE-1,CASP1,,,,K OBS / 1,=,120.0,M-1 S-1,,,,,,,,,,,,,,Compound was tested for inhibition of IL-1 beta converting enzyme by measuring second order rate of inactivation,,Bioorg. Med. Chem. Lett.,PUBLICATION,
2062897,CHEMBL1385946,JQYBHRWSTHGKGJ-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Human Muscle isoform 2 Pyruvate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2059353,CHEMBL1411134,JQQDSKJFZNTFDA-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,6510.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1668593,CHEMBL1480553,HZCUNBNUSSDQPN-UHFFFAOYSA-N,,,Q8WZA2,RAP GUANINE NUCLEOTIDE EXCHANGE FACTOR 4,RAPGEF4,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1209109,CHEMBL1510987,GBDVFBMKYKZKQG-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
910989,CHEMBL1454512,DUCQSFOKMHSULU-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4311547,CHEMBL1705315,TXGYYWCQXDVHML-PQDHALMWSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,12589.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
590470,CHEMBL1360928,CLIKVKNRVFGNSJ-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,89.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3243582,CHEMBL1403344,OQLGBSGAQITNNB-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human alpha-Glucosidase as a Potential Chaperone Treatment of Pompe Disease. (Class of assay: confirmatory) [Related pubchem assays: 997 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
427150,CHEMBL1486164,BTGYFMZRCNIJRW-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4296120,CHEMBL1565401,TVOQQCQDXGJVJN-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5696606,CHEMBL288064,ZRHRPGSSSVYBRG-UHFFFAOYSA-N,,,P29323,EPHRIN TYPE-B RECEPTOR 2,EPHB2,wild_type,,23398362.0,ACTIVITY,=,106.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of EPHB2 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 10 mM MnCl2",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1732876,CHEMBL1381706,IGBYVLPLKYJBGQ-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,707.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1927585,CHEMBL23936,JBPZHQMEGZUBPG-UHFFFAOYSA-N,,,Q92731,ESTROGEN RECEPTOR BETA,ESR2,,,11392537.0,RBA,=,6.5,%,,,,,,,,,,,,,,Relative binding affinity for human Estrogen receptor beta compared to estradiol (E2),Synthesis and evaluation of hexahydrochrysene and tetrahydrobenzofluorene ligands for the estrogen receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5054374,CHEMBL2063869,WZRFLSDVFPIXOV-LRQRDZAKSA-N,,,P98170,INHIBITOR OF APOPTOSIS PROTEIN 3,XIAP,,,22413863.0,INHIBITION,,,,,cell_based,,,,,,,,,,,,Inhibition of Flag-tagged XIAP BIR3 domain binding to cIAP1 expressed in human HEK293T cells at 1 to 50 uM after 2 hrs by immunoprecipitation,Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152).,J. Med. Chem.,PUBLICATION,
4527831,CHEMBL1365786,UUQMXHZCDBSSJO-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
358353,CHEMBL386491,BLLBQYADQFPQDW-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,17034146.0,ACTIVITY,,,,,cell_based,,,,,HEK293,,,,,,,Activity at human D2L dopamine receptor expressed in HEK293 cells by calcium fluorescence assay,Dopamine/serotonin receptor ligands. 13: Homologization of a benzindoloazecine-type dopamine receptor antagonist modulates the affinities for dopamine D(1)-D(5) receptors.,J. Med. Chem.,PUBLICATION,
2022313,CHEMBL411317,JMKSVONWZFVEAI-UHFFFAOYSA-N,RICCARDI C,,Q13133,LXR-ALPHA,NR1H3,,,18343126.0,IC50,=,4900.0,NM,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at human recombinant LXRalpha expressed in HEK293 cells by luciferase reporter gene assay,Co-existence of alpha-glucosidase-inhibitory and liver X receptor-regulatory activities and their separation by structural development.,Bioorg. Med. Chem.,PUBLICATION,
79674,CHEMBL1476098,AGURDZYBVWWEDQ-CVEARBPZSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4227573,CHEMBL2153631,SUGFMEFUDZKJDP-UHFFFAOYSA-N,,,P0DMS8,ADENOSINE A3 RECEPTOR,ADORA3,,,21664729.0,INHIBITION,=,0.0,%,,cell_based,,,,,CHO,,,,,,,Displacement of [3H]PSB-11 from human recombinant adenosine A3 receptor expressed in CHO cells at 10 uM,"Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones.",Eur. J. Med. Chem.,PUBLICATION,
918248,CHEMBL1909378,DUZCSXXJVYCEKF-UHFFFAOYSA-N,SB-431542A,,Q16816,PHOSPHORYLASE KINASE GAMMA SUBUNIT 1,PHKG1,,,,INHIBITION,=,4.79,%,,,,,,,,,,,,,,GSK_PKIS: PHKG1 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5041534,CHEMBL1556815,WYMWYIQTKUGUQH-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,3981.1,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2315362,CHEMBL1585982,KSBQVHUJCKXUPQ-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3506448,CHEMBL1545314,PTDJRWGKSVZSJY-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,18356.4,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3809142,CHEMBL1394955,RALPFKOZHLTYFY-UHFFFAOYSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
4666804,CHEMBL2087144,VJRBXZFHKYDEQV-KPHYXMJDSA-N,INTEGRISTERONE A,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,22578055.0,RATIO,=,0.94,,,cell_based,,,,,,,,,,,,Inhibition of human ABCB1 pump expressed in mouse L5178 cells assessed as fluorescence activity ratio at 20 uM for 10 mins by flow cytometry relative to control,Significant Activity of Ecdysteroids on the Resistance to Doxorubicin in Mammalian Cancer Cells Expressing the Human ABCB1 Transporter.,J. Med. Chem.,PUBLICATION,
321364,CHEMBL1934868,BHNZEYVIYRIQCZ-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,22182575.0,ACTIVITY,=,-2.2,%,,cell_based,,,,,CHO,,,,,,,Allosteric enhancer activity at recombinant human A1 adenosine receptor expressed in CHO cells assessed as change in forskolin-induced cAMP production at 1 uM after 6 mins by radioimmunoassay,Structure-activity relationships of 2-amino-3-aroyl-4-[(4-arylpiperazin-1-yl)methyl]thiophenes. Part 2: Probing the influence of diverse substituents at the phenyl of the arylpiperazine moiety on allosteric enhancer activity at the A1 adenosine receptor.,Bioorg. Med. Chem.,PUBLICATION,
929735,CHEMBL259389,DWHVZCLBMTZRQM-UHFFFAOYSA-N,QUINOXALINE1,,Q16816,PHOSPHORYLASE KINASE GAMMA SUBUNIT 1,PHKG1,wild_type,,22037377.0,ACTIVITY,=,86.93073139,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ZIPTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3652693,CHEMBL3189908,QJTWICGSVOTYSP-WUXMJOGZSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2256827,CHEMBL570402,KLUCUOQHRAOQQT-UHFFFAOYSA-N,,,P08183,P-GLYCOPROTEIN 1,ABCB1,,,19679475.0,RATIO IC50,,,,,cell_based,,,,,,,,,,,,Inhibition of ABCB1 in human MES-SA/Dx5 cells assessed as reduction in DiOC2 efflux at 1 uM after 1 hr,A novel class of highly potent multidrug resistance reversal agents: disubstituted adamantyl derivatives.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2841272,CHEMBL278724,MYKGURNPAUBQLJ-UHFFFAOYSA-N,SB-202474,,O43353,SERINE/THREONINE-PROTEIN KINASE RIPK2,RIPK2,wild_type,,23398362.0,ACTIVITY,=,82.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,120,uM,"Millipore: Percentage of residual kinase activity of RIPK2 at 10uM relative to control. Control inhibitor: Phosphoric acid* at 0.3uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1988641,CHEMBL1599654,JIPMLKPLJQQBCK-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,103.2,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3119330,CHEMBL1472043,ODEBZPPVEDECDB-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2716981,CHEMBL1575917,MKSFFMSGBPRIDG-UHFFFAOYSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,707.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
532580,CHEMBL1353823,CEWFNUWMCVDAIC-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5161558,CHEMBL192417,XLGKHWGSIZWZNN-UHFFFAOYSA-N,GW632046X,,Q9Y6M4,CASEIN KINASE I ISOFORM GAMMA-3,CSNK1G3,,,,INHIBITION,=,2.99,%,,,,,,,,,,,,,,GSK_PKIS: CK1-g3 mean inhibition at 1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4162275,CHEMBL1369461,SNGNCYILSHZBLM-IHVYINHVSA-N,,,P15289,CEREBROSIDE-SULFATASE,ARSA,,,,POTENCY,,33.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS screen for enhancers of Arylsulfatase A (ASA1): LOPAC Validation Assay.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4190527,CHEMBL1600298,SQGPVRYEOOPCDV-UHFFFAOYSA-N,,,P38532,HEAT SHOCK FACTOR PROTEIN 1,,,,,EC50,>,195000.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Luminescence Cell-Based Dose Confirmation HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). (Class of assay: confirmatory) [Related pubchem assays: 2118 (Project Summary), 2098 (Primary HTS)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1061224,CHEMBL1465923,FKMQPNLAOTYLQI-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4033556,CHEMBL1554987,RYWWNIHPYYHRCO-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1213827,CHEMBL1474838,GBSFBDVOXISYTP-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1073619,CHEMBL1818137,FMAUVBTYAZVBCK-NTEUORMPSA-N,,,Q13547,HISTONE DEACETYLASE 1,HDAC1,,,21215647.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Inhibition of HDAC1 in human U937 cells assessed as increase in alpha-tubulin acetylation at 5 uM after 24 hrs by Western blot analysis,Epigenetic profiling of the antitumor natural product psammaplin A and its analogues.,Bioorg. Med. Chem.,PUBLICATION,
604290,CHEMBL3559614,CMUNUTVVOOHQPW-ZCFIWIBFSA-N,,,O42713,TYROSINASE,,,,17287127.0,INHIBITION,=,11.08,%,,,,,,,,,,,,,,Inhibition of diphenolase activity of mushroom tyrosinase at 0.231 mM,Identification of tyrosinase inhibitors from Marrubium velutinum and Marrubium cylleneum.,Bioorg. Med. Chem.,PUBLICATION,
3271733,CHEMBL1412556,OTMCIDOARZOVGL-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3546537,CHEMBL1329440,PXQQCFKCBWOOTK-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2815028,CHEMBL1535562,MVIKQTBUJJXZJA-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
609834,CHEMBL1508951,CNMVCJDNMHGRSE-UHFFFAOYSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5670407,CHEMBL251580,ZOPWMEPOXLCRCK-FYYLOGMGSA-N,,,P13945,BETA-3 ADRENERGIC RECEPTOR,ADRB3,,,17533126.0,KI,=,460.0,NM,,cell_based,,,,,CHO,,,,,,,Displacement of [125I]iodocyanopindolol from cloned human adrenergic beta-3 receptor expressed in CHO cells,Arylpropanolamines: selective beta3 agonists arising from strategies to mitigate phase I metabolic transformations.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2024255,CHEMBL1391756,JMPXGMYPMGZGOG-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,=,12589.25,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
709908,CHEMBL1708510,CYNLZIBKERMMOA-AWQFTUOYSA-N,CID 27456,,Q9HC97,G-PROTEIN COUPLED RECEPTOR 35,GPR35,,,,IC50,=,1390.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: SAR Analysis for the identification of Selective Antagonists of ERK1/2 Activity in GPR35-Overexpressing U2OS Cells - Set 2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2058, AID2079]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5001198,CHEMBL1613412,WUFWCBQCHDRQOT-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,4609.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493106, AID493143]",PUBCHEM BIOASSAY DATA SET,,DATASET,
51853,CHEMBL1630250,ADUDQKMQQHYYGO-LBPRGKRZSA-N,,,P23219,CYCLOOXYGENASE-1,PTGS1,,,20709553.0,IC50,=,1950.0,NM,,,,,,,,,,,,,,Inhibition of human COX1,The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: the second clinical candidate having a shorter and favorable human half-life.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1538260,CHEMBL388978,HKSZLNNOFSGOKW-FYTWVXJKSA-N,STAUROSPORINE,,"P22612, P17612, P22694",CAMP-DEPENDENT PROTEIN KINASE (PKA),"PRKACA, PRKACB, PRKACG",,,12941331.0,IC50,=,4.0,NM,,,,,,,,,,,,,,Inhibition of Protein kinase A,Macrocyclic bisindolylmaleimides as inhibitors of protein kinase C and glycogen synthase kinase-3.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2356509,CHEMBL1288014,KWMDFXCWUUOHPX-UHFFFAOYSA-N,NSC-99550,,P16083,QUINONE REDUCTASE 2,NQO2,,,21074425.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of human recombinant NQO2 at 100 uM,In silico identification and biochemical evaluation of novel inhibitors of NRH:quinone oxidoreductase 2 (NQO2).,Bioorg. Med. Chem. Lett.,PUBLICATION,
2600363,CHEMBL3190125,LXLRKXSWZSSPDT-RGVLZGJSSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1079301,CHEMBL1324123,FMPHHVFXOVHBPR-UHFFFAOYSA-N,,,O15118,NIEMANN-PICK C1 PROTEIN,NPC1,,,,POTENCY,=,707.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for NPC1 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5082168,CHEMBL3314918,XCVQRDMKSKEIRQ-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,24972108.0,KI,=,4490.0,NM,,cell_based,,,,,,,,,,,,Displacement of [3H]CCPA from human adenosine A1 receptor expressed in CHO cells,"Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.",J. Med. Chem.,PUBLICATION,
2344072,CHEMBL3113615,KVBMVFBQTPCVFF-LJQANCHMSA-N,,,P04054,PHOSPHOLIPASE A2 GROUP 1B,PLA2G1B,,,24508141.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of PLA2 (unknown origin) by Ellman's method,Lead modification: Amino acid appended indoles as highly effective 5-LOX inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
2751014,CHEMBL1426865,MOAWLPRKDPKASH-UHFFFAOYSA-N,,,P07378,"PHOSPHOGLYCERATE KINASE, GLYCOSOMAL",,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2655586,CHEMBL1490471,MDPWWVJXWNBLFR-UHFFFAOYSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709],PUBCHEM BIOASSAY DATA SET,,DATASET,
5211284,CHEMBL1339245,XQTWWQCHTYENDU-UHFFFAOYSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
885031,CHEMBL1914582,DRCMOBXYYPJOSY-UHFFFAOYSA-N,,,Q9HC97,G-PROTEIN COUPLED RECEPTOR 35,GPR35,,,21950657.0,ACTIVITY,,,,,cell_based,,,,,HT-29,,,,,,,Agonist activity at GPR35 in human HT-29 cells after 1 hr by dynamic mass redistribution assay in presence of 64 uM GPR35 antagonist SPB05142,"Discovery of 2-(4-Methylfuran-2(5H)-ylidene)malononitrile and Thieno[3,2-b]thiophene-2-carboxylic Acid Derivatives as G Protein-Coupled Receptor 35 (GPR35) Agonists.",J. Med. Chem.,PUBLICATION,
5723395,CHEMBL1420952,ZUHOURBGNLTGOZ-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3916650,CHEMBL1515416,RLQNWMVZHUAFJO-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
838658,CHEMBL1334510,DMKAYWUGTKYBJT-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1216849,CHEMBL3317928,GCBILDMRDHTEGR-UHFFFAOYSA-N,,,P33527,MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1,ABCC1,,,25093931.0,IC50,>,100000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of MRP1 (unknown origin) expressed in MDCK cells after 30 mins by Calcein-AM assay,Trimethoxybenzanilide-based P-glycoprotein modulators: an interesting case of lipophilicity tuning by intramolecular hydrogen bonding.,J. Med. Chem.,PUBLICATION,
4288441,CHEMBL573339,TUVCWJQQGGETHL-UHFFFAOYSA-N,PI-103,,Q13131,"AMP-ACTIVATED PROTEIN KINASE, ALPHA-1 SUBUNIT",PRKAA1,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for AMPK-alpha1 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
180009,CHEMBL2347963,ASCVQXWPIHGQIB-RUZDIDTESA-N,,,P23458,TYROSINE-PROTEIN KINASE JAK1,JAK1,,,23611691.0,INHIBITION,=,-14.0,%,,,,,,,,,,,,,,Inhibition of JAK1 (unknown origin) at 1 uM relative to control,Protein kinase inhibitor design by targeting the Asp-Phe-Gly (DFG) motif: the role of the DFG motif in the design of epidermal growth factor receptor inhibitors.,J. Med. Chem.,PUBLICATION,
1600404,CHEMBL1578431,HRODNMNKFBNWQE-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2480790,CHEMBL1596003,LKXYHGQRIWQASP-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3413309,CHEMBL3287396,PIZUPLOSIUAOMH-UHFFFAOYSA-N,,,P14416,DOPAMINE D2 RECEPTOR,DRD2,,,24831693.0,EMAX,=,28.0,%,,cell_based,,,,,,,,,,,,Agonist activity at human dopamine D2 short receptor transiently expressed in HEK293 cells co-expressing Galphai2 after 30 mins by [35S]GTPgammaS binding assay relative to quinpirole,"Functionally selective dopamine d2, d3 receptor partial agonists.",J. Med. Chem.,PUBLICATION,
1706240,CHEMBL1556256,IDALHZBWBHNQOL-UHFFFAOYSA-N,,,O75030,MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR,MITF,,,,ABSAC40_UM,,336.0,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qPCR Assay for TRPM1 Expression Measured in Cell-Based System Using RT-PCR - 2084-09_Inhibitor_Dose_DryPowder_Activity. (absACnn = the concentration at which the curve crosses threshold nn uM)  (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4777386,CHEMBL596512,VVYAFINAZYPVSB-ZHACJKMWSA-N,,,P37136,ACETYLCHOLINESTERASE,,,,19692250.0,IC50,=,1610.0,NM,,,,,,,,,,,,,,Inhibition of AChE in rat cortex after 15 mins by modified Ellman's method,"Design, synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors.",Bioorg. Med. Chem.,PUBLICATION,
5230851,CHEMBL1965845,XSRHBCYNCKAFKS-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,KI,=,199.53,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MAPK1,PUBCHEM BIOASSAY DATA SET,,DATASET,
5433597,CHEMBL1735734,YOLGBFGSUGGSMW-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3344763,CHEMBL3357420,PBLITAVBQJQFQV-MDZDMXLPSA-N,,,Q96RI1,BILE ACID RECEPTOR FXR,NR1H4,,,25499883.0,EC50,=,145.0,NM,,,,,,,,,,,,,,Agonist activity at FXR (unknown origin) transfected into african green monkey CV1 cells assessed as ligand-mediated transcription by luciferase reporter/ transient transfection assay,Novel heterocyclic scaffolds of GW4064 as farnesoid X receptor agonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
5282485,CHEMBL1892529,XYMOYUJPBNIGDX-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1453578,CHEMBL224827,HCEFXOMYHGQVRM-UHFFFAOYSA-N,,,P78527,DNA-DEPENDENT PROTEIN KINASE,PRKDC,,,17371003.0,IC50,=,1060.0,NM,,,,,,,,,,,,,,Inhibition of DNA-PK in HeLa cell nuclear extracts,"Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structure-activity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase.",J. Med. Chem.,PUBLICATION,
3850779,CHEMBL1866186,REUIGQIYJPCKGV-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2531965,CHEMBL1559654,LPYYHWQSSYGPFI-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6. (Class of assay: confirmatory) [Related pubchem assays: 410 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
3477092,CHEMBL1457634,PPYPAHBZIUWAHA-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,1995.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3499623,CHEMBL1581683,PSKAJKMJFXYKJG-UYRXBGFRSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
5405401,CHEMBL1470935,YLQDDZPDBBXCHC-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,35481.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2421113,CHEMBL1201193,LEBVLXFERQHONN-INIZCTEOSA-N,LEVOBUPIVACAINE,,P33032,MELANOCORTIN RECEPTOR 5,MC5R,,,,KI,,,,,,,,,,HEK293,,,,,,,DRUGMATRIX: Melanocortin MC5 radioligand binding (ligand: [125I] NDP-alpha-MSH),DrugMatrix in vitro pharmacology data,,DATASET,
4999797,CHEMBL1722621,WUBVEQDFVGFESY-UHFFFAOYSA-N,,,P33261,CYTOCHROME P450 2C19,CYP2C19,,,,AC50,=,5623.41,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c19 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
260172,CHEMBL1463252,BAVNRKXIGOPEMT-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4481105,CHEMBL3197807,UPTZHMXVDFHCMU-OBGWFSINSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
1360113,CHEMBL1475466,GRSUUHAWJULINM-SIKLNZKXSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5496586,CHEMBL1527146,YVVXFSUFBIJTJU-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,23109.3,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2228161,CHEMBL1439694,KIXLLUDDWPPWIW-UHFFFAOYSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3479979,CHEMBL1586103,PQHPYNGPKZJEBW-VAWYXSNFSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
982647,CHEMBL1340453,FBTHGRKYCPQOEI-LUAWRHEFSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4771477,CHEMBL1408246,VVEKGHBNLQCSDL-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
117286,CHEMBL424146,ALCTZFTWBPOPAW-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,10000.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3435907,CHEMBL3698444,PLNKGQHICRZXGJ-SANMLTNESA-N,,,P43405,TYROSINE-PROTEIN KINASE SYK,SYK,,,,IC50,=,0.6,NM,,,,,,,,,,,,,,"BindingDB_Patents: Homogeneous Time-Resolved Fluorescence Assay. A recombinant GST-hSyk fusion protein was used to measure potency of compounds to inhibit human Syk activity. The recombinant human GST-Syk (Cama Biosciences #08-176) (5 pM final concentration) was incubated with various concentrations of the inhibitor diluted in DMSO (0.1% final concentration) for 10 minutes at rt in 15 mM Tris-HCl (pH 7.5), 0.01% tween 20, 2 mM DTT in 384 well plate format. To initiate the reaction the biotinylated substrate peptide (250 nM final concentration) that contains the phosphorylation site for Syk was added with magnesium (5 mM final concentration) and ATP (25 uM final concentration). Final volume of the reaction was 10 uL. Phosphorylation of the peptide was allowed to proceed for 45' at rt. To quench the reaction and detect the phosphorylated product, 2 nM of a Europium-anti-phosphotyrosine antibody (Perkin Elmer #AD0161) and 70 nM SA-APC (Perkin-Elmer #CR130-100) were added together in 15 mM Tris pH 7.5, 40 mM EDTA, 0.01% tween 20.",Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitors,,PATENT,
1232398,CHEMBL258302,GDPOVVOCCNPUOW-UHFFFAOYSA-N,,,Q9QYN8,HISTAMINE H3 RECEPTOR,,,,18194865.0,KI,=,6.76,NM,,,,,,,,,,,,,,Displacement of N-[3H]methylhistamine from histamine H3 receptor in rat cortex,A new family of H3 receptor antagonists based on the natural product Conessine.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3308534,CHEMBL1258006,OXKRFEWMSWPKKV-GHTZIAJQSA-N,BRADANICLINE,,P58154,ACETYLCHOLINE-BINDING PROTEIN,,,,20828128.0,KI,=,14.45,NM,,,,,,,,,,,,,,Displacement of [3H]epibatidine from Lymnaea stagnalis His6-AChBP expressed in Bac-to-Bac baculovirus expression system,Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE Hot Spots) by deconstruction of nicotinic acetylcholine receptor a7 ligands.,J. Med. Chem.,PUBLICATION,
3364202,CHEMBL3212486,PDUIQNSQXSOLEV-HYARGMPZSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1595920,CHEMBL1413986,HRCCUOJXCGWDAT-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1668940,CHEMBL1579518,HZDUGBHIIHKUQT-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5190771,CHEMBL1538232,XOKTXQZCVARUHE-UHFFFAOYSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5297678,CHEMBL558752,YABJJWZLRMPFSI-UHFFFAOYSA-N,CHIR-265,,Q9UQ88,PITSLRE SERINE/THREONINE-PROTEIN KINASE CDC2L2,CDK11A,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for CDC2L2 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2071285,CHEMBL1594384,JRWKCNOTEZRVLS-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,1032.3,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1864338,CHEMBL1340549,IUVFPBIQVDOKSG-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
749608,CHEMBL1729,DCSUBABJRXZOMT-UHFFFAOYSA-N,CISAPRIDE,,P11509,CYTOCHROME P450 2A6,CYP2A6,,,,IC50,,,,,cell_based,,,,,BTI-TN-5B1-4,,,,,,,"DRUGMATRIX: CYP450, 2A6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)",DrugMatrix in vitro pharmacology data,,DATASET,
266075,CHEMBL1365422,BBMWNEXSYXLWEO-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,5623.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5767607,CHEMBL1505003,ZZJGTLJERDOEQV-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,20596.2,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4549673,CHEMBL1529753,UWYTYVSPQBYBQP-UHFFFAOYSA-N,,,P51151,RAS-RELATED PROTEIN RAB-9A,RAB9A,,,,POTENCY,=,1995.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3436041,CHEMBL1520890,PLNVIJKPUASHEI-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5628506,CHEMBL576671,ZJWKZFMAEHKGBA-UHFFFAOYSA-N,,,Q99685,MONOGLYCERIDE LIPASE,MGLL,,,19883085.0,IC50,=,269.15,NM,,,,,,,,,,,,,,Inhibition of human MGL activity using [3H]2-oleoylglycerol substrate by liquid scintillation counting,Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.,J. Med. Chem.,PUBLICATION,
5055782,CHEMBL1479103,WZUVPPKBWHMQCE-UHFFFAOYSA-N,HAEMATOXYLIN,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2557844,CHEMBL3208685,LSVJOVRKUPKVMV-MRCUWXFGSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18348.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2724253,CHEMBL149867,MLFLNTUOZJKDGS-ZMVGRULKSA-N,,,P32300,DELTA OPIOID RECEPTOR,,,,12408719.0,IC50,>,1000.0,NM,,,,,,,,,,,,,,Binding affinity towards Opioid receptor delta 1 by the displacement of [3H]deltorphin-II in mouse spinal cord,"Synthesis and structure-activity relationships of an orally available and long-acting analgesic peptide, N(alpha)-amidino-Tyr-D-Arg-Phe-MebetaAla-OH (ADAMB).",J. Med. Chem.,PUBLICATION,
269926,CHEMBL235845,BBXZEECKMNPTIO-UHFFFAOYSA-N,,,P04062,BETA-GLUCOCEREBROSIDASE,GBA,,,17827006.0,IC50,=,7750.0,NM,,,,,,,,,,,,,,Inhibition of glucocerebrosidase,"N4-phenyl modifications of N2-(2-hydroxyl)ethyl-6-(pyrrolidin-1-yl)-1,3,5-triazine-2,4-diamines enhance glucocerebrosidase inhibition by small molecules with potential as chemical chaperones for Gaucher disease.",Bioorg. Med. Chem. Lett.,PUBLICATION,
315078,CHEMBL1336774,BGUZOBOOECOTEF-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,2511.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5265236,CHEMBL1384243,XWSZDQVAHYXUJW-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,18348.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1966113,CHEMBL1345381,JGALFUVOWSGBIV-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3243177,CHEMBL1354139,OQJSSFKWEIGNKG-UHFFFAOYSA-N,,,Q9Y5S8,NADPH OXIDASE 1,NOX1,,,,IC50,=,363.5,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Late-stage luminescence-based cell-based dose response assay to identify inhibitors of NADPH oxidase 1 (NOX1): Purchased analogs. (Class of assay: confirmatory) [Related pubchem assays: 2752 (Primary screen (NOX1 inhibitors, synthesized analogs set 2)), 2532 (Dose response (NOX1 inhibitors, HEK/293 cells)), 2664 (Primary screen (NOX1 inhibitors, synthesized analogs)), 1792 (Primary Screen (NOX1 inhibitors)), 2556 (Counterscreen (Xanthine oxidase inhibitors)), 2538 (Dose response screen (NOX1 inhibitors)), 1796 (Summary AID (NOX1 inhibitors)), 2773 (Primary screen (NOX1 inhibitors, synthesized analogs set 3)), 2545 (Confirmation screen (NOX1 inhibitors, HEK/293 cells)), 2539 (Counterscreen (NOX2, NOX3, NOX4 inhibitors)), 2541 (Confirmation screen (NOX1 inhibitors)), 1823 (Counterscreen (luminal))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4899745,CHEMBL1996500,WIRUYYYAAJOIKO-UHFFFAOYSA-N,,,Q13131,"AMP-ACTIVATED PROTEIN KINASE, ALPHA-1 SUBUNIT",PRKAA1,,,,KI,>,3162.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1,PUBCHEM BIOASSAY DATA SET,,DATASET,
1078041,CHEMBL390075,FMLZZRADBXIUOK-UHFFFAOYSA-N,,,Q13639,SEROTONIN 4 (5-HT4) RECEPTOR,HTR4,,,16190749.0,KI,=,20.0,NM,,,,,,,,,,,,,,Binding affinity for 5-HT4 receptor using [3H]GR-113808,Design and synthesis of specific probes for human 5-HT4 receptor dimerization studies.,J. Med. Chem.,PUBLICATION,
3807125,CHEMBL572881,RAHBGWKEPAQNFF-UHFFFAOYSA-N,MOTESANIB,,Q9BWU1,CELL DIVISION CYCLE 2-LIKE PROTEIN KINASE 6,CDK19,,,18183025.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding constant for CDK11 kinase domain,A quantitative analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
2194586,CHEMBL3193979,KFEBLGYEVFCJCX-VXLYETTFSA-N,,,Q27686,PYRUVATE KINASE,,,,,POTENCY,=,22387.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3699,CHEMBL553,AAKJLRGGTJKAMG-UHFFFAOYSA-N,ERLOTINIB,,Q8IV63,INACTIVE SERINE/THREONINE-PROTEIN KINASE VRK3,VRK3,,,18077363.0,THERMAL MELTING CHANGE,=,0.2,DEGREES C,,,,,,,,,,,,,,Delta TM value showing the stabilisation of VRK3 produced by compound binding,A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.,Proc. Natl. Acad. Sci. U.S.A.,PUBLICATION,
4083879,CHEMBL1357592,SEKRNLFMCNXIDL-UHFFFAOYSA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
4223278,CHEMBL1462956,STTFMIKZFVMWJL-OVCLIPMQSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3254810,CHEMBL1405963,ORRNHYBKTCMPED-UHFFFAOYSA-N,,,Q4R6F8,T-COMPLEX PROTEIN 1 SUBUNIT BETA,,,,,POTENCY,,794328.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991],PUBCHEM BIOASSAY DATA SET,,DATASET,
5244783,CHEMBL1610631,XUIDIVNOOAVBBF-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,25929.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
477047,CHEMBL1368609,BYXYOOUBQILWGZ-UHFFFAOYSA-N,,,P01215,GLYCOPROTEIN HORMONES ALPHA CHAIN,CGA,,,,POTENCY,,4466.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1141183,CHEMBL425065,FTFJWXKUFGYKLO-UHFFFAOYSA-N,,,O75604,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 2,USP2,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a Using CHOP2 as the Reporter. (Class of assay: confirmatory) [Related pubchem assays: 2281 (Summary of qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a), 463106 (LOPAC Validation Assay for Inhibitors of Ubiquitin-specific Protease USP2a)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3026435,CHEMBL2112283,NSKPGTTUWOXHBF-HKBQPEDESA-N,,,P25023,BRADYKININ B2 RECEPTOR,,,,12014954.0,KI,=,10.7,NM,,,,,,,,,,,,,,Inhibition of specific binding of [3H]-BK (1 nM) to rat Bradykinin receptor B2 by 50% in NG108-15 cell membranes,"Nonpeptide bradykinin B2 receptor antagonists: conversion of rodent-selective bradyzide analogues into potent, orally-active human bradykinin B2 receptor antagonists.",J. Med. Chem.,PUBLICATION,
102998,CHEMBL1453654,AJNJIAQYKBMFCM-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5704585,CHEMBL1381399,ZSCYTFHITASAHD-UHFFFAOYSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
744952,CHEMBL1525532,DCHQETFIZCXJJE-UHFFFAOYSA-N,,,Q194T2,NONSTRUCTURAL PROTEIN 1,,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2141039,CHEMBL1522697,JZHSTCFALYCRND-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3941870,CHEMBL1496875,RONLMBSAVQKFDD-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3068093,CHEMBL3234384,NXHYIEABELXCMM-UHFFFAOYSA-N,,,O75936,GAMMA-BUTYROBETAINE DIOXYGENASE,BBOX1,,,24571165.0,IC50,=,90.0,NM,,,,,,,,,,,,,,Inhibition of human recombinant BBOX expressed in Saccharomyces cerevisiae AH22 assessed as formation of carnitine from gamma-butyrobetaine preincubated for 15 mins measured after 30 mins by UPLC-MS/MS analysis,Targeting carnitine biosynthesis: discovery of new inhibitors against ¿-butyrobetaine hydroxylase.,J. Med. Chem.,PUBLICATION,
5756474,CHEMBL1577436,ZXZYRZAWBXUYSH-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,141.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
4957379,CHEMBL2007422,WPHMUUAOLOLBMV-LZYBPNLTSA-N,,,P42858,HUNTINGTIN,HTT,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay Multiplex Screening to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (Protease release). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471, 1688 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
284010,CHEMBL1734476,BDMPCFPYGCTGCM-UHFFFAOYSA-N,,,Q13148,TAR DNA-BINDING PROTEIN 43,TARDBP,,,,POTENCY,,562.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of TDP-43 Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4987081,CHEMBL1494964,WSPZKBAYHGXCMA-UHFFFAOYSA-N,,,O94782,UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 1,USP1,,,,POTENCY,,31.6,NM,,,,,,,,,,,,,,PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4131077,CHEMBL1471171,SJOVSWOAZWNOCE-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1874524,CHEMBL418333,IWALGNIFYOBRKC-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4533842,CHEMBL1320651,UVHMTIBLCBIEQC-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
5731878,CHEMBL298166,ZVHOLIZEVQEFBP-UHFFFAOYSA-N,,,P21917,DOPAMINE D4 RECEPTOR,DRD4,,,9191952.0,MAX EFFECT,=,50.0,%,,,,,,,,,,,,,,Agonist action was estimated by measuring the cellular uptake of [3H]thymidine by comparing with the full Dopamine receptor D4 agonist quinpirole (100%),Substituted [(4-phenylpiperazinyl)-methyl]benzamides: selective dopamine D4 agonists.,J. Med. Chem.,PUBLICATION,
4366512,CHEMBL1257503,UDDKMAVCHONARO-UHFFFAOYSA-N,,,P41594,METABOTROPIC GLUTAMATE RECEPTOR 5,GRM5,,,20809633.0,IC50,=,129.0,NM,,cell_based,,,,,CHO,,,,,,,Modulation of human recombinant mGluR5 expressed in CHO cells assessed as inhibition of glutamate-induced response,"Design, synthesis, and structure-activity relationships of novel bicyclic azole-amines as negative allosteric modulators of metabotropic glutamate receptor 5.",J. Med. Chem.,PUBLICATION,
5735860,CHEMBL1973906,ZVTZZLWJUBYSSI-RGVLZGJSSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): Confirmation of Cherrypicks. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
168204,CHEMBL1300347,AQTRGIVMUKTOCV-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5297792,CHEMBL558752,YABJJWZLRMPFSI-UHFFFAOYSA-N,CHIR-265,,Q92918,MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE KINASE 1,MAP4K1,wild_type,,22037378.0,KD,>,10000.0,NM,inverse_agonist,biochemical,binding,binding_reversible,,qPCR,,10,uM,ATP,,,,Binding constant for HPK1 kinase domain,Comprehensive analysis of kinase inhibitor selectivity.,Nat. Biotechnol.,PUBLICATION,
1095939,CHEMBL1485002,FOKMHRZFGGDAQO-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
1564308,CHEMBL3214032,HNMDBQUDQYTEPV-ZDLGFXPLSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,63095.7,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4999415,CHEMBL398951,WUBHCQHBUVGGRX-UHFFFAOYSA-N,,,Q96GD4,SERINE/THREONINE-PROTEIN KINASE AURORA-B,AURKB,wild_type,,21336281.0,KI,=,501.0,NM,inhibition,biochemical,functional,enzyme_activity,competitive_inhibitor,fluoresecence,,"3-10,000",NM,ATP,,,,,NAVIGATING THE KINOME,NATURE CHEMICAL BIOLOGY,,
4008823,CHEMBL1945339,RVZBSFXPXDGMAG-UHFFFAOYSA-N,,,Q86YV6,MYOSIN LIGHT CHAIN KINASE FAMILY MEMBER 4,MYLK4,,,22136433.0,DELTA TM,=,0.4,DEGREES C,,,,,,,,,,,,,,Binding affinity to SGK085 assessed as change in thermal denaturation at 10 uM by thermal stability shift assay,"7,8-dichloro-1-oxo-ß-carbolines as a versatile scaffold for the development of potent and selective kinase inhibitors with unusual binding modes.",J. Med. Chem.,PUBLICATION,
3076341,CHEMBL1528861,NYEXQTFCVPYYHX-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
4599935,CHEMBL352517,VCIDGSGOLDAGPN-UHFFFAOYSA-N,,,P30542,ADENOSINE A1 RECEPTOR,ADORA1,,,12593659.0,CHANGE,=,-6.0,%,,cell_based,,,,,CHO,,,,,,,Percent change in cAMP content of CHO (Chinese hamster ovary) cells expressing human Adenosine A1 receptor at 1 uM,Synthesis and biological effects of novel 2-amino-3-naphthoylthiophenes as allosteric enhancers of the A1 adenosine receptor.,J. Med. Chem.,PUBLICATION,
4615061,CHEMBL1387220,VDZSXFFCUIEPCS-UHFFFAOYSA-N,,,P53350,SERINE/THREONINE-PROTEIN KINASE PLK1,PLK1,,,,POTENCY,,16833.6,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3922177,CHEMBL9967,RMHMFHUVIITRHF-UHFFFAOYSA-N,PIRENZEPINE,,"P12657, Q9ERZ3, P32211, Q920H4, Q9ERZ4",MUSCARINIC ACETYLCHOLINE RECEPTOR,,,,2785211.0,IC50,=,750.0,NM,,,,,,,,,,,,,,Ability (10 ug/kg) to inhibit binding of [125I]iododexetimide to muscarinic receptor in mice,"Synthesis and biological evaluation of [125I]- and [123I]-4-iododexetimide, a potent muscarinic cholinergic receptor antagonist.",J. Med. Chem.,PUBLICATION,
1917591,CHEMBL1557691,JARWWLDFLXGFFO-UHFFFAOYSA-N,,,P78536,ADAM17,ADAM17,,,,IC50,,69513.0,NM,,,,,,,,,,,,,,PubChem BioAssay. QFRET-based biochemical high throughput dose response assay to identify exosite inhibitors of ADAM17.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
83790,CHEMBL1556020,AHIUDHPBRRINPQ-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2231546,CHEMBL1976433,KJHGOCSTIPXLON-UZYVYHOESA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,15101.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5226502,CHEMBL1512,XSFJVAJPIHIPKU-XWCQMRHXSA-N,FLUNISOLIDE,,P08588,BETA-1 ADRENERGIC RECEPTOR,ADRB1,,,,KI,,,,,,,,,,CHO-K1,,,,,,,DRUGMATRIX: Adrenergic beta1 radioligand binding (ligand: [125I] Cyanopindolol),DrugMatrix in vitro pharmacology data,,DATASET,
5209478,CHEMBL407209,XQOMHPQXEDJCGI-JDBXKHNRSA-N,,,P30874,SOMATOSTATIN RECEPTOR 2,SSTR2,,,11311064.0,KD,=,23.5,NM,,,,,,,,,,,,,,Binding affinity was determined on cloned human somatostatin receptor-1 (hsst2),N-Methyl scan of somatostatin octapeptide agonists produces interesting effects on receptor subtype specificity.,J. Med. Chem.,PUBLICATION,
4989202,CHEMBL1866351,WSXCIECFBMTIQD-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2342777,CHEMBL1425295,KUWZQLYBZPVLON-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
3492860,CHEMBL1474841,PRSBWRGPRVPLDG-UHFFFAOYSA-N,,,P80244,ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT,,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
928846,CHEMBL1343229,DWGFNMRHMGURGK-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2340896,CHEMBL1607113,KUSDDNKFWISVJL-UHFFFAOYSA-N,,,P9WQ81,ADENOSYLMETHIONINE-8-AMINO-7-OXONONANOATE AMINOTRANSFERASE,,,,,AC50,,3390.0,NM,,biochemical,,,,,,,,,,,,PubChem BioAssay. Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-02_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2836513,CHEMBL1327750,MXXNVSHHJRUVJF-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,50118.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2464393,CHEMBL3695794,LJCFZGSEPCINDX-NRFANRHFSA-N,,,P37231,PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA,PPARG,,,,IC50,>,1000.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Lanthascreen Competitive Binding Assay. The assay was performed according to manufacturer protocol. A mixture of nM GST-PPARG-LBD, 5 nM Tb-GST-antibody, 5 nM Fluormone Pan-PPAR Green, and serial dilutions of the experimental compound, beginning at 10 µM downwards, was added to wells of black 384-well low-volume plates (Greiner) to a total volume of 18 µL. All dilutions were made in TR-FRET assay buffer C. DMSO at 2% final concentration was used as a no-ligand control. Experiment was performed in triplicate, and incubated for 2 hours in the dark prior to assay read in Perkin Elmer ViewLux ultra HTS microplate reader. FRET signal was measured by excitation at 340 nm and emission at 520 nm for fluorescein and 490 nm for terbium. Fold change over DMSO was calculated using GraphPad Prism Software (La Jolla, Calif.) by calculating 520 nm/490 nm ratio. Graphs were plotted as fold change of FRET signal for compound treatment over DMSO-only control.",N-biphenylmethylindole modulators of PPARG,,PATENT,
5368248,CHEMBL1559802,YHNZOFJSWGMHLE-UHFFFAOYSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,1.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4101912,CHEMBL1471481,SGKKPTPWLFVGJO-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3314715,CHEMBL1415241,OYBPNKPXXAKELN-UHFFFAOYSA-N,,,P49798,REGULATOR OF G-PROTEIN SIGNALING 4,RGS4,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504856],PUBCHEM BIOASSAY DATA SET,,DATASET,
362190,CHEMBL1540571,BLVJYZMMPDHHHO-MDZDMXLPSA-N,,,Q27686,PYRUVATE KINASE,,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK). (Class of assay: confirmatory) [Related pubchem assays: 1379 ],PUBCHEM BIOASSAY DATA SET,,DATASET,
2878632,CHEMBL1529254,NCIDEKDUBRWLJO-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
3990568,CHEMBL1581773,RTVLEAXHBFOWBS-XYGWBWBKSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4600754,CHEMBL3674038,VCJKLMCWHVGINW-UHFFFAOYSA-N,,,Q64663,P2X PURINOCEPTOR 7,,,,,Ki,=,251.2,NM,,,,,,,,,,,,,,"BindingDB_Patents: Radioligand Binding Assay. human or rat P2X7-1321N1 cells were collected and frozen @ -80° C. On the day of the experiment, cell membrane preparations were made according to standard published methods. The total assay volume was 100 uL:10 uL compound (10×)+(b) 40 uL tracer (2.5x)+50 uL membrane (2×). The tracer used for the assay was tritiated A-804598. The compound can be prepared as described in the literature. (Donnelly-Roberts, D. Neuropharmacology 2008, 56 (1), 223-229.) Compounds, tracer and membranes were incubated for 1 hour @ 4° C. The assay was terminated by filtration (GF/B filters pre-soaked with 0.3% PEI) and washed with washing buffer (Tris-HCl 50 mM).",P2X7 modulators,,PATENT,
2009017,CHEMBL212250,JLBVWHHVKVXOOR-UHFFFAOYSA-N,GW615311X,,Q13557,CAM KINASE II DELTA,CAMK2D,,,,INHIBITION,=,0.42,%,,,,,,,,,,,,,,GSK_PKIS: CAMK2D mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
968465,CHEMBL1556220,FAIXVMCSJBKOIG-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2089697,CHEMBL1996697,JTUXXVHIFQFGLN-ZZIIXHQDSA-N,,,Q9UIF8,BROMODOMAIN ADJACENT TO ZINC FINGER DOMAIN PROTEIN 2B,BAZ2B,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391],PUBCHEM BIOASSAY DATA SET,,DATASET,
1325463,CHEMBL527775,GNRUCBIEUBRFDK-UHFFFAOYSA-N,TCMDC-124006,,O97467,HEXOSE TRANSPORTER 1,,,,,INHIBITION,=,1.85,%,,,,,,,,,,,,,,ST_JUDE_LEISH: Cytotoxicity at 2uM final concentration against transgenic Leishmania Mexicana promastigotes LmPfHT that are glucose transport deficient and complemented with the Plasmodium falciparum hexose transporter. Activity is measured by by DNA content using SYBR green in vitro,St. Jude Leishmania screening dataset.,,DATASET,
4361076,CHEMBL1349615,UCNNLUFXUJQOTI-UHFFFAOYSA-N,,,O95977,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-6,S1PR4,,,22119461.0,EC50,=,162.0,NM,,cell_based,,,,,U2OS,,,,,,,Agonist activity at human S1P4R expressed in human U2OS cells containing EDG6 gene co-expressing GAL4-VP16 and beta-arrestin/TEV protease assessed as migration of VP16-GAL4 into nucleus by FERT based beta-lactamase reporter gene assay,"Discovery, design and synthesis of novel potent and selective sphingosine-1-phosphate 4 receptor (S1P4-R) agonists.",Bioorg. Med. Chem. Lett.,PUBLICATION,
3373685,CHEMBL3700695,PEWDQFGSGNSCPM-RWMHUUSOSA-N,,,P28845,11-BETA-HYDROXYSTEROID DEHYDROGENASE 1,HSD11B1,,,,IC50,=,1572.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Homogeneous Time-Resolved Fluorescence (HTRF). In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio international, France) detecting cortisol generated from cortisterone by human liver microsomes. Briefly, compounds were incubated for 1 hour at 37 C. in Tris buffer (20 mM tris, 5 mM EDTA, pH 6.0) containing NADPH (200 uM) and cortisone (80 nM). Cortisol generated in the reaction is then detected with a competitive immunoassay, involving two HTRF conjugates: cortisol linked to XL665 and anti-cortisol antibody labeled with Europium cryptate. The incubation period for detection reaction was typically 2 hours. The amount of cortisol is determined by reading the time-resolved fluorescence of the wells (Ex 320/75 nm; Em 615/8.5 nm and 665/7.5 nm). The ratio of the two emission signals is then calculated (Em665*10000/Em615).","Alicyclic carboxylic acid derivatives of benzomorphans and related scaffolds, medicaments containing such compounds and their use",,PATENT,
2947639,CHEMBL538798,NJTUORMLOPXPBY-UHFFFAOYSA-N,ZM-39923 HCL,,P53355,DEATH-ASSOCIATED PROTEIN KINASE 1,DAPK1,wild_type,,22037377.0,ACTIVITY,=,97.87844828,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,ZIPTIDE,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
3749553,CHEMBL1450791,QTYRXDNEKDYHIG-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1339720,CHEMBL574787,GPIKIQYFADSPRZ-UHFFFAOYSA-N,,,P27487,DIPEPTIDYL PEPTIDASE IV,DPP4,,,21478015.0,INHIBITION,=,0.0,%,,,,,,,,,,,,,,Inhibition of DPP4 at 10 uM assessed as p-nitrophenol release after 1 hr relative to control,Non-competitive and selective dipeptidyl peptidase IV inhibitors with phenethylphenylphthalimide skeleton derived from thalidomide-related a-glucosidase inhibitors and liver X receptor antagonists.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2472148,CHEMBL2079587,LKAJKIOFIWVMDJ-IYRCEVNGSA-N,STANOZOLOL,,P05412,PROTO-ONCOGENE C-JUN,JUN,,,,POTENCY,,8485.2,NM,,,,,,,,,,,,,,PubChem BioAssay: Tox21. qHTS assay to identify small molecule agonists of the AP-1 signaling pathway.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5422293,CHEMBL473107,YNKDEHKXKOAEBW-UHFFFAOYSA-N,,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4420178,CHEMBL3655947,UJBBRLRSUNALSO-UHFFFAOYSA-N,,,O15379,HISTONE DEACETYLASE 3,HDAC3,,,,IC50,=,1313.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Assay. Compounds for testing were diluted in DMSO to 50 fold the final concentration and a ten point three fold dilution series was made. The compounds were diluted in assay buffer (50 mM HEPES, pH 7.4, 100 mM KCl, 0.001% Tween-20, 0.05% BSA, 20 uM TCEP) to 6 fold their final concentration. The HDAC enzymes (purchased from BPS Biosciences) were diluted to 1.5 fold their final concentration in assay buffer. The tripeptide substrate and trypsin at 0.05 uM final concentration were diluted in assay buffer at 6 fold their final concentration. The final enzyme concentrations used in these assays were 3.3 ng/ml (HDAC1), 0.2 ng/ml (HDAC2), 0.08 ng/ml (HDAC3) and 2 ng/ml (HDAC6). The final substrate concentrations used were 16 uM (HDAC1), 10 uM (HDAC2), 17 uM (HDAC3) and 14 uM (HDAC6). Five ul of compounds and 20 ul of enzyme were added to wells of a black, opaque 384 well plate in duplicate. Enzyme and compound were incubated together at room temperature.",Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof,,PATENT,
5058337,CHEMBL1344041,XAAUKWVHFNDWSO-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
1212858,CHEMBL46874,GBOQUHPYCRYKGV-UHFFFAOYSA-N,PINAFIDE,,O95977,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-6,S1PR4,,,,EC50,>,5530.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence dose response cell-based high throughput screening assay for agonists of the Sphingosine 1-Phosphate Receptor 4 (S1P4). (Class of assay: confirmatory) [Related pubchem assays: 1509 (Primary screen.), 1523 (Confirmation screen in triplicates.)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
711424,CHEMBL3634484,CYQUEABUCOXLPT-UHFFFAOYSA-N,,,P21453,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-1,S1PR1,,,26592813.0,ACTIVITY,,,,,cell_based,,,,,,,,,,,,Agonist activity at human sphingosin-1-phosphate receptor 1 expressed in CHO cells assessed as phosphorylation status of p44/42 MAPK after 5 mins by Western blotting,New fluorinated agonists for targeting the sphingosin-1-phosphate receptor 1 (S1P1).,Bioorg. Med. Chem. Lett.,PUBLICATION,
2904867,CHEMBL1337827,NFIURIJVCVTHSO-CMDGGOBGSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,20596.2,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1732025,CHEMBL1417803,IFYKGQFWHJBGCH-UHFFFAOYSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,12995.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1756811,CHEMBL1397673,IIVCGJRIOTWNMR-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2923923,CHEMBL475251,NHHQJBCNYHBUSI-UHFFFAOYSA-N,TAMATINIB,,Q13131,"AMP-ACTIVATED PROTEIN KINASE, ALPHA-1 SUBUNIT",PRKAA1,,,,KI,>,1000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PRKAA1,PUBCHEM BIOASSAY DATA SET,,DATASET,
3507627,CHEMBL1214597,PTHKODBAQNKPNK-UHFFFAOYSA-N,,,P31645,SEROTONIN TRANSPORTER,SLC6A4,,,20637635.0,IC50,=,45.0,NM,,cell_based,,,,,HEK293,,,,,,,Displacement of [3H]imipramine from human SERT expressed in HEK293 cells,"Further optimization of novel pyrrole 3-carboxamides for targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.",Bioorg. Med. Chem.,PUBLICATION,
2478564,CHEMBL1975975,LKRQLYBYTPCUHR-XAYXJRQQSA-N,,,Q9NR56,MUSCLEBLIND-LIKE PROTEIN 1,MBNL1,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2102269,CHEMBL1605184,JVCFQVFBMQKQMA-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,44668.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1726984,CHEMBL1613528,IFJMZJAIRVJYLM-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
537038,CHEMBL1483555,CFGNRLRSPNPFQP-UHFFFAOYSA-N,,,P14735,INSULIN-DEGRADING ENZYME,IDE,,,,IC50,=,2568.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Dose Response: Fluorescence polarization-based cell-based high throughput dose response assay for inhibitors of insulin-degrading enzyme (IDE). (Class of assay: confirmatory) [Related pubchem assays: 434962 (Primary screen (IDE inhibitors in singlicate)), 449730 (Counterscreen (Cytotoxicity in triplicate)), 435028 (Confirmation (IDE inhibitors in triplicate)), 434984 (Summary (IDE inhibitors))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1472080,CHEMBL217406,HEAUFJZALFKPBA-JPQUDPSNSA-N,NEUROKININ A,,P21452,NEUROKININ 2 RECEPTOR,TACR2,,,,IC50,=,7.7,NM,,cell_based,,,,,,,,,,,,Tested for the binding affinity to human NK2 receptor expressed in Sf-9 insect larval cells using 0.1 nM 2-[125 I] iodohistidyl neurokinin A,,Bioorg. Med. Chem. Lett.,PUBLICATION,
3425382,CHEMBL1581542,PKIIOZAICIYOSN-UHFFFAOYSA-N,,,Q92830,HISTONE ACETYLTRANSFERASE GCN5,KAT2A,,,,POTENCY,,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398],PUBCHEM BIOASSAY DATA SET,,DATASET,
3239353,CHEMBL1697882,OPZIZOFSNNLOQV-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,1299.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5833272,CHEMBL1374360,,MERCURIC CHLORIDE,,P25094,PERIPHERAL MYELIN PROTEIN 22,,,,,POTENCY,,3159.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: S16 Schwann cell PMP22 intronic element beta-lactamase assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1059113,CHEMBL1525095,FKFVNEMKVJISPX-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,11582.1,NM,,cell_based,,,,,,,,,,,,PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5355769,CHEMBL547266,YGDWDKVACVMXAO-UHFFFAOYSA-N,TCMDC-125558,,Q8IDJ8,LYSINE--TRNA LIGASE,,,,,IC50,>,2500.0,NM,,,,,,,,,,,,,,"MMV: KRS recombinant Plasmodium falciparum Lysyl-tRNA-synthetase, assay with yeast tRNA, ATP, and lysine and 3 uM MMV malaria box compound, assay read out with kinase glo as % inhibition.",MMV Box screening against Plasmodium falciparum protein kinases and aminoacyl tRNA synthetases.,,DATASET,
5647761,CHEMBL1324355,ZMBDSVLGZZHWJU-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
2989770,CHEMBL1507605,NOIVINMTTBTFGA-BQYQJAHWSA-N,,,P27695,DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE,APEX1,,,,POTENCY,,2818.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1).   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3165947,CHEMBL1377448,OHVUEZODLPIXQC-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
72874,CHEMBL3209775,AGAJUPDCUCZELF-OWBHPGMISA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,23099.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1065068,CHEMBL1575427,FKZXDQZTEDBGAE-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,5173.5,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3031285,CHEMBL1456141,NTAYQQFNWIOEMY-UHFFFAOYSA-N,,,P02791,FERRITIN LIGHT CHAIN,,,,,POTENCY,=,891.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Identification of Novel General Anesthetics. In this assay, a GABAergic mimetic model system, apoferritin and a profluorescent 1-aminoanthracene ligand (1-AMA), was used to construct a competitive binding assay for identification of novel general anesthetics (Class of assay: confirmatory) [Related pubchem assays: 2385 (Probe Development Summary for Identification of Novel General Anesthetics), 2323 (Validation apoferritin assay run on SigmaAldrich LOPAC1280 collection)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3220437,CHEMBL3660673,ONWAXLHYHNNLHF-UHFFFAOYSA-N,,,Q9QYJ6,"CAMP AND CAMP-INHIBITED CGMP 3',5'-CYCLIC PHOSPHODIESTERASE 10A",,,,,IC50,=,48.7,NM,,,,,,,,,,,,,,"BindingDB_Patents: Enzyme Inhibition Assay. An IMAP TR-FRET assay was used to analyze the enzyme activity (Molecular Devices Corp., Sunnyvale Calif.). 5 µL of serial diluted PDE10A (BPS Bioscience, San Diego, Calif.) or tissue homogenate was incubated with equal volumes of diluted fluorescein labeled cAMP or cGMP for 60 min in 384-well polystyrene assay plates (Corning, Corning, N.Y.) at room temperature. After incubation, the reaction was stopped by adding 60 µL of diluted binding reagents and was incubated for 3 hours to overnight at room temperature. The plates were read on an Envision (Perkin Elmer, Waltham, Mass.) for time resolved fluorescence resonance energy transfer.",Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors,,PATENT,
2455867,CHEMBL1596244,LIDGBWGDDVKUBT-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS.   (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
4621873,CHEMBL277474,VEQOALNAAJBPNY-UHFFFAOYSA-N,ANTIPYRINE,,P51681,C-C CHEMOKINE RECEPTOR TYPE 5,CCR5,,,,IC50,,,,,,,,,,HEK293T,,,,,,,DRUGMATRIX: Chemokine CCR5 radioligand binding (ligand: [125I] MIP-1alpha),DrugMatrix in vitro pharmacology data,,DATASET,
396264,CHEMBL1733273,BPORHTRAUOJMSX-AONPBBLGSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5495381,CHEMBL1213080,YVSPMRDDQVNTAP-ZQPXUAGQSA-E,,,P00743,COAGULATION FACTOR X,,,,19805567.0,IC50,=,93.0,NM,,,,,,,,,,,,,,Inhibition of bovine coagulation factor 10a by spectrophotometry,Long-lasting enfuvirtide carrier pentasaccharide conjugates with potent anti-human immunodeficiency virus type 1 activity.,Antimicrob. Agents Chemother.,PUBLICATION,
5398623,CHEMBL1992342,YKYRQCWLYUTVIE-UHFFFAOYSA-N,,,Q8N4C8,MISSHAPEN-LIKE KINASE 1,MINK1,,,,KI,>,7943.28,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: MINK,PUBCHEM BIOASSAY DATA SET,,DATASET,
550673,CHEMBL1496179,CGUOOZDAHRSBJP-UHFFFAOYSA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,10000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1495790,CHEMBL1496231,HGMKBBRZPVVVKX-UHFFFAOYSA-N,,,Q6W5P4,NEUROPEPTIDE S RECEPTOR,NPSR1,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4167531,CHEMBL188381,SNRUTMWCDZHKKM-UHFFFAOYSA-N,GW806742X,,P35968,VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2,KDR,,,,INHIBITION,=,78.77,%,,,,,,,,,,,,,,GSK_PKIS: KDR mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5472175,CHEMBL1510681,YSWNKYJWULCQJI-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5041203,CHEMBL318373,WYMHIANDDRWFBX-UHFFFAOYSA-N,,,O70536,ACYL COENZYME A:CHOLESTEROL ACYLTRANSFERASE 1,,,,,IC50,=,180.0,NM,,,,,,,,,,,,,,Concentration required for the in vitro inhibition of Acyl coenzyme A:cholesterol acyltransferase (ACAT) in liver microsomes isolated from cholesterol-fed rats,,Bioorg. Med. Chem. Lett.,PUBLICATION,
1603032,CHEMBL1389922,HRXREXGFCJUTCY-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,37933.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5851656,CHEMBL3746022,,,,P07949,TYROSINE-PROTEIN KINASE RECEPTOR RET,RET,,,26704265.0,Inhibition,=,24.0,%,,,,,,,,,,,,,,Inhibition of RET (unknown origin) at 10 uM,Novel compounds reducing IRS-1 serine phosphorylation for treatment of diabetes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
244918,CHEMBL1909358,AZCBRJLSKDKJBS-UHFFFAOYSA-N,GW654652C,,P36888,TYROSINE-PROTEIN KINASE RECEPTOR FLT3,FLT3,,,,INHIBITION,=,6.38,%,,,,,,,,,,,,,,GSK_PKIS: FLT3 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2168890,CHEMBL1360565,KCKWMVZRDOHYMC-UHFFFAOYSA-N,,,P25779,CRUZIPAIN,,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5041390,CHEMBL1580969,WYMPXWBKIMANQJ-UHFFFAOYSA-N,,,Q03530,CAAX PRENYL PROTEASE 2,,,,,AC50,=,25440.0,NM,,biochemical,,,,,,,,,,,,PUBCHEM_BIOASSAY: Ras-converting Enzyme/Cell Proliferation Pathway Measured in Biochemical System Using Plate Reader - 2034-01_Inhibitor_Dose_CherryPick. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2618],PUBCHEM BIOASSAY DATA SET,,DATASET,
5138954,CHEMBL617,XIURVHNZVLADCM-IUODEOHRSA-N,CEPHALOTHIN,,P46059,OLIGOPEPTIDE TRANSPORTER SMALL INTESTINE ISOFORM,SLC15A1,,,15974593.0,KI,>,10000000.0,NM,,cell_based,,,,,Caco-2,,,,,,,Binding affinity against membrane transport protein PEPT1 in human Caco-2 cells,Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.,J. Med. Chem.,PUBLICATION,
3854447,CHEMBL2402433,RFERSOCUKWHMKG-UHFFFAOYSA-N,,,P21731,THROMBOXANE A2 RECEPTOR,TBXA2R,,,23688698.0,IC50,=,2330.0,NM,,cell_based,,,,,HEK293,,,,,,,Antagonist activity at human thromboxane A2 receptor beta over-expressed in HEK293 cells assessed as inhibition of U-46619-induced intracellular calcium mobilization mobilization by fluorescence assay,Synthesis and pharmacological evaluation of 2-aryloxy/arylamino-5-cyanobenzenesulfonylureas as novel thromboxane A2 receptor antagonists.,Eur. J. Med. Chem.,PUBLICATION,
1958420,CHEMBL1905564,JFFMGMUAUZUXPN-KSVNGYGVSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,25929.0,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of TGF-b: Confirmation of Cherry Picks.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
203299,CHEMBL1876170,AUNHWJRZKLUWCF-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5811443,CHEMBL3799308,,,,P49721,PROTEASOME MACROPAIN SUBUNIT,PSMB2,,,27158142.0,IC50,=,557700.0,NM,,,,,,,,,,,,,,Inhibition of trypsin-like activity of 20S human proteasome assessed as Z-LRR-AMC hydrolysis at using Promega proteasome-Glo-3 substrate incubated for 15 mins by luminescence assay,Development of novel proteasome inhibitors based on phthalazinone scaffold.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3833634,CHEMBL1559719,RDASNEXWIRCFSI-UHFFFAOYSA-N,,,Q13526,PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1,PIN1,,,,POTENCY,,75686.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay to Find Inhibitors of Pin1. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4850568,CHEMBL297752,WDSZUSABLKNHCZ-QWRGUYRKSA-N,AGN-190837,,P08913,ALPHA-2A ADRENERGIC RECEPTOR,ADRA2A,,,10794687.0,INTRINSIC ACTIVITY,=,1.0,,,,,,,,,,,,,,,Alpha-2A adrenergic receptor agonism measured as ability to inhibit forskolin-stimulated synthesis of cAMP,2-amino-2-oxazolines as subtype selective alpha(2) adrenoceptor agonists.,J. Med. Chem.,PUBLICATION,
3645084,CHEMBL1613089,QIVRRACHCHNCFK-MDWZMJQESA-N,,,P51450,NUCLEAR RECEPTOR ROR-GAMMA,,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4268608,CHEMBL3039517,SYYBDNPGDKKJDU-ZDUSSCGKSA-N,RABUSERTIB,,,3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE 1,,wild_type,,24114124.0,IC50,=,893.0,NM,inhibition,biochemical,functional,enzyme_activity,,,,,,,,,,INHIBITION OF PDK1 BY PROTEIN KINASE ASSAY,,INVEST NEW DRUGS,,
4921685,CHEMBL1475211,WLDWKJYWQIPSLH-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,17782.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5278615,CHEMBL3616594,XYBSGFLFCZXVQH-RZZGVLQVSA-N,,,P04746,PANCREATIC ALPHA-AMYLASE,AMY2A,,,26395057.0,KI,=,14.3,NM,,,,,,,,,,,,,,Inhibition of human pancreatic alpha-amylase expressed in Pichia pastoris using amylase as substrate preincubated with substrate for 10 mins followed by protein addition measured every 5 mins by Dixon plot analysis,From carbohydrates to drug-like fragments: Rational development of novel a-amylase inhibitors.,Bioorg. Med. Chem.,PUBLICATION,
2908498,CHEMBL1353325,NFTKXFZEGFQWST-UHFFFAOYSA-N,,,P63092,"GUANINE NUCLEOTIDE-BINDING PROTEIN G(S), SUBUNIT ALPHA",GNAS,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,"PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
1204497,CHEMBL240829,GAPDGBDSBXIFHK-UHFFFAOYSA-N,,,Q9WUD9,TYROSINE-PROTEIN KINASE SRC,,,,17188862.0,IC50,=,430.0,NM,,,,,,,,,,,,,,Inhibition of Src in rat fibroblasts,Inhibition of Src kinase activity by 7-ethynyl-4-phenylamino-3-quinolinecarbonitriles: identification of SKS-927.,Bioorg. Med. Chem. Lett.,PUBLICATION,
2872056,CHEMBL1335615,NBQJKNSAKITVLO-UHFFFAOYSA-N,,,Q63470,DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A,,,,,AC50,=,3594.0,NM,,biochemical,,,,,,,,,,,,PUBCHEM_BIOASSAY: MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504442],PUBCHEM BIOASSAY DATA SET,,DATASET,
1304710,CHEMBL1613110,GLJKDDKHOVGHNK-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,25118.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
572551,CHEMBL3144182,CJJFDBWBZJGYIY-XLPZGREQSA-N,,,P49652,P2Y PURINOCEPTOR 1,,,,10229631.0,INHIBITION,,,,,,,,,,,,,,,,,"Antagonist activity for inhibition of PLC elicited by 10 nM 2-MeSADP at P2Y purinoceptor 1 in the turkey erythrocyte membranes; No effect, low potency",Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists.,J. Med. Chem.,PUBLICATION,
5036756,CHEMBL121893,WXYWMSOSIIBMMM-UHFFFAOYSA-N,,,O70344,VOLTAGE-GATED POTASSIUM CHANNEL SUBUNIT KV7.1,,,,11689063.0,IC50,=,4000.0,NM,,,,,,,,,,,,,,Molar concentration required to inhibit 50% of the activating delayed-rectifier K+ current in isolated guinea pig ventricular myocytes,"Design and synthesis of 4-substituted benzamides as potent, selective, and orally bioavailable I(Ks) blockers.",J. Med. Chem.,PUBLICATION,
3726221,CHEMBL411171,QRLGFIZARXASGQ-RLODRQSLSA-N,,,Q29010,ENDOTHELIN RECEPTOR ET-A,,,,8258832.0,KD,=,5011.87,NM,,,,,,,,,,,,,,ETA receptor antagonist activity was measured by inhibition of ET-1 induced vasoconstriction in isolated porcine coronary artery,Endothelin-1 analogues substituted at both position 18 and 19: highly potent endothelin antagonists with no selectivity for either receptor subtype ETA or ETB.,J. Med. Chem.,PUBLICATION,
5716278,CHEMBL1505038,ZTORBZVXSXEQKW-UHFFFAOYSA-N,,,O15296,"ARACHIDONATE 15-LIPOXYGENASE, TYPE II",ALOX15B,,,,POTENCY,,15848.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2125748,CHEMBL379811,JXNPVMRAKCYGTB-UHFFFAOYSA-N,,,P49841,GLYCOGEN SYNTHASE KINASE-3 BETA,GSK3B,,,16616489.0,IC50,>,100000.0,NM,,,,,,,,,,,,,,Inhibition of GSK3-beta,Suzuki-type Pd(0) coupling reactions in the synthesis of 2-arylpurines as Cdk inhibitors.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1134528,CHEMBL210833,FSPQCTGGIANIJZ-UHFFFAOYSA-N,,,Q05513,PROTEIN KINASE C ZETA,PRKCZ,wild_type,,23398362.0,ACTIVITY,=,109.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,10.0,uM,"Millipore: Percentage of residual kinase activity of PRKCZ at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
1443801,CHEMBL322470,HBEXMCMIWXPPAH-UHFFFAOYSA-N,,,"P35563, Q9JJ16",SEROTONIN 3 (5-HT3) RECEPTOR,,,,1732548.0,INHIBITION,=,78.2,%,,organism_based,,,,,,,,,,,,5-hydroxytryptamine 3 receptor antagonistic activity as inhibition of 5-HT-induced bradycardia after iv administration of 100 ug/kg dose in urethane-anesthetized rats,"Zatosetron, a potent, selective, and long-acting 5HT3 receptor antagonist: synthesis and structure-activity relationships.",J. Med. Chem.,PUBLICATION,
491458,CHEMBL1482087,CAKDQFSVKOJVCV-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,56234.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
4634980,CHEMBL1412748,VFZYASUJPYBXST-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
5398014,CHEMBL1453856,YKWUSRJDCUMXOT-UHFFFAOYSA-N,,,P16473,THYROID STIMULATING HORMONE RECEPTOR,TSHR,,,,POTENCY,=,5011.9,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2057035,CHEMBL444537,JQIKQYOPMLBMRB-UHFFFAOYSA-N,,,P27487,DIPEPTIDYL PEPTIDASE IV,DPP4,,,14584950.0,IC50,=,52000.0,NM,,,,,,,,,,,,,,Inhibitory activity against Dipeptidylpeptidase IV (DPP IV),"Design, synthesis, and SAR of potent and selective dipeptide-derived inhibitors for dipeptidyl peptidases.",J. Med. Chem.,PUBLICATION,
3874956,CHEMBL91704,RHJLQMVZXQKJKB-FPHSVDBKSA-N,K-777,,P25779,CRUZIPAIN,,,,17977725.0,IC50,=,5.0,NM,,,,,,,,,,,,,,Inhibition of cruzain,"Dipeptidyl-alpha,beta-epoxyesters as potent irreversible inhibitors of the cysteine proteases cruzain and rhodesain.",Bioorg. Med. Chem. Lett.,PUBLICATION,
4913525,CHEMBL1979057,WKEYMNLZBZKLOG-UHFFFAOYSA-N,,,P16591,TYROSINE-PROTEIN KINASE FER,FER,,,,KI,>,1584.89,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FER,PUBCHEM BIOASSAY DATA SET,,DATASET,
2177747,CHEMBL1566885,KDIQWDOHXRBUBC-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,37933.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5561059,CHEMBL261131,ZCNBZFRECRPCKU-UHFFFAOYSA-N,DIACYLGLYCEROL KINASE INHIBITOR II,,Q9H422,HOMEODOMAIN-INTERACTING PROTEIN KINASE 3,HIPK3,wild_type,,23398362.0,ACTIVITY,=,88.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15.0,uM,"Millipore: Percentage of residual kinase activity of HIPK3 at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
57283,CHEMBL1179,AELCINSCMGFISI-DTWKUNHWSA-N,PARNATE,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,=,39810.72,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
1042900,CHEMBL1425874,FIKUABFGRMXMCJ-PKHIMPSTSA-N,,,P11712,CYTOCHROME P450 2C9,CYP2C9,,,,AC50,=,2238.72,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2c9 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
4853900,CHEMBL1481664,WEAYMMLYVVWHLH-UHFFFAOYSA-N,,,P02545,PRELAMIN-A/C,LMNA,,,,POTENCY,=,11220.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
3880462,CHEMBL1451492,RHXZTRGESMJZMO-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,5804.8,NM,,,,,,,,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1307261,CHEMBL378853,GLRTXVAYAGJSJF-JTQLQIEISA-N,,,Q16539,MAP KINASE P38 ALPHA,MAPK14,,,16632356.0,IC50,>,5000.0,NM,,cell_based,,,,,,,,,,,,Inhibition of LPS-stimulated TNFalpha production in human THP1 cells,"Development of N-2,4-pyrimidine-N-phenyl-N'-phenyl ureas as inhibitors of tumor necrosis factor alpha (TNF-alpha) synthesis. Part 1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2124052,CHEMBL1603609,JXKHEYBHLMNXDV-HAVVHWLPSA-N,,,Q96QE3,ATPASE FAMILY AAA DOMAIN-CONTAINING PROTEIN 5,ATAD5,,,,POTENCY,,11582.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125]",PUBCHEM BIOASSAY DATA SET,,DATASET,
179630,CHEMBL212884,ASBPTJRKOKLUNT-XQKJNEPASA-N,,,P41143,DELTA OPIOID RECEPTOR,OPRD1,,,16942033.0,IC50,=,0.72,NM,,cell_based,,,,,CHO,,,,,,,Inverse agonist activity at human cloned delta opioid receptor expressed in CHO cells assessed as inhibition of DPDPE-stimulated [35S]GTP-gamma-S binding in presence of 1 uM GDP,Highly potent and selective phenylmorphan-based inverse agonists of the opioid delta receptor.,J. Med. Chem.,PUBLICATION,
2377979,CHEMBL1585445,KZBRCQVQYZVOAM-UHFFFAOYSA-N,,,Q9F4F7,4'-PHOSPHOPANTETHEINYL TRANSFERASE FFP,,,,,POTENCY,=,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2692634,CHEMBL1501629,MHVIYOQNFDBKFZ-UHFFFAOYSA-N,,,O75164,LYSINE-SPECIFIC DEMETHYLASE 4A,KDM4A,,,,POTENCY,,7079.5,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402],PUBCHEM BIOASSAY DATA SET,,DATASET,
3029513,CHEMBL1359034,NSVBCQKQQMHCQC-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,21331.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2393932,CHEMBL1256295,LAZPBGZRMVRFKY-PPHPATTJSA-N,(-)-TETRAMISOLE HCL,,P05186,"ALKALINE PHOSPHATASE, TISSUE-NONSPECIFIC ISOZYME",ALPL,,,566327.0,INHIBITION,=,56.0,%,,,,,,,,,,,,,,Inhibition of human serum containing 86% liver alkaline phosphatase using p-nitrophenyl phosphate as substrate at 8.7 x 10'-5 M up to 35 mins by spectrophotometry,Selenium-sulfur analogues. 1. Synthesis and biochemical evaluation of selenotetramisole.,J. Med. Chem.,PUBLICATION,
5637735,CHEMBL104264,ZKZXNDJNWUTGDK-NSCUHMNNSA-N,H89,,Q96RG2,PAS DOMAIN-CONTAINING SERINE/THREONINE-PROTEIN KINASE,PASK,wild_type,,23398362.0,ACTIVITY,=,81.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,15.0,uM,"Millipore: Percentage of residual kinase activity of PASK at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
694441,CHEMBL2304102,CWWARWOPSKGELM-XPKMYCGBSA-N,,,P25103,NEUROKININ 1 RECEPTOR,TACR1,,,2433442.0,CHANGE IN AMPLITUDE RESPONSE,=,27.0,%,,,,,,,,,,,,,,Antagonistic activity against Substance P receptor in rat spinal cord at concentration of 50 uM.,Analogues of substance P. Peptides containing D-amino acid residues in various positions of substance P and displaying agonist or receptor selective antagonist effects.,J. Med. Chem.,PUBLICATION,
2310666,CHEMBL1452389,KRNAPVRIULRUAL-UHFFFAOYSA-N,,,Q9UNQ0,ATP-BINDING CASSETTE SUB-FAMILY G MEMBER 2,ABCG2,,,18089721.0,IC50,=,2600.0,NM,,,,,,,,,,,,,,,,,,
2510133,CHEMBL601351,LNUAAHAFERZTED-UHFFFAOYSA-N,GNF-PF-2260,,B2RXH2,LYSINE-SPECIFIC DEMETHYLASE 4D-LIKE,KDM4E,,,,POTENCY,=,35481.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Human Jumonji Domain Containing 2E (JMJD2E). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
334404,CHEMBL1317752,BIVSYVODYFFTCU-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization. This assay monitors tau fibrillation by fluorescence polarization (FP) of Alexa 594-labeled K18 P301L, which does not fibrillize readily but incorporates into growing filaments of unlabeled tau. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
5106412,CHEMBL232387,XFORQXBHYSVKGZ-UHFFFAOYSA-N,,,P32245,MELANOCORTIN RECEPTOR 4,MC4R,,,17574418.0,KI,=,7.5,NM,,cell_based,,,,,CHO-K1,,,,,,,Displacement of [125I]NDP-alphaMSH from human melanocortin 4 receptor expressed in CHOK1 cells,Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4557987,CHEMBL1613623,UXXCUDYYOMDFPX-IMELTUGJSA-N,,,P05177,CYTOCHROME P450 1A2,CYP1A2,,,,AC50,=,12589.25,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp1a2 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3952873,CHEMBL524057,RPRZAINAFJBVOV-UHFFFAOYSA-N,GW683768X,,P10721,STEM CELL GROWTH FACTOR RECEPTOR,KIT,,,,INHIBITION,=,0.78,%,,,,,,,,,,,,,,GSK_PKIS: KIT (V560G mutant) mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
4776588,CHEMBL3126382,VVUGQHSQCFTHGT-CZCBIWLKSA-N,,,P08588,BETA-1 ADRENERGIC RECEPTOR,ADRB1,,,24359185.0,EC50,=,501.19,NM,,cell_based,,,,,,,,,,,,Agonist activity at human beta1 adrenoceptor transfected in CHO cells assessed as cyclic AMP accumulation after 45 mins by fluorescence polarization assay,"Discovery of a rapidly metabolized, long-acting ß(2) adrenergic receptor agonist with a short onset time incorporating a sulfone group suitable for once-daily dosing.",J. Med. Chem.,PUBLICATION,
3945363,CHEMBL1553209,ROWGDOHNVBSFGV-UHFFFAOYSA-N,,,P10828,THYROID HORMONE RECEPTOR BETA-1,THRB,,,,POTENCY,=,0.2,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4985526,CHEMBL3671362,WSLIKYNIUQHBIX-QHCPKHFHSA-N,,,P21453,SPHINGOSINE 1-PHOSPHATE RECEPTOR EDG-1,S1PR1,,,,IC50,=,0.12,NM,,,,,,,,,,,,,,"BindingDB_Patents: Binding Assay. Membranes were prepared from CHO cells expressing human S1P1. Cells pellets (1x 108 cells/pellet) were suspended in buffer containing 20 mM HEPES, pH 7.5, 50 mM NaCl, 2 mM EDTA and Protease Inhibitor cocktail (Roche), and disrupted on ice using the Polytron homogenizer. The homogenate was centrifuged at 20,000 rpm (48,000 g) and the supernatant was discarded. The membrane pellets were resuspended in buffer containing 50 mM HEPES, pH 7.5, 100 mM NaCl, 1 mM MgCl2, 2 mM EDTA and stored in aliquots at -800C after protein concentration determination. Membranes (2 ug/well) and 0.03 nM final concentration of 33P-S1P ligand (1 mCi/ml, American Radiolabeled Chemicals) diluted in assay buffer (50 mM HEPES, pH7.4, 5 mM MgCl2, 1 mM CaCl2, 0.5% fatty acid free BSA, 1 mM NaF) were added to the compound plates (384 Falcon v-bottom plate (0.5 ul/well in a 11 point, 3-fold dilution). Binding was performed for 45 minutes at room temperature.","Substituted 3-phenyl-1,2,4-Oxadiazole compounds",,PATENT,
561442,CHEMBL1601046,CICNJQWJQRQCRV-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,70794.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2112348,,JWEYNDRAHPIRPI-YBEHBXKENA-N,SURECN5185683,,P23280,CARBONIC ANHYDRASE VI,CA6,,,22050606.0,KI,=,145000.0,NM,,,,,,,,,,,,,,,,,,
1708261,CHEMBL1288695,IDFHCDIRYRPEOQ-NSHDSACASA-N,,,P23219,CYCLOOXYGENASE-1,PTGS1,,,20728356.0,IC50,=,4990.0,NM,,,,,,,,,,,,,,Inhibition of human COX-1,The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: the three microdose candidates.,Bioorg. Med. Chem. Lett.,PUBLICATION,
1622240,CHEMBL1425227,HUCVGGUGYKTHBA-UHFFFAOYSA-N,,,Q99714,ENDOPLASMIC RETICULUM-ASSOCIATED AMYLOID BETA-PEPTIDE-BINDING PROTEIN,HSD17B10,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4. (Class of assay: confirmatory) ",PUBCHEM BIOASSAY DATA SET,,DATASET,
2826112,CHEMBL1533893,MWNZCQZNNMSJTI-UHFFFAOYSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3229426,CHEMBL3326325,OOYIVHVYYYOCHB-UHFFFAOYSA-N,,,Q02750,DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1,MAP2K1,,,25078316.0,INHIBITION,,,,,,,,,,,,,,,,,Inhibition of MEK1 (unknown origin) at 1 uM,Towards the development of chromone-based MEK1/2 modulators.,Eur. J. Med. Chem.,PUBLICATION,
4672931,CHEMBL12089,VKJGBAJNNALVAV-UHFFFAOYSA-M,BERBERINE CHLORIDE,,P29466,CASPASE-1,CASP1,,,,KI,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protease, Caspase 1 enzyme inhibition (substrate: Ac-YVAD-AMC)",DrugMatrix in vitro pharmacology data,,DATASET,
4556142,CHEMBL1347854,UXRAFCINHRVTJE-UHFFFAOYSA-N,,,Q9UNA4,DNA POLYMERASE IOTA,POLI,,,,POTENCY,,112201.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623],PUBCHEM BIOASSAY DATA SET,,DATASET,
2388702,CHEMBL3210051,LAJNBPJSTYDHQO-RPPGKUMJSA-N,,,C4YTQ8,ATP-DEPENDENT MOLECULAR CHAPERONE HSP82,,,,,EC50,=,6485.0,NM,,cell_based,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Fluorescence Cell-Based Secondary Assay to Identify Inhibitors of Resistant C. albicans Growth in the Presence of Fluconazole. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID1979, AID2007]",PUBCHEM BIOASSAY DATA SET,,DATASET,
799741,CHEMBL1335844,DIHWMXSCKBJTOT-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,17782.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5712079,CHEMBL1613605,ZSZUKAFVJIPBNX-UHFFFAOYSA-N,,,P10253,LYSOSOMAL ALPHA-GLUCOSIDASE,GAA,,,,POTENCY,=,7079.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2428779,CHEMBL182122,LEZWLARUMMJWQA-IINYFYTJSA-N,,,"P0AES4, P0AES6",DNA GYRASE,,,,15357962.0,ACTIVITY,=,5000.0,NM,,,,,,,,,,,,,,Concentration required to inhibit in vitro DNA gyrase activity isolated from Escherichia coli,"Synthesis and structural-activity relationships of 3-hydroxyquinazoline-2,4-dione antibacterial agents.",Bioorg. Med. Chem. Lett.,PUBLICATION,
871663,CHEMBL1426047,DPVFHMWNLCQOKP-UHFFFAOYSA-N,,,O89049,"THIOREDOXIN REDUCTASE 1, CYTOPLASMIC",,,,,POTENCY,,79432.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771],PUBCHEM BIOASSAY DATA SET,,DATASET,
121624,CHEMBL1940973,ALQJHGNZBSIMRJ-FIXSFTCYSA-N,KMI-1723,,P56817,BETA-SECRETASE 1,BACE1,,,22178553.0,INHIBITION,=,92.0,%,,,,,,,,,,,,,,Inhibition of human recombinant BACE1 at 2 uM by FRET assay,Tripeptidic BACE1 inhibitors devised by in-silico conformational structure-based design.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3571469,CHEMBL1742300,QANQHYNPWQXIGR-XEONRPGESA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
5378312,CHEMBL3683258,YISMQBFJYDFMAL-AESIHLKFSA-N,,,Q9NYY3,SERINE/THREONINE-PROTEIN KINASE PLK2,PLK2,,,,IC50,=,8.0,NM,,,,,,,,,,,,,,"BindingDB_Patents: Kinase Inhibition Assay. The compound of Example 39, 2-(1H-indol-5-ylamino)-6-(2,4-difluorophenylsulfonyl)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one, was subjected to a kinase inhibition assay for the kinases. Compounds were tested in 5 dose IC50 mode with 10-fold serial dilution starting at 10 µM. Staurosporine, a known protein kinase inhibitor, was tested in 5-dose IC50 mode with 3-fold serial dilution starting at 20 µM. Reactions were carried out in 10 µM ATP. The results are shown in Table 5. The results show that the compound of Example 39 is a kinase inhibitor highly selective for the kinase Plk2.","Substituted pyrido[2,3-d]pyrimidin-7(8H)-ones and therapeutic uses thereof",,PATENT,
4739925,CHEMBL1466752,VRQYVIRCOYTWOQ-UHFFFAOYSA-N,,,Q77YF9,ABERRANT VPR PROTEIN,,,,,POTENCY,,44668.4,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS Assay for Inhibitors of the HIV-1 protein Vpr. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4851804,CHEMBL1551408,WDWFNPVEERMAJN-UHFFFAOYSA-N,,,P84022,MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 3,SMAD3,,,,POTENCY,,1584.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860]",PUBCHEM BIOASSAY DATA SET,,DATASET,
2477677,CHEMBL1684327,LKOXULGCOKSXQQ-UHFFFAOYSA-N,BENZYL 1-(BIS(3-CHLOROPHENOXY)PHOSPHORYL)PROPYLCARBAMATE,,P00772,ELASTASE 1,,,,21315589.0,RATIO,<,50.0,/M/S,,,,,,,,,,,,,,Ratio of dissociation of enzyme-inhibitor-substrate complex to Ki for porcine pancreatic elastase,Simple phosphonic inhibitors of human neutrophil elastase.,Bioorg. Med. Chem. Lett.,PUBLICATION,
4544904,CHEMBL1720670,UWLPIPYMWKNQGO-UHFFFAOYSA-N,,,P83916,CHROMOBOX PROTEIN HOMOLOG 1,CBX1,,,,POTENCY,,100000.0,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962],PUBCHEM BIOASSAY DATA SET,,DATASET,
5111559,CHEMBL939,XGALLCVXEZPNRQ-UHFFFAOYSA-N,GEFITINIB,,P49841,GLYCOGEN SYNTHASE KINASE-3 BETA,GSK3B,wild_type,,22037377.0,ACTIVITY,=,100.3013948,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,PHOSPHOGLYCOGEN ,=,10.0,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
2900443,CHEMBL1462638,NEWNEUQAQBVDEJ-UHFFFAOYSA-N,,,"Q03164, O00255",MENIN/HISTONE-LYSINE N-METHYLTRANSFERASE MLL,"KMT2A, MEN1",,,,POTENCY,=,14125.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
118603,CHEMBL1506711,ALFWSWFNOGURCO-UHFFFAOYSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,1510.1,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1083927,CHEMBL1909379,FNFDRKGPSWNLTB-UHFFFAOYSA-N,GR-269666A,,Q00535,CYCLIN-DEPENDENT KINASE 5,CDK5,,,,INHIBITION,=,3.52,%,,,,,,,,,,,,,,GSK_PKIS: CDK5/p35 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
2045275,CHEMBL462547,JOYRKODLDBILNP-UHFFFAOYSA-N,URETHANE,,P08913,ALPHA-2A ADRENERGIC RECEPTOR,ADRA2A,,,,KI,,,,,,,,,,Sf9,,,,,,,DRUGMATRIX: Alpha-2A adrenergic receptor radioligand binding (ligand: MK-912),DrugMatrix in vitro pharmacology data,,DATASET,
3506673,CHEMBL1555411,PTEHSVQGRNRJPF-UHFFFAOYSA-N,,,P43220,GLUCAGON-LIKE PEPTIDE 1 RECEPTOR,GLP1R,,,,POTENCY,,8912.5,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2280102,CHEMBL207410,KOOYTOMPIPMGEP-UHFFFAOYSA-N,GW772405X,,O96017,SERINE/THREONINE-PROTEIN KINASE CHK2,CHEK2,,,,INHIBITION,=,0.62,%,,,,,,,,,,,,,,GSK_PKIS: CHEK2 mean inhibition at 0.1 uM [Nanosyn],Compounds: GSK PKIS; Assays: Nanosyn kinase panel,,DATASET,
5822469,CHEMBL3732322,,,,P34998,CORTICOTROPIN RELEASING FACTOR RECEPTOR 1,CRHR1,,,,IC50,=,47.0,NM,,,,,,,,,,,,,,Antagonist activity against rat/human CRFR1 expressed in CHO cells assessed as inhibition of rat/human CRF-induced cAMP accumulation pre-incubated for 15 mins before CRF stimulation for 30 mins by FRET based HTRF assay,Cyclohexyl amide derivatives as CRF receptor antagonists,,PATENT,
135915,CHEMBL1983220,ANMBFHAKWNJVSM-DVZYZQHMSA-N,,,P08659,LUCIFERIN 4-MONOOXYGENASE,,,,,POTENCY,,11995.5,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS profiling assay for firefly luciferase inhibitor/activator using purified enzyme and Km concentrations of substrates (counterscreen for miR-21 project). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2288, AID2289, AID2598, AID411]",PUBCHEM BIOASSAY DATA SET,,DATASET,
3182408,CHEMBL1609867,OJSZQDXSXYUHML-VAWYXSNFSA-N,,,P15428,15-HYDROXYPROSTAGLANDIN DEHYDROGENASE [NAD+],HPGD,,,,POTENCY,=,28183.8,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase). (Class of assay: confirmatory) [Related pubchem assays: 2429 (Confirmation qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2407 (Probe Development Summary for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase)), 2427 (Thermal Shift Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4074127,CHEMBL2374050,SDHTXBWLVGWJFT-LGCBLANNSA-N,,,P04637,CELLULAR TUMOR ANTIGEN P53,TP53,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
1950179,,JEDSJNJJPRACAZ-NVVXHNQNSA-N,BIM 23023,,P30936,SOMATOSTATIN RECEPTOR 3,,,,9600011.0,KI,=,92.0,NM,,,,,,,,,,,,,,,,,,
1450851,CHEMBL92461,HBWLNACPIFKNIP-UHFFFAOYSA-N,,,P12931,TYROSINE-PROTEIN KINASE SRC,SRC,wild_type,,23398362.0,ACTIVITY,=,102.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,200.0,uM,"Millipore: Percentage of residual kinase activity of SRC at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3116028,CHEMBL277277,OCUSUKPNXDAERP-NCQKMRCOSA-N,,,P23724,PROTEASOME COMPONENT C5,,,,16630721.0,KI,=,260000.0,NM,,,,,,,,,,,,,,Inhibition of post acid activity of yeast 20S proteasome at 625 uM,Development of lipopeptides for inhibiting 20S proteasomes.,Bioorg. Med. Chem. Lett.,PUBLICATION,
191380,CHEMBL1536007,ATFNUSPXCODRJQ-VXNXHJTFSA-N,,,P11473,VITAMIN D RECEPTOR,VDR,,,,POTENCY,,89125.1,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855],PUBCHEM BIOASSAY DATA SET,,DATASET,
3260070,CHEMBL1089031,OSHHPTLFAFGHPH-UHFFFAOYSA-N,,,P14618,PYRUVATE KINASE ISOZYMES M1/M2,PKM,,,20017496.0,AC50,>,10000.0,NM,,,,,,,,,,,,,,Activation of PKM2 assessed as ATP product formation by luminescent pyruvate kinase-luciferase coupled assay,"Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase.",J. Med. Chem.,PUBLICATION,
5234179,CHEMBL3628485,XTBVFMBDSSTZDQ-YCVJPRETSA-N,,,P00734,THROMBIN,F2,,,26367391.0,IC50,,,,,,,,,,,,,,,,,Inhibition of human thrombin preincubated with protein for 15 mins followed by boc-Val-Pro-Arg-AMC substrate addition measured after 10 mins by continuous fluorometric analysis,Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors.,J. Med. Chem.,PUBLICATION,
2394677,CHEMBL2407785,LBBOLBNLXHDGBI-UHFFFAOYSA-N,,,"Q15750, O43318",TAK1/TAB1,"MAP3K7, TAB1",,,23850198.0,IC50,=,750.0,NM,,,,,,,,,,,,,,Inhibition of truncated TAK1-TAB1(unknown origin) using MKK7 as substrate by ALPHAScreen assay in presence of ATP,"Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1.",Bioorg. Med. Chem. Lett.,PUBLICATION,
2318081,CHEMBL3189794,KSIQIJQOBJLICW-WUXMJOGZSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,19952.6,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
4230027,CHEMBL1555752,SUNBETZXGKUILP-UHFFFAOYSA-N,,,Q962Y6,THIOREDOXIN GLUTATHIONE REDUCTASE,,,,,POTENCY,=,3162.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins. (Class of assay: confirmatory) [Related pubchem assays: 1011 (Confirmation Concentration-Response Assay for Inhibitors of the Schistosoma mansoni Redox Cascade ), 448 (Schistosoma Mansoni Peroxiredoxins (Prx2) and thioredoxin glutathione reductase (TGR) coupled assay)]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1532879,CHEMBL1312443,HKJBHSCPZIIZOD-UHFFFAOYSA-N,,,O75496,GEMININ,GMNN,,,,POTENCY,,29092.9,NM,,cell_based,,,,,SW480,,,,,,,PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5861766,CHEMBL3742042,,,,O60885,BROMODOMAIN-CONTAINING PROTEIN 4,BRD4,,,,IC50,<=,1000.0,NM,,,,,,,,,,,,,,Inhibition of human BRD4 by alpha screen assay,Design and synthesis of potent and selective inhibitors of BRD7 and BRD9 bromodomains,MedChemComm,PUBLICATION,
5432526,CHEMBL387187,YOHYSYJDKVYCJI-UHFFFAOYSA-N,,,O75116,RHO-ASSOCIATED PROTEIN KINASE 2,ROCK2,wild_type,,22037377.0,ACTIVITY,=,92.83798807,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,500,NM,LONG S6 ,=,10,UM,,COMPREHENSIVE ASSAY OF KINASE CATALYTIC ACTIVITY REVEALS FEATURES OF KINASE INHIBITOR SELECTIVITY,NATURE BIOTECHNOLOGY,,HOTSPOT ASSAY PLATFORM
4066404,CHEMBL3198259,SCJBAQCKEQRFJA-UHFFFAOYSA-N,,,P10636,MICROTUBULE-ASSOCIATED PROTEIN TAU,MAPT,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1229349,CHEMBL1375032,GDHDJAHRNLVMQQ-UHFFFAOYSA-N,,,Q03431,PARATHYROID HORMONE RECEPTOR,PTH1R,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen.   (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
5411868,CHEMBL1464544,YMJFGYOKXBCJOT-LCYFTJDESA-N,,,P39748,FLAP ENDONUCLEASE 1,FEN1,,,,POTENCY,,31622.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813],PUBCHEM BIOASSAY DATA SET,,DATASET,
1904123,CHEMBL932,IZEKFCXSFNUWAM-UHFFFAOYSA-N,DIPYRIDAMOLE,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,1778.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
242522,CHEMBL1306228,AYVSFMUZQJRZLP-UHFFFAOYSA-N,,,P00811,BETA-LACTAMASE AMPC,,,,,POTENCY,=,1584.9,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))]",PUBCHEM BIOASSAY DATA SET,,DATASET,
1858291,CHEMBL2086650,IUCMLAGMPMOAKS-UHFFFAOYSA-N,,,Q7TQP3,GLUCOSE-DEPENDENT INSULINOTROPIC RECEPTOR,,,,22545772.0,EC50,=,41.0,NM,,,,,,,,,,,,,,Agonist activity at mouse GPR119 receptor assessed as increase in cAMP level after 45 mins by HTRF assay,Use of small-molecule crystal structures to address solubility in a novel series of g protein coupled receptor 119 agonists: optimization of a lead and in vivo evaluation.,J. Med. Chem.,PUBLICATION,
895726,CHEMBL1537574,DSLDRNSDVGXMPU-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4526852,CHEMBL357995,UUOJIACWOAYWEZ-UHFFFAOYSA-N,BOPINDOLOL,,P28482,MAP KINASE ERK2,MAPK1,,,,KI,,,,,,,,,,,,,,,,,"DRUGMATRIX: Protein Serine/Threonine Kinase, ERK2 enzyme inhibition (substrate: Myelin Basic Protein)",DrugMatrix in vitro pharmacology data,,DATASET,
2447206,CHEMBL1500404,LHCHMNFZVIHXMW-UHFFFAOYSA-N,,,P27467,PROTEIN WNT-3A,,,,,IC50,,1140.0,NM,,,,,,,,,,,,,,PubChem BioAssay. Dose response validation of uHTS Gli-SUFU antagonist hits in a Wnt3a luminescent reporter assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4479462,CHEMBL1315920,UPPQZEIIOKYCSS-UHFFFAOYSA-N,,,P08684,CYTOCHROME P450 3A4,CYP3A4,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp3a4 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
317793,CHEMBL322850,BHBPTTBKKZBFIQ-UHFFFAOYSA-N,,,"P53609, P49354",GERANYLGERANYL TRANSFERASE TYPE I,"FNTA, PGGT1B",,,11714612.0,IC50,=,10000.0,NM,,,,,,,,,,,,,,Inhibition of Geranylgeranyl transferase type I,"A novel class of highly potent, selective, and non-peptidic inhibitor of Ras farnesyltransferase (FTase).",Bioorg. Med. Chem. Lett.,PUBLICATION,
3086577,CHEMBL1583206,NZHNRADMHYXMJA-UHFFFAOYSA-N,,,Q96KQ7,"HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-9 SPECIFIC 3",EHMT2,,,,POTENCY,,50118.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404],PUBCHEM BIOASSAY DATA SET,,DATASET,
2459876,CHEMBL1469777,LIPJEJWNTPJQLD-UHFFFAOYSA-N,,,Q57TT1,PUTATIVE UNCHARACTERIZED PROTEIN,,,,,POTENCY,,7943.3,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS of Trypanosoma Brucei Inhibitors. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
685877,CHEMBL576982,CVWXJKQAOSCOAB-UHFFFAOYSA-N,QUIZARTINIB,,Q6PHR2,SERINE/THREONINE-PROTEIN KINASE ULK3,ULK3,,,19654408.0,KD,>,10000.0,NM,,,,,,,,,,,,,,Binding affinity to ULK3,AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML).,Blood,PUBLICATION,
1497299,CHEMBL1587941,HGRHXNRVXGLWLA-UHFFFAOYSA-N,,,Q99700,ATAXIN-2,ATXN2,,,,POTENCY,,25118.9,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2414328,CHEMBL460050,LDGJWESGRMFAAG-OQLLNIDSSA-N,,,P52270,"TRIOSEPHOSPHATE ISOMERASE, GLYCOSOMAL",,,,20889239.0,INHIBITION,=,60.0,%,,,,,,,,,,,,,,Inhibition of Trypanosoma cruzi triosephosphate isomerase at 400 uM after 2 hrs,Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.,Eur. J. Med. Chem.,PUBLICATION,
2494970,CHEMBL327715,LMGQGPVCSYOMNS-UHFFFAOYSA-N,,,P00749,UROKINASE-TYPE PLASMINOGEN ACTIVATOR,PLAU,,,11731301.0,KI,=,450.0,NM,,,,,,,,,,,,,,,,,,
715668,CHEMBL266325,CZDUJGOCEPWCNA-UHFFFAOYSA-N,,,Q13188,SERINE/THREONINE-PROTEIN KINASE MST2,STK3,wild_type,,23398362.0,ACTIVITY,=,71.0,%,inhibition,biochemical,functional,enzyme_activity,,radiometry,,"1, 10",uM,ATP,,155.0,uM,"Millipore: Percentage of residual kinase activity of STK3 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA",A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.,Biochem. J.,PUBLICATION,two concentrations 1uM and 10uM
3653968,CHEMBL1595020,QJXUQTNPYSTTFZ-UHFFFAOYSA-N,,,O75874,ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC,IDH1,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): Confirmation of Cherrypicks. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4967451,CHEMBL1481364,WQJVOYWMLYHYOK-UHFFFAOYSA-N,,,Q14191,WERNER SYNDROME ATP-DEPENDENT HELICASE,WRN,,,,POTENCY,,28183.8,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of WRN Helicase. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4074930,CHEMBL1741863,SDKPPSAEKUFQKQ-UHFFFAOYSA-N,,,P10635,CYTOCHROME P450 2D6,CYP2D6,,,,AC50,,,,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: Cytochrome panel assay with activity outcomes. (Class of assay: other) Panel member name: p450-cyp2d6 Compounds with AC50 equal or less than 10 uM are considered active,PUBCHEM BIOASSAY DATA SET,,DATASET,
3739169,CHEMBL1305022,QSYFDIUVXGGGDZ-UHFFFAOYSA-N,,,P00352,ALDEHYDE DEHYDROGENASE 1A1,ALDH1A1,,,,POTENCY,=,39810.7,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))],PUBCHEM BIOASSAY DATA SET,,DATASET,
3009032,CHEMBL1461972,NQMVNYIMBARVFB-UHFFFAOYSA-N,,,Q16236,NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR 2,NFE2L2,,,,POTENCY,,14581.0,NM,,,,,,,,,,,,,,"PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648]",PUBCHEM BIOASSAY DATA SET,,DATASET,
4390414,CHEMBL1462097,UFZZSTGFLPULTF-UHFFFAOYSA-N,,,P28482,MAP KINASE ERK2,MAPK1,,,,POTENCY,=,12589.3,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
2943069,CHEMBL590331,NJFUCAPBXYJVNU-UHFFFAOYSA-N,,,P28223,SEROTONIN 2A (5-HT2A) RECEPTOR,HTR2A,,,20022752.0,EC50,>,1000.0,NM,,cell_based,,,,,,,,,,,,Agonist activity at human recombinant 5HT2A receptor expressed in HEK293E cells by FLIPR assay,Tricyclic dihydroquinazolinones as novel 5-HT2C selective and orally efficacious anti-obesity agents.,Bioorg. Med. Chem. Lett.,PUBLICATION,
3384462,CHEMBL1376423,PGBIOSQIULJKPX-UHFFFAOYSA-N,,,Q9NUW8,TYROSYL-DNA PHOSPHODIESTERASE 1,TDP1,,,,POTENCY,=,4466.8,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
4484823,CHEMBL22973,UQFCLENKCDVITL-INIZCTEOSA-N,TCMDC-132046,,P00380,DIHYDROFOLATE REDUCTASE,,,,850245.0,IC50,=,1600.0,NM,,,,,,,,,,,,,,Inhibition of Streptococcus faecium dihydrofolate reductase using dihydrofolate as substrate,Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.,J. Med. Chem.,PUBLICATION,
3428406,CHEMBL1361450,PKRQZDYXCIDDIF-UHFFFAOYSA-N,,,Q16637,SURVIVAL MOTOR NEURON PROTEIN,"SMN1, SMN2",,,,POTENCY,=,2818.4,NM,,,,,,,,,,,,,,PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
261513,CHEMBL1559614,BAZNRKJZCFJTKZ-UHFFFAOYSA-N,,,O94925,"GLUTAMINASE KIDNEY ISOFORM, MITOCHONDRIAL",GLS,,,,POTENCY,,11220.2,NM,,,,,,,,,,,,,,PubChem BioAssay. qHTS for Inhibitors of Glutaminase (GLS). (Class of assay: confirmatory) ,PUBCHEM BIOASSAY DATA SET,,DATASET,
